DATE ADDED TO CATALOG	PUBMEDID	FIRST AUTHOR	DATE	JOURNAL	LINK	STUDY	DISEASE/TRAIT	INITIAL SAMPLE SIZE	REPLICATION SAMPLE SIZE	REGION	CHR_ID	CHR_POS	REPORTED GENE(S)	MAPPED_GENE	UPSTREAM_GENE_ID	DOWNSTREAM_GENE_ID	SNP_GENE_IDS	UPSTREAM_GENE_DISTANCE	DOWNSTREAM_GENE_DISTANCE	STRONGEST SNP-RISK ALLELE	SNPS	MERGED	SNP_ID_CURRENT	CONTEXT	INTERGENIC	RISK ALLELE FREQUENCY	P-VALUE	PVALUE_MLOG	P-VALUE (TEXT)	OR or BETA	95% CI (TEXT)	PLATFORM [SNPS PASSING QC]	CNV	MAPPED_TRAIT	MAPPED_TRAIT_URI	STUDY ACCESSION	GENOTYPING TECHNOLOGY
2021-05-18	33269293	Kannambath S	2020-10-16	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33269293	Genome-Wide Association Study Identifies Novel Colony Stimulating Factor 1 Locus Conferring Susceptibility to Cryptococcosis in Human Immunodeficiency Virus-Infected South Africans.	Cryptococcosis in HIV infection	319 South African ancestry cases, 399 South African ancestry controls	NA	1p13.3	1	109907411	CSF1	LINC01768 - CSF1	ENSG00000228420	ENSG00000184371		35975	2831	rs1999714-?	rs1999714	0	1999714	intergenic_variant	1	NR	3E-7	6.522878745280337		0.6656	[NR]	Illumina [2686126] (imputed)	N	cryptococcosis	http://www.ebi.ac.uk/efo/EFO_0007229	GCST011681	Genome-wide genotyping array
2021-05-18	33269293	Kannambath S	2020-10-16	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33269293	Genome-Wide Association Study Identifies Novel Colony Stimulating Factor 1 Locus Conferring Susceptibility to Cryptococcosis in Human Immunodeficiency Virus-Infected South Africans.	Cryptococcosis in HIV infection	319 South African ancestry cases, 399 South African ancestry controls	NA	10q23.31	10	90177983	LINC01375	LINC01374			ENSG00000280560			rs4933565-?	rs4933565	0	4933565	intron_variant	0	NR	1E-6	6.0		1.637	[NR]	Illumina [2686126] (imputed)	N	cryptococcosis	http://www.ebi.ac.uk/efo/EFO_0007229	GCST011681	Genome-wide genotyping array
2021-05-18	33269293	Kannambath S	2020-10-16	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33269293	Genome-Wide Association Study Identifies Novel Colony Stimulating Factor 1 Locus Conferring Susceptibility to Cryptococcosis in Human Immunodeficiency Virus-Infected South Africans.	Cryptococcosis in HIV infection	319 South African ancestry cases, 399 South African ancestry controls	NA	15q23	15	67889916	RNU6-1	RNU6-1 - NA	ENSG00000206625			49871		rs28445794-?	rs28445794	0	28445794	intergenic_variant	1	NR	4E-6	5.3979400086720375		0.9292	[NR]	Illumina [2686126] (imputed)	N	cryptococcosis	http://www.ebi.ac.uk/efo/EFO_0007229	GCST011681	Genome-wide genotyping array
2021-05-18	33269293	Kannambath S	2020-10-16	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33269293	Genome-Wide Association Study Identifies Novel Colony Stimulating Factor 1 Locus Conferring Susceptibility to Cryptococcosis in Human Immunodeficiency Virus-Infected South Africans.	Cryptococcosis in HIV infection	319 South African ancestry cases, 399 South African ancestry controls	NA	5q14.1	5	79342896	JMY, HOMER1	JMY - HOMER1	ENSG00000152409	ENSG00000152413		15685	29740	rs114228467-?	rs114228467	0	114228467	intergenic_variant	1	NR	7E-6	5.154901959985743		3.249	[NR]	Illumina [2686126] (imputed)	N	cryptococcosis	http://www.ebi.ac.uk/efo/EFO_0007229	GCST011681	Genome-wide genotyping array
2021-05-18	33269293	Kannambath S	2020-10-16	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33269293	Genome-Wide Association Study Identifies Novel Colony Stimulating Factor 1 Locus Conferring Susceptibility to Cryptococcosis in Human Immunodeficiency Virus-Infected South Africans.	Cryptococcosis in HIV infection	319 South African ancestry cases, 399 South African ancestry controls	NA	6p12.2	6	52297617	MCM3, IL17F	MCM3 - PAQR8	ENSG00000112118	ENSG00000170915		12736	63804	rs61126502-?	rs61126502	0	61126502	TF_binding_site_variant	1	NR	8E-6	5.096910013008056		1.065	[NR]	Illumina [2686126] (imputed)	N	cryptococcosis	http://www.ebi.ac.uk/efo/EFO_0007229	GCST011681	Genome-wide genotyping array
2021-05-18	33269293	Kannambath S	2020-10-16	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33269293	Genome-Wide Association Study Identifies Novel Colony Stimulating Factor 1 Locus Conferring Susceptibility to Cryptococcosis in Human Immunodeficiency Virus-Infected South Africans.	Cryptococcosis in HIV infection	319 South African ancestry cases, 399 South African ancestry controls	NA	9q21.31	9	79220822	LOC101927450							rs273465-?	rs273465	0	273465	regulatory_region_variant	1	NR	8E-6	5.096910013008056		0.9073	[NR]	Illumina [2686126] (imputed)	N	cryptococcosis	http://www.ebi.ac.uk/efo/EFO_0007229	GCST011681	Genome-wide genotyping array
2021-05-18	33269293	Kannambath S	2020-10-16	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33269293	Genome-Wide Association Study Identifies Novel Colony Stimulating Factor 1 Locus Conferring Susceptibility to Cryptococcosis in Human Immunodeficiency Virus-Infected South Africans.	Cryptococcosis in HIV infection	319 South African ancestry cases, 399 South African ancestry controls	NA	6p22.1	6	29865280	HLA-H	HLA-G - HCP5B	ENSG00000235680	ENSG00000281831		34155	6615	rs3128900-?	rs3128900	0	3128900	intron_variant	1	NR	5E-6	5.301029995663981		0.9658	[NR]	Illumina [2686126] (imputed)	N	cryptococcosis	http://www.ebi.ac.uk/efo/EFO_0007229	GCST011681	Genome-wide genotyping array
2021-05-18	33269293	Kannambath S	2020-10-16	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33269293	Genome-Wide Association Study Identifies Novel Colony Stimulating Factor 1 Locus Conferring Susceptibility to Cryptococcosis in Human Immunodeficiency Virus-Infected South Africans.	Cryptococcosis in HIV infection	319 South African ancestry cases, 399 South African ancestry controls	NA	6p22.1	6	29975911	HLA-H	HCG9, HCG9, HCG9, HCG9, HCG9, HCG9, HCG9			ENSG00000206504, ENSG00000204625, ENSG00000236579, ENSG00000237812, ENSG00000227647, ENSG00000234313, ENSG00000234599			rs2394251-?	rs2394251	0	2394251	intron_variant	0	NR	9E-6	5.045757490560675		0.7439	[NR]	Illumina [2686126] (imputed)	N	cryptococcosis	http://www.ebi.ac.uk/efo/EFO_0007229	GCST011681	Genome-wide genotyping array
2021-09-03	33736632	Zeng Z	2021-03-18	BMC Med Genomics	www.ncbi.nlm.nih.gov/pubmed/33736632	Genome-wide association study identifies new loci associated with risk of HBV infection and disease progression.	Chronic hepatitis B infection vs asymptomatic persistence	93 Chinese ancestry chronic hepatitis B cases, 92 Chinese ancestry asymptomatic persistence infection controls	NA	8q22.3	8	101419355	GRHL2	RN7SL563P - GRHL2	ENSG00000239211	ENSG00000083307		21422	73084	rs1264473-C	rs1264473	0	1264473	intron_variant	1	0.1957	2E-6	5.698970004336019		3.931	NR	Affymetrix [607153]	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST012288	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	8q24.3	8	140480970		TRAPPC9 - CHRAC1	ENSG00000167632	ENSG00000104472		22391	30341	rs62527813-?	rs62527813	0	62527813	intergenic_variant	1	NR	9E-6	5.045757490560675		0.5870102	[0.33-0.84] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	9p22.2	9	17858907		SH3GL2 - ADAMTSL1	ENSG00000107295	ENSG00000178031		61783	47656	rs16936038-?	rs16936038	0	16936038	intergenic_variant	1	NR	3E-6	5.522878745280337		0.7604793	[0.44-1.08] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	9p13.2	9	36687109		MELK - MIR4475	ENSG00000165304	ENSG00000266255		9426	136430	rs10046792-?	rs10046792	0	10046792	intergenic_variant	1	NR	4E-6	5.3979400086720375		1.0135854	[0.59-1.44] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	10p14	10	6711894		LINP1			ENSG00000223784			rs7086011-?	rs7086011	0	7086011	intron_variant	0	NR	9E-7	6.045757490560675		0.2108151	[0.13-0.29] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	10p11.1	10	38296983		PLD5P1			ENSG00000283930			rs377599840-?	rs377599840	0	377599840	intron_variant	0	NR	5E-6	5.301029995663981		0.5015996	[0.29-0.72] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	10q25.3	10	113232499		TCF7L2 - RNU7-165P	ENSG00000148737	ENSG00000238380		64821	120926	rs35947579-?	rs35947579	0	35947579	intergenic_variant	1	NR	3E-6	5.522878745280337		0.2886701	[0.17-0.41] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	11p14.3	11	26139061		LINC02699 - ANO3	ENSG00000254456	ENSG00000134343		357044	49781	rs112930223-?	rs112930223	0	112930223	intergenic_variant	1	NR	5E-6	5.301029995663981		1.5155605	[0.87-2.16] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	12p13.1	12	13534461		GRIN2B			ENSG00000273079			rs61056024-?	rs61056024	0	61056024	intron_variant	0	NR	7E-6	5.154901959985743		0.3824923	[0.22-0.55] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	12p12.1	12	22819235		RPS27P22 - SOX5	ENSG00000241451	ENSG00000134532		96766	710269	rs10842075-?	rs10842075	0	10842075	intron_variant	1	NR	6E-6	5.221848749616356		0.3623695	[0.21-0.52] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	12p11.21	12	30983755		TSPAN11			ENSG00000110900			rs117993590-?	rs117993590	0	117993590	intron_variant	0	NR	2E-6	5.698970004336019		0.4376923	[0.26-0.62] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	12q12	12	45013442		NELL2 - DBX2	ENSG00000184613	ENSG00000185610		91594	1230	rs118121120-?	rs118121120	0	118121120	intergenic_variant	1	NR	2E-6	5.698970004336019		0.5910329	[0.35-0.83] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	12q21.31	12	84778806		RPL6P25 - SLC6A15	ENSG00000213270	ENSG00000072041		1626616	80685	rs117703208-?	rs117703208	0	117703208	intergenic_variant	1	NR	9E-6	5.045757490560675		0.4023429	[0.23-0.58] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	12q23.3	12	106677272		RFX4			ENSG00000111783			rs78815430-?	rs78815430	0	78815430	intron_variant	0	NR	4E-6	5.3979400086720375		0.4961045	[0.29-0.71] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	12q23.3	12	106807711		RIC8B			ENSG00000111785			rs76282986-?	rs76282986	0	76282986	intron_variant	0	NR	5E-6	5.301029995663981		0.4628001	[0.27-0.66] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	12q24.31	12	121771060		TMEM120B			ENSG00000188735			rs28685863-?	rs28685863	0	28685863	intron_variant	0	NR	5E-6	5.301029995663981		0.7340212	[0.42-1.05] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	13q21.1	13	55974809		MIR5007 - HNF4GP1	ENSG00000264387	ENSG00000228611		800261	24391	rs118137757-?	rs118137757	0	118137757	intergenic_variant	1	NR	7E-7	6.154901959985743		0.7096201	[0.43-0.99] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	14q23.2	14	63424680		PPP2R5E			ENSG00000154001			rs28402153-?	rs28402153	0	28402153	intron_variant	0	NR	4E-6	5.3979400086720375		0.3796407	[0.22-0.54] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	15q25.3	15	87916337		NTRK3			ENSG00000140538			rs79804987-?	rs79804987	0	79804987	3_prime_UTR_variant	0	NR	7E-6	5.154901959985743		0.5249158	[0.3-0.75] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	16p13.3	16	6470495		RBFOX1			ENSG00000078328			rs10492829-?	rs10492829	0	10492829	intron_variant	0	NR	9E-6	5.045757490560675		0.4670772	[0.26-0.67] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	16q12.1	16	51225610		SALL1 - UNGP1	ENSG00000103449	ENSG00000260818		74243	52242	rs28604368-?	rs28604368	0	28604368	intron_variant	1	NR	7E-6	5.154901959985743		0.5337214	[0.3-0.76] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	17q11.2	17	31610747		MIR365B - RNU6-1134P	ENSG00000283978	ENSG00000202026		35226	103006	rs147209203-?	rs147209203	0	147209203	intron_variant	1	NR	8E-6	5.096910013008056		0.9268718	[0.52-1.33] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	17q11.2	17	33446845		ASIC2			ENSG00000108684			rs149924615-?	rs149924615	0	149924615	intron_variant	0	NR	7E-7	6.154901959985743		0.8279309	[0.5-1.15] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	17q12	17	37274361		ACACA, ACACA			ENSG00000278540, ENSG00000275176			rs76298822-?	rs76298822	0	76298822	intron_variant	0	NR	4E-6	5.3979400086720375		0.4981422	[0.29-0.71] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	17q21.33	17	50481574		RSAD1			ENSG00000136444			rs35090128-?	rs35090128	0	35090128	intron_variant	0	NR	7E-6	5.154901959985743		0.6268712	[0.35-0.9] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	19p13.3	19	2458655		LMNB2 - LINC01775	ENSG00000176619	ENSG00000267201		1696	280	rs546350165-?	rs546350165	0	546350165	intergenic_variant	1	NR	4E-6	5.3979400086720375		0.879131	[0.51-1.25] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	19p13.2	19	10317045		RAVER1			ENSG00000161847			rs74956615-?	rs74956615	0	74956615	3_prime_UTR_variant	0	NR	9E-6	5.045757490560675		0.3913596	[0.22-0.56] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	20p11.21	20	23337826		RNA5SP478 - NXT1-AS1	ENSG00000201527	ENSG00000234832		176855	9115	rs6076052-?	rs6076052	0	6076052	regulatory_region_variant	1	NR	3E-6	5.522878745280337		0.474173	[0.28-0.67] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	20q13.33	20	61111166		LINC01718 - CDH4	ENSG00000229606	ENSG00000179242		27416	141095	rs77117355-?	rs77117355	0	77117355	intergenic_variant	1	NR	6E-6	5.221848749616356		0.4584662	[0.26-0.65] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	22q12.1	22	26856491		MIATNB - LINC01422	ENSG00000244625	ENSG00000223704		75598	2143	rs9306427-?	rs9306427	0	9306427	intergenic_variant	1	NR	7E-6	5.154901959985743		0.3012349	[0.17-0.43] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	Xp22.31	X	8154585		MIR651 - VCX2	ENSG00000207628	ENSG00000177504		27524	15359	rs186962951-?	rs186962951	0	186962951	intron_variant	1	NR	5E-6	5.301029995663981		0.2886205	[0.17-0.41] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	Xq21.1	X	81083060		RNU6-995P - HMGN5	ENSG00000212546	ENSG00000198157		146520	30639	rs5913398-?	rs5913398	0	5913398	intergenic_variant	1	NR	1E-6	6.0		0.5481946	[0.33-0.77] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	Xq21.1	X	81229030		SH3BGRL			ENSG00000131171			rs147771334-?	rs147771334	0	147771334	intron_variant	0	NR	5E-7	6.301029995663981		0.5201156	[0.32-0.72] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	Xq26.2	X	132044622		STK26			ENSG00000134602			rs774534540-?	rs774534540	0	774534540	intron_variant	0	NR	4E-7	6.3979400086720375		1.0045888	[0.62-1.39] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	3p21.31	3	45820440		SLC6A20 - LZTFL1	ENSG00000163817	ENSG00000163818		23904	2876	rs13078854-?	rs13078854	0	13078854	non_coding_transcript_exon_variant	1	NR	6E-17	16.221848749616356		0.589	[0.521-0.667]	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	1p32.2	1	58323730		DAB1			ENSG00000173406			rs148621091-?	rs148621091	0	148621091	intron_variant	0	NR	5E-6	5.301029995663981		0.6587074	[0.38-0.94] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	1p31.1	1	78702480		IFI44 - ADGRL4	ENSG00000137965	ENSG00000162618		38402	187284	rs79687006-?	rs79687006	0	79687006	intergenic_variant	1	NR	9E-6	5.045757490560675		0.3742652	[0.21-0.54] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	1p22.1	1	92004918		BRDT			ENSG00000137948			rs200648143-?	rs200648143	0	200648143	intron_variant	0	NR	5E-6	5.301029995663981		0.7042074	[0.4-1] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	1p13.3	1	106909908		LINC01661 - PRMT6	ENSG00000237460	ENSG00000198890		44592	146766	rs71092085-?	rs71092085	0	71092085	intergenic_variant	1	NR	2E-6	5.698970004336019		0.2537112	[0.15-0.36] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	1q42.2	1	232888801		RNU1-74P - NTPCR	ENSG00000206835	ENSG00000135778		56614	61804	rs7512435-?	rs7512435	0	7512435	intron_variant	1	NR	3E-6	5.522878745280337		0.1955271	[0.11-0.28] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	2p12	2	82938344		DHFRP3 - LINC01809	ENSG00000168129	ENSG00000232548		80960	584470	rs114327102-?	rs114327102	0	114327102	intergenic_variant	1	NR	5E-6	5.301029995663981		0.9826112	[0.56-1.4] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	2p12	2	83061968		DHFRP3 - LINC01809	ENSG00000168129	ENSG00000232548		204584	460846	rs75129011-?	rs75129011	0	75129011	intergenic_variant	1	NR	7E-6	5.154901959985743		0.9228858	[0.52-1.32] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	2q11.2	2	101031668		TBC1D8			ENSG00000204634			rs114390074-?	rs114390074	0	114390074	intron_variant	0	NR	1E-5	5.0		0.6583493	[0.37-0.95] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	2q14.2	2	118957663		MARCO			ENSG00000019169			rs147200332-?	rs147200332	0	147200332	intron_variant	0	NR	4E-6	5.3979400086720375		0.469868	[0.27-0.67] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	2q22.2	2	141625915		LRP1B			ENSG00000168702			rs140606184-?	rs140606184	0	140606184	intron_variant	0	NR	4E-6	5.3979400086720375		0.7094424	[0.41-1.01] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	2q24.1	2	154355704		GALNT13			ENSG00000144278			rs10490528-?	rs10490528	0	10490528	intron_variant	0	NR	7E-6	5.154901959985743		0.4700129	[0.27-0.67] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	2q34	2	209764356		MAP2 - UNC80	ENSG00000078018	ENSG00000144406		30238	7476	rs149862866-?	rs149862866	0	149862866	intergenic_variant	1	NR	4E-6	5.3979400086720375		1.6379544	[0.95-2.33] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	3p24.3	3	17139233		PLCL2 - TBC1D5	ENSG00000284017	ENSG00000131374		48629	17929	rs4342095-?	rs4342095	0	4342095	regulatory_region_variant	1	NR	1E-6	6.0		0.3098693	[0.19-0.43] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	3p21.31	3	45954233		FYCO1			ENSG00000163820			rs140221038-?	rs140221038	0	140221038	intron_variant	0	NR	1E-12	12.0		0.5374411	[0.39-0.68] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	3p21.31	3	46081695		XCR1			ENSG00000173578			rs111793438-?	rs111793438	1	66818091	intron_variant	0	NR	8E-11	10.096910013008056		0.3899282	[0.27-0.51] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	3p21.31	3	46212321		CCR3			ENSG00000183625			rs13095946-?	rs13095946	0	13095946	intron_variant	0	NR	6E-6	5.221848749616356		0.3042465	[0.17-0.44] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	3q21.3	3	126382123		CCDC37-DT	ENSG00000163884			24715		rs143640167-?	rs143640167	0	143640167	intergenic_variant	0	NR	6E-6	5.221848749616356		0.7532746	[0.43-1.08] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	3q21.3	3	129229126		RPS27P12 - COPG1	ENSG00000241673	ENSG00000181789		10776	20480	rs62266860-?	rs62266860	0	62266860	TF_binding_site_variant	1	NR	4E-6	5.3979400086720375		0.6420375	[0.37-0.91] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	4p16.3	4	4483862		STX18			ENSG00000168818			rs149430155-?	rs149430155	0	149430155	intron_variant	0	NR	6E-6	5.221848749616356		0.6858898	[0.39-0.98] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	4p14	4	39212292		WDR19			ENSG00000157796			rs79515186-?	rs79515186	0	79515186	intron_variant	0	NR	1E-5	5.0		0.7196878	[0.4-1.04] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	4p14	4	39524995		UGDH			ENSG00000109814			rs114804393-?	rs114804393	0	114804393	intron_variant	0	NR	3E-6	5.522878745280337		0.5643312	[0.33-0.8] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	4q35.2	4	186558766		MTNR1A - FAT1	ENSG00000168412	ENSG00000083857		3199	29028	rs13114144-?	rs13114144	0	13114144	intergenic_variant	1	NR	5E-6	5.301029995663981		0.8150307	[0.47-1.16] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	5q21.3	5	106286190		RNA5SP189 - LINC01950	ENSG00000201790	ENSG00000251027		363082	529007	rs142891837-?	rs142891837	0	142891837	intergenic_variant	1	NR	8E-6	5.096910013008056		0.7266252	[0.41-1.04] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	5q23.1	5	116784245		LINC02214 - RPL35AP15	ENSG00000251311	ENSG00000243758		22036	516859	rs765250782-?	rs765250782	0	765250782	intergenic_variant	1	NR	4E-6	5.3979400086720375		0.6023419	[0.35-0.86] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls	NA	3p21.31	3	45820440		SLC6A20 - LZTFL1	ENSG00000163817	ENSG00000163818		23904	2876	rs13078854-?	rs13078854	0	13078854	non_coding_transcript_exon_variant	1	NR	4E-15	14.397940008672037		0.57	[0.5-0.649]	Illumina [23640711] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027252	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	5q32	5	147355781		STK32A			ENSG00000169302			rs10065264-?	rs10065264	0	10065264	intron_variant	0	NR	7E-6	5.154901959985743		0.3088665	[0.18-0.44] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	5q32	5	147540296		DPYSL3 - JAKMIP2-AS1	ENSG00000113657	ENSG00000280780		30228	19698	rs10477338-?	rs10477338	0	10477338	intergenic_variant	1	NR	1E-6	6.0		0.4580914	[0.28-0.64] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	6q22.31	6	124641484		NKAIN2			ENSG00000188580			rs574961294-?	rs574961294	0	574961294	intron_variant	0	NR	4E-6	5.3979400086720375		0.8728554	[0.51-1.24] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	7p22.3	7	1021786		C7orf50			ENSG00000146540			rs4723518-?	rs4723518	0	4723518	intron_variant	0	NR	9E-6	5.045757490560675		0.6261943	[0.35-0.9] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	7p22.3	7	2575580		IQCE			ENSG00000106012			rs149962820-?	rs149962820	0	149962820	intron_variant	0	NR	7E-6	5.154901959985743		0.3737531	[0.21-0.54] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	7p22.2	7	2874067		GNA12 - CARD11	ENSG00000146535	ENSG00000198286		29759	32075	rs883831-?	rs883831	0	883831	intergenic_variant	1	NR	7E-7	6.154901959985743		0.4775274	[0.29-0.67] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	8p23.2	8	3486682		CSMD1			ENSG00000183117			rs11777685-?	rs11777685	0	11777685	intron_variant	0	NR	1E-5	5.0		0.2257843	[0.13-0.33] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	8p12	8	31911387		NRG1			ENSG00000157168			rs28668895-?	rs28668895	0	28668895	intron_variant	0	NR	3E-6	5.522878745280337		0.2573443	[0.15-0.36] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	8p12	8	35704343		UNC5D			ENSG00000156687			rs78930937-?	rs78930937	0	78930937	intron_variant	0	NR	1E-6	6.0		0.3657574	[0.22-0.51] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	8q11.23	8	52281306		ST18			ENSG00000147488			rs117558878-?	rs117558878	0	117558878	intron_variant	0	NR	7E-6	5.154901959985743		0.5279233	[0.3-0.76] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	8q22.2	8	99851686		VPS13B			ENSG00000132549			rs75251638-?	rs75251638	0	75251638	intron_variant	0	NR	7E-6	5.154901959985743		0.5608204	[0.32-0.8] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	8q22.2	8	99953922		COX6C - RGS22	ENSG00000164919	ENSG00000132554		60215	7014	rs187295289-?	rs187295289	0	187295289	intergenic_variant	1	NR	1E-6	6.0		0.5997758	[0.36-0.84] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	15q13.1	15	29572822		FAM189A1 - TUBBP8	ENSG00000273564	ENSG00000259300		1843	39748	rs545838826-?	rs545838826	1	113305335	regulatory_region_variant	1	NR	7E-7	6.154901959985743		0.3089434	[0.19-0.43] unit increase	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid pneumonia vs population)	1,004 European ancestry cases, 680,354 European ancestry controls, 218 Hispanic or Latin American cases, 94,318 Hispanic or Latin American controls, 64 Black or African American cases, 22,412 Black or African American controls	NA	4q35.2	4	189509771		HSP90AA4P - LINC01262	ENSG00000281610	ENSG00000250739		34579	149834	rs191546174-?	rs191546174	0	191546174	intergenic_variant	1	NR	5E-6	5.301029995663981		0.5184948	[0.3-0.74] unit decrease	Illumina [9901720] (imputed)	N	pneumonia, COVID-19	http://www.ebi.ac.uk/efo/EFO_0003106, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027247	Genome-wide genotyping array
2021-03-24	26942285	Sobota RS	2016-03-01	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/26942285	A Locus at 5q33.3 Confers Resistance to Tuberculosis in Highly Susceptible Individuals.	Tuberculosis susceptibility in HIV infection	267 Sub-Saharan African cases, 314 Sub-Saharan African controls	NA	5q33.3	5	159263943	UBLCP1, IL12B	UBLCP1			ENSG00000164332			rs4921437-T	rs4921437	0	4921437	intron_variant	0	0.209	2E-8	7.698970004336019		0.374	[0.266-0.528]	Illumina [NR] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST011395	Genome-wide genotyping array
2021-03-24	26942285	Sobota RS	2016-03-01	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/26942285	A Locus at 5q33.3 Confers Resistance to Tuberculosis in Highly Susceptible Individuals.	Tuberculosis susceptibility in HIV infection	267 Sub-Saharan African cases, 314 Sub-Saharan African controls	NA	15q22.2	15	61724906	VPS13C	NA - LINC02349		ENSG00000259284			4859	rs8028149-C	rs8028149	0	8028149	intergenic_variant	1	0.416	2E-6	5.698970004336019		0.509	[0.385-0.672]	Illumina [NR] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST011395	Genome-wide genotyping array
2021-03-24	26942285	Sobota RS	2016-03-01	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/26942285	A Locus at 5q33.3 Confers Resistance to Tuberculosis in Highly Susceptible Individuals.	Tuberculosis susceptibility in HIV infection	267 Sub-Saharan African cases, 314 Sub-Saharan African controls	NA	6p21.2	6	38711900	GLO1	GLO1 - DNAH8	ENSG00000124767	ENSG00000124721		8755	3411	rs1616723-G	rs1616723	0	1616723	intergenic_variant	1	0.201	4E-6	5.3979400086720375		0.439	[0.309-0.624]	Illumina [NR] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST011395	Genome-wide genotyping array
2014-11-18	24847357	Ye Z	2014-05-09	Front Genet	www.ncbi.nlm.nih.gov/pubmed/24847357	Genome wide association study of SNP-, gene-, and pathway-based approaches to identify genes influencing susceptibility to Staphylococcus aureus infections.	Staphylococcus aureus infection	309 European ancestry cases, 2,925 European ancestry controls	NA	1p31.3	1	66055315	PDE4B	PDE4B			ENSG00000184588			rs2455012-T	rs2455012	0	2455012	intron_variant	0	0.04519	7E-7	6.154901959985743		2.17	[1.59-2.93]	Illumina [508921]	N	Staphylococcus aureus infection	http://www.ebi.ac.uk/efo/EFO_0005681	GCST002440	Genome-wide genotyping array
2014-11-18	24847357	Ye Z	2014-05-09	Front Genet	www.ncbi.nlm.nih.gov/pubmed/24847357	Genome wide association study of SNP-, gene-, and pathway-based approaches to identify genes influencing susceptibility to Staphylococcus aureus infections.	Staphylococcus aureus infection	309 European ancestry cases, 2,925 European ancestry controls	NA	22q11.21	22	19892114	TXNRD2	TXNRD2			ENSG00000184470			rs3804047-C	rs3804047	0	3804047	intron_variant	0	0.281143	3E-6	5.522878745280337		1.52	[1.27-1.81]	Illumina [508921]	N	Staphylococcus aureus infection	http://www.ebi.ac.uk/efo/EFO_0005681	GCST002440	Genome-wide genotyping array
2014-11-18	24847357	Ye Z	2014-05-09	Front Genet	www.ncbi.nlm.nih.gov/pubmed/24847357	Genome wide association study of SNP-, gene-, and pathway-based approaches to identify genes influencing susceptibility to Staphylococcus aureus infections.	Staphylococcus aureus infection	309 European ancestry cases, 2,925 European ancestry controls	NA	22q13.31	22	43880291	PNPLA5	PNPLA5			ENSG00000100341			rs470093-T	rs470093	0	470093	3_prime_UTR_variant	0	0.146838	7E-6	5.154901959985743		1.63	[1.31-2.02]	Illumina [508921]	N	Staphylococcus aureus infection	http://www.ebi.ac.uk/efo/EFO_0005681	GCST002440	Genome-wide genotyping array
2014-11-18	24847357	Ye Z	2014-05-09	Front Genet	www.ncbi.nlm.nih.gov/pubmed/24847357	Genome wide association study of SNP-, gene-, and pathway-based approaches to identify genes influencing susceptibility to Staphylococcus aureus infections.	Staphylococcus aureus infection	309 European ancestry cases, 2,925 European ancestry controls	NA	14q32.2	14	98174878	VRK1, BCL11B	LINC02295 - NA	ENSG00000258511			35636		rs7152530-G	rs7152530	0	7152530	intron_variant	1	0.633254	8E-7	6.096910013008056		1.61	[1.33-1.96]	Illumina [508921]	N	Staphylococcus aureus infection	http://www.ebi.ac.uk/efo/EFO_0005681	GCST002440	Genome-wide genotyping array
2017-02-10	27339598	Ulveling D	2016-07-29	Hepatology	www.ncbi.nlm.nih.gov/pubmed/27339598	A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients.	Liver fibrosis severity in HIV/hepatitis C co-infection	289 French ancestry cases	NA	3p25.3	3	8764738	OXTR	OXTR, CAV3			ENSG00000180914, ENSG00000182533			rs73132848-?	rs73132848	0	73132848	intron_variant	0		1E-9	9.0		1.13	[0.78-1.48] unit increase	Illumina [8426597] (imputed)	N	Hepatic fibrosis	http://purl.obolibrary.org/obo/HP_0001395	GCST003606	Genome-wide genotyping array
2017-02-10	27339598	Ulveling D	2016-07-29	Hepatology	www.ncbi.nlm.nih.gov/pubmed/27339598	A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients.	Liver fibrosis severity in HIV/hepatitis C co-infection	289 French ancestry cases	NA	6q23.2	6	131504454	intergenic	ARG1			ENSG00000118520			rs143633948-?	rs143633948	0	143633948	intron_variant	0		9E-8	7.045757490560675		1.07	[0.68-1.46] unit increase	Illumina [8426597] (imputed)	N	Hepatic fibrosis	http://purl.obolibrary.org/obo/HP_0001395	GCST003606	Genome-wide genotyping array
2017-02-10	27339598	Ulveling D	2016-07-29	Hepatology	www.ncbi.nlm.nih.gov/pubmed/27339598	A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients.	Liver fibrosis severity in HIV/hepatitis C co-infection	289 French ancestry cases	NA	9p22.1	9	19469848	MAP1LC3BP1	MAP1LC3BP1 - SLC24A2	ENSG00000231909	ENSG00000155886		5324	37604	rs11790131-?	rs11790131	0	11790131	intergenic_variant	1		9E-9	8.045757490560675		0.6	[0.4-0.8] unit increase	Illumina [8426597] (imputed)	N	Hepatic fibrosis	http://purl.obolibrary.org/obo/HP_0001395	GCST003606	Genome-wide genotyping array
2017-02-10	27339598	Ulveling D	2016-07-29	Hepatology	www.ncbi.nlm.nih.gov/pubmed/27339598	A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients.	Liver fibrosis severity in HIV/hepatitis C co-infection	289 French ancestry cases	NA	11p13	11	33436311	intergenic	KIAA1549L			ENSG00000110427			rs35897606-?	rs35897606	0	35897606	intron_variant	0		6E-8	7.221848749616356		0.8	[0.51-1.09] unit increase	Illumina [8426597] (imputed)	N	Hepatic fibrosis	http://purl.obolibrary.org/obo/HP_0001395	GCST003606	Genome-wide genotyping array
2017-02-10	27339598	Ulveling D	2016-07-29	Hepatology	www.ncbi.nlm.nih.gov/pubmed/27339598	A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients.	Liver fibrosis severity in HIV/hepatitis C co-infection	289 French ancestry cases	NA	13q12.12	13	24740488	intergenic	ATP12A - IRX1P1	ENSG00000075673	ENSG00000231417		28016	2189	rs79709413-?	rs79709413	0	79709413	intergenic_variant	1		8E-7	6.096910013008056		0.95	[0.58-1.32] unit increase	Illumina [8426597] (imputed)	N	Hepatic fibrosis	http://purl.obolibrary.org/obo/HP_0001395	GCST003606	Genome-wide genotyping array
2017-02-10	27339598	Ulveling D	2016-07-29	Hepatology	www.ncbi.nlm.nih.gov/pubmed/27339598	A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients.	Liver fibrosis severity in HIV/hepatitis C co-infection	289 French ancestry cases	NA	17q25.1	17	73383923	SDK2	SDK2			ENSG00000069188			rs35467001-?	rs35467001	0	35467001	missense_variant	0		5E-7	6.301029995663981		0.87	[0.54-1.2] unit increase	Illumina [8426597] (imputed)	N	Hepatic fibrosis	http://purl.obolibrary.org/obo/HP_0001395	GCST003606	Genome-wide genotyping array
2017-02-10	27339598	Ulveling D	2016-07-29	Hepatology	www.ncbi.nlm.nih.gov/pubmed/27339598	A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients.	Liver fibrosis severity in HIV/hepatitis C co-infection	289 French ancestry cases	NA	20p13	20	3430406	intergenic	C20orf194		ENSG00000088812			40612	rs73084982-?	rs73084982	0	73084982	intergenic_variant	0		2E-7	6.698970004336019		0.92	[0.57-1.27] unit increase	Illumina [8426597] (imputed)	N	Hepatic fibrosis	http://purl.obolibrary.org/obo/HP_0001395	GCST003606	Genome-wide genotyping array
2019-02-11	30228239	Wojcik GL	2018-09-18	MBio	www.ncbi.nlm.nih.gov/pubmed/30228239	Genome-Wide Association Study Reveals Genetic Link between Diarrhea-Associated Entamoeba histolytica Infection and Inflammatory Bowel Disease.	Diarrhoea-associated Entamoeba histolytica infection	170 Bangladeshi ancestry cases, 574 Bangladeshi ancestry controls	NA	10p11.21	10	35228708	CCNY, CREM	LINC02634			ENSG00000233200			rs58000832-C	rs58000832	0	58000832	intron_variant	0	NR	6E-9	8.221848749616356		2.45	[1.83-3.29]	Illumina [6703908] (imputed)	N	amebiasis	http://www.ebi.ac.uk/efo/EFO_0007144	GCST007109	Genome-wide genotyping array
2019-08-01	30092369	Mainali B	2018-08-06	Papillomavirus Res	www.ncbi.nlm.nih.gov/pubmed/30092369	Variants in Immune-related Genes and Genital HPV 16 Persistence in Men.	Infection persistence (>18 months) in genital human papillomavirus 16 infection	21 European ancestry male cases, 15 Brazilian ancestry male cases,  4 African-American male cases, 62 European ancestry male controls, 69 Brazilian ancestry male controls, 20 African-American male controls	NA	20q13.2	20	54334508	intergenic							rs1293153-G	rs1293153	0	1293153	intergenic_variant	1	NR	6E-6	5.221848749616356		1.617	[NR] unit increase	Affymetrix [605885]	N	chronic human papillomavirus infection	http://www.ebi.ac.uk/efo/EFO_0010060	GCST008308	Genome-wide genotyping array
2019-08-01	30092369	Mainali B	2018-08-06	Papillomavirus Res	www.ncbi.nlm.nih.gov/pubmed/30092369	Variants in Immune-related Genes and Genital HPV 16 Persistence in Men.	Infection persistence (>18 months) in genital human papillomavirus 16 infection	21 European ancestry male cases, 15 Brazilian ancestry male cases,  4 African-American male cases, 62 European ancestry male controls, 69 Brazilian ancestry male controls, 20 African-American male controls	NA	15q26.1	15	89073999	LOC102724566	CARMAL			ENSG00000260123			rs405103-T	rs405103	0	405103	intron_variant	0	NR	6E-6	5.221848749616356		2.221	[NR] unit increase	Affymetrix [605885]	N	chronic human papillomavirus infection	http://www.ebi.ac.uk/efo/EFO_0010060	GCST008308	Genome-wide genotyping array
2020-04-17	32019797	Wojcik GL	2020-02-04	mBio	www.ncbi.nlm.nih.gov/pubmed/32019797	Genome-Wide Association Study of Cryptosporidiosis in Infants Implicates PRKCA.	Cryptosporidiosis	183 Bangladeshi ancestry cases, 873 Bangladeshi ancestry controls	NA	17q24.2	17	66473763	PRKCA	PRKCA			ENSG00000154229			rs58296998-T	rs58296998	0	58296998	intron_variant	0	NR	4E-8	7.3979400086720375		2.4	[NR]	Illumina [6504706] (imputed)	N	cryptosporidiosis	http://purl.obolibrary.org/obo/MONDO_0015474	GCST009861	Genome-wide genotyping array
2020-04-17	32019797	Wojcik GL	2020-02-04	mBio	www.ncbi.nlm.nih.gov/pubmed/32019797	Genome-Wide Association Study of Cryptosporidiosis in Infants Implicates PRKCA.	Cryptosporidiosis	183 Bangladeshi ancestry cases, 873 Bangladeshi ancestry controls	NA	11p15.4	11	5997956	Intergenic	KRT18P58 - OR56A4	ENSG00000254831	ENSG00000183389		2961	1489	rs4758351-A	rs4758351	0	4758351	intergenic_variant	1	NR	4E-7	6.3979400086720375		2.39	[NR]	Illumina [6504706] (imputed)	N	cryptosporidiosis	http://purl.obolibrary.org/obo/MONDO_0015474	GCST009861	Genome-wide genotyping array
2020-04-17	32019797	Wojcik GL	2020-02-04	mBio	www.ncbi.nlm.nih.gov/pubmed/32019797	Genome-Wide Association Study of Cryptosporidiosis in Infants Implicates PRKCA.	Cryptosporidiosis	183 Bangladeshi ancestry cases, 873 Bangladeshi ancestry controls	NA	16q21	16	59784010	APOOP5	APOOP5 - LINC02141	ENSG00000260240	ENSG00000261807		28984	71343	rs9937140-G	rs9937140	0	9937140	intergenic_variant	1	NR	8E-7	6.096910013008056		1.99	[NR]	Illumina [6504706] (imputed)	N	cryptosporidiosis	http://purl.obolibrary.org/obo/MONDO_0015474	GCST009861	Genome-wide genotyping array
2020-06-16	32313116	Manry J	2020-04-20	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/32313116	Genome-wide association study of Buruli ulcer in rural Benin highlights role of two LncRNAs and the autophagy pathway.	Buruli ulcer	402 Sub-Saharan African ancestry cases, 401 Sub-Saharan African ancestry controls	455 Sub-Saharan African ancestry cases, 238 Sub-Saharan African ancestry controls	3q24	3	145962558	ENSG00000240095.1							rs9814705-C	rs9814705	0	9814705	intron_variant	1	0.1	3E-7	6.522878745280337		1.8	[1.43-2.27]	Illumina [10014109] (imputed)	N	Buruli ulcer disease	http://purl.obolibrary.org/obo/MONDO_0000327	GCST010077	Genome-wide genotyping array
2020-06-16	32313116	Manry J	2020-04-20	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/32313116	Genome-wide association study of Buruli ulcer in rural Benin highlights role of two LncRNAs and the autophagy pathway.	Buruli ulcer (age at onset)	402 Sub-Saharan African ancestry cases	455 Sub-Saharan African ancestry cases	6p25.3	6	984961	LINC01622	LINC01622			ENSG00000286785			rs76647377-G	rs76647377	0	76647377	intron_variant	0	0.95	1E-7	7.0		2.4390244	[1.67-3.57]	Illumina [10014109] (imputed)	N	Buruli ulcer disease, age at onset	http://purl.obolibrary.org/obo/MONDO_0000327, http://www.ebi.ac.uk/efo/EFO_0004847	GCST010076	Genome-wide genotyping array
2017-06-29	28388302	Petros Z	2017-04-01	OMICS	www.ncbi.nlm.nih.gov/pubmed/28388302	Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs.	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	27 Ethiopian cases with HIV and tuberculosis, 159 Ethiopian controls with HIV and tuberculosis.	8 Ethiopian cases with HIV and tuberculosis, up to 108 Ethiopian controls with HIV and tuberculosis.	12q21.2	12	78807293	LOC642550	NA - SYT1		ENSG00000067715			56700	rs4842407-C	rs4842407	0	4842407	intron_variant	1	0.44	3E-7	6.522878745280337		5.4	[2.8-10.3]	Illumina [662807]	N	response to rifampicin, response to efavirenz, drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0007866, http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0004228	GCST004262	Genome-wide genotyping array
2017-06-29	28388302	Petros Z	2017-04-01	OMICS	www.ncbi.nlm.nih.gov/pubmed/28388302	Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs.	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	27 Ethiopian cases with HIV and tuberculosis, 159 Ethiopian controls with HIV and tuberculosis.	8 Ethiopian cases with HIV and tuberculosis, up to 108 Ethiopian controls with HIV and tuberculosis.	10p12.31	10	21003994	NEBL	NEBL			ENSG00000078114			rs11012476-A	rs11012476	0	11012476	intron_variant	0	0.03	1E-6	6.0		14.3	[5.3-39.9]	Illumina [662807]	N	response to rifampicin, response to efavirenz, drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0007866, http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0004228	GCST004262	Genome-wide genotyping array
2017-06-29	28388302	Petros Z	2017-04-01	OMICS	www.ncbi.nlm.nih.gov/pubmed/28388302	Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs.	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	27 Ethiopian cases with HIV and tuberculosis, 159 Ethiopian controls with HIV and tuberculosis.	8 Ethiopian cases with HIV and tuberculosis, up to 108 Ethiopian controls with HIV and tuberculosis.	5q22.3	5	115714665	TMED7	TMED7 - H3P24	ENSG00000134970	ENSG00000251118		81673	55921	rs251891-A	rs251891	0	251891	intergenic_variant	1	0.11	4E-6	5.3979400086720375		5.2	[2.9-9.5]	Illumina [662807]	N	response to rifampicin, response to efavirenz, drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0007866, http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0004228	GCST004262	Genome-wide genotyping array
2010-09-15	20694013	Davila S	2010-08-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20694013	Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease.	Meningococcal disease	475 European ancestry cases, 4,703 European ancestry controls	929 European ancestry cases, 1,351 European ancestry controls	1q31.3	1	196791287	CFHR3, CFH	CFHR3			ENSG00000116785			rs426736-?	rs426736	0	426736	intron_variant	0	0.84	5E-13	12.301029995663981		1.59	[1.41-1.82]	Illumina [518920]	N	meningococcal infection	http://www.ebi.ac.uk/efo/EFO_0004249	GCST000762	Genome-wide genotyping array
2016-09-19	26450422	DeLorenze GN	2015-10-08	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/26450422	Polymorphisms in HLA Class II Genes Are Associated With Susceptibility to Staphylococcus aureus Infection in a White Population.	Staphylococcus aureus infection	4,701 European ancestry cases, 45,344 European ancestry controls	NA	6p21.32	6	32431410	HLA-DRA	TSBP1-AS1 - HLA-DRA	ENSG00000225914	ENSG00000204287		23647	8468	rs4321864-A	rs4321864	0	4321864	intergenic_variant	1	NR	9E-8	7.045757490560675		1.13	[NR]	Affymetrix [at least 584535] (imputed)	N	Staphylococcus aureus infection	http://www.ebi.ac.uk/efo/EFO_0005681	GCST003150	Genome-wide genotyping array
2016-09-19	26450422	DeLorenze GN	2015-10-08	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/26450422	Polymorphisms in HLA Class II Genes Are Associated With Susceptibility to Staphylococcus aureus Infection in a White Population.	Staphylococcus aureus infection	4,701 European ancestry cases, 45,344 European ancestry controls	NA	6p21.32	6	32575268	HLA-DRB1	HLA-DRB6 - HLA-DRB1	ENSG00000229391	ENSG00000206240		15246	3501	rs115231074-T	rs115231074	0	115231074	intergenic_variant	1	NR	1E-10	10.0		1.22	[NR]	Affymetrix [at least 584535] (imputed)	N	Staphylococcus aureus infection	http://www.ebi.ac.uk/efo/EFO_0005681	GCST003150	Genome-wide genotyping array
2016-09-19	26450422	DeLorenze GN	2015-10-08	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/26450422	Polymorphisms in HLA Class II Genes Are Associated With Susceptibility to Staphylococcus aureus Infection in a White Population.	Skin and soft tissue Staphylococcus aureus infection	2,130 European ancestry cases, 45,434 European ancestry controls	NA	6p21.32	6	32575268	HLA-DRB1	HLA-DRB6 - HLA-DRB1	ENSG00000229391	ENSG00000206240		15246	3501	rs115231074-T	rs115231074	0	115231074	intergenic_variant	1	NR	5E-8	7.301029995663981		1.28	[NR]	Affymetrix [at least 584535] (imputed)	N	skin and soft tissue Staphylococcus aureus infection	http://www.ebi.ac.uk/efo/EFO_1001489	GCST003149	Genome-wide genotyping array
2021-04-13	33662382	Rogne T	2021-03-01	J Invest Dermatol	www.ncbi.nlm.nih.gov/pubmed/33662382	Genome-Wide Association Study Identifies LINC01184/SLC12A2 As Risk Locus for Skin and Soft Tissue Infections.	Skin and soft tissue infections	6,107 European ancestry cases and 399,239 European ancestry controls	1,657 European ancestry cases and 67,522 European ancestry controls	2q34	2	209331894	MAP2	NA - MAP2		ENSG00000078018			92153	rs72989928-G	rs72989928	0	72989928	regulatory_region_variant	1	0.017	2E-6	5.698970004336019		0.72	[0.63-0.83]	Affymetrix, Illumina [9211777] (imputed)	N	skin and soft tissue Staphylococcus aureus infection	http://www.ebi.ac.uk/efo/EFO_1001489	GCST90013411	Genome-wide genotyping array
2021-04-13	33662382	Rogne T	2021-03-01	J Invest Dermatol	www.ncbi.nlm.nih.gov/pubmed/33662382	Genome-Wide Association Study Identifies LINC01184/SLC12A2 As Risk Locus for Skin and Soft Tissue Infections.	Skin and soft tissue infections	6,107 European ancestry cases and 399,239 European ancestry controls	1,657 European ancestry cases and 67,522 European ancestry controls	5q23.3	5	128014857	LINC01184	LINC01184			ENSG00000245937			rs3749748-T	rs3749748	0	3749748	intron_variant	0	0.248	4E-18	17.397940008672037		1.18	[1.14-1.23]	Affymetrix, Illumina [9211777] (imputed)	N	skin and soft tissue Staphylococcus aureus infection	http://www.ebi.ac.uk/efo/EFO_1001489	GCST90013411	Genome-wide genotyping array
2021-04-13	33662382	Rogne T	2021-03-01	J Invest Dermatol	www.ncbi.nlm.nih.gov/pubmed/33662382	Genome-Wide Association Study Identifies LINC01184/SLC12A2 As Risk Locus for Skin and Soft Tissue Infections.	Skin and soft tissue infections	6,107 European ancestry cases and 399,239 European ancestry controls	1,657 European ancestry cases and 67,522 European ancestry controls	6p22.2	6	26123274	H2BC4	H2BC4			ENSG00000180596			rs115740542-C	rs115740542	0	115740542	intron_variant	0	0.075	4E-7	6.3979400086720375		1.17	[1.10-1.24]	Affymetrix, Illumina [9211777] (imputed)	N	skin and soft tissue Staphylococcus aureus infection	http://www.ebi.ac.uk/efo/EFO_1001489	GCST90013411	Genome-wide genotyping array
2021-04-13	33662382	Rogne T	2021-03-01	J Invest Dermatol	www.ncbi.nlm.nih.gov/pubmed/33662382	Genome-Wide Association Study Identifies LINC01184/SLC12A2 As Risk Locus for Skin and Soft Tissue Infections.	Skin and soft tissue infections	6,107 European ancestry cases and 399,239 European ancestry controls	1,657 European ancestry cases and 67,522 European ancestry controls	11p15.2	11	14641176	PSMA1	PSMA1			ENSG00000129084			rs2007361-G	rs2007361	0	2007361	intron_variant	0	0.342	5E-8	7.301029995663981		0.91	[0.88-0.94]	Affymetrix, Illumina [9211777] (imputed)	N	skin and soft tissue Staphylococcus aureus infection	http://www.ebi.ac.uk/efo/EFO_1001489	GCST90013411	Genome-wide genotyping array
2021-04-13	33662382	Rogne T	2021-03-01	J Invest Dermatol	www.ncbi.nlm.nih.gov/pubmed/33662382	Genome-Wide Association Study Identifies LINC01184/SLC12A2 As Risk Locus for Skin and Soft Tissue Infections.	Skin and soft tissue infections	6,107 European ancestry cases and 399,239 European ancestry controls	1,657 European ancestry cases and 67,522 European ancestry controls	16q23.2	16	81368675	GAN	GAN			ENSG00000261609			rs78625038-CT	rs78625038	0	78625038	intron_variant	0	0.006	6E-8	7.221848749616356		1.86	[1.48-2.32]	Affymetrix, Illumina [9211777] (imputed)	N	skin and soft tissue Staphylococcus aureus infection	http://www.ebi.ac.uk/efo/EFO_1001489	GCST90013411	Genome-wide genotyping array
2018-05-18	29523850	Gilchrist JJ	2018-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/29523850	Risk of nontyphoidal Salmonella bacteraemia in African children is modified by STAT4.	Nontyphoidal Salmonella bacteraemia	180 Kenyan ancestry cases, 2,677 Kenyan ancestry controls	171 Sub-Saharan African ancestry cases, 563 Sub-Saharan African ancestry controls	8q24.22	8	133286261	NDRG1	NDRG1			ENSG00000104419			rs16904882-?	rs16904882	0	16904882	intron_variant	0	NR	2E-7	6.698970004336019	(additive model)	2.08	[1.58-2.74]	Affymetrix [at least 4669480] (imputed)	N	non-typhoidal Salmonella bacteremia	http://www.ebi.ac.uk/efo/EFO_0009087	GCST005590	Genome-wide genotyping array
2018-05-18	29523850	Gilchrist JJ	2018-03-09	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/29523850	Risk of nontyphoidal Salmonella bacteraemia in African children is modified by STAT4.	Nontyphoidal Salmonella bacteraemia	180 Kenyan ancestry cases, 2,677 Kenyan ancestry controls	171 Sub-Saharan African ancestry cases, 563 Sub-Saharan African ancestry controls	2q32.2	2	191090090	STAT4	STAT4			ENSG00000138378			rs13390936-T	rs13390936	0	13390936	intron_variant	0	NR	9E-10	9.045757490560675	(recessive model)	7.61	[3.98-14.55]	Affymetrix [at least 4669480] (imputed)	N	non-typhoidal Salmonella bacteremia	http://www.ebi.ac.uk/efo/EFO_0009087	GCST005590	Genome-wide genotyping array
2021-01-25	33115937	Cho J	2020-10-28	Thorax	www.ncbi.nlm.nih.gov/pubmed/33115937	Genome-wide association study of non-tuberculous mycobacterial pulmonary disease.	Non-tuberculous mycobacterial pulmonary disease	403 Korean ancestry cases, 306 Korean ancestry controls	184 Korean ancestry cases, 1680 Korean ancestry controls	7p13	7	43744189	NR	COA1 - BLVRA	ENSG00000106603	ENSG00000106605		14472	14491	rs849177-C	rs849177	0	849177	intergenic_variant	1	0.63	5E-8	7.301029995663981		1.29	[1.02-1.62] (replication cohort)	Illumina [4877242] (imputed)	N	pulmonary non-tuberculous mycobacterial infection	http://purl.obolibrary.org/obo/MONDO_0018469	GCST010983	Genome-wide genotyping array
2021-01-25	33115937	Cho J	2020-10-28	Thorax	www.ncbi.nlm.nih.gov/pubmed/33115937	Genome-wide association study of non-tuberculous mycobacterial pulmonary disease.	Non-tuberculous mycobacterial pulmonary disease	403 Korean ancestry cases, 306 Korean ancestry controls	184 Korean ancestry cases, 1680 Korean ancestry controls	1q43	1	238930372	NR							rs9428778 -G	rs9428778	0	9428778	intergenic_variant	1	0.07	7E-6	5.154901959985743				Illumina [4877242] (imputed)	N	pulmonary non-tuberculous mycobacterial infection	http://purl.obolibrary.org/obo/MONDO_0018469	GCST010983	Genome-wide genotyping array
2021-01-25	33115937	Cho J	2020-10-28	Thorax	www.ncbi.nlm.nih.gov/pubmed/33115937	Genome-wide association study of non-tuberculous mycobacterial pulmonary disease.	Non-tuberculous mycobacterial pulmonary disease	403 Korean ancestry cases, 306 Korean ancestry controls	184 Korean ancestry cases, 1680 Korean ancestry controls	3p21.31	3	47418189	NR	SCAP			ENSG00000114650			rs12487736 -C	rs12487736	0	12487736	missense_variant	0	0.49	1E-5	5.0				Illumina [4877242] (imputed)	N	pulmonary non-tuberculous mycobacterial infection	http://purl.obolibrary.org/obo/MONDO_0018469	GCST010983	Genome-wide genotyping array
2021-01-25	33115937	Cho J	2020-10-28	Thorax	www.ncbi.nlm.nih.gov/pubmed/33115937	Genome-wide association study of non-tuberculous mycobacterial pulmonary disease.	Non-tuberculous mycobacterial pulmonary disease	403 Korean ancestry cases, 306 Korean ancestry controls	184 Korean ancestry cases, 1680 Korean ancestry controls	3q13.13	3	109157067	NR	C3orf85 - LINC00488	ENSG00000241224	ENSG00000214381		5666	21076	rs2699943-C	rs2699943	0	2699943	intergenic_variant	1	0.06	3E-6	5.522878745280337				Illumina [4877242] (imputed)	N	pulmonary non-tuberculous mycobacterial infection	http://purl.obolibrary.org/obo/MONDO_0018469	GCST010983	Genome-wide genotyping array
2021-01-25	33115937	Cho J	2020-10-28	Thorax	www.ncbi.nlm.nih.gov/pubmed/33115937	Genome-wide association study of non-tuberculous mycobacterial pulmonary disease.	Non-tuberculous mycobacterial pulmonary disease	403 Korean ancestry cases, 306 Korean ancestry controls	184 Korean ancestry cases, 1680 Korean ancestry controls	8q24.3	8	141966427	NR							rs28709344 -G	rs28709344	0	28709344	intergenic_variant	1	0.38	6E-6	5.221848749616356				Illumina [4877242] (imputed)	N	pulmonary non-tuberculous mycobacterial infection	http://purl.obolibrary.org/obo/MONDO_0018469	GCST010983	Genome-wide genotyping array
2021-01-25	33115937	Cho J	2020-10-28	Thorax	www.ncbi.nlm.nih.gov/pubmed/33115937	Genome-wide association study of non-tuberculous mycobacterial pulmonary disease.	Non-tuberculous mycobacterial pulmonary disease	403 Korean ancestry cases, 306 Korean ancestry controls	184 Korean ancestry cases, 1680 Korean ancestry controls	12q23.3	12	106087258	NR	NUAK1			ENSG00000074590			rs7301800 -G	rs7301800	0	7301800	intron_variant	0	0.67	8E-6	5.096910013008056				Illumina [4877242] (imputed)	N	pulmonary non-tuberculous mycobacterial infection	http://purl.obolibrary.org/obo/MONDO_0018469	GCST010983	Genome-wide genotyping array
2021-01-25	33115937	Cho J	2020-10-28	Thorax	www.ncbi.nlm.nih.gov/pubmed/33115937	Genome-wide association study of non-tuberculous mycobacterial pulmonary disease.	Non-tuberculous mycobacterial pulmonary disease	403 Korean ancestry cases, 306 Korean ancestry controls	184 Korean ancestry cases, 1680 Korean ancestry controls	13q12.13	13	24990188	NR	RPL34P27 - LSP1P1	ENSG00000232858	ENSG00000269099		1263	27216	rs9511572 -C	rs9511572	0	9511572	intergenic_variant	1	0.48	8E-6	5.096910013008056				Illumina [4877242] (imputed)	N	pulmonary non-tuberculous mycobacterial infection	http://purl.obolibrary.org/obo/MONDO_0018469	GCST010983	Genome-wide genotyping array
2021-01-25	33115937	Cho J	2020-10-28	Thorax	www.ncbi.nlm.nih.gov/pubmed/33115937	Genome-wide association study of non-tuberculous mycobacterial pulmonary disease.	Non-tuberculous mycobacterial pulmonary disease	403 Korean ancestry cases, 306 Korean ancestry controls	184 Korean ancestry cases, 1680 Korean ancestry controls	13q12.3	13	28441740	NR	FLT1			ENSG00000102755			rs9508036-G	rs9508036	0	9508036	intron_variant	0	0.35	4E-6	5.3979400086720375				Illumina [4877242] (imputed)	N	pulmonary non-tuberculous mycobacterial infection	http://purl.obolibrary.org/obo/MONDO_0018469	GCST010983	Genome-wide genotyping array
2021-01-25	33115937	Cho J	2020-10-28	Thorax	www.ncbi.nlm.nih.gov/pubmed/33115937	Genome-wide association study of non-tuberculous mycobacterial pulmonary disease.	Non-tuberculous mycobacterial pulmonary disease	403 Korean ancestry cases, 306 Korean ancestry controls	184 Korean ancestry cases, 1680 Korean ancestry controls	15q11.2	15	24861407	NR	SNRPN			ENSG00000128739			rs72693656 -T	rs72693656	0	72693656	intron_variant	0	0.48	8E-6	5.096910013008056				Illumina [4877242] (imputed)	N	pulmonary non-tuberculous mycobacterial infection	http://purl.obolibrary.org/obo/MONDO_0018469	GCST010983	Genome-wide genotyping array
2021-01-25	33115937	Cho J	2020-10-28	Thorax	www.ncbi.nlm.nih.gov/pubmed/33115937	Genome-wide association study of non-tuberculous mycobacterial pulmonary disease.	Non-tuberculous mycobacterial pulmonary disease	403 Korean ancestry cases, 306 Korean ancestry controls	184 Korean ancestry cases, 1680 Korean ancestry controls	16p12.2	16	23814403	NR	CHP2 - PRKCB	ENSG00000166869	ENSG00000166501		55468	21580	rs77953657 -C	rs77953657	0	77953657	intergenic_variant	1	0.76	1E-5	5.0				Illumina [4877242] (imputed)	N	pulmonary non-tuberculous mycobacterial infection	http://purl.obolibrary.org/obo/MONDO_0018469	GCST010983	Genome-wide genotyping array
2021-01-25	33115937	Cho J	2020-10-28	Thorax	www.ncbi.nlm.nih.gov/pubmed/33115937	Genome-wide association study of non-tuberculous mycobacterial pulmonary disease.	Non-tuberculous mycobacterial pulmonary disease	403 Korean ancestry cases, 306 Korean ancestry controls	184 Korean ancestry cases, 1680 Korean ancestry controls	21q22.3	21	44434857	NR	TRPM2			ENSG00000142185			rs45593631 -T	rs45593631	0	45593631	intron_variant	0	0.25	2E-6	5.698970004336019				Illumina [4877242] (imputed)	N	pulmonary non-tuberculous mycobacterial infection	http://purl.obolibrary.org/obo/MONDO_0018469	GCST010983	Genome-wide genotyping array
2021-08-13	33649051	Duchen D	2021-03-01	Infect Immun	www.ncbi.nlm.nih.gov/pubmed/33649051	Host genome wide association study of infant susceptibility to <i>Shigella</i>-associated diarrhea.	Shigella-associated diarrhea	143 Bangladeshi cases, 446 Bangladeshi controls	NA	1p31.3	1	67161577	C1orf141	IL23R, C1orf141			ENSG00000162594, ENSG00000203963			rs12041056-?	rs12041056	0	12041056	intron_variant	0	NR	9E-6	5.045757490560675				Illumina [5729117] (imputed)	N	shigellosis	http://www.ebi.ac.uk/efo/EFO_0005585	GCST012207	Genome-wide genotyping array
2021-08-13	33649051	Duchen D	2021-03-01	Infect Immun	www.ncbi.nlm.nih.gov/pubmed/33649051	Host genome wide association study of infant susceptibility to <i>Shigella</i>-associated diarrhea.	Shigella-associated diarrhea	143 Bangladeshi cases, 446 Bangladeshi controls	NA	4p15.1	4	29829012	AC109351.1, RP11-390C19.1	EEF1A1P21 - NA	ENSG00000249542			78912		rs35260253-?	rs35260253	0	35260253	intergenic_variant	1	NR	5E-6	5.301029995663981				Illumina [5729117] (imputed)	N	shigellosis	http://www.ebi.ac.uk/efo/EFO_0005585	GCST012207	Genome-wide genotyping array
2021-08-13	33649051	Duchen D	2021-03-01	Infect Immun	www.ncbi.nlm.nih.gov/pubmed/33649051	Host genome wide association study of infant susceptibility to <i>Shigella</i>-associated diarrhea.	Shigella-associated diarrhea	143 Bangladeshi cases, 446 Bangladeshi controls	NA				PDE4D							chr5:58406871-?	chr5:58406871	0			1	NR	6E-6	5.221848749616356				Illumina [5729117] (imputed)	N	shigellosis	http://www.ebi.ac.uk/efo/EFO_0005585	GCST012207	Genome-wide genotyping array
2021-08-13	33649051	Duchen D	2021-03-01	Infect Immun	www.ncbi.nlm.nih.gov/pubmed/33649051	Host genome wide association study of infant susceptibility to <i>Shigella</i>-associated diarrhea.	Shigella-associated diarrhea	143 Bangladeshi cases, 446 Bangladeshi controls	NA	6p25.2	6	2743777	MYLK4	MYLK4			ENSG00000145949			rs73352601-?	rs73352601	0	73352601	intron_variant	0	NR	6E-6	5.221848749616356				Illumina [5729117] (imputed)	N	shigellosis	http://www.ebi.ac.uk/efo/EFO_0005585	GCST012207	Genome-wide genotyping array
2021-08-13	33649051	Duchen D	2021-03-01	Infect Immun	www.ncbi.nlm.nih.gov/pubmed/33649051	Host genome wide association study of infant susceptibility to <i>Shigella</i>-associated diarrhea.	Shigella-associated diarrhea	143 Bangladeshi cases, 446 Bangladeshi controls	NA	6p24.3	6	7395251	RIOK1	RIOK1			ENSG00000124784			rs62386195-?	rs62386195	0	62386195	intron_variant	0	NR	7E-6	5.154901959985743				Illumina [5729117] (imputed)	N	shigellosis	http://www.ebi.ac.uk/efo/EFO_0005585	GCST012207	Genome-wide genotyping array
2021-08-13	33649051	Duchen D	2021-03-01	Infect Immun	www.ncbi.nlm.nih.gov/pubmed/33649051	Host genome wide association study of infant susceptibility to <i>Shigella</i>-associated diarrhea.	Shigella-associated diarrhea	143 Bangladeshi cases, 446 Bangladeshi controls	NA	7p22.1	7	6164589	CYTH3	CYTH3			ENSG00000008256			rs10266841-?	rs10266841	0	10266841	3_prime_UTR_variant	0	NR	1E-6	6.0		0.49	[NR]	Illumina [5729117] (imputed)	N	shigellosis	http://www.ebi.ac.uk/efo/EFO_0005585	GCST012207	Genome-wide genotyping array
2021-08-13	33649051	Duchen D	2021-03-01	Infect Immun	www.ncbi.nlm.nih.gov/pubmed/33649051	Host genome wide association study of infant susceptibility to <i>Shigella</i>-associated diarrhea.	Shigella-associated diarrhea	143 Bangladeshi cases, 446 Bangladeshi controls	NA	8p23.1	8	9348021	RP11-115J16.1	RNU6-1151P - RNU6-526P	ENSG00000284864	ENSG00000201815		60443	23069	rs12550437-?	rs12550437	0	12550437	intron_variant	1	NR	1E-7	7.0		0.48	[NR]	Illumina [5729117] (imputed)	N	shigellosis	http://www.ebi.ac.uk/efo/EFO_0005585	GCST012207	Genome-wide genotyping array
2021-08-13	33649051	Duchen D	2021-03-01	Infect Immun	www.ncbi.nlm.nih.gov/pubmed/33649051	Host genome wide association study of infant susceptibility to <i>Shigella</i>-associated diarrhea.	Shigella-associated diarrhea	143 Bangladeshi cases, 446 Bangladeshi controls	NA	9p21.3	9	21952927	RP11-145E5.5	MTAP - CDKN2A-DT	ENSG00000099810	ENSG00000224854		15276	14002	rs2518722-?	rs2518722	0	2518722	intron_variant	1	NR	3E-6	5.522878745280337				Illumina [5729117] (imputed)	N	shigellosis	http://www.ebi.ac.uk/efo/EFO_0005585	GCST012207	Genome-wide genotyping array
2021-08-13	33649051	Duchen D	2021-03-01	Infect Immun	www.ncbi.nlm.nih.gov/pubmed/33649051	Host genome wide association study of infant susceptibility to <i>Shigella</i>-associated diarrhea.	Shigella-associated diarrhea	143 Bangladeshi cases, 446 Bangladeshi controls	NA	10p12.1	10	27148200	YME1L1	YME1L1			ENSG00000136758			rs147818229-?	rs147818229	1	60147959	intron_variant	0	NR	3E-6	5.522878745280337				Illumina [5729117] (imputed)	N	shigellosis	http://www.ebi.ac.uk/efo/EFO_0005585	GCST012207	Genome-wide genotyping array
2021-08-13	33649051	Duchen D	2021-03-01	Infect Immun	www.ncbi.nlm.nih.gov/pubmed/33649051	Host genome wide association study of infant susceptibility to <i>Shigella</i>-associated diarrhea.	Shigella-associated diarrhea	143 Bangladeshi cases, 446 Bangladeshi controls	NA	10p12.1	10	28047767	RP11-218D6.4	MRPS21P5 - MPP7	ENSG00000226395	ENSG00000150054		42835	3226	rs7920436-?	rs7920436	0	7920436	intron_variant	1	NR	2E-6	5.698970004336019				Illumina [5729117] (imputed)	N	shigellosis	http://www.ebi.ac.uk/efo/EFO_0005585	GCST012207	Genome-wide genotyping array
2021-08-13	33649051	Duchen D	2021-03-01	Infect Immun	www.ncbi.nlm.nih.gov/pubmed/33649051	Host genome wide association study of infant susceptibility to <i>Shigella</i>-associated diarrhea.	Shigella-associated diarrhea	143 Bangladeshi cases, 446 Bangladeshi controls	NA	11q24.2	11	125122939	KRT18P59	KRT18P59			ENSG00000187686			rs582240-?	rs582240	0	582240	intron_variant	0	NR	6E-8	7.221848749616356		0.43	[NR]	Illumina [5729117] (imputed)	N	shigellosis	http://www.ebi.ac.uk/efo/EFO_0005585	GCST012207	Genome-wide genotyping array
2021-08-13	33649051	Duchen D	2021-03-01	Infect Immun	www.ncbi.nlm.nih.gov/pubmed/33649051	Host genome wide association study of infant susceptibility to <i>Shigella</i>-associated diarrhea.	Shigella-associated diarrhea	143 Bangladeshi cases, 446 Bangladeshi controls	NA	12q23.2	12	101915245	DRAM1	DRAM1			ENSG00000136048			rs35920088-?	rs35920088	0	35920088	intron_variant	0	NR	3E-6	5.522878745280337				Illumina [5729117] (imputed)	N	shigellosis	http://www.ebi.ac.uk/efo/EFO_0005585	GCST012207	Genome-wide genotyping array
2021-05-26	32830257	Castellucci LC	2020-08-23	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32830257	A Genome-Wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1 and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis In Brazil.	Cutaneous leishmaniasis	2,066 Hispanic/Latino cases, 2,046 Hispanic/Latino controls	NR	3p24.3	3	22076244	ZNF385D	ZNF385D			ENSG00000151789			rs1383086-T	rs1383086	0	1383086	intron_variant	0		2E-6	5.698970004336019		0.853	[0.794-0.916]	Illumina [4498586] (imputed)	N	cutaneous Leishmaniasis	http://www.ebi.ac.uk/efo/EFO_0005046	GCST011739	Genome-wide genotyping array
2021-05-26	32830257	Castellucci LC	2020-08-23	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32830257	A Genome-Wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1 and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis In Brazil.	Cutaneous leishmaniasis	2,066 Hispanic/Latino cases, 2,046 Hispanic/Latino controls	NR	3q27.1	3	183139473	LAMP3	LAMP3			ENSG00000078081			rs74285558-T	rs74285558	0	74285558	intron_variant	0		7E-6	5.154901959985743		0.868	[0.817-0.923]	Illumina [4498586] (imputed)	N	cutaneous Leishmaniasis	http://www.ebi.ac.uk/efo/EFO_0005046	GCST011739	Genome-wide genotyping array
2021-05-26	32830257	Castellucci LC	2020-08-23	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32830257	A Genome-Wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1 and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis In Brazil.	Cutaneous leishmaniasis	2,066 Hispanic/Latino cases, 2,046 Hispanic/Latino controls	NR	6q23.2	6	132494423	STX7	STX7			ENSG00000079950			rs144488134-A	rs144488134	0	144488134	intron_variant	0		6E-6	5.221848749616356		0.821	[0.754-0.894]	Illumina [4498586] (imputed)	N	cutaneous Leishmaniasis	http://www.ebi.ac.uk/efo/EFO_0005046	GCST011739	Genome-wide genotyping array
2021-05-26	32830257	Castellucci LC	2020-08-23	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32830257	A Genome-Wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1 and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis In Brazil.	Cutaneous leishmaniasis	2,066 Hispanic/Latino cases, 2,046 Hispanic/Latino controls	NR	7q21.3	7	93435767	CALCR	CALCR			ENSG00000004948			rs143586968-T	rs143586968	0	143586968	intron_variant	0		3E-6	5.522878745280337		1.159	[1.089-1.234]	Illumina [4498586] (imputed)	N	cutaneous Leishmaniasis	http://www.ebi.ac.uk/efo/EFO_0005046	GCST011739	Genome-wide genotyping array
2021-05-26	32830257	Castellucci LC	2020-08-23	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32830257	A Genome-Wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1 and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis In Brazil.	Cutaneous leishmaniasis	2,066 Hispanic/Latino cases, 2,046 Hispanic/Latino controls	NR	8q11.23	8	51716260	PXDNL	PXDNL			ENSG00000147485			rs13261618-A	rs13261618	0	13261618	intron_variant	0		1E-6	6.0		0.868	[0.819-0.919]	Illumina [4498586] (imputed)	N	cutaneous Leishmaniasis	http://www.ebi.ac.uk/efo/EFO_0005046	GCST011739	Genome-wide genotyping array
2021-05-26	32830257	Castellucci LC	2020-08-23	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32830257	A Genome-Wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1 and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis In Brazil.	Cutaneous leishmaniasis	2,066 Hispanic/Latino cases, 2,046 Hispanic/Latino controls	NR	12p13.32	12	3288238	TSPAN9	TSPAN9 - LINC02827	ENSG00000011105	ENSG00000236908		1674	30480	rs77563142-G	rs77563142	0	77563142	intergenic_variant	1		2E-6	5.698970004336019		1.277	[1.154-1.413]	Illumina [4498586] (imputed)	N	cutaneous Leishmaniasis	http://www.ebi.ac.uk/efo/EFO_0005046	GCST011739	Genome-wide genotyping array
2021-05-26	32830257	Castellucci LC	2020-08-23	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32830257	A Genome-Wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1 and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis In Brazil.	Cutaneous leishmaniasis	2,066 Hispanic/Latino cases, 2,046 Hispanic/Latino controls	NR	12q13.13	12	52196220	KRT80	LINC00592			ENSG00000258279			rs10783496-A	rs10783496	0	10783496	intron_variant	0		7E-6	5.154901959985743		1.059	[1.033-1.086]	Illumina [4498586] (imputed)	N	cutaneous Leishmaniasis	http://www.ebi.ac.uk/efo/EFO_0005046	GCST011739	Genome-wide genotyping array
2021-05-26	32830257	Castellucci LC	2020-08-23	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32830257	A Genome-Wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1 and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis In Brazil.	Cutaneous leishmaniasis	2,066 Hispanic/Latino cases, 2,046 Hispanic/Latino controls	NR	17q11.2	17	30809108	CRLF3	CRLF3			ENSG00000176390			rs75270613-T	rs75270613	0	75270613	intron_variant	0		5E-6	5.301029995663981		0.832	[0.769-0.901]	Illumina [4498586] (imputed)	N	cutaneous Leishmaniasis	http://www.ebi.ac.uk/efo/EFO_0005046	GCST011739	Genome-wide genotyping array
2021-05-26	32830257	Castellucci LC	2020-08-23	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32830257	A Genome-Wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1 and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis In Brazil.	Cutaneous leishmaniasis	2,066 Hispanic/Latino cases, 2,046 Hispanic/Latino controls	NR	18q21.1	18	49239784	DYM	DYM			ENSG00000141627			rs4939853-G	rs4939853	0	4939853	intron_variant	0		2E-6	5.698970004336019		1.09	[1.052-1.13]	Illumina [4498586] (imputed)	N	cutaneous Leishmaniasis	http://www.ebi.ac.uk/efo/EFO_0005046	GCST011739	Genome-wide genotyping array
2021-05-26	32830257	Castellucci LC	2020-08-23	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32830257	A Genome-Wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1 and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis In Brazil.	Cutaneous leishmaniasis	2,066 Hispanic/Latino cases, 2,046 Hispanic/Latino controls	NR	18q21.2	18	55288444	TCF4	TCF4			ENSG00000196628			rs8090418-T	rs8090418	0	8090418	intron_variant	0		6E-6	5.221848749616356		0.909	[0.873-0.947]	Illumina [4498586] (imputed)	N	cutaneous Leishmaniasis	http://www.ebi.ac.uk/efo/EFO_0005046	GCST011739	Genome-wide genotyping array
2021-05-26	32830257	Castellucci LC	2020-08-23	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32830257	A Genome-Wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1 and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis In Brazil.	Cutaneous leishmaniasis	2,066 Hispanic/Latino cases, 2,046 Hispanic/Latino controls	NR	18q22.1	18	63931529	SERPINB10	SERPINB10			ENSG00000242550			rs8084306-C	rs8084306	0	8084306	intron_variant	0		2E-6	5.698970004336019		1.068	[1.04-1.097]	Illumina [4498586] (imputed)	N	cutaneous Leishmaniasis	http://www.ebi.ac.uk/efo/EFO_0005046	GCST011739	Genome-wide genotyping array
2021-05-26	32830257	Castellucci LC	2020-08-23	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32830257	A Genome-Wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1 and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis In Brazil.	Cutaneous leishmaniasis	2,066 Hispanic/Latino cases, 2,046 Hispanic/Latino controls	NR	19q13.42	19	55250857	PPP6R1	PPP6R1			ENSG00000105063			rs3848610-T	rs3848610	0	3848610	intron_variant	0		5E-6	5.301029995663981		0.836	[0.774-0.903]	Illumina [4498586] (imputed)	N	cutaneous Leishmaniasis	http://www.ebi.ac.uk/efo/EFO_0005046	GCST011739	Genome-wide genotyping array
2021-05-26	32830257	Castellucci LC	2020-08-23	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32830257	A Genome-Wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1 and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis In Brazil.	Cutaneous leishmaniasis	2,066 Hispanic/Latino cases, 2,046 Hispanic/Latino controls	NR	21q22.3	21	46603727	S100B	S100B			ENSG00000160307			rs201555201-TAGATGTTAAAA	rs201555201	0	201555201	intron_variant	0		9E-6	5.045757490560675		1.061	[1.033-1.089]	Illumina [4498586] (imputed)	N	cutaneous Leishmaniasis	http://www.ebi.ac.uk/efo/EFO_0005046	GCST011739	Genome-wide genotyping array
2021-05-26	32830257	Castellucci LC	2020-08-23	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32830257	A Genome-Wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1 and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis In Brazil.	Cutaneous leishmaniasis	2,066 Hispanic/Latino cases, 2,046 Hispanic/Latino controls	NR	22q13.33	22	50600379	MAPK8IP2, CHKB	CHKB			ENSG00000100288			rs1239627205-G	rs1239627205	0	1239627205	intron_variant	0		3E-6	5.522878745280337		1.086	[1.049-1.124]	Illumina [4498586] (imputed)	N	cutaneous Leishmaniasis	http://www.ebi.ac.uk/efo/EFO_0005046	GCST011739	Genome-wide genotyping array
2021-11-01	34668383	Leskela J	2021-10-20	J Am Heart Assoc	www.ncbi.nlm.nih.gov/pubmed/34668383	Genetic Profile of Endotoxemia Reveals an Association With Thromboembolism and Stroke.	Serum lipopolysaccharide activity	11,296 European ancestry individuals	NA	3q27.3	3	186741160	NR	KNG1			ENSG00000113889			rs5030082-G	rs5030082	0	5030082	intron_variant	0	0.3764	3E-19	18.522878745280337		0.1216	[0.095-0.148] unit increase	Affymetrix, Illumina [9900000] (imputed)	N	serum lipopolysaccharide activity	http://www.ebi.ac.uk/efo/EFO_0600064	GCST90032674	Genome-wide genotyping array
2021-11-01	34668383	Leskela J	2021-10-20	J Am Heart Assoc	www.ncbi.nlm.nih.gov/pubmed/34668383	Genetic Profile of Endotoxemia Reveals an Association With Thromboembolism and Stroke.	Serum lipopolysaccharide activity	11,296 European ancestry individuals	NA	4q35.2	4	186239966	NR	KLKB1			ENSG00000164344			rs71640036-G	rs71640036	0	71640036	intron_variant	0	0.4204	5E-78	77.30102999566398		0.251	[0.22-0.28] unit decrease	Affymetrix, Illumina [9900000] (imputed)	N	serum lipopolysaccharide activity	http://www.ebi.ac.uk/efo/EFO_0600064	GCST90032674	Genome-wide genotyping array
2021-11-01	34668383	Leskela J	2021-10-20	J Am Heart Assoc	www.ncbi.nlm.nih.gov/pubmed/34668383	Genetic Profile of Endotoxemia Reveals an Association With Thromboembolism and Stroke.	Serum lipopolysaccharide activity	11,296 European ancestry individuals	NA	5q35.3	5	177409531	NR	F12, GRK6			ENSG00000131187, ENSG00000198055			rs1801020-G	rs1801020	0	1801020	5_prime_UTR_variant	0	0.7477	7E-65	64.15490195998575		0.2588	[0.23-0.29] unit increase	Affymetrix, Illumina [9900000] (imputed)	N	serum lipopolysaccharide activity	http://www.ebi.ac.uk/efo/EFO_0600064	GCST90032674	Genome-wide genotyping array
2021-11-01	34668383	Leskela J	2021-10-20	J Am Heart Assoc	www.ncbi.nlm.nih.gov/pubmed/34668383	Genetic Profile of Endotoxemia Reveals an Association With Thromboembolism and Stroke.	Serum lipopolysaccharide activity	11,296 European ancestry individuals	NA	11q12.1	11	57644269	NR	MIR130A - YPEL4	ENSG00000208009	ENSG00000166793		2983	818	rs2081361-C	rs2081361	0	2081361	intron_variant	1	0.7023	4E-9	8.397940008672037		0.0864	[0.058-0.115] unit increase	Affymetrix, Illumina [9900000] (imputed)	N	serum lipopolysaccharide activity	http://www.ebi.ac.uk/efo/EFO_0600064	GCST90032674	Genome-wide genotyping array
2021-11-01	34668383	Leskela J	2021-10-20	J Am Heart Assoc	www.ncbi.nlm.nih.gov/pubmed/34668383	Genetic Profile of Endotoxemia Reveals an Association With Thromboembolism and Stroke.	Serum lipopolysaccharide activity	11,296 European ancestry individuals	NA	15q21.3	15	58378979	NR	ALDH1A2			ENSG00000128918			rs10152355-C	rs10152355	0	10152355	intron_variant	0	0.5389	3E-9	8.522878745280337		0.0835	[0.056-0.111] unit decrease	Affymetrix, Illumina [9900000] (imputed)	N	serum lipopolysaccharide activity	http://www.ebi.ac.uk/efo/EFO_0600064	GCST90032674	Genome-wide genotyping array
2020-09-17	32634583	Meng Y	2020-07-04	Int J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32634583	Genome-wide association study identifies TPH2 variant as a novel locus for severe CV-A6-associated hand, foot, and mouth disease in Han Chinese.	CV-A6-associated hand, foot, and mouth disease (severe vs mild)	115 Han Chinese ancestry severe cases, 115 Han Chinese ancestry mild controls	NA	2q37.3	2	238956383	FLJ43879, HDAC4	LINC01940 - HDAC4	ENSG00000227744	ENSG00000068024		30114	91785	rs4073751-?	rs4073751	0	4073751	regulatory_region_variant	1	NR	5E-6	5.301029995663981				Illumina [NR]	N	hand, foot and mouth disease, illness severity status	http://www.ebi.ac.uk/efo/EFO_0007294, http://www.ebi.ac.uk/efo/EFO_0007863	GCST010578	Genome-wide genotyping array
2020-09-17	32634583	Meng Y	2020-07-04	Int J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32634583	Genome-wide association study identifies TPH2 variant as a novel locus for severe CV-A6-associated hand, foot, and mouth disease in Han Chinese.	CV-A6-associated hand, foot, and mouth disease (severe vs mild)	115 Han Chinese ancestry severe cases, 115 Han Chinese ancestry mild controls	NA	3q22.2	3	134991109	EPHB1	EPHB1			ENSG00000154928			rs7613213-?	rs7613213	0	7613213	intron_variant	0	NR	4E-6	5.3979400086720375				Illumina [NR]	N	hand, foot and mouth disease, illness severity status	http://www.ebi.ac.uk/efo/EFO_0007294, http://www.ebi.ac.uk/efo/EFO_0007863	GCST010578	Genome-wide genotyping array
2020-09-17	32634583	Meng Y	2020-07-04	Int J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32634583	Genome-wide association study identifies TPH2 variant as a novel locus for severe CV-A6-associated hand, foot, and mouth disease in Han Chinese.	CV-A6-associated hand, foot, and mouth disease (severe vs mild)	115 Han Chinese ancestry severe cases, 115 Han Chinese ancestry mild controls	NA	3q28	3	188620975	LPP	LPP			ENSG00000145012			rs9877898-?	rs9877898	0	9877898	intron_variant	0	NR	5E-6	5.301029995663981				Illumina [NR]	N	hand, foot and mouth disease, illness severity status	http://www.ebi.ac.uk/efo/EFO_0007294, http://www.ebi.ac.uk/efo/EFO_0007863	GCST010578	Genome-wide genotyping array
2020-09-17	32634583	Meng Y	2020-07-04	Int J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32634583	Genome-wide association study identifies TPH2 variant as a novel locus for severe CV-A6-associated hand, foot, and mouth disease in Han Chinese.	CV-A6-associated hand, foot, and mouth disease (severe vs mild)	115 Han Chinese ancestry severe cases, 115 Han Chinese ancestry mild controls	NA	8p23.1	8	10940321	XKR6	XKR6			ENSG00000171044			rs11990550-?	rs11990550	0	11990550	intron_variant	0	NR	6E-6	5.221848749616356				Illumina [NR]	N	hand, foot and mouth disease, illness severity status	http://www.ebi.ac.uk/efo/EFO_0007294, http://www.ebi.ac.uk/efo/EFO_0007863	GCST010578	Genome-wide genotyping array
2020-09-17	32634583	Meng Y	2020-07-04	Int J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32634583	Genome-wide association study identifies TPH2 variant as a novel locus for severe CV-A6-associated hand, foot, and mouth disease in Han Chinese.	CV-A6-associated hand, foot, and mouth disease (severe vs mild)	115 Han Chinese ancestry severe cases, 115 Han Chinese ancestry mild controls	NA	16q24.1	16	86215879	MUSP1	LINC01082 - LINC01081	ENSG00000269186	ENSG00000268754		16159	5541	rs9938195-?	rs9938195	0	9938195	intergenic_variant	1	NR	8E-6	5.096910013008056				Illumina [NR]	N	hand, foot and mouth disease, illness severity status	http://www.ebi.ac.uk/efo/EFO_0007294, http://www.ebi.ac.uk/efo/EFO_0007863	GCST010578	Genome-wide genotyping array
2020-09-17	32634583	Meng Y	2020-07-04	Int J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/32634583	Genome-wide association study identifies TPH2 variant as a novel locus for severe CV-A6-associated hand, foot, and mouth disease in Han Chinese.	CV-A6-associated hand, foot, and mouth disease (severe vs mild)	115 Han Chinese ancestry severe cases, 115 Han Chinese ancestry mild controls	NA	20q13.32	20	57943637	PMEPA1	NA - LINC01742		ENSG00000275852			60267	rs9680020-?	rs9680020	0	9680020	intergenic_variant	1	NR	9E-6	5.045757490560675				Illumina [NR]	N	hand, foot and mouth disease, illness severity status	http://www.ebi.ac.uk/efo/EFO_0007294, http://www.ebi.ac.uk/efo/EFO_0007863	GCST010578	Genome-wide genotyping array
2019-07-11	31241743	Jaeger M	2019-04-24	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31241743	A Genome-Wide Functional Genomics Approach Identifies Susceptibility Pathways to Fungal Bloodstream Infection in Humans.	Candidemia	161 European ancestry cases, 152 European ancestry controls	NA	1q25.3	1	182118149	NR	LINC01344			ENSG00000228918			rs11588087-C	rs11588087	0	11588087	intron_variant	0	0.21	4E-6	5.3979400086720375		3.07	[NR]	Illumina [5326313] (imputed)	N	Candidemia	http://www.ebi.ac.uk/efo/EFO_1001282	GCST008106	Genome-wide genotyping array
2019-07-11	31241743	Jaeger M	2019-04-24	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31241743	A Genome-Wide Functional Genomics Approach Identifies Susceptibility Pathways to Fungal Bloodstream Infection in Humans.	Candidemia	161 European ancestry cases, 152 European ancestry controls	NA	6p21.33	6	31965741	NR	SKIV2L, SKIV2L, SKIV2L, SKIV2L, SKIV2L, SKIV2L			ENSG00000232616, ENSG00000228896, ENSG00000225737, ENSG00000204351, ENSG00000206353, ENSG00000223493			rs492899-?	rs492899	0	492899	intron_variant	0	NR	2E-6	5.698970004336019		5.5555553	[NR]	Illumina [5326313] (imputed)	N	Candidemia	http://www.ebi.ac.uk/efo/EFO_1001282	GCST008106	Genome-wide genotyping array
2019-07-11	31241743	Jaeger M	2019-04-24	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31241743	A Genome-Wide Functional Genomics Approach Identifies Susceptibility Pathways to Fungal Bloodstream Infection in Humans.	Candidemia	161 European ancestry cases, 152 European ancestry controls	NA	13q22.3	13	78483863	NR	OBI1-AS1			ENSG00000234377			rs6563046-T	rs6563046	0	6563046	intron_variant	0	0.53	4E-6	5.3979400086720375		2.12	[NR]	Illumina [5326313] (imputed)	N	Candidemia	http://www.ebi.ac.uk/efo/EFO_1001282	GCST008106	Genome-wide genotyping array
2019-07-11	31241743	Jaeger M	2019-04-24	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31241743	A Genome-Wide Functional Genomics Approach Identifies Susceptibility Pathways to Fungal Bloodstream Infection in Humans.	Candidemia	161 European ancestry cases, 152 European ancestry controls	NA	14q32.13	14	94916733	NR	NA - LINC02279		ENSG00000258933			43544	rs714286-?	rs714286	0	714286	intergenic_variant	1	NR	9E-6	5.045757490560675		3.5714285	[NR]	Illumina [5326313] (imputed)	N	Candidemia	http://www.ebi.ac.uk/efo/EFO_1001282	GCST008106	Genome-wide genotyping array
2019-07-11	31241743	Jaeger M	2019-04-24	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31241743	A Genome-Wide Functional Genomics Approach Identifies Susceptibility Pathways to Fungal Bloodstream Infection in Humans.	Candidemia	161 European ancestry cases, 152 European ancestry controls	NA	15q15.1	15	41863503	NR	SPTBN5			ENSG00000137877			rs8028958-?	rs8028958	0	8028958	intron_variant	0	NR	8E-8	7.096910013008056		2.5	[NR]	Illumina [5326313] (imputed)	N	Candidemia	http://www.ebi.ac.uk/efo/EFO_1001282	GCST008106	Genome-wide genotyping array
2019-07-11	31241743	Jaeger M	2019-04-24	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31241743	A Genome-Wide Functional Genomics Approach Identifies Susceptibility Pathways to Fungal Bloodstream Infection in Humans.	Candidemia	161 European ancestry cases, 152 European ancestry controls	NA	15q26.1	15	91834787	NR	THRAP3P2 - SLCO3A1	ENSG00000259057	ENSG00000176463		90832	18921	rs79298927-?	rs79298927	0	79298927	intergenic_variant	1	NR	5E-6	5.301029995663981		7.142857	[NR]	Illumina [5326313] (imputed)	N	Candidemia	http://www.ebi.ac.uk/efo/EFO_1001282	GCST008106	Genome-wide genotyping array
2019-07-11	31241743	Jaeger M	2019-04-24	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31241743	A Genome-Wide Functional Genomics Approach Identifies Susceptibility Pathways to Fungal Bloodstream Infection in Humans.	Candidemia	161 European ancestry cases, 152 European ancestry controls	NA	18q23	18	78635325	NR	Y_RNA - NA	ENSG00000199357			91137		rs72987764-?	rs72987764	0	72987764	intergenic_variant	1	NR	3E-6	5.522878745280337		2.631579	[NR]	Illumina [5326313] (imputed)	N	Candidemia	http://www.ebi.ac.uk/efo/EFO_1001282	GCST008106	Genome-wide genotyping array
2019-07-11	31241743	Jaeger M	2019-04-24	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31241743	A Genome-Wide Functional Genomics Approach Identifies Susceptibility Pathways to Fungal Bloodstream Infection in Humans.	Candidemia	161 European ancestry cases, 152 European ancestry controls	NA	22q12.3	22	36094437	NR	RBFOX2 - APOL3	ENSG00000100320	ENSG00000128284		65613	45893	rs4369966-G	rs4369966	0	4369966	intergenic_variant	1	0.38	8E-6	5.096910013008056		2.24	[NR]	Illumina [5326313] (imputed)	N	Candidemia	http://www.ebi.ac.uk/efo/EFO_1001282	GCST008106	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation (recipients)	up to 1,301 European ancestry recipients	up to 868 European ancestry recipients	2p22.2	2	37671088		CDC42EP3			ENSG00000163171			rs11686168-?	rs11686168	0	11686168	intron_variant	0	NR	4E-8	7.3979400086720375		1.35	[1.22-1.51]	Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0020106, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90085702	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation (recipients)	up to 1,301 European ancestry recipients	up to 868 European ancestry recipients	2q32.1	2	182574679		PDE1A - DNAJC10	ENSG00000115252	ENSG00000077232		51487	141576	rs4386288-?	rs4386288	0	4386288	intergenic_variant	1	NR	3E-7	6.522878745280337		0.7	[0.61-0.81]	Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0020106, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90085702	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation (recipients)	up to 1,301 European ancestry recipients	up to 868 European ancestry recipients	5q31.1	5	133933222		WSPAR - C5orf15	ENSG00000249073	ENSG00000113583		15953	22288	rs58681704-?	rs58681704	0	58681704	intergenic_variant	1	NR	2E-7	6.698970004336019		1.43	[1.25-1.63]	Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0020106, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90085702	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation (recipients)	up to 1,301 European ancestry recipients	up to 868 European ancestry recipients	20q13.31	20	56529169		FAM209A - FAM209B	ENSG00000124103	ENSG00000213714		3017	4077	rs6069770-?	rs6069770	0	6069770	intergenic_variant	1	NR	5E-7	6.301029995663981		0.46	[0.33-0.63]	Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0020106, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90085702	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation (recipients)	up to 1,301 European ancestry recipients	up to 868 European ancestry recipients	2q32.1	2	182503732		PDE1A			ENSG00000115252			rs1430146-?	rs1430146	0	1430146	intron_variant	0	NR	7E-7	6.154901959985743		0.71	[0.62-0.82]	Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0020106, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90085702	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus high-level reactivation after allogeneic hematopoietic cell transplantation (recipients)	up to 1,301 European ancestry recipients	up to 868 European ancestry recipients	4q32.1	4	160704669		LINC02477 - RPS14P7	ENSG00000249425	ENSG00000242635		117852	113753	rs78758335-?	rs78758335	0	78758335	intergenic_variant	1	NR	7E-7	6.154901959985743		0.59	[0.47-0.73]	Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0020106, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90085703	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus high-level reactivation after allogeneic hematopoietic cell transplantation (recipients)	up to 1,301 European ancestry recipients	up to 868 European ancestry recipients	10q22.1	10	71535584		CDH23			ENSG00000107736			rs11599279-?	rs11599279	0	11599279	intron_variant	0	NR	8E-7	6.096910013008056		1.74	[1.41-2.14]	Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0020106, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90085703	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus high-level reactivation after allogeneic hematopoietic cell transplantation (recipients)	up to 1,301 European ancestry recipients	up to 868 European ancestry recipients	13q32.3	13	100772317		NALCN-AS1			ENSG00000233009			rs1621374-?	rs1621374	0	1621374	intron_variant	0	NR	1E-6	6.0		1.67	[1.37-2.02]	Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0020106, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90085703	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation (donors)	up to 1,301 European ancestry donors	up to 868 European ancestry donors	8p23.1	8	6918790		RPL23AP96 - DEFA6	ENSG00000250752	ENSG00000285136		19322	5907	rs2741695-?	rs2741695	0	2741695	intergenic_variant	1	NR	1E-7	7.0		1.58	[1.35-1.85]	Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0020106, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90092527	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus high-level reactivation after allogeneic hematopoietic cell transplantation (donors)	up to 1,301 European ancestry donors	up to 868 European ancestry donors	2p15	2	61947437		COMMD1			ENSG00000173163			rs186559207-?	rs186559207	0	186559207	intron_variant	0	NR	3E-7	6.522878745280337		4.37	[2.75-6.95]	Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0020106, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90092528	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus high-level reactivation after allogeneic hematopoietic cell transplantation (donors)	up to 1,301 European ancestry donors	up to 868 European ancestry donors	3q13.31	3	117589319		RNU6-1200P - LINC02024	ENSG00000206889	ENSG00000241213		45008	89374	rs76102962-?	rs76102962	0	76102962	regulatory_region_variant	1	NR	2E-7	6.698970004336019		3.36	[2.28-4.95]	Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0020106, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90092528	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus high-level reactivation after allogeneic hematopoietic cell transplantation (donors)	up to 1,301 European ancestry donors	up to 868 European ancestry donors	7q21.11	7	82618952		MTHFD2P5 - PCLO	ENSG00000213530	ENSG00000186472		28261	135060	rs11312945-?	rs11312945	0	11312945	intergenic_variant	1	NR	8E-8	7.096910013008056		0.24	[0.13-0.44]	Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0020106, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90092528	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus high-level reactivation after allogeneic hematopoietic cell transplantation (donors)	up to 1,301 European ancestry donors	up to 868 European ancestry donors	16q24.1	16	85280611		GSE1			ENSG00000131149			rs2930240-?	rs2930240	0	2930240	intron_variant	0	NR	8E-7	6.096910013008056		2.88	[1.99-4.18]	Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0020106, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90092528	Genome-wide genotyping array
2016-02-04	25918841	Sanchez-Juan P	2015-04-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25918841	A genome wide association study links glutamate receptor pathway to sporadic Creutzfeldt-Jakob disease risk.	Creutzfeldt-Jakob disease (sporadic)	434 European ancestry cases, 1,939 European ancestry controls	1,109 European ancestry cases, 2,264 European ancestry controls	20p13	20	4696446	PRNP	PRNP			ENSG00000171867			rs6107516-C	rs6107516	0	6107516	intron_variant	0	0.759	8E-9	8.096910013008056		1.35	[1.22-1.50]	Affymetrix [279389]	N	sporadic Creutzfeld Jacob disease	http://www.ebi.ac.uk/efo/EFO_1000656	GCST002878	Genome-wide genotyping array
2016-02-04	25918841	Sanchez-Juan P	2015-04-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25918841	A genome wide association study links glutamate receptor pathway to sporadic Creutzfeldt-Jakob disease risk.	Creutzfeldt-Jakob disease (sporadic)	434 European ancestry cases, 1,939 European ancestry controls	1,109 European ancestry cases, 2,264 European ancestry controls	7q31.33	7	126789463	GRM8	GRM8			ENSG00000179603			rs6951643-A	rs6951643	0	6951643	intron_variant	0	0.519	2E-8	7.698970004336019		1.27	[1.17-1.38]	Affymetrix [279389]	N	sporadic Creutzfeld Jacob disease	http://www.ebi.ac.uk/efo/EFO_1000656	GCST002878	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA	15q15.1	15	41583162	NR	TYRO3			ENSG00000092445			rs7183231-C	rs7183231	0	7183231	3_prime_UTR_variant	0	NR	7E-6	5.154901959985743		1.0897	[1.05-1.13]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA	17q21.33	17	50726160	NR	LUC7L3			ENSG00000108848			rs35439759-CTT	rs35439759	0	35439759	intron_variant	0	NR	5E-6	5.301029995663981		1.0886	[1.05-1.13]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA	9q34.2	9	133279427	NR	ABO - Y_RNA	ENSG00000281879	ENSG00000199357		3403	23043	rs635634-T	rs635634	0	635634	intergenic_variant	1	NR	3E-8	7.522878745280337		1.1336	[1.09-1.18]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA	5q13.1	5	67720940	NR	LINC02242 - NA	ENSG00000249736			74151		rs12517727-A	rs12517727	0	12517727	intron_variant	1	NR	4E-6	5.3979400086720375		1.1574	[1.1-1.22]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA	9q34.2	9	133405414	NR	STKLD1, STKLD1			ENSG00000198870, ENSG00000281245			rs41302673-G	rs41302673	0	41302673	missense_variant	0	NR	5E-7	6.301029995663981		1.169	[1.11-1.23]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA	12q12	12	42624720	NR	LINC02402			ENSG00000257510			rs117347473-A	rs117347473	0	117347473	intron_variant	0	NR	2E-6	5.698970004336019		1.2641	[1.17-1.36]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA				NR							chr2:207883727-G	chr2:207883727	0			1	NR	9E-6	5.045757490560675		1.325	[1.2-1.45]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA	3p14.3	3	57985796	NR	PPIAP16 - FLNB	ENSG00000213509	ENSG00000136068		43492	22602	rs1866164-T	rs1866164	0	1866164	intergenic_variant	1	NR	2E-6	5.698970004336019		1.3466	[1.22-1.47]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA	8p23.1	8	8832883	NR	MFHAS1, MFHAS1			ENSG00000147324, ENSG00000285022			rs11995244-T	rs11995244	0	11995244	intron_variant	0	NR	7E-6	5.154901959985743		1.3719	[1.23-1.51]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA				NR							chr3:188240857-G	chr3:188240857	0			1	NR	8E-6	5.096910013008056		1.441	[1.28-1.6]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA	11q14.3	11	91380674	NR	LINC02758 - NA	ENSG00000248990			62697205		rs376479926-C	rs376479926	0	376479926	intergenic_variant	1	NR	7E-6	5.154901959985743		1.4867	[1.31-1.66]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA	3p24.1	3	28650645	NR	RBMS3			ENSG00000144642			rs115249766-C	rs115249766	0	115249766	intron_variant	0	NR	1E-6	6.0		1.4912	[1.33-1.65]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA	2q22.3	2	147162376	NR							rs143538360-C	rs143538360	0	143538360	intergenic_variant	1	NR	4E-6	5.3979400086720375		1.5529	[1.37-1.74]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA	3q13.13	3	111561865	NR	CD96			ENSG00000153283			rs369614251-C	rs369614251	1	62273558	intron_variant	0	NR	2E-6	5.698970004336019		1.1487651	[1.09-1.21]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA	5q13.2	5	72682599	NR	LINC02056 - RPL7P22	ENSG00000248371	ENSG00000226544		21930	42820	rs3010256-T	rs3010256	0	3010256	intergenic_variant	1	NR	2E-6	5.698970004336019		1.3351135	[1.22-1.45]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA	6p22.3	6	16680847	NR	ATXN1			ENSG00000124788			rs3793102-A	rs3793102	0	3793102	intron_variant	0	NR	6E-6	5.221848749616356		1.0899183	[1.05-1.13]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA	11q21	11	95146961	NR	BUD13P1 - SESN3	ENSG00000270689	ENSG00000149212		1836	18552	rs75887387-G	rs75887387	0	75887387	intergenic_variant	1	NR	5E-6	5.301029995663981		1.1214534	[1.07-1.17]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA	11q22.1	11	100065492	NR	CNTN5			ENSG00000149972			rs7112253-A	rs7112253	0	7112253	intron_variant	0	NR	4E-6	5.3979400086720375		1.1215792	[1.07-1.17]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA	12p11.23	12	26402797	NR	ITPR2			ENSG00000123104			rs3825165-T	rs3825165	0	3825165	intron_variant	0	NR	8E-6	5.096910013008056		1.1641443	[1.1-1.23]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2020-05-29	32152699	Nudel R	2020-03-09	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/32152699	A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.	Gastrointestinal infection	7,197 Danish ancestry cases, 37,062 Danish ancestry controls	NA	18q11.2	18	23596806	NR	NPC1 - ANKRD29	ENSG00000141458	ENSG00000154065		10300	2120	rs1652362-T	rs1652362	0	1652362	regulatory_region_variant	1	NR	9E-6	5.045757490560675		1.1914691	[1.11-1.27]	Illumina [11600722] (imputed)	N	digestive system infectious disorder	http://purl.obolibrary.org/obo/MONDO_0043424	GCST010008	Genome-wide genotyping array
2014-07-23	24324551	Deng X	2013-11-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24324551	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	207 Brazilian ancestry cases, 306 Brazilian ancestry controls	NA	1p36.21	1	14466039	NR	KAZN			ENSG00000189337			rs2480054-?	rs2480054	0	2480054	intron_variant	0	NR	4E-6	5.3979400086720375				Affymetrix [5486770] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST002285	Genome-wide genotyping array
2014-07-23	24324551	Deng X	2013-11-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24324551	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	207 Brazilian ancestry cases, 306 Brazilian ancestry controls	NA	3p13	3	69774942	NR	MITF			ENSG00000187098			rs78356356-?	rs78356356	0	78356356	intron_variant	0	NR	5E-6	5.301029995663981				Affymetrix [5486770] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST002285	Genome-wide genotyping array
2014-07-23	24324551	Deng X	2013-11-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24324551	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	207 Brazilian ancestry cases, 306 Brazilian ancestry controls	NA	6p21.31	6	33566949	NR	GGNBP1			ENSG00000204188			rs6910233-?	rs6910233	0	6910233	intron_variant	0	NR	4E-6	5.3979400086720375				Affymetrix [5486770] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST002285	Genome-wide genotyping array
2014-07-23	24324551	Deng X	2013-11-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24324551	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	207 Brazilian ancestry cases, 306 Brazilian ancestry controls	NA	6p21.31	6	34614497	C6orf106	ILRUN			ENSG00000196821			rs182503338-?	rs182503338	0	182503338	intron_variant	0	NR	1E-6	6.0				Affymetrix [5486770] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST002285	Genome-wide genotyping array
2014-07-23	24324551	Deng X	2013-11-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24324551	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	207 Brazilian ancestry cases, 306 Brazilian ancestry controls	NA	6p21.2	6	40360639	NR	TDRG1			ENSG00000204091			rs2038868-?	rs2038868	0	2038868	intron_variant	0	NR	9E-6	5.045757490560675				Affymetrix [5486770] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST002285	Genome-wide genotyping array
2014-07-23	24324551	Deng X	2013-11-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24324551	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	207 Brazilian ancestry cases, 306 Brazilian ancestry controls	NA	6p21.1	6	44204326	NR	CAPN11 - RN7SL811P	ENSG00000137225	ENSG00000265439		19925	5440	rs35131064-?	rs35131064	0	35131064	regulatory_region_variant	1	NR	6E-6	5.221848749616356				Affymetrix [5486770] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST002285	Genome-wide genotyping array
2014-07-23	24324551	Deng X	2013-11-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24324551	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	207 Brazilian ancestry cases, 306 Brazilian ancestry controls	NA	8p22	8	17604713	NR	PDGFRL			ENSG00000104213			rs7829987-?	rs7829987	0	7829987	non_coding_transcript_exon_variant	0	NR	4E-6	5.3979400086720375				Affymetrix [5486770] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST002285	Genome-wide genotyping array
2014-07-23	24324551	Deng X	2013-11-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24324551	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	207 Brazilian ancestry cases, 306 Brazilian ancestry controls	NA	8p12	8	32460839	NR	NRG1			ENSG00000157168			rs12542743-?	rs12542743	0	12542743	intron_variant	0	NR	4E-6	5.3979400086720375				Affymetrix [5486770] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST002285	Genome-wide genotyping array
2014-07-23	24324551	Deng X	2013-11-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24324551	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	207 Brazilian ancestry cases, 306 Brazilian ancestry controls	NA	11p15.4	11	7374960	SYT9	SYT9			ENSG00000170743			rs10769783-?	rs10769783	0	10769783	intron_variant	0	NR	6E-6	5.221848749616356				Affymetrix [5486770] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST002285	Genome-wide genotyping array
2014-07-23	24324551	Deng X	2013-11-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24324551	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	207 Brazilian ancestry cases, 306 Brazilian ancestry controls	NA	12p12.3	12	18871624	NR							rs12319113-?	rs12319113	0	12319113	intergenic_variant	1	NR	1E-6	6.0				Affymetrix [5486770] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST002285	Genome-wide genotyping array
2014-07-23	24324551	Deng X	2013-11-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24324551	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	207 Brazilian ancestry cases, 306 Brazilian ancestry controls	NA	12p12.1	12	21138627	SLCO1B1	SLCO1B1			ENSG00000134538			rs4149018-?	rs4149018	0	4149018	intron_variant	0	NR	1E-7	7.0				Affymetrix [5486770] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST002285	Genome-wide genotyping array
2014-07-23	24324551	Deng X	2013-11-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24324551	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	207 Brazilian ancestry cases, 306 Brazilian ancestry controls	NA	14q11.2	14	21728267	NR	TRAV3 - TRAV4	ENSG00000211777	ENSG00000211778		3946	7885	rs10132760-?	rs10132760	0	10132760	intergenic_variant	1	NR	5E-6	5.301029995663981				Affymetrix [5486770] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST002285	Genome-wide genotyping array
2014-07-23	24324551	Deng X	2013-11-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24324551	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	207 Brazilian ancestry cases, 306 Brazilian ancestry controls	NA	15q15.1	15	42142639	NR	PLA2G4F			ENSG00000168907			rs1356410-?	rs1356410	0	1356410	missense_variant	0	NR	8E-6	5.096910013008056				Affymetrix [5486770] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST002285	Genome-wide genotyping array
2014-07-23	24324551	Deng X	2013-11-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24324551	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	207 Brazilian ancestry cases, 306 Brazilian ancestry controls	NA	14q23.3	14	64852643	NR	SPTB			ENSG00000070182			rs35955841-?	rs35955841	0	35955841	intron_variant	0	NR	3E-6	5.522878745280337				Affymetrix [5486770] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST002285	Genome-wide genotyping array
2014-07-23	24324551	Deng X	2013-11-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24324551	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	207 Brazilian ancestry cases, 306 Brazilian ancestry controls	NA	19p12	19	21952468	NR	ZNF208			ENSG00000160321			rs2262909-?	rs2262909	0	2262909	intron_variant	0	NR	4E-6	5.3979400086720375				Affymetrix [5486770] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST002285	Genome-wide genotyping array
2014-07-23	24324551	Deng X	2013-11-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24324551	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	207 Brazilian ancestry cases, 306 Brazilian ancestry controls	NA	21q22.11	21	31512535	NR	TIAM1			ENSG00000156299			rs73199525-?	rs73199525	0	73199525	intron_variant	0	NR	7E-6	5.154901959985743				Affymetrix [5486770] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST002285	Genome-wide genotyping array
2014-07-23	24324551	Deng X	2013-11-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24324551	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	207 Brazilian ancestry cases, 306 Brazilian ancestry controls	NA	22q12.3	22	34748420	NR	NA - LINC02885		ENSG00000286592			8256	rs4493363-?	rs4493363	0	4493363	intergenic_variant	1	NR	4E-6	5.3979400086720375				Affymetrix [5486770] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST002285	Genome-wide genotyping array
2014-07-23	24324551	Deng X	2013-11-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24324551	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	207 Brazilian ancestry cases, 306 Brazilian ancestry controls	NA	15q14	15	38142690	NR	LINC01852 - NA	ENSG00000236914			69700		rs10468092-?	rs10468092	0	10468092	non_coding_transcript_exon_variant	1	NR	4E-6	5.3979400086720375				Affymetrix [5486770] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST002285	Genome-wide genotyping array
2021-08-25	33539531	Casares-Marfil D	2021-02-04	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33539531	A genome-wide association study identifies novel susceptibility loci in chronic Chagas cardiomyopathy.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	981 Latin American cases, 1,328 Latin American controls	NA	5p14.3	5	18718887		LINC02100			ENSG00000248693			rs10472156-A	rs10472156	0	10472156	intron_variant	0	0.73	9E-7	6.045757490560675		1.1	[1.06-1.14]	Illumina [8218190] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST90026454	Genome-wide genotyping array
2021-08-25	33539531	Casares-Marfil D	2021-02-04	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33539531	A genome-wide association study identifies novel susceptibility loci in chronic Chagas cardiomyopathy.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	981 Latin American cases, 1,328 Latin American controls	NA	9q31.2	9	107479876		RNU6-492P - KLF4	ENSG00000199905	ENSG00000136826		4737	4976	rs10759240-C	rs10759240	0	10759240	intergenic_variant	1	0.54	5E-7	6.301029995663981		0.92	[0.89-0.95]	Illumina [8218190] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST90026454	Genome-wide genotyping array
2021-08-25	33539531	Casares-Marfil D	2021-02-04	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33539531	A genome-wide association study identifies novel susceptibility loci in chronic Chagas cardiomyopathy.	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	981 Latin American cases, 1,328 Latin American controls	NA	11q13.1	11	65047341		NAALADL1			ENSG00000168060			rs2458298-G	rs2458298	0	2458298	intron_variant	0	0.26	3E-8	7.522878745280337		0.9	[0.87-0.94]	Illumina [8218190] (imputed)	N	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529	GCST90026454	Genome-wide genotyping array
2021-08-24	33542050	Namkoong H	2021-02-04	Eur Respir J	www.ncbi.nlm.nih.gov/pubmed/33542050	Genome-wide association study in patients with pulmonary <i>Mycobacterium avium</i> complex disease.	Pulmonary mycobacterium avium complex disease	475 Japanese ancestry cases, 417 Japanese ancestry controls	1,313 East Asian ancestry cases, 2,440 East Asian ancestry controls, 276 European ancestry cases, 206 European ancestry controls	16p12.2	16	23757389		CHP2			ENSG00000166869			rs109592-?	rs109592	0	109592	intron_variant	0	NR	2E-13	12.698970004336019	(East Asian)	0.54	[0.45-0.63]	Affymetrix [5876247] (imputed)	N	Mycobacterium avium complex disease	http://www.ebi.ac.uk/efo/EFO_0007386	GCST90026449	Genome-wide genotyping array
2009-02-05	19081515	Mead S	2008-12-11	Lancet Neurol	www.ncbi.nlm.nih.gov/pubmed/19081515	Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study.	Creutzfeldt-Jakob disease	117 European ancestry cases, 3,083 European ancestry controls	2 European ancestry vCJD cases, 506 Oceania ancestry sCJD cases, 28 Oceania ancestry iCJD cases, 151 Oceania ancestry Kuru cases, 125 Oceania ancestry Kuru resistant cases, 3,608 European ancestry controls, 562 Oceania ancestry controls	8q21.13	8	79315213	STMN2	NA - HMGB1P46		ENSG00000254146			27857987	rs1460163-A	rs1460163	0	1460163	intergenic_variant	1	NR	6E-8	7.221848749616356				Affymetrix [288908]	N	Creutzfeldt Jacob Disease	http://www.ebi.ac.uk/efo/EFO_0004226	GCST000294	Genome-wide genotyping array
2009-02-05	19081515	Mead S	2008-12-11	Lancet Neurol	www.ncbi.nlm.nih.gov/pubmed/19081515	Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study.	Creutzfeldt-Jakob disease	117 European ancestry cases, 3,083 European ancestry controls	2 European ancestry vCJD cases, 506 Oceania ancestry sCJD cases, 28 Oceania ancestry iCJD cases, 151 Oceania ancestry Kuru cases, 125 Oceania ancestry Kuru resistant cases, 3,608 European ancestry controls, 562 Oceania ancestry controls	20p13	20	4699605	PRNP	PRNP			ENSG00000171867			rs1799990-A	rs1799990	0	1799990	missense_variant	0	NR	2E-21	20.69897000433602				Affymetrix [288908]	N	Creutzfeldt Jacob Disease	http://www.ebi.ac.uk/efo/EFO_0004226	GCST000294	Genome-wide genotyping array
2012-01-07	22137330	Sanchez-Juan P	2011-11-30	Neurobiol Aging	www.ncbi.nlm.nih.gov/pubmed/22137330	Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk.	Creutzfeldt-Jakob disease (variant)	93 European ancestry cases, 1,504 European ancestry controls	42 European ancestry cases	20p13	20	4696446	PRNP	PRNP			ENSG00000171867			rs6107516-?	rs6107516	0	6107516	intron_variant	0	NR	3E-18	17.522878745280337				Affymetrix [287554]	N	Creutzfeldt Jacob Disease	http://www.ebi.ac.uk/efo/EFO_0004226	GCST001334	Genome-wide genotyping array
2012-01-07	22137330	Sanchez-Juan P	2011-11-30	Neurobiol Aging	www.ncbi.nlm.nih.gov/pubmed/22137330	Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk.	Creutzfeldt-Jakob disease (variant)	93 European ancestry cases, 1,504 European ancestry controls	42 European ancestry cases	20p13	20	4717980	PRNP	PRNP - PRND	ENSG00000171867	ENSG00000171864		16390	3929	rs6116492-?	rs6116492	0	6116492	regulatory_region_variant	1	NR	5E-7	6.301029995663981				Affymetrix [287554]	N	Creutzfeldt Jacob Disease	http://www.ebi.ac.uk/efo/EFO_0004226	GCST001334	Genome-wide genotyping array
2012-01-07	22137330	Sanchez-Juan P	2011-11-30	Neurobiol Aging	www.ncbi.nlm.nih.gov/pubmed/22137330	Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk.	Creutzfeldt-Jakob disease (variant)	93 European ancestry cases, 1,504 European ancestry controls	42 European ancestry cases	12q21.1	12	71183321	NR	TSPAN8			ENSG00000127324			rs1495377-?	rs1495377	0	1495377	intron_variant	0	NR	2E-6	5.698970004336019				Affymetrix [287554]	N	Creutzfeldt Jacob Disease	http://www.ebi.ac.uk/efo/EFO_0004226	GCST001334	Genome-wide genotyping array
2012-01-07	22137330	Sanchez-Juan P	2011-11-30	Neurobiol Aging	www.ncbi.nlm.nih.gov/pubmed/22137330	Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk.	Creutzfeldt-Jakob disease (variant)	93 European ancestry cases, 1,504 European ancestry controls	42 European ancestry cases	11q24.2	11	125371150	NR	PKNOX2			ENSG00000165495			rs12273350-?	rs12273350	0	12273350	intron_variant	0	NR	2E-6	5.698970004336019				Affymetrix [287554]	N	Creutzfeldt Jacob Disease	http://www.ebi.ac.uk/efo/EFO_0004226	GCST001334	Genome-wide genotyping array
2012-01-07	22137330	Sanchez-Juan P	2011-11-30	Neurobiol Aging	www.ncbi.nlm.nih.gov/pubmed/22137330	Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk.	Creutzfeldt-Jakob disease (variant)	93 European ancestry cases, 1,504 European ancestry controls	42 European ancestry cases	8p22	8	17348068	MTMR7	MTMR7			ENSG00000003987			rs4921542-?	rs4921542	0	4921542	intron_variant	0	NR	2E-8	7.698970004336019		3.25	[2.22-4.78]	Affymetrix [287554]	N	Creutzfeldt Jacob Disease	http://www.ebi.ac.uk/efo/EFO_0004226	GCST001334	Genome-wide genotyping array
2012-01-07	22137330	Sanchez-Juan P	2011-11-30	Neurobiol Aging	www.ncbi.nlm.nih.gov/pubmed/22137330	Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk.	Creutzfeldt-Jakob disease (variant)	93 European ancestry cases, 1,504 European ancestry controls	42 European ancestry cases	2q11.2	2	100807869	NPAS2	NA - NPAS2		ENSG00000170485			12270	rs7565981-?	rs7565981	0	7565981	intergenic_variant	1	NR	4E-8	7.3979400086720375		2.98	[2.03-4.35]	Affymetrix [287554]	N	Creutzfeldt Jacob Disease	http://www.ebi.ac.uk/efo/EFO_0004226	GCST001334	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Pyelonephritis	1,811 East Asian ancestry cases, 175,288 East Asian ancestry controls	NA	14q21.2	14	44736740		FSCB - LINC02302	ENSG00000189139	ENSG00000258998		229457	26413	rs17703846-T	rs17703846	0	17703846	intergenic_variant	1	0.016129254	2E-8	7.698970004336019		0.83403707	[0.54-1.13] unit increase	Illumina [13429797] (imputed)	N	pyelonephritis	http://www.ebi.ac.uk/efo/EFO_1001141	GCST90018689	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus infection after allogeneic hematopoietic cell transplantation (recipients)	up to 1,301 European ancestry recipients	up to 868 European ancestry recipients	1q42.3	1	236003668		NID1			ENSG00000116962			rs140964551-?	rs140964551	0	140964551	intron_variant	0	NR	7E-7	6.154901959985743				Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus infection, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0001062, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90085704	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus infection after allogeneic hematopoietic cell transplantation (recipients)	up to 1,301 European ancestry recipients	up to 868 European ancestry recipients	16p13.3	16	5715120		RBFOX1			ENSG00000078328			rs145791081-?	rs145791081	0	145791081	intron_variant	0	NR	4E-8	7.3979400086720375		3.31	[2.29-4.78]	Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus infection, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0001062, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90085704	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus infection after allogeneic hematopoietic cell transplantation (recipients)	up to 1,301 European ancestry recipients	up to 868 European ancestry recipients	17q22	17	54656317		ISCA1P3 - ARL2BPP8	ENSG00000261965	ENSG00000263125		178149	97848	rs117683430-?	rs117683430	0	117683430	intron_variant	1	NR	2E-7	6.698970004336019		2.39	[1.78-3.21]	Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus infection, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0001062, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90085704	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus infection after allogeneic hematopoietic cell transplantation (recipients)	up to 1,301 European ancestry recipients	up to 868 European ancestry recipients	17q24.3	17	72304712		LINC00511			ENSG00000227036			rs1555594574-?	rs1555594574	0	1555594574	intron_variant	0	NR	3E-7	6.522878745280337				Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus infection, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0001062, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90085704	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus infection after allogeneic hematopoietic cell transplantation (donors)	up to 1,301 European ancestry donors	up to 868 European ancestry donors	2p25.1	2	10419186		HPCAL1			ENSG00000115756			rs79661622-?	rs79661622	0	79661622	intron_variant	0	NR	4E-7	6.3979400086720375		0.27	[0.14-0.51]	Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus infection, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0001062, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90092529	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus infection after allogeneic hematopoietic cell transplantation (donors)	up to 1,301 European ancestry donors	up to 868 European ancestry donors	3q13.31	3	116387566		LSAMP			ENSG00000185565			rs77488831-?	rs77488831	0	77488831	intron_variant	0	NR	8E-7	6.096910013008056		0.14	[0.04-0.43]	Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus infection, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0001062, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90092529	Genome-wide genotyping array
2022-02-09	34269803	Casto A	2021-07-16	Blood	www.ncbi.nlm.nih.gov/pubmed/34269803	Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation.	Cytomegalovirus infection after allogeneic hematopoietic cell transplantation (donors)	up to 1,301 European ancestry donors	up to 868 European ancestry donors	9q34.3	9	137352913		EXD3			ENSG00000187609			rs28688712-?	rs28688712	0	28688712	non_coding_transcript_exon_variant	0	NR	1E-6	6.0		0.59	[0.47-0.74]	Affymetrix, Illumina [29826485] (imputed)	N	cytomegalovirus infection, response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0001062, http://www.ebi.ac.uk/efo/EFO_0007044	GCST90092529	Genome-wide genotyping array
2022-02-07	34125832	Borda V	2021-06-14	PLoS Negl Trop Dis	www.ncbi.nlm.nih.gov/pubmed/34125832	Whole-exome sequencing reveals insights into genetic susceptibility to Congenital Zika Syndrome.	Congenital Zika syndrome	29 Hispanic or Latin American cases, 11 Hispanic or Latin American controls	NA	1p36.22	1	11524107		DISP3			ENSG00000204624			rs2076469-G	rs2076469	0	2076469	intron_variant	0	0.14	3E-6	5.522878745280337	(dominant model, unadjusted p-value)	0.012	[9.0E-5-0.1136]	NR [144153]	N			GCST90093463	Exome-wide sequencing
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Ringworm	692 East Asian ancestry cases, 178,034 East Asian ancestry controls	NA	10q26.3	10	129000451		LINC02667 - MGMT	ENSG00000224190	ENSG00000170430		84022	466739	rs561774588-G	rs561774588	0	561774588	intergenic_variant	1	0.001401638	5E-9	8.301029995663981		7.0142403	[4.66-9.37] unit increase	Illumina [13429980] (imputed)	N	tinea	http://www.ebi.ac.uk/efo/EFO_0007510	GCST90018694	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Ringworm	46 European ancestry cases, 354,498 European ancestry controls, 692 East Asian ancestry cases, 178,034 East Asian ancestry controls	NA	10q26.3	10	129000451		LINC02667 - MGMT	ENSG00000224190	ENSG00000170430		84022	466739	rs561774588-G	rs561774588	0	561774588	intergenic_variant	1	NR	5E-9	8.301029995663981		7.0142	[4.66-9.37] unit increase	Affymetrix, Illumina [20458126] (imputed)	N	tinea	http://www.ebi.ac.uk/efo/EFO_0007510	GCST90018914	Genome-wide genotyping array
2016-02-05	25897833	Thompson AG	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897833	Genome-wide association study of behavioural and psychiatric features in human prion disease.	Psychotic symptoms and prion disease	Up to 170 cases, 5,200 controls	NA	6p21.33	6	31472305	HCG26	HCP5			ENSG00000206337			rs1055569-?	rs1055569	0	1055569	non_coding_transcript_exon_variant	0	0.291	3E-6	5.522878745280337		2.36	[1.663.35]	Illumina [518938]	N	prion disease, psychotic symptoms	http://www.ebi.ac.uk/efo/EFO_0004720, http://www.ebi.ac.uk/efo/EFO_0005940	GCST002871	Genome-wide genotyping array
2016-02-05	25897833	Thompson AG	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897833	Genome-wide association study of behavioural and psychiatric features in human prion disease.	Mood disorder and prion disease	Up to 170 cases, 5,200 controls	NA	7q34	7	141600811	AGK	AGK, AGK			ENSG00000006530, ENSG00000262327			rs7789850-?	rs7789850	0	7789850	intron_variant	0	0.026	2E-6	5.698970004336019		4.6	[2.707.83]	Illumina [518938]	N	prion disease, mood disorder	http://www.ebi.ac.uk/efo/EFO_0004720, http://www.ebi.ac.uk/efo/EFO_0004247	GCST002862	Genome-wide genotyping array
2016-02-05	25897833	Thompson AG	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897833	Genome-wide association study of behavioural and psychiatric features in human prion disease.	Mood disorder and prion disease	Up to 170 cases, 5,200 controls	NA	11q21	11	94674570	PIWIL4	LINC02700 - AMOTL1	ENSG00000255666	ENSG00000166025		21686	31861	rs12789145-?	rs12789145	0	12789145	intron_variant	1	0.084	4E-6	5.3979400086720375				Illumina [518938]	N	prion disease, mood disorder	http://www.ebi.ac.uk/efo/EFO_0004720, http://www.ebi.ac.uk/efo/EFO_0004247	GCST002862	Genome-wide genotyping array
2016-02-05	25897833	Thompson AG	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897833	Genome-wide association study of behavioural and psychiatric features in human prion disease.	Mood disorder and prion disease	Up to 170 cases, 5,200 controls	NA	5q23.2	5	122518830	SNCAIP	MGC32805 - NA	ENSG00000250328			39743		rs6867820-?	rs6867820	0	6867820	intergenic_variant	1	0.224	6E-6	5.221848749616356		2.24	[1.603.12]	Illumina [518938]	N	prion disease, mood disorder	http://www.ebi.ac.uk/efo/EFO_0004720, http://www.ebi.ac.uk/efo/EFO_0004247	GCST002862	Genome-wide genotyping array
2016-02-05	25897833	Thompson AG	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897833	Genome-wide association study of behavioural and psychiatric features in human prion disease.	Behavioral disturbance or psychiatric symptoms and prion disease	Up to 170 cases, 5,200 controls	NA	10q21.2	10	60167108	ANK3	ANK3			ENSG00000151150			rs10509125-?	rs10509125	0	10509125	intron_variant	0	0.402	1E-6	6.0		2.09	[1.552.82]	Illumina [518938]	N	prion disease, Behavioral abnormality	http://www.ebi.ac.uk/efo/EFO_0004720, http://purl.obolibrary.org/obo/HP_0000708	GCST002866	Genome-wide genotyping array
2016-02-05	25897833	Thompson AG	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897833	Genome-wide association study of behavioural and psychiatric features in human prion disease.	Behavioral disturbance or psychiatric symptoms and prion disease	Up to 170 cases, 5,200 controls	NA	13q34	13	110283880	COL4A1	COL4A1			ENSG00000187498			rs561437-?	rs561437	0	561437	intron_variant	0	0.499	5E-6	5.301029995663981		2.04	[1.49-2.86]	Illumina [518938]	N	prion disease, Behavioral abnormality	http://www.ebi.ac.uk/efo/EFO_0004720, http://purl.obolibrary.org/obo/HP_0000708	GCST002866	Genome-wide genotyping array
2016-02-05	25897833	Thompson AG	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897833	Genome-wide association study of behavioural and psychiatric features in human prion disease.	Behavioral disturbance or psychiatric symptoms and prion disease	Up to 170 cases, 5,200 controls	NA	14q21.3	14	48132233	LOC100506433							rs7151968-?	rs7151968	0	7151968	intergenic_variant	1	0.205	6E-6	5.221848749616356		2.12	[1.552.90]	Illumina [518938]	N	prion disease, Behavioral abnormality	http://www.ebi.ac.uk/efo/EFO_0004720, http://purl.obolibrary.org/obo/HP_0000708	GCST002866	Genome-wide genotyping array
2011-11-09	22001756	Khor CC	2011-10-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22001756	Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1.	Dengue shock syndrome	2,008 Vietnamese ancestry child cases, 2,018 Vietnamese ancestry child controls	1,737 Vietnamese ancestry child cases, 2,934 Vietnamese ancestry child controls	6p21.33	6	31507709	MICB	MICB, MICB, MICB, MICB			ENSG00000204516, ENSG00000234218, ENSG00000227772, ENSG00000238289			rs3132468-?	rs3132468	0	3132468	intron_variant	0	0.13	4E-11	10.397940008672037		1.34	[1.23-1.46]	Illumina [481342]	N	Dengue Hemorrhagic Fever	http://www.ebi.ac.uk/efo/EFO_0004227	GCST001278	Genome-wide genotyping array
2011-11-09	22001756	Khor CC	2011-10-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22001756	Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1.	Dengue shock syndrome	2,008 Vietnamese ancestry child cases, 2,018 Vietnamese ancestry child controls	1,737 Vietnamese ancestry child cases, 2,934 Vietnamese ancestry child controls	8q11.23	8	54527508	NR	RP1			ENSG00000104237			rs10104997-?	rs10104997	0	10104997	intron_variant	0	NR	9E-7	6.045757490560675		1.2	[NR]	Illumina [481342]	N	Dengue Hemorrhagic Fever	http://www.ebi.ac.uk/efo/EFO_0004227	GCST001278	Genome-wide genotyping array
2011-11-09	22001756	Khor CC	2011-10-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22001756	Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1.	Dengue shock syndrome	2,008 Vietnamese ancestry child cases, 2,018 Vietnamese ancestry child controls	1,737 Vietnamese ancestry child cases, 2,934 Vietnamese ancestry child controls	10q23.33	10	94298541	PLCE1	PLCE1			ENSG00000138193			rs3765524-?	rs3765524	0	3765524	missense_variant	0	0.70	3E-10	9.522878745280337		1.25	[1.16-1.33]	Illumina [481342]	N	Dengue Hemorrhagic Fever	http://www.ebi.ac.uk/efo/EFO_0004227	GCST001278	Genome-wide genotyping array
2011-11-09	22001756	Khor CC	2011-10-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22001756	Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1.	Dengue shock syndrome	2,008 Vietnamese ancestry child cases, 2,018 Vietnamese ancestry child controls	1,737 Vietnamese ancestry child cases, 2,934 Vietnamese ancestry child controls	16p13.3	16	6767374	NR	RBFOX1			ENSG00000078328			rs6500818-?	rs6500818	0	6500818	intron_variant	0	NR	2E-7	6.698970004336019		1.31	[NR]	Illumina [481342]	N	Dengue Hemorrhagic Fever	http://www.ebi.ac.uk/efo/EFO_0004227	GCST001278	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Dysentery	411 East Asian ancestry cases, 178,071 East Asian ancestry controls	NA	7p14.2	7	35324908		TBX20 - HERPUD2	ENSG00000164532	ENSG00000122557		70808	307751	rs190894416-T	rs190894416	0	190894416	intron_variant	1	0.01084269	7E-9	8.154901959985743		2.7683785	[1.83-3.71] unit increase	Illumina [13429933] (imputed)	N	dysentery	http://www.ebi.ac.uk/efo/EFO_1001869	GCST90018616	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Dysentery	2,733 European ancestry cases, 346,689 European ancestry controls, 411 East Asian ancestry cases, 178,071 East Asian ancestry controls	NA	5q34	5	165219146		RNU6-209P - LINC01938	ENSG00000206845	ENSG00000254066		283878	1431	rs143977447-A	rs143977447	0	143977447	intergenic_variant	1	NR	1E-8	8.0		1.2871	[0.84-1.73] unit increase	Affymetrix, Illumina [20457834] (imputed)	N	dysentery	http://www.ebi.ac.uk/efo/EFO_1001869	GCST90018836	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Dysentery	2,733 European ancestry cases, 346,689 European ancestry controls, 411 East Asian ancestry cases, 178,071 East Asian ancestry controls	NA	7p14.2	7	35324908		TBX20 - HERPUD2	ENSG00000164532	ENSG00000122557		70808	307751	rs190894416-T	rs190894416	0	190894416	intron_variant	1	NR	7E-9	8.154901959985743		2.7684	[1.83-3.71] unit increase	Affymetrix, Illumina [20457834] (imputed)	N	dysentery	http://www.ebi.ac.uk/efo/EFO_1001869	GCST90018836	Genome-wide genotyping array
2015-07-07	25383971	Dunstan SJ	2014-11-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25383971	Variation at HLA-DRB1 is associated with resistance to enteric fever.	Enteric fever	432 Vietnamese ancestry cases, 2,011 Vietnamese ancestry controls	151 Vietnamese ancestry cases,  668 Vietnamese ancestry controls, 595 Nepalese ancestry cases, 386 Nepalese ancestry controls	6p21.32	6	32713151	HLA-DRB1, HLA-DQB1	MTCO3P1 - HLA-DQB3	ENSG00000237145	ENSG00000224197		6196	17607	rs7765379-A	rs7765379	0	7765379	regulatory_region_variant	1	0.945	2E-13	12.698970004336019		4.55	[2.94-6.67]	Illumina [709725]	N	typhoid fever	http://www.ebi.ac.uk/efo/EFO_0006789	GCST002693	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Typhoid fever	2,733 European ancestry cases, 346,689 European ancestry controls, 257 East Asian ancestry cases, 178,071 East Asian ancestry controls	NA	5q34	5	165219146		RNU6-209P - LINC01938	ENSG00000206845	ENSG00000254066		283878	1431	rs143977447-A	rs143977447	0	143977447	intergenic_variant	1	NR	1E-8	8.0		1.2871	[0.84-1.73] unit increase	Affymetrix, Illumina [20457818] (imputed)	N	typhoid fever	http://www.ebi.ac.uk/efo/EFO_0006789	GCST90018931	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Pulmonary tuberculosis	7,800 East Asian ancestry cases, 170,871 East Asian ancestry controls	NA	6p21.32	6	32657607		HLA-DQA1 - HLA-DQB1	ENSG00000196735	ENSG00000231939		10545	1860	rs140780894-T	rs140780894	0	140780894	regulatory_region_variant	1	0.370504007	3E-23	22.522878745280337		0.18728146	[0.15-0.22] unit increase	Illumina [13429952] (imputed)	N	pulmonary tuberculosis	http://www.ebi.ac.uk/efo/EFO_1000049	GCST90018672	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Pulmonary tuberculosis	895 European ancestry cases, 476,491 European ancestry controls, 7,800 East Asian ancestry cases, 170,871 East Asian ancestry controls	NA	6p21.32	6	32657607		HLA-DQA1 - HLA-DQB1	ENSG00000196735	ENSG00000231939		10545	1860	rs140780894-T	rs140780894	0	140780894	regulatory_region_variant	1	NR	3E-23	22.522878745280337		0.1873	[0.15-0.22] unit increase	Affymetrix, Illumina [25844658] (imputed)	N	pulmonary tuberculosis	http://www.ebi.ac.uk/efo/EFO_1000049	GCST90018892	Genome-wide genotyping array
2017-06-23	28355295	Hong EP	2017-03-29	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28355295	Risk prediction of pulmonary tuberculosis using genetic and conventional risk factors in adult Korean population.	Tuberculosis	467 Korean ancestry cases, 1,313 Korean ancestry controls	179 Korean ancestry cases, 500 Korean ancestry controls	6q27	6	164882472	C6orf118							rs9365798-C	rs9365798	0	9365798	regulatory_region_variant	1	NR	2E-6	5.698970004336019	(dominant model)	1.59	[1.32-1.92]	Affymetrix [~ 4750000] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST004226	Genome-wide genotyping array
2019-11-22	31092817	Lees JA	2019-05-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31092817	Joint sequencing of human and pathogen genomes reveals the genetics of pneumococcal meningitis.	Bacterial meningitis	1,149 European and unknown ancestry cases, 4,836 European and unknown ancestry controls	NA	6q25.2	6	153261855	RGS17							rs3870369-T	rs3870369	0	3870369	intron_variant	1	NR	7E-8	7.154901959985743		1.27	[NR]	Illumina [6800000] (imputed)	N	bacterial meningitis	http://www.ebi.ac.uk/efo/EFO_1000831	GCST009083	Genome-wide genotyping array
2019-11-22	31092817	Lees JA	2019-05-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31092817	Joint sequencing of human and pathogen genomes reveals the genetics of pneumococcal meningitis.	Bacterial meningitis	2,345 European and unknown ancestry cases, 345,042 European and unknown ancestry controls	NA	15q24.1	15	74309203	CCDC33	CCDC33			ENSG00000140481			rs116264669-?	rs116264669	0	116264669	intron_variant	0	NR	4E-8	7.3979400086720375				Affymetrix, Illumina [6800000] (imputed)	N	bacterial meningitis	http://www.ebi.ac.uk/efo/EFO_1000831	GCST009085	Genome-wide genotyping array
2019-11-22	31092817	Lees JA	2019-05-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31092817	Joint sequencing of human and pathogen genomes reveals the genetics of pneumococcal meningitis.	Severe bacterial meningitis	277 European and unknown ancestry cases, 4,836 European and unknown ancestry controls	NA	1p31.3	1	64215092	UBE2U, ROR1	UBE2U			ENSG00000177414			rs12081070-A	rs12081070	0	12081070	intron_variant	0	NR	2E-8	7.698970004336019		1.62	NR	Illumina [6800000] (imputed)	N	bacterial meningitis	http://www.ebi.ac.uk/efo/EFO_1000831	GCST009088	Genome-wide genotyping array
2019-11-22	31092817	Lees JA	2019-05-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31092817	Joint sequencing of human and pathogen genomes reveals the genetics of pneumococcal meningitis.	Severe bacterial meningitis	277 European and unknown ancestry cases, 4,836 European and unknown ancestry controls	NA	4q34.3	4	181902651	AC108142.1	TENM3-AS1			ENSG00000177822			rs2309554-A	rs2309554	0	2309554	intron_variant	0	NR	4E-7	6.3979400086720375		1.58	NR	Illumina [6800000] (imputed)	N	bacterial meningitis	http://www.ebi.ac.uk/efo/EFO_1000831	GCST009088	Genome-wide genotyping array
2019-11-22	31092817	Lees JA	2019-05-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31092817	Joint sequencing of human and pathogen genomes reveals the genetics of pneumococcal meningitis.	Severe bacterial meningitis	277 European and unknown ancestry cases, 4,836 European and unknown ancestry controls	NA	9p13.2	9	37382234	ZCCHC7, GRHPR	ZCCHC7 - LINC01627	ENSG00000147905	ENSG00000224648		24085	944	rs72739603-A	rs72739603	0	72739603	intergenic_variant	1	NR	7E-7	6.154901959985743		2.36	NR	Illumina [6800000] (imputed)	N	bacterial meningitis	http://www.ebi.ac.uk/efo/EFO_1000831	GCST009088	Genome-wide genotyping array
2021-08-27	33649182	Penova M	2021-03-01	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/33649182	Genome wide association study of HTLV-1-associated myelopathy/tropical spastic paraparesis in the Japanese population.	HTLV-1 associated myelopathy	731 Japanese ancestry cases, 846 Japanese ancestry controls	NA	6p21.33	6	30946974		HCG21, HCG21, HCG21, HCG21, HCG21, MUCL3, MUCL3, MUCL3, MUCL3, MUCL3, SFTA2			ENSG00000228448, ENSG00000233529, ENSG00000223454, ENSG00000235747, ENSG00000230541, ENSG00000168631, ENSG00000232308, ENSG00000229284, ENSG00000257232, ENSG00000232251, ENSG00000196260			rs2517451-C	rs2517451	0	2517451	intron_variant	0	0.04	2E-9	8.698970004336019		2.69	[1.95-3.71]	Illumina [126394]	N	tropical spastic paraparesis	http://www.ebi.ac.uk/efo/EFO_0007527	GCST90026455	Genome-wide genotyping array
2021-08-27	33649182	Penova M	2021-03-01	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/33649182	Genome wide association study of HTLV-1-associated myelopathy/tropical spastic paraparesis in the Japanese population.	HTLV-1 associated myelopathy	731 Japanese ancestry cases, 846 Japanese ancestry controls	NA	6p21.33	6	31164308		TCF19, TCF19, TCF19, TCF19, TCF19, TCF19, TCF19			ENSG00000224941, ENSG00000224379, ENSG00000206455, ENSG00000137310, ENSG00000234674, ENSG00000233890, ENSG00000224472			rs3130933-T	rs3130933	0	3130933	intron_variant	0	0.04	5E-9	8.301029995663981		2.44	[1.81-3.29]	Illumina [126394]	N	tropical spastic paraparesis	http://www.ebi.ac.uk/efo/EFO_0007527	GCST90026455	Genome-wide genotyping array
2021-08-27	33649182	Penova M	2021-03-01	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/33649182	Genome wide association study of HTLV-1-associated myelopathy/tropical spastic paraparesis in the Japanese population.	HTLV-1 associated myelopathy	731 Japanese ancestry cases, 846 Japanese ancestry controls	NA	6p21.32	6	32451687		HLA-DRA - HLA-DRB9	ENSG00000204287	ENSG00000226035		6641	8134	rs28895103-G	rs28895103	0	28895103	intergenic_variant	1	0.95	1E-8	8.0		0.44	[0.33-0.58]	Illumina [126394]	N	tropical spastic paraparesis	http://www.ebi.ac.uk/efo/EFO_0007527	GCST90026455	Genome-wide genotyping array
2021-08-27	33649182	Penova M	2021-03-01	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/33649182	Genome wide association study of HTLV-1-associated myelopathy/tropical spastic paraparesis in the Japanese population.	HTLV-1 associated myelopathy	731 Japanese ancestry cases, 846 Japanese ancestry controls	NA	6p21.33	6	31364052		HLA-B - DHFRP2	ENSG00000232126	ENSG00000230016		6864	2300	rs2523554-C	rs2523554	0	2523554	intergenic_variant	1	0.11	3E-8	7.522878745280337		1.83	[1.48-2.27]	Illumina [126394]	N	tropical spastic paraparesis	http://www.ebi.ac.uk/efo/EFO_0007527	GCST90026455	Genome-wide genotyping array
2021-08-27	33649182	Penova M	2021-03-01	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/33649182	Genome wide association study of HTLV-1-associated myelopathy/tropical spastic paraparesis in the Japanese population.	HTLV-1 associated myelopathy	731 Japanese ancestry cases, 846 Japanese ancestry controls	NA	6p22.2	6	26463432		BTN2A1			ENSG00000112763			rs13195509-G	rs13195509	0	13195509	missense_variant	0	0.97	3E-7	6.522878745280337		0.37	[0.26-0.55]	Illumina [126394]	N	tropical spastic paraparesis	http://www.ebi.ac.uk/efo/EFO_0007527	GCST90026455	Genome-wide genotyping array
2021-08-27	33649182	Penova M	2021-03-01	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/33649182	Genome wide association study of HTLV-1-associated myelopathy/tropical spastic paraparesis in the Japanese population.	HTLV-1 associated myelopathy	731 Japanese ancestry cases, 846 Japanese ancestry controls	NA	6p21.33	6	31529148		MCCD1, MCCD1, MCCD1, MCCD1			ENSG00000226841, ENSG00000226923, ENSG00000204511, ENSG00000228662			rs3093983-G	rs3093983	0	3093983	missense_variant	0	0.08	4E-7	6.3979400086720375		1.86	[1.47-2.37]	Illumina [126394]	N	tropical spastic paraparesis	http://www.ebi.ac.uk/efo/EFO_0007527	GCST90026455	Genome-wide genotyping array
2021-08-27	33649182	Penova M	2021-03-01	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/33649182	Genome wide association study of HTLV-1-associated myelopathy/tropical spastic paraparesis in the Japanese population.	HTLV-1 associated myelopathy	731 Japanese ancestry cases, 846 Japanese ancestry controls	NA	6p21.32	6	32696681		HLA-DQB1 - MTCO3P1	ENSG00000231939	ENSG00000237145		28298	9443	rs2647012-T	rs2647012	0	2647012	intergenic_variant	1	0.17	5E-7	6.301029995663981		0.56	[0.45-0.7]	Illumina [126394]	N	tropical spastic paraparesis	http://www.ebi.ac.uk/efo/EFO_0007527	GCST90026455	Genome-wide genotyping array
2021-08-27	33649182	Penova M	2021-03-01	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/33649182	Genome wide association study of HTLV-1-associated myelopathy/tropical spastic paraparesis in the Japanese population.	HTLV-1 associated myelopathy	731 Japanese ancestry cases, 846 Japanese ancestry controls	NA	6p22.1	6	27858082		H2BC15 - H2BC16P	ENSG00000233822	ENSG00000217646		2373	5980	rs9461416-G	rs9461416	0	9461416	intergenic_variant	1	0.95	2E-6	5.698970004336019		0.51	[0.39-0.67]	Illumina [126394]	N	tropical spastic paraparesis	http://www.ebi.ac.uk/efo/EFO_0007527	GCST90026455	Genome-wide genotyping array
2013-05-02	23358160	Borglum AD	2013-01-29	Mol Psychiatry	www.ncbi.nlm.nih.gov/pubmed/23358160	Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci.	Schizophrenia (cytomegalovirus infection interaction)	888 European ancestry cases, 882 European ancestry controls	2539 European ancestry cases, 5486 European ancestry controls	10q21.3	10	66838534	CTNNA3	CTNNA3			ENSG00000183230			rs7902091-A	rs7902091	0	7902091	intron_variant	0	NR	7E-7	6.154901959985743		5.331	[NR]	Illumina [541148]	N	schizophrenia, cytomegalovirus infection	http://purl.obolibrary.org/obo/MONDO_0005090, http://www.ebi.ac.uk/efo/EFO_0001062	GCST001833	Genome-wide genotyping array
2012-01-20	22210626	Mead S	2011-12-30	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22210626	Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP.	Prion diseases	1,281 European ancestry cases, 6,015 European ancestry controls, 290 Papua New Guinean ancestry cases, 286 Papua New Guinean ancestry controls	NA	20p13	20	4699605	PRNP	PRNP			ENSG00000171867			rs1799990-?	rs1799990	0	1799990	missense_variant	0	NR	7E-7	6.154901959985743		1.3	[NR]	Illumina [NR] (imputed)	N	prion disease	http://www.ebi.ac.uk/efo/EFO_0004720	GCST001366	Genome-wide genotyping array
2012-01-20	22210626	Mead S	2011-12-30	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22210626	Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP.	Prion diseases	1,281 European ancestry cases, 6,015 European ancestry controls, 290 Papua New Guinean ancestry cases, 286 Papua New Guinean ancestry controls	NA	3q23	3	141359346	ZBTB38, RASA2	PXYLP1, ZBTB38			ENSG00000155893, ENSG00000177311			rs9857275-?	rs9857275	0	9857275	intron_variant	0	NR	2E-6	5.698970004336019		1.28	[NR]	Illumina [NR] (imputed)	N	prion disease	http://www.ebi.ac.uk/efo/EFO_0004720	GCST001366	Genome-wide genotyping array
2012-01-20	22210626	Mead S	2011-12-30	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22210626	Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP.	Prion diseases	1,281 European ancestry cases, 6,015 European ancestry controls, 290 Papua New Guinean ancestry cases, 286 Papua New Guinean ancestry controls	NA	7q21.11	7	84281955	SEMA3A	SEMA3A			ENSG00000075213			rs488333-?	rs488333	0	488333	intron_variant	0	NR	3E-6	5.522878745280337		1.2681	[NR]	Illumina [NR] (imputed)	N	prion disease	http://www.ebi.ac.uk/efo/EFO_0004720	GCST001366	Genome-wide genotyping array
2012-01-20	22210626	Mead S	2011-12-30	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22210626	Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP.	Prion diseases	1,281 European ancestry cases, 6,015 European ancestry controls, 290 Papua New Guinean ancestry cases, 286 Papua New Guinean ancestry controls	NA	10q25.1	10	107810092	NR	LINC01435			ENSG00000229981			rs12570947-?	rs12570947	0	12570947	intron_variant	0	NR	4E-6	5.3979400086720375		1.45	[NR]	Illumina [NR] (imputed)	N	prion disease	http://www.ebi.ac.uk/efo/EFO_0004720	GCST001366	Genome-wide genotyping array
2012-01-20	22210626	Mead S	2011-12-30	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22210626	Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP.	Prion diseases	1,281 European ancestry cases, 6,015 European ancestry controls, 290 Papua New Guinean ancestry cases, 286 Papua New Guinean ancestry controls	NA	4q21.1	4	75407765	NR	LINC02483 - RCHY1	ENSG00000251383	ENSG00000163743		45199	71268	rs2903698-?	rs2903698	0	2903698	intron_variant	1	NR	6E-6	5.221848749616356		1.2528	[NR]	Illumina [NR] (imputed)	N	prion disease	http://www.ebi.ac.uk/efo/EFO_0004720	GCST001366	Genome-wide genotyping array
2012-01-20	22210626	Mead S	2011-12-30	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22210626	Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP.	Prion diseases	1,281 European ancestry cases, 6,015 European ancestry controls, 290 Papua New Guinean ancestry cases, 286 Papua New Guinean ancestry controls	NA	10q22.1	10	70767761	NR	ADAMTS14 - TBATA	ENSG00000138316	ENSG00000166220		5320	3477	rs12761224-?	rs12761224	0	12761224	intergenic_variant	1	NR	6E-6	5.221848749616356		1.3861	[NR]	Illumina [NR] (imputed)	N	prion disease	http://www.ebi.ac.uk/efo/EFO_0004720	GCST001366	Genome-wide genotyping array
2012-01-20	22210626	Mead S	2011-12-30	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22210626	Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP.	Prion diseases	1,281 European ancestry cases, 6,015 European ancestry controls, 290 Papua New Guinean ancestry cases, 286 Papua New Guinean ancestry controls	NA	3p21.31	3	48445644	NR	TMA7 - ATRIP	ENSG00000232112	ENSG00000164053		1436	1066	rs730566-?	rs730566	0	730566	intron_variant	1	NR	7E-6	5.154901959985743		1.27	[NR]	Illumina [NR] (imputed)	N	prion disease	http://www.ebi.ac.uk/efo/EFO_0004720	GCST001366	Genome-wide genotyping array
2012-01-20	22210626	Mead S	2011-12-30	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22210626	Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP.	Prion diseases	1,281 European ancestry cases, 6,015 European ancestry controls, 290 Papua New Guinean ancestry cases, 286 Papua New Guinean ancestry controls	NA	8p23.1	8	8864868	NR	MFHAS1, MFHAS1			ENSG00000147324, ENSG00000285022			rs10108954-?	rs10108954	0	10108954	intron_variant	0	NR	7E-6	5.154901959985743		1.7359	[NR]	Illumina [NR] (imputed)	N	prion disease	http://www.ebi.ac.uk/efo/EFO_0004720	GCST001366	Genome-wide genotyping array
2012-01-20	22210626	Mead S	2011-12-30	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22210626	Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP.	Prion diseases	1,281 European ancestry cases, 6,015 European ancestry controls, 290 Papua New Guinean ancestry cases, 286 Papua New Guinean ancestry controls	NA	19q13.2	19	41167943	NR	CYP2T3P - RPL36P16	ENSG00000268529	ENSG00000224476		30635	1918	rs8105815-?	rs8105815	0	8105815	regulatory_region_variant	1	NR	8E-6	5.096910013008056		1.3918	[NR]	Illumina [NR] (imputed)	N	prion disease	http://www.ebi.ac.uk/efo/EFO_0004720	GCST001366	Genome-wide genotyping array
2012-01-20	22210626	Mead S	2011-12-30	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22210626	Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP.	Prion diseases	1,281 European ancestry cases, 6,015 European ancestry controls, 290 Papua New Guinean ancestry cases, 286 Papua New Guinean ancestry controls	NA	8q22.2	8	98117279	NR	RIDA - POP1	ENSG00000132541	ENSG00000104356		108	14	rs2071598-?	rs2071598	0	2071598	regulatory_region_variant	1	NR	9E-6	5.045757490560675		1.2646	[NR]	Illumina [NR] (imputed)	N	prion disease	http://www.ebi.ac.uk/efo/EFO_0004720	GCST001366	Genome-wide genotyping array
2012-01-20	22210626	Mead S	2011-12-30	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22210626	Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP.	Prion diseases	1,281 European ancestry cases, 6,015 European ancestry controls, 290 Papua New Guinean ancestry cases, 286 Papua New Guinean ancestry controls	NA	5q35.2	5	173932328	NR	CPEB4			ENSG00000113742			rs17763373-?	rs17763373	0	17763373	intron_variant	0	NR	7E-6	5.154901959985743		1.5106	[NR]	Illumina [NR] (imputed)	N	prion disease	http://www.ebi.ac.uk/efo/EFO_0004720	GCST001366	Genome-wide genotyping array
2015-01-13	24940741	Chang SW	2014-06-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24940741	A genome-wide association study on chronic HBV infection and its clinical progression in male Han-Taiwanese.	Chronic hepatitis B infection	321 Chinese ancestry cases, 304 Chinese ancestry controls	1,302 Chinese ancestry cases, 761 Chinese ancestry controls				HLA-DPA3							rs9366816-C	rs9366816	0	9366816	intron_variant	1	0.414	3E-10	9.522878745280337		1.43	[1.28-1.60]	Illumina [456262]	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002490	Genome-wide genotyping array
2013-03-21	23291585	Fakiola M	2013-01-06	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23291585	Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis.	Leishmaniasis (visceral)	989 Indian ancestry cases, 1,089 Indian ancestry controls, 357 Brazilian ancestry cases, 1,613 Brazilian ancestry unaffected relatives	951 Indian ancestry cases, 990 Indian ancestry controls	6p21.32	6	32627446	HLA, HLA-DRB1, HLA-DQA1	HLA-DRB1 - HLA-DQA1	ENSG00000206240	ENSG00000196735		37598	733	rs9271858-G	rs9271858	0	9271858	intergenic_variant	1	0.39	3E-17	16.522878745280337		1.41	[1.30-1.52]	Illumina [521134]	N	visceral Leishmaniasis	http://www.ebi.ac.uk/efo/EFO_0005045	GCST001805	Genome-wide genotyping array
2021-06-11	33225922	Adebamowo SN	2020-11-23	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/33225922	Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.	Cervical high-risk human papilloma virus infection (persistent)	51 Nigerian ancestry cases, 355 Nigerian ancestry controls	NA				DAP							chr5:10847898-?	chr5:10847898	0			1	NR	7E-8	7.154901959985743		6.87	3.41-13.84	Illumina [~ 18000000] (imputed)	N	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668	GCST011836	Genome-wide genotyping array
2021-06-11	33225922	Adebamowo SN	2020-11-23	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/33225922	Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.	Cervical high-risk human papilloma virus infection (persistent)	51 Nigerian ancestry cases, 355 Nigerian ancestry controls	NA				PAFAH2							chr1:26304144-?	chr1:26304144	0			1	NR	8E-6	5.096910013008056		10.19	4.01-25.92	Illumina [~ 18000000] (imputed)	N	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668	GCST011836	Genome-wide genotyping array
2021-06-11	33225922	Adebamowo SN	2020-11-23	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/33225922	Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.	Cervical high-risk human papilloma virus infection (persistent)	51 Nigerian ancestry cases, 355 Nigerian ancestry controls	NA	17q11.2	17	31590709	MIR365-2	MIR365B - NA	ENSG00000283978			15188		rs200516199-?	rs200516199	0	200516199	intron_variant	1	NR	3E-7	6.522878745280337		7.71	3.54-16.78	Illumina [~ 18000000] (imputed)	N	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668	GCST011836	Genome-wide genotyping array
2021-06-11	33225922	Adebamowo SN	2020-11-23	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/33225922	Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.	Cervical high-risk human papilloma virus infection (persistent)	51 Nigerian ancestry cases, 355 Nigerian ancestry controls	NA	11p12	11	37202126	C11orf74							rs150410476-?	rs150410476	0	150410476	intergenic_variant	1	NR	7E-7	6.154901959985743		8.31	3.60-19.16	Illumina [~ 18000000] (imputed)	N	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668	GCST011836	Genome-wide genotyping array
2021-06-11	33225922	Adebamowo SN	2020-11-23	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/33225922	Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.	Cervical high-risk human papilloma virus infection (persistent)	51 Nigerian ancestry cases, 355 Nigerian ancestry controls	NA	20q13.12	20	44113618	JPH2	JPH2			ENSG00000149596			rs116834259-?	rs116834259	0	116834259	intron_variant	0	NR	3E-7	6.522878745280337		4.42	2.50-7.81	Illumina [~ 18000000] (imputed)	N	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668	GCST011836	Genome-wide genotyping array
2021-06-11	33225922	Adebamowo SN	2020-11-23	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/33225922	Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.	Cervical high-risk human papilloma virus infection (persistent)	51 Nigerian ancestry cases, 355 Nigerian ancestry controls	NA	2q21.2	2	132495670	GPR390	GPR39			ENSG00000183840			rs16832308-?	rs16832308	0	16832308	intron_variant	0	NR	6E-7	6.221848749616356		6.3	3.05-13.01	Illumina [~ 18000000] (imputed)	N	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668	GCST011836	Genome-wide genotyping array
2021-06-11	33225922	Adebamowo SN	2020-11-23	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/33225922	Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.	Cervical high-risk human papilloma virus infection (persistent)	51 Nigerian ancestry cases, 355 Nigerian ancestry controls	NA	1q32.1	1	199724931	NR5A2							rs1429702-?	rs1429702	0	1429702	intergenic_variant	1	NR	8E-6	5.096910013008056		3.1	1.96-4.87	Illumina [~ 18000000] (imputed)	N	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668	GCST011836	Genome-wide genotyping array
2021-06-11	33225922	Adebamowo SN	2020-11-23	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/33225922	Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.	Cervical high-risk human papilloma virus infection (persistent)	51 Nigerian ancestry cases, 355 Nigerian ancestry controls	NA	1q32.1	1	199732754	NR5A2							rs143668247-?	rs143668247	0	143668247	intergenic_variant	1	NR	2E-7	6.698970004336019		3.66	2.24-5.97	Illumina [~ 18000000] (imputed)	N	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668	GCST011836	Genome-wide genotyping array
2021-06-11	33225922	Adebamowo SN	2020-11-23	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/33225922	Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.	Cervical high-risk human papilloma virus infection	125 Nigerian ancestry cases, 392 Nigerian ancestry controls	NA	21q22.11	21	31588943	TIAM1	TIAM1 - FBXW11P1	ENSG00000156299	ENSG00000230870		28966	38184	rs35833676-?	rs35833676	0	35833676	intergenic_variant	1	NR	2E-6	5.698970004336019		3.45	2.07-5.73	Illumina [~ 18000000] (imputed)	N	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668	GCST011837	Genome-wide genotyping array
2021-06-11	33225922	Adebamowo SN	2020-11-23	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/33225922	Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.	Cervical high-risk human papilloma virus infection	125 Nigerian ancestry cases, 392 Nigerian ancestry controls	NA				LOC440434							chr17:36374963-?	chr17:36374963	0			1	NR	3E-6	5.522878745280337		0.48	0.35-0.65	Illumina [~ 18000000] (imputed)	N	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668	GCST011837	Genome-wide genotyping array
2021-06-11	33225922	Adebamowo SN	2020-11-23	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/33225922	Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.	Cervical high-risk human papilloma virus infection	125 Nigerian ancestry cases, 392 Nigerian ancestry controls	NA	20q13.33	20	60100620	C20orf197	MIR646HG			ENSG00000228340			rs3818252-?	rs3818252	0	3818252	intron_variant	0	NR	2E-6	5.698970004336019		2.22	1.60-3.10	Illumina [~ 18000000] (imputed)	N	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668	GCST011837	Genome-wide genotyping array
2021-06-11	33225922	Adebamowo SN	2020-11-23	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/33225922	Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.	Cervical high-risk human papilloma virus infection	125 Nigerian ancestry cases, 392 Nigerian ancestry controls	NA	11q13.1	11	64395425	RPS6KA4	LINC02723			ENSG00000231680			rs506594-?	rs506594	0	506594	non_coding_transcript_exon_variant	0	NR	3E-6	5.522878745280337		0.44	0.31-0.62	Illumina [~ 18000000] (imputed)	N	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668	GCST011837	Genome-wide genotyping array
2021-06-11	33225922	Adebamowo SN	2020-11-23	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/33225922	Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.	Cervical high-risk human papilloma virus infection	125 Nigerian ancestry cases, 392 Nigerian ancestry controls	NA	1p31.1	1	72149879	NEGR1	NEGR1			ENSG00000172260			rs375435036-?	rs375435036	0	375435036	intron_variant	0	NR	3E-6	5.522878745280337		2.52	1.71-3.73	Illumina [~ 18000000] (imputed)	N	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668	GCST011837	Genome-wide genotyping array
2021-06-11	33225922	Adebamowo SN	2020-11-23	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/33225922	Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.	Cervical high-risk human papilloma virus infection	125 Nigerian ancestry cases, 392 Nigerian ancestry controls	NA	13q22.1	13	73464920	KLF12	LINC00393			ENSG00000224853			rs17090215-?	rs17090215	0	17090215	intron_variant	0	NR	3E-6	5.522878745280337		3.9	2.20-6.92	Illumina [~ 18000000] (imputed)	N	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668	GCST011837	Genome-wide genotyping array
2021-06-11	33225922	Adebamowo SN	2020-11-23	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/33225922	Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.	Cervical high-risk human papilloma virus infection	125 Nigerian ancestry cases, 392 Nigerian ancestry controls	NA	13q22.1	13	73721630	KLF12	KLF12			ENSG00000118922			rs149473200-?	rs149473200	0	149473200	intron_variant	0	NR	1E-6	6.0		7.06	3.19-15.63	Illumina [~ 18000000] (imputed)	N	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668	GCST011837	Genome-wide genotyping array
2021-06-11	33225922	Adebamowo SN	2020-11-23	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/33225922	Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.	Cervical high-risk human papilloma virus infection	125 Nigerian ancestry cases, 392 Nigerian ancestry controls	NA	13q22.1	13	73725268	KLF12	KLF12			ENSG00000118922			rs151071053-?	rs151071053	0	151071053	intron_variant	0	NR	1E-6	6.0		7.06	3.19-15.63	Illumina [~ 18000000] (imputed)	N	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668	GCST011837	Genome-wide genotyping array
2021-06-11	33225922	Adebamowo SN	2020-11-23	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/33225922	Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.	Cervical high-risk human papilloma virus infection	125 Nigerian ancestry cases, 392 Nigerian ancestry controls	NA				UBE2W							chr8:74725256-?	chr8:74725256	0			1	NR	2E-6	5.698970004336019		3.31	2.01-5.44	Illumina [~ 18000000] (imputed)	N	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668	GCST011837	Genome-wide genotyping array
2021-06-11	33225922	Adebamowo SN	2020-11-23	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/33225922	Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.	Cervical high-risk human papilloma virus infection	125 Nigerian ancestry cases, 392 Nigerian ancestry controls	NA	14q24.3	14	74262504	VSX2	VSX2			ENSG00000119614			rs6574170-?	rs6574170	0	6574170	3_prime_UTR_variant	0	NR	3E-6	5.522878745280337		5.29	2.63-10.67	Illumina [~ 18000000] (imputed)	N	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668	GCST011837	Genome-wide genotyping array
2021-06-11	33225922	Adebamowo SN	2020-11-23	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/33225922	Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.	Cervical high-risk human papilloma virus infection	125 Nigerian ancestry cases, 392 Nigerian ancestry controls	NA	4q34.3	4	180389551	NCRNA00290							rs73010975-?	rs73010975	0	73010975	intergenic_variant	1	NR	2E-6	5.698970004336019		3.86	2.22-6.72	Illumina [~ 18000000] (imputed)	N	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668	GCST011837	Genome-wide genotyping array
2008-11-12	18835860	Mushiroda T	2008-10-01	J Med Genet	www.ncbi.nlm.nih.gov/pubmed/18835860	A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis.	Idiopathic pulmonary fibrosis	159 Japanese ancestry cases, 934 Japanese ancestry controls	83 Japanese ancestry cases, 535 Japanese ancestry controls	5p15.33	5	1286401	TERT	TERT			ENSG00000164362			rs2736100-A	rs2736100	0	2736100	3_prime_UTR_variant	0	0.41	3E-8	7.522878745280337		2.11	[1.61-2.78]	Illumina [214508]	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST000238	Genome-wide genotyping array
2014-08-06	24429156	Noth I	2013-04-17	Lancet Respir Med	www.ncbi.nlm.nih.gov/pubmed/24429156	Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.	Idiopathic pulmonary fibrosis	542 European ancestry cases, 542 European ancestry controls	868 European ancestry cases, 1,389 European ancestry controls	11p15.5	11	1219991	MUC5AC, TOLLIP, MUC5B	MUC5AC - MUC5B	ENSG00000215182	ENSG00000117983		18853	3075	rs35705950-T	rs35705950	0	35705950	splice_region_variant	1	0.14	2E-50	49.69897000433602		2.43	[2.13-2.77]	Affymetrix [10601812] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST001974	Genome-wide genotyping array
2014-08-06	24429156	Noth I	2013-04-17	Lancet Respir Med	www.ncbi.nlm.nih.gov/pubmed/24429156	Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.	Idiopathic pulmonary fibrosis	542 European ancestry cases, 542 European ancestry controls	868 European ancestry cases, 1,389 European ancestry controls	14q21.3	14	47571172	MDGA2	MDGA2			ENSG00000139915			rs7144383-G	rs7144383	0	7144383	intron_variant	0	0.11	4E-6	5.3979400086720375		1.44	[1.23-1.69]	Affymetrix [10601812] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST001974	Genome-wide genotyping array
2014-08-06	24429156	Noth I	2013-04-17	Lancet Respir Med	www.ncbi.nlm.nih.gov/pubmed/24429156	Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.	Idiopathic pulmonary fibrosis	542 European ancestry cases, 542 European ancestry controls	868 European ancestry cases, 1,389 European ancestry controls	17q21.31	17	45847931	SPPL2C, KANSL1, MAPT, CRHR1, STH	MAPT-AS1, MAPT-AS1, MAPT-AS1			ENSG00000264589, ENSG00000281578, ENSG00000282067			rs17690703-C	rs17690703	0	17690703	intron_variant	0	0.76	6E-9	8.221848749616356		1.43	[1.27-1.61]	Affymetrix [10601812] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST001974	Genome-wide genotyping array
2014-08-06	24429156	Noth I	2013-04-17	Lancet Respir Med	www.ncbi.nlm.nih.gov/pubmed/24429156	Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.	Idiopathic pulmonary fibrosis	542 European ancestry cases, 542 European ancestry controls	868 European ancestry cases, 1,389 European ancestry controls	11p15.5	11	1303542	TOLLIP, BRSK2, MUC5B	TOLLIP			ENSG00000078902			rs5743894-G	rs5743894	0	5743894	intron_variant	0	0.18	1E-12	12.0		1.49	[1.33-1.68]	Affymetrix [10601812] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST001974	Genome-wide genotyping array
2014-08-06	24429156	Noth I	2013-04-17	Lancet Respir Med	www.ncbi.nlm.nih.gov/pubmed/24429156	Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.	Idiopathic pulmonary fibrosis	542 European ancestry cases, 542 European ancestry controls	868 European ancestry cases, 1,389 European ancestry controls	11p15.5	11	1304599	TOLLIP, BRSK2, MUC5B	TOLLIP			ENSG00000078902			rs5743890-A	rs5743890	0	5743890	intron_variant	0	0.83	3E-11	10.522878745280337		1.64	[1.41-1.92]	Affymetrix [10601812] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST001974	Genome-wide genotyping array
2020-08-25	32421744	Gzara C	2020-05-18	PLoS Pathog	www.ncbi.nlm.nih.gov/pubmed/32421744	Family-based genome-wide association study of leprosy in Vietnam.	Leprosy	1,749 Vietnamese ancestry cases	1,181 Vietnamese ancestry cases, 688 Vietnamese ancestry controls	6p21.33	6	31113632	C6orf15	C6orf15 - PSORS1C1	ENSG00000229432	ENSG00000235487		1057	1118	rs1265048-T	rs1265048	0	1265048	intergenic_variant	1	0.51	6E-11	10.221848749616356		1.4492754	[1.25-1.72]	Illumina [5607170] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST010457	Genome-wide genotyping array
2020-08-25	32421744	Gzara C	2020-05-18	PLoS Pathog	www.ncbi.nlm.nih.gov/pubmed/32421744	Family-based genome-wide association study of leprosy in Vietnam.	Leprosy	1,749 Vietnamese ancestry cases	1,181 Vietnamese ancestry cases, 688 Vietnamese ancestry controls	6p21.33	6	31287665	HLA-C	WASF5P, WASF5P, WASF5P, WASF5P, WASF5P, WASF5P, WASF5P			ENSG00000231309, ENSG00000225403, ENSG00000231402, ENSG00000225954, ENSG00000231433, ENSG00000229103, ENSG00000234980			rs114598080-A	rs114598080	0	114598080	non_coding_transcript_exon_variant	0	0.1	9E-13	12.045757490560675		1.47	[1.46-1.48]	Illumina [5607170] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST010457	Genome-wide genotyping array
2020-08-25	32421744	Gzara C	2020-05-18	PLoS Pathog	www.ncbi.nlm.nih.gov/pubmed/32421744	Family-based genome-wide association study of leprosy in Vietnam.	Leprosy	1,749 Vietnamese ancestry cases	1,181 Vietnamese ancestry cases, 688 Vietnamese ancestry controls	6p21.32	6	32637430	HLA-DQA1	HLA-DQA1, HLA-DQA1, HLA-DQA1, HLA-DQA1, HLA-DQA1			ENSG00000232062, ENSG00000206305, ENSG00000236418, ENSG00000225890, ENSG00000196735			rs3187964-C	rs3187964	0	3187964	5_prime_UTR_variant	0	0.41	8E-16	15.096910013008056		1.67	[1.55-1.80]	Illumina [5607170] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST010457	Genome-wide genotyping array
2020-08-25	32421744	Gzara C	2020-05-18	PLoS Pathog	www.ncbi.nlm.nih.gov/pubmed/32421744	Family-based genome-wide association study of leprosy in Vietnam.	Leprosy	1,749 Vietnamese ancestry cases	1,181 Vietnamese ancestry cases, 688 Vietnamese ancestry controls	13q14.11	13	43883789	LACC1	LACC1			ENSG00000179630			rs3764147-G	rs3764147	0	3764147	missense_variant	0	0.35	5E-14	13.301029995663981		1.52	[1.41-1.63]	Illumina [5607170] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST010457	Genome-wide genotyping array
2020-08-25	32421744	Gzara C	2020-05-18	PLoS Pathog	www.ncbi.nlm.nih.gov/pubmed/32421744	Family-based genome-wide association study of leprosy in Vietnam.	Leprosy	1,749 Vietnamese ancestry cases	1,181 Vietnamese ancestry cases, 688 Vietnamese ancestry controls	5q33.3	5	159399784	IL12B	IL12B - LINC01845	ENSG00000113302	ENSG00000253298		69297	48772	rs6871626-C	rs6871626	0	6871626	intron_variant	1	0.65	6E-8	7.221848749616356		1.369863	[1.19-1.64]	Illumina [5607170] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST010457	Genome-wide genotyping array
2009-09-30	19754311	Le Clerc S	2009-09-15	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/19754311	Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03).	AIDS	85 European ancestry cases, 2,049 European ancestry controls	NA	8q22.3	8	100829318	intergenic	RPS20P23 - RNU4-83P	ENSG00000242399	ENSG00000222795		52453	2410	rs3108919-C	rs3108919	0	3108919	regulatory_region_variant	1	0.27	4E-6	5.3979400086720375		2.13	[1.56-2.91]	Illumina [291119]	N	AIDS	http://www.ebi.ac.uk/efo/EFO_0000765	GCST000487	Genome-wide genotyping array
2009-09-30	19754311	Le Clerc S	2009-09-15	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/19754311	Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03).	AIDS	85 European ancestry cases, 2,049 European ancestry controls	NA	2q12.1	2	105281283	TGFBRAP1	TGFBRAP1			ENSG00000135966			rs1020064-G	rs1020064	0	1020064	intron_variant	0	0.77	7E-6	5.154901959985743		2.94	[1.75-5.00]	Illumina [291119]	N	AIDS	http://www.ebi.ac.uk/efo/EFO_0000765	GCST000487	Genome-wide genotyping array
2009-09-30	19754311	Le Clerc S	2009-09-15	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/19754311	Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03).	AIDS	85 European ancestry cases, 2,049 European ancestry controls	NA	12p12.1	12	24241438	SOX5	SOX5-AS1, SOX5			ENSG00000256120, ENSG00000134532			rs1522232-C	rs1522232	0	1522232	intron_variant	0	0.52	2E-6	5.698970004336019		2.22	[1.59-3.13]	Illumina [291119]	N	AIDS	http://www.ebi.ac.uk/efo/EFO_0000765	GCST000487	Genome-wide genotyping array
2009-09-30	19754311	Le Clerc S	2009-09-15	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/19754311	Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03).	AIDS	85 European ancestry cases, 2,049 European ancestry controls	NA	1p13.3	1	107035210	intergenic	NA - PRMT6		ENSG00000198890			21464	rs4118325-G	rs4118325	0	4118325	intergenic_variant	1	0.81	6E-7	6.221848749616356		4.17	[2.17-8.33]	Illumina [291119]	N	AIDS	http://www.ebi.ac.uk/efo/EFO_0000765	GCST000487	Genome-wide genotyping array
2009-09-30	19754311	Le Clerc S	2009-09-15	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/19754311	Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03).	AIDS	85 European ancestry cases, 2,049 European ancestry controls	NA	1q23.3	1	165439858	RXRG	RXRG			ENSG00000143171			rs10800098-A	rs10800098	0	10800098	intron_variant	0	0.05	4E-6	5.3979400086720375		3.29	[2.08-5.20]	Illumina [291119]	N	AIDS	http://www.ebi.ac.uk/efo/EFO_0000765	GCST000487	Genome-wide genotyping array
2009-09-30	19754311	Le Clerc S	2009-09-15	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/19754311	Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03).	AIDS	85 European ancestry cases, 2,049 European ancestry controls	NA	9p23	9	13007130	intergenic	PRDX1P1 - MPDZ	ENSG00000214121	ENSG00000107186		33692	98576	rs1360517-A	rs1360517	0	1360517	intron_variant	1	0.06	3E-6	5.522878745280337		3.09	[2.00-4.78]	Illumina [291119]	N	AIDS	http://www.ebi.ac.uk/efo/EFO_0000765	GCST000487	Genome-wide genotyping array
2009-09-30	19754311	Le Clerc S	2009-09-15	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/19754311	Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03).	AIDS	85 European ancestry cases, 2,049 European ancestry controls	NA	9p22.3	9	14446003	NR	NFIB - CDCA4P1	ENSG00000147862	ENSG00000229029		47020	147574	rs1556032-C	rs1556032	0	1556032	intron_variant	1	0.49	9E-6	5.045757490560675		2.05	[1.48-2.84]	Illumina [291119]	N	AIDS	http://www.ebi.ac.uk/efo/EFO_0000765	GCST000487	Genome-wide genotyping array
2011-06-01	21502085	Troyer JL	2011-05-01	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/21502085	Genome-wide association study implicates PARD3B-based AIDS restriction.	AIDS progression	755 European ancestry seroconverter cases	NA	3p21.31	3	46410189	LTF	CCRL2			ENSG00000121797			rs1015164-?	rs1015164	0	1015164	intron_variant	0	0.31	9E-6	5.045757490560675		1.46	[NR]	Affymetrix [700022]	N	AIDS	http://www.ebi.ac.uk/efo/EFO_0000765	GCST001060	Genome-wide genotyping array
2011-06-01	21502085	Troyer JL	2011-05-01	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/21502085	Genome-wide association study implicates PARD3B-based AIDS restriction.	AIDS progression	755 European ancestry seroconverter cases	NA	1q21.1	1	147089017	NBPF14	RNVU1-8 - NBPF13P	ENSG00000286172	ENSG00000283342		4261	10465	rs11239930-?	rs11239930	0	11239930	intergenic_variant	1	0.58	2E-6	5.698970004336019		1.47	[NR]	Affymetrix [700022]	N	AIDS	http://www.ebi.ac.uk/efo/EFO_0000765	GCST001060	Genome-wide genotyping array
2011-06-01	21502085	Troyer JL	2011-05-01	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/21502085	Genome-wide association study implicates PARD3B-based AIDS restriction.	AIDS progression	755 European ancestry seroconverter cases	NA	7q33	7	137519073	DGKI	DGKI			ENSG00000157680			rs6467710-?	rs6467710	0	6467710	intron_variant	0	0.02	6E-7	6.221848749616356		4.3	[NR]	Affymetrix [700022]	N	AIDS	http://www.ebi.ac.uk/efo/EFO_0000765	GCST001060	Genome-wide genotyping array
2011-06-01	21502085	Troyer JL	2011-05-01	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/21502085	Genome-wide association study implicates PARD3B-based AIDS restriction.	AIDS progression	755 European ancestry seroconverter cases	NA	2q33.3	2	205453869	PARD3B	PARD3B			ENSG00000116117			rs11884476-?	rs11884476	0	11884476	intron_variant	0	0.94	3E-9	8.522878745280337		3.32	[NR]	Affymetrix [700022]	N	AIDS	http://www.ebi.ac.uk/efo/EFO_0000765	GCST001060	Genome-wide genotyping array
2011-06-01	21502085	Troyer JL	2011-05-01	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/21502085	Genome-wide association study implicates PARD3B-based AIDS restriction.	AIDS progression	755 European ancestry seroconverter cases	NA	17p13.3	17	189133	RPH3AL	LINC02091, LINC02091			ENSG00000273172, ENSG00000282365			rs7217319-?	rs7217319	0	7217319	intron_variant	0	0.63	4E-6	5.3979400086720375		1.48	[NR]	Affymetrix [700022]	N	AIDS	http://www.ebi.ac.uk/efo/EFO_0000765	GCST001060	Genome-wide genotyping array
2011-06-01	21502085	Troyer JL	2011-05-01	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/21502085	Genome-wide association study implicates PARD3B-based AIDS restriction.	AIDS progression	755 European ancestry seroconverter cases	NA	3p21.31	3	46386699	CCRL2	CCR5AS			ENSG00000223552			rs6441975-?	rs6441975	0	6441975	intron_variant	0	0.31	5E-6	5.301029995663981		1.483	[NR]	Affymetrix [700022]	N	AIDS	http://www.ebi.ac.uk/efo/EFO_0000765	GCST001060	Genome-wide genotyping array
2011-06-01	21502085	Troyer JL	2011-05-01	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/21502085	Genome-wide association study implicates PARD3B-based AIDS restriction.	AIDS progression	755 European ancestry seroconverter cases	NA	5q31.1	5	135132010	H2AFY	C5orf66						rs477687-?	rs477687	0	477687	intron_variant	0	0.18	6E-6	5.221848749616356		1.55	[NR]	Affymetrix [700022]	N	AIDS	http://www.ebi.ac.uk/efo/EFO_0000765	GCST001060	Genome-wide genotyping array
2009-01-16	19115949	Limou S	2009-01-01	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/19115949	Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02).	AIDS progression	275 European ancestry seropositive non-progressors, 86 European ancestry seropositive rapid progressors, 1,352 European ancestry seronegative controls	(see Fellay 2007)	6p21.33	6	31464003	MCCD1, BAT1, TNF, LTB, HCP5, MICB	HCP5			ENSG00000206337			rs2395029-G	rs2395029	0	2395029	non_coding_transcript_exon_variant	0	0.03	3E-19	18.522878745280337		3.47	[2.39-5.04]	Illumina [291119]	N	AIDS	http://www.ebi.ac.uk/efo/EFO_0000765	GCST000308	Genome-wide genotyping array
2009-04-16	19349983	Kamatani Y	2009-04-06	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19349983	A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians.	Hepatitis B	179 Japanese ancestry cases, 934 Japanese ancestry controls	1,599 Japanese ancestry cases, 2,821 Japanese ancestry controls, 308 Thai ancestry cases, 546 Thai ancestry controls	6p21.32	6	33087084	HLA-DPB1	HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1			ENSG00000215048, ENSG00000237710, ENSG00000223865, ENSG00000229295, ENSG00000226826, ENSG00000230708			rs9277535-G	rs9277535	0	9277535	3_prime_UTR_variant	0		6E-39	38.221848749616356		1.75	[1.61-1.92]	Illumina [499544]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST000375	Genome-wide genotyping array
2013-12-11	23760081	Kim YJ	2013-06-10	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23760081	A genome-wide association study identified new variants associated with the risk of chronic hepatitis B.	Chronic hepatitis B infection	400 Korean ancestry cases, 1,000 Korean ancestry controls	971 Korean ancestry cases, 1,938 Korean ancestry controls	6p21.32	6	33087084	HLA-DP	HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1			ENSG00000215048, ENSG00000237710, ENSG00000223865, ENSG00000229295, ENSG00000226826, ENSG00000230708			rs9277535-?	rs9277535	0	9277535	3_prime_UTR_variant	0	NR	4E-40	39.39794000867204		1.89	[1.72-2.08]	Illumina [719265]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST002068	Genome-wide genotyping array
2013-12-11	23760081	Kim YJ	2013-06-10	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23760081	A genome-wide association study identified new variants associated with the risk of chronic hepatitis B.	Chronic hepatitis B infection	400 Korean ancestry cases, 1,000 Korean ancestry controls	971 Korean ancestry cases, 1,938 Korean ancestry controls	6p21.33	6	31883457	EHMT2	EHMT2, EHMT2, EHMT2, EHMT2, EHMT2, EHMT2, EHMT2-AS1			ENSG00000236759, ENSG00000206376, ENSG00000227333, ENSG00000224143, ENSG00000204371, ENSG00000238134, ENSG00000237080			rs652888-?	rs652888	0	652888	non_coding_transcript_exon_variant	0	NR	7E-13	12.154901959985743		1.38	[1.22-1.57]	Illumina [719265]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST002068	Genome-wide genotyping array
2013-12-11	23760081	Kim YJ	2013-06-10	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23760081	A genome-wide association study identified new variants associated with the risk of chronic hepatitis B.	Chronic hepatitis B infection	400 Korean ancestry cases, 1,000 Korean ancestry controls	971 Korean ancestry cases, 1,938 Korean ancestry controls	6p21.33	6	31162816	TCF19	TCF19, TCF19, TCF19, TCF19, TCF19, TCF19, TCF19			ENSG00000224941, ENSG00000224379, ENSG00000206455, ENSG00000137310, ENSG00000234674, ENSG00000233890, ENSG00000224472			rs1419881-?	rs1419881	0	1419881	3_prime_UTR_variant	0	NR	1E-18	18.0		1.37	[1.23-1.52]	Illumina [719265]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST002068	Genome-wide genotyping array
2011-11-04	22004137	Liu L	2011-10-01	Viral Immunol	www.ncbi.nlm.nih.gov/pubmed/22004137	A genome-wide association study with DNA pooling identifies the variant rs11866328 in the GRIN2A gene that affects disease progression of chronic HBV infection.	Hepatitis B	1,944 Han Chinese ancestry progressed cases, 854 Han Chinese ancestry asymptomatic carriers	NA	16p13.2	16	9768699	GRIN2A	GRIN2A			ENSG00000183454			rs11866328-G	rs11866328	0	11866328	intron_variant	0	NR	2E-8	7.698970004336019		1.68	[1.40-2.02]	Affymetrix [NR]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST001257	Genome-wide genotyping array
2011-08-05	21750111	Mbarek H	2011-07-12	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21750111	A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population.	Hepatitis B	458 Japanese ancestry cases, 2,056 Japanese ancestry controls	2,209 Japanese ancestry cases, 4,440 Japanese ancestry controls	6p21.32	6	32702478	HLA-DQB1	HLA-DQB1 - MTCO3P1	ENSG00000231939	ENSG00000237145		34095	3646	rs2856718-A	rs2856718	0	2856718	regulatory_region_variant	1	0.48	4E-37	36.39794000867204		1.56	[1.45-1.67]	Illumina [423627]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST001150	Genome-wide genotyping array
2011-08-05	21750111	Mbarek H	2011-07-12	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21750111	A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population.	Hepatitis B	458 Japanese ancestry cases, 2,056 Japanese ancestry controls	2,209 Japanese ancestry cases, 4,440 Japanese ancestry controls	6p21.32	6	33065245	HLA-DPA1	HLA-DPA1			ENSG00000235844			rs3077-G	rs3077	0	3077	3_prime_UTR_variant	0	0.60	2E-61	60.69897000433602		1.87	[1.73-2.01]	Illumina [423627]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST001150	Genome-wide genotyping array
2011-08-05	21750111	Mbarek H	2011-07-12	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21750111	A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population.	Hepatitis B	458 Japanese ancestry cases, 2,056 Japanese ancestry controls	2,209 Japanese ancestry cases, 4,440 Japanese ancestry controls	6p21.32	6	33087084	HLA-DPB1	HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1			ENSG00000215048, ENSG00000237710, ENSG00000223865, ENSG00000229295, ENSG00000226826, ENSG00000230708			rs9277535-G	rs9277535	0	9277535	3_prime_UTR_variant	0	0.57	3E-54	53.52287874528034		1.77	[1.65-1.91]	Illumina [423627]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST001150	Genome-wide genotyping array
2011-08-05	21750111	Mbarek H	2011-07-12	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21750111	A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population.	Hepatitis B	458 Japanese ancestry cases, 2,056 Japanese ancestry controls	2,209 Japanese ancestry cases, 4,440 Japanese ancestry controls	6p21.32	6	32762235	HAL-DQB2	HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2			ENSG00000232629, ENSG00000224305, ENSG00000228813, ENSG00000196610, ENSG00000229493, ENSG00000228254, ENSG00000226165			rs7453920-G	rs7453920	0	7453920	intron_variant	0	0.83	6E-28	27.221848749616356		1.81	[1.62-2.01]	Illumina [423627]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST001150	Genome-wide genotyping array
2021-09-03	33736632	Zeng Z	2021-03-18	BMC Med Genomics	www.ncbi.nlm.nih.gov/pubmed/33736632	Genome-wide association study identifies new loci associated with risk of HBV infection and disease progression.	Hepatitis B	460 Chinese ancestry cases, 169 Chinese ancestry controls	NA	6p21.32	6	32606394	HLA-DRB1	HLA-DRB1 - HLA-DQA1	ENSG00000206240	ENSG00000196735		16546	21785	rs615672-?	rs615672	0	615672	intron_variant	1	NR	1E-6	6.0				Affymetrix [607153]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST012285	Genome-wide genotyping array
2021-09-03	33736632	Zeng Z	2021-03-18	BMC Med Genomics	www.ncbi.nlm.nih.gov/pubmed/33736632	Genome-wide association study identifies new loci associated with risk of HBV infection and disease progression.	Hepatitis B	460 Chinese ancestry cases, 169 Chinese ancestry controls	NA	6p21.32	6	33087470	HLA-DPB1	HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1			ENSG00000215048, ENSG00000237710, ENSG00000223865, ENSG00000229295, ENSG00000226826, ENSG00000230708			rs9277542-?	rs9277542	0	9277542	3_prime_UTR_variant	0	NR	2E-9	8.698970004336019				Affymetrix [607153]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST012285	Genome-wide genotyping array
2021-09-03	33736632	Zeng Z	2021-03-18	BMC Med Genomics	www.ncbi.nlm.nih.gov/pubmed/33736632	Genome-wide association study identifies new loci associated with risk of HBV infection and disease progression.	Hepatitis B	460 Chinese ancestry cases, 169 Chinese ancestry controls	NA	6p21.32	6	33103545	HLA-DPA2	HLA-DPA2 - COL11A2P1	ENSG00000227286	ENSG00000230816		6250	249	rs3128923-?	rs3128923	0	3128923	intergenic_variant	1	NR	2E-6	5.698970004336019				Affymetrix [607153]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST012285	Genome-wide genotyping array
2021-09-03	33736632	Zeng Z	2021-03-18	BMC Med Genomics	www.ncbi.nlm.nih.gov/pubmed/33736632	Genome-wide association study identifies new loci associated with risk of HBV infection and disease progression.	Hepatitis B	460 Chinese ancestry cases, 169 Chinese ancestry controls	NA	6q21	6	108368952	LACE1	AFG1L			ENSG00000135537			rs1537862-?	rs1537862	0	1537862	intron_variant	0	NR	2E-6	5.698970004336019				Affymetrix [607153]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST012285	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)(time to event)	165 European ancestry cases, 2,023 European ancestry controls, 56 East Asian ancestry cases, 237 East Asian ancestry controls, 23 Hispanic cases, 399 Hispanic controls	NA	20q13.31	20	57641643	PMEPA1	ZBP1 - PMEPA1	ENSG00000124256	ENSG00000124225		21067	6749	rs59967896-?	rs59967896	0	59967896	intergenic_variant	1		8E-10	9.096910013008056	(EA)	3.75	[2.46-5.71]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012086	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)(time to event)	165 European ancestry cases, 2,023 European ancestry controls, 56 East Asian ancestry cases, 237 East Asian ancestry controls, 23 Hispanic cases, 399 Hispanic controls	NA	3p21.1	3	54084687	IL17RB	CABYRP1 - CACNA2D3	ENSG00000242983	ENSG00000157445		35894	37860	rs58861611-?	rs58861611	0	58861611	intron_variant	1		3E-7	6.522878745280337	(East Asian)	3.4	[2.95-3.85]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012086	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)(time to event)	165 European ancestry cases, 2,023 European ancestry controls, 56 East Asian ancestry cases, 237 East Asian ancestry controls, 23 Hispanic cases, 399 Hispanic controls	NA	16q12.1	16	52471255	TOX3	TOX3			ENSG00000103460			rs79025327-?	rs79025327	0	79025327	intron_variant	0		7E-8	7.154901959985743	(East Asian)	3.12	[2.71-3.53]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012086	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)(time to event)	165 European ancestry cases, 2,023 European ancestry controls, 56 East Asian ancestry cases, 237 East Asian ancestry controls, 23 Hispanic cases, 399 Hispanic controls	NA	16q24.3	16	89145003	ACSF3	ACSF3			ENSG00000176715			rs142820005-?	rs142820005	0	142820005	intron_variant	0		7E-7	6.154901959985743	(EA)	2.35	[2.02-2.68]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012086	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment in psoriasis (herpes zoster)(time to event)	56 European ancestry cases, 1,543 European ancestry controls, 10 East Asian ancestry cases, 80 East Asian ancestry controls, 4 Hispanic cases, 245 Hispanic controls	NA	6p23	6	14292589	CD83	LINC01108 - NA	ENSG00000226673			7135		rs112817503-?	rs112817503	0	112817503	intergenic_variant	1		1E-10	10.0	(EA)	5.47	[3.38-9.77]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012085	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment in psoriasis (herpes zoster)(time to event)	56 European ancestry cases, 1,543 European ancestry controls, 10 East Asian ancestry cases, 80 East Asian ancestry controls, 4 Hispanic cases, 245 Hispanic controls	NA	4p14	4	39534903	UGDH	UGDH-AS1			ENSG00000249348			rs150665541-?	rs150665541	0	150665541	intron_variant	0		2E-8	7.698970004336019	(EA)	4.86	[2.79-8.45]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012085	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment in psoriasis (herpes zoster)(time to event)	56 European ancestry cases, 1,543 European ancestry controls, 10 East Asian ancestry cases, 80 East Asian ancestry controls, 4 Hispanic cases, 245 Hispanic controls	NA	12p13.31	12	5993661	VWF	VWF			ENSG00000110799			rs200638456-?	rs200638456	0	200638456	intron_variant	0		3E-8	7.522878745280337	(EA)	3.5	[2.25-5.46]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012085	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment in psoriasis (herpes zoster)(time to event)	56 European ancestry cases, 1,543 European ancestry controls, 10 East Asian ancestry cases, 80 East Asian ancestry controls, 4 Hispanic cases, 245 Hispanic controls	NA	7p14.1	7	37763129	GPR141	EPDR1, GPR141			ENSG00000086289, ENSG00000187037			rs56114331-?	rs56114331	0	56114331	intron_variant	0		2E-6	5.698970004336019	(EA)	5.85	[5.12-6.58]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012085	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)	165 European ancestry cases, 2,023 European ancestry controls, 56 East Asian ancestry cases, 237 East Asian ancestry controls, 23 Hispanic cases, 399 Hispanic controls	NA	16q24.3	16	89145003	ACSF3	ACSF3			ENSG00000176715			rs142820005-?	rs142820005	0	142820005	intron_variant	0	NR	2E-6	5.698970004336019	(EA)	2.68	[2.31-3.05]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012084	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)	165 European ancestry cases, 2,023 European ancestry controls, 56 East Asian ancestry cases, 237 East Asian ancestry controls, 23 Hispanic cases, 399 Hispanic controls	NA	20q13.31	20	57641643	PMEPA1	ZBP1 - PMEPA1	ENSG00000124256	ENSG00000124225		21067	6749	rs59967896-?	rs59967896	0	59967896	intergenic_variant	1		2E-7	6.698970004336019	(EA)	4.1	[2.51-6.69]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012084	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)	165 European ancestry cases, 2,023 European ancestry controls, 56 East Asian ancestry cases, 237 East Asian ancestry controls, 23 Hispanic cases, 399 Hispanic controls	NA	3p21.1	3	54084687	IL17RB	CABYRP1 - CACNA2D3	ENSG00000242983	ENSG00000157445		35894	37860	rs58861611-?	rs58861611	0	58861611	intron_variant	1		2E-6	5.698970004336019	(East Asian)	5.06	[4.37-5.75]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012084	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)	165 European ancestry cases, 2,023 European ancestry controls, 56 East Asian ancestry cases, 237 East Asian ancestry controls, 23 Hispanic cases, 399 Hispanic controls	NA	16q12.1	16	52471255	TOX3	TOX3			ENSG00000103460			rs79025327-?	rs79025327	0	79025327	intron_variant	0		5E-7	6.301029995663981	(East Asian)	4.87	[4.24-5.5]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012084	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment in psoriasis (herpes zoster)	56 European ancestry cases, 1,543 European ancestry controls, 10 East Asian ancestry cases, 80 East Asian ancestry controls, 4 Hispanic cases, 245 Hispanic controls	NA	6p23	6	14292589	CD83	LINC01108 - NA	ENSG00000226673			7135		rs112817503-?	rs112817503	0	112817503	intergenic_variant	1		6E-8	7.221848749616356	(EA)	7.71	[4.02-14.8]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012083	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment in psoriasis (herpes zoster)	56 European ancestry cases, 1,543 European ancestry controls, 10 East Asian ancestry cases, 80 East Asian ancestry controls, 4 Hispanic cases, 245 Hispanic controls	NA	4p14	4	39534903	UGDH	UGDH-AS1			ENSG00000249348			rs150665541-?	rs150665541	0	150665541	intron_variant	0		4E-6	5.3979400086720375	(EA)	5.46	[2.88-10.3]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012083	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment in psoriasis (herpes zoster)	56 European ancestry cases, 1,543 European ancestry controls, 10 East Asian ancestry cases, 80 East Asian ancestry controls, 4 Hispanic cases, 245 Hispanic controls	NA	12p13.31	12	5993661	VWF	VWF			ENSG00000110799			rs200638456-?	rs200638456	0	200638456	intron_variant	0		1E-6	6.0	(EA)	4.04	[2.42-6.75]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012083	Genome-wide genotyping array
2020-08-03	32376702	Shen J	2020-05-06	mSphere	www.ncbi.nlm.nih.gov/pubmed/32376702	Genetic Association Reveals Protection against Recurrence of Clostridium difficile Infection with Bezlotoxumab Treatment.	Recurrence of Clostridium difficile infection x bezlotuxumab treatment interaction (2df test)	704 European, African American and Asian ancestry individuals	NA	6p21.33	6	31479811	NR	HCP5 - MICB-DT	ENSG00000206337	ENSG00000286940		875	162	rs2516513-T	rs2516513	0	2516513	intergenic_variant	1	0.41	3E-8	7.522878745280337				Affymetrix [7570264] (imputed)	N	clostridium difficile infection, response to bezlotoxumab	http://www.ebi.ac.uk/efo/EFO_0009130, http://www.ebi.ac.uk/efo/EFO_0010730	GCST010380	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	1p22.2	1	87929394	NR	PKN2-AS1			ENSG00000237505			rs17130215-?	rs17130215	0	17130215	intron_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	11q13.2	11	67611545	NR	NDUFV1			ENSG00000167792			rs11227859-?	rs11227859	0	11227859	synonymous_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	11q13.2	11	67633095	NR	TBX10			ENSG00000167800			rs11227870-?	rs11227870	0	11227870	synonymous_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	1q42.2	1	231663846	NR	DISC1, TSNAX-DISC1			ENSG00000162946, ENSG00000270106			rs12060910-?	rs12060910	0	12060910	intron_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	12q13.12	12	49990566	NR	RACGAP1			ENSG00000161800			rs2292721-?	rs2292721	0	2292721	intron_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	12q13.2	12	55237784	NR	OR10A7 - OR6C74	ENSG00000179919	ENSG00000197706		15809	9504	rs11171380-?	rs11171380	0	11171380	intergenic_variant	1		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	12q22	12	92386298	NR	LINC02391 - CLLU1-AS1	ENSG00000277851	ENSG00000205057		22466	33796	rs11106530-?	rs11106530	0	11106530	intergenic_variant	1		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	12q24.33	12	129947107	NR	TMEM132D - LINC02418	ENSG00000151952	ENSG00000214039		43082	85821	rs12423717-?	rs12423717	0	12423717	intergenic_variant	1		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	13q12.13	13	25103371	NR	PABPC3 - AMER2	ENSG00000151846	ENSG00000165566		4117	58308	rs12864436-?	rs12864436	0	12864436	intergenic_variant	1		6E-7	6.221848749616356				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	13q31.1	13	79801869	NR	NA - LINC01038		ENSG00000229011			2549	rs12584389-?	rs12584389	0	12584389	intergenic_variant	1		1E-6	6.0				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	5p15.2	5	10240437	NR	ATPSCKMT			ENSG00000150756			rs2607324-?	rs2607324	0	2607324	intron_variant	0		4E-6	5.3979400086720375				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	13q34	13	113193821	NR	PCID2			ENSG00000126226			rs7329583-?	rs7329583	0	7329583	intron_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	5q22.3	5	115188701	NR	TRIM36 - PGGT1B	ENSG00000152503	ENSG00000164219		8155	15311	rs7736737-?	rs7736737	0	7736737	non_coding_transcript_exon_variant	1		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	14q13.3	14	36680588	NR	SLC25A21			ENSG00000183032			rs17104988-?	rs17104988	0	17104988	3_prime_UTR_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	5q35.2	5	174953675	NR	LINC01951			ENSG00000204754			rs17064169-?	rs17064169	0	17064169	intron_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	16p13.3	16	7093498	NR	RBFOX1			ENSG00000078328			rs12103267-?	rs12103267	0	12103267	intron_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA				NR							SNP6-56615521-?	SNP6-56615521	0			1		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	6q16.2	6	99843632	NR	PSMG4 - MCHR2	ENSG00000180822	ENSG00000152034		96540259	74887	rs9385905-?	rs9385905	0	9385905	intergenic_variant	1		2E-6	5.698970004336019				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	6q16.3	6	103108352	NR							rs9404319-?	rs9404319	0	9404319	intergenic_variant	1		2E-6	5.698970004336019				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	7p12.2	7	50392510	NR	IKZF1			ENSG00000185811			rs7797772-?	rs7797772	0	7797772	intron_variant	0		6E-7	6.221848749616356				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	7p12.1	7	50542915	NR	DDC-AS1, DDC			ENSG00000226122, ENSG00000132437			rs3807553-?	rs3807553	0	3807553	non_coding_transcript_exon_variant	0		2E-6	5.698970004336019				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	Xp21.2	X	30044474	NR	PIGFP3 - NA	ENSG00000227592			26593		rs10126910-?	rs10126910	0	10126910	intergenic_variant	1		8E-6	5.096910013008056				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	19q13.11	19	32600776	NR	ANKRD27			ENSG00000105186			rs2903754-?	rs2903754	0	2903754	intron_variant	0		1E-6	6.0				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	8p23.3	8	1470728	NR	DLGAP2, DLGAP2			ENSG00000198010, ENSG00000282318			rs28367414-?	rs28367414	0	28367414	intron_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	1p36.11	1	25861484	NR	PAQR7			ENSG00000182749			rs12067275-?	rs12067275	0	12067275	3_prime_UTR_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	5q35.2	5	175054011	FLJ16171	LINC01951 - NA	ENSG00000204754			58498		rs1875968-A	rs1875968	0	1875968	intergenic_variant	1	NR	9E-9	8.045757490560675				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	1q21.2	1	147513925	NR	LINC00624			ENSG00000278811			rs12057959-?	rs12057959	0	12057959	intron_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	1q42.12	1	226789330	NR	RPS27P5 - PSEN2	ENSG00000238183	ENSG00000143801		7586	80854	rs6426540-?	rs6426540	0	6426540	intergenic_variant	1		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA				ATP7B							SNP13-51471313-A	SNP13-51471313	0			1	NR	4E-8	7.3979400086720375				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	2q23.3	2	149993013	NR	MMADHC-DT			ENSG00000231969			rs12618095-?	rs12618095	0	12618095	intron_variant	0		9E-6	5.045757490560675				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	2q23.3	2	151205369	NR	FABP5P10 - RBM43	ENSG00000213201	ENSG00000184898		18774	42571	rs289864-?	rs289864	0	289864	regulatory_region_variant	1		6E-6	5.221848749616356				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	2q31.1	2	174130669	NR	OLA1			ENSG00000138430			rs9679651-?	rs9679651	0	9679651	intron_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	3q11.2	3	94072546	NR	NSUN3			ENSG00000178694			rs6414259-?	rs6414259	0	6414259	intron_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	3q11.2	3	95905623	NR							rs9825648-?	rs9825648	0	9825648	regulatory_region_variant	1		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	3q29	3	197350933	NR	DLG1-AS1 - NA	ENSG00000227375			47178		rs4916473-?	rs4916473	0	4916473	intergenic_variant	1		5E-8	7.301029995663981				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	4q31.3	4	150873055	NR	LRBA			ENSG00000198589			rs17027158-?	rs17027158	0	17027158	intron_variant	0		4E-6	5.3979400086720375				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	13q33.2	13	105740015	NR	LINC00343			ENSG00000226620			rs7993290-?	rs7993290	0	7993290	intron_variant	0		6E-6	5.221848749616356				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	5q22.2	5	112850455	NR	APC - SRP19	ENSG00000134982	ENSG00000153037		4216	10733	rs6877425-?	rs6877425	0	6877425	intron_variant	1		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	14q12	14	25766264	NR	LINC02306			ENSG00000257986			rs10148451-?	rs10148451	0	10148451	intron_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	5q34	5	164084868	NR							rs13163167-?	rs13163167	0	13163167	intergenic_variant	1		9E-7	6.045757490560675				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA				NR							SNP15-49545118-?	SNP15-49545118	0			1		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	5q35.2	5	175919787	NR	THOC3			ENSG00000051596			rs10476176-?	rs10476176	0	10476176	intron_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	17p13.3	17	3195340	NR	OR1P1 - OR1A2	ENSG00000262085	ENSG00000172150		40458	2179	rs11868164-?	rs11868164	0	11868164	intergenic_variant	1		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	17q24.2	17	66986976	NR	CACNG4			ENSG00000075461			rs8070529-?	rs8070529	0	8070529	intron_variant	0		1E-6	6.0				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	18p11.32	18	612819	NR	CLUL1			ENSG00000079101			rs9947236-?	rs9947236	0	9947236	non_coding_transcript_exon_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	18q21.1	18	46460596	NR	RNF165			ENSG00000141622			rs4290554-?	rs4290554	0	4290554	3_prime_UTR_variant	0		1E-6	6.0				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	19p13.2	19	7170494	NR	INSR			ENSG00000171105			rs7252268-?	rs7252268	0	7252268	intron_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	19p13.2	19	12388576	NR	RPS29P23 - ZNF799	ENSG00000231361	ENSG00000196466		14845	1440	rs10407238-?	rs10407238	0	10407238	intron_variant	1		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	Xq22.3	X	107568958	NR	FRMPD3			ENSG00000147234			rs16985240-?	rs16985240	0	16985240	intron_variant	0		5E-6	5.301029995663981				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	19q13.2	19	40685488	NR	NUMBL			ENSG00000105245			rs13343737-?	rs13343737	0	13343737	non_coding_transcript_exon_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	8q24.22	8	131011356	NR	ADCY8			ENSG00000155897			rs885381-?	rs885381	0	885381	intron_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	8q24.22	8	131485703	NR	SNORA72 - NA	ENSG00000201944			52834		rs12114496-?	rs12114496	0	12114496	intergenic_variant	1		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	9p24.2	9	2844261	NR	PUM3 - GPS2P1	ENSG00000080608	ENSG00000236496		166	31181	rs16910644-?	rs16910644	0	16910644	TF_binding_site_variant	1		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	9p22.3	9	15788189	NR	CCDC171			ENSG00000164989			rs7853304-?	rs7853304	0	7853304	intron_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	9p21.2	9	27170623	NR	TEK			ENSG00000120156			rs601359-?	rs601359	0	601359	intron_variant	0		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA				NR							SNP20-32054530-?	SNP20-32054530	0			1		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA				NR							SNP20-32162120-?	SNP20-32162120	0			1		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	20q12	20	42154752	NR	PTPRT			ENSG00000196090			rs6030011-?	rs6030011	0	6030011	intron_variant	0		9E-6	5.045757490560675				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2018-06-11	29594489	Apewokin S	2018-03-28	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/29594489	Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.	Clostridium difficile infection in multiple myeloma	57 European ancestry cases, 589 European ancestry controls	NA	10q11.21	10	44472287	NR	RPL9P21 - NA	ENSG00000214089			57134		rs1147953-?	rs1147953	0	1147953	intergenic_variant	1		3E-6	5.522878745280337				Illumina [892589]	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST005686	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	1p35.2	1	30064385	NR	LINC01648 - NA	ENSG00000233399			26773		rs867720-C	rs867720	0	867720	intergenic_variant	1	0.2573	5E-6	5.301029995663981		1.23	[1.14-1.35]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	5p15.2	5	10969185	CTNND2	NA - CTNND2		ENSG00000169862			2651	rs13181507-A	rs13181507	0	13181507	intergenic_variant	1	0.0144	3E-7	6.522878745280337		1.98	[1.58-2.4]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	6p21.33	6	31536417	SNORD117	ATP6V1G2-DDX39B, DDX39B, DDX39B, DDX39B, DDX39B, SNORD117, SNORD117, SNORD117, SNORD117			ENSG00000254870, ENSG00000198563, ENSG00000235439, ENSG00000229496, ENSG00000225073, ENSG00000263359, ENSG00000263358, ENSG00000263625, ENSG00000201785			rs114751021-G	rs114751021	0	114751021	non_coding_transcript_exon_variant	0	0.024	5E-8	7.301029995663981		2.41	[1.84-3.09]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	16p13.2	16	9976428	GRIN2A	GRIN2A			ENSG00000183454			rs12924396-G	rs12924396	0	12924396	intron_variant	0	0.4689	8E-7	6.096910013008056		0.81	[0.75-0.88]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	6p21.33	6	31097260	NR	RNU6-1133P - C6orf15	ENSG00000222895	ENSG00000229432		14151	13963	rs146508039-T	rs146508039	0	146508039	regulatory_region_variant	1	0.025	5E-7	6.301029995663981		2.24	[1.7-2.88]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	2q24.1	2	156861846	AC096589.2, AC096589.1	RPLP0P7 - NA	ENSG00000238069			83474		rs13409177-A	rs13409177	0	13409177	intron_variant	1	0.0573	2E-6	5.698970004336019		1.46	[1.27-1.66]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	6p21.33	6	31895099	ZBTB12	EHMT2, EHMT2, EHMT2, EHMT2, EHMT2, EHMT2			ENSG00000236759, ENSG00000206376, ENSG00000227333, ENSG00000224143, ENSG00000204371, ENSG00000238134			rs115062572-T	rs115062572	0	115062572	intron_variant	0	0.022	1E-6	6.0		2.29	[1.7-2.98]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	11p15.5	11	2303962	NR	TSPAN32			ENSG00000064201			rs117600357-A	rs117600357	0	117600357	intron_variant	0	0.0244	2E-6	5.698970004336019		1.69	[1.39-2.01]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	6q21	6	106637066	QRSL1	QRSL1			ENSG00000130348			rs1419054-A	rs1419054	0	1419054	intron_variant	0	0.115	4E-6	5.3979400086720375		0.59	[0.43-0.75]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	6q16.1	6	93107324	RP1NR23E21.2	COPS5P1 - NA	ENSG00000213187			14564		rs146471836-T	rs146471836	0	146471836	intergenic_variant	1	0.026	4E-6	5.3979400086720375		2.11	[1.59-2.72]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	4q27	4	120516660	AC073475.1							rs72672568-C	rs72672568	0	72672568	intron_variant	1	0.0556	3E-6	5.522878745280337		1.45	[1.27-1.67]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	13q33.2	13	104485179	NR							rs4772629-T	rs4772629	0	4772629	intergenic_variant	1	0.1813	3E-6	5.522878745280337		0.79	[0.72-0.87]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	1q23.2	1	159552202	NR	OR10J5 - OR10AE1P	ENSG00000184155	ENSG00000271890		16195	29418	rs56040707-G	rs56040707	0	56040707	intergenic_variant	1	0.027	5E-6	5.301029995663981		2.04	[1.55-2.62]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	11q13.5	11	76661008	LRRC32	LRRC32			ENSG00000137507			rs3740779-A	rs3740779	0	3740779	synonymous_variant	0	0.36	6E-6	5.221848749616356		0.73	[0.63-0.84]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	8q23.3	8	114032037	NR	Y_RNA - NA	ENSG00000199357			81039		rs80176672-T	rs80176672	0	80176672	intergenic_variant	1	0.0122	3E-6	5.522878745280337		1.96	[1.54-2.44]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	7q34	7	142694913	TRBV26	TRBVA - TRBV26	ENSG00000239992	ENSG00000249912		13044	786	rs17719655-A	rs17719655	0	17719655	intergenic_variant	1	0.0113	3E-6	5.522878745280337		2.02	[1.57-2.5]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	21q21.1	21	15652835	NR	RNU6-1326P - RAD23BP3	ENSG00000212564	ENSG00000226298		38446	41465	rs192418381-C	rs192418381	0	192418381	intergenic_variant	1	0.0124	3E-6	5.522878745280337		1.96	[1.54-2.44]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	1p36.22	1	9496499	RP13NR392I16.1	LINC02606 - SLC25A33	ENSG00000284693	ENSG00000171612		55935	42966	rs11121431-G	rs11121431	0	11121431	intergenic_variant	1	0.033	8E-6	5.096910013008056		1.92	[1.48-2.42]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	8q23.3	8	115035778	NR							rs72675948-T	rs72675948	0	72675948	intergenic_variant	1	0.027	8E-6	5.096910013008056		2.07	[1.56-2.68]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	2q14.2	2	119167031	RN7SL468P	C1QL2 - RN7SL468P	ENSG00000144119	ENSG00000264833		8280	2791	rs146426342-G	rs146426342	0	146426342	intergenic_variant	1	0.013	8E-6	5.096910013008056		2.54	[1.78-3.48]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	13q33.2	13	104392942	NR							rs11617974-C	rs11617974	0	11617974	intergenic_variant	1	0.3288	4E-6	5.3979400086720375		1.22	[1.12-1.33]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	13q21.32	13	66334267	PCDH9	PCDH9			ENSG00000184226			rs1982305-G	rs1982305	0	1982305	intron_variant	0	0.2358	4E-6	5.3979400086720375		1.25	[1.14-1.37]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	4p14	4	37277838	NWD2	NWD2			ENSG00000174145			rs116838950-C	rs116838950	0	116838950	intron_variant	0	0.0116	4E-6	5.3979400086720375		2.0	[1.54-2.44]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	6p21.33	6	31895099	ZBTB12, EHMT2, C2, CYP21A2	EHMT2, EHMT2, EHMT2, EHMT2, EHMT2, EHMT2			ENSG00000236759, ENSG00000206376, ENSG00000227333, ENSG00000224143, ENSG00000204371, ENSG00000238134			rs115062572-T	rs115062572	0	115062572	intron_variant	0	0.0203	4E-6	5.3979400086720375		1.74	[1.41-2.08]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	18q11.2	18	26718322	AQP4NRAS1	AQP4-AS1			ENSG00000260372			rs57118264-A	rs57118264	0	57118264	intron_variant	0	0.0179	4E-6	5.3979400086720375		1.79	[1.44-2.15]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	6p21.33	6	31065866	NR	HCG22 - RNU6-1133P	ENSG00000238234	ENSG00000222895		5976	17144	rs149917912-C	rs149917912	0	149917912	intergenic_variant	1	0.0242	5E-6	5.301029995663981		1.67	[1.37-2]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	11p14.3	11	23908087	NR	RNU6-783P - NA	ENSG00000252519			58205		rs35294279-C	rs35294279	0	35294279	intergenic_variant	1	0.037	2E-7	6.698970004336019		1.67	[1.39-1.92]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	7q33	7	135493856	CNOT4, TSPAN32, C11orf21	CNOT4			ENSG00000080802			rs117373257-A	rs117373257	0	117373257	intron_variant	0	0.0133	3E-7	6.522878745280337		2.02	[1.61-2.47]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	19q13.32	19	44730629	RF00285	CEACAM16-AS1 - BCL3	ENSG00000266903	ENSG00000069399		5412	17076	rs138769755-T	rs138769755	0	138769755	intergenic_variant	1	0.0222	8E-7	6.096910013008056		1.76	[1.45-2.1]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	7q31.1	7	110117051	NR							rs6948305-G	rs6948305	0	6948305	intron_variant	1	0.014	4E-7	6.3979400086720375		2.72	[1.95-3.67]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	13q33.2	13	104625860	NR							rs114995101-G	rs114995101	0	114995101	regulatory_region_variant	1	0.02	5E-7	6.301029995663981		2.42	[1.8-3.17]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	16q21	16	61955227	CDH8	CDH8			ENSG00000150394			rs141932469-T	rs141932469	0	141932469	intron_variant	0	0.0128	9E-7	6.045757490560675		2.03	[1.6-2.48]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	4p16.1	4	7197405	SORCS2	SORCS2			ENSG00000184985			rs12641357-T	rs12641357	0	12641357	intron_variant	0	0.1621	1E-6	6.0		1.32	[1.18-1.45]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	7p21.3	7	9108332	NR	NA - HDAC9		ENSG00000048052			8978617	rs78701439-A	rs78701439	0	78701439	intron_variant	1	0.017	5E-7	6.301029995663981		2.55	[1.86-3.39]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	3p26.2	3	3853712	SUMF1	SUMF1			ENSG00000144455			rs139959052-T	rs139959052	0	139959052	intron_variant	0	0.0288	2E-6	5.698970004336019		1.73	[1.42-2.07]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	4q13.3	4	74406801	NR	EREG - AREG	ENSG00000124882	ENSG00000109321		18052	38335	rs140966705-C	rs140966705	0	140966705	intergenic_variant	1	0.041	2E-6	5.698970004336019		1.85	[1.47-2.28]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	8p23.2	8	4213992	CSMD1	CSMD1			ENSG00000183117			rs890001-C	rs890001	0	890001	intron_variant	0	0.0206	3E-6	5.522878745280337		1.77	[1.44-2.12]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	11q24.2	11	127728092	NR	RAB3IL1 - NA	ENSG00000167994			65807823		rs183570761-T	rs183570761	0	183570761	intergenic_variant	1	0.017	4E-6	5.3979400086720375		2.38	[1.72-3.17]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	9p13.1	9	38389517	ALDH1B1	NA - ALDH1B1		ENSG00000137124			3185	rs4142260-T	rs4142260	0	4142260	intergenic_variant	1	0.466	5E-6	5.301029995663981		0.74	[0.65-0.84]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	4p14	4	37277838	KIAA1239	NWD2			ENSG00000174145			rs116838950-C	rs116838950	0	116838950	intron_variant	0	0.013	5E-6	5.301029995663981		2.65	[1.84-3.66]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	21q22.13	21	37991668	DSCR4, KCNJ6	KCNJ6, DSCR4			ENSG00000157542, ENSG00000184029			rs62222030-C	rs62222030	0	62222030	intron_variant	0	0.0746	3E-6	5.522878745280337		1.41	[1.23-1.59]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	18p11.32	18	1771062	CTDNR2015H3.2							rs17586705-T	rs17586705	0	17586705	intron_variant	1	0.176	7E-6	5.154901959985743		1.42	[1.23-1.64]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	15q24.3	15	76885514	SCAPER	SCAPER			ENSG00000140386			rs118090546-T	rs118090546	0	118090546	intron_variant	0	0.012	7E-6	5.154901959985743		2.65	[1.84-3.69]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	18q22.3	18	71687186	NR	NA - LINC01899		ENSG00000265352			45429	rs73462173-G	rs73462173	0	73462173	intergenic_variant	1	0.114	8E-6	5.096910013008056		0.59	[0.44-0.76]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	6p21.33	6	31133806	PSORS1C2	PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1			ENSG00000231094, ENSG00000233439, ENSG00000206458, ENSG00000233734, ENSG00000204540, ENSG00000235487			rs4294047-A	rs4294047	0	4294047	intron_variant	0	0.103	8E-6	5.096910013008056		1.53	[1.28-1.8]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	17q22	17	59249127	GDPD1	GDPD1			ENSG00000153982			rs73321289-T	rs73321289	0	73321289	non_coding_transcript_exon_variant	0	0.0121	3E-6	5.522878745280337		1.98	[1.55-2.44]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection	1,160 European ancestry cases, 14,144 European ancestry controls	NA	13q33.2	13	104501466	NR							rs1434351-T	rs1434351	0	1434351	intergenic_variant	1	0.3535	3E-6	5.522878745280337		1.22	[1.12-1.32]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012277	Genome-wide genotyping array
2021-08-31	33841421	Li J	2021-03-25	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/33841421	Variants at the MHC Region Associate With Susceptibility to <i>Clostridioides difficile</i> Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.	Clostridioides difficle infection in antibiotics-users	587 European ancestry cases, 3,166 European ancestry controls	NA	2q13	2	112180774	FBLN7	FBLN7			ENSG00000144152			rs115611612-A	rs115611612	0	115611612	intron_variant	0	0.063	8E-6	5.096910013008056		1.66	[1.35-2]	Illumina [64973696] (imputed)	N	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130	GCST012276	Genome-wide genotyping array
2020-10-01	32949544	Jones E	2020-09-16	Lancet Neurol	www.ncbi.nlm.nih.gov/pubmed/32949544	Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study.	Creutzfeldt-Jakob disease (sporadic)	4,110 European ancestry cases, 13,569 European ancestry controls	1,098 European ancestry cases, 498,016 European ancestry controls	20p13	20	4699605	PRNP	PRNP			ENSG00000171867			rs1799990-A	rs1799990	0	1799990	missense_variant	0	0341	1E-16	16.0		1.15	[104128]	Affymetrix, Illumina [6314492] (imputed)	N	sporadic Creutzfeld Jacob disease	http://www.ebi.ac.uk/efo/EFO_1000656	GCST90001389	Genome-wide genotyping array
2020-10-01	32949544	Jones E	2020-09-16	Lancet Neurol	www.ncbi.nlm.nih.gov/pubmed/32949544	Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study.	Creutzfeldt-Jakob disease (sporadic)	4,110 European ancestry cases, 13,569 European ancestry controls	1,098 European ancestry cases, 498,016 European ancestry controls	1q25.3	1	180984717	STX6	STX6			ENSG00000135823			rs3747957-A	rs3747957	0	3747957	synonymous_variant	0	0.41	1E-10	10.0		1.15	[104128]	Affymetrix, Illumina [6314492] (imputed)	N	sporadic Creutzfeld Jacob disease	http://www.ebi.ac.uk/efo/EFO_1000656	GCST90001389	Genome-wide genotyping array
2020-10-01	32949544	Jones E	2020-09-16	Lancet Neurol	www.ncbi.nlm.nih.gov/pubmed/32949544	Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study.	Creutzfeldt-Jakob disease (sporadic)	4,110 European ancestry cases, 13,569 European ancestry controls	1,098 European ancestry cases, 498,016 European ancestry controls	22q12.2	22	30557308	GAL3ST1	GAL3ST1			ENSG00000128242			rs2267161-C	rs2267161	0	2267161	missense_variant	0	0.322	2E-10	9.698970004336019		1.11	[100123]	Affymetrix, Illumina [6314492] (imputed)	N	sporadic Creutzfeld Jacob disease	http://www.ebi.ac.uk/efo/EFO_1000656	GCST90001389	Genome-wide genotyping array
2020-10-01	32949544	Jones E	2020-09-16	Lancet Neurol	www.ncbi.nlm.nih.gov/pubmed/32949544	Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study.	Creutzfeldt-Jakob disease (sporadic)	4,110 European ancestry cases, 13,569 European ancestry controls	1,098 European ancestry cases, 498,016 European ancestry controls	16p13.11	16	15446044	BMERB1	BMERB1, BMERB1			ENSG00000278823, ENSG00000166780			rs6498552-T	rs6498552	0	6498552	intron_variant	0	0.102	6E-8	7.221848749616356		1.11	[096129]	Affymetrix, Illumina [6314492] (imputed)	N	sporadic Creutzfeld Jacob disease	http://www.ebi.ac.uk/efo/EFO_1000656	GCST90001389	Genome-wide genotyping array
2009-09-09	19684573	Ge D	2009-08-16	Nature	www.ncbi.nlm.nih.gov/pubmed/19684573	Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.	Response to hepatitis C treatment	871 European ancestry cases, 191 African American cases, 75 Hispanic cases	NA	4q34.3	4	179127208	intergenic							rs17067123-?	rs17067123	0	17067123	intergenic_variant	1	NR	8E-6	5.096910013008056	(combined)			Illumina [565759]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST000465	Genome-wide genotyping array
2009-09-09	19684573	Ge D	2009-08-16	Nature	www.ncbi.nlm.nih.gov/pubmed/19684573	Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.	Response to hepatitis C treatment	871 European ancestry cases, 191 African American cases, 75 Hispanic cases	NA	6q21	6	109686444	AKD2	AK9			ENSG00000155085			rs9400317-?	rs9400317	0	9400317	intron_variant	0	NR	7E-6	5.154901959985743	(combined)			Illumina [565759]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST000465	Genome-wide genotyping array
2009-09-09	19684573	Ge D	2009-08-16	Nature	www.ncbi.nlm.nih.gov/pubmed/19684573	Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.	Response to hepatitis C treatment	871 European ancestry cases, 191 African American cases, 75 Hispanic cases	NA	19q13.2	19	39248147	IL28B	IFNL4			ENSG00000272395			rs12979860-C	rs12979860	0	12979860	intron_variant	0	0.72	1E-28	28.0	(combined, EA)	2.0	[1.8-2.3]	Illumina [565759]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST000465	Genome-wide genotyping array
2011-12-20	22095909	Lange CM	2011-11-16	Hepatology	www.ncbi.nlm.nih.gov/pubmed/22095909	Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy.	Response to hepatitis C treatment	707 European ancestry cases	NA	9q34.3	9	135137855	OLFM1	OLFM1 - NA	ENSG00000130558			16675		rs10776934-T	rs10776934	0	10776934	regulatory_region_variant	1	NR	1E-6	6.0		0.281	[0.17-0.39] ug/L decrease	NR [NR]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST001325	Genome-wide genotyping array
2011-12-20	22095909	Lange CM	2011-11-16	Hepatology	www.ncbi.nlm.nih.gov/pubmed/22095909	Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy.	Response to hepatitis C treatment	707 European ancestry cases	NA	2q36.1	2	223594965	SCG2	CCDC141 - SCG2	ENSG00000163492	ENSG00000171951		44544879	1975	rs16864968-G	rs16864968	0	16864968	intergenic_variant	1	NR	3E-6	5.522878745280337		0.826	[0.48-1.17] ug/L decrease	NR [NR]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST001325	Genome-wide genotyping array
2011-12-20	22095909	Lange CM	2011-11-16	Hepatology	www.ncbi.nlm.nih.gov/pubmed/22095909	Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy.	Response to hepatitis C treatment	707 European ancestry cases	NA	4p11	4	49060875	CWH43	CWH43			ENSG00000109182			rs11725957-G	rs11725957	0	11725957	intron_variant	0	NR	8E-6	5.096910013008056		0.727	[0.41-1.05] ug/L increase	NR [NR]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST001325	Genome-wide genotyping array
2011-12-20	22095909	Lange CM	2011-11-16	Hepatology	www.ncbi.nlm.nih.gov/pubmed/22095909	Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy.	Response to hepatitis C treatment	707 European ancestry cases	NA	6q25.3	6	160402996	SLC22A3	SLC22A3			ENSG00000146477			rs2504916-T	rs2504916	0	2504916	intron_variant	0	NR	2E-6	5.698970004336019		0.306	[0.18-0.43] ug/L increase	NR [NR]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST001325	Genome-wide genotyping array
2011-12-20	22095909	Lange CM	2011-11-16	Hepatology	www.ncbi.nlm.nih.gov/pubmed/22095909	Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy.	Response to hepatitis C treatment	707 European ancestry cases	NA	6p25.3	6	1535763	RP11-157J24.1	RN7SL352P - FOXCUT	ENSG00000243439	ENSG00000280916		28165	65891	rs11242704-G	rs11242704	0	11242704	regulatory_region_variant	1	NR	5E-6	5.301029995663981		0.257	[0.15-0.37] ug/L decrease	NR [NR]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST001325	Genome-wide genotyping array
2011-12-20	22095909	Lange CM	2011-11-16	Hepatology	www.ncbi.nlm.nih.gov/pubmed/22095909	Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy.	Response to hepatitis C treatment	707 European ancestry cases	NA	6q16.1	6	93201401	EPHA7	NA - EPHA7		ENSG00000135333			38619	rs12527818-T	rs12527818	0	12527818	intergenic_variant	1	NR	7E-6	5.154901959985743		0.274	[0.15-0.39] ug/L increase	NR [NR]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST001325	Genome-wide genotyping array
2011-12-20	22095909	Lange CM	2011-11-16	Hepatology	www.ncbi.nlm.nih.gov/pubmed/22095909	Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy.	Response to hepatitis C treatment	707 European ancestry cases	NA	1p33	1	46713638	KIAA0494	EFCAB14			ENSG00000159658			rs10789491-G	rs10789491	0	10789491	intron_variant	0	NR	1E-6	6.0		0.312	[0.19-0.44] ug/L increase	NR [NR]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST001325	Genome-wide genotyping array
2011-12-20	22095909	Lange CM	2011-11-16	Hepatology	www.ncbi.nlm.nih.gov/pubmed/22095909	Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy.	Response to hepatitis C treatment	707 European ancestry cases	NA	1p36.13	1	17508246	ARHGEF10L	RCC2 - ARHGEF10L	ENSG00000281540	ENSG00000074964		68569	31452	rs2254135-T	rs2254135	0	2254135	regulatory_region_variant	1	NR	3E-6	5.522878745280337		0.269	[0.16-0.38] ug/L increase	NR [NR]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST001325	Genome-wide genotyping array
2011-12-20	22095909	Lange CM	2011-11-16	Hepatology	www.ncbi.nlm.nih.gov/pubmed/22095909	Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy.	Response to hepatitis C treatment	707 European ancestry cases	NA	1p31.1	1	84399547	DNASE2B	DNASE2B			ENSG00000137976			rs12144715-T	rs12144715	0	12144715	intron_variant	0	NR	7E-6	5.154901959985743		0.636	[0.36-0.91] ug/L decrease	NR [NR]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST001325	Genome-wide genotyping array
2011-06-25	21659334	Tanaka Y	2011-06-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21659334	Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C.	Response to hepatitis C treatment	303 Japanese ancestry cases	391 Japanese ancestry cases	20p13	20	3204477	DDRGK1	DDRGK1			ENSG00000198171			rs11697186-T	rs11697186	0	11697186	intron_variant	0	0.15	5E-17	16.30102999566398	(Decrease of PLT)	4.5	[3.10-6.50]	Affymetrix [595052]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST001094	Genome-wide genotyping array
2011-06-25	21659334	Tanaka Y	2011-06-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21659334	Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C.	Response to hepatitis C treatment	303 Japanese ancestry cases	391 Japanese ancestry cases	20p13	20	3207087	ITPA	DDRGK1 - ITPA	ENSG00000198171	ENSG00000125877		2402	1781	rs6139030-C	rs6139030	0	6139030	intergenic_variant	1	0.17	1E-15	15.0	(Decrease of PLT)	3.9	[2.80-5.50]	Affymetrix [595052]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST001094	Genome-wide genotyping array
2011-06-25	21659334	Tanaka Y	2011-06-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21659334	Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C.	Response to hepatitis C treatment	303 Japanese ancestry cases	391 Japanese ancestry cases	20p13	20	3204477	DDRGK1	DDRGK1			ENSG00000198171			rs11697186-A	rs11697186	0	11697186	intron_variant	0	0.85	9E-25	24.045757490560675	(Change in Hb)	33.33	[12.50-100]	Affymetrix [595052]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST001094	Genome-wide genotyping array
2011-06-25	21659334	Tanaka Y	2011-06-09	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21659334	Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C.	Response to hepatitis C treatment	303 Japanese ancestry cases	391 Japanese ancestry cases	20p13	20	3207087	ITPA	DDRGK1 - ITPA	ENSG00000198171	ENSG00000125877		2402	1781	rs6139030-T	rs6139030	0	6139030	intergenic_variant	1	0.83	2E-25	24.69897000433602	(Change of Hb)	25.0	[11.11-50.0]	Affymetrix [595052]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST001094	Genome-wide genotyping array
2011-02-23	21228123	Ochi H	2011-01-12	J Gen Virol	www.ncbi.nlm.nih.gov/pubmed/21228123	IL-28B predicts response to chronic hepatitis C therapy--fine-mapping and replication study in Asian populations.	Response to hepatitis C treatment	2,101 East Asian ancestry cases, 282 Japanese ancestry controls	NA	19q13.2	19	39252525	IL28B	IFNL4 - MSRB1P1	ENSG00000272395	ENSG00000213926		3669	2391	rs8099917-G	rs8099917	0	8099917	intergenic_variant	1	0.083	1E-20	20.0		3.0	[2.4-3.8]	Illumina [510537]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST000944	Genome-wide genotyping array
2012-11-12	20173735	Fellay J	2010-02-21	Nature	www.ncbi.nlm.nih.gov/pubmed/20173735	ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.	Chronic hepatitis C infection	988 European ancestry cases, 198 African American cases, 100 Hispanic cases	NA	20p13	20	3213247	ITPA	ITPA			ENSG00000125877			rs7270101-C	rs7270101	0	7270101	intron_variant	0	0.11	9E-76	75.04575749056067				Illumina [565759]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST000604	Genome-wide genotyping array
2012-11-12	20173735	Fellay J	2010-02-21	Nature	www.ncbi.nlm.nih.gov/pubmed/20173735	ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.	Chronic hepatitis C infection	988 European ancestry cases, 198 African American cases, 100 Hispanic cases	NA	20p13	20	3213196	ITPA	ITPA			ENSG00000125877			rs1127354-A	rs1127354	0	1127354	missense_variant	0	0.069	2E-58	57.69897000433602				Illumina [565759]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST000604	Genome-wide genotyping array
2011-07-29	21725309	Miki D	2011-07-03	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21725309	Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers.	Chronic hepatitis C infection	212 Japanese ancestry chronic hepatitis C with hepatocellular carcinoma cases, 765 Japanese ancestry chronic hepatitis C without hepatocellular carcinoma cases	710 Japanese ancestry chronic hepatitis C with hepatocellular carcinoma cases, 1,625 Japanese ancestry chronic hepatitis C without hepatocellular carcinoma cases	22q12.3	22	31869917	DEPDC5	DEPDC5			ENSG00000100150			rs1012068-G	rs1012068	0	1012068	intron_variant	0	0.12	1E-13	13.0		1.75	[1.51-2.03]	Illumina [467538]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST001139	Genome-wide genotyping array
2020-09-07	32433338	St Jean PL	2020-05-19	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/32433338	Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria.	Tafenoquine efficacy in P. vivax malaria (recurrence by 6 months)	438 cases	NA	18q12.3	18	43844132	RNU6-443P							rs62103056-A	rs62103056	0	62103056	intergenic_variant	1	0.25	4E-8	7.3979400086720375		2.98	[1.99-4.46]	Affymetrix [10600000] (imputed)	N	disease recurrence, response to tafenoquine	http://www.ebi.ac.uk/efo/EFO_0004952, http://www.ebi.ac.uk/efo/EFO_0010808	GCST010503	Genome-wide genotyping array
2020-09-07	32433338	St Jean PL	2020-05-19	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/32433338	Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria.	Tafenoquine efficacy in P. vivax malaria (recurrence by 4 months)	438 cases	NA	12q21.33	12	88657857		RNU1-117P - NA	ENSG00000252850			76061		rs11104986-G	rs11104986	0	11104986	regulatory_region_variant	1		4E-9	8.397940008672037		42.3	[7.95225.10]	Affymetrix [10600000] (imputed)	N	disease recurrence, response to tafenoquine	http://www.ebi.ac.uk/efo/EFO_0004952, http://www.ebi.ac.uk/efo/EFO_0010808	GCST010502	Genome-wide genotyping array
2021-04-30	32592749	Butler-Laporte G	2020-06-24	Clin Microbiol Infect	www.ncbi.nlm.nih.gov/pubmed/32592749	Elevated body-mass index is associated with an increased risk of infectious disease admissions and mortality: a mendelian randomization study.	Pneumonia (28-day mortality)	513 European ancestry cases, 6,685 European ancestry controls	NA	3q25.33	3	159375757	IQCJ-SCHIP1	IQCJ-SCHIP1			ENSG00000283154			rs1198929434-TAAAC	rs1198929434	0	1198929434	intron_variant	0	0.99	1E-10	10.0		0.14	[0.099-0.181] unit decrease	NR [NR]	N	pneumonia, mortality	http://www.ebi.ac.uk/efo/EFO_0003106, http://www.ebi.ac.uk/efo/EFO_0004352	GCST011597	Genome-wide genotyping array
2021-04-30	32592749	Butler-Laporte G	2020-06-24	Clin Microbiol Infect	www.ncbi.nlm.nih.gov/pubmed/32592749	Elevated body-mass index is associated with an increased risk of infectious disease admissions and mortality: a mendelian randomization study.	Pneumonia (90-day mortality)	738 European ancestry cases, 6,460 European ancestry controls	NA	17q24.1	17	64765521	ARHGAP27P1-BPTFP1-KPNA2P3	ARHGAP27P1-BPTFP1-KPNA2P3			ENSG00000215769			rs80069184-C	rs80069184	0	80069184	intron_variant	0	0.99	1E-8	8.0		0.15	[0.097-0.203] unit decrease	NR [NR]	N	pneumonia, mortality	http://www.ebi.ac.uk/efo/EFO_0003106, http://www.ebi.ac.uk/efo/EFO_0004352	GCST011596	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	15q25.1	15	78461760		IREB2			ENSG00000136381			rs2009746-A	rs2009746	0	2009746	intron_variant	0	NR	8E-10	9.096910013008056		0.012	[0.0081-0.0159] unit decrease	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	15q25.1	15	78592211		CHRNA5			ENSG00000169684			rs76474922-A	rs76474922	0	76474922	intron_variant	0	NR	3E-9	8.522878745280337		0.02	[0.014-0.026] unit increase	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	3q25.1	3	151866506		AADACL2-AS1			ENSG00000242908			rs11708673-A	rs11708673	0	11708673	intron_variant	0	NR	6E-8	7.221848749616356		0.014	[0.01-0.018] unit decrease	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	4p14	4	37125840		LINC02616 - MIR4801	ENSG00000261761	ENSG00000264319		102341	116070	rs144242331-A	rs144242331	0	144242331	intron_variant	1	NR	2E-7	6.698970004336019		0.036	[0.022-0.05] unit increase	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	1q24.2	1	169498416		SLC19A2 - F5	ENSG00000117479	ENSG00000198734		12472	13535	rs1894692-A	rs1894692	0	1894692	non_coding_transcript_exon_variant	1	NR	3E-7	6.522878745280337		0.034	[0.02-0.048] unit decrease	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	20q13.33	20	63560122		HELZ2			ENSG00000130589			rs3810478-T	rs3810478	0	3810478	intron_variant	0	NR	8E-7	6.096910013008056		0.01	[0.0061-0.0139] unit increase	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	16p11.2	16	28519966		IL27 - NUPR1	ENSG00000197272	ENSG00000176046		7915	12742	rs4787458-A	rs4787458	0	4787458	intron_variant	1	NR	9E-7	6.045757490560675		0.01	[0.0061-0.0139] unit decrease	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	11q22.2	11	102779125		WTAPP1, MMP10			ENSG00000255282, ENSG00000166670			rs470263-T	rs470263	0	470263	intron_variant	0	NR	1E-6	6.0		0.01	[0.0061-0.0139] unit decrease	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	2p25.3	2	3493890		TRAPPC12 - ADI1	ENSG00000171853	ENSG00000182551		8796	3476	rs9309718-A	rs9309718	0	9309718	intergenic_variant	1	NR	1E-6	6.0		0.01	[0.0061-0.0139] unit increase	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	1p31.1	1	77984833		DNAJB4, GIPC2			ENSG00000162616, ENSG00000137960			rs34517439-A	rs34517439	0	34517439	intron_variant	0	NR	2E-6	5.698970004336019		0.014	[0.0081-0.0199] unit increase	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	17q12	17	33964001		ASIC2			ENSG00000108684			rs62057446-T	rs62057446	0	62057446	intron_variant	0	NR	2E-6	5.698970004336019		0.019	[0.011-0.027] unit increase	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	11q25	11	134905423		LINC02714 - LINC02697	ENSG00000251226	ENSG00000255327		141613	45285	rs1154905-A	rs1154905	0	1154905	intergenic_variant	1	NR	2E-6	5.698970004336019		0.009	[0.0051-0.0129] unit decrease	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	11q23.3	11	118911765		BCL9L			ENSG00000186174			rs11606719-C	rs11606719	0	11606719	intron_variant	0	NR	3E-6	5.522878745280337		0.028	[0.016-0.04] unit increase	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	6p24.2	6	11484551		NEDD9 - RNU1-64P	ENSG00000111859	ENSG00000202313		102203	18958	rs200243764-G	rs200243764	0	200243764	intron_variant	1	NR	3E-6	5.522878745280337		0.022	[0.012-0.032] unit increase	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	2q22.3	2	147775069		RNA5SP106 - ACVR2A	ENSG00000253083	ENSG00000121989		61515	69448	rs62169465-T	rs62169465	0	62169465	intergenic_variant	1	NR	3E-6	5.522878745280337		0.01	[0.0061-0.0139] unit decrease	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	9q22.2	9	90408341		LINC01508			ENSG00000231107			rs150438131-A	rs150438131	0	150438131	intron_variant	0	NR	3E-6	5.522878745280337		0.043	[0.025-0.061] unit increase	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	13q32.3	13	99574560		TM9SF2 - LINC01039	ENSG00000125304	ENSG00000234168		10512	2552	rs76713055-A	rs76713055	0	76713055	intergenic_variant	1	NR	4E-6	5.3979400086720375		0.033	[0.019-0.047] unit decrease	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	10p13	10	15297391		FAM171A1			ENSG00000148468			rs138075843-T	rs138075843	0	138075843	intron_variant	0	NR	4E-6	5.3979400086720375		0.026	[0.014-0.038] unit decrease	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	12p13.32	12	3398314		PRMT8			ENSG00000111218			rs79345814-A	rs79345814	0	79345814	intron_variant	0	NR	5E-6	5.301029995663981		0.029	[0.017-0.041] unit increase	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2021-10-22	34340725	Campos AI	2021-08-03	Twin Res Hum Genet	www.ncbi.nlm.nih.gov/pubmed/34340725	Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen.	Pneumonia	24,760 European ancestry cases, 525,615 European ancestry controls	NA	9q33.3	9	125866895		PBX3			ENSG00000167081			rs10819081-A	rs10819081	0	10819081	intron_variant	0	NR	5E-6	5.301029995663981		0.009	[0.0051-0.0129] unit decrease	NR [7831927]	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90027159	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	5p13.3	5	31541035	DROSHA	C5orf22			ENSG00000082213			rs17410035-?	rs17410035	0	17410035	intron_variant	0	NR	2E-6	5.698970004336019		2.4752474		Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007231	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	5q12.1	5	61759730	C5orf64	C5orf64			ENSG00000178722			rs1501847-G	rs1501847	0	1501847	non_coding_transcript_exon_variant	0	NR	3E-6	5.522878745280337		1.708	[1.372.14]	Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007231	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	7q21.3	7	97825668	ASNS	TAC1 - ASNS	ENSG00000006128	ENSG00000070669		85196	26009	rs2665441-C	rs2665441	0	2665441	intergenic_variant	1	NR	6E-6	5.221848749616356		1.681	[1.342.10]	Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007231	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	9p21.3	9	25262833	RN7SKP120							rs1662230-G	rs1662230	0	1662230	intergenic_variant	1	NR	9E-6	5.045757490560675		2.278	[1.583.27]	Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007231	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	12q23.1	12	96551485	CFAP54	CFAP54			ENSG00000188596			rs199911028-G	rs199911028	0	199911028	intron_variant	0	NR	3E-6	5.522878745280337		2.966	[1.894.67]	Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007231	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	15q26.3	15	101459446	PCSK6	PCSK6			ENSG00000140479			rs142644068-?	rs142644068	0	142644068	intron_variant	0	NR	2E-6	5.698970004336019		7.5757575		Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007231	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	5q23.2	5	125687497	GRAMD2B	LINC02240 - NA	ENSG00000260192			85270		rs11960504-T	rs11960504	0	11960504	intron_variant	1	NR	7E-6	5.154901959985743	(Male)	2.801	[1.794.39]	Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007231	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	14q11.2	14	21534327	SALL2	SALL2			ENSG00000165821			rs8016621-?	rs8016621	0	8016621	intron_variant	0	NR	6E-6	5.221848749616356	(Male)	3.9682539		Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007231	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	5p15.31	5	6900353	TENT4A	LINC02196			ENSG00000250974			rs2894967-C	rs2894967	0	2894967	intron_variant	0	NR	5E-6	5.301029995663981	(Female)	2.173	[1.562.90]	Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007231	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	9q34.11	9	130184336	NCS1	NCS1			ENSG00000107130			rs10819610-?	rs10819610	0	10819610	intron_variant	0	NR	2E-6	5.698970004336019	(Female)	1.9455254		Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007231	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	14q24.2	14	72813710	DPF3	DPF3			ENSG00000205683			rs7152005-T	rs7152005	0	7152005	intron_variant	0	NR	2E-6	5.698970004336019	(Female)	2.13	[1.662.90]	Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007231	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	21q11.2	21	14840848	LINC02246	LINC02246			ENSG00000281903			rs2150367-?	rs2150367	0	2150367	intron_variant	0	NR	2E-6	5.698970004336019	(Female)	1.992032		Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007231	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis (SNP x SNP interaction)	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	Xp22.2	X	12340899	ARSF x FRMPD4	No mapped genes x FRMPD4						rs1823897-? x rs7064174-?	rs1823897 x rs7064174	0		intergenic_variant x intron_variant		NR	7E-14	13.154901959985743				Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007232	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis (SNP x SNP interaction)	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	Xq21.31	X	92573550	ARSE x PCDH11X	No mapped genes x PCDH11X						rs426247-? x rs68046754-?	rs426247 x rs68046754	0		intergenic_variant x intron_variant		NR	2E-12	11.698970004336019				Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007232	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis (SNP x SNP interaction)	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	10q21.1	10	52438832	LOC107986418 x RPL31P44	No mapped genes x THAP12P3 - LNCAROD						rs2112508-? x rs1194709-?	rs2112508 x rs1194709	0		intergenic_variant x intergenic_variant		NR	3E-12	11.522878745280337				Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007232	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis (SNP x SNP interaction)	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	8p23.1	8	9340151	LOC107986770 x LOC157273	No mapped genes x RNU6-1151P - RNU6-526P						rs1347075-? x rs958374-?	rs1347075 x rs958374	0		intron_variant x intron_variant		NR	3E-12	11.522878745280337				Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007232	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis (SNP x SNP interaction)	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	Xq21.31	X	90457930	MAOA x RNU6-555P	No mapped genes x No mapped genes						rs5991619-? x rs73535318-?	rs5991619 x rs73535318	0		intron_variant x intergenic_variant		NR	6E-12	11.221848749616356				Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007232	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis (SNP x SNP interaction)	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	16q12.2	16	55549638	GPC6 x LPCAT2	No mapped genes x LPCAT2						rs7991005-? x rs2287072-?	rs7991005 x rs2287072	0		intron_variant x intron_variant		NR	6E-12	11.221848749616356				Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007232	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis (SNP x SNP interaction)	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	Xq21.31	X	92573550	NLGN4X x PCDH11X	No mapped genes x PCDH11X						rs11094800-? x rs68046754-?	rs11094800 x rs68046754	0		intron_variant x intron_variant		NR	7E-12	11.154901959985743				Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007232	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis (SNP x SNP interaction)	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	12q21.2	12	79231982	LINC02147 x SYT1	No mapped genes x SYT1						rs7341174-? x rs1918191-?	rs7341174 x rs1918191	0		intron_variant x intron_variant		NR	8E-12	11.096910013008056				Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007232	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis (SNP x SNP interaction)	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	Xq21.31 x Xq27.2	X x X	92573550 x 142088761	PCDH11X x MAGEC2	PCDH11X			ENSG00000102290			rs68046754-? x rs6528958-?	rs68046754 x rs6528958	0		intron_variant x intron_variant		NR	8E-12	11.096910013008056				Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007232	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis (SNP x SNP interaction)	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	2q33.1	2	200343969	PAPPA2 x SPATS2L	No mapped genes x SPATS2L						rs6694239-? x rs985256-?	rs6694239 x rs985256	0		intergenic_variant x intron_variant		NR	1E-11	11.0				Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007232	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis (SNP x SNP interaction)	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	Xq21.31	X	91953478	FUNDC1 x LOC107986770	No mapped genes x PCDH11X						rs4824843-? x rs58762927-?	rs4824843 x rs58762927	1		intergenic_variant x intron_variant		NR	1E-11	11.0				Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007232	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis (SNP x SNP interaction)	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	Xq21.33	X	97778139	DIAPH2 x DIAPH2	No mapped genes						rs2170314-? x rs4633188-?	rs2170314 x rs4633188	0		intergenic_variant x intergenic_variant		NR	1E-11	11.0				Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007232	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis (SNP x SNP interaction)	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	10q21.1	10	52437013	LOC107986418 x RPL31P44	No mapped genes x THAP12P3 - LNCAROD						rs2112508-? x rs1194716-?	rs2112508 x rs1194716	0		intergenic_variant x TF_binding_site_variant		NR	1E-11	11.0				Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007232	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis (SNP x SNP interaction)	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	Xq21.31	X	90457930	DMD x RNY6-555P	No mapped genes x No mapped genes						rs5972637-? x rs73535318-?	rs5972637 x rs73535318	0		intron_variant x intergenic_variant		NR	2E-11	10.698970004336019				Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007232	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis (SNP x SNP interaction)	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	Xq21.31	X	92573550	EDA2R x PCDH11X	No mapped genes x PCDH11X						rs1352015-? x rs68046754-?	rs1352015 x rs68046754	0		intron_variant x intron_variant		NR	2E-11	10.698970004336019				Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007232	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis (SNP x SNP interaction)	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	Xq21.31	X	92573550	NLGN4X x PCDH11X	No mapped genes x PCDH11X						rs5916341-? x rs68046754-?	rs5916341 x rs68046754	0		intron_variant x intron_variant		NR	3E-11	10.522878745280337				Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007232	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis (SNP x SNP interaction)	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	Xq21.31	X	92573550	NLGN4X x PCDH11X	No mapped genes x PCDH11X						rs3072699-? x rs68046754-?	rs3072699 x rs68046754	0		intron_variant x intron_variant		NR	3E-11	10.522878745280337				Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007232	Genome-wide genotyping array
2019-02-27	30713548	Schurz H	2019-01-18	Front Genet	www.ncbi.nlm.nih.gov/pubmed/30713548	A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array.	Tuberculosis (SNP x SNP interaction)	242 South African admixed female cases, 168 South African admixed male cases, 223 South African admixed female controls, 182 South African admixed male controls	NA	Xq13.1	X	71629984	ARSE x CXCR3	No mapped genes x CXCR3 - LINC00891						rs1823897-? x rs7053176-?	rs1823897 x rs7053176	0		intergenic_variant x regulatory_region_variant		NR	3E-11	10.522878745280337				Illumina [848325]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST007232	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls, (see Thye 2010)	NA	11p13	11	32342641	WT1	THEM7P			ENSG00000227160			rs2057178-?	rs2057178	0	2057178	intron_variant	0	NR	1E-12	12.0	(binary model)			Affymetrix [1009364] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002197	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls, (see Thye 2010)	NA	18q11.2	18	22610832	NR	RPS4XP18 - RNU6-1032P	ENSG00000239490	ENSG00000206827		23605	36750	rs4331426-?	rs4331426	0	4331426	intergenic_variant	1	NR	2E-8	7.698970004336019	(binary model)			Affymetrix [1009364] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002197	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	22q12.3	22	37148446	IL2RB	IL2RB			ENSG00000100385			rs3218255-G	rs3218255	0	3218255	intron_variant	0	0.69	2E-7	6.698970004336019		4.0	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	3p24.1	3	26501929	intergenic							rs2202157-T	rs2202157	0	2202157	intergenic_variant	1	0.84	8E-7	6.096910013008056		4.0	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	Xp11.23	X	48047088	intergenic	ZNF630			ENSG00000221994			rs142513793-C	rs142513793	0	142513793	intron_variant	0	0.97	2E-7	6.698970004336019		5.0	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	Xp21.1	X	33765946	intergenic							rs5928363-C	rs5928363	0	5928363	intron_variant	1	0.98	4E-6	5.3979400086720375		8.3333	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	6p25.2	6	2355441	LOC100508120	GMDS-DT			ENSG00000250903			rs2505675-T	rs2505675	0	2505675	non_coding_transcript_exon_variant	0	0.85	4E-6	5.3979400086720375		4.5455	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	16p13.3	16	3459056	NAA60	NAA60			ENSG00000122390			rs40363-G	rs40363	0	40363	intron_variant	0	0.72	3E-6	5.522878745280337		11.1111	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	1q43	1	242711583	PLD5	NA - RSL24D1P4		ENSG00000215800			61037	rs6676375-T	rs6676375	0	6676375	intergenic_variant	1	0.87	8E-7	6.096910013008056		3.0303	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	1q42.13	1	228515588	RNF187	BTNL10 - RNA5SP19	ENSG00000215811	ENSG00000202056		3283	40205	rs1925714-G	rs1925714	0	1925714	regulatory_region_variant	1	0.86	2E-7	6.698970004336019		2.8571	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	14q24.2	14	70035333	SMOC1	SMOC1 - SLC8A3	ENSG00000198732	ENSG00000100678		2967	8882	rs17175227-G	rs17175227	0	17175227	intergenic_variant	1	0.98	9E-9	8.045757490560675		7.1429	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	2p25.2	2	5113465	SOX11							rs1075309-T	rs1075309	0	1075309	intergenic_variant	1	0.91	7E-7	6.154901959985743		2.8571	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	13q14.11	13	41931538	VWA8	VWA8			ENSG00000102763			rs1900442-T	rs1900442	0	1900442	intron_variant	0	0.85	5E-6	5.301029995663981		2.7027	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	11p13	11	32342641	WT1	THEM7P			ENSG00000227160			rs2057178-A	rs2057178	0	2057178	intron_variant	0	0.92	3E-6	5.522878745280337		1.6129	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	8q23.1	8	105601093	ZFPM2	ZFPM2-AS1, ZFPM2			ENSG00000251003, ENSG00000169946			rs17217757-G	rs17217757	0	17217757	intron_variant	0	0.82	3E-6	5.522878745280337		2.3256	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	9p21.3	9	22488679	DMRTA1	DMRTA1 - NA	ENSG00000176399			32939		rs586716-G	rs586716	0	586716	intergenic_variant	1	0.846	8E-6	5.096910013008056		4.7619	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	11q22.3	11	103109865	intergenic	DYNC2H1			ENSG00000187240			rs12283022-G	rs12283022	0	12283022	intron_variant	0	0.75	2E-6	5.698970004336019		7.1429	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	11p15.2	11	13974608	SPON1	SPON1			ENSG00000262655			rs1819084-C	rs1819084	0	1819084	intron_variant	0	0.71	9E-6	5.045757490560675		6.25	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	14q32.31	14	101212918	SNORD114-31	U3 - NA	ENSG00000212610			67223		rs6575836-G	rs6575836	0	6575836	intergenic_variant	1	0.79	8E-6	5.096910013008056		4.0	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	Xq27.3	X	143759024	intergenic	SPANXN2 - NA	ENSG00000268988			37601		rs139956886-C	rs139956886	0	139956886	intron_variant	1	0.98	6E-6	5.221848749616356		8.3333	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	21q22.3	21	41923401	C2CD2	C2CD2			ENSG00000157617			rs451390-G	rs451390	0	451390	intron_variant	0	0.85	2E-7	6.698970004336019		4.5455	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	4q21.1	4	77684215	CNOT6L	CXCL13 - CNOT6L	ENSG00000156234	ENSG00000138767		72381	29172	rs958617-G	rs958617	0	958617	intergenic_variant	1	0.7	3E-7	6.522878745280337		6.6667	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	10q23.33	10	95032445	CYP2C8	CYP2C60P - CYP2C8	ENSG00000260863	ENSG00000138115		22633	4327	rs1934954-T	rs1934954	0	1934954	intergenic_variant	1	0.98	3E-6	5.522878745280337		7.1429	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	11q22.3	11	103076736	DCUN1D5	DCUN1D5			ENSG00000137692			rs7947821-T	rs7947821	0	7947821	intron_variant	0	0.75	2E-6	5.698970004336019		7.1429	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	21q22.2	21	40845029	DSCAM	DSCAM			ENSG00000171587			rs2837857-T	rs2837857	0	2837857	intron_variant	0	0.7	2E-6	5.698970004336019		3.3333	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	11q22.3	11	103256336	DYNC2H1	DYNC2H1			ENSG00000187240			rs12294076-T	rs12294076	0	12294076	intron_variant	0	0.83	1E-7	7.0		6.25	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2014-04-10	24057671	Chimusa ER	2013-09-18	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/24057671	Genome-wide association study of ancestry-specific TB risk in the South African Coloured population.	Tuberculosis	642 South African coloured cases, 91 South African coloured controls	NA	12q21.2	12	77344225	E2F7	NAV3			ENSG00000067798			rs6538140-G	rs6538140	0	6538140	intron_variant	0	0.74	4E-6	5.3979400086720375		4.3478	[NR]	Affymetrix [up to 4467279] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002198	Genome-wide genotyping array
2017-11-02	29036319	Qi H	2017-09-26	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/29036319	Discovery of susceptibility loci associated with tuberculosis in Han Chinese.	Tuberculosis	972 Chinese ancestry cases, 1,316 Gambian ancestry cases, 1,537 Chinese ancestry controls, 1,382 Gambian ancestry controls	NA	4p14	4	37598131	NR	RELL1, C4orf19			ENSG00000181826, ENSG00000154274			rs2939731-?	rs2939731	0	2939731	intron_variant	0	NR	6E-6	5.221848749616356				Illumina [7333833] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST004922	Genome-wide genotyping array
2017-11-02	29036319	Qi H	2017-09-26	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/29036319	Discovery of susceptibility loci associated with tuberculosis in Han Chinese.	Tuberculosis	972 Chinese ancestry cases, 1,316 Gambian ancestry cases, 1,537 Chinese ancestry controls, 1,382 Gambian ancestry controls	NA	4p14	4	37598977	NR	C4orf19, RELL1			ENSG00000154274, ENSG00000181826			rs2940989-?	rs2940989	0	2940989	intron_variant	0	NR	2E-6	5.698970004336019				Illumina [7333833] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST004922	Genome-wide genotyping array
2017-11-02	29036319	Qi H	2017-09-26	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/29036319	Discovery of susceptibility loci associated with tuberculosis in Han Chinese.	Tuberculosis	972 Chinese ancestry cases, 1,316 Gambian ancestry cases, 1,537 Chinese ancestry controls, 1,382 Gambian ancestry controls	NA	4p14	4	37600130	NR	C4orf19, RELL1			ENSG00000154274, ENSG00000181826			rs2940991-?	rs2940991	0	2940991	intron_variant	0	NR	3E-6	5.522878745280337				Illumina [7333833] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST004922	Genome-wide genotyping array
2017-11-02	29036319	Qi H	2017-09-26	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/29036319	Discovery of susceptibility loci associated with tuberculosis in Han Chinese.	Tuberculosis	972 Chinese ancestry cases, 1,316 Gambian ancestry cases, 1,537 Chinese ancestry controls, 1,382 Gambian ancestry controls	NA	5p14.1	5	25321925	NR	LINC02211			ENSG00000245662			rs931924-?	rs931924	0	931924	intron_variant	0	NR	5E-7	6.301029995663981				Illumina [7333833] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST004922	Genome-wide genotyping array
2017-11-02	29036319	Qi H	2017-09-26	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/29036319	Discovery of susceptibility loci associated with tuberculosis in Han Chinese.	Tuberculosis	972 Chinese ancestry cases, 1,316 Gambian ancestry cases, 1,537 Chinese ancestry controls, 1,382 Gambian ancestry controls	NA	5p14.1	5	25323598	NR	LINC02211			ENSG00000245662			rs11958933-?	rs11958933	0	11958933	intron_variant	0	NR	6E-7	6.221848749616356				Illumina [7333833] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST004922	Genome-wide genotyping array
2017-11-02	29036319	Qi H	2017-09-26	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/29036319	Discovery of susceptibility loci associated with tuberculosis in Han Chinese.	Tuberculosis	972 Chinese ancestry cases, 1,316 Gambian ancestry cases, 1,537 Chinese ancestry controls, 1,382 Gambian ancestry controls	NA	6p21.32	6	32639242	NR	HLA-DQA1, HLA-DQA1, HLA-DQA1, HLA-DQA1, HLA-DQA1			ENSG00000232062, ENSG00000206305, ENSG00000236418, ENSG00000225890, ENSG00000196735			rs28802989-?	rs28802989	0	28802989	3_prime_UTR_variant	0	NR	2E-6	5.698970004336019				Illumina [7333833] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST004922	Genome-wide genotyping array
2017-11-02	29036319	Qi H	2017-09-26	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/29036319	Discovery of susceptibility loci associated with tuberculosis in Han Chinese.	Tuberculosis	972 Chinese ancestry cases, 1,316 Gambian ancestry cases, 1,537 Chinese ancestry controls, 1,382 Gambian ancestry controls	NA	9q21.13	9	75608213	NR							rs1854330-?	rs1854330	0	1854330	intergenic_variant	1	NR	9E-6	5.045757490560675				Illumina [7333833] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST004922	Genome-wide genotyping array
2017-11-02	29036319	Qi H	2017-09-26	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/29036319	Discovery of susceptibility loci associated with tuberculosis in Han Chinese.	Tuberculosis	972 Chinese ancestry cases, 1,316 Gambian ancestry cases, 1,537 Chinese ancestry controls, 1,382 Gambian ancestry controls	NA	9q21.13	9	75614962	NR							rs751303-?	rs751303	0	751303	intergenic_variant	1	NR	4E-6	5.3979400086720375				Illumina [7333833] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST004922	Genome-wide genotyping array
2017-11-02	29036319	Qi H	2017-09-26	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/29036319	Discovery of susceptibility loci associated with tuberculosis in Han Chinese.	Tuberculosis	972 Chinese ancestry cases, 1,316 Gambian ancestry cases, 1,537 Chinese ancestry controls, 1,382 Gambian ancestry controls	NA	9q21.13	9	75619929	NR							rs10869606-?	rs10869606	0	10869606	intergenic_variant	1	NR	7E-6	5.154901959985743				Illumina [7333833] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST004922	Genome-wide genotyping array
2017-11-02	29036319	Qi H	2017-09-26	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/29036319	Discovery of susceptibility loci associated with tuberculosis in Han Chinese.	Tuberculosis	972 Chinese ancestry cases, 1,316 Gambian ancestry cases, 1,537 Chinese ancestry controls, 1,382 Gambian ancestry controls	NA	9q21.13	9	75620786	NR							rs11525994-?	rs11525994	0	11525994	intergenic_variant	1	NR	5E-6	5.301029995663981				Illumina [7333833] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST004922	Genome-wide genotyping array
2017-11-02	29036319	Qi H	2017-09-26	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/29036319	Discovery of susceptibility loci associated with tuberculosis in Han Chinese.	Tuberculosis	972 Chinese ancestry cases, 1,316 Gambian ancestry cases, 1,537 Chinese ancestry controls, 1,382 Gambian ancestry controls	NA	10p11.23	10	30812814	NR	LINC02644 - ZNF438	ENSG00000230720	ENSG00000183621		89074	7393	rs1417569-?	rs1417569	0	1417569	regulatory_region_variant	1	NR	4E-6	5.3979400086720375				Illumina [7333833] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST004922	Genome-wide genotyping array
2017-11-02	29036319	Qi H	2017-09-26	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/29036319	Discovery of susceptibility loci associated with tuberculosis in Han Chinese.	Tuberculosis	972 Chinese ancestry cases, 1,316 Gambian ancestry cases, 1,537 Chinese ancestry controls, 1,382 Gambian ancestry controls	NA	21q22.2	21	40630550	NR	DSCAM, DSCAM-IT1			ENSG00000171587, ENSG00000233756			rs11702781-?	rs11702781	0	11702781	intron_variant	0	NR	9E-6	5.045757490560675				Illumina [7333833] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST004922	Genome-wide genotyping array
2017-11-02	29036319	Qi H	2017-09-26	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/29036319	Discovery of susceptibility loci associated with tuberculosis in Han Chinese.	Tuberculosis	972 Chinese ancestry cases, 1,537 Chinese ancestry controls	3,338 Chinese ancestry cases, 4,849 Chinese ancestry controls	1p36.22	1	11982698	CLCN6, MTHFR, NPPA, NPPB, KIAA2013, PLOD1, MFN2, MIIP, TNFRSF8, TNFRSF1B	MFN2			ENSG00000116688			rs4240897-?	rs4240897	0	4240897	intron_variant	0	0.493	1E-11	11.0		1.27	[1.20-1.33]	Illumina [691388]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST004923	Genome-wide genotyping array
2017-11-02	29036319	Qi H	2017-09-26	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/29036319	Discovery of susceptibility loci associated with tuberculosis in Han Chinese.	Tuberculosis	972 Chinese ancestry cases, 1,537 Chinese ancestry controls	3,338 Chinese ancestry cases, 4,849 Chinese ancestry controls	4p16.3	4	3428129	MSANTD1, RGS12, HGF, ACDOK7, LRPAP1, LINC00955, HTT	RGS12			ENSG00000159788			rs2269497-?	rs2269497	0	2269497	missense_variant	0	0.056	3E-8	7.522878745280337		1.51	[1.35-1.68]	Illumina [691388]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST004923	Genome-wide genotyping array
2020-09-15	32573827	Huang YH	2020-06-23	Aliment Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32573827	Large-scale genome-wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank.	Chronic hepatitis B infection	1,810 East Asian cases, 9,002 East Asian seropositive controls	648 East Asian cases, 3,190 East Asian seropositive controls	6p21.32	6	33081144	NR	HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1			ENSG00000215048, ENSG00000237710, ENSG00000223865, ENSG00000229295, ENSG00000226826, ENSG00000230708			rs7770370-G	rs7770370	0	7770370	non_coding_transcript_exon_variant	0	0.5739	3E-35	34.52287874528034		1.6393442	[1.52-1.79]	Affymetrix [583383]	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST010560	Genome-wide genotyping array
2020-09-15	32573827	Huang YH	2020-06-23	Aliment Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32573827	Large-scale genome-wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank.	Chronic hepatitis B infection	1,810 East Asian cases, 9,002 East Asian seropositive controls	648 East Asian cases, 3,190 East Asian seropositive controls	6p21.32	6	32687200	NR	HLA-DQB1 - MTCO3P1	ENSG00000231939	ENSG00000237145		18817	18924	rs28747027-G	rs28747027	0	28747027	regulatory_region_variant	1	0.4639	7E-21	20.154901959985743		1.41	[1.32-1.52]	Affymetrix [583383]	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST010560	Genome-wide genotyping array
2013-12-11	23760081	Kim YJ	2013-06-10	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23760081	A genome-wide association study identified new variants associated with the risk of chronic hepatitis B.	Chronic hepatitis B infection	400 Korean ancestry cases, 1,000 Korean ancestry controls	971 Korean ancestry cases, 1,938 Korean ancestry controls	6p21.32	6	33065245	HLA-DP	HLA-DPA1			ENSG00000235844			rs3077-?	rs3077	0	3077	3_prime_UTR_variant	0	NR	5E-39	38.30102999566398		1.89	[1.69-2.08]	Illumina [719265]	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002068	Genome-wide genotyping array
2013-12-11	23760081	Kim YJ	2013-06-10	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23760081	A genome-wide association study identified new variants associated with the risk of chronic hepatitis B.	Chronic hepatitis B infection	400 Korean ancestry cases, 1,000 Korean ancestry controls	971 Korean ancestry cases, 1,938 Korean ancestry controls	6p21.32	6	32702478	HLA-DQ	HLA-DQB1 - MTCO3P1	ENSG00000231939	ENSG00000237145		34095	3646	rs2856718-?	rs2856718	0	2856718	regulatory_region_variant	1	NR	2E-24	23.69897000433602		1.6	[1.46-1.75]	Illumina [719265]	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002068	Genome-wide genotyping array
2013-12-11	23760081	Kim YJ	2013-06-10	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23760081	A genome-wide association study identified new variants associated with the risk of chronic hepatitis B.	Chronic hepatitis B infection	400 Korean ancestry cases, 1,000 Korean ancestry controls	971 Korean ancestry cases, 1,938 Korean ancestry controls	6p21.32	6	32762235	HLA-DQ	HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2			ENSG00000232629, ENSG00000224305, ENSG00000228813, ENSG00000196610, ENSG00000229493, ENSG00000228254, ENSG00000226165			rs7453920-?	rs7453920	0	7453920	intron_variant	0	NR	7E-26	25.154901959985743		2.0	[1.72-2.27]	Illumina [719265]	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002068	Genome-wide genotyping array
2015-01-13	24940741	Chang SW	2014-06-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24940741	A genome-wide association study on chronic HBV infection and its clinical progression in male Han-Taiwanese.	Chronic hepatitis B infection	321 Chinese ancestry cases, 304 Chinese ancestry controls	1,302 Chinese ancestry cases, 761 Chinese ancestry controls	6p21.32	6	32739518	HLA-DQA2	HLA-DQB3 - HLA-DQA2	ENSG00000224197	ENSG00000257473		7823	1873	rs9276370-T	rs9276370	0	9276370	intergenic_variant	1	0.076	2E-12	11.698970004336019		1.95	[1.62-2.34]	Illumina [456262]	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002490	Genome-wide genotyping array
2015-01-13	24940741	Chang SW	2014-06-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24940741	A genome-wide association study on chronic HBV infection and its clinical progression in male Han-Taiwanese.	Chronic hepatitis B infection	321 Chinese ancestry cases, 304 Chinese ancestry controls	1,302 Chinese ancestry cases, 761 Chinese ancestry controls	6p21.32	6	32762235	HLA-DQB2	HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2			ENSG00000232629, ENSG00000224305, ENSG00000228813, ENSG00000196610, ENSG00000229493, ENSG00000228254, ENSG00000226165			rs7453920-G	rs7453920	0	7453920	intron_variant	0	0.051	7E-15	14.154901959985743		2.31	[1.87-2.85]	Illumina [456262]	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002490	Genome-wide genotyping array
2015-01-13	24940741	Chang SW	2014-06-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24940741	A genome-wide association study on chronic HBV infection and its clinical progression in male Han-Taiwanese.	Chronic hepatitis B infection	321 Chinese ancestry cases, 304 Chinese ancestry controls	1,302 Chinese ancestry cases, 761 Chinese ancestry controls	6p21.32	6	33087084	HLA-DPB1	HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1			ENSG00000215048, ENSG00000237710, ENSG00000223865, ENSG00000229295, ENSG00000226826, ENSG00000230708			rs9277535-G	rs9277535	0	9277535	3_prime_UTR_variant	0	0.251	5E-14	13.301029995663981		1.59	[1.41-1.79]	Illumina [456262]	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002490	Genome-wide genotyping array
2015-01-13	24940741	Chang SW	2014-06-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24940741	A genome-wide association study on chronic HBV infection and its clinical progression in male Han-Taiwanese.	Chronic hepatitis B infection	321 Chinese ancestry cases, 304 Chinese ancestry controls	1,302 Chinese ancestry cases, 761 Chinese ancestry controls	6p21.32	6;6;6	32762235;33087084;32739518	HLA-DQA2, HLA-DQB2, HLA-DPB1, HLA-DPA3	HLA-DQB2; HLA-DPB1; No mapped genes; HLA-DQB3 - HLA-DQA2; No mapped genes						rs7453920-G; rs9277535-G; rs7756516-T; rs9276370-T; rs9366816-T	rs7453920; rs9277535; rs7756516; rs9276370; rs9366816	0		intron_variant; 3_prime_UTR_variant; 3_prime_UTR_variant; intergenic_variant; intron_variant		0.4305	1E-12	12.0		1.49	[1.33-1.66]	Illumina [456262]	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002490	Genome-wide genotyping array
2021-09-03	33736632	Zeng Z	2021-03-18	BMC Med Genomics	www.ncbi.nlm.nih.gov/pubmed/33736632	Genome-wide association study identifies new loci associated with risk of HBV infection and disease progression.	Development of chronic hepatitis B	up to 495 Chinese ancestry cases, up to 367 Chinese ancestry controls	NA	7p21.3	7	13215782	NR	RBMX2P4 - ETV1	ENSG00000230879	ENSG00000006468		292862	675447	rs6942409-?	rs6942409	0	6942409	intron_variant	1	NR	3E-6	5.522878745280337				Affymetrix [607153]	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST012284	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	6p21.33	6	30571428	GCN20, ABCF1	ABCF1, ABCF1, ABCF1, ABCF1, ABCF1, ABCF1, ABCF1			ENSG00000206490, ENSG00000236149, ENSG00000231129, ENSG00000232169, ENSG00000225989, ENSG00000204574, ENSG00000236342			rs4148247-?	rs4148247	0	4148247	5_prime_UTR_variant	0	0.0167	1E-8	8.0		5.963	[5.27-6.66]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	20q13.12	20	46011266	MMP9	MMP9			ENSG00000100985			rs41529445-?	rs41529445	0	41529445	missense_variant	0	0.0	2E-8	7.698970004336019				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	9p21.1	9	28395334	LINGO2	LINGO2			ENSG00000174482			rs7851437-?	rs7851437	0	7851437	intron_variant	0	0.02695	9E-13	12.045757490560675		6.225	[5.66-6.79]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	6p21.32	6	32743078	HLA-DQA2	HLA-DQA2			ENSG00000257473			rs9276423-?	rs9276423	0	9276423	intron_variant	0	0.0	3E-8	7.522878745280337				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	13q31.3	13	89709462	MIR622, SLITRK5	LINC02336			ENSG00000271395			rs9560417-?	rs9560417	0	9560417	intron_variant	0	0.04503	4E-11	10.397940008672037		4.611	[4.12-5.1]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	13q34	13	113559810	TMC03, TFDP1	TMCO3 - TFDP1	ENSG00000150403	ENSG00000198176		5220	24911	rs9604153-?	rs9604153	0	9604153	intergenic_variant	1	0.0	1E-9	9.0				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	1p36.33	1	1962845	KIAA1751	CFAP74			ENSG00000142609			rs4648739-?	rs4648739	0	4648739	intron_variant	0	0.004664	8E-10	9.096910013008056		16.85	[5.027-56.46]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	1p36.11	1	25682968	MAN1C1	MAN1C1			ENSG00000117643			rs3014707-?	rs3014707	0	3014707	intron_variant	0	0.0	9E-11	10.045757490560675				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	1p31.1	1	78098512	GIPC2	GIPC2			ENSG00000137960			rs718294-?	rs718294	0	718294	intron_variant	0	0.004647	4E-8	7.3979400086720375		14.67	[4.153-51.83]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	2p14	2	65431235	SPRED2	SPRED2			ENSG00000198369			rs7576126-?	rs7576126	0	7576126	intron_variant	0	0.007576	2E-17	16.69897000433602		20.47	[7.811-53.64]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	2p13.3	2	70792111	CLEC4F	FIGLA - HMGN2P21	ENSG00000183733	ENSG00000228034		1468	11046	rs11894344-?	rs11894344	0	11894344	regulatory_region_variant	1	0.003731	2E-9	8.698970004336019		19.35	[5.081-73.68]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	2q14.1	2	117524654	DDX18, DPP10							rs1996277-?	rs1996277	0	1996277	intergenic_variant	1	0.02222	2E-19	18.69897000433602		12.26	[6.257-24.03]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	2q22.1	2	140306261	LRP1B	LRP1B			ENSG00000168702			rs643684-?	rs643684	0	643684	intron_variant	0	0.0	6E-21	20.221848749616356				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	3p22.3	3	34110310	PDCD6IP, ARPP21	LINC01811			ENSG00000226320			rs17031323-?	rs17031323	0	17031323	intron_variant	0	0.01019	2E-8	7.698970004336019		9.859	[3.706-26.23]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA				KIF15							rs11795222-?	rs11795222	0	11795222		1	0.0	9E-14	13.045757490560675				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	3p13	3	69914184	MITF	MITF			ENSG00000187098			rs11711047-?	rs11711047	0	11711047	intron_variant	0	0.0	2E-11	10.698970004336019				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	3q13.32	3	117852668	IGSF11, TUSC7							rs9876710-?	rs9876710	0	9876710	intron_variant	1	0.0	2E-10	9.698970004336019				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	3q28	3	191977324	FGF12	GPS2P2 - NA	ENSG00000230951			5203848		rs4261353-?	rs4261353	0	4261353	intergenic_variant	1	0.001866	1E-8	8.0		27.44	[4.948-152.1]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	4q13.2	4	68112851	TMPRSS11F	TMPRSS11F			ENSG00000198092			rs13107461-?	rs13107461	0	13107461	intron_variant	0	0.007605	3E-9	8.522878745280337		12.18	[4.3-34.5]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	4q35.1	4	184200580	ENPP6	ENPP6			ENSG00000164303			rs17623373-?	rs17623373	0	17623373	intron_variant	0	0.009259	4E-10	9.397940008672037		11.57	[4.433-30.18]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	5q34	5	162409879	GABRG2, CCNG1	NA - RNU6-164P		ENSG00000262922			68012	rs7718928-?	rs7718928	0	7718928	intergenic_variant	1	0.0	2E-13	12.698970004336019				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	6p21.33	6	31001226	MUC21, MUC22	MUC21 - MUC22	ENSG00000223590	ENSG00000261272		11323	9248	rs1632862-?	rs1632862	0	1632862	intergenic_variant	1	0.009311	2E-14	13.698970004336019		15.2	[6.123-37.73]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	7p21.1	7	17572761	SNX13, AHR	LINC02889 - NA	ENSG00000236039			13852		rs7777054-?	rs7777054	0	7777054	intergenic_variant	1	0.0	7E-11	10.154901959985743				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	7q11.23	7	74549905	GTF2IRD1	GTF2IRD1			ENSG00000006704			rs7793359-?	rs7793359	0	7793359	intron_variant	0	0.002788	2E-16	15.698970004336019		37.37	[9.45-147.8]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	8p21.3	8	20945592	LOC286114, LZTS1	TMEM97P2 - LINC02153	ENSG00000253866	ENSG00000253199		10755	26429	rs500816-?	rs500816	0	500816	intron_variant	1	0.0	3E-32	31.522878745280337				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	8q23.3	8	115151634	TRPS1, CSMD3							rs1845529-?	rs1845529	0	1845529	intergenic_variant	1	0.0	6E-11	10.221848749616356				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	9p13.3	9	33218924	SPINK4, B4GALT1	SPINK4			ENSG00000122711			rs28447319-?	rs28447319	0	28447319	intron_variant	0	0.003788	9E-11	10.045757490560675		20.76	[5.736-75.16]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	9q22.33	9	98247330	TBC1D2	TBC1D2			ENSG00000095383			rs34334323-?	rs34334323	0	34334323	intron_variant	0	0.0	4E-8	7.3979400086720375				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	10p12.2	10	22549797	PIP4K2A	PIP4K2A			ENSG00000150867			rs7904655-?	rs7904655	0	7904655	intron_variant	0	0.0	9E-14	13.045757490560675				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA				DRAP1, TSGA10IP							rs34410689-?	rs34410689	0	34410689		1	0.01721	3E-17	16.522878745280337		12.9	[6.128-27.14]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	11q13.4	11	72051039	NUMA1	NUMA1			ENSG00000137497			rs7116495-?	rs7116495	0	7116495	intron_variant	0	0.0	8E-17	16.096910013008056				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	11q23.3	11	116762864	BUD13	BUD13			ENSG00000137656			rs11216131-?	rs11216131	0	11216131	missense_variant	0	0.0	1E-10	10.0				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	12q13.2	12	55057910	OR9K2, NEUROD4	NEUROD4 - OR9K1P	ENSG00000123307	ENSG00000196534		27893	55167	rs11833289-?	rs11833289	0	11833289	regulatory_region_variant	1	0.0	1E-10	10.0				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	12q23.3	12	106911950	C12ORF23, RIC8B	RPL30P12 - TMEM263	ENSG00000240631	ENSG00000151135		841	43769	rs7312774-?	rs7312774	0	7312774	regulatory_region_variant	1	0.001859	3E-9	8.522878745280337		29.83	[5.374-165.6]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	14q21.2	14	45537037	RPL10L, FANCM							rs12100649-?	rs12100649	0	12100649	intergenic_variant	1	0.0	3E-10	9.522878745280337				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	15q26.2	15	97197508	LOC101927286, SPATA8	NA - LINC02253		ENSG00000259485			18304	rs28377390-?	rs28377390	0	28377390	regulatory_region_variant	1	0.007407	4E-12	11.397940008672037		15.31	[5.581-42.02]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	17p13.2	17	5926528	LOC339166							rs35841741-?	rs35841741	0	35841741	intron_variant	1	0.0	1E-10	10.0				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	19q13.12	19	35871260	APLP1	APLP1			ENSG00000105290			rs11551002-?	rs11551002	0	11551002	missense_variant	0	0.0	2E-13	12.698970004336019				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	22q13.2	22	42572508	SERHL2	RRP7BP, SERHL2			ENSG00000182841, ENSG00000183569			rs1137256-?	rs1137256	0	1137256	synonymous_variant	0	0.004682	8E-15	14.096910013008056		23.62	[7.536-74.05]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Severe influenza A (H1N1) infection	49 European ancestry severe cases, 549 European ancestry population controls	NA	Xq27.3	X	143629396	SLITRK4	SLITRK4			ENSG00000179542			rs41300938-?	rs41300938	0	41300938	synonymous_variant	0	0.0	2E-16	15.698970004336019				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003123	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Influenza A (H1N1) infection	49 European ancestry severe cases, 107 European ancestry mild cases, 549 European ancestry population controls	NA	4p14	4	36005283	ARAP2, PCDH7	ARAP2			ENSG00000047365			rs1397427-?	rs1397427	0	1397427	intron_variant	0	0.06052	5E-9	8.301029995663981		3.222	[2.138-4.856]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003125	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Influenza A (H1N1) infection	49 European ancestry severe cases, 107 European ancestry mild cases, 549 European ancestry population controls	NA	6q23.1	6	130132737	L3MBTL3	L3MBTL3			ENSG00000198945			rs12528886-?	rs12528886	0	12528886	intron_variant	0	0.006579	3E-8	7.522878745280337		8.736	[3.488-21.88]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003125	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Influenza A (H1N1) infection	49 European ancestry severe cases, 107 European ancestry mild cases, 549 European ancestry population controls	NA	9p21.1	9	28395334	LINGO2	LINGO2			ENSG00000174482			rs7851437-?	rs7851437	0	7851437	intron_variant	0	0.02695	2E-10	9.698970004336019		4.879	[2.87-8.293]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003125	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Influenza A (H1N1) infection	49 European ancestry severe cases, 107 European ancestry mild cases, 549 European ancestry population controls	NA	9p13.3	9	33218924	SPINK4, B4GALT1	SPINK4			ENSG00000122711			rs28447319-?	rs28447319	0	28447319	intron_variant	0	0.003788	1E-14	14.0		21.08	[[7.107-62.55]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003125	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Influenza A (H1N1) infection	49 European ancestry severe cases, 107 European ancestry mild cases, 549 European ancestry population controls	NA	10q23.1	10	83884859	GHITM, NRG3							rs10788289-?	rs10788289	0	10788289	intergenic_variant	1	0.04713	4E-9	8.397940008672037		3.556	[2.279-5.549]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003125	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Influenza A (H1N1) infection	49 European ancestry severe cases, 107 European ancestry mild cases, 549 European ancestry population controls	NA	10q25.3	10	116427932	PNLIPRP3	PNLIPRP3			ENSG00000203837			rs41284366-?	rs41284366	0	41284366	5_prime_UTR_variant	0	0.01017	3E-8	7.522878745280337		6.756	[3.125-14.61]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003125	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Influenza A (H1N1) infection	49 European ancestry severe cases, 107 European ancestry mild cases, 549 European ancestry population controls	NA	11q14.1	11	84624623	DLG2	DLG2			ENSG00000150672			rs17807909-?	rs17807909	0	17807909	intron_variant	0	0.01117	5E-15	14.301029995663981		10.09	[5.018-20.3]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003125	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Influenza A (H1N1) infection	49 European ancestry severe cases, 107 European ancestry mild cases, 549 European ancestry population controls	NA	12q15	12	70816898	PTPRR	PTPRR			ENSG00000153233			rs1040026-?	rs1040026	0	1040026	intron_variant	0	0.003704	3E-18	17.522878745280337		26.11	[8.945-76.19]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003125	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Influenza A (H1N1) infection	49 European ancestry severe cases, 107 European ancestry mild cases, 549 European ancestry population controls	NA	13q12.3	13	30921698	MEDAG	TEX26-AS1, MEDAG			ENSG00000224743, ENSG00000102802			rs41433250-?	rs41433250	0	41433250	synonymous_variant	0	0.003795	2E-8	7.698970004336019		12.8	[4.095-40.04]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003125	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Influenza A (H1N1) infection	49 European ancestry severe cases, 107 European ancestry mild cases, 549 European ancestry population controls	NA	13q34	13	113559810	TMCO3	TMCO3 - TFDP1	ENSG00000150403	ENSG00000198176		5220	24911	rs9604153-?	rs9604153	0	9604153	intergenic_variant	1	NR	5E-8	7.301029995663981				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003125	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Influenza A (H1N1) infection	49 European ancestry severe cases, 107 European ancestry mild cases, 549 European ancestry population controls	NA	Xp21.1	X	32217032	DMD	DMD			ENSG00000198947			rs16990169-?	rs16990169	0	16990169	missense_variant	0	0.006579	4E-11	10.397940008672037		11.05	[4.565-26.74]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003125	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Influenza A (H1N1) infection	49 European ancestry severe cases, 107 European ancestry mild cases, 549 European ancestry population controls	NA	8p21.3	8	20945592	LOC286114, LZTS1	TMEM97P2 - LINC02153	ENSG00000253866	ENSG00000253199		10755	26429	rs500816-?	rs500816	0	500816	intron_variant	1	NR	1E-13	13.0				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003125	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Influenza A (H1N1) infection	49 European ancestry severe cases, 107 European ancestry mild cases, 549 European ancestry population controls	NA	2p23.3	2	23914948	ATAD2B	ATAD2B			ENSG00000119778			rs34357008-?	rs34357008	0	34357008	intron_variant	0	NR	7E-9	8.154901959985743				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003125	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Influenza A (H1N1) infection	49 European ancestry severe cases, 107 European ancestry mild cases, 549 European ancestry population controls	NA	2q22.1	2	140306261	LRP1B	LRP1B			ENSG00000168702			rs643684-?	rs643684	0	643684	intron_variant	0	NR	4E-8	7.3979400086720375				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003125	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	4p15.1	4	34908853	ARAP2, PCDH7							rs10034950-?	rs10034950	0	10034950	intergenic_variant	1	0.009311	3E-10	9.522878745280337		9.195	[8.37-10.02]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	14q31.1	14	80564149	CEP128	CEP128			ENSG00000100629			rs10162376-?	rs10162376	0	10162376	intron_variant	0	0.0	3E-8	7.522878745280337				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	12q15	12	70816898	PTPRR	PTPRR			ENSG00000153233			rs1040026-?	rs1040026	0	1040026	intron_variant	0	0.003704	4E-25	24.397940008672037		37.46	[36.38-38.54]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	10q23.1	10	83884859	GHITM, NRG3							rs10788289-?	rs10788289	0	10788289	intergenic_variant	1	0.04713	3E-10	9.522878745280337		4.271	[3.79-4.75]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	10q26.3	10	133297990	TUBGCP2	TUBGCP2			ENSG00000130640			rs11101682-?	rs11101682	0	11101682	missense_variant	0	0.0	1E-9	9.0				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	13q13.3	13	37983874	TRPC4	LINC02334			ENSG00000274317			rs11308613-?	rs11308613	0	11308613	intron_variant	0	0.0	2E-8	7.698970004336019				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	1p31.1	1	82478098	TTLL7, LPHN2							rs12143151-?	rs12143151	0	12143151	non_coding_transcript_exon_variant	1	0.04453	1E-9	9.0		4.231	[3.73-4.73]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	6q23.1	6	130132737	L3MBTL3	L3MBTL3			ENSG00000198945			rs12528886-?	rs12528886	0	12528886	intron_variant	0	0.006579	3E-12	11.522878745280337		13.21	[12.29-14.13]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	2q36.3	2	227557073	AGFG1	AGFG1			ENSG00000173744			rs13400297-?	rs13400297	0	13400297	3_prime_UTR_variant	0	0.02138	3E-8	7.522878745280337		5.151	[4.51-5.79]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	17p13.1	17	6803942	TEKT1	TEKT1			ENSG00000167858			rs138879185-?	rs138879185	1	9635710	intron_variant	0	0.0	2E-8	7.698970004336019				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	4p14	4	36005283	ARAP2, PCDH7	ARAP2			ENSG00000047365			rs1397427-?	rs1397427	0	1397427	intron_variant	0	0.06052	1E-9	9.0		3.77	[3.32-4.22]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	10q26.2	10	126148271	ADAM12	ADAM12			ENSG00000148848			rs1676712-?	rs1676712	0	1676712	intron_variant	0	0.03078	4E-8	7.3979400086720375		4.329	[3.76-4.89]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	Xp21.1	X	32217032	DMD	DMD			ENSG00000198947			rs16990169-?	rs16990169	0	16990169	missense_variant	0	0.006579	5E-14	13.301029995663981		14.55	[13.65-15.45]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	4p15.1	4	35007586	ARAP2, PCDH7							rs16990641-?	rs16990641	0	16990641	intergenic_variant	1	0.0	2E-8	7.698970004336019				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	2p12	2	82389326	LOC1720, CTNNA2	Y_RNA - SPATS2L	ENSG00000199357	ENSG00000196141		82158	117916555	rs17021683-?	rs17021683	0	17021683	intergenic_variant	1	0.001852	2E-8	7.698970004336019		22.87	[21.29-24.45]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	10p14	10	9022639	SFTA1P, GATA3							rs17432979-?	rs17432979	0	17432979	intergenic_variant	1	0.0	3E-8	7.522878745280337				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	11q14.1	11	84624623	DLG2	DLG2			ENSG00000150672			rs17807909-?	rs17807909	0	17807909	intron_variant	0	0.01117	2E-19	18.69897000433602		13.66	[12.94-14.38]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	8q11.22	8	51495376	PXDNL	PXDNL			ENSG00000147485			rs201466262-?	rs201466262	1	75422920	intron_variant	0	0.0	2E-8	7.698970004336019				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	9p13.3	9	33218924	SPINK4, B4GALT1	SPINK4			ENSG00000122711			rs28447319-?	rs28447319	0	28447319	intron_variant	0	0.003788	1E-13	13.0		21.24	[20.11-22.37]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	2p23.3	2	23914948	ATAD2B	ATAD2B			ENSG00000119778			rs34357008-?	rs34357008	0	34357008	intron_variant	0	0.0	2E-9	8.698970004336019				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	2q36.1	2	222924591	ACSL3	ACSL3			ENSG00000123983			rs34626661-?	rs34626661	0	34626661	missense_variant	0	0.0	2E-8	7.698970004336019				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	8p11.23	8	37670154	ZNF703, KCNU1	RNU6-607P - ZNF703	ENSG00000223215	ENSG00000183779		1149	25628	rs34766442-?	rs34766442	0	34766442	intron_variant	1	0.0	1E-9	9.0				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	Xp22.2	X	10151209	WWC3, CLCN4	WWC3 - CLCN4	ENSG00000047644	ENSG00000073464		6735	5766	rs34777570-?	rs34777570	0	34777570	intergenic_variant	1	0.0	1E-9	9.0				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA				NR							rs34835598-?	rs34835598	0	34835598		1	0.0	1E-8	8.0				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	12q21.32	12	88123784	CEP290	CEP290			ENSG00000198707			rs35110721-?	rs35110721	0	35110721	intron_variant	0	0.0	1E-9	9.0				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	7q34	7	140786445	BRAF	BRAF			ENSG00000157764			rs35407685-?	rs35407685	0	35407685	intron_variant	0	0.0	3E-8	7.522878745280337				Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	7q36.3	7	158817956	ESYT2	ESYT2			ENSG00000117868			rs35513757-?	rs35513757	0	35513757	intron_variant	0	0.001848	2E-8	7.698970004336019		23.19	[21.61-24.77]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	10q25.3	10	116427932	PNLIPRP3	PNLIPRP3			ENSG00000203837			rs41284366-?	rs41284366	0	41284366	5_prime_UTR_variant	0	0.01017	1E-12	12.0		10.15	[9.37-10.93]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2016-09-12	26379185	Garcia-Etxebarria K	2015-09-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/26379185	No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity.	Mild influenza (H1N1) infection	107 European ancestry mild cases, 549 European ancestry population controls	NA	13q12.3	13	30921698	MEDAG	TEX26-AS1, MEDAG			ENSG00000224743, ENSG00000102802			rs41433250-?	rs41433250	0	41433250	synonymous_variant	0	0.003795	2E-8	7.698970004336019		13.98	[12.79-15.17]	Affymetrix [547296]	N	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488	GCST003124	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Pneumococcal bacteremia	429 African ancestry cases, 2,677 African ancestry controls	113  African ancestry cases, 1,336 African ancestry controls	5p14.1	5	26568134	intergenic							rs6452345-?	rs6452345	0	6452345	intergenic_variant	1	NR	5E-6	5.301029995663981		3.22	[NR]	Affymetrix [up to 10996499] (imputed)	N	pneumococcal bacteremia	http://www.ebi.ac.uk/efo/EFO_1001925	GCST003649	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Pneumococcal bacteremia	429 African ancestry cases, 2,677 African ancestry controls	113  African ancestry cases, 1,336 African ancestry controls	7q31.1	7	108117398	LAMB4	LAMB4			ENSG00000091128			rs17155006-?	rs17155006	0	17155006	intron_variant	0	NR	8E-6	5.096910013008056		1.3513513	[NR]	Affymetrix [up to 10996499] (imputed)	N	pneumococcal bacteremia	http://www.ebi.ac.uk/efo/EFO_1001925	GCST003649	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Pneumococcal bacteremia	429 African ancestry cases, 2,677 African ancestry controls	113  African ancestry cases, 1,336 African ancestry controls	8q24.22	8	133193470	WISP1	CCN4			ENSG00000104415			rs3739262-?	rs3739262	0	3739262	intron_variant	0	NR	5E-6	5.301029995663981		1.53	[NR]	Affymetrix [up to 10996499] (imputed)	N	pneumococcal bacteremia	http://www.ebi.ac.uk/efo/EFO_1001925	GCST003649	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Pneumococcal bacteremia	429 African ancestry cases, 2,677 African ancestry controls	113  African ancestry cases, 1,336 African ancestry controls	13q14.13	13	45833902	LOC283514	SIAH3			ENSG00000215475			rs9526114-?	rs9526114	0	9526114	intron_variant	0	NR	6E-6	5.221848749616356		1.35	[NR]	Affymetrix [up to 10996499] (imputed)	N	pneumococcal bacteremia	http://www.ebi.ac.uk/efo/EFO_1001925	GCST003649	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Pneumococcal bacteremia	429 African ancestry cases, 2,677 African ancestry controls	113  African ancestry cases, 1,336 African ancestry controls	1p31.3	1	62467144	DOCK7	DOCK7			ENSG00000116641			rs1168000-?	rs1168000	0	1168000	intron_variant	0	NR	5E-6	5.301029995663981		2.85	[NR]	Affymetrix [up to 10996499] (imputed)	N	pneumococcal bacteremia	http://www.ebi.ac.uk/efo/EFO_1001925	GCST003649	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Pneumococcal bacteremia	429 African ancestry cases, 2,677 African ancestry controls	113  African ancestry cases, 1,336 African ancestry controls				OR6P1							rs863345-?	rs863345	0	863345	intron_variant	1	NR	1E-6	6.0		1.55	[NR]	Affymetrix [up to 10996499] (imputed)	N	pneumococcal bacteremia	http://www.ebi.ac.uk/efo/EFO_1001925	GCST003649	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Pneumococcal bacteremia	429 African ancestry cases, 2,677 African ancestry controls	113  African ancestry cases, 1,336 African ancestry controls	3q21.3	3	128982287	KIAA1257	CFAP92			ENSG00000114656			rs6439153-?	rs6439153	0	6439153	intron_variant	0	NR	5E-7	6.301029995663981		2.39	[NR]	Affymetrix [up to 10996499] (imputed)	N	pneumococcal bacteremia	http://www.ebi.ac.uk/efo/EFO_1001925	GCST003649	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Pneumococcal bacteremia	429 African ancestry cases, 2,677 African ancestry controls	113  African ancestry cases, 1,336 African ancestry controls	5q35.1	5	170026088	DOCK2	DOCK2			ENSG00000134516			rs114183953-?	rs114183953	0	114183953	intron_variant	0	NR	2E-6	5.698970004336019		2.77	[NR]	Affymetrix [up to 10996499] (imputed)	N	pneumococcal bacteremia	http://www.ebi.ac.uk/efo/EFO_1001925	GCST003649	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Pneumococcal bacteremia	429 African ancestry cases, 2,677 African ancestry controls	113  African ancestry cases, 1,336 African ancestry controls	7p21.3	7	13357005	intergenic							rs140817150-?	rs140817150	0	140817150	intron_variant	1	NR	2E-9	8.698970004336019		2.47	[NR]	Affymetrix [up to 10996499] (imputed)	N	pneumococcal bacteremia	http://www.ebi.ac.uk/efo/EFO_1001925	GCST003649	Genome-wide genotyping array
2014-10-20	24503447	Nelson D	2014-02-06	Antivir Ther	www.ncbi.nlm.nih.gov/pubmed/24503447	Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitor.	Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)	176 European ancestry individuals	NA	20q13.12	20	47205635	ZMYND8	EYA2 - ZMYND8	ENSG00000064655	ENSG00000101040		16791	3579	rs7262634-?	rs7262634	0	7262634	TF_binding_site_variant	1	NR	1E-6	6.0		25.0	[NR]	Illumina [4466593]	N	hepatitis C virus infection, response to protease inhibitor, bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0003047, http://www.ebi.ac.uk/efo/EFO_0005657, http://www.ebi.ac.uk/efo/EFO_0004570	GCST002347	Genome-wide genotyping array
2014-10-20	24503447	Nelson D	2014-02-06	Antivir Ther	www.ncbi.nlm.nih.gov/pubmed/24503447	Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitor.	Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)	176 European ancestry individuals	NA				KCNH5							kgp6774393-?	kgp6774393	0			1	NR	6E-6	5.221848749616356		4.35	[NR]	Illumina [4466593]	N	hepatitis C virus infection, response to protease inhibitor, bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0003047, http://www.ebi.ac.uk/efo/EFO_0005657, http://www.ebi.ac.uk/efo/EFO_0004570	GCST002347	Genome-wide genotyping array
2014-10-20	24503447	Nelson D	2014-02-06	Antivir Ther	www.ncbi.nlm.nih.gov/pubmed/24503447	Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitor.	Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)	176 European ancestry individuals	NA				FGF14							kgp9755615-?	kgp9755615	0			1	NR	8E-6	5.096910013008056		3.23	[NR]	Illumina [4466593]	N	hepatitis C virus infection, response to protease inhibitor, bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0003047, http://www.ebi.ac.uk/efo/EFO_0005657, http://www.ebi.ac.uk/efo/EFO_0004570	GCST002347	Genome-wide genotyping array
2014-10-20	24503447	Nelson D	2014-02-06	Antivir Ther	www.ncbi.nlm.nih.gov/pubmed/24503447	Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitor.	Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	176 European ancestry individuals	NA				TMEM18							kgp3085785-?	kgp3085785	0			1	NR	1E-6	6.0		0.36	[NR] unit increase	Illumina [4466593]	N	hepatitis C virus infection, response to protease inhibitor, bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0003047, http://www.ebi.ac.uk/efo/EFO_0005657, http://www.ebi.ac.uk/efo/EFO_0004570	GCST002349	Genome-wide genotyping array
2014-10-20	24503447	Nelson D	2014-02-06	Antivir Ther	www.ncbi.nlm.nih.gov/pubmed/24503447	Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitor.	Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	176 European ancestry individuals	NA				RUNX3							kgp11613116-?	kgp11613116	0			1	NR	2E-6	5.698970004336019		0.37	[NR] unit increase	Illumina [4466593]	N	hepatitis C virus infection, response to protease inhibitor, bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0003047, http://www.ebi.ac.uk/efo/EFO_0005657, http://www.ebi.ac.uk/efo/EFO_0004570	GCST002349	Genome-wide genotyping array
2016-02-05	25897833	Thompson AG	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897833	Genome-wide association study of behavioural and psychiatric features in human prion disease.	Psychotic symptoms in prion disease	Up to 170 cases	NA	11p15.4	11	11514940	GALNTL4	GALNT18			ENSG00000110328			rs4077732-?	rs4077732	0	4077732	intron_variant	0	0.33	2E-6	5.698970004336019		3.33	[2.00-1.25]	Illumina [518938]	N	psychotic symptoms	http://www.ebi.ac.uk/efo/EFO_0005940	GCST002867	Genome-wide genotyping array
2016-02-05	25897833	Thompson AG	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897833	Genome-wide association study of behavioural and psychiatric features in human prion disease.	Psychotic symptoms in prion disease	Up to 170 cases	NA	18q22.3	18	73599284	LOC100505817							rs7231996-?	rs7231996	0	7231996	intergenic_variant	1	0.131	3E-6	5.522878745280337		5.56	[2.5911.95]	Illumina [518938]	N	psychotic symptoms	http://www.ebi.ac.uk/efo/EFO_0005940	GCST002867	Genome-wide genotyping array
2016-02-05	25897833	Thompson AG	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897833	Genome-wide association study of behavioural and psychiatric features in human prion disease.	Psychotic symptoms in prion disease	Up to 170 cases	NA	3q25.31	3	155352676	LOC100507537	PABPC1P10 - PLCH1	ENSG00000239443	ENSG00000114805		42869	22904	rs6440974-?	rs6440974	0	6440974	regulatory_region_variant	1	0.099	4E-6	5.3979400086720375		5.27	[2.5211.03]	Illumina [518938]	N	psychotic symptoms	http://www.ebi.ac.uk/efo/EFO_0005940	GCST002867	Genome-wide genotyping array
2013-05-01	23326239	Rubicz R	2013-01-10	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23326239	A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).	Epstein-Barr virus immune response (EBNA-1)	1,367 Mexican American indivduals	589 Mexican American indivduals	6p21.32	6	32601914	HLA-DRB1	HLA-DRB1 - HLA-DQA1	ENSG00000206240	ENSG00000196735		12066	26265	rs477515-T	rs477515	0	477515	intron_variant	1	0.32	3E-13	12.522878745280337	(Quantitative)	0.28	[NR] unit decrease	Illumina [944565]	N	antibody measurement, Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0004556, http://www.ebi.ac.uk/efo/EFO_0000769	GCST001812	Genome-wide genotyping array
2013-05-01	23326239	Rubicz R	2013-01-10	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23326239	A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).	Epstein-Barr virus immune response (EBNA-1)	1,367 Mexican American indivduals	589 Mexican American indivduals	6p21.32	6	32660651	PSORS1C1, BAT2, EHMT2, HLA-DQB1, C6orf15, BAT4, NOTCH4, PRRT1, HLA-B	HLA-DQB1-AS1, HLA-DQB1-AS1, HLA-DQB1-AS1, HLA-DQB1-AS1, HLA-DQB1-AS1, HLA-DQB1-AS1, HLA-DQB1, HLA-DQB1, HLA-DQB1, HLA-DQB1, HLA-DQB1, HLA-DQB1			ENSG00000237455, ENSG00000238226, ENSG00000223534, ENSG00000230414, ENSG00000231677, ENSG00000233744, ENSG00000233209, ENSG00000179344, ENSG00000206302, ENSG00000206237, ENSG00000225824, ENSG00000231939			rs2854275-T	rs2854275	0	2854275	non_coding_transcript_exon_variant	0	0.064	2E-10	9.698970004336019	(Conditional on rs477515 - Quantitative)	0.45	[NR] unit decrease	Illumina [944565]	N	antibody measurement, Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0004556, http://www.ebi.ac.uk/efo/EFO_0000769	GCST001812	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	1p36.11	1	25130790	MIR4425, SYF2	IFITM3P7 - SYF2	ENSG00000233419	ENSG00000117614		5336	91486	rs75251726-?	rs75251726	0	75251726	regulatory_region_variant	1	NR	9E-6	5.045757490560675	(AA and Sub-Saharan African)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	1q42.2	1	233984064	SLC35F3	SLC35F3			ENSG00000183780			rs12759054-?	rs12759054	0	12759054	intron_variant	0	NR	1E-6	6.0	(AA and Sub-Saharan African)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	3q13.13	3	109735523	MIR4445, PVRL3-AS1	LINC01205 - NA	ENSG00000228980			12250		rs6797827-?	rs6797827	0	6797827	intron_variant	1	NR	7E-7	6.154901959985743	(AA and Sub-Saharan African)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	4q25	4	107189709	DKK2, PAPSS1	DKK2			ENSG00000155011			rs116671518-?	rs116671518	0	116671518	intron_variant	0	NR	1E-6	6.0	(AA and Sub-Saharan African)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	7q36.1	7	150328278	LRRC61	LRRC61, ZBED6CL			ENSG00000127399, ENSG00000188707			rs4395803-?	rs4395803	0	4395803	intron_variant	0	NR	4E-6	5.3979400086720375	(AA and Sub-Saharan African)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	8p23.2	8	5305238	CSMD1, LOC100287015							rs10099002-?	rs10099002	0	10099002	intergenic_variant	1	NR	5E-6	5.301029995663981	(AA and Sub-Saharan African)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	8p22	8	13414654	DLC1	DLC1			ENSG00000164741			rs116179838-?	rs116179838	0	116179838	intron_variant	0	NR	7E-6	5.154901959985743	(AA and Sub-Saharan African)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	9q31.1	9	100836070	MURC, PLPPR1	PTCH1 - NA	ENSG00000185920			5319013		rs73501482-?	rs73501482	0	73501482	intergenic_variant	1	NR	9E-6	5.045757490560675	(AA and Sub-Saharan African)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	11p15.3	11	12454577	PARVA	PARVA			ENSG00000197702			rs55992909-?	rs55992909	0	55992909	intron_variant	0	NR	6E-6	5.221848749616356	(AA and Sub-Saharan African)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	11p15.1	11	20653596	SLC6A5	SLC6A5			ENSG00000165970			rs77394600-?	rs77394600	0	77394600	intron_variant	0	NR	8E-6	5.096910013008056	(AA and Sub-Saharan African)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	11q23.3	11	115448377	CADM1	CADM1			ENSG00000182985			rs220839-?	rs220839	0	220839	intron_variant	0	NR	5E-6	5.301029995663981	(AA and Sub-Saharan African)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	16p13.3	16	3348899	ZNF75A, OR2C1	ZNF75A - OR2C1	ENSG00000162086	ENSG00000168158		30047	6990	rs138117677-?	rs138117677	0	138117677	TF_binding_site_variant	1	NR	2E-7	6.698970004336019	(AA and Sub-Saharan African)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	20p12.1	20	15683126	MACROD2	MACROD2			ENSG00000172264			rs6105452-?	rs6105452	0	6105452	intron_variant	0	NR	2E-8	7.698970004336019	(AA and Sub-Saharan African)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	4q32.1	4	155127918	RBM46, NPY2R	NA - NPY2R		ENSG00000185149			80718	rs7669967-?	rs7669967	0	7669967	intergenic_variant	1	NR	7E-6	5.154901959985743	(EA)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	5q32	5	150298255	ARSI	ARSI			ENSG00000183876			rs77943970-?	rs77943970	0	77943970	synonymous_variant	0	NR	7E-6	5.154901959985743	(EA)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	6p21.2	6	37002834	MTCH1, FGD2	MTCH1 - FGD2	ENSG00000137409	ENSG00000146192		16536	2812	rs13204008-?	rs13204008	0	13204008	regulatory_region_variant	1	NR	3E-6	5.522878745280337	(EA)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	6q25.1	6	151470602	ARMT1	ARMT1 - CCDC170	ENSG00000146476	ENSG00000120262		501	23415	rs13202913-?	rs13202913	0	13202913	intergenic_variant	1	NR	6E-6	5.221848749616356	(EA)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	10q23.1	10	82625296	NRG3	NRG3			ENSG00000185737			rs594418-?	rs594418	0	594418	intron_variant	0	NR	7E-7	6.154901959985743	(EA)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	1p13.1	1	116037356	SLC22A15	SLC22A15			ENSG00000163393			rs80274284-?	rs80274284	0	80274284	missense_variant	0	NR	1E-6	6.0	(East and South Asian)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	1q25.3	1	184795373	FAM129A	NIBAN1			ENSG00000135842			rs201130852-?	rs201130852	0	201130852	synonymous_variant	0	NR	9E-6	5.045757490560675	(East and South Asian)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	2q31.2	2	178711222	TTN	TTN-AS1, TTN			ENSG00000237298, ENSG00000155657			rs200655768-?	rs200655768	0	200655768	synonymous_variant	0	NR	3E-7	6.522878745280337	(East and South Asian)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	4q28.2	4	129344228	C4orf33, LOC101927282							rs5861895-?	rs5861895	0	5861895	regulatory_region_variant	1	NR	1E-6	6.0	(East and South Asian)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	6q11.1	6	62002189	KHDRBS2	KHDRBS2			ENSG00000112232			rs11324540-?	rs11324540	0	11324540	intron_variant	0	NR	2E-6	5.698970004336019	(East and South Asian)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	6q11.1	6	62257812	KHDRBS2	KHDRBS2			ENSG00000112232			rs855408-?	rs855408	0	855408	intron_variant	0	NR	9E-6	5.045757490560675	(East and South Asian)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	6q11.1	6	62460168	KHDRBS2, LGSN	NA - DHFRP5		ENSG00000216859			772	rs12154141-?	rs12154141	0	12154141	intergenic_variant	1	NR	4E-7	6.3979400086720375	(East and South Asian)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	9q32	9	112404107	HSDL2	HSDL2, C9orf147			ENSG00000119471, ENSG00000230185			rs184202621-?	rs184202621	0	184202621	missense_variant	0	NR	3E-6	5.522878745280337	(East and South Asian)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	10q21.1	10	53806747	PCDH15	PCDH15			ENSG00000150275			rs201255786-?	rs201255786	0	201255786	synonymous_variant	0	NR	2E-6	5.698970004336019	(East and South Asian)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	14q31.3	14	87737048	LOC283585, GALC	LINC02330 - NA	ENSG00000258770			81754		rs2153486-?	rs2153486	0	2153486	intron_variant	1	NR	1E-6	6.0	(East and South Asian)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	15q25.1	15	79358175	TMED3	TMED3			ENSG00000166557			rs62025977-?	rs62025977	0	62025977	intron_variant	0	NR	3E-6	5.522878745280337	(East and South Asian)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	19q13.2	19	41720990	CEACAM5	CEACAM5			ENSG00000105388			rs201761909-?	rs201761909	0	201761909	missense_variant	0	NR	2E-6	5.698970004336019	(East and South Asian)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	4q28.3	4	136134743	LINC00613, PCDH18							rs62309385-?	rs62309385	0	62309385	intron_variant	1	NR	1E-6	6.0	(Hispanic/Latino)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	6q22.31	6	119095307	FAM184A	FAM184A			ENSG00000111879			rs6569038-?	rs6569038	0	6569038	intron_variant	0	NR	7E-6	5.154901959985743	(Hispanic/Latino)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	7q36.3	7	157467496	LOC101927914	DNAJB6 - PTPRN2	ENSG00000105993	ENSG00000155093		50057	71560	rs6459788-?	rs6459788	0	6459788	non_coding_transcript_exon_variant	1	NR	7E-6	5.154901959985743	(Hispanic/Latino)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	8q22.1	8	96785908	CPQ	CPQ			ENSG00000104324			rs56064043-?	rs56064043	0	56064043	intron_variant	0	NR	7E-6	5.154901959985743	(Hispanic/Latino)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	10q21.3	10	66044423	CTNNA3	CTNNA3			ENSG00000183230			rs71035108-?	rs71035108	0	71035108	intron_variant	0	NR	7E-6	5.154901959985743	(Hispanic/Latino)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	10q26.3	10	130217007	GLRX3, MIR378C	LINC02646			ENSG00000236303			rs9943465-?	rs9943465	0	9943465	intron_variant	0	NR	8E-6	5.096910013008056	(Hispanic/Latino)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	12q15	12	67453680	CAND1, LOC100507175	LINC02408			ENSG00000203585			rs1161098-?	rs1161098	0	1161098	intron_variant	0	NR	5E-7	6.301029995663981	(Hispanic/Latino)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	16q23.1	16	78623987	WWOX	WWOX			ENSG00000186153			rs12596233-?	rs12596233	0	12596233	intron_variant	0	NR	7E-6	5.154901959985743	(Hispanic/Latino)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA				SLC39A11, SSTR2							rs60350499-?	rs60350499	0	60350499		1	NR	3E-6	5.522878745280337	(Hispanic/Latino)			NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	4q34.1	4	173430888	SCRG1, HAND2	RPL5P11 - RNU6-1096P	ENSG00000242882	ENSG00000252898		10751	15715	rs200699422-?	rs200699422	0	200699422	intergenic_variant	1	NR	5E-6	5.301029995663981				NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	6p21.33	6	31170330	POU5F1	POU5F1, POU5F1, POU5F1, POU5F1, POU5F1, POU5F1, POU5F1			ENSG00000204531, ENSG00000233911, ENSG00000229094, ENSG00000230336, ENSG00000206454, ENSG00000237582, ENSG00000235068			rs1062630-?	rs1062630	0	1062630	synonymous_variant	0	NR	1E-6	6.0				NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2017-09-15	28654678	Mandage R	2017-06-27	PLoS One	www.ncbi.nlm.nih.gov/pubmed/28654678	Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.	Epstein-Barr virus copy number in lymphoblastoid cell lines	389 East Asian ancestry individuals, 189 South Asian ancestry individuals, 492 European ancestry individuals, 467 Sub-Saharan African ancestry individuals, 59 African American individuals, 157 Hispanic/Latino individuals	NA	13q12.12	13	22735243	LINC00540, BASP1P1	DDX39AP1 - SNORD36	ENSG00000225777	ENSG00000253094		29037	67902	rs314879-?	rs314879	0	314879	intergenic_variant	1	NR	5E-7	6.301029995663981				NR [at least 880000]	N	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769	GCST004735	Genome-wide genotyping array
2018-02-28	29395996	van Laarhoven A	2018-01-23	Lancet Infect Dis	www.ncbi.nlm.nih.gov/pubmed/29395996	Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study.	CSF tryptophan concentration in tuberculous meningitis	130 individuals	NA	2q32.3	2	192131789	TMEFF2	TMEFF2			ENSG00000144339			rs111552533-?	rs111552533	0	111552533	intron_variant	0		3E-6	5.522878745280337		1.26	unit increase	Illumina [4751257] (imputed)	N	tryptophan measurement	http://www.ebi.ac.uk/efo/EFO_0008534	GCST005331	Genome-wide genotyping array
2018-02-28	29395996	van Laarhoven A	2018-01-23	Lancet Infect Dis	www.ncbi.nlm.nih.gov/pubmed/29395996	Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study.	CSF tryptophan concentration in tuberculous meningitis	130 individuals	NA	5q23.2	5	123682194	CSNK1G3	KRT18P16 - NA	ENSG00000235275			44791		rs13156386-?	rs13156386	0	13156386	intergenic_variant	1		4E-6	5.3979400086720375		1.6	unit increase	Illumina [4751257] (imputed)	N	tryptophan measurement	http://www.ebi.ac.uk/efo/EFO_0008534	GCST005331	Genome-wide genotyping array
2018-02-28	29395996	van Laarhoven A	2018-01-23	Lancet Infect Dis	www.ncbi.nlm.nih.gov/pubmed/29395996	Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study.	CSF tryptophan concentration in tuberculous meningitis	130 individuals	NA	7q21.11	7	81237740	SEMA3C							rs141710116-?	rs141710116	0	141710116	intergenic_variant	1		6E-6	5.221848749616356		1.94	unit decrease	Illumina [4751257] (imputed)	N	tryptophan measurement	http://www.ebi.ac.uk/efo/EFO_0008534	GCST005331	Genome-wide genotyping array
2018-02-28	29395996	van Laarhoven A	2018-01-23	Lancet Infect Dis	www.ncbi.nlm.nih.gov/pubmed/29395996	Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study.	CSF tryptophan concentration in tuberculous meningitis	130 individuals	NA	7p14.3	7	33873792	BMPER	BBS9			ENSG00000122507			rs3815652-?	rs3815652	0	3815652	intron_variant	0		1E-7	7.0		1.83	unit increase	Illumina [4751257] (imputed)	N	tryptophan measurement	http://www.ebi.ac.uk/efo/EFO_0008534	GCST005331	Genome-wide genotyping array
2018-02-28	29395996	van Laarhoven A	2018-01-23	Lancet Infect Dis	www.ncbi.nlm.nih.gov/pubmed/29395996	Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study.	CSF tryptophan concentration in tuberculous meningitis	130 individuals	NA	7p14.3	7	29363572	CHN2	CHN2			ENSG00000106069			rs2391754-?	rs2391754	0	2391754	intron_variant	0		3E-6	5.522878745280337		1.73	unit increase	Illumina [4751257] (imputed)	N	tryptophan measurement	http://www.ebi.ac.uk/efo/EFO_0008534	GCST005331	Genome-wide genotyping array
2018-02-28	29395996	van Laarhoven A	2018-01-23	Lancet Infect Dis	www.ncbi.nlm.nih.gov/pubmed/29395996	Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study.	CSF tryptophan concentration in tuberculous meningitis	130 individuals	NA	10q22.1	10	69735970	COL13A1	LINC02651 - RPL5P26	ENSG00000235645	ENSG00000230469		43518	42992	rs10998941-?	rs10998941	0	10998941	regulatory_region_variant	1		7E-6	5.154901959985743		1.22	unit increase	Illumina [4751257] (imputed)	N	tryptophan measurement	http://www.ebi.ac.uk/efo/EFO_0008534	GCST005331	Genome-wide genotyping array
2018-02-28	29395996	van Laarhoven A	2018-01-23	Lancet Infect Dis	www.ncbi.nlm.nih.gov/pubmed/29395996	Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study.	CSF tryptophan concentration in tuberculous meningitis	130 individuals	NA	12q21.2	12	75991069	PHLDA1	RN7SL734P - PHLDA1	ENSG00000243420	ENSG00000139289		32939	34378	rs12814611-?	rs12814611	0	12814611	regulatory_region_variant	1		6E-6	5.221848749616356		1.28	unit increase	Illumina [4751257] (imputed)	N	tryptophan measurement	http://www.ebi.ac.uk/efo/EFO_0008534	GCST005331	Genome-wide genotyping array
2018-02-28	29395996	van Laarhoven A	2018-01-23	Lancet Infect Dis	www.ncbi.nlm.nih.gov/pubmed/29395996	Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study.	CSF tryptophan concentration in tuberculous meningitis	130 individuals	NA	13q14.11	13	41096949	WBP4	WBP4 - MIR3168	ENSG00000120688	ENSG00000264226		12943	4070	rs11838725-?	rs11838725	0	11838725	intergenic_variant	1		2E-6	5.698970004336019		1.89	unit decrease	Illumina [4751257] (imputed)	N	tryptophan measurement	http://www.ebi.ac.uk/efo/EFO_0008534	GCST005331	Genome-wide genotyping array
2018-02-28	29395996	van Laarhoven A	2018-01-23	Lancet Infect Dis	www.ncbi.nlm.nih.gov/pubmed/29395996	Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study.	CSF tryptophan concentration in tuberculous meningitis	130 individuals	NA	13q14.3	13	53973439	LINC00558	LINC00558 - NA	ENSG00000261517			33479		rs147182487-?	rs147182487	0	147182487	intergenic_variant	1		3E-6	5.522878745280337		2.35	unit increase	Illumina [4751257] (imputed)	N	tryptophan measurement	http://www.ebi.ac.uk/efo/EFO_0008534	GCST005331	Genome-wide genotyping array
2018-02-28	29395996	van Laarhoven A	2018-01-23	Lancet Infect Dis	www.ncbi.nlm.nih.gov/pubmed/29395996	Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study.	CSF tryptophan concentration in tuberculous meningitis	130 individuals	NA	17p13.1	17	10594428	MYHAS	MYHAS			ENSG00000272975			rs55854133-?	rs55854133	0	55854133	intron_variant	0		5E-6	5.301029995663981		1.87	unit increase	Illumina [4751257] (imputed)	N	tryptophan measurement	http://www.ebi.ac.uk/efo/EFO_0008534	GCST005331	Genome-wide genotyping array
2017-11-28	29066090	Allen RJ	2017-10-20	Lancet Respir Med	www.ncbi.nlm.nih.gov/pubmed/29066090	Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.	Idiopathic pulmonary fibrosis	602 European ancestry cases, 3,366 European ancestry controls	2,158 cases, 5,195 controls	2p23.1	2	31561411	SRD5A2	SRD5A2			ENSG00000277893			rs191031841-T	rs191031841	0	191031841	intron_variant	0	0.041	6E-6	5.221848749616356		1.73	[1.36-2.18]	Affymetrix [NR] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST004986	Genome-wide genotyping array
2017-11-28	29066090	Allen RJ	2017-10-20	Lancet Respir Med	www.ncbi.nlm.nih.gov/pubmed/29066090	Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.	Idiopathic pulmonary fibrosis	602 European ancestry cases, 3,366 European ancestry controls	2,158 cases, 5,195 controls	4q22.1	4	89655739	Intergenic	NA - SNCA		ENSG00000145335			44606	rs28673968-T	rs28673968	0	28673968	intron_variant	1	0.877	1E-7	7.0		1.2658228	[1.16-1.39]	Affymetrix [NR] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST004986	Genome-wide genotyping array
2017-11-28	29066090	Allen RJ	2017-10-20	Lancet Respir Med	www.ncbi.nlm.nih.gov/pubmed/29066090	Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.	Idiopathic pulmonary fibrosis	602 European ancestry cases, 3,366 European ancestry controls	2,158 cases, 5,195 controls	6p24.3	6	7562999	DSP	DSP			ENSG00000096696			rs2076295-G	rs2076295	0	2076295	intron_variant	0	0.463	8E-28	27.096910013008056		1.44	[1.35-1.54]	Affymetrix [NR] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST004986	Genome-wide genotyping array
2017-11-28	29066090	Allen RJ	2017-10-20	Lancet Respir Med	www.ncbi.nlm.nih.gov/pubmed/29066090	Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.	Idiopathic pulmonary fibrosis	602 European ancestry cases, 3,366 European ancestry controls	2,158 cases, 5,195 controls				MRPL13							chr8:121446432-T	chr8:121446432	0			1	0.03	2E-7	6.698970004336019		15.9	[5.61-45.0]	Affymetrix [NR] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST004986	Genome-wide genotyping array
2017-11-28	29066090	Allen RJ	2017-10-20	Lancet Respir Med	www.ncbi.nlm.nih.gov/pubmed/29066090	Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.	Idiopathic pulmonary fibrosis	602 European ancestry cases, 3,366 European ancestry controls	2,158 cases, 5,195 controls	11p15.5	11	1219991	MUC5B	MUC5AC - MUC5B	ENSG00000215182	ENSG00000117983		18853	3075	rs35705950-T	rs35705950	0	35705950	splice_region_variant	1	0.143	1E-66	66.0		2.89	[2.56-3.26]	Affymetrix [NR] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST004986	Genome-wide genotyping array
2017-11-28	29066090	Allen RJ	2017-10-20	Lancet Respir Med	www.ncbi.nlm.nih.gov/pubmed/29066090	Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.	Idiopathic pulmonary fibrosis	602 European ancestry cases, 3,366 European ancestry controls	2,158 cases, 5,195 controls	15q25.3	15	85756967	AKAP13, KLHL25	LINC02883 - KLHL25	ENSG00000259416	ENSG00000183655		730	2359	rs62025270-A	rs62025270	0	62025270	regulatory_region_variant	1	0.247	1E-9	9.0		1.27	[1.18-1.37]	Affymetrix [NR] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST004986	Genome-wide genotyping array
2017-11-28	29066090	Allen RJ	2017-10-20	Lancet Respir Med	www.ncbi.nlm.nih.gov/pubmed/29066090	Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.	Idiopathic pulmonary fibrosis	602 European ancestry cases, 3,366 European ancestry controls	2,158 cases, 5,195 controls	17q21.32	17	46930382	GOSR2	GOSR2			ENSG00000108433			rs117791180-T	rs117791180	0	117791180	non_coding_transcript_exon_variant	0	0.034	4E-6	5.3979400086720375		2.04	[1.51-2.77]	Affymetrix [NR] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST004986	Genome-wide genotyping array
2017-11-28	29066090	Allen RJ	2017-10-20	Lancet Respir Med	www.ncbi.nlm.nih.gov/pubmed/29066090	Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.	Idiopathic pulmonary fibrosis	602 European ancestry cases, 3,366 European ancestry controls	2,158 cases, 5,195 controls	19q13.42	19	54420809	TTYH1	TTYH1, TTYH1, TTYH1, TTYH1			ENSG00000276887, ENSG00000276537, ENSG00000167614, ENSG00000275650			rs73606754-C	rs73606754	0	73606754	splice_region_variant	0	0.863	3E-9	8.522878745280337		1.5384616	[1.33-1.75]	Affymetrix [NR] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST004986	Genome-wide genotyping array
2022-02-01	33758299	Dhindsa RS	2021-03-23	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/33758299	Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.	Idiopathic pulmonary fibrosis	752 European ancestry cases, 119,055 European ancestry controls	1,028 Finnish ancestry cases, 196,986 Finnish ancestry controls											chr11:1099802-?	chr11:1099802	0			1	NR	2E-26	25.69897000433602		1.8608	[1.6678-2.0761]	NR [564159]	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST90093310	Genome-wide sequencing, Exome-wide sequencing
2022-02-01	33758299	Dhindsa RS	2021-03-23	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/33758299	Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.	Idiopathic pulmonary fibrosis	752 European ancestry cases, 119,055 European ancestry controls	1,028 Finnish ancestry cases, 196,986 Finnish ancestry controls											chr11:1167980-?	chr11:1167980	0			1	NR	7E-26	25.154901959985743		2.7818	[2.3515-3.2907]	NR [564159]	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST90093310	Genome-wide sequencing, Exome-wide sequencing
2022-02-01	33758299	Dhindsa RS	2021-03-23	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/33758299	Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.	Idiopathic pulmonary fibrosis	752 European ancestry cases, 119,055 European ancestry controls	1,028 Finnish ancestry cases, 196,986 Finnish ancestry controls											chr11:1102586-?	chr11:1102586	0			1	NR	4E-11	10.397940008672037		1.4084	[1.2724-1.5589]	NR [564159]	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST90093310	Genome-wide sequencing, Exome-wide sequencing
2022-02-01	33758299	Dhindsa RS	2021-03-23	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/33758299	Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.	Idiopathic pulmonary fibrosis	752 European ancestry cases, 119,055 European ancestry controls	1,028 Finnish ancestry cases, 196,986 Finnish ancestry controls											chr11:1288726-?	chr11:1288726	0			1	NR	1E-9	9.0		1.373	[1.2404-1.5197]	NR [564159]	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST90093310	Genome-wide sequencing, Exome-wide sequencing
2022-02-01	33758299	Dhindsa RS	2021-03-23	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/33758299	Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.	Idiopathic pulmonary fibrosis	752 European ancestry cases, 119,055 European ancestry controls	1,028 Finnish ancestry cases, 196,986 Finnish ancestry controls											chr11:1232712-?	chr11:1232712	0			1	NR	2E-8	7.698970004336019		0.7464	[0.6737-0.8269]	NR [564159]	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST90093310	Genome-wide sequencing, Exome-wide sequencing
2022-02-01	33758299	Dhindsa RS	2021-03-23	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/33758299	Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.	Idiopathic pulmonary fibrosis	752 European ancestry cases, 119,055 European ancestry controls	1,028 Finnish ancestry cases, 196,986 Finnish ancestry controls											chr11:1242457-?	chr11:1242457	0			1	NR	2E-7	6.698970004336019		1.681	[1.4021-2.0154]	NR [564159]	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST90093310	Genome-wide sequencing, Exome-wide sequencing
2022-02-01	33758299	Dhindsa RS	2021-03-23	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/33758299	Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.	Idiopathic pulmonary fibrosis	752 European ancestry cases, 119,055 European ancestry controls	1,028 Finnish ancestry cases, 196,986 Finnish ancestry controls											chr11:1245928-?	chr11:1245928	0			1	NR	2E-7	6.698970004336019		1.9619	[1.5555-2.4744]	NR [564159]	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST90093310	Genome-wide sequencing, Exome-wide sequencing
2022-02-01	33758299	Dhindsa RS	2021-03-23	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/33758299	Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.	Idiopathic pulmonary fibrosis	752 European ancestry cases, 119,055 European ancestry controls	1,028 Finnish ancestry cases, 196,986 Finnish ancestry controls											chr5:169588475-?	chr5:169588475	0			1	NR	2E-7	6.698970004336019		2.8712	[2.0273-4.0663]	NR [564159]	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST90093310	Genome-wide sequencing, Exome-wide sequencing
2022-02-01	33758299	Dhindsa RS	2021-03-23	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/33758299	Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.	Idiopathic pulmonary fibrosis	752 European ancestry cases, 119,055 European ancestry controls	1,028 Finnish ancestry cases, 196,986 Finnish ancestry controls											chr11:1160678-?	chr11:1160678	0			1	NR	5E-7	6.301029995663981		1.9874	[1.556-2.5384]	NR [564159]	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST90093310	Genome-wide sequencing, Exome-wide sequencing
2022-02-01	33758299	Dhindsa RS	2021-03-23	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/33758299	Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.	Idiopathic pulmonary fibrosis	752 European ancestry cases, 119,055 European ancestry controls	1,028 Finnish ancestry cases, 196,986 Finnish ancestry controls											chr15:73992248-?	chr15:73992248	0			1	NR	6E-7	6.221848749616356		22.7034	[9.6368-53.4869]	NR [564159]	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST90093310	Genome-wide sequencing, Exome-wide sequencing
2022-02-01	33758299	Dhindsa RS	2021-03-23	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/33758299	Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.	Idiopathic pulmonary fibrosis	752 European ancestry cases, 119,055 European ancestry controls	1,028 Finnish ancestry cases, 196,986 Finnish ancestry controls											chr18:25227603-?	chr18:25227603	0			1	NR	9E-7	6.045757490560675		11.5702	[5.6345-23.7587]	NR [564159]	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST90093310	Genome-wide sequencing, Exome-wide sequencing
2022-02-01	33758299	Dhindsa RS	2021-03-23	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/33758299	Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.	Idiopathic pulmonary fibrosis	752 European ancestry cases, 119,055 European ancestry controls	1,028 Finnish ancestry cases, 196,986 Finnish ancestry controls											chr11:1082898-?	chr11:1082898	0			1	NR	2E-6	5.698970004336019		1.8621	[1.4677-2.3626]	NR [564159]	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST90093310	Genome-wide sequencing, Exome-wide sequencing
2022-02-01	33758299	Dhindsa RS	2021-03-23	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/33758299	Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.	Idiopathic pulmonary fibrosis	752 European ancestry cases, 119,055 European ancestry controls	1,028 Finnish ancestry cases, 196,986 Finnish ancestry controls											chr5:178986782-?	chr5:178986782	0			1	NR	3E-6	5.522878745280337		52.9107	[17.0451-164.2434]	NR [564159]	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST90093310	Genome-wide sequencing, Exome-wide sequencing
2022-02-01	33758299	Dhindsa RS	2021-03-23	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/33758299	Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.	Idiopathic pulmonary fibrosis	752 European ancestry cases, 119,055 European ancestry controls	1,028 Finnish ancestry cases, 196,986 Finnish ancestry controls											chr11:1085327-?	chr11:1085327	0			1	NR	6E-6	5.221848749616356		4.241	[2.5333-7.0999]	NR [564159]	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST90093310	Genome-wide sequencing, Exome-wide sequencing
2022-02-01	33758299	Dhindsa RS	2021-03-23	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/33758299	Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.	Idiopathic pulmonary fibrosis	752 European ancestry cases, 119,055 European ancestry controls	1,028 Finnish ancestry cases, 196,986 Finnish ancestry controls											chr19:43599236-?	chr19:43599236	0			1	NR	1E-5	5.0		19.8522	[7.8242-50.3708]	NR [564159]	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST90093310	Genome-wide sequencing, Exome-wide sequencing
2022-02-01	33758299	Dhindsa RS	2021-03-23	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/33758299	Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.	Idiopathic pulmonary fibrosis	752 European ancestry cases, 119,055 European ancestry controls	1,028 Finnish ancestry cases, 196,986 Finnish ancestry controls	5q35.1	5	169588475		SPDL1			ENSG00000040275			rs116483731-A	rs116483731	0	116483731	missense_variant	0	NR	2E-20	19.69897000433602	(combined evidence from both cohorts)			NR [564159]	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST90093310	Genome-wide sequencing, Exome-wide sequencing
2011-11-24	22019778	Zhang F	2011-10-23	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22019778	Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy.	Leprosy	706 Han Chinese ancestry cases, 5,581 Han Chinese ancestry controls	3,301 Han Chinese ancestry cases, 5,299 Han Chinese ancestry controls	6q24.3	6	146597814	RAB32	RAB32 - ADGB	ENSG00000118508	ENSG00000118492		42861	1153	rs2275606-A	rs2275606	0	2275606	intron_variant	1	0.21	4E-14	13.397940008672037		1.3	[1.21-1.39]	NR [1701673] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST001292	Genome-wide genotyping array
2011-11-24	22019778	Zhang F	2011-10-23	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22019778	Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy.	Leprosy	706 Han Chinese ancestry cases, 5,581 Han Chinese ancestry controls	3,301 Han Chinese ancestry cases, 5,299 Han Chinese ancestry controls	11q13.1	11	64362250	RPS6KA4	RPS6KA4			ENSG00000162302			rs538147-A	rs538147	0	538147	intron_variant	0	0.23	7E-6	5.154901959985743		1.17	[1.09-1.25]	NR [1701673] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST001292	Genome-wide genotyping array
2011-11-24	22019778	Zhang F	2011-10-23	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22019778	Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy.	Leprosy	706 Han Chinese ancestry cases, 5,581 Han Chinese ancestry controls	3,301 Han Chinese ancestry cases, 5,299 Han Chinese ancestry controls	16q12.1	16	50820507	CYLD	LINC02168 - LINC02128	ENSG00000261703	ENSG00000261241		12878	19510	rs16948876-A	rs16948876	0	16948876	intergenic_variant	1	0.03	2E-10	9.698970004336019		1.56	[1.36-1.79]	NR [1701673] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST001292	Genome-wide genotyping array
2011-11-24	22019778	Zhang F	2011-10-23	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22019778	Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy.	Leprosy	706 Han Chinese ancestry cases, 5,581 Han Chinese ancestry controls	3,301 Han Chinese ancestry cases, 5,299 Han Chinese ancestry controls	1p31.3	1	67131436	IL23R	C1orf141			ENSG00000203963			rs3762318-A	rs3762318	0	3762318	intron_variant	0	0.10	3E-11	10.522878745280337		1.45	[1.30-1.61]	NR [1701673] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST001292	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	1p31.3	1	67132294	IL23R	C1orf141			ENSG00000203963			rs2024825-A	rs2024825	0	2024825	intron_variant	0	0.895	4E-33	32.39794000867204		1.5873016	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	2q12.1	2	102328956	IL18R1, IL18RAP	IL18R1, IL1RL1			ENSG00000115604, ENSG00000115602			rs76886731-T	rs76886731	0	76886731	intron_variant	0	0.448	2E-23	22.69897000433602		1.24	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	5q33.3	5	159416227	IL12B	IL12B - LINC01845	ENSG00000113302	ENSG00000253298		85740	32329	rs6863015-C	rs6863015	0	6863015	intron_variant	1	0.696	2E-21	20.69897000433602		1.25	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	6p21.32	6	32608701	HLA-DR-DQ	HLA-DRB1 - HLA-DQA1	ENSG00000206240	ENSG00000196735		18853	19478	rs9271100-T	rs9271100	0	9271100	intron_variant	1	0.217	8E-95	94.09691001300806		1.68	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	6q24.3	6	146576497	RAB32	RAB32 - ADGB	ENSG00000118508	ENSG00000118492		21544	22470	rs13220141-A	rs13220141	0	13220141	intergenic_variant	1	.209	1E-22	22.0		1.27	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	8q21.3	8	89650713	RIPK2							rs160451-C	rs160451	0	160451	intron_variant	1	0.77	1E-21	21.0		1.2820514	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	9q32	9	114802595	TNFSF15	TNFSF15			ENSG00000181634			rs4366152-A	rs4366152	0	4366152	intron_variant	0	0.483	9E-42	41.045757490560675		1.3333333	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	13q14.11	13	43900381	LACC1	LACC1 - NRAD1	ENSG00000179630	ENSG00000233725		6449	8288	rs8002861-A	rs8002861	0	8002861	intron_variant	1	0.67	7E-6	5.154901959985743		1.1111112	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	16q12.1	16	50680424	NOD2	SNX20			ENSG00000167208			rs2270368-G	rs2270368	0	2270368	intron_variant	0	0.304	1E-67	67.0		1.5	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	16q12.1	16	50747891	NOD2, CYLD	CYLD			ENSG00000083799			rs8060598-C	rs8060598	0	8060598	intron_variant	0	0.167	5E-6	5.301029995663981		1.14	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	1q32.3	1	212700089	BATF3	BATF3 - NSL1	ENSG00000123685	ENSG00000117697		249	26064	rs2221593-T	rs2221593	0	2221593	regulatory_region_variant	1	0.203	3E-8	7.522878745280337		1.15	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	5p14.3	5	20374104	intergenic	CDH18			ENSG00000145526			rs73058713-A	rs73058713	0	73058713	intron_variant	0	0.146	1E-8	8.0		1.19	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	9q33.1	9	115381654	DEC1	DELEC1			ENSG00000173077			rs10817758-T	rs10817758	0	10817758	intron_variant	0	0.367	1E-8	8.0		1.13	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	10q21.2	10	62748144	intergenic	ALDH7A1P4 - ADO	ENSG00000234489	ENSG00000181915		6759	56576	rs58600253-T	rs58600253	0	58600253	intron_variant	1	0.120	3E-12	11.522878745280337		1.22	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	11q13.1	11	64340263	CCDC88B	CCDC88B			ENSG00000168071			rs663743-A	rs663743	0	663743	5_prime_UTR_variant	0	0.156	9E-14	13.045757490560675		1.24	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	16p13.13	16	11358685	LOC388210	RMI2			ENSG00000175643			rs77061563-C	rs77061563	0	77061563	intron_variant	0	0.617	6E-15	14.221848749616356		1.1904762	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	16q24.1	16	85802650	COX4I1	COX4I1			ENSG00000131143			rs2733954-C	rs2733954	0	2733954	intron_variant	0	0.721	4E-7	6.3979400086720375		1.14	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	19q13.41	19	51624491	SIGLEC5	SIGLEC5, SIGLEC5			ENSG00000105501, ENSG00000268500			rs10414149-A	rs10414149	0	10414149	intron_variant	0	0.835	3E-9	8.522878745280337		1.2048193	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	8q21.3	8	89792100	RIPK2	RIPK2 - COX6B1P6	ENSG00000104312	ENSG00000253349		1036	31448	rs383592-G	rs383592	0	383592	regulatory_region_variant	1	0.584	2E-35	34.69897000433602		1.32	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	12q12	12	40031285	LRRK2	SLC2A13			ENSG00000151229			rs11174812-A	rs11174812	0	11174812	intron_variant	0	0.746	2E-7	6.698970004336019		1.14	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	13q14.11	13	43897741	LACC1	LACC1 - NRAD1	ENSG00000179630	ENSG00000233725		3809	10928	rs9567307-T	rs9567307	0	9567307	intron_variant	1	0.314	1E-93	93.0		1.58	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2015-05-18	25642632	Liu H	2015-02-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25642632	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	Leprosy	1,548 Chinese ancestry cases, 2,150 Chinese ancestry controls, 4,362 Chinese ancestry controls with immune-related diseases	6,765 Chinese ancestry cases, 9,505 Chinese ancestry controls	16q12.1	16	50820507	NOD2, CYLD	LINC02168 - LINC02128	ENSG00000261703	ENSG00000261241		12878	19510	rs16948876-A	rs16948876	0	16948876	intergenic_variant	1	0.041	4E-11	10.397940008672037		1.39	[NR]	Illumina [4577171] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST002772	Genome-wide genotyping array
2017-05-11	27976721	Wang Z	2016-12-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27976721	A large-scale genome-wide association and meta-analysis identified four novel susceptibility loci for leprosy.	Leprosy	2,743 Chinese ancestry cases, 3,573 Chinese ancestry controls	5,413 Han Chinese ancestry cases, 12,037 Han Chinese ancestry controls	8q24.11	8	117614040	MED30	MED30 - NA	ENSG00000164758			73778		rs10100465-G	rs10100465	0	10100465	regulatory_region_variant	1	0.71	3E-11	10.522878745280337		1.1764705		Illumina [5546030] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST004009	Genome-wide genotyping array
2017-05-11	27976721	Wang Z	2016-12-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27976721	A large-scale genome-wide association and meta-analysis identified four novel susceptibility loci for leprosy.	Leprosy	2,743 Chinese ancestry cases, 3,573 Chinese ancestry controls	5,413 Han Chinese ancestry cases, 12,037 Han Chinese ancestry controls	7p14.3	7	33429629	BBS9	BBS9			ENSG00000122507			rs4720118-T	rs4720118	0	4720118	intron_variant	0	0.31	4E-10	9.397940008672037		1.16		Illumina [5546030] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST004009	Genome-wide genotyping array
2017-05-11	27976721	Wang Z	2016-12-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27976721	A large-scale genome-wide association and meta-analysis identified four novel susceptibility loci for leprosy.	Leprosy	2,743 Chinese ancestry cases, 3,573 Chinese ancestry controls	5,413 Han Chinese ancestry cases, 12,037 Han Chinese ancestry controls	8p23.1	8	11891733	CTSB	CTSB - OR7E158P	ENSG00000164733	ENSG00000254948		22200	28167	rs55894533-C	rs55894533	0	55894533	intergenic_variant	1	0.43	5E-11	10.301029995663981		1.15		Illumina [5546030] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST004009	Genome-wide genotyping array
2017-05-11	27976721	Wang Z	2016-12-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27976721	A large-scale genome-wide association and meta-analysis identified four novel susceptibility loci for leprosy.	Leprosy	2,743 Chinese ancestry cases, 3,573 Chinese ancestry controls	5,413 Han Chinese ancestry cases, 12,037 Han Chinese ancestry controls	3p25.2	3	12272347	SYN2	GSTM5P1 - PPARG	ENSG00000236062	ENSG00000132170		13887	15021	rs6807915-T	rs6807915	0	6807915	intergenic_variant	1	0.5	2E-8	7.698970004336019		1.1235955		Illumina [5546030] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST004009	Genome-wide genotyping array
2017-05-11	27976721	Wang Z	2016-12-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27976721	A large-scale genome-wide association and meta-analysis identified four novel susceptibility loci for leprosy.	Leprosy	2,743 Chinese ancestry cases, 3,573 Chinese ancestry controls	5,413 Han Chinese ancestry cases, 12,037 Han Chinese ancestry controls	4q34.3	4	180303682	intergenic							rs72715458-G	rs72715458	0	72715458	intergenic_variant	1	0.84	3E-7	6.522878745280337		1.1764705		Illumina [5546030] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST004009	Genome-wide genotyping array
2017-05-11	27976721	Wang Z	2016-12-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27976721	A large-scale genome-wide association and meta-analysis identified four novel susceptibility loci for leprosy.	Leprosy	2,743 Chinese ancestry cases, 3,573 Chinese ancestry controls	5,413 Han Chinese ancestry cases, 12,037 Han Chinese ancestry controls	16p12.1	16	27395368	IL4R, IL21R	IL4R - IL21R	ENSG00000077238	ENSG00000103522		30590	6806	rs34411505-A	rs34411505	0	34411505	intergenic_variant	1	0.84	6E-7	6.221848749616356		1.1627907		Illumina [5546030] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST004009	Genome-wide genotyping array
2017-05-11	27976721	Wang Z	2016-12-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27976721	A large-scale genome-wide association and meta-analysis identified four novel susceptibility loci for leprosy.	Leprosy	2,743 Chinese ancestry cases, 3,573 Chinese ancestry controls	5,413 Han Chinese ancestry cases, 12,037 Han Chinese ancestry controls	1p13.2	1	113542523	NR	MAGI3			ENSG00000081026			rs17508449-C	rs17508449	0	17508449	intron_variant	0	NR	5E-6	5.301029995663981		1.1389521		Illumina [5546030] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST004009	Genome-wide genotyping array
2017-05-11	27976721	Wang Z	2016-12-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27976721	A large-scale genome-wide association and meta-analysis identified four novel susceptibility loci for leprosy.	Leprosy	2,743 Chinese ancestry cases, 3,573 Chinese ancestry controls	5,413 Han Chinese ancestry cases, 12,037 Han Chinese ancestry controls	6q24.2	6	144068802	NR	PLAGL1 - SF3B5	ENSG00000118495	ENSG00000169976		4203	26082	rs76996465-T	rs76996465	0	76996465	intergenic_variant	1	NR	2E-6	5.698970004336019		1.165		Illumina [5546030] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST004009	Genome-wide genotyping array
2017-05-11	27976721	Wang Z	2016-12-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27976721	A large-scale genome-wide association and meta-analysis identified four novel susceptibility loci for leprosy.	Leprosy	2,743 Chinese ancestry cases, 3,573 Chinese ancestry controls	5,413 Han Chinese ancestry cases, 12,037 Han Chinese ancestry controls				HLA-DQ, HLA-DR							HLA-DR-DQ-?	HLA-DR-DQ	0			1	NR	5E-8	7.301029995663981				Illumina [5546030] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST004009	Genome-wide genotyping array
2017-05-11	27976721	Wang Z	2016-12-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27976721	A large-scale genome-wide association and meta-analysis identified four novel susceptibility loci for leprosy.	Leprosy	2,743 Chinese ancestry cases, 3,573 Chinese ancestry controls	5,413 Han Chinese ancestry cases, 12,037 Han Chinese ancestry controls				RAB32							RAB32-?	RAB32	0			1	NR	5E-8	7.301029995663981				Illumina [5546030] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST004009	Genome-wide genotyping array
2017-05-11	27976721	Wang Z	2016-12-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27976721	A large-scale genome-wide association and meta-analysis identified four novel susceptibility loci for leprosy.	Leprosy	2,743 Chinese ancestry cases, 3,573 Chinese ancestry controls	5,413 Han Chinese ancestry cases, 12,037 Han Chinese ancestry controls				RIPK2							RIPK2-?	RIPK2	0			1	NR	5E-8	7.301029995663981				Illumina [5546030] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST004009	Genome-wide genotyping array
2017-05-11	27976721	Wang Z	2016-12-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27976721	A large-scale genome-wide association and meta-analysis identified four novel susceptibility loci for leprosy.	Leprosy	2,743 Chinese ancestry cases, 3,573 Chinese ancestry controls	5,413 Han Chinese ancestry cases, 12,037 Han Chinese ancestry controls				LACC1							LACC1-?	LACC1	0			1	NR	5E-8	7.301029995663981				Illumina [5546030] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST004009	Genome-wide genotyping array
2017-05-11	27976721	Wang Z	2016-12-15	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27976721	A large-scale genome-wide association and meta-analysis identified four novel susceptibility loci for leprosy.	Leprosy	2,743 Chinese ancestry cases, 3,573 Chinese ancestry controls	5,413 Han Chinese ancestry cases, 12,037 Han Chinese ancestry controls				NOD2							NOD2-?	NOD2	0			1	NR	5E-8	7.301029995663981				Illumina [5546030] (imputed)	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST004009	Genome-wide genotyping array
2014-04-15	24162738	Hu Z	2013-10-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24162738	New loci associated with chronic hepatitis B virus infection in Han Chinese.	Hepatitis B	951 Han Chinese ancestry HBV carrier cases, 937 Han Chinese ancestry HBV cleared controls	4,230 Chinese ancestry HBV carrier cases, 3,051 Chinese ancestry HBV cleared controls, 2,622 Chinese ancestry controls	6p21.32	6	32762235	HLA-DQB2	HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2			ENSG00000232629, ENSG00000224305, ENSG00000228813, ENSG00000196610, ENSG00000229493, ENSG00000228254, ENSG00000226165			rs7453920-G	rs7453920	0	7453920	intron_variant	0	0.87	5E-37	36.30102999566398		1.8868	[1.69-2.08]	Illumina [490610]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST002246	Genome-wide genotyping array
2014-04-15	24162738	Hu Z	2013-10-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24162738	New loci associated with chronic hepatitis B virus infection in Han Chinese.	Hepatitis B	951 Han Chinese ancestry HBV carrier cases, 937 Han Chinese ancestry HBV cleared controls	4,230 Chinese ancestry HBV carrier cases, 3,051 Chinese ancestry HBV cleared controls, 2,622 Chinese ancestry controls	6p21.33	6	31264334	HLA-C	HCG27 - HLA-C	ENSG00000220890	ENSG00000228299		60366	4415	rs3130542-A	rs3130542	0	3130542	intergenic_variant	1	0.13	9E-14	13.045757490560675		1.33	[1.23-1.44]	Illumina [490610]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST002246	Genome-wide genotyping array
2014-04-15	24162738	Hu Z	2013-10-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24162738	New loci associated with chronic hepatitis B virus infection in Han Chinese.	Hepatitis B	951 Han Chinese ancestry HBV carrier cases, 937 Han Chinese ancestry HBV cleared controls	4,230 Chinese ancestry HBV carrier cases, 3,051 Chinese ancestry HBV cleared controls, 2,622 Chinese ancestry controls	22q11.21	22	21619030	UBE2L3	UBE2L3			ENSG00000185651			rs4821116-G	rs4821116	0	4821116	intron_variant	0	0.59	2E-12	11.698970004336019		1.2195	[1.15-1.3]	Illumina [490610]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST002246	Genome-wide genotyping array
2021-08-13	33669428	Franco LAM	2021-02-16	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/33669428	Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole.	Adverse response to benznidazole in Chagas disease	61 Hispanic/Latino or unknown ancestry cases, 29 Hispanic/Latino or unknown ancestry controls	NA	4p13	4	42719234	NR	ATP8A1 - NA	ENSG00000124406			62129		rs2612528-T	rs2612528	0	2612528	regulatory_region_variant	1	NR	1E-6	6.0				Affymetrix [at least 811691] (imputed)	N	response to benznidazole	http://www.ebi.ac.uk/efo/EFO_0600031	GCST012184	Genome-wide genotyping array
2021-08-13	33669428	Franco LAM	2021-02-16	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/33669428	Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole.	Adverse response to benznidazole in Chagas disease	61 Hispanic/Latino or unknown ancestry cases, 29 Hispanic/Latino or unknown ancestry controls	NA	4q32.3	4	164607280	NR	NA - RNU6-284P		ENSG00000223037			13452	rs6819334-C	rs6819334	0	6819334	intergenic_variant	1	NR	3E-7	6.522878745280337				Affymetrix [at least 811691] (imputed)	N	response to benznidazole	http://www.ebi.ac.uk/efo/EFO_0600031	GCST012184	Genome-wide genotyping array
2021-08-13	33669428	Franco LAM	2021-02-16	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/33669428	Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole.	Adverse response to benznidazole in Chagas disease	61 Hispanic/Latino or unknown ancestry cases, 29 Hispanic/Latino or unknown ancestry controls	NA	5q33.2	5	154498162	NR	HAND1 - CIR1P1	ENSG00000113196	ENSG00000253146		19935	61146	rs2619732-G	rs2619732	0	2619732	regulatory_region_variant	1	NR	1E-6	6.0				Affymetrix [at least 811691] (imputed)	N	response to benznidazole	http://www.ebi.ac.uk/efo/EFO_0600031	GCST012184	Genome-wide genotyping array
2021-08-13	33669428	Franco LAM	2021-02-16	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/33669428	Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole.	Adverse response to benznidazole in Chagas disease	61 Hispanic/Latino or unknown ancestry cases, 29 Hispanic/Latino or unknown ancestry controls	NA	7q35	7	144626876	NR	TPK1			ENSG00000196511			rs6464597-C	rs6464597	0	6464597	intron_variant	0	NR	2E-6	5.698970004336019				Affymetrix [at least 811691] (imputed)	N	response to benznidazole	http://www.ebi.ac.uk/efo/EFO_0600031	GCST012184	Genome-wide genotyping array
2021-08-13	33669428	Franco LAM	2021-02-16	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/33669428	Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole.	Adverse response to benznidazole in Chagas disease	61 Hispanic/Latino or unknown ancestry cases, 29 Hispanic/Latino or unknown ancestry controls	NA	11q14.3	11	92148887	NR	NA - RPL7AP57		ENSG00000242248			12219	rs1496707-G	rs1496707	0	1496707	intergenic_variant	1	NR	2E-6	5.698970004336019				Affymetrix [at least 811691] (imputed)	N	response to benznidazole	http://www.ebi.ac.uk/efo/EFO_0600031	GCST012184	Genome-wide genotyping array
2021-08-13	33669428	Franco LAM	2021-02-16	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/33669428	Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole.	Adverse response to benznidazole in Chagas disease	61 Hispanic/Latino or unknown ancestry cases, 29 Hispanic/Latino or unknown ancestry controls	NA	12p13.2	12	11764463	NR	ETV6			ENSG00000139083			rs7963499-T	rs7963499	0	7963499	intron_variant	0	NR	9E-7	6.045757490560675				Affymetrix [at least 811691] (imputed)	N	response to benznidazole	http://www.ebi.ac.uk/efo/EFO_0600031	GCST012184	Genome-wide genotyping array
2021-08-13	33669428	Franco LAM	2021-02-16	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/33669428	Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole.	Adverse response to benznidazole in Chagas disease	61 Hispanic/Latino or unknown ancestry cases, 29 Hispanic/Latino or unknown ancestry controls	NA	15q12	15	27627089	NR	GABRG3 - NA	ENSG00000182256			85105		rs3097435-T	rs3097435	0	3097435	intron_variant	1	NR	7E-7	6.154901959985743				Affymetrix [at least 811691] (imputed)	N	response to benznidazole	http://www.ebi.ac.uk/efo/EFO_0600031	GCST012184	Genome-wide genotyping array
2021-08-13	33669428	Franco LAM	2021-02-16	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/33669428	Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole.	Adverse response to benznidazole in Chagas disease	61 Hispanic/Latino or unknown ancestry cases, 29 Hispanic/Latino or unknown ancestry controls	NA	16q23.2	16	80255066	NR							rs11861761-A	rs11861761	0	11861761	intron_variant	1	NR	6E-8	7.221848749616356				Affymetrix [at least 811691] (imputed)	N	response to benznidazole	http://www.ebi.ac.uk/efo/EFO_0600031	GCST012184	Genome-wide genotyping array
2021-08-13	33669428	Franco LAM	2021-02-16	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/33669428	Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole.	Adverse response to benznidazole in Chagas disease	61 Hispanic/Latino or unknown ancestry cases, 29 Hispanic/Latino or unknown ancestry controls	NA	20q13.32	20	59086543	NR	PRELID3B - MRPS16P2	ENSG00000101166	ENSG00000232925		43734	26681	rs6026692-A	rs6026692	0	6026692	intergenic_variant	1	NR	7E-7	6.154901959985743				Affymetrix [at least 811691] (imputed)	N	response to benznidazole	http://www.ebi.ac.uk/efo/EFO_0600031	GCST012184	Genome-wide genotyping array
2021-08-13	33669428	Franco LAM	2021-02-16	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/33669428	Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole.	Adverse response to benznidazole in Chagas disease	61 Hispanic/Latino or unknown ancestry cases, 29 Hispanic/Latino or unknown ancestry controls	NA	2q32.3	2	195099712	NR							rs2569913-C	rs2569913	0	2569913	intergenic_variant	1	NR	1E-6	6.0				Affymetrix [at least 811691] (imputed)	N	response to benznidazole	http://www.ebi.ac.uk/efo/EFO_0600031	GCST012184	Genome-wide genotyping array
2021-08-13	33669428	Franco LAM	2021-02-16	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/33669428	Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole.	Adverse response to benznidazole in Chagas disease	61 Hispanic/Latino or unknown ancestry cases, 29 Hispanic/Latino or unknown ancestry controls	NA	2q36.3	2	228634991	NR	LINC01807			ENSG00000232023			rs7563279-G	rs7563279	0	7563279	intron_variant	0	NR	7E-7	6.154901959985743				Affymetrix [at least 811691] (imputed)	N	response to benznidazole	http://www.ebi.ac.uk/efo/EFO_0600031	GCST012184	Genome-wide genotyping array
2021-08-13	33669428	Franco LAM	2021-02-16	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/33669428	Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole.	Adverse response to benznidazole in Chagas disease	61 Hispanic/Latino or unknown ancestry cases, 29 Hispanic/Latino or unknown ancestry controls	NA	3p14.1	3	69134253	NR	LMOD3 - FRMD4B	ENSG00000163380	ENSG00000114541		11221	34529	rs3968927-T	rs3968927	0	3968927	intergenic_variant	1	NR	3E-7	6.522878745280337				Affymetrix [at least 811691] (imputed)	N	response to benznidazole	http://www.ebi.ac.uk/efo/EFO_0600031	GCST012184	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Bacteremia	1,536 African ancestry cases, 2,677 African ancestry controls	434 African ancestry cases, 1,336 African ancestry controls	1p13.2	1	113623939	MAGI3	MAGI3			ENSG00000081026			rs6669008-?	rs6669008	0	6669008	intron_variant	0	NR	5E-6	5.301029995663981		1.32	[NR]	Affymetrix [up to 10996499] (imputed)	N	bacteriemia	http://www.ebi.ac.uk/efo/EFO_0003033	GCST003650	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Bacteremia	1,536 African ancestry cases, 2,677 African ancestry controls	434 African ancestry cases, 1,336 African ancestry controls	2q22.1	2	139166548	intergenic							rs6716368-?	rs6716368	0	6716368	intergenic_variant	1	NR	9E-6	5.045757490560675		1.26	[NR]	Affymetrix [up to 10996499] (imputed)	N	bacteriemia	http://www.ebi.ac.uk/efo/EFO_0003033	GCST003650	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Bacteremia	1,536 African ancestry cases, 2,677 African ancestry controls	434 African ancestry cases, 1,336 African ancestry controls				DOCK3							rs9869826-?	rs9869826	0	9869826	intron_variant	1	NR	4E-6	5.3979400086720375		1.2658228	[NR]	Affymetrix [up to 10996499] (imputed)	N	bacteriemia	http://www.ebi.ac.uk/efo/EFO_0003033	GCST003650	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Bacteremia	1,536 African ancestry cases, 2,677 African ancestry controls	434 African ancestry cases, 1,336 African ancestry controls	3p14.2	3	62153280	PTPRG	PTPRG			ENSG00000144724			rs7633054-?	rs7633054	0	7633054	intron_variant	0	NR	1E-7	7.0		1.36	[NR]	Affymetrix [up to 10996499] (imputed)	N	bacteriemia	http://www.ebi.ac.uk/efo/EFO_0003033	GCST003650	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Bacteremia	1,536 African ancestry cases, 2,677 African ancestry controls	434 African ancestry cases, 1,336 African ancestry controls	4q13.3	4	69460938	UGT2B4	UGT2B24P - UGT2B4	ENSG00000249956	ENSG00000156096		37774	19227	rs4694744-?	rs4694744	0	4694744	intergenic_variant	1	NR	7E-7	6.154901959985743		1.5873016	[NR]	Affymetrix [up to 10996499] (imputed)	N	bacteriemia	http://www.ebi.ac.uk/efo/EFO_0003033	GCST003650	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Bacteremia	1,536 African ancestry cases, 2,677 African ancestry controls	434 African ancestry cases, 1,336 African ancestry controls	4q32.3	4	168747226	PALLD	PALLD			ENSG00000129116			rs1500801-?	rs1500801	0	1500801	intron_variant	0	NR	4E-6	5.3979400086720375		1.64	[NR]	Affymetrix [up to 10996499] (imputed)	N	bacteriemia	http://www.ebi.ac.uk/efo/EFO_0003033	GCST003650	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Bacteremia	1,536 African ancestry cases, 2,677 African ancestry controls	434 African ancestry cases, 1,336 African ancestry controls	5p15.2	5	9902717	LOC285692	LINC02112			ENSG00000249781			rs11959975-?	rs11959975	0	11959975	non_coding_transcript_exon_variant	0	NR	5E-6	5.301029995663981		1.27	[NR]	Affymetrix [up to 10996499] (imputed)	N	bacteriemia	http://www.ebi.ac.uk/efo/EFO_0003033	GCST003650	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Bacteremia	1,536 African ancestry cases, 2,677 African ancestry controls	434 African ancestry cases, 1,336 African ancestry controls	5q32	5	146008617	SH3RF2	SH3RF2			ENSG00000156463			rs7725038-?	rs7725038	0	7725038	intron_variant	0	NR	4E-6	5.3979400086720375		1.3	[NR]	Affymetrix [up to 10996499] (imputed)	N	bacteriemia	http://www.ebi.ac.uk/efo/EFO_0003033	GCST003650	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Bacteremia	1,536 African ancestry cases, 2,677 African ancestry controls	434 African ancestry cases, 1,336 African ancestry controls	11p15.5	11	2358904	intergenic	CD81-AS1			ENSG00000238184			rs800160-?	rs800160	0	800160	intron_variant	0	NR	2E-6	5.698970004336019		1.24	[NR]	Affymetrix [up to 10996499] (imputed)	N	bacteriemia	http://www.ebi.ac.uk/efo/EFO_0003033	GCST003650	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Bacteremia	1,536 African ancestry cases, 2,677 African ancestry controls	434 African ancestry cases, 1,336 African ancestry controls	11p15.4	11	9608006	intergenic	RPL23AP65 - SWAP70	ENSG00000243964	ENSG00000133789		1397	56071	rs10840270-?	rs10840270	0	10840270	intergenic_variant	1	NR	2E-6	5.698970004336019		1.25	[NR]	Affymetrix [up to 10996499] (imputed)	N	bacteriemia	http://www.ebi.ac.uk/efo/EFO_0003033	GCST003650	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Bacteremia	1,536 African ancestry cases, 2,677 African ancestry controls	434 African ancestry cases, 1,336 African ancestry controls	12q12	12	40153577	intergenic	LINC02555 - LINC02471	ENSG00000260943	ENSG00000223914		10701	2536	rs9652020-?	rs9652020	0	9652020	regulatory_region_variant	1	NR	8E-6	5.096910013008056		1.2658228	[NR]	Affymetrix [up to 10996499] (imputed)	N	bacteriemia	http://www.ebi.ac.uk/efo/EFO_0003033	GCST003650	Genome-wide genotyping array
2017-02-24	27236921	Rautanen A	2016-06-02	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27236921	Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.	Bacteremia	1,536 African ancestry cases, 2,677 African ancestry controls	434 African ancestry cases, 1,336 African ancestry controls	18q22.3	18	71995346	intergenic							rs7240462-?	rs7240462	0	7240462	intergenic_variant	1	NR	8E-6	5.096910013008056		1.1904762	[NR]	Affymetrix [up to 10996499] (imputed)	N	bacteriemia	http://www.ebi.ac.uk/efo/EFO_0003033	GCST003650	Genome-wide genotyping array
2019-02-13	30298529	Stanaway IB	2018-10-08	Genet Epidemiol	www.ncbi.nlm.nih.gov/pubmed/30298529	The eMERGE genotype set of 83,717 subjects imputed to ~40million variants genome wide and association with the herpes zoster medical record phenotype.	Shingles	3,201 European ancestry cases, 34,960 European ancestry controls, 398 African American cases, 5,922 African American controls, 756 Asian ancestry individuals	NA	3q29	3	193028537	TFBS							rs9810195-A	rs9810195	0	9810195	regulatory_region_variant	1	0.13	3E-9	8.522878745280337		1.26	NR	Affymetrix, Illumina [39127678] (imputed)	N	Herpes Zoster	http://www.ebi.ac.uk/efo/EFO_0006510	GCST007139	Genome-wide genotyping array
2019-02-13	30298529	Stanaway IB	2018-10-08	Genet Epidemiol	www.ncbi.nlm.nih.gov/pubmed/30298529	The eMERGE genotype set of 83,717 subjects imputed to ~40million variants genome wide and association with the herpes zoster medical record phenotype.	Shingles	3,201 European ancestry cases, 34,960 European ancestry controls, 398 African American cases, 5,922 African American controls, 756 Asian ancestry individuals	NA	8q12.1	8	58095231	FAM110B	FAM110B			ENSG00000169122			rs541558502-A	rs541558502	0	541558502	intron_variant	0	0.0004	1E-8	8.0		9.754	NR	Affymetrix, Illumina [39127678] (imputed)	N	Herpes Zoster	http://www.ebi.ac.uk/efo/EFO_0006510	GCST007139	Genome-wide genotyping array
2019-02-13	30298529	Stanaway IB	2018-10-08	Genet Epidemiol	www.ncbi.nlm.nih.gov/pubmed/30298529	The eMERGE genotype set of 83,717 subjects imputed to ~40million variants genome wide and association with the herpes zoster medical record phenotype.	Shingles	3,201 European ancestry cases, 34,960 European ancestry controls, 398 African American cases, 5,922 African American controls, 756 Asian ancestry individuals	NA	11q13.5	11	76667642	LRRC32	LRRC32			ENSG00000137507			rs147482218-G	rs147482218	0	147482218	intron_variant	0	0.002	2E-9	8.698970004336019		3.487	NR	Affymetrix, Illumina [39127678] (imputed)	N	Herpes Zoster	http://www.ebi.ac.uk/efo/EFO_0006510	GCST007139	Genome-wide genotyping array
2019-02-13	30298529	Stanaway IB	2018-10-08	Genet Epidemiol	www.ncbi.nlm.nih.gov/pubmed/30298529	The eMERGE genotype set of 83,717 subjects imputed to ~40million variants genome wide and association with the herpes zoster medical record phenotype.	Shingles	3,201 European ancestry cases, 34,960 European ancestry controls, 398 African American cases, 5,922 African American controls, 756 Asian ancestry individuals	NA	12q21.33	12	90550058	intergenic	NA - LINC02822		ENSG00000286021			26344	rs537841689-T	rs537841689	0	537841689	intergenic_variant	1	0.0004	2E-8	7.698970004336019		7.954	NR	Affymetrix, Illumina [39127678] (imputed)	N	Herpes Zoster	http://www.ebi.ac.uk/efo/EFO_0006510	GCST007139	Genome-wide genotyping array
2019-02-13	30298529	Stanaway IB	2018-10-08	Genet Epidemiol	www.ncbi.nlm.nih.gov/pubmed/30298529	The eMERGE genotype set of 83,717 subjects imputed to ~40million variants genome wide and association with the herpes zoster medical record phenotype.	Shingles	3,201 European ancestry cases, 34,960 European ancestry controls, 398 African American cases, 5,922 African American controls, 756 Asian ancestry individuals	NA	16p12.3	16	18993889	TMC7	TMC7			ENSG00000170537			rs144721899-G	rs144721899	0	144721899	intron_variant	0	0.001	6E-9	8.221848749616356		4.652	NR	Affymetrix, Illumina [39127678] (imputed)	N	Herpes Zoster	http://www.ebi.ac.uk/efo/EFO_0006510	GCST007139	Genome-wide genotyping array
2019-02-13	30298529	Stanaway IB	2018-10-08	Genet Epidemiol	www.ncbi.nlm.nih.gov/pubmed/30298529	The eMERGE genotype set of 83,717 subjects imputed to ~40million variants genome wide and association with the herpes zoster medical record phenotype.	Shingles	3,201 European ancestry cases, 34,960 European ancestry controls, 398 African American cases, 5,922 African American controls, 756 Asian ancestry individuals	NA	6p21.33	6	31465789	HCP5	HCP5			ENSG00000206337			rs75640364-G	rs75640364	0	75640364	non_coding_transcript_exon_variant	0	0.91	8E-9	8.096910013008056	(EA)	1.36	NR	Affymetrix, Illumina [39127678] (imputed)	N	Herpes Zoster	http://www.ebi.ac.uk/efo/EFO_0006510	GCST007139	Genome-wide genotyping array
2019-02-13	30298529	Stanaway IB	2018-10-08	Genet Epidemiol	www.ncbi.nlm.nih.gov/pubmed/30298529	The eMERGE genotype set of 83,717 subjects imputed to ~40million variants genome wide and association with the herpes zoster medical record phenotype.	Shingles	3,201 European ancestry cases, 34,960 European ancestry controls, 398 African American cases, 5,922 African American controls, 756 Asian ancestry individuals	NA	6p21.33	6	31354618	HLAB	HLA-B			ENSG00000232126			rs17199328-G	rs17199328	0	17199328	non_coding_transcript_exon_variant	0	0.88	2E-10	9.698970004336019		1.3	NR	Affymetrix, Illumina [39127678] (imputed)	N	Herpes Zoster	http://www.ebi.ac.uk/efo/EFO_0006510	GCST007139	Genome-wide genotyping array
2019-02-13	30298529	Stanaway IB	2018-10-08	Genet Epidemiol	www.ncbi.nlm.nih.gov/pubmed/30298529	The eMERGE genotype set of 83,717 subjects imputed to ~40million variants genome wide and association with the herpes zoster medical record phenotype.	Shingles	3,201 European ancestry cases, 34,960 European ancestry controls, 398 African American cases, 5,922 African American controls, 756 Asian ancestry individuals	NA				intergenic							rs2574974-T	rs2574974	0	2574974		1	0.017	4E-18	17.397940008672037		2.061	NR	Affymetrix, Illumina [39127678] (imputed)	N	Herpes Zoster	http://www.ebi.ac.uk/efo/EFO_0006510	GCST007139	Genome-wide genotyping array
2019-02-13	30298529	Stanaway IB	2018-10-08	Genet Epidemiol	www.ncbi.nlm.nih.gov/pubmed/30298529	The eMERGE genotype set of 83,717 subjects imputed to ~40million variants genome wide and association with the herpes zoster medical record phenotype.	Shingles	3,201 European ancestry cases, 34,960 European ancestry controls, 398 African American cases, 5,922 African American controls, 756 Asian ancestry individuals	NA	1p13.3	1	108070308	intergenic	LINC02785, LINC02785			ENSG00000226822, ENSG00000284338			rs142765674-G	rs142765674	0	142765674	intron_variant	0	0.004	1E-8	8.0		2.196	NR	Affymetrix, Illumina [39127678] (imputed)	N	Herpes Zoster	http://www.ebi.ac.uk/efo/EFO_0006510	GCST007139	Genome-wide genotyping array
2019-02-13	30298529	Stanaway IB	2018-10-08	Genet Epidemiol	www.ncbi.nlm.nih.gov/pubmed/30298529	The eMERGE genotype set of 83,717 subjects imputed to ~40million variants genome wide and association with the herpes zoster medical record phenotype.	Shingles	3,201 European ancestry cases, 34,960 European ancestry controls, 398 African American cases, 5,922 African American controls, 756 Asian ancestry individuals	NA	6q16.3	6	104245432	intergenic							rs765885335-G	rs765885335	0	765885335	intergenic_variant	1	0.0003	3E-8	7.522878745280337		10.15	NR	Affymetrix, Illumina [39127678] (imputed)	N	Herpes Zoster	http://www.ebi.ac.uk/efo/EFO_0006510	GCST007139	Genome-wide genotyping array
2019-02-13	30298529	Stanaway IB	2018-10-08	Genet Epidemiol	www.ncbi.nlm.nih.gov/pubmed/30298529	The eMERGE genotype set of 83,717 subjects imputed to ~40million variants genome wide and association with the herpes zoster medical record phenotype.	Shingles	3,201 European ancestry cases, 34,960 European ancestry controls, 398 African American cases, 5,922 African American controls, 756 Asian ancestry individuals	NA	6p21.33	6	31354618	HLA-B	HLA-B			ENSG00000232126			rs17199328-G	rs17199328	0	17199328	non_coding_transcript_exon_variant	0	0.86	9E-11	10.045757490560675	(EA)	1.32	NR	Affymetrix, Illumina [39127678] (imputed)	N	Herpes Zoster	http://www.ebi.ac.uk/efo/EFO_0006510	GCST007139	Genome-wide genotyping array
2015-06-11	25297839	Crosslin DR	2014-10-09	Genes Immun	www.ncbi.nlm.nih.gov/pubmed/25297839	Genetic variation in the HLA region is associated with susceptibility to herpes zoster.	Shingles	2,016 European ancestry cases, 16,407 European ancestry controls, 173 African ancestry cases, 3,312 African ancestry controls, 41 Hispanic cases, 580 Hispanic controls	NA	6p21.33	6	31461210	HCP5, HLA-B, DHFR	LINC01149 - HCP5	ENSG00000230174	ENSG00000206337		14237	1960	rs114864815-?	rs114864815	1	77349273	intron_variant	1	0.92	1E-6	6.0		1.37	[1.20-1.54]	NR [NR] (imputed)	N	Herpes Zoster	http://www.ebi.ac.uk/efo/EFO_0006510	GCST002654	Genome-wide genotyping array
2015-06-11	25297839	Crosslin DR	2014-10-09	Genes Immun	www.ncbi.nlm.nih.gov/pubmed/25297839	Genetic variation in the HLA region is associated with susceptibility to herpes zoster.	Shingles	2,016 European ancestry cases, 16,407 European ancestry controls, 173 African ancestry cases, 3,312 African ancestry controls, 41 Hispanic cases, 580 Hispanic controls	NA	6p21.33	6	31461210	HCP5, HLA-B, DHFR	LINC01149 - HCP5	ENSG00000230174	ENSG00000206337		14237	1960	rs114864815-?	rs114864815	1	77349273	intron_variant	1	0.91	4E-6	5.3979400086720375	(EA)	1.35	[1.19-1.54]	NR [NR] (imputed)	N	Herpes Zoster	http://www.ebi.ac.uk/efo/EFO_0006510	GCST002654	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment (herpes zoster)(time to event)	165 European ancestry rheumatoid arthritis cases, 56 East Asian ancestry rheumatoid arthritis cases, 23 Hispanic rheumatoid arthritis cases, 56 European ancestry psoriasis cases, 10 East Asian ancestry psoriasis cases, 4 Hispanic psoriasis cases, 3,566 European ancestry controls, 317 East Asian ancestry controls, 644 Hispanic controls	NA	3p21.1	3	54084687	IL17RB	CABYRP1 - CACNA2D3	ENSG00000242983	ENSG00000157445		35894	37860	rs58861611-?	rs58861611	0	58861611	intron_variant	1		8E-10	9.096910013008056		3.6	[2.40-5.44]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012082	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment (herpes zoster)(time to event)	165 European ancestry rheumatoid arthritis cases, 56 East Asian ancestry rheumatoid arthritis cases, 23 Hispanic rheumatoid arthritis cases, 56 European ancestry psoriasis cases, 10 East Asian ancestry psoriasis cases, 4 Hispanic psoriasis cases, 3,566 European ancestry controls, 317 East Asian ancestry controls, 644 Hispanic controls	NA	6p23	6	14292589	CD83	LINC01108 - NA	ENSG00000226673			7135		rs112817503-?	rs112817503	0	112817503	intergenic_variant	1		2E-10	9.698970004336019		3.6	[2.43-5.32]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012082	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment (herpes zoster)(time to event)	165 European ancestry rheumatoid arthritis cases, 56 East Asian ancestry rheumatoid arthritis cases, 23 Hispanic rheumatoid arthritis cases, 56 European ancestry psoriasis cases, 10 East Asian ancestry psoriasis cases, 4 Hispanic psoriasis cases, 3,566 European ancestry controls, 317 East Asian ancestry controls, 644 Hispanic controls	NA	7p14.1	7	37763129	GPR141	EPDR1, GPR141			ENSG00000086289, ENSG00000187037			rs56114331-?	rs56114331	0	56114331	intron_variant	0		6E-9	8.221848749616356		3.7	[2.37-5.73]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012082	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment (herpes zoster)(time to event)	165 European ancestry rheumatoid arthritis cases, 56 East Asian ancestry rheumatoid arthritis cases, 23 Hispanic rheumatoid arthritis cases, 56 European ancestry psoriasis cases, 10 East Asian ancestry psoriasis cases, 4 Hispanic psoriasis cases, 3,566 European ancestry controls, 317 East Asian ancestry controls, 644 Hispanic controls	NA	16q12.1	16	52471255	TOX3	TOX3			ENSG00000103460			rs79025327-?	rs79025327	0	79025327	intron_variant	0		6E-9	8.221848749616356		2.9	[2.04-4.22]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012082	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment (herpes zoster)(time to event)	165 European ancestry rheumatoid arthritis cases, 56 East Asian ancestry rheumatoid arthritis cases, 23 Hispanic rheumatoid arthritis cases, 56 European ancestry psoriasis cases, 10 East Asian ancestry psoriasis cases, 4 Hispanic psoriasis cases, 3,566 European ancestry controls, 317 East Asian ancestry controls, 644 Hispanic controls	NA	16q24.3	16	89145003	ACSF3	ACSF3			ENSG00000176715			rs142820005-?	rs142820005	0	142820005	intron_variant	0		2E-8	7.698970004336019		2.3	[1.72-3.09]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012082	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment (herpes zoster)	165 European ancestry rheumatoid arthritis cases, 56 East Asian ancestry rheumatoid arthritis cases, 23 Hispanic rheumatoid arthritis cases, 56 European ancestry psoriasis cases, 10 East Asian ancestry psoriasis cases, 4 Hispanic psoriasis cases, 3,566 European ancestry controls, 317 East Asian ancestry controls, 644 Hispanic controls	NA	3p21.1	3	54084687	IL17RB	CABYRP1 - CACNA2D3	ENSG00000242983	ENSG00000157445		35894	37860	rs58861611-?	rs58861611	0	58861611	intron_variant	1		3E-6	5.522878745280337		3.8	[2.17-6.67]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012081	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment (herpes zoster)	165 European ancestry rheumatoid arthritis cases, 56 East Asian ancestry rheumatoid arthritis cases, 23 Hispanic rheumatoid arthritis cases, 56 European ancestry psoriasis cases, 10 East Asian ancestry psoriasis cases, 4 Hispanic psoriasis cases, 3,566 European ancestry controls, 317 East Asian ancestry controls, 644 Hispanic controls	NA	6p23	6	14292589	CD83	LINC01108 - NA	ENSG00000226673			7135		rs112817503-?	rs112817503	0	112817503	intergenic_variant	1		2E-8	7.698970004336019		3.7	[2.35-5.87]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012081	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment (herpes zoster)	165 European ancestry rheumatoid arthritis cases, 56 East Asian ancestry rheumatoid arthritis cases, 23 Hispanic rheumatoid arthritis cases, 56 European ancestry psoriasis cases, 10 East Asian ancestry psoriasis cases, 4 Hispanic psoriasis cases, 3,566 European ancestry controls, 317 East Asian ancestry controls, 644 Hispanic controls	NA	7p14.1	7	37763129	GPR141	EPDR1, GPR141			ENSG00000086289, ENSG00000187037			rs56114331-?	rs56114331	0	56114331	intron_variant	0		2E-6	5.698970004336019		3.4	[2.05-5.49]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012081	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment (herpes zoster)	165 European ancestry rheumatoid arthritis cases, 56 East Asian ancestry rheumatoid arthritis cases, 23 Hispanic rheumatoid arthritis cases, 56 European ancestry psoriasis cases, 10 East Asian ancestry psoriasis cases, 4 Hispanic psoriasis cases, 3,566 European ancestry controls, 317 East Asian ancestry controls, 644 Hispanic controls	NA	16q12.1	16	52471255	TOX3	TOX3			ENSG00000103460			rs79025327-?	rs79025327	0	79025327	intron_variant	0		2E-7	6.698970004336019		3.8	[2.28-6.23]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012081	Genome-wide genotyping array
2021-07-27	33455090	Bing N	2021-01-17	Arthritis Rheumatol	www.ncbi.nlm.nih.gov/pubmed/33455090	Contribution of a European-Prevalent Variant near CD83 and an East Asian-Prevalent Variant near IL17RB to Herpes Zoster Risk in Tofacitinib Treatment: Results of Genome-Wide Association Study Meta-Analyses.	Response to tofacitinib treatment (herpes zoster)	165 European ancestry rheumatoid arthritis cases, 56 East Asian ancestry rheumatoid arthritis cases, 23 Hispanic rheumatoid arthritis cases, 56 European ancestry psoriasis cases, 10 East Asian ancestry psoriasis cases, 4 Hispanic psoriasis cases, 3,566 European ancestry controls, 317 East Asian ancestry controls, 644 Hispanic controls	NA	16q24.3	16	89145003	ACSF3	ACSF3			ENSG00000176715			rs142820005-?	rs142820005	0	142820005	intron_variant	0		3E-8	7.522878745280337		2.5	[1.81-3.45]	Illumina [up to 8000000] (imputed)	N	Herpes Zoster, response to tofacitinib	http://www.ebi.ac.uk/efo/EFO_0006510, http://www.ebi.ac.uk/efo/EFO_0600024	GCST012081	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Zoster infection	2,209 East Asian ancestry cases, 166,603 East Asian ancestry controls	NA	9p21.3	9	24761759		IZUMO3 - RMRPP5	ENSG00000205442	ENSG00000223088		215813	143710	rs117171752-G	rs117171752	0	117171752	intergenic_variant	1	0.007405229	5E-8	7.301029995663981		1.2265667	[0.79-1.67] unit increase	Illumina [13428120] (imputed)	N	Herpes Zoster	http://www.ebi.ac.uk/efo/EFO_0006510	GCST90018721	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Zoster infection	522 European ancestry cases, 351,740 European ancestry controls, 2,209 East Asian ancestry cases, 166,603 East Asian ancestry controls	NA	9p21.3	9	24761759		IZUMO3 - RMRPP5	ENSG00000205442	ENSG00000223088		215813	143710	rs117171752-G	rs117171752	0	117171752	intergenic_variant	1	NR	5E-8	7.301029995663981		1.2266	[0.79-1.67] unit increase	Affymetrix, Illumina [20457058] (imputed)	N	Herpes Zoster	http://www.ebi.ac.uk/efo/EFO_0006510	GCST90018941	Genome-wide genotyping array
2009-01-16	19115949	Limou S	2009-01-01	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/19115949	Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02).	AIDS progression	275 European ancestry seropositive non-progressors, 86 European ancestry seropositive rapid progressors, 1,352 European ancestry seronegative controls	(see Fellay 2007)	6p21.33	6	31306778	HLA-C	LINC02571 - HLA-B	ENSG00000256166	ENSG00000232126		5136	47094	rs10484554-T	rs10484554	0	10484554	intron_variant	1	0.13	6E-8	7.221848749616356				Illumina [291119]	N	AIDS	http://www.ebi.ac.uk/efo/EFO_0000765	GCST000308	Genome-wide genotyping array
2009-01-16	19115949	Limou S	2009-01-01	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/19115949	Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02).	AIDS progression	275 European ancestry seropositive non-progressors, 86 European ancestry seropositive rapid progressors, 1,352 European ancestry seronegative controls	(see Fellay 2007)	6p22.1	6	30064745	ZNRD1, RNF39	POLR1H, POLR1H, POLR1H, POLR1H, POLR1H, POLR1H, POLR1H			ENSG00000235176, ENSG00000206502, ENSG00000066379, ENSG00000224859, ENSG00000233795, ENSG00000236949, ENSG00000236808			rs8321-G	rs8321	0	8321	3_prime_UTR_variant	0	NR	5E-7	6.301029995663981				Illumina [291119]	N	AIDS	http://www.ebi.ac.uk/efo/EFO_0000765	GCST000308	Genome-wide genotyping array
2009-09-30	19749758	Suppiah V	2009-09-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19749758	IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.	Response to hepatitis C treatment	131 European ancestry responders, 162 European ancestry non-responders	261 European ancestry responders, 294 European ancestry non-responders	19q13.2	19	39252525	IL28A, IL28B	IFNL4 - MSRB1P1	ENSG00000272395	ENSG00000213926		3669	2391	rs8099917-G	rs8099917	0	8099917	intergenic_variant	1	NR	9E-9	8.045757490560675		1.98	[1.57-2.52]	Illumina [311159]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST000485	Genome-wide genotyping array
2010-01-21	20060832	Rauch A	2010-01-07	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/20060832	Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.	Chronic hepatitis C infection	1,015 European ancestry chronic HCV carriers, 347 European ancestry spontaneously cleared HCV individuals	NA	19q13.2	19	39252525	IL29, IL28B, IL28A	IFNL4 - MSRB1P1	ENSG00000272395	ENSG00000213926		3669	2391	rs8099917-G	rs8099917	0	8099917	intergenic_variant	1	0.24	6E-9	8.221848749616356		2.31	[1.74-3.06]	Illumina [~ 500000]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST000557	Genome-wide genotyping array
2009-09-30	19749757	Tanaka Y	2009-09-13	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19749757	Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.	Response to hepatitis C treatment	64 Japanese ancestry responders, 78 Japanese ancestry non-responders	122 Japanese ancestry responders, 50 Japanese ancestry non-responders	19q13.2	19	39252525	IL28B	IFNL4 - MSRB1P1	ENSG00000272395	ENSG00000213926		3669	2391	rs8099917-G	rs8099917	0	8099917	intergenic_variant	1	0.12	3E-32	31.522878745280337		27.1	[14.6-50.3]	Affymetrix [621220]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST000486	Genome-wide genotyping array
2013-06-06	23420232	Duggal P	2013-02-19	Ann Intern Med	www.ncbi.nlm.nih.gov/pubmed/23420232	Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.	Chronic hepatitis C infection	1,482 chronic HCV cases, 919 spontaneously cleared HCV cases	461 chronic HCV cases, 284 spontaneously cleared HCV cases	19q13.2	19	39248147	IL-28B	IFNL4			ENSG00000272395			rs12979860-?	rs12979860	0	12979860	intron_variant	0	NR	2E-30	29.69897000433602		2.2		Illumina [792721] (imputed)	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST001867	Genome-wide genotyping array
2013-06-06	23420232	Duggal P	2013-02-19	Ann Intern Med	www.ncbi.nlm.nih.gov/pubmed/23420232	Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.	Chronic hepatitis C infection	1,482 chronic HCV cases, 919 spontaneously cleared HCV cases	461 chronic HCV cases, 284 spontaneously cleared HCV cases	6p21.32	6	32710820	HLA	MTCO3P1 - HLA-DQB3	ENSG00000237145	ENSG00000224197		3865	19938	rs4273729-?	rs4273729	0	4273729	intergenic_variant	1	NR	5E-17	16.30102999566398		1.59		Illumina [792721] (imputed)	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST001867	Genome-wide genotyping array
2011-07-30	21703177	Thompson AJ	2011-05-20	J Hepatol	www.ncbi.nlm.nih.gov/pubmed/21703177	Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients.	IFN-related cytopenia	984 European ancestry with genotype 1 HCV cases, 201 African American genotype 1 HCV cases, 99 Hispanic genotype 1 HCV cases	NA	20p13	20	3400902	ITPA	C20orf194						rs965469-?	rs965469	0	965469	intron_variant	0	NR	1E-9	9.0	(IFN-related thrombocytopenia at wk 4)			Illumina [565759]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST001076	Genome-wide genotyping array
2014-08-01	24376798	Miki D	2013-12-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24376798	HLA-DQB1*03 confers susceptibility to chronic hepatitis C in Japanese: a genome-wide association study.	Chronic hepatitis C infection	481 Japanese ancestry cases, 2,963 Japanese ancestry controls	5,737 Japanese ancestry cases, 26,931 Japanese ancestry controls	6p21.32	6	32711222	HLA-DQB1, HLA-DQA1	MTCO3P1 - HLA-DQB3	ENSG00000237145	ENSG00000224197		4267	19536	rs9275572-T	rs9275572	0	9275572	intergenic_variant	1	0.359	4E-16	15.397940008672037		1.27	[1.19-1.33]	Illumina [458207]	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST002316	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Chronic hepatitis C infection	7,110 East Asian ancestry cases, 169,588 East Asian ancestry controls	NA											chr1:225536401-C	chr1:225536401	0			1	8.93931E-4	5E-8	7.301029995663981		1.9577609	[1.25-2.66] unit increase	Illumina [13429570] (imputed)	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST90018585	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Chronic hepatitis C infection	7,110 East Asian ancestry cases, 169,588 East Asian ancestry controls	NA	19q13.2	19	39243580		IFNL3			ENSG00000197110			rs4803217-A	rs4803217	0	4803217	3_prime_UTR_variant	0	0.105533202	1E-22	22.0		0.28809556	[0.23-0.35] unit increase	Illumina [13429570] (imputed)	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST90018585	Genome-wide genotyping array
2018-11-28	30287856	Zheng R	2018-10-04	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30287856	Genome-wide association study identifies two risk loci for tuberculosis in Han Chinese.	Tuberculosis	833 Han Chinese ancestry cases, 1,220 Han Chinese ancestry controls	2,116 Han Chinese ancestry cases, 3,870 Han Chinese ancestry controls	14q24.3	14	76517387	ESRRB	ESRRB - NA	ENSG00000119715			15550		rs12437118-A	rs12437118	0	12437118	intron_variant	1	0.261	2E-11	10.698970004336019		1.277	[1.189-1.371]	Affymetrix [5374021] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST006619	Genome-wide genotyping array
2018-11-28	30287856	Zheng R	2018-10-04	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30287856	Genome-wide association study identifies two risk loci for tuberculosis in Han Chinese.	Tuberculosis	833 Han Chinese ancestry cases, 1,220 Han Chinese ancestry controls	2,116 Han Chinese ancestry cases, 3,870 Han Chinese ancestry controls	20p13	20	2398952	TGM6	TGM6			ENSG00000166948			rs6114027-C	rs6114027	0	6114027	intron_variant	0	0.158	2E-11	10.698970004336019		1.339	[1.229-1.459]	Affymetrix [5374021] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST006619	Genome-wide genotyping array
2019-08-23	31434886	Luo Y	2019-08-21	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31434886	Early progression to active tuberculosis is a highly heritable trait driven by 3q23 in Peruvians.	Early progression to active pulmonary tuberculosis in Mycobacterium tuberculosis-infected individuals	2,160 Peruvian cases, 1,820 Peruvian controls	NA	3q23	3	141681811		LINC02618			ENSG00000242104			rs73226617-A	rs73226617	0	73226617	intron_variant	0	0.032	4E-8	7.3979400086720375		0.165	[0.11-0.22] unit increase	Affymetrix [7756401] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST008488	Genome-wide genotyping array
2010-09-16	20694014	Thye T	2010-08-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20694014	Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2.	Tuberculosis	2,237 Sub-Saharan African ancestry cases, 3,122 Sub-Saharan African ancestry controls	1,462 Sub-Saharan African ancestry cases, 4,604 Sub-Saharan African ancestry controls	8q21.3	8	89644760	NR							rs160441-T	rs160441	0	160441	intron_variant	1	0.41	8E-6	5.096910013008056		1.2	[1.10-1.30]	Affymetrix [> 333754] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST000764	Genome-wide genotyping array
2010-09-16	20694014	Thye T	2010-08-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20694014	Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2.	Tuberculosis	2,237 Sub-Saharan African ancestry cases, 3,122 Sub-Saharan African ancestry controls	1,462 Sub-Saharan African ancestry cases, 4,604 Sub-Saharan African ancestry controls	14q32.13	14	95560816	NR	GLRX5 - LINC02318	ENSG00000182512	ENSG00000258390		16092	12704	rs8005962-?	rs8005962	0	8005962	regulatory_region_variant	1	0.63	8E-6	5.096910013008056		1.2	[1.11-1.25]	Affymetrix [> 333754] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST000764	Genome-wide genotyping array
2010-09-16	20694014	Thye T	2010-08-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20694014	Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2.	Tuberculosis	2,237 Sub-Saharan African ancestry cases, 3,122 Sub-Saharan African ancestry controls	1,462 Sub-Saharan African ancestry cases, 4,604 Sub-Saharan African ancestry controls	4q24	4	104923116	NR	NA - RNU6-351P		ENSG00000251906			51556	rs10005603-?	rs10005603	0	10005603	intron_variant	1	0.65	7E-6	5.154901959985743		1.2	[1.11-1.25]	Affymetrix [> 333754] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST000764	Genome-wide genotyping array
2010-09-16	20694014	Thye T	2010-08-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20694014	Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2.	Tuberculosis	2,237 Sub-Saharan African ancestry cases, 3,122 Sub-Saharan African ancestry controls	1,462 Sub-Saharan African ancestry cases, 4,604 Sub-Saharan African ancestry controls	16q23.1	16	75957548	NR	RNA5SP430 - NA	ENSG00000199299			96391		rs1948632-?	rs1948632	0	1948632	intergenic_variant	1	0.04	8E-6	5.096910013008056		1.55	[1.30-1.90]	Affymetrix [> 333754] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST000764	Genome-wide genotyping array
2010-09-16	20694014	Thye T	2010-08-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20694014	Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2.	Tuberculosis	2,237 Sub-Saharan African ancestry cases, 3,122 Sub-Saharan African ancestry controls	1,462 Sub-Saharan African ancestry cases, 4,604 Sub-Saharan African ancestry controls	16q23.3	16	82783986	NR	CDH13			ENSG00000140945			rs12386026-?	rs12386026	0	12386026	intron_variant	0	0.04	2E-6	5.698970004336019		1.66	[1.30-2.00]	Affymetrix [> 333754] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST000764	Genome-wide genotyping array
2010-09-16	20694014	Thye T	2010-08-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20694014	Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2.	Tuberculosis	2,237 Sub-Saharan African ancestry cases, 3,122 Sub-Saharan African ancestry controls	1,462 Sub-Saharan African ancestry cases, 4,604 Sub-Saharan African ancestry controls	18q21.32	18	60441957	NR	MC4R - MRPS5P4	ENSG00000166603	ENSG00000266915		69182	77884	rs4257308-?	rs4257308	0	4257308	intron_variant	1	0.04	6E-6	5.221848749616356		1.55	[1.30-1.90]	Affymetrix [> 333754] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST000764	Genome-wide genotyping array
2010-09-16	20694014	Thye T	2010-08-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20694014	Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2.	Tuberculosis	2,237 Sub-Saharan African ancestry cases, 3,122 Sub-Saharan African ancestry controls	1,462 Sub-Saharan African ancestry cases, 4,604 Sub-Saharan African ancestry controls	19q13.31	19	44428797	NR	ZNF229			ENSG00000278318			rs1434579-?	rs1434579	0	1434579	stop_gained	0	0.06	4E-6	5.3979400086720375		1.46	[1.20-1.70]	Affymetrix [> 333754] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST000764	Genome-wide genotyping array
2010-09-16	20694014	Thye T	2010-08-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20694014	Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2.	Tuberculosis	2,237 Sub-Saharan African ancestry cases, 3,122 Sub-Saharan African ancestry controls	1,462 Sub-Saharan African ancestry cases, 4,604 Sub-Saharan African ancestry controls	2q33.3	2	205000109	intergenic	PARD3B			ENSG00000116117			rs2335704-C	rs2335704	0	2335704	intron_variant	0	0.20	2E-6	5.698970004336019		1.19	[1.10-1.30]	Affymetrix [> 333754] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST000764	Genome-wide genotyping array
2010-09-16	20694014	Thye T	2010-08-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20694014	Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2.	Tuberculosis	2,237 Sub-Saharan African ancestry cases, 3,122 Sub-Saharan African ancestry controls	1,462 Sub-Saharan African ancestry cases, 4,604 Sub-Saharan African ancestry controls	2p15	2	61545122	NR	XPO1 - RPS29P10	ENSG00000082898	ENSG00000226884		6381	44376	rs6545883-?	rs6545883	0	6545883	intergenic_variant	1	0.52	5E-6	5.301029995663981		1.2	[1.11-1.25]	Affymetrix [> 333754] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST000764	Genome-wide genotyping array
2010-09-16	20694014	Thye T	2010-08-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20694014	Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2.	Tuberculosis	2,237 Sub-Saharan African ancestry cases, 3,122 Sub-Saharan African ancestry controls	1,462 Sub-Saharan African ancestry cases, 4,604 Sub-Saharan African ancestry controls	6q24.3	6	147379997	NR	STXBP5			ENSG00000164506			rs9373523-?	rs9373523	0	9373523	intron_variant	0	0.81	1E-6	6.0		1.3	[1.11-1.43]	Affymetrix [> 333754] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST000764	Genome-wide genotyping array
2010-09-16	20694014	Thye T	2010-08-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20694014	Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2.	Tuberculosis	2,237 Sub-Saharan African ancestry cases, 3,122 Sub-Saharan African ancestry controls	1,462 Sub-Saharan African ancestry cases, 4,604 Sub-Saharan African ancestry controls	7q32.1	7	129383756	NR	AHCYL2			ENSG00000158467			rs7787531-?	rs7787531	0	7787531	intron_variant	0	0.29	9E-6	5.045757490560675		1.22	[1.10-1.30]	Affymetrix [> 333754] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST000764	Genome-wide genotyping array
2010-09-16	20694014	Thye T	2010-08-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20694014	Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2.	Tuberculosis	2,237 Sub-Saharan African ancestry cases, 3,122 Sub-Saharan African ancestry controls	1,462 Sub-Saharan African ancestry cases, 4,604 Sub-Saharan African ancestry controls	8q11.22	8	51304202	NR	NA - PXDNL		ENSG00000147485			15375	rs7821565-?	rs7821565	0	7821565	intron_variant	1	0.61	8E-6	5.096910013008056		1.2	[1.11-1.25]	Affymetrix [> 333754] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST000764	Genome-wide genotyping array
2010-09-16	20694014	Thye T	2010-08-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20694014	Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2.	Tuberculosis	2,237 Sub-Saharan African ancestry cases, 3,122 Sub-Saharan African ancestry controls	1,462 Sub-Saharan African ancestry cases, 4,604 Sub-Saharan African ancestry controls	17q12	17	37490447	NR	DUSP14, DUSP14			ENSG00000275932, ENSG00000276023			rs712039-?	rs712039	0	712039	intron_variant	0	0.49	3E-6	5.522878745280337		1.21	[1.10-1.30]	Affymetrix [> 333754] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST000764	Genome-wide genotyping array
2012-03-09	22306650	Thye T	2012-02-05	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22306650	Common variants at 11p13 are associated with susceptibility to tuberculosis.	Tuberculosis	1,329 African ancestry cases, 1,847 African ancestry controls	2,024 African ancestry cases, 5,154 African ancestry controls, 1,025 Indonesian ancestry cases, 983 Indonesian ancestry controls, 4,441 European ancestry cases, 5,874 European ancestry controls	11p13	11	32342641	WT1	THEM7P			ENSG00000227160			rs2057178-?	rs2057178	0	2057178	intron_variant	0	NR	3E-11	10.522878745280337		1.1	[1.01-1.22] Russian samples	Affymetrix [793964]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST001398	Genome-wide genotyping array
2015-12-03	25774636	Curtis J	2015-03-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25774636	Susceptibility to tuberculosis is associated with variants in the ASAP1 gene encoding a regulator of dendritic cell migration.	Tuberculosis	5,530 European ancestry cases, 5,607 European ancestry controls	1,085 Russian ancestry cases, 2,865 Russian ancestry controls, 2,277 Sub-Saharan African ancestry cases, 2,360 Sub-Saharan African ancestry controls	8q24.21	8	130284521	ASAP1	ASAP1			ENSG00000153317			rs4733781-A	rs4733781	0	4733781	intron_variant	0	0.687	4E-12	11.397940008672037				Affymetrix [7614862] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002810	Genome-wide genotyping array
2015-12-03	25774636	Curtis J	2015-03-16	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25774636	Susceptibility to tuberculosis is associated with variants in the ASAP1 gene encoding a regulator of dendritic cell migration.	Tuberculosis	5,530 European ancestry cases, 5,607 European ancestry controls	1,085 Russian ancestry cases, 2,865 Russian ancestry controls, 2,277 Sub-Saharan African ancestry cases, 2,360 Sub-Saharan African ancestry controls	8q24.21	8	130284521	ASAP1	ASAP1			ENSG00000153317			rs4733781-A	rs4733781	0	4733781	intron_variant	0	0.687	3E-11	10.522878745280337	(Russian)	1.19	[1.14-1.25]	Affymetrix [7614862] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST002810	Genome-wide genotyping array
2017-11-02	29036319	Qi H	2017-09-26	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/29036319	Discovery of susceptibility loci associated with tuberculosis in Han Chinese.	Tuberculosis	972 Chinese ancestry cases, 1,537 Chinese ancestry controls	3,338 Chinese ancestry cases, 4,849 Chinese ancestry controls	6p21.32	6	32518625	BTNL2, C6OF10, HCG23, HLA-DRA, HLA-DRB5, HLA-DRB1, HLA-DRB6, HLA-DQB1, HLA- DQA1	HLA-DRB5			ENSG00000198502			rs41553512-?	rs41553512	0	41553512	missense_variant	0	0.016	8E-11	10.096910013008056		2.14	[1.78-2.57]	Illumina [691388]	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST004923	Genome-wide genotyping array
2020-01-27	31667592	Milet J	2019-10-30	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31667592	First genome-wide association study of non-severe malaria in two birth cohorts in Benin.	Recurrence of malaria infection (mild or asymptomatic)	525 Beninese individuals	250 Beninese individuals	3q21.3	3	126499368	UROC1	UROC1			ENSG00000159650			rs9871671-A	rs9871671	0	9871671	missense_variant	0	0.11	8E-6	5.096910013008056		1.49	[1.22-1.81]	Illumina [15566900] (imputed)	N	disease recurrence, malaria	http://www.ebi.ac.uk/efo/EFO_0004952, http://www.ebi.ac.uk/efo/EFO_0001068	GCST009515	Genome-wide genotyping array
2020-01-27	31667592	Milet J	2019-10-30	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31667592	First genome-wide association study of non-severe malaria in two birth cohorts in Benin.	Recurrence of malaria infection (mild or asymptomatic)	525 Beninese individuals	250 Beninese individuals	20q12	20	42134228	PTPRT	PTPRT			ENSG00000196090			rs6124419-A	rs6124419	0	6124419	intron_variant	0	0.12	4E-7	6.3979400086720375		1.58	[1.31-1.91]	Illumina [15566900] (imputed)	N	disease recurrence, malaria	http://www.ebi.ac.uk/efo/EFO_0004952, http://www.ebi.ac.uk/efo/EFO_0001068	GCST009515	Genome-wide genotyping array
2020-01-27	31667592	Milet J	2019-10-30	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31667592	First genome-wide association study of non-severe malaria in two birth cohorts in Benin.	Recurrence of mild malaria attacks	525 Beninese individuals	250 Beninese individuals	6p25.2	6	2606805	C6orf195	GMDS-DT - LINC02521	ENSG00000250903	ENSG00000228718		80829	10339	rs76088706-T	rs76088706	0	76088706	intergenic_variant	1	0.025	4E-7	6.3979400086720375		2.22	[1.59-3.11]	Illumina [15566900] (imputed)	N	disease recurrence, malaria	http://www.ebi.ac.uk/efo/EFO_0004952, http://www.ebi.ac.uk/efo/EFO_0001068	GCST009514	Genome-wide genotyping array
2020-01-27	31667592	Milet J	2019-10-30	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31667592	First genome-wide association study of non-severe malaria in two birth cohorts in Benin.	Recurrence of mild malaria attacks	525 Beninese individuals	250 Beninese individuals	6p25.2	6	2666821	MYLK4	MYLK4			ENSG00000145949			rs142480106-T	rs142480106	0	142480106	3_prime_UTR_variant	0	0.019	5E-8	7.301029995663981		2.52	[1.73-3.66]	Illumina [15566900] (imputed)	N	disease recurrence, malaria	http://www.ebi.ac.uk/efo/EFO_0004952, http://www.ebi.ac.uk/efo/EFO_0001068	GCST009514	Genome-wide genotyping array
2020-01-27	31667592	Milet J	2019-10-30	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31667592	First genome-wide association study of non-severe malaria in two birth cohorts in Benin.	Recurrence of mild malaria attacks	525 Beninese individuals	250 Beninese individuals	10q26.3	10	133220763	KNDC1	KNDC1			ENSG00000171798			rs182416945-A	rs182416945	0	182416945	intron_variant	0	0.12	8E-7	6.096910013008056		1.55	[1.28-1.87]	Illumina [15566900] (imputed)	N	disease recurrence, malaria	http://www.ebi.ac.uk/efo/EFO_0004952, http://www.ebi.ac.uk/efo/EFO_0001068	GCST009514	Genome-wide genotyping array
2020-01-27	31667592	Milet J	2019-10-30	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31667592	First genome-wide association study of non-severe malaria in two birth cohorts in Benin.	Recurrence of mild malaria attacks	525 Beninese individuals	250 Beninese individuals	14q23.2	14	61996593	SYT16	SYT16			ENSG00000139973			rs62639692-G	rs62639692	0	62639692	intron_variant	0	0.047	6E-6	5.221848749616356		1.69	[1.33-2.16]	Illumina [15566900] (imputed)	N	disease recurrence, malaria	http://www.ebi.ac.uk/efo/EFO_0004952, http://www.ebi.ac.uk/efo/EFO_0001068	GCST009514	Genome-wide genotyping array
2020-01-27	31667592	Milet J	2019-10-30	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31667592	First genome-wide association study of non-severe malaria in two birth cohorts in Benin.	Recurrence of mild malaria attacks	525 Beninese individuals	250 Beninese individuals	18p11.23	18	7754656	PTPRM	PTPRM			ENSG00000173482			rs113776891-?	rs113776891	0	113776891	intron_variant	0	0.924	1E-6	6.0		2.2222223	[1.61-3.03]	Illumina [15566900] (imputed)	N	disease recurrence, malaria	http://www.ebi.ac.uk/efo/EFO_0004952, http://www.ebi.ac.uk/efo/EFO_0001068	GCST009514	Genome-wide genotyping array
2020-01-27	31667592	Milet J	2019-10-30	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31667592	First genome-wide association study of non-severe malaria in two birth cohorts in Benin.	Recurrence of mild malaria attacks	525 Beninese individuals	250 Beninese individuals	20q12	20	42134228	PTPRT	PTPRT			ENSG00000196090			rs6124419-A	rs6124419	0	6124419	intron_variant	0	0.12	7E-7	6.154901959985743		1.53	[1.28-1.83]	Illumina [15566900] (imputed)	N	disease recurrence, malaria	http://www.ebi.ac.uk/efo/EFO_0004952, http://www.ebi.ac.uk/efo/EFO_0001068	GCST009514	Genome-wide genotyping array
2016-09-07	26416757	Band G	2015-09-30	Nature	www.ncbi.nlm.nih.gov/pubmed/26416757	A novel locus of resistance to severe malaria in a region of ancient balancing selection.	Severe malaria	5,130 African ancestry cases, 5,291 African ancestry controls	5,535 African ancestry cases, 9,948 African ancestry controls	4q31.21	4	143781321	FREM3, GYPA, GYPE, GYPB	FREM3 - GYPE	ENSG00000183090	ENSG00000197465		80646	89543	rs186873296-?	rs186873296	0	186873296	intron_variant	1	NR	4E-11	10.397940008672037	(East African)			Illumina [~ 38000000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST003145	Genome-wide genotyping array
2016-09-07	26416757	Band G	2015-09-30	Nature	www.ncbi.nlm.nih.gov/pubmed/26416757	A novel locus of resistance to severe malaria in a region of ancient balancing selection.	Severe malaria	5,130 African ancestry cases, 5,291 African ancestry controls	5,535 African ancestry cases, 9,948 African ancestry controls	4q31.21	4	142617358	INPP4B	INPP4B			ENSG00000109452			rs77389579-?	rs77389579	0	77389579	intron_variant	0	NR	6E-6	5.221848749616356	(East African)			Illumina [~ 38000000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST003145	Genome-wide genotyping array
2016-09-07	26416757	Band G	2015-09-30	Nature	www.ncbi.nlm.nih.gov/pubmed/26416757	A novel locus of resistance to severe malaria in a region of ancient balancing selection.	Severe malaria	5,130 African ancestry cases, 5,291 African ancestry controls	5,535 African ancestry cases, 9,948 African ancestry controls	4q31.21	4	143781321	FREM3, GYPE, GYPA, GYPB	FREM3 - GYPE	ENSG00000183090	ENSG00000197465		80646	89543	rs186873296-?	rs186873296	0	186873296	intron_variant	1	NR	1E-10	10.0		1.49	[1.32-1.67]	Illumina [~ 38000000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST003145	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria (adjusted for sickle cell variant rs334)	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	12q24.32	12	126753075	LINC00944	LINC00944			ENSG00000256128			rs11335470-?	rs11335470	0	11335470	intron_variant	0	NR	2E-6	5.698970004336019	(Heterozygous)		[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005357	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria (adjusted for sickle cell variant rs334)	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	5p12	5	43909241	Intergenic							rs113449872-?	rs113449872	0	113449872	intergenic_variant	1	NR	3E-7	6.522878745280337	(Heterozygous)		[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005357	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria (adjusted for sickle cell variant rs334)	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	13q33.3	13	107575665	FAM155A	FAM155A						rs144312179-?	rs144312179	0	144312179	intron_variant	0	NR	3E-6	5.522878745280337	(Additive)		[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005357	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria (adjusted for sickle cell variant rs334)	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	17p12	17	12496210	LINC00670	NA - LINC00670		ENSG00000179136			53554	rs149085856-?	rs149085856	0	149085856	intergenic_variant	1	NR	1E-6	6.0	(Additive)		[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005357	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria (adjusted for sickle cell variant rs334)	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	7p12.1	7	53609144	Intergenic	NA - LINC01446		ENSG00000205628			46364	rs17624383-?	rs17624383	0	17624383	intergenic_variant	1	NR	3E-6	5.522878745280337	(Additive)		[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005357	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria (adjusted for sickle cell variant rs334)	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	4q34.3	4	181901179	AC108142.1	TENM3-AS1			ENSG00000177822			rs1878468-?	rs1878468	0	1878468	intron_variant	0	NR	1E-6	6.0	(Heterozygous)		[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005357	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria (adjusted for sickle cell variant rs334)	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	5q31.2	5	137676072	KLHL3, MYOT	KLHL3			ENSG00000146021			rs2967790-?	rs2967790	0	2967790	intron_variant	0	NR	2E-6	5.698970004336019	(Additive)		[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005357	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria (adjusted for sickle cell variant rs334)	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	11q24.3	11	130547627	Intergenic	BAK1P2 - NA	ENSG00000236616			198		rs3133394-?	rs3133394	0	3133394	intergenic_variant	1	NR	1E-6	6.0	(Additive)		[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005357	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria (adjusted for sickle cell variant rs334)	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	1p31.3	1	67273345	IL23R, IL12RB2	RNU4ATAC4P - DNAJB6P4	ENSG00000252116	ENSG00000228523		5619	4707	rs6588252-?	rs6588252	0	6588252	intergenic_variant	1	NR	9E-7	6.045757490560675	(Recessive)		[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005357	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria (adjusted for sickle cell variant rs334)	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	8p23.2	8	4897316	CSMD1	CSMD1			ENSG00000183117			rs73505850-?	rs73505850	0	73505850	intron_variant	0	NR	1E-6	6.0	(Additive)		[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005357	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria (adjusted for sickle cell variant rs334)	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	4q23	4	99508600	C4orf17	ADH7 - C4orf17	ENSG00000196344	ENSG00000138813		73090	2412	rs73832816-?	rs73832816	0	73832816	regulatory_region_variant	1	NR	9E-7	6.045757490560675	(Recessive)		[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005357	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria (adjusted for sickle cell variant rs334)	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	19q12	19	30578732	ZNF536	ZNF536			ENSG00000198597			rs8109875-?	rs8109875	0	8109875	intron_variant	0	NR	4E-6	5.3979400086720375	(Recessive)		[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005357	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria (adjusted for sickle cell variant rs334)	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	6p21.1	6	41237952	TREML4	TREML4			ENSG00000188056			rs9296359-?	rs9296359	0	9296359	3_prime_UTR_variant	0	NR	4E-7	6.3979400086720375	(Heterozygous)		[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005357	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	12q24.32	12	126753075	LINC00944	LINC00944			ENSG00000256128			rs11335470-?	rs11335470	0	11335470	intron_variant	0	NR	3E-7	6.522878745280337	(Heterozygous)	2.4813895	[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005356	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	5p12	5	43909241	Intergenic							rs113449872-?	rs113449872	0	113449872	intergenic_variant	1	NR	2E-7	6.698970004336019	(Heterozygous)	2.8248587	[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005356	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	4q35.2	4	189796550	AF146191.4-004	FRG1-DT, FRG1-DT, FRG1-DT, FRG1-DT			ENSG00000280716, ENSG00000281543, ENSG00000281787, ENSG00000245685			rs114169033-?	rs114169033	0	114169033	intron_variant	0	NR	7E-7	6.154901959985743	(Additive)	3.326	[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005356	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	13q33.3	13	107575665	FAM155A	FAM155A						rs144312179-?	rs144312179	0	144312179	intron_variant	0	NR	6E-7	6.221848749616356	(Additive)	4.830918	[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005356	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	17p12	17	12496210	LINC00670	NA - LINC00670		ENSG00000179136			53554	rs149085856-?	rs149085856	0	149085856	intergenic_variant	1	NR	2E-7	6.698970004336019	(Additive)	3.867	[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005356	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	7p12.1	7	53609144	Intergenic	NA - LINC01446		ENSG00000205628			46364	rs17624383-?	rs17624383	0	17624383	intergenic_variant	1	NR	6E-7	6.221848749616356	(Additive)	0.4	[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005356	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	4q34.3	4	181901179	AC108142.1	TENM3-AS1			ENSG00000177822			rs1878468-?	rs1878468	0	1878468	intron_variant	0	NR	9E-7	6.045757490560675	(Heterozygous)	2.6109662	[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005356	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	5q31.2	5	137676072	KLHL3, MYOT	KLHL3			ENSG00000146021			rs2967790-?	rs2967790	0	2967790	intron_variant	0	NR	6E-7	6.221848749616356	(Additive)	1.6949153	[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005356	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	11q24.3	11	130547627	Intergenic	BAK1P2 - NA	ENSG00000236616			198		rs3133394-?	rs3133394	0	3133394	intergenic_variant	1	NR	9E-7	6.045757490560675	(Additive)	1.814882	[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005356	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	11p15.4	11	5227002	HBB	HBB			ENSG00000244734			rs334-?	rs334	0	334	missense_variant	0	NR	9E-13	12.045757490560675	(Heterozygous)	7.633588	[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005356	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	1p31.3	1	67265931	IL23R, IL12RB2	IL23R - RNU4ATAC4P	ENSG00000162594	ENSG00000252116		5952	1670	rs6682413-?	rs6682413	0	6682413	regulatory_region_variant	1	NR	8E-7	6.096910013008056	(Recessive)	2.0876827	[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005356	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	8p23.2	8	4897316	CSMD1	CSMD1			ENSG00000183117			rs73505850-?	rs73505850	0	73505850	intron_variant	0	NR	8E-7	6.096910013008056	(Additive)	4.795	[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005356	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	4q23	4	99508600	C4orf17	ADH7 - C4orf17	ENSG00000196344	ENSG00000138813		73090	2412	rs73832816-?	rs73832816	0	73832816	regulatory_region_variant	1	NR	4E-7	6.3979400086720375	(Recessive)	3.4602075	[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005356	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	19q12	19	30578732	ZNF536	ZNF536			ENSG00000198597			rs8109875-?	rs8109875	0	8109875	intron_variant	0	NR	9E-7	6.045757490560675	(Recessive)	1.9723865	[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005356	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	6p21.1	6	41237952	TREML4	TREML4			ENSG00000188056			rs9296359-?	rs9296359	0	9296359	3_prime_UTR_variant	0	NR	1E-7	7.0	(Heterozygous)	4.087	[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005356	Genome-wide genotyping array
2015-12-03	25802187	Jiang DK	2015-04-28	Hepatology	www.ncbi.nlm.nih.gov/pubmed/25802187	Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B.	Chronic hepatitis B infection	2,514 Chinese ancestry cases, 1,130 Chinese ancestry controls	6,600 Chinese ancestry cases, 8,127 Chinese ancestry controls	6p21.33	6	31946402	CFB	CFB, CFB, CFB, CFB, CFB, CFB			ENSG00000243649, ENSG00000239754, ENSG00000242335, ENSG00000241534, ENSG00000241253, ENSG00000243570			rs12614-T	rs12614	0	12614	stop_gained	0	0.92	1E-34	34.0		1.89	[1.69-2.08]	Illumina [3680900] (imputed)	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002879	Genome-wide genotyping array
2015-12-03	25802187	Jiang DK	2015-04-28	Hepatology	www.ncbi.nlm.nih.gov/pubmed/25802187	Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B.	Chronic hepatitis B infection	2,514 Chinese ancestry cases, 1,130 Chinese ancestry controls	6,600 Chinese ancestry cases, 8,127 Chinese ancestry controls	6p21.32	6	32220606	NOTCH4	NOTCH4, NOTCH4, NOTCH4, NOTCH4, NOTCH4, NOTCH4			ENSG00000235396, ENSG00000223355, ENSG00000204301, ENSG00000232339, ENSG00000234876, ENSG00000206312			rs422951-G	rs422951	0	422951	missense_variant	0	0.81	5E-16	15.301029995663981		1.27	[1.20-1.35]	Illumina [3680900] (imputed)	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002879	Genome-wide genotyping array
2015-12-03	25802187	Jiang DK	2015-04-28	Hepatology	www.ncbi.nlm.nih.gov/pubmed/25802187	Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B.	Chronic hepatitis B infection	2,514 Chinese ancestry cases, 1,130 Chinese ancestry controls	6,600 Chinese ancestry cases, 8,127 Chinese ancestry controls	6p21.32	6	33007157	HLA-DOA	HLA-DOA, HLA-DOA, HLA-DOA, HLA-DOA, HLA-DOA, HLA-DOA			ENSG00000206292, ENSG00000232957, ENSG00000231558, ENSG00000204252, ENSG00000232962, ENSG00000230141			rs378352-T	rs378352	0	378352	synonymous_variant	0	0.39	1E-23	23.0		1.26	[1.20-1.31]	Illumina [3680900] (imputed)	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002879	Genome-wide genotyping array
2015-12-03	25802187	Jiang DK	2015-04-28	Hepatology	www.ncbi.nlm.nih.gov/pubmed/25802187	Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B.	Chronic hepatitis B infection	2,514 Chinese ancestry cases, 1,130 Chinese ancestry controls	6,600 Chinese ancestry cases, 8,127 Chinese ancestry controls	20q13.12	20	46118343	CD40	CD40			ENSG00000101017			rs1883832-T	rs1883832	0	1883832	5_prime_UTR_variant	0	0.37	3E-15	14.522878745280337		1.19	[1.14-1.25]	Illumina [3680900] (imputed)	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002879	Genome-wide genotyping array
2015-12-03	25802187	Jiang DK	2015-04-28	Hepatology	www.ncbi.nlm.nih.gov/pubmed/25802187	Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B.	Chronic hepatitis B infection	2,514 Chinese ancestry cases, 1,130 Chinese ancestry controls	6,600 Chinese ancestry cases, 8,127 Chinese ancestry controls	6p21.33	6	31264334	HLA-C	HCG27 - HLA-C	ENSG00000220890	ENSG00000228299		60366	4415	rs3130542-A	rs3130542	0	3130542	intergenic_variant	1	0.16	9E-7	6.045757490560675		1.17	[1.10-1.24]	Illumina [3680900] (imputed)	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002879	Genome-wide genotyping array
2015-12-03	25802187	Jiang DK	2015-04-28	Hepatology	www.ncbi.nlm.nih.gov/pubmed/25802187	Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B.	Chronic hepatitis B infection	2,514 Chinese ancestry cases, 1,130 Chinese ancestry controls	6,600 Chinese ancestry cases, 8,127 Chinese ancestry controls	6p21.33	6	31883457	EHMT2	EHMT2, EHMT2, EHMT2, EHMT2, EHMT2, EHMT2, EHMT2-AS1			ENSG00000236759, ENSG00000206376, ENSG00000227333, ENSG00000224143, ENSG00000204371, ENSG00000238134, ENSG00000237080			rs652888-G	rs652888	0	652888	non_coding_transcript_exon_variant	0	0.24	1E-6	6.0		1.14	[1.08-1.19]	Illumina [3680900] (imputed)	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002879	Genome-wide genotyping array
2015-12-03	25802187	Jiang DK	2015-04-28	Hepatology	www.ncbi.nlm.nih.gov/pubmed/25802187	Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B.	Chronic hepatitis B infection	2,514 Chinese ancestry cases, 1,130 Chinese ancestry controls	6,600 Chinese ancestry cases, 8,127 Chinese ancestry controls	6p21.32	6	32702478	HLA-DQB1	HLA-DQB1 - MTCO3P1	ENSG00000231939	ENSG00000237145		34095	3646	rs2856718-C	rs2856718	0	2856718	regulatory_region_variant	1	0.55	7E-28	27.154901959985743		1.28	[1.22-1.33]	Illumina [3680900] (imputed)	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002879	Genome-wide genotyping array
2015-12-03	25802187	Jiang DK	2015-04-28	Hepatology	www.ncbi.nlm.nih.gov/pubmed/25802187	Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B.	Chronic hepatitis B infection	2,514 Chinese ancestry cases, 1,130 Chinese ancestry controls	6,600 Chinese ancestry cases, 8,127 Chinese ancestry controls	6p21.32	6	32762235	HLA-DQB2	HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2			ENSG00000232629, ENSG00000224305, ENSG00000228813, ENSG00000196610, ENSG00000229493, ENSG00000228254, ENSG00000226165			rs7453920-A	rs7453920	0	7453920	intron_variant	0	0.88	1E-60	60.0		2.0	[1.82-2.17]	Illumina [3680900] (imputed)	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002879	Genome-wide genotyping array
2015-12-03	25802187	Jiang DK	2015-04-28	Hepatology	www.ncbi.nlm.nih.gov/pubmed/25802187	Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B.	Chronic hepatitis B infection	2,514 Chinese ancestry cases, 1,130 Chinese ancestry controls	6,600 Chinese ancestry cases, 8,127 Chinese ancestry controls	6p21.32	6	33065245	HLA-DPA1	HLA-DPA1			ENSG00000235844			rs3077-A	rs3077	0	3077	3_prime_UTR_variant	0	0.66	1E-53	53.0		1.45	[1.39-1.52]	Illumina [3680900] (imputed)	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002879	Genome-wide genotyping array
2015-12-03	25802187	Jiang DK	2015-04-28	Hepatology	www.ncbi.nlm.nih.gov/pubmed/25802187	Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B.	Chronic hepatitis B infection	2,514 Chinese ancestry cases, 1,130 Chinese ancestry controls	6,600 Chinese ancestry cases, 8,127 Chinese ancestry controls	6p21.32	6	33087084	HLA-DPB1	HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1			ENSG00000215048, ENSG00000237710, ENSG00000223865, ENSG00000229295, ENSG00000226826, ENSG00000230708			rs9277535-A	rs9277535	0	9277535	3_prime_UTR_variant	0	0.58	1E-70	70.0		1.52	[1.45-1.59]	Illumina [3680900] (imputed)	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002879	Genome-wide genotyping array
2015-12-03	25802187	Jiang DK	2015-04-28	Hepatology	www.ncbi.nlm.nih.gov/pubmed/25802187	Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B.	Chronic hepatitis B infection	2,514 Chinese ancestry cases, 1,130 Chinese ancestry controls	6,600 Chinese ancestry cases, 8,127 Chinese ancestry controls	6p21.33	6	31267728	HLA-C	HCG27 - HLA-C	ENSG00000220890	ENSG00000228299		63760	1021	rs2853953-A	rs2853953	0	2853953	intergenic_variant	1	0.9	5E-20	19.30102999566398		1.47	[1.35-1.59]	Illumina [3680900] (imputed)	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002879	Genome-wide genotyping array
2015-12-03	25802187	Jiang DK	2015-04-28	Hepatology	www.ncbi.nlm.nih.gov/pubmed/25802187	Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B.	Chronic hepatitis B infection	2,514 Chinese ancestry cases, 1,130 Chinese ancestry controls	6,600 Chinese ancestry cases, 8,127 Chinese ancestry controls	6p21.33	6	31162816	TCF19	TCF19, TCF19, TCF19, TCF19, TCF19, TCF19, TCF19			ENSG00000224941, ENSG00000224379, ENSG00000206455, ENSG00000137310, ENSG00000234674, ENSG00000233890, ENSG00000224472			rs1419881-G	rs1419881	0	1419881	3_prime_UTR_variant	0	0.55	3E-7	6.522878745280337		1.12	[1.08-1.18]	Illumina [3680900] (imputed)	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST002879	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Chronic hepatitis B infection	2,234 East Asian ancestry cases, 169,588 East Asian ancestry controls	NA	6p21.32	6	33088985		HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1			ENSG00000215048, ENSG00000237710, ENSG00000223865, ENSG00000229295, ENSG00000226826, ENSG00000230708			rs9277562-T	rs9277562	0	9277562	3_prime_UTR_variant	0	0.575524651	5E-45	44.30102999566398		0.44033504	[0.38-0.5] unit increase	Illumina [13428705] (imputed)	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST90018584	Genome-wide genotyping array
2021-10-07	34512620	Matzaraki V	2021-08-26	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/34512620	Inflammatory Protein Profiles in Plasma of Candidaemia Patients and the Contribution of Host Genetics to Their Variability.	Candida albicans stimulated MCP-2 levels	378 European ancestry individuals	NA	4p15.32	4	16116877		PROM1 - TAPT1	ENSG00000007062	ENSG00000169762		32499	43628	rs59199268-?	rs59199268	0	59199268	intron_variant	1	NR	1E-8	8.0		5.71	z-score increase	Illumina [NR] (imputed)	N	monocyte chemotactic protein-2 measurement	http://www.ebi.ac.uk/efo/EFO_0010789	GCST90038445	Genome-wide genotyping array
2021-10-07	34512620	Matzaraki V	2021-08-26	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/34512620	Inflammatory Protein Profiles in Plasma of Candidaemia Patients and the Contribution of Host Genetics to Their Variability.	Candida albicans stimulated CCL3 levels	378 European ancestry individuals	NA	9p23	9	11477574		AKAP8P1 - JKAMPP1	ENSG00000234146	ENSG00000231491		464478	809746	rs12343816-?	rs12343816	0	12343816	intergenic_variant	1	NR	6E-9	8.221848749616356		5.81	z-score increase	Illumina [NR] (imputed)	N	CCL3 measurement	http://www.ebi.ac.uk/efo/EFO_0010770	GCST90038446	Genome-wide genotyping array
2021-10-07	34512620	Matzaraki V	2021-08-26	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/34512620	Inflammatory Protein Profiles in Plasma of Candidaemia Patients and the Contribution of Host Genetics to Their Variability.	Candida albicans stimulated CCL3 levels	378 European ancestry individuals	NA	15q23	15	69630420		DRAIC			ENSG00000245750			rs55642284-?	rs55642284	0	55642284	intron_variant	0	NR	1E-8	8.0		5.74	z-score increase	Illumina [NR] (imputed)	N	CCL3 measurement	http://www.ebi.ac.uk/efo/EFO_0010770	GCST90038446	Genome-wide genotyping array
2021-10-07	34512620	Matzaraki V	2021-08-26	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/34512620	Inflammatory Protein Profiles in Plasma of Candidaemia Patients and the Contribution of Host Genetics to Their Variability.	Candida albicans stimulated MMP-1 levels	378 European ancestry individuals	NA	9q22.2	9	89694772		UNQ6494			ENSG00000237372			rs10114707-?	rs10114707	0	10114707	intron_variant	0	NR	4E-8	7.3979400086720375		5.51	z-score increase	Illumina [NR] (imputed)	N	matrix metalloproteinase 1 measurement	http://www.ebi.ac.uk/efo/EFO_0010588	GCST90038447	Genome-wide genotyping array
2021-10-07	34512620	Matzaraki V	2021-08-26	Front Immunol	www.ncbi.nlm.nih.gov/pubmed/34512620	Inflammatory Protein Profiles in Plasma of Candidaemia Patients and the Contribution of Host Genetics to Their Variability.	Candida albicans stimulated IL-8 levels	378 European ancestry individuals	NA	9p24.3	9	1439567		RNA5SP279 - SMARCA2	ENSG00000202383	ENSG00000080503		105614	540723	rs658817-?	rs658817	0	658817	intergenic_variant	1	NR	7E-9	8.154901959985743		5.79	z-score increase	Illumina [NR] (imputed)	N	interleukin 8 measurement	http://www.ebi.ac.uk/efo/EFO_0008191	GCST90038448	Genome-wide genotyping array
2019-04-24	30593799	Vergara C	2018-12-26	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/30593799	Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.	Hepatitis C (spontaneous viral clearance)	701 European ancestry cases, 1,035 European ancestry controls, 445 African American cases, 1,756 African American controls, 173 Hispanic ancestry cases, 313 Hispanic ancestry controls	NA	6p21.32	6	32692805	HLA-DQB1, HLA-DQA2	HLA-DQB1 - MTCO3P1	ENSG00000231939	ENSG00000237145		24422	13319	rs2647006-C	rs2647006	0	2647006	intergenic_variant	1	0.62	1E-21	21.0		1.79	NR (AA)	Illumina [15704341] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST007631	Genome-wide genotyping array
2019-04-24	30593799	Vergara C	2018-12-26	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/30593799	Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.	Hepatitis C (spontaneous viral clearance)	701 European ancestry cases, 1,035 European ancestry controls, 445 African American cases, 1,756 African American controls, 173 Hispanic ancestry cases, 313 Hispanic ancestry controls	NA	19q13.2	19	39248515	IFNL3, IFNL4	IFNL4			ENSG00000272395			rs74597329-T	rs74597329	0	74597329	missense_variant	0	0.37	6E-50	49.221848749616356		2.14	NR (AA)	Illumina [15704341] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST007631	Genome-wide genotyping array
2019-04-24	30593799	Vergara C	2018-12-26	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/30593799	Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.	Hepatitis C (spontaneous viral clearance)	701 European ancestry cases, 1,035 European ancestry controls, 445 African American cases, 1,756 African American controls, 173 Hispanic ancestry cases, 313 Hispanic ancestry controls	NA	10p12.1	10	25385685	GPR158	GPR158			ENSG00000151025			rs1754257-A	rs1754257	0	1754257	intron_variant	0	0.76	2E-7	6.698970004336019		1.55	NR (AA)	Illumina [15704341] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST007631	Genome-wide genotyping array
2019-04-24	30593799	Vergara C	2018-12-26	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/30593799	Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.	Hepatitis C (spontaneous viral clearance)	445 African American cases, 1,756 African American controls	NA	19q13.2	19	39248515	IFNL4, IFNL3	IFNL4			ENSG00000272395			rs74597329-T	rs74597329	0	74597329	missense_variant	0	0.37	1E-15	15.0		2.14	NR	Illumina [at least 15383342] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST007632	Genome-wide genotyping array
2019-04-24	30593799	Vergara C	2018-12-26	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/30593799	Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.	Hepatitis C (spontaneous viral clearance)	701 European ancestry cases, 1,035 European ancestry controls	NA				IFNL4, IFNL3							chr19:39739129-C	chr19:39739129	0			1	0.8	7E-24	23.154901959985743		2.78	[2.57-2.99]	Illumina [8968220] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST007633	Genome-wide genotyping array
2019-04-24	30593799	Vergara C	2018-12-26	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/30593799	Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.	Hepatitis C (spontaneous viral clearance)	701 European ancestry cases, 1,035 European ancestry controls	NA	6p21.32	6	32703120	HLA-DQB1, HLA-DQA2	HLA-DQB1 - MTCO3P1	ENSG00000231939	ENSG00000237145		34737	3004	rs2647051-C	rs2647051	0	2647051	intergenic_variant	1	0.64	1E-9	9.0		1.79	NR	Illumina [8968220] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST007633	Genome-wide genotyping array
2019-04-24	30593799	Vergara C	2018-12-26	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/30593799	Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.	Hepatitis C (spontaneous viral clearance)	173 Hispanic ancestry cases, 313 Hispanic ancestry controls	NA	19q13.2	19	39248515	IFNL3, IFNL4	IFNL4			ENSG00000272395			rs74597329-T	rs74597329	0	74597329	missense_variant	0	0.58	3E-12	11.522878745280337		3.28	NR	Illumina [12650831] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST007634	Genome-wide genotyping array
2014-10-20	24503447	Nelson D	2014-02-06	Antivir Ther	www.ncbi.nlm.nih.gov/pubmed/24503447	Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitor.	Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	176 European ancestry individuals	NA	8q24.22	8	133603893	ST3GAL1	ST3GAL1-DT - Metazoa_SRP	ENSG00000261220	ENSG00000277055		30032	64527	rs2978048-?	rs2978048	0	2978048	intergenic_variant	1	NR	1E-6	6.0		0.25	[NR] unit increase	Illumina [4466593]	N	hepatitis C virus infection, response to protease inhibitor, bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0003047, http://www.ebi.ac.uk/efo/EFO_0005657, http://www.ebi.ac.uk/efo/EFO_0004570	GCST002349	Genome-wide genotyping array
2014-10-20	24503447	Nelson D	2014-02-06	Antivir Ther	www.ncbi.nlm.nih.gov/pubmed/24503447	Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitor.	Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	176 European ancestry individuals	NA	17q24.2	17	67414818	PITPNC1	PITPNC1			ENSG00000154217			rs7224000-?	rs7224000	0	7224000	intron_variant	0	NR	3E-6	5.522878745280337		0.12	[NR] unit increase	Illumina [4466593]	N	hepatitis C virus infection, response to protease inhibitor, bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0003047, http://www.ebi.ac.uk/efo/EFO_0005657, http://www.ebi.ac.uk/efo/EFO_0004570	GCST002349	Genome-wide genotyping array
2021-07-07	33119750	Vergara C	2020-10-29	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33119750	A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus.	Hepatitis C (spontaneous viral clearance)	239 African ancestry male cases, 1,184 African ancestry male controls, 206 African ancestry female cases, 572 African ancestry female controls, 489 European ancestry male cases, 703 European ancestry male controls, 212 European ancestry female cases, 332 European ancestry female controls, 91 Hispanic male cases, 197 Hispanic male controls, 82 Hispanic female cases, 116 Hispanic female controls	NA	Xq24	X	119752407	SEPT6, RPL39	SEPTIN6 - SOWAHD	ENSG00000125354	ENSG00000187808		59037	6181	rs12852885-?	rs12852885	0	12852885	regulatory_region_variant	1	NR	2E-6	5.698970004336019				Illumina [5730693] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST011999	Genome-wide genotyping array
2021-07-07	33119750	Vergara C	2020-10-29	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33119750	A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus.	Hepatitis C (spontaneous viral clearance)	239 African ancestry male cases, 1,184 African ancestry male controls, 206 African ancestry female cases, 572 African ancestry female controls, 489 European ancestry male cases, 703 European ancestry male controls, 212 European ancestry female cases, 332 European ancestry female controls, 91 Hispanic male cases, 197 Hispanic male controls, 82 Hispanic female cases, 116 Hispanic female controls	NA	2q14.1	2	114515136	NR	DPP10			ENSG00000175497			rs1346763-T	rs1346763	0	1346763	intron_variant	0	0.32	9E-7	6.045757490560675	(male)	1.4	[NR]	Illumina [5730693] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST011999	Genome-wide genotyping array
2021-07-07	33119750	Vergara C	2020-10-29	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33119750	A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus.	Hepatitis C (spontaneous viral clearance)	239 African ancestry male cases, 1,184 African ancestry male controls, 206 African ancestry female cases, 572 African ancestry female controls, 489 European ancestry male cases, 703 European ancestry male controls, 212 European ancestry female cases, 332 European ancestry female controls, 91 Hispanic male cases, 197 Hispanic male controls, 82 Hispanic female cases, 116 Hispanic female controls	NA	6p21.32	6	32694503	NR	HLA-DQB1 - MTCO3P1	ENSG00000231939	ENSG00000237145		26120	11621	rs2858317-A	rs2858317	0	2858317	intergenic_variant	1	0.63	1E-11	11.0	(male)	1.73	[NR]	Illumina [5730693] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST011999	Genome-wide genotyping array
2021-07-07	33119750	Vergara C	2020-10-29	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33119750	A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus.	Hepatitis C (spontaneous viral clearance)	239 African ancestry male cases, 1,184 African ancestry male controls, 206 African ancestry female cases, 572 African ancestry female controls, 489 European ancestry male cases, 703 European ancestry male controls, 212 European ancestry female cases, 332 European ancestry female controls, 91 Hispanic male cases, 197 Hispanic male controls, 82 Hispanic female cases, 116 Hispanic female controls	NA	10p12.31	10	18819130	ARL5B	AIFM1P1 - NA	ENSG00000225509			80499		rs76398191-C	rs76398191	0	76398191	intergenic_variant	1	0.31	2E-7	6.698970004336019	(male)	0.69	[NR]	Illumina [5730693] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST011999	Genome-wide genotyping array
2021-07-07	33119750	Vergara C	2020-10-29	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33119750	A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus.	Hepatitis C (spontaneous viral clearance)	239 African ancestry male cases, 1,184 African ancestry male controls, 206 African ancestry female cases, 572 African ancestry female controls, 489 European ancestry male cases, 703 European ancestry male controls, 212 European ancestry female cases, 332 European ancestry female controls, 91 Hispanic male cases, 197 Hispanic male controls, 82 Hispanic female cases, 116 Hispanic female controls	NA	10p12.1	10	25389364	NR	GPR158			ENSG00000151025			rs1760726-G	rs1760726	0	1760726	intron_variant	0	0.75	2E-6	5.698970004336019	(male)	1.44	[NR]	Illumina [5730693] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST011999	Genome-wide genotyping array
2021-07-07	33119750	Vergara C	2020-10-29	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33119750	A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus.	Hepatitis C (spontaneous viral clearance)	239 African ancestry male cases, 1,184 African ancestry male controls, 206 African ancestry female cases, 572 African ancestry female controls, 489 European ancestry male cases, 703 European ancestry male controls, 212 European ancestry female cases, 332 European ancestry female controls, 91 Hispanic male cases, 197 Hispanic male controls, 82 Hispanic female cases, 116 Hispanic female controls	NA	19q13.2	19	39248515	IFNL3, IFNL4	IFNL4			ENSG00000272395			rs74597329-T	rs74597329	0	74597329	missense_variant	0	0.52	4E-25	24.397940008672037	(male)	2.19	[NR]	Illumina [5730693] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST011999	Genome-wide genotyping array
2021-07-07	33119750	Vergara C	2020-10-29	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33119750	A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus.	Hepatitis C (spontaneous viral clearance)	239 African ancestry male cases, 1,184 African ancestry male controls, 206 African ancestry female cases, 572 African ancestry female controls, 489 European ancestry male cases, 703 European ancestry male controls, 212 European ancestry female cases, 332 European ancestry female controls, 91 Hispanic male cases, 197 Hispanic male controls, 82 Hispanic female cases, 116 Hispanic female controls	NA	20q11.22	20	34196021	NR	ASIP			ENSG00000101440			rs6087561-C	rs6087561	0	6087561	intron_variant	0	0.12	6E-7	6.221848749616356	(male)	1.6	[NR]	Illumina [5730693] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST011999	Genome-wide genotyping array
2021-07-07	33119750	Vergara C	2020-10-29	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33119750	A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus.	Hepatitis C (spontaneous viral clearance)	239 African ancestry male cases, 1,184 African ancestry male controls, 206 African ancestry female cases, 572 African ancestry female controls, 489 European ancestry male cases, 703 European ancestry male controls, 212 European ancestry female cases, 332 European ancestry female controls, 91 Hispanic male cases, 197 Hispanic male controls, 82 Hispanic female cases, 116 Hispanic female controls	NA	6p21.32	6	32245080	NR	NOTCH4 - TSBP1-AS1	ENSG00000206312	ENSG00000225914		21013	9560	rs10456404-C	rs10456404	0	10456404	TF_binding_site_variant	1	0.13	2E-7	6.698970004336019	(female)	1.89	[NR]	Illumina [5730693] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST011999	Genome-wide genotyping array
2021-07-07	33119750	Vergara C	2020-10-29	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33119750	A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus.	Hepatitis C (spontaneous viral clearance)	239 African ancestry male cases, 1,184 African ancestry male controls, 206 African ancestry female cases, 572 African ancestry female controls, 489 European ancestry male cases, 703 European ancestry male controls, 212 European ancestry female cases, 332 European ancestry female controls, 91 Hispanic male cases, 197 Hispanic male controls, 82 Hispanic female cases, 116 Hispanic female controls	NA	6p21.32	6	32484810	NR	HLA-DRB9 - HLA-DRB5	ENSG00000226035	ENSG00000198502		11310	32543	rs28368843-T	rs28368843	0	28368843	intergenic_variant	1	0.07	5E-7	6.301029995663981	(female)	2.38	[NR]	Illumina [5730693] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST011999	Genome-wide genotyping array
2021-07-07	33119750	Vergara C	2020-10-29	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33119750	A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus.	Hepatitis C (spontaneous viral clearance)	239 African ancestry male cases, 1,184 African ancestry male controls, 206 African ancestry female cases, 572 African ancestry female controls, 489 European ancestry male cases, 703 European ancestry male controls, 212 European ancestry female cases, 332 European ancestry female controls, 91 Hispanic male cases, 197 Hispanic male controls, 82 Hispanic female cases, 116 Hispanic female controls	NA	6p21.32	6	32693516	NR	HLA-DQB1 - MTCO3P1	ENSG00000231939	ENSG00000237145		25133	12608	rs2858320-G	rs2858320	0	2858320	intergenic_variant	1	0.58	2E-12	11.698970004336019	(female)	1.96	[NR]	Illumina [5730693] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST011999	Genome-wide genotyping array
2021-07-07	33119750	Vergara C	2020-10-29	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33119750	A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus.	Hepatitis C (spontaneous viral clearance)	239 African ancestry male cases, 1,184 African ancestry male controls, 206 African ancestry female cases, 572 African ancestry female controls, 489 European ancestry male cases, 703 European ancestry male controls, 212 European ancestry female cases, 332 European ancestry female controls, 91 Hispanic male cases, 197 Hispanic male controls, 82 Hispanic female cases, 116 Hispanic female controls	NA	7p12.1	7	52712519	NR							rs1649709-G	rs1649709	0	1649709	regulatory_region_variant	1	0.59	9E-7	6.045757490560675	(female)	1.62	[NR]	Illumina [5730693] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST011999	Genome-wide genotyping array
2021-07-07	33119750	Vergara C	2020-10-29	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33119750	A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus.	Hepatitis C (spontaneous viral clearance)	239 African ancestry male cases, 1,184 African ancestry male controls, 206 African ancestry female cases, 572 African ancestry female controls, 489 European ancestry male cases, 703 European ancestry male controls, 212 European ancestry female cases, 332 European ancestry female controls, 91 Hispanic male cases, 197 Hispanic male controls, 82 Hispanic female cases, 116 Hispanic female controls	NA	13q11	13	18870688	NR	ANKRD20A9P			ENSG00000206192			rs1838126-T	rs1838126	0	1838126	non_coding_transcript_exon_variant	0	0.24	3E-6	5.522878745280337	(female)	1.8	[NR]	Illumina [5730693] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST011999	Genome-wide genotyping array
2021-07-07	33119750	Vergara C	2020-10-29	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33119750	A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus.	Hepatitis C (spontaneous viral clearance)	239 African ancestry male cases, 1,184 African ancestry male controls, 206 African ancestry female cases, 572 African ancestry female controls, 489 European ancestry male cases, 703 European ancestry male controls, 212 European ancestry female cases, 332 European ancestry female controls, 91 Hispanic male cases, 197 Hispanic male controls, 82 Hispanic female cases, 116 Hispanic female controls	NA	13q12.3	13	30383161	NR	LINC00426 - LINC01058	ENSG00000238121	ENSG00000225039		6016	36358	rs12161828-T	rs12161828	0	12161828	regulatory_region_variant	1	0.08	1E-5	5.0	(female)	2.01	[NR]	Illumina [5730693] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST011999	Genome-wide genotyping array
2021-07-07	33119750	Vergara C	2020-10-29	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33119750	A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus.	Hepatitis C (spontaneous viral clearance)	239 African ancestry male cases, 1,184 African ancestry male controls, 206 African ancestry female cases, 572 African ancestry female controls, 489 European ancestry male cases, 703 European ancestry male controls, 212 European ancestry female cases, 332 European ancestry female controls, 91 Hispanic male cases, 197 Hispanic male controls, 82 Hispanic female cases, 116 Hispanic female controls	NA	19q13.2	19	39248513	IFNL3, IFNL4	IFNL4			ENSG00000272395			rs778086851-CT	rs778086851	0	778086851	inframe_deletion	0	0.51	5E-21	20.30102999566398	(female)	2.5	[NR]	Illumina [5730693] (imputed)	N	remission, hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0009785, http://www.ebi.ac.uk/efo/EFO_0003047	GCST011999	Genome-wide genotyping array
2019-08-29	31260374	Pedergnana V	2019-07-01	J Interferon Cytokine Res	www.ncbi.nlm.nih.gov/pubmed/31260374	Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.	Response to interferon treatment in hepatitis C virus genotype 3	717 European, Asian and unknown ancestry responders, 541 European, Asian and unknown ancestry non-responders	NA	4q22.3	4	97038456	NR							rs76755915-?	rs76755915	0	76755915	regulatory_region_variant	1	NR	5E-7	6.301029995663981		4.5454545	NR	Affymetrix [~ 18000000] (imputed)	N	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	GCST008517	Genome-wide genotyping array
2019-08-29	31260374	Pedergnana V	2019-07-01	J Interferon Cytokine Res	www.ncbi.nlm.nih.gov/pubmed/31260374	Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.	Response to interferon treatment in hepatitis C virus genotype 3	717 European, Asian and unknown ancestry responders, 541 European, Asian and unknown ancestry non-responders	NA	6q13	6	72445473	NR	RIMS1 - NA	ENSG00000079841			42330		rs2492965-?	rs2492965	0	2492965	intergenic_variant	1	NR	1E-6	6.0		2.857143	NR	Affymetrix [~ 18000000] (imputed)	N	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	GCST008517	Genome-wide genotyping array
2019-08-29	31260374	Pedergnana V	2019-07-01	J Interferon Cytokine Res	www.ncbi.nlm.nih.gov/pubmed/31260374	Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.	Response to interferon treatment in hepatitis C virus genotype 3	717 European, Asian and unknown ancestry responders, 541 European, Asian and unknown ancestry non-responders	NA	13q13.2	13	34857816	NR	NA - Metazoa_SRP		ENSG00000277055			52729	rs7332270-?	rs7332270	0	7332270	intergenic_variant	1	NR	1E-6	6.0		1.6393442	NR	Affymetrix [~ 18000000] (imputed)	N	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	GCST008517	Genome-wide genotyping array
2019-08-29	31260374	Pedergnana V	2019-07-01	J Interferon Cytokine Res	www.ncbi.nlm.nih.gov/pubmed/31260374	Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.	Response to interferon treatment in hepatitis C virus genotype 3	717 European, Asian and unknown ancestry responders, 541 European, Asian and unknown ancestry non-responders	NA	3q26.31	3	173063177	NR	SPATA16			ENSG00000144962			rs6445096-?	rs6445096	0	6445096	intron_variant	0	NR	3E-7	6.522878745280337		1.57	NR	Affymetrix [~ 18000000] (imputed)	N	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	GCST008517	Genome-wide genotyping array
2019-08-29	31260374	Pedergnana V	2019-07-01	J Interferon Cytokine Res	www.ncbi.nlm.nih.gov/pubmed/31260374	Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.	Response to interferon treatment in hepatitis C virus genotype 3	717 European, Asian and unknown ancestry responders, 541 European, Asian and unknown ancestry non-responders	NA	19q13.2	19	39248515	NR	IFNL4			ENSG00000272395			rs74597329-?	rs74597329	0	74597329	missense_variant	0	NR	2E-7	6.698970004336019		1.59	NR	Affymetrix [~ 18000000] (imputed)	N	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	GCST008517	Genome-wide genotyping array
2019-08-29	31260374	Pedergnana V	2019-07-01	J Interferon Cytokine Res	www.ncbi.nlm.nih.gov/pubmed/31260374	Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.	Response to interferon treatment in hepatitis C virus genotype 3	717 European, Asian and unknown ancestry responders, 541 European, Asian and unknown ancestry non-responders	NA	2p16.1	2	55025078	NR	RTN4			ENSG00000115310			rs13401937-?	rs13401937	0	13401937	splice_region_variant	0	NR	9E-7	6.045757490560675		1.94	NR	Affymetrix [~ 18000000] (imputed)	N	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	GCST008517	Genome-wide genotyping array
2019-08-29	31260374	Pedergnana V	2019-07-01	J Interferon Cytokine Res	www.ncbi.nlm.nih.gov/pubmed/31260374	Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.	Response to interferon treatment in hepatitis C virus genotype 3	717 European, Asian and unknown ancestry responders, 541 European, Asian and unknown ancestry non-responders	NA	12p12.1	12	22022003	NR	ABCC9 - CMAS	ENSG00000069431	ENSG00000111726		79460	24215	rs75707332-?	rs75707332	0	75707332	intergenic_variant	1	NR	1E-6	6.0		2.56	NR	Affymetrix [~ 18000000] (imputed)	N	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	GCST008517	Genome-wide genotyping array
2019-08-29	31260374	Pedergnana V	2019-07-01	J Interferon Cytokine Res	www.ncbi.nlm.nih.gov/pubmed/31260374	Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.	Response to interferon treatment in hepatitis C virus genotype 3	717 European, Asian and unknown ancestry responders, 541 European, Asian and unknown ancestry non-responders	NA	5q31.3	5	143150821	NR	ARHGAP26			ENSG00000145819			rs72799981-?	rs72799981	0	72799981	intron_variant	0	NR	1E-6	6.0		6.64	NR	Affymetrix [~ 18000000] (imputed)	N	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	GCST008517	Genome-wide genotyping array
2019-08-29	31260374	Pedergnana V	2019-07-01	J Interferon Cytokine Res	www.ncbi.nlm.nih.gov/pubmed/31260374	Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.	Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	325 European, Asian and unknown ancestry responders, 84 European, Asian and unknown ancestry non-responders	NA	7q31.1	7	109456395	NR							rs76810409-?	rs76810409	0	76810409	TF_binding_site_variant	1	NR	1E-6	6.0		Infinity	NR	Affymetrix [~ 18000000] (imputed)	N	response to antiviral drug	http://www.ebi.ac.uk/efo/EFO_0010123	GCST008520	Genome-wide genotyping array
2019-08-29	31260374	Pedergnana V	2019-07-01	J Interferon Cytokine Res	www.ncbi.nlm.nih.gov/pubmed/31260374	Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.	Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	325 European, Asian and unknown ancestry responders, 84 European, Asian and unknown ancestry non-responders	NA	15q26.1	15	93306014	NR							rs62042908-?	rs62042908	0	62042908	intron_variant	1	NR	1E-6	6.0		2.56	NR	Affymetrix [~ 18000000] (imputed)	N	response to antiviral drug	http://www.ebi.ac.uk/efo/EFO_0010123	GCST008520	Genome-wide genotyping array
2019-08-29	31260374	Pedergnana V	2019-07-01	J Interferon Cytokine Res	www.ncbi.nlm.nih.gov/pubmed/31260374	Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.	Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	325 European, Asian and unknown ancestry responders, 84 European, Asian and unknown ancestry non-responders	NA	6q15	6	91130685	NR							rs57030374-?	rs57030374	0	57030374	intergenic_variant	1	NR	2E-6	5.698970004336019		3.72	NR	Affymetrix [~ 18000000] (imputed)	N	response to antiviral drug	http://www.ebi.ac.uk/efo/EFO_0010123	GCST008520	Genome-wide genotyping array
2019-08-29	31260374	Pedergnana V	2019-07-01	J Interferon Cytokine Res	www.ncbi.nlm.nih.gov/pubmed/31260374	Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.	Pre-treatment viral load in hepatitis C virus genotype 3	1,498 European, Asian and unknown ancestry individuals	NA	19q13.2	19	39248489	NR	IFNL4			ENSG00000272395			rs4803221-?	rs4803221	0	4803221	missense_variant	0	NR	2E-11	10.698970004336019		0.284517	[0.21-0.36] unit decrease	Affymetrix [~ 18000000] (imputed)	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008515	Genome-wide genotyping array
2011-04-06	21364930	Bol SM	2011-02-25	PLoS One	www.ncbi.nlm.nih.gov/pubmed/21364930	Genome-wide association study identifies single nucleotide polymorphism in DYRK1A associated with replication of HIV-1 in monocyte-derived macrophages.	HIV-1 replication	191 European ancestry individuals	31 individuals	21q22.13	21	37368522	DYRK1A	DYRK1A			ENSG00000157540			rs12483205-?	rs12483205	0	12483205	intron_variant	0	NR	5E-6	5.301029995663981				Illumina [494656]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000990	Genome-wide genotyping array
2011-01-19	21160409	Petrovski S	2010-12-14	AIDS	www.ncbi.nlm.nih.gov/pubmed/21160409	Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population.	HIV-1 susceptibility	531 Sub-Saharan African ancestry cases, 848 Sub-Saharan African ancestry controls	NA	3q29	3	196201983	ZDHHC19	ZDHHC19			ENSG00000163958			rs11924930-?	rs11924930	0	11924930	intron_variant	0	0.40	7E-6	5.154901959985743				Illumina [~ 800000]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000918	Genome-wide genotyping array
2011-01-19	21160409	Petrovski S	2010-12-14	AIDS	www.ncbi.nlm.nih.gov/pubmed/21160409	Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population.	HIV-1 susceptibility	531 Sub-Saharan African ancestry cases, 848 Sub-Saharan African ancestry controls	NA	15q26.1	15	92635945	FAM174B	FAM174B			ENSG00000185442			rs285757-?	rs285757	0	285757	intron_variant	0	0.15	7E-6	5.154901959985743				Illumina [~ 800000]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000918	Genome-wide genotyping array
2011-01-19	21160409	Petrovski S	2010-12-14	AIDS	www.ncbi.nlm.nih.gov/pubmed/21160409	Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population.	HIV-1 susceptibility	531 Sub-Saharan African ancestry cases, 848 Sub-Saharan African ancestry controls	NA	10q26.3	10	130258151	GLRX3, TXNL3	LINC02646			ENSG00000236303			rs4751185-?	rs4751185	0	4751185	intron_variant	0	0.12	7E-6	5.154901959985743				Illumina [~ 800000]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000918	Genome-wide genotyping array
2011-01-19	21160409	Petrovski S	2010-12-14	AIDS	www.ncbi.nlm.nih.gov/pubmed/21160409	Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population.	HIV-1 susceptibility	531 Sub-Saharan African ancestry cases, 848 Sub-Saharan African ancestry controls	NA	11q23.3	11	116649810	BUD13	LINC02702			ENSG00000237937			rs1240773-?	rs1240773	0	1240773	intron_variant	0	0.12	8E-6	5.096910013008056				Illumina [~ 800000]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000918	Genome-wide genotyping array
2011-01-19	21160409	Petrovski S	2010-12-14	AIDS	www.ncbi.nlm.nih.gov/pubmed/21160409	Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population.	HIV-1 susceptibility	531 Sub-Saharan African ancestry cases, 848 Sub-Saharan African ancestry controls	NA	18q21.2	18	56188294	AC009271.7	LINC01539 - NA	ENSG00000267712			50758		rs12604483-?	rs12604483	0	12604483	non_coding_transcript_exon_variant	1	0.30	7E-6	5.154901959985743				Illumina [~ 800000]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000918	Genome-wide genotyping array
2011-01-19	21160409	Petrovski S	2010-12-14	AIDS	www.ncbi.nlm.nih.gov/pubmed/21160409	Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population.	HIV-1 susceptibility	531 Sub-Saharan African ancestry cases, 848 Sub-Saharan African ancestry controls	NA	9p24.1	9	7682601	AL591509.5	PPIAP33 - NA	ENSG00000178654			84224		rs842304-?	rs842304	0	842304	intergenic_variant	1	0.42	4E-6	5.3979400086720375				Illumina [~ 800000]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000918	Genome-wide genotyping array
2020-03-09	31710517	Allen RJ	2019-11-11	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/31710517	Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.	Idiopathic pulmonary fibrosis	2,668 European ancestry cases, 8,591 European ancestry controls	1,456 European ancestry cases, 11,874 European ancestry controls	3p21.31	3	44860894	KIF15	KIF15			ENSG00000163808			rs78238620-A	rs78238620	0	78238620	intron_variant	0	0.053	4E-14	13.397940008672037		1.54	[1.38-1.73]	Affymetrix, Illumina [10790934] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST009758	Genome-wide genotyping array
2020-03-09	31710517	Allen RJ	2019-11-11	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/31710517	Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.	Idiopathic pulmonary fibrosis	2,668 European ancestry cases, 8,591 European ancestry controls	1,456 European ancestry cases, 11,874 European ancestry controls	7p22.3	7	1869843	MAD1L1	MAD1L1			ENSG00000002822			rs12699415-A	rs12699415	0	12699415	intron_variant	0	0.42	9E-20	19.045757490560675		1.28	[1.21-1.35]	Affymetrix, Illumina [10790934] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST009758	Genome-wide genotyping array
2020-03-09	31710517	Allen RJ	2019-11-11	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/31710517	Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.	Idiopathic pulmonary fibrosis	2,668 European ancestry cases, 8,591 European ancestry controls	1,456 European ancestry cases, 11,874 European ancestry controls	8q24.12	8	119921886	DEPTOR	DEPTOR			ENSG00000155792			rs28513081-A	rs28513081	0	28513081	intron_variant	0	0.572	2E-11	10.698970004336019		1.2048193	[1.14-1.27]	Affymetrix, Illumina [10790934] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST009758	Genome-wide genotyping array
2020-03-09	31710517	Allen RJ	2019-11-11	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/31710517	Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.	Idiopathic pulmonary fibrosis	2,668 European ancestry cases, 8,591 European ancestry controls	1,456 European ancestry cases, 11,874 European ancestry controls	10q23.32	10	91511259	HECTD2	HECTD2			ENSG00000165338			rs537322302-G	rs537322302	0	537322302	intron_variant	0	0.003	6E-7	6.221848749616356		3.85	[2.27-6.54]	Affymetrix, Illumina [10790934] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST009758	Genome-wide genotyping array
2020-03-09	31710517	Allen RJ	2019-11-11	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/31710517	Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.	Idiopathic pulmonary fibrosis	2,668 European ancestry cases, 8,591 European ancestry controls	1,456 European ancestry cases, 11,874 European ancestry controls	20q13.33	20	63693038	RTEL1	RTEL1-TNFRSF6B, RTEL1			ENSG00000026036, ENSG00000258366			rs41308092-A	rs41308092	0	41308092	intron_variant	0	0.021	2E-10	9.698970004336019		1.82	[1.51-2.19]	Affymetrix, Illumina [10790934] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST009758	Genome-wide genotyping array
2020-03-09	31710517	Allen RJ	2019-11-11	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/31710517	Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.	Idiopathic pulmonary fibrosis	2,668 European ancestry cases, 8,591 European ancestry controls	1,456 European ancestry cases, 11,874 European ancestry controls	17q21.31	17	46137522	MAPT	KANSL1, KANSL1, KANSL1			ENSG00000120071, ENSG00000275867, ENSG00000278458			rs2077551-T	rs2077551	0	2077551	intron_variant	0	0.814	3E-16	15.522878745280337		1.4084507	[1.3-1.54]	Affymetrix, Illumina [10790934] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST009758	Genome-wide genotyping array
2020-03-09	31710517	Allen RJ	2019-11-11	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/31710517	Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.	Idiopathic pulmonary fibrosis	2,668 European ancestry cases, 8,591 European ancestry controls	1,456 European ancestry cases, 11,874 European ancestry controls	5p15.33	5	1282299	TERT	TERT			ENSG00000164362			rs7725218-G	rs7725218	0	7725218	intron_variant	0	0.675	2E-20	19.69897000433602		1.3888888	[1.3-1.49]	Affymetrix, Illumina [10790934] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST009758	Genome-wide genotyping array
2020-03-09	31710517	Allen RJ	2019-11-11	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/31710517	Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.	Idiopathic pulmonary fibrosis	2,668 European ancestry cases, 8,591 European ancestry controls	1,456 European ancestry cases, 11,874 European ancestry controls	13q34	13	112880670	ATP11A	ATP11A			ENSG00000068650			rs9577395-C	rs9577395	0	9577395	intron_variant	0	0.793	1E-10	10.0		1.2987013	[1.2-1.41]	Affymetrix, Illumina [10790934] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST009758	Genome-wide genotyping array
2020-03-09	31710517	Allen RJ	2019-11-11	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/31710517	Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.	Idiopathic pulmonary fibrosis	2,668 European ancestry cases, 8,591 European ancestry controls	1,456 European ancestry cases, 11,874 European ancestry controls	15q15.1	15	40428343	IVD	IVD			ENSG00000128928			rs59424629-T	rs59424629	0	59424629	intron_variant	0	0.539	7E-16	15.154901959985743		1.2987013	[1.22-1.41]	Affymetrix, Illumina [10790934] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST009758	Genome-wide genotyping array
2020-03-09	31710517	Allen RJ	2019-11-11	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/31710517	Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.	Idiopathic pulmonary fibrosis	2,668 European ancestry cases, 8,591 European ancestry controls	1,456 European ancestry cases, 11,874 European ancestry controls	4q22.1	4	88963935	FAM13A	FAM13A			ENSG00000138640			rs2013701-G	rs2013701	0	2013701	intron_variant	0	0.513	3E-13	12.522878745280337		1.2820514	[1.19-1.35]	Affymetrix, Illumina [10790934] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST009758	Genome-wide genotyping array
2020-03-09	31710517	Allen RJ	2019-11-11	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/31710517	Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.	Idiopathic pulmonary fibrosis	2,668 European ancestry cases, 8,591 European ancestry controls	1,456 European ancestry cases, 11,874 European ancestry controls	10q24.33	10	103913084	OBFC1	STN1			ENSG00000107960			rs11191865-A	rs11191865	0	11191865	intron_variant	0	0.491	9E-6	5.045757490560675		1.16	[1.09-1.24]	Affymetrix, Illumina [10790934] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST009758	Genome-wide genotyping array
2020-03-09	31710517	Allen RJ	2019-11-11	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/31710517	Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.	Idiopathic pulmonary fibrosis	2,668 European ancestry cases, 8,591 European ancestry controls	1,456 European ancestry cases, 11,874 European ancestry controls	15q25.3	15	85553985	AKAP13	AKAP13			ENSG00000170776			rs62023891-A	rs62023891	0	62023891	intron_variant	0	0.3	1E-10	10.0		1.27	[1.18-1.36]	Affymetrix, Illumina [10790934] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST009758	Genome-wide genotyping array
2020-03-09	31710517	Allen RJ	2019-11-11	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/31710517	Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.	Idiopathic pulmonary fibrosis	2,668 European ancestry cases, 8,591 European ancestry controls	1,456 European ancestry cases, 11,874 European ancestry controls	7q22.1	7	100032719	NR	ZKSCAN1			ENSG00000106261			rs2897075-T	rs2897075	0	2897075	intron_variant	0	0.391	3E-14	13.522878745280337		1.3	[1.21-1.38]	Affymetrix, Illumina [10790934] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST009758	Genome-wide genotyping array
2020-03-09	31710517	Allen RJ	2019-11-11	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/31710517	Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.	Idiopathic pulmonary fibrosis	2,668 European ancestry cases, 8,591 European ancestry controls	1,456 European ancestry cases, 11,874 European ancestry controls	3q26.2	3	169763483	LRRC34	RNU6-637P - TERC	ENSG00000206777	ENSG00000270141		43190	1037	rs12696304-G	rs12696304	0	12696304	regulatory_region_variant	1	0.279	7E-13	12.154901959985743		1.31	[1.21-1.40]	Affymetrix, Illumina [10790934] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST009758	Genome-wide genotyping array
2020-03-09	31710517	Allen RJ	2019-11-11	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/31710517	Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.	Idiopathic pulmonary fibrosis	2,668 European ancestry cases, 8,591 European ancestry controls	1,456 European ancestry cases, 11,874 European ancestry controls	19p13.3	19	4717660	DPP9	DPP9			ENSG00000142002			rs12610495-G	rs12610495	0	12610495	missense_variant	0	0.305	3E-12	11.522878745280337		1.31	[1.22-1.42]	Affymetrix, Illumina [10790934] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST009758	Genome-wide genotyping array
2020-03-09	31710517	Allen RJ	2019-11-11	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/31710517	Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.	Idiopathic pulmonary fibrosis	2,668 European ancestry cases, 8,591 European ancestry controls	1,456 European ancestry cases, 11,874 European ancestry controls	6p24.3	6	7562999	DSP	DSP			ENSG00000096696			rs2076295-G	rs2076295	0	2076295	intron_variant	0	0.469	3E-30	29.522878745280337		1.46	[1.37-1.56]	Affymetrix, Illumina [10790934] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST009758	Genome-wide genotyping array
2020-03-09	31710517	Allen RJ	2019-11-11	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/31710517	Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.	Idiopathic pulmonary fibrosis	2,668 European ancestry cases, 8,591 European ancestry controls	1,456 European ancestry cases, 11,874 European ancestry controls	11p15.5	11	1219991	MUC5B	MUC5AC - MUC5B	ENSG00000215182	ENSG00000117983		18853	3075	rs35705950-T	rs35705950	0	35705950	splice_region_variant	1	0.149	1E-203	203.0		4.84	[4.37-5.36]	Affymetrix, Illumina [10790934] (imputed)	N	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768	GCST009758	Genome-wide genotyping array
2009-12-28	20018961	Zhang FR	2009-12-16	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/20018961	Genomewide association study of leprosy.	Leprosy	706 Han Chinese ancestry cases, 1,225 Han Chinese ancestry controls	3,254 Chinese ancestry cases, 5,955 Chinese ancestry controls	9q32	9	114796423	TNFSF15	TNFSF15			ENSG00000181634			rs6478108-A	rs6478108	0	6478108	intron_variant	0	0.46	3E-21	20.522878745280337		1.37	[1.28-1.46]	Illumina [491883]	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST000546	Genome-wide genotyping array
2009-12-28	20018961	Zhang FR	2009-12-16	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/20018961	Genomewide association study of leprosy.	Leprosy	706 Han Chinese ancestry cases, 1,225 Han Chinese ancestry controls	3,254 Chinese ancestry cases, 5,955 Chinese ancestry controls	13q14.11	13	43883789	C13orf31	LACC1			ENSG00000179630			rs3764147-G	rs3764147	0	3764147	missense_variant	0	0.31	4E-54	53.39794000867204		1.68	[1.57-1.80]	Illumina [491883]	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST000546	Genome-wide genotyping array
2009-12-28	20018961	Zhang FR	2009-12-16	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/20018961	Genomewide association study of leprosy.	Leprosy	706 Han Chinese ancestry cases, 1,225 Han Chinese ancestry controls	3,254 Chinese ancestry cases, 5,955 Chinese ancestry controls	16q12.1	16	50685192	NOD2	SNX20 - NOD2	ENSG00000167208	ENSG00000167207		3839	8396	rs9302752-G	rs9302752	0	9302752	intergenic_variant	1	0.29	4E-40	39.39794000867204		1.59	[1.49-1.71]	Illumina [491883]	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST000546	Genome-wide genotyping array
2009-12-28	20018961	Zhang FR	2009-12-16	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/20018961	Genomewide association study of leprosy.	Leprosy	706 Han Chinese ancestry cases, 1,225 Han Chinese ancestry controls	3,254 Chinese ancestry cases, 5,955 Chinese ancestry controls	6p21.32	6	32605852	HLA-DR-DQ	HLA-DRB1 - HLA-DQA1	ENSG00000206240	ENSG00000196735		16004	22327	rs602875-A	rs602875	0	602875	intron_variant	1	0.68	5E-27	26.30102999566398		1.61	[1.39-1.61]	Illumina [491883]	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST000546	Genome-wide genotyping array
2009-12-28	20018961	Zhang FR	2009-12-16	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/20018961	Genomewide association study of leprosy.	Leprosy	706 Han Chinese ancestry cases, 1,225 Han Chinese ancestry controls	3,254 Chinese ancestry cases, 5,955 Chinese ancestry controls	8q21.3	8	89811459	RIPK2	RIPK2 - COX6B1P6	ENSG00000104312	ENSG00000253349		20395	12089	rs40457-A	rs40457	0	40457	intergenic_variant	1	0.28	1E-12	12.0		1.3	[1.20-1.39]	Illumina [491883]	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST000546	Genome-wide genotyping array
2009-12-28	20018961	Zhang FR	2009-12-16	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/20018961	Genomewide association study of leprosy.	Leprosy	706 Han Chinese ancestry cases, 1,225 Han Chinese ancestry controls	3,254 Chinese ancestry cases, 5,955 Chinese ancestry controls	8q21.3	8	89766285	RIPK2	RIPK2			ENSG00000104312			rs42490-G	rs42490	0	42490	intron_variant	0	0.58	1E-16	16.0		1.32	[1.23-1.41]	Illumina [491883]	N	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054	GCST000546	Genome-wide genotyping array
2016-02-05	25897833	Thompson AG	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897833	Genome-wide association study of behavioural and psychiatric features in human prion disease.	Mood disorder in prion disease	Up to 170 cases	NA	11q24.1	11	121873470	SORL1							rs1219407-?	rs1219407	0	1219407	intron_variant	1	0.073	4E-6	5.3979400086720375		7.6	[2.8320.39]	Illumina [518938]	N	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	GCST002864	Genome-wide genotyping array
2016-02-05	25897833	Thompson AG	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897833	Genome-wide association study of behavioural and psychiatric features in human prion disease.	Mood disorder in prion disease	Up to 170 cases	NA	20p12.1	20	14329306	FLRT3	FLRT3, MACROD2			ENSG00000125848, ENSG00000172264			rs761998-?	rs761998	0	761998	5_prime_UTR_variant	0	0.352	7E-6	5.154901959985743		2.86	[1.82-4.55]	Illumina [518938]	N	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	GCST002864	Genome-wide genotyping array
2016-02-05	25897833	Thompson AG	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897833	Genome-wide association study of behavioural and psychiatric features in human prion disease.	Mood disorder in prion disease	Up to 170 cases	NA	11q21	11	94674570	PIWIL4	LINC02700 - AMOTL1	ENSG00000255666	ENSG00000166025		21686	31861	rs12789145-?	rs12789145	0	12789145	intron_variant	1	0.084	8E-6	5.096910013008056				Illumina [518938]	N	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247	GCST002864	Genome-wide genotyping array
2016-02-05	25897833	Thompson AG	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897833	Genome-wide association study of behavioural and psychiatric features in human prion disease.	Behavioral disturbance or psychiatric symptoms in prion disease	Up to 170 cases	NA	6p21.1	6	44053549	C6orf223	SCIRT			ENSG00000237686			rs9472202-?	rs9472202	0	9472202	intron_variant	0	0.208	8E-6	5.096910013008056		3.32	[1.92-5.73]	Illumina [518938]	N	Behavioral abnormality	http://purl.obolibrary.org/obo/HP_0000708	GCST002863	Genome-wide genotyping array
2016-02-05	25897833	Thompson AG	2015-04-21	Transl Psychiatry	www.ncbi.nlm.nih.gov/pubmed/25897833	Genome-wide association study of behavioural and psychiatric features in human prion disease.	Behavioral disturbance or psychiatric symptoms in prion disease	Up to 170 cases	NA	9q31.1	9	105107553	SLC44A1	RN7SKP191 - NA	ENSG00000201583			10492		rs4743805-?	rs4743805	0	4743805	intron_variant	1	0.165	6E-6	5.221848749616356		4.51	[2.249.08]	Illumina [518938]	N	Behavioral abnormality	http://purl.obolibrary.org/obo/HP_0000708	GCST002863	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Pneumonia	7,423 East Asian ancestry cases, 171,303 East Asian ancestry controls	NA	6p21.33	6	31351826		LINC02571 - HLA-B	ENSG00000256166	ENSG00000232126		50184	2046	rs28380929-T	rs28380929	0	28380929	intron_variant	1	0.015924804	5E-22	21.30102999566398		0.70876914	[0.56-0.85] unit increase	Illumina [13429980] (imputed)	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90018681	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Pneumonia	7,423 East Asian ancestry cases, 171,303 East Asian ancestry controls	NA	9q34.3	9	137420573		EXD3			ENSG00000187609			rs28787940-A	rs28787940	0	28787940	intron_variant	0	0.61860754	4E-8	7.3979400086720375		0.09555619	[0.061-0.13] unit decrease	Illumina [13429980] (imputed)	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90018681	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Pneumonia	16,887 European ancestry cases, 463,412 European ancestry controls, 7,423 East Asian ancestry cases, 171,303 East Asian ancestry controls	NA	6p21.33	6	31395105		HLA-S - MICA	ENSG00000225851	ENSG00000231225		12817	4679	rs183809241-C	rs183809241	0	183809241	non_coding_transcript_exon_variant	1	NR	9E-16	15.045757490560675		0.7693	[0.58-0.96] unit increase	Affymetrix, Illumina [25843326] (imputed)	N	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106	GCST90018901	Genome-wide genotyping array
2012-08-10	22737229	Nishida N	2012-06-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/22737229	Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean.	Hepatitis B (viral clearance)	181 East Asian ancestry HBV carriers, 184 East Asian ancestry controls, 185 East Asian ancestry spontaneously HBV-resolved individuals	Up to 8,045 East Asian ancestry HBV carriers, up to 9,003 East Asian ancestry controls, up to 3,995 East Asian ancestry spontaneously HBV-resolved individuals	6p21.32	6	33065245	HLA-DPA1	HLA-DPA1			ENSG00000235844			rs3077-C	rs3077	0	3077	3_prime_UTR_variant	0	0.60	1E-9	9.0	(Clearance of HBV)	1.67	[1.43-2.0]	Affymetrix [597789]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST001582	Genome-wide genotyping array
2012-08-10	22737229	Nishida N	2012-06-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/22737229	Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean.	Hepatitis B (viral clearance)	181 East Asian ancestry HBV carriers, 184 East Asian ancestry controls, 185 East Asian ancestry spontaneously HBV-resolved individuals	Up to 8,045 East Asian ancestry HBV carriers, up to 9,003 East Asian ancestry controls, up to 3,995 East Asian ancestry spontaneously HBV-resolved individuals	6p21.32	6	33087084	HLA-DPB1	HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1			ENSG00000215048, ENSG00000237710, ENSG00000223865, ENSG00000229295, ENSG00000226826, ENSG00000230708			rs9277535-G	rs9277535	0	9277535	3_prime_UTR_variant	0	0.57	2E-17	16.69897000433602	(Clearance of HBV)	1.52	[1.37-1.67]	Affymetrix [597789]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST001582	Genome-wide genotyping array
2012-08-10	22737229	Nishida N	2012-06-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/22737229	Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean.	Hepatitis B (viral clearance)	181 East Asian ancestry HBV carriers, 184 East Asian ancestry controls, 185 East Asian ancestry spontaneously HBV-resolved individuals	Up to 8,045 East Asian ancestry HBV carriers, up to 9,003 East Asian ancestry controls, up to 3,995 East Asian ancestry spontaneously HBV-resolved individuals	6p21.32	6	33065245	HLA-DPA1	HLA-DPA1			ENSG00000235844			rs3077-C	rs3077	0	3077	3_prime_UTR_variant	0	0.60	4E-45	44.39794000867204	(Protective effects against CHB)	1.82	[1.67-1.96]	Affymetrix [597789]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST001582	Genome-wide genotyping array
2012-08-10	22737229	Nishida N	2012-06-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/22737229	Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean.	Hepatitis B (viral clearance)	181 East Asian ancestry HBV carriers, 184 East Asian ancestry controls, 185 East Asian ancestry spontaneously HBV-resolved individuals	Up to 8,045 East Asian ancestry HBV carriers, up to 9,003 East Asian ancestry controls, up to 3,995 East Asian ancestry spontaneously HBV-resolved individuals	6p21.32	6	33087084	HLA-DPB1	HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1			ENSG00000215048, ENSG00000237710, ENSG00000223865, ENSG00000229295, ENSG00000226826, ENSG00000230708			rs9277535-G	rs9277535	0	9277535	3_prime_UTR_variant	0	0.57	2E-21	20.69897000433602	(Protective effects against CHB)	1.64	[1.47-1.82]	Affymetrix [597789]	N	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197	GCST001582	Genome-wide genotyping array
2017-02-15	27244555	Li Y	2016-05-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27244555	Genome-wide association study identifies 8p21.3 associated with persistent hepatitis B virus infection among Chinese.	Persistent hepatitis B virus infection	1,251 Chinese ancestry persistently infected cases, 1,057 Chinese ancestry spontaneously recovered controls	3,905 Chinese ancestry persistently infected cases, 3,356 Chinese ancestry spontaneously recovered controls	6p21.32	6	33207006	MIR219A1	HSD17B8 - MIR219A1	ENSG00000112474	ENSG00000199036		175	829	rs421446-G	rs421446	0	421446	regulatory_region_variant	1		3E-6	5.522878745280337		1.47	[1.25-1.72]	Affymetrix, Illumina [up to 4494311] (imputed)	N	hepatitis B virus infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0004197, http://www.orpha.net/ORDO/Orphanet_391311	GCST003615	Genome-wide genotyping array
2017-02-15	27244555	Li Y	2016-05-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27244555	Genome-wide association study identifies 8p21.3 associated with persistent hepatitis B virus infection among Chinese.	Persistent hepatitis B virus infection	1,251 Chinese ancestry persistently infected cases, 1,057 Chinese ancestry spontaneously recovered controls	3,905 Chinese ancestry persistently infected cases, 3,356 Chinese ancestry spontaneously recovered controls	6p21.32	6	33087084	HLA-DPB1	HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1			ENSG00000215048, ENSG00000237710, ENSG00000223865, ENSG00000229295, ENSG00000226826, ENSG00000230708			rs9277535-A	rs9277535	0	9277535	3_prime_UTR_variant	0		4E-6	5.3979400086720375		1.45	[1.23-1.69]	Affymetrix, Illumina [up to 4494311] (imputed)	N	hepatitis B virus infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0004197, http://www.orpha.net/ORDO/Orphanet_391311	GCST003615	Genome-wide genotyping array
2017-02-15	27244555	Li Y	2016-05-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27244555	Genome-wide association study identifies 8p21.3 associated with persistent hepatitis B virus infection among Chinese.	Persistent hepatitis B virus infection	1,251 Chinese ancestry persistently infected cases, 1,057 Chinese ancestry spontaneously recovered controls	3,905 Chinese ancestry persistently infected cases, 3,356 Chinese ancestry spontaneously recovered controls	8p21.3	8	20535695	INTS10, CSGALNACT1, LPL, SLC18A1, ATP6V1B2, LZTS1							rs7000921-C	rs7000921	0	7000921	intergenic_variant	1	0.278	3E-12	11.522878745280337		1.28	[1.19-1.37]	Affymetrix, Illumina [up to 4494311] (imputed)	N	hepatitis B virus infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0004197, http://www.orpha.net/ORDO/Orphanet_391311	GCST003615	Genome-wide genotyping array
2017-02-15	27244555	Li Y	2016-05-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27244555	Genome-wide association study identifies 8p21.3 associated with persistent hepatitis B virus infection among Chinese.	Persistent hepatitis B virus infection	1,251 Chinese ancestry persistently infected cases, 1,057 Chinese ancestry spontaneously recovered controls	3,905 Chinese ancestry persistently infected cases, 3,356 Chinese ancestry spontaneously recovered controls	6p21.32	6	32762235	HLA-DQB2	HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2, HLA-DQB2			ENSG00000232629, ENSG00000224305, ENSG00000228813, ENSG00000196610, ENSG00000229493, ENSG00000228254, ENSG00000226165			rs7453920-A	rs7453920	0	7453920	intron_variant	0		6E-6	5.221848749616356		2.0	[1.47-2.78]	Affymetrix, Illumina [up to 4494311] (imputed)	N	hepatitis B virus infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0004197, http://www.orpha.net/ORDO/Orphanet_391311	GCST003615	Genome-wide genotyping array
2018-05-11	29246937	Li Y	2018-02-15	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/29246937	Genome-Wide Association Study Identifies a New Locus at 7q21.13 Associated with Hepatitis B Virus-Related Hepatocellular Carcinoma.	Hepatitis B virus-related hepatocellular carcinoma	348 Chinese ancestry carrier cases, 359 Chinese ancestry carrier controls, 189 Chinese ancestry trios	3,796 Chinese ancestry carrier cases, 2,544 Chinese ancestry carrier controls	7q21.13	7	90689160	CDK14	CDK14			ENSG00000058091			rs10272859-G	rs10272859	0	10272859	intron_variant	0	0.313	9E-10	9.045757490560675		1.28	[1.18-1.38]	Affymetrix, Illumina [up to 6089459] (imputed)	N	hepatitis B virus infection, hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0004197, http://www.ebi.ac.uk/efo/EFO_0000182	GCST005570	Genome-wide genotyping array
2018-05-11	29246937	Li Y	2018-02-15	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/29246937	Genome-Wide Association Study Identifies a New Locus at 7q21.13 Associated with Hepatitis B Virus-Related Hepatocellular Carcinoma.	Hepatitis B virus-related hepatocellular carcinoma	348 Chinese ancestry carrier cases, 359 Chinese ancestry carrier controls, 189 Chinese ancestry trios	3,796 Chinese ancestry carrier cases, 2,544 Chinese ancestry carrier controls	1p36.22	1	10325413	KIF1B	KIF1B			ENSG00000054523			rs17401966-G	rs17401966	0	17401966	intron_variant	0	0.269	6E-6	5.221848749616356		1.89	[1.43-2.44]	Affymetrix, Illumina [up to 6089459] (imputed)	N	hepatitis B virus infection, hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0004197, http://www.ebi.ac.uk/efo/EFO_0000182	GCST005570	Genome-wide genotyping array
2019-06-14	31109976	Suvichapanich S	2019-05-20	Antimicrob Agents Chemother	www.ncbi.nlm.nih.gov/pubmed/31109976	Genome-Wide Association Study Confirming the Association of NAT2 with Susceptibility to Anti-tuberculosis Drug-Induced Liver Injury in Thai Patients.	Liver injury in anti-tuberculosis drug treatment	79 Thai ancestry cases, 239 Thai ancestry controls	NA	8p22	8	18415371	NAT2	NAT2 - PSD3	ENSG00000156006	ENSG00000156011		14153	111932	rs1495741-A	rs1495741	0	1495741	regulatory_region_variant	1	0.59	7E-11	10.154901959985743	(recessive)	6.01	[3.42-10.57]	Illumina [545492]	N	Tuberculosis, response to anti-tuberculosis drug, drug-induced liver injury	http://www.orpha.net/ORDO/Orphanet_3389, http://www.ebi.ac.uk/efo/EFO_0007918, http://www.ebi.ac.uk/efo/EFO_0004228	GCST007897	Genome-wide genotyping array
2019-06-14	31109976	Suvichapanich S	2019-05-20	Antimicrob Agents Chemother	www.ncbi.nlm.nih.gov/pubmed/31109976	Genome-Wide Association Study Confirming the Association of NAT2 with Susceptibility to Anti-tuberculosis Drug-Induced Liver Injury in Thai Patients.	Liver injury in anti-tuberculosis drug treatment	79 Thai ancestry cases, 239 Thai ancestry controls	NA	20p13	20	4725110	PRND	PRND			ENSG00000171864			rs2756263-G	rs2756263	0	2756263	3_prime_UTR_variant	0	0.40	7E-6	5.154901959985743	(dominant)	4.47	[2.19-9.11]	Illumina [545492]	N	Tuberculosis, response to anti-tuberculosis drug, drug-induced liver injury	http://www.orpha.net/ORDO/Orphanet_3389, http://www.ebi.ac.uk/efo/EFO_0007918, http://www.ebi.ac.uk/efo/EFO_0004228	GCST007897	Genome-wide genotyping array
2010-09-16	20694014	Thye T	2010-08-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20694014	Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2.	Tuberculosis	2,237 Sub-Saharan African ancestry cases, 3,122 Sub-Saharan African ancestry controls	1,462 Sub-Saharan African ancestry cases, 4,604 Sub-Saharan African ancestry controls	18q11.2	18	22610832	RBBP8, CABLES1, GATA6, CTAGE1	RPS4XP18 - RNU6-1032P	ENSG00000239490	ENSG00000206827		23605	36750	rs4331426-G	rs4331426	0	4331426	intergenic_variant	1	0.48	7E-9	8.154901959985743		1.19	[1.10-1.30]	Affymetrix [> 333754] (imputed)	N	Tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389	GCST000764	Genome-wide genotyping array
2016-12-13	26767831	Grant AV	2016-01-14	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/26767831	A genome-wide association study of pulmonary tuberculosis in Morocco.	Tuberculosis	up to 42 Moroccan ancestry affected parents, 210 Moroccan ancestry unaffected parents, up to 239 Moroccan ancestry affected offspring and 67 Moroccan ancestry unaffected offspring from 135 families	up to 317 Moroccan ancestry cases, 650 Moroccan ancestry controls	7p21.2	7	15554143	AGMO	AGMO			ENSG00000187546			rs916943-T	rs916943	0	916943	intron_variant	0	0.05	2E-6	5.698970004336019	(age at onset < 25 years)	2.73	[1.78-4.18]	Illumina [5390648] (imputed)	N	Tuberculosis, age at onset	http://www.orpha.net/ORDO/Orphanet_3389, http://www.ebi.ac.uk/efo/EFO_0004847	GCST003451	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Chronic hepatitis C infection	7,110 East Asian ancestry cases, 169,588 East Asian ancestry controls	NA	6p21.33	6	31356300		HLA-B			ENSG00000232126			rs709053-G	rs709053	0	709053	synonymous_variant	0	0.531697454	2E-9	8.698970004336019		0.10874995	[0.073-0.144] unit increase	Illumina [13429570] (imputed)	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST90018585	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Chronic hepatitis C infection	7,110 East Asian ancestry cases, 169,588 East Asian ancestry controls	NA	6p21.32	6	32694648		HLA-DQB1 - MTCO3P1	ENSG00000231939	ENSG00000237145		26265	11476	rs9275267-G	rs9275267	0	9275267	intergenic_variant	1	0.623579949	3E-12	11.522878745280337		0.1242382	[0.089-0.159] unit decrease	Illumina [13429570] (imputed)	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST90018585	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Chronic hepatitis C infection	273 European ancestry cases, 351,740 European ancestry controls, 7,110 East Asian ancestry cases, 169,588 East Asian ancestry controls	NA											chr1:225536401-C	chr1:225536401	0			1	NR	5E-8	7.301029995663981		1.9578	[1.25-2.66] unit increase	Affymetrix, Illumina [20457788] (imputed)	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST90018805	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Chronic hepatitis C infection	273 European ancestry cases, 351,740 European ancestry controls, 7,110 East Asian ancestry cases, 169,588 East Asian ancestry controls	NA	6p21.33	6	31413574		MICA, MICA, MICA			ENSG00000233051, ENSG00000204520, ENSG00000231225			rs2853968-G	rs2853968	0	2853968	intron_variant	0	NR	2E-10	9.698970004336019		0.1124	[0.078-0.147] unit increase	Affymetrix, Illumina [20457788] (imputed)	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST90018805	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Chronic hepatitis C infection	273 European ancestry cases, 351,740 European ancestry controls, 7,110 East Asian ancestry cases, 169,588 East Asian ancestry controls	NA	6p21.32	6	32694567		HLA-DQB1 - MTCO3P1	ENSG00000231939	ENSG00000237145		26184	11557	rs9275263-G	rs9275263	0	9275263	intergenic_variant	1	NR	2E-12	11.698970004336019		0.1228	[0.088-0.157] unit decrease	Affymetrix, Illumina [20457788] (imputed)	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST90018805	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Chronic hepatitis C infection	273 European ancestry cases, 351,740 European ancestry controls, 7,110 East Asian ancestry cases, 169,588 East Asian ancestry controls	NA	19q13.2	19	39252463		IFNL4 - MSRB1P1	ENSG00000272395	ENSG00000213926		3607	2453	rs8113007-T	rs8113007	0	8113007	intergenic_variant	1	NR	5E-22	21.30102999566398		0.2709	[0.22-0.33] unit increase	Affymetrix, Illumina [20457788] (imputed)	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST90018805	Genome-wide genotyping array
2021-08-13	33536081	Hu J	2021-02-03	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/33536081	Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data.	Mortality in COVID-19	292 European ancestry cases, 804 European ancestry controls	NA	1p34.1	1	44364495	NR	ERI3 - RNU6-369P	ENSG00000117419	ENSG00000199385		9235	26227	rs55989849-?	rs55989849	0	55989849	intergenic_variant	1	NR	1E-5	5.0				NR [18617478] (imputed)	N	COVID-19, mortality	http://purl.obolibrary.org/obo/MONDO_0100096, http://www.ebi.ac.uk/efo/EFO_0004352	GCST012192	Genome-wide genotyping array
2021-08-13	33536081	Hu J	2021-02-03	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/33536081	Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data.	Mortality in COVID-19	292 European ancestry cases, 804 European ancestry controls	NA	2p14	2	65660100	NR	NA - KRT18P33		ENSG00000214533			6595	rs56003331-?	rs56003331	0	56003331	intron_variant	1	NR	1E-5	5.0				NR [18617478] (imputed)	N	COVID-19, mortality	http://purl.obolibrary.org/obo/MONDO_0100096, http://www.ebi.ac.uk/efo/EFO_0004352	GCST012192	Genome-wide genotyping array
2021-08-13	33536081	Hu J	2021-02-03	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/33536081	Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data.	Mortality in COVID-19	292 European ancestry cases, 804 European ancestry controls	NA	3p13	3	72375778	NR	RYBP, RYBP			ENSG00000163602, ENSG00000281766			rs115769518-?	rs115769518	0	115769518	3_prime_UTR_variant	0	NR	1E-5	5.0				NR [18617478] (imputed)	N	COVID-19, mortality	http://purl.obolibrary.org/obo/MONDO_0100096, http://www.ebi.ac.uk/efo/EFO_0004352	GCST012192	Genome-wide genotyping array
2021-08-13	33536081	Hu J	2021-02-03	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/33536081	Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data.	Mortality in COVID-19	292 European ancestry cases, 804 European ancestry controls	NA	5p13.3	5	31656283	NR	PDZD2			ENSG00000133401			rs4867360-?	rs4867360	0	4867360	intron_variant	0	NR	1E-5	5.0				NR [18617478] (imputed)	N	COVID-19, mortality	http://purl.obolibrary.org/obo/MONDO_0100096, http://www.ebi.ac.uk/efo/EFO_0004352	GCST012192	Genome-wide genotyping array
2021-08-13	33536081	Hu J	2021-02-03	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/33536081	Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data.	Mortality in COVID-19	292 European ancestry cases, 804 European ancestry controls	NA	4q32.1	4	158971841	NR	C4orf45			ENSG00000164123			rs77272671-?	rs77272671	0	77272671	intron_variant	0	NR	1E-5	5.0				NR [18617478] (imputed)	N	COVID-19, mortality	http://purl.obolibrary.org/obo/MONDO_0100096, http://www.ebi.ac.uk/efo/EFO_0004352	GCST012192	Genome-wide genotyping array
2021-08-13	33536081	Hu J	2021-02-03	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/33536081	Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data.	Mortality in COVID-19	292 European ancestry cases, 804 European ancestry controls	NA	6p23	6	13942600	NR	RNF182			ENSG00000180537			rs280151-?	rs280151	0	280151	intron_variant	0	NR	1E-5	5.0				NR [18617478] (imputed)	N	COVID-19, mortality	http://purl.obolibrary.org/obo/MONDO_0100096, http://www.ebi.ac.uk/efo/EFO_0004352	GCST012192	Genome-wide genotyping array
2021-08-13	33536081	Hu J	2021-02-03	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/33536081	Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data.	Mortality in COVID-19	292 European ancestry cases, 804 European ancestry controls	NA	7q21.3	7	94591904	NR	SGCE			ENSG00000127990			rs78415215-?	rs78415215	0	78415215	intron_variant	0	NR	1E-5	5.0				NR [18617478] (imputed)	N	COVID-19, mortality	http://purl.obolibrary.org/obo/MONDO_0100096, http://www.ebi.ac.uk/efo/EFO_0004352	GCST012192	Genome-wide genotyping array
2021-08-13	33536081	Hu J	2021-02-03	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/33536081	Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data.	Mortality in COVID-19	292 European ancestry cases, 804 European ancestry controls	NA	8q22.1	8	97130901	NR	CPQ			ENSG00000104324			rs531453964-?	rs531453964	1	79868487	intron_variant	0	NR	3E-6	5.522878745280337		1.849	NR	NR [18617478] (imputed)	N	COVID-19, mortality	http://purl.obolibrary.org/obo/MONDO_0100096, http://www.ebi.ac.uk/efo/EFO_0004352	GCST012192	Genome-wide genotyping array
2021-08-13	33536081	Hu J	2021-02-03	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/33536081	Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data.	Mortality in COVID-19	292 European ancestry cases, 804 European ancestry controls	NA	11q13.4	11	70798734	NR	SHANK2			ENSG00000162105			rs11237534-?	rs11237534	0	11237534	intron_variant	0	NR	1E-5	5.0				NR [18617478] (imputed)	N	COVID-19, mortality	http://purl.obolibrary.org/obo/MONDO_0100096, http://www.ebi.ac.uk/efo/EFO_0004352	GCST012192	Genome-wide genotyping array
2021-08-13	33536081	Hu J	2021-02-03	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/33536081	Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data.	Mortality in COVID-19	292 European ancestry cases, 804 European ancestry controls	NA	12q23.3	12	108499011	NR	LINC01498			ENSG00000247213			rs75177500-?	rs75177500	0	75177500	intron_variant	0	NR	1E-5	5.0				NR [18617478] (imputed)	N	COVID-19, mortality	http://purl.obolibrary.org/obo/MONDO_0100096, http://www.ebi.ac.uk/efo/EFO_0004352	GCST012192	Genome-wide genotyping array
2021-08-13	33536081	Hu J	2021-02-03	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/33536081	Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data.	Mortality in COVID-19	292 European ancestry cases, 804 European ancestry controls	NA	18q23	18	77087562	NR	MBP			ENSG00000197971			rs7242091-?	rs7242091	0	7242091	non_coding_transcript_exon_variant	0	NR	1E-5	5.0				NR [18617478] (imputed)	N	COVID-19, mortality	http://purl.obolibrary.org/obo/MONDO_0100096, http://www.ebi.ac.uk/efo/EFO_0004352	GCST012192	Genome-wide genotyping array
2021-08-13	33536081	Hu J	2021-02-03	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/33536081	Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data.	Mortality in COVID-19	292 European ancestry cases, 804 European ancestry controls	NA	10q22.1	10	71985408	NR	CHST3			ENSG00000122863			rs76691147-?	rs76691147	0	76691147	intron_variant	0	NR	1E-5	5.0				NR [18617478] (imputed)	N	COVID-19, mortality	http://purl.obolibrary.org/obo/MONDO_0100096, http://www.ebi.ac.uk/efo/EFO_0004352	GCST012192	Genome-wide genotyping array
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	COVID-19 (critical illness vs population)	133 African ancestry cases, 2,610 African ancestry controls, 304 East Asian ancestry cases, 2,450 East Asian ancestry controls, 5,101 European ancestry cases, 1,383,241 European ancestry controls, 641 Hispanic or Latin American cases, 95,479 Hispanic or Latin American controls	NA	3p21.31	3	45823240		SLC6A20 - LZTFL1	ENSG00000163817	ENSG00000163818		26704	76	rs10490770-C	rs10490770	0	10490770	intron_variant	1	0.07517	2E-61	60.69897000433602		1.8848156	[1.7483625776346177-2.031918295499278]	Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095123	Genome-wide genotyping array
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	COVID-19 (critical illness vs population)	133 African ancestry cases, 2,610 African ancestry controls, 304 East Asian ancestry cases, 2,450 East Asian ancestry controls, 5,101 European ancestry cases, 1,383,241 European ancestry controls, 641 Hispanic or Latin American cases, 95,479 Hispanic or Latin American controls	NA	9q34.2	9	133274084		ABO, ABO			ENSG00000175164, ENSG00000281879			rs912805253-T	rs912805253	1	529565	intron_variant	0	0.6525	2E-6	5.698970004336019		0.87748975	[0.8313049698962632-0.9262404248214096]	Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095123	Genome-wide genotyping array
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	COVID-19 (critical illness vs population)	133 African ancestry cases, 2,610 African ancestry controls, 304 East Asian ancestry cases, 2,450 East Asian ancestry controls, 5,101 European ancestry cases, 1,383,241 European ancestry controls, 641 Hispanic or Latin American cases, 95,479 Hispanic or Latin American controls	NA	12q24.13	12	112919388		OAS1			ENSG00000089127			rs10774671-A	rs10774671	0	10774671	splice_acceptor_variant	0	0.6518	4E-13	12.397940008672037		1.1998901	[1.1422351034880305-1.2604553442434507]	Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095123	Genome-wide genotyping array
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	COVID-19 (critical illness vs population)	133 African ancestry cases, 2,610 African ancestry controls, 304 East Asian ancestry cases, 2,450 East Asian ancestry controls, 5,101 European ancestry cases, 1,383,241 European ancestry controls, 641 Hispanic or Latin American cases, 95,479 Hispanic or Latin American controls	NA	17q21.33	17	49863303		TAC4 - RNU6-1313P	ENSG00000176358	ENSG00000199492		15234	102772	rs77534576-T	rs77534576	0	77534576	regulatory_region_variant	1	0.03275	4E-9	8.397940008672037		1.4459405	[1.2784125078885984-1.635422073558583]	Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095123	Genome-wide genotyping array
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	COVID-19 (critical illness vs population)	133 African ancestry cases, 2,610 African ancestry controls, 304 East Asian ancestry cases, 2,450 East Asian ancestry controls, 5,101 European ancestry cases, 1,383,241 European ancestry controls, 641 Hispanic or Latin American cases, 95,479 Hispanic or Latin American controls	NA	19p13.3	19	4719431		DPP9			ENSG00000142002			rs2109069-A	rs2109069	0	2109069	intron_variant	0	0.3158	1E-21	21.0		1.2595191	[1.2014454336815512-1.3203998930516965]	Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095123	Genome-wide genotyping array
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	COVID-19 (critical illness vs population)	133 African ancestry cases, 2,610 African ancestry controls, 304 East Asian ancestry cases, 2,450 East Asian ancestry controls, 5,101 European ancestry cases, 1,383,241 European ancestry controls, 641 Hispanic or Latin American cases, 95,479 Hispanic or Latin American controls	NA	19p13.2	19	10317045		RAVER1			ENSG00000161847			rs74956615-A	rs74956615	0	74956615	3_prime_UTR_variant	0	0.04816	1E-11	11.0		1.4339889	[1.2926896399458667-1.5907330695298332]	Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095123	Genome-wide genotyping array
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	COVID-19 (critical illness vs population)	133 African ancestry cases, 2,610 African ancestry controls, 304 East Asian ancestry cases, 2,450 East Asian ancestry controls, 5,101 European ancestry cases, 1,383,241 European ancestry controls, 641 Hispanic or Latin American cases, 95,479 Hispanic or Latin American controls	NA	21q22.11	21	33242905		IFNAR2			ENSG00000159110			rs13050728-C	rs13050728	0	13050728	intron_variant	0	0.6617	1E-16	16.0		0.81885356	[0.7811041370023486-0.8584273728086177]	Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095123	Genome-wide genotyping array
2022-01-19	34775353	Mousa M	2021-11-11	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/34775353	Genome-wide association study of hospitalized COVID-19 patients in the United Arab Emirates.	COVID-19 severity	72 East Asian ancestry cases, 35 East Asian ancestry controls, 81 South Asian ancestry cases, 18 South Asian ancestry controls, 210 European ancestry cases, 92 European ancestry controls, 90 American ancestry cases, 12 American ancestry controls	NA	13q14.11	13	41746691		VWA8			ENSG00000102763			rs10507497-A	rs10507497	0	10507497	intron_variant	0	0.23	1E-6	6.0		3.12	[1.98-4.93]	Illumina [9175654] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90093112	Genome-wide genotyping array
2022-01-19	34775353	Mousa M	2021-11-11	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/34775353	Genome-wide association study of hospitalized COVID-19 patients in the United Arab Emirates.	COVID-19 severity	72 East Asian ancestry cases, 35 East Asian ancestry controls, 81 South Asian ancestry cases, 18 South Asian ancestry controls, 210 European ancestry cases, 92 European ancestry controls, 90 American ancestry cases, 12 American ancestry controls	NA	5q13.3	5	77379593		PDE8B			ENSG00000113231			rs7715119-A	rs7715119	0	7715119	intron_variant	0	0.15	2E-6	5.698970004336019		0.34	[0.22-0.54]	Illumina [9175654] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90093112	Genome-wide genotyping array
2022-01-19	34775353	Mousa M	2021-11-11	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/34775353	Genome-wide association study of hospitalized COVID-19 patients in the United Arab Emirates.	COVID-19 severity	72 East Asian ancestry cases, 35 East Asian ancestry controls, 81 South Asian ancestry cases, 18 South Asian ancestry controls, 210 European ancestry cases, 92 European ancestry controls, 90 American ancestry cases, 12 American ancestry controls	NA	11q14.2	11	88436431		GAPDHP70 - GRM5-AS1	ENSG00000249489	ENSG00000255082		27208	68145	rs72953026-T	rs72953026	0	72953026	regulatory_region_variant	1	0.18	2E-6	5.698970004336019		0.35	[0.23-0.54]	Illumina [9175654] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90093112	Genome-wide genotyping array
2022-01-19	34775353	Mousa M	2021-11-11	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/34775353	Genome-wide association study of hospitalized COVID-19 patients in the United Arab Emirates.	COVID-19 severity	72 East Asian ancestry cases, 35 East Asian ancestry controls, 81 South Asian ancestry cases, 18 South Asian ancestry controls, 210 European ancestry cases, 92 European ancestry controls, 90 American ancestry cases, 12 American ancestry controls	NA	2q22.1	2	136948486		THSD7B			ENSG00000144229			rs7605851-G	rs7605851	0	7605851	intron_variant	0	0.19	3E-6	5.522878745280337		0.35	[0.22-0.54]	Illumina [9175654] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90093112	Genome-wide genotyping array
2022-01-19	34775353	Mousa M	2021-11-11	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/34775353	Genome-wide association study of hospitalized COVID-19 patients in the United Arab Emirates.	COVID-19 severity	72 East Asian ancestry cases, 35 East Asian ancestry controls, 81 South Asian ancestry cases, 18 South Asian ancestry controls, 210 European ancestry cases, 92 European ancestry controls, 90 American ancestry cases, 12 American ancestry controls	NA	2q24.3	2	167953627		B3GALT1-AS1 - STK39	ENSG00000235335	ENSG00000198648		12447	393	rs7595310-A	rs7595310	0	7595310	downstream_gene_variant	1	0.26	5E-6	5.301029995663981		0.41	[0.27-0.59]	Illumina [9175654] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90093112	Genome-wide genotyping array
2022-01-19	34775353	Mousa M	2021-11-11	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/34775353	Genome-wide association study of hospitalized COVID-19 patients in the United Arab Emirates.	COVID-19 severity	72 East Asian ancestry cases, 35 East Asian ancestry controls, 81 South Asian ancestry cases, 18 South Asian ancestry controls, 210 European ancestry cases, 92 European ancestry controls, 90 American ancestry cases, 12 American ancestry controls	NA	14q22.3	14	55263686		FBXO34-AS1			ENSG00000258413			rs10140801-T	rs10140801	0	10140801	intron_variant	0	0.42	8E-6	5.096910013008056		2.1	[1.51-2.91]	Illumina [9175654] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90093112	Genome-wide genotyping array
2022-01-19	34775353	Mousa M	2021-11-11	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/34775353	Genome-wide association study of hospitalized COVID-19 patients in the United Arab Emirates.	COVID-19 severity	72 East Asian ancestry cases, 35 East Asian ancestry controls, 81 South Asian ancestry cases, 18 South Asian ancestry controls, 210 European ancestry cases, 92 European ancestry controls, 90 American ancestry cases, 12 American ancestry controls	NA	18p11.31	18	6461231		RNU6-349P - RPL6P27	ENSG00000199272	ENSG00000235552		6163	913	rs11659676-C	rs11659676	0	11659676	downstream_gene_variant	1	0.41	9E-6	5.045757490560675		0.48	[0.34-0.66]	Illumina [9175654] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90093112	Genome-wide genotyping array
2022-01-19	34775353	Mousa M	2021-11-11	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/34775353	Genome-wide association study of hospitalized COVID-19 patients in the United Arab Emirates.	COVID-19 severity	72 East Asian ancestry cases, 35 East Asian ancestry controls, 81 South Asian ancestry cases, 18 South Asian ancestry controls, 210 European ancestry cases, 92 European ancestry controls, 90 American ancestry cases, 12 American ancestry controls	NA	13q33.1	13	102695866		METTL21C - CCDC168	ENSG00000139780	ENSG00000175820		822	33501	rs599976-G	rs599976	0	599976	upstream_gene_variant	1	NR	9E-6	5.045757490560675		0.37	[0.24-1.22]	Illumina [9175654] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90093112	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls	NA	9q34.2	9	133270015		ABO, ABO			ENSG00000175164, ENSG00000281879			rs9411378-?	rs9411378	0	9411378	intron_variant	0	NR	1E-14	14.0		0.865	[0.834-0.898]	Illumina [31704722] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027250	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls	NA	3p21.31	3	45796808		SLC6A20 - LZTFL1	ENSG00000163817	ENSG00000163818		272	26508	rs2531743-?	rs2531743	0	2531743	intron_variant	1	NR	7E-8	7.154901959985743		0.918	[0.89-0.947]	Illumina [31704722] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027250	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls	NA	3p21.31	3	45867532		LZTFL1			ENSG00000163818			rs35044562-?	rs35044562	0	35044562	intron_variant	0	NR	5E-10	9.301029995663981		1.87	[1.557-2.246]	Illumina [21433846] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027251	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls	NA	Xq22.3	X	107471346		FRMPD3			ENSG00000147234			rs57801596-?	rs57801596	0	57801596	intron_variant	0	NR	2E-6	5.698970004336019		0.589	[0.484-0.717]	Illumina [21433846] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027251	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls	NA	3p21.31	3	45867532		LZTFL1			ENSG00000163818			rs35044562-?	rs35044562	0	35044562	intron_variant	0	NR	5E-10	9.301029995663981		1.87	[1.557-2.246]	Illumina [20506675] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027253	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls	NA	3p21.31	3	45820440		SLC6A20 - LZTFL1	ENSG00000163817	ENSG00000163818		23904	2876	rs13078854-?	rs13078854	0	13078854	non_coding_transcript_exon_variant	1	NR	4E-15	14.397940008672037		0.57	[0.5-0.649]	Illumina [2412076] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027254	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls	NA	9q34.2	9	133270015		ABO, ABO			ENSG00000175164, ENSG00000281879			rs9411378-?	rs9411378	0	9411378	intron_variant	0	NR	2E-6	5.698970004336019		0.818	[0.754-0.888]	Illumina [35218582] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027255	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls	NA	7q11.21	7	66879664		GTF2IRD1P1 - GTF2IP23	ENSG00000230583	ENSG00000230295		34782	1044	rs142658912-?	rs142658912	0	142658912	intergenic_variant	1	NR	1E-5	5.0		4.969	[2.772-8.908]	Illumina [19031602] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027258	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	39 Black or African American cases, 22,410 Black or African American controls	NA	10q22.3	10	78069803		GNAI2P2 - LINC00856	ENSG00000231957	ENSG00000230417		265	109382	rs117479047-?	rs117479047	0	117479047	intergenic_variant	1	NR	2E-6	5.698970004336019		0.054	[0.022-0.132]	Illumina [20847880] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027263	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA											chr12:105367111-?	chr12:105367111	0			1	NR	2E-6	5.698970004336019		0.3585776	[0.21-0.51] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA											esv3608396-?	esv3608396	0			1	NR	5E-6	5.301029995663981		0.9694092	[0.55-1.39] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	3p21.31	3	45796808		SLC6A20 - LZTFL1	ENSG00000163817	ENSG00000163818		272	26508	rs2531743-?	rs2531743	0	2531743	intron_variant	1	NR	8E-10	9.096910013008056		0.917	[0.892-0.942]	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	3p21.31	3	45867532		LZTFL1			ENSG00000163818			rs35044562-?	rs35044562	0	35044562	intron_variant	0	NR	4E-14	13.397940008672037		1.813	[1.555-2.114]	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-27	33949668	Ma Y	2021-05-05	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/33949668	Integrative Genomics Analysis Reveals a 21q22.11 Locus Contributing Risk to COVID-19.	COVID-19	3,288 European ancestry cases, 676,840 European ancestry controls	NA				SLC6A20							rs11385942-?	rs11385942	0	11385942		1		3E-16	15.522878745280337		1.61	[1.43-1.80]	NR [8424883] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST012399	Genome-wide genotyping array
2021-09-27	33949668	Ma Y	2021-05-05	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/33949668	Integrative Genomics Analysis Reveals a 21q22.11 Locus Contributing Risk to COVID-19.	COVID-19	3,288 European ancestry cases, 676,840 European ancestry controls	NA	9q34.2	9	133257522	ABO	ABO, ABO			ENSG00000175164, ENSG00000281879			rs8176719-?	rs8176719	0	8176719	frameshift_variant	0		5E-7	6.301029995663981		1.17	[1.10-1.25]	NR [8424883] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST012399	Genome-wide genotyping array
2021-09-27	33949668	Ma Y	2021-05-05	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/33949668	Integrative Genomics Analysis Reveals a 21q22.11 Locus Contributing Risk to COVID-19.	COVID-19	3,288 European ancestry cases, 676,840 European ancestry controls	NA				IFNAR2, IL10RB							rs9976829-?	rs9976829	0	9976829		1		3E-6	5.522878745280337		1.16	[1.09-1.23]	NR [8424883] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST012399	Genome-wide genotyping array
2012-11-04	22895189	Timmann C	2012-08-15	Nature	www.ncbi.nlm.nih.gov/pubmed/22895189	Genome-wide association study indicates two novel resistance loci for severe malaria.	Malaria	1,325 African ancestry, 828 African ancestry controls	2,229 African ancestry cases, 3,526 African ancestry controls	11p15.4	11	5496926	HBB	HBE1, OR51B5, HBG2			ENSG00000213931, ENSG00000167355, ENSG00000196565			rs372091-C	rs372091	0	372091	intron_variant	0	0.972	6E-14	13.221848749616356		2.17	[NR]	Affymetrix [4205739] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST001637	Genome-wide genotyping array
2012-11-04	22895189	Timmann C	2012-08-15	Nature	www.ncbi.nlm.nih.gov/pubmed/22895189	Genome-wide association study indicates two novel resistance loci for severe malaria.	Malaria	1,325 African ancestry, 828 African ancestry controls	2,229 African ancestry cases, 3,526 African ancestry controls	1q32.1	1	203684896	ATP2B4	ATP2B4			ENSG00000058668			rs10900585-T	rs10900585	0	10900585	intron_variant	0	0.62	2E-10	9.698970004336019		1.64	[NR]	Affymetrix [4205739] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST001637	Genome-wide genotyping array
2012-11-04	22895189	Timmann C	2012-08-15	Nature	www.ncbi.nlm.nih.gov/pubmed/22895189	Genome-wide association study indicates two novel resistance loci for severe malaria.	Malaria	1,325 African ancestry, 828 African ancestry controls	2,229 African ancestry cases, 3,526 African ancestry controls	9q34.2	9	133257522	ABO	ABO, ABO			ENSG00000175164, ENSG00000281879			rs8176719-G	rs8176719	0	8176719	frameshift_variant	0	0.37	4E-21	20.397940008672037		1.48	[NR]	Affymetrix [4205739] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST001637	Genome-wide genotyping array
2012-11-04	22895189	Timmann C	2012-08-15	Nature	www.ncbi.nlm.nih.gov/pubmed/22895189	Genome-wide association study indicates two novel resistance loci for severe malaria.	Malaria	1,325 African ancestry, 828 African ancestry controls	2,229 African ancestry cases, 3,526 African ancestry controls	16q22.2	16	71619734	MARVELD3	TAT-AS1 - MARVELD3	ENSG00000260886	ENSG00000140832		41547	6427	rs2334880-C	rs2334880	0	2334880	intergenic_variant	1	0.45	2E-6	5.698970004336019		1.19	[NR]	Affymetrix [4205739] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST001637	Genome-wide genotyping array
2013-11-20	23717212	Band G	2013-05-23	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23717212	Imputation-based meta-analysis of severe malaria in three African populations.	Malaria	5,425 African ancestry cases, 6,891 African ancestry controls	NA	2q32.1	2	184932501	NR	ZNF804A			ENSG00000170396			rs6755404-A	rs6755404	0	6755404	intron_variant	0	NR	1E-6	6.0		1.26	[1.15-1.38]	Illumina [1300000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST002033	Genome-wide genotyping array
2013-11-20	23717212	Band G	2013-05-23	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23717212	Imputation-based meta-analysis of severe malaria in three African populations.	Malaria	5,425 African ancestry cases, 6,891 African ancestry controls	NA	9q34.2	9	133257367	ABO	ABO, ABO			ENSG00000175164, ENSG00000281879			rs8176722-A	rs8176722	0	8176722	intron_variant	0	NR	9E-10	9.045757490560675		1.28	[1.19-1.39]	Illumina [1300000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST002033	Genome-wide genotyping array
2013-11-20	23717212	Band G	2013-05-23	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23717212	Imputation-based meta-analysis of severe malaria in three African populations.	Malaria	5,425 African ancestry cases, 6,891 African ancestry controls	NA	11p15.4	11	4769345	HBB	OR51F1, MMP26			ENSG00000280021, ENSG00000167346			rs12788102-A	rs12788102	0	12788102	synonymous_variant	0	NR	2E-16	15.698970004336019		2.15	[1.79-2.59]	Illumina [1300000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST002033	Genome-wide genotyping array
2013-11-20	23717212	Band G	2013-05-23	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23717212	Imputation-based meta-analysis of severe malaria in three African populations.	Malaria	5,425 African ancestry cases, 6,891 African ancestry controls	NA	11q23.1	11	110870290	NR	HNRNPA1P60 - NA	ENSG00000233497			81314		rs1469170-A	rs1469170	0	1469170	intergenic_variant	1	NR	8E-8	7.096910013008056		1.2	[1.12-1.29]	Illumina [1300000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST002033	Genome-wide genotyping array
2013-11-20	23717212	Band G	2013-05-23	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23717212	Imputation-based meta-analysis of severe malaria in three African populations.	Malaria	5,425 African ancestry cases, 6,891 African ancestry controls	NA	14q13.3	14	36384931	NR	DPPA3P2 - RNU7-93P	ENSG00000188831	ENSG00000238540		12548	20283	rs12590640-T	rs12590640	0	12590640	intron_variant	1	NR	4E-6	5.3979400086720375		1.15	[1.09-1.23]	Illumina [1300000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST002033	Genome-wide genotyping array
2013-11-20	23717212	Band G	2013-05-23	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23717212	Imputation-based meta-analysis of severe malaria in three African populations.	Malaria	5,425 African ancestry cases, 6,891 African ancestry controls	NA	16q23.3	16	83327170	NR	CDH13			ENSG00000140945			rs9940464-T	rs9940464	0	9940464	intron_variant	0	NR	5E-7	6.301029995663981		1.17	[1.10-1.25]	Illumina [1300000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST002033	Genome-wide genotyping array
2018-03-12	29381699	Ravenhall M	2018-01-30	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/29381699	Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.	Severe malaria (adjusted for sickle cell variant rs334)	449 Tanzanian ancestry cases, 465 Tanzanian ancestry controls	NA	4q35.2	4	189796550	AF146191.4-004	FRG1-DT, FRG1-DT, FRG1-DT, FRG1-DT			ENSG00000280716, ENSG00000281543, ENSG00000281787, ENSG00000245685			rs114169033-?	rs114169033	0	114169033	intron_variant	0	NR	1E-6	6.0	(Additive)		[NR]	Illumina [15200000] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST005357	Genome-wide genotyping array
2021-12-14	34594039	Sakaue S	2021-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Chronic hepatitis B infection	145 European ancestry cases, 351,740 European ancestry controls, 2,234 East Asian ancestry cases, 169,588 East Asian ancestry controls	NA	6p21.32	6	33084120		HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1, HLA-DPB1			ENSG00000215048, ENSG00000237710, ENSG00000223865, ENSG00000229295, ENSG00000226826, ENSG00000230708			rs142975055-GAAATA	rs142975055	0	142975055	intron_variant	0	NR	1E-44	44.0		0.4385	[0.38-0.5] unit increase	Affymetrix, Illumina [20457334] (imputed)	N	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239	GCST90018804	Genome-wide genotyping array
2013-09-25	20064070	Herbeck JT	2010-02-15	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/20064070	Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS.	HIV-1 progression	51 European ancestry rapid progressor male cases, 57 European ancestry moderate progressor male cases, 48 European ancestry long-term progressor male cases	590 European ancestry seroconverter male cases	1q32.3	1	213951784	PROX1	PROX1-AS1			ENSG00000230461			rs17762192-G	rs17762192	0	17762192	intron_variant	0	0.59	2E-6	5.698970004336019		1.45	[NR]	Affymetrix [345926]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000596	Genome-wide genotyping array
2010-05-10	20205591	Pelak K	2010-04-15	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/20205591	Host determinants of HIV-1 control in African Americans.	HIV-1 viral setpoint	515 African American cases	NA	13q31.3	13	92561223	GPC5	GPC5			ENSG00000179399			rs1413191-?	rs1413191	0	1413191	intron_variant	0	0.18	5E-6	5.301029995663981				Illumina [1212217]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000656	Genome-wide genotyping array
2010-05-10	20205591	Pelak K	2010-04-15	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/20205591	Host determinants of HIV-1 control in African Americans.	HIV-1 viral setpoint	515 African American cases	NA	3p24.3	3	22080904	AC023798.16	ZNF385D			ENSG00000151789			rs2593321-?	rs2593321	0	2593321	intron_variant	0	0.23	8E-6	5.096910013008056				Illumina [1212217]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000656	Genome-wide genotyping array
2010-05-10	20205591	Pelak K	2010-04-15	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/20205591	Host determinants of HIV-1 control in African Americans.	HIV-1 viral setpoint	515 African American cases	NA	8p21.3	8	22547327	SORBS3	SORBS3			ENSG00000120896			rs2280890-?	rs2280890	0	2280890	intron_variant	0	0.01	9E-6	5.045757490560675				Illumina [1212217]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000656	Genome-wide genotyping array
2010-05-10	20205591	Pelak K	2010-04-15	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/20205591	Host determinants of HIV-1 control in African Americans.	HIV-1 viral setpoint	515 African American cases	NA	6q22.31	6	120778991	RP11-100A16.1	RNA5SP215 - COX6A1P3	ENSG00000200310	ENSG00000216710		92249	2229	rs2789066-?	rs2789066	0	2789066	intergenic_variant	1	0.13	9E-6	5.045757490560675				Illumina [1212217]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000656	Genome-wide genotyping array
2010-05-10	20205591	Pelak K	2010-04-15	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/20205591	Host determinants of HIV-1 control in African Americans.	HIV-1 viral setpoint	515 African American cases	NA	20p12.3	20	5963047	MCM8	MCM8			ENSG00000125885			rs454422-?	rs454422	0	454422	intron_variant	0	0.26	1E-6	6.0				Illumina [1212217]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000656	Genome-wide genotyping array
2010-05-10	20205591	Pelak K	2010-04-15	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/20205591	Host determinants of HIV-1 control in African Americans.	HIV-1 viral setpoint	515 African American cases	NA	7p14.2	7	36570887	AOAH	AOAH			ENSG00000136250			rs6948404-?	rs6948404	0	6948404	intron_variant	0	0.07	3E-6	5.522878745280337				Illumina [1212217]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000656	Genome-wide genotyping array
2010-05-10	20205591	Pelak K	2010-04-15	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/20205591	Host determinants of HIV-1 control in African Americans.	HIV-1 viral setpoint	515 African American cases	NA	19p13.2	19	7844997	EVI5L	EVI5L			ENSG00000142459			rs558718-?	rs558718	0	558718	intron_variant	0	0.11	4E-6	5.3979400086720375				Illumina [1212217]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000656	Genome-wide genotyping array
2010-05-10	20205591	Pelak K	2010-04-15	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/20205591	Host determinants of HIV-1 control in African Americans.	HIV-1 viral setpoint	515 African American cases	NA	11q14.1	11	81143332	intergenic	PSMA1 - NA	ENSG00000129084			66499697		rs1357339-?	rs1357339	0	1357339	intergenic_variant	1	0.04	5E-6	5.301029995663981				Illumina [1212217]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000656	Genome-wide genotyping array
2010-05-10	20205591	Pelak K	2010-04-15	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/20205591	Host determinants of HIV-1 control in African Americans.	HIV-1 viral setpoint	515 African American cases	NA	6p21.33	6	31354782	HLA-B	HLA-B			ENSG00000232126			rs2523608-?	rs2523608	0	2523608	non_coding_transcript_exon_variant	0	0.37	3E-6	5.522878745280337				Illumina [1212217]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000656	Genome-wide genotyping array
2010-05-10	20205591	Pelak K	2010-04-15	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/20205591	Host determinants of HIV-1 control in African Americans.	HIV-1 viral setpoint	515 African American cases	NA	8p21.3	8	22543476	PPP3CC	PPP3CC - SORBS3	ENSG00000120910	ENSG00000120896		2334	1510	rs4872511-?	rs4872511	0	4872511	non_coding_transcript_exon_variant	1	0.01	9E-6	5.045757490560675				Illumina [1212217]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000656	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	8 European ancestry cases, 12 African American cases, 3 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	2q32.3	2	194695273	intergenic	Metazoa_SRP - LINC01790	ENSG00000277055	ENSG00000230173		36598	35322	rs801378-?	rs801378	0	801378	intergenic_variant	1		2E-8	7.698970004336019	(Hispanic)		[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002363	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	8 European ancestry cases, 12 African American cases, 3 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	7p21.1	7	18464885	HDAC9	HDAC9			ENSG00000048052			rs213273-?	rs213273	0	213273	intron_variant	0		2E-8	7.698970004336019	(Hispanic)		[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002363	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	19 European ancestry cases, 30 African American cases, 9 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	8p21.2	8	24942229	NEFL	NEFM - NEFL	ENSG00000104722	ENSG00000277586		23131	8726	rs6557786-?	rs6557786	0	6557786	intergenic_variant	1	NR	5E-6	5.301029995663981	(Hispanic)	23.2	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002365	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	19 European ancestry cases, 30 African American cases, 9 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	Xq27.3	X	144281548	intergenic	NA - RRM2P4		ENSG00000235598			27584	rs6637197-?	rs6637197	0	6637197	intergenic_variant	1		1E-6	6.0	(EA)	14.9	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002365	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	19 European ancestry cases, 30 African American cases, 9 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	13q31.3	13	93226778	GPC6	NA - GPC6		ENSG00000183098			29	rs7985891-?	rs7985891	0	7985891	non_coding_transcript_exon_variant	1		2E-7	6.698970004336019	(EA)	38.2	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002365	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	19 European ancestry cases, 30 African American cases, 9 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	10q23.31	10	89981680	KIF20B	LINC01374			ENSG00000280560			rs10509586-?	rs10509586	0	10509586	intron_variant	0		4E-7	6.3979400086720375	(EA)	9.3	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002365	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	19 European ancestry cases, 30 African American cases, 9 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	2q14.1	2	112906296	IL37	XIAPP3 - IL37	ENSG00000180152	ENSG00000125571		52174	4869	rs2708973-?	rs2708973	0	2708973	intergenic_variant	1		3E-6	5.522878745280337	(EA)	31.7	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002365	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	19 European ancestry cases, 30 African American cases, 9 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	14q22.3	14	55017068	WDHD1	WDHD1			ENSG00000198554			rs28489712-?	rs28489712	0	28489712	intron_variant	0		3E-6	5.522878745280337	(EA)	31.7	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002365	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	19 European ancestry cases, 30 African American cases, 9 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	7p15.2	7	26143746	NFE2L3	NA - NFE2L3		ENSG00000050344			8452	rs4722585-?	rs4722585	0	4722585	regulatory_region_variant	1		5E-6	5.301029995663981	(AA)	5.0	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002365	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	19 European ancestry cases, 30 African American cases, 9 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	2p24.3	2	16458298	FAM49A	NA - CYRIA		ENSG00000197872			91161	rs1346751-?	rs1346751	0	1346751	intergenic_variant	1		8E-6	5.096910013008056	(AA)	10.0	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002365	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	19 European ancestry cases, 30 African American cases, 9 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	20p13	20	945754	RSP04	ANGPT4 - RSPO4	ENSG00000101280	ENSG00000101282		29420	12698	rs502716-?	rs502716	0	502716	regulatory_region_variant	1		3E-8	7.522878745280337	(Hispanic)	28.0	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002365	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	19 European ancestry cases, 30 African American cases, 9 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	13q33.3	13	106686453	LINCOO443	LINC00551			ENSG00000272274			rs1330950-?	rs1330950	0	1330950	intron_variant	0		8E-7	6.096910013008056	(Hispanic)	17.5	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002365	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	19 European ancestry cases, 30 African American cases, 9 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	16q24.2	16	87331044	FBX031	FBXO31			ENSG00000103264			rs1062746-?	rs1062746	0	1062746	3_prime_UTR_variant	0		2E-6	5.698970004336019	(Hispanic)	15.6	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002365	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	19 European ancestry cases, 30 African American cases, 9 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	9p24.2	9	3844061	GLIS3	GLIS3			ENSG00000107249			rs717423-?	rs717423	0	717423	intron_variant	0		4E-6	5.3979400086720375	(Hispanic)	14.1	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002365	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	19 European ancestry cases, 30 African American cases, 9 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	1q21.3	1	154429203	IL6R	IL6R			ENSG00000160712			rs8192282-?	rs8192282	1	2228144	synonymous_variant	0		5E-6	5.301029995663981	(Hispanic)	23.2	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002365	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	40 European ancestry cases, 37 African American cases, 13 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	18p11.22	18	8931654	intergenic	MTCL1 - RPS4XP19	ENSG00000168502	ENSG00000242058		98876	88375	rs7244245-?	rs7244245	0	7244245	intergenic_variant	1		1E-6	6.0	(EA)	5.365	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002366	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	40 European ancestry cases, 37 African American cases, 13 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	17q24.3	17	69436244	MAP2K6	MAP2K6			ENSG00000108984			rs817565-?	rs817565	0	817565	intron_variant	0		3E-6	5.522878745280337	(EA)	3.779	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002366	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	40 European ancestry cases, 37 African American cases, 13 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	7q33	7	134805711	CALD1	CALD1			ENSG00000122786			rs17169635-?	rs17169635	0	17169635	intron_variant	0		6E-6	5.221848749616356	(EA)	3.526	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002366	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	40 European ancestry cases, 37 African American cases, 13 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	7p15.3	7	24067707	intergenic	NA - RNA5SP228		ENSG00000252041			64998	rs10216322-?	rs10216322	0	10216322	intergenic_variant	1		8E-6	5.096910013008056	(EA)	4.776	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002366	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	40 European ancestry cases, 37 African American cases, 13 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	7p15.2	7	26143746	NFE2L3	NA - NFE2L3		ENSG00000050344			8452	rs4722585-?	rs4722585	0	4722585	regulatory_region_variant	1		5E-6	5.301029995663981	(AA)	5.0	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002366	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	40 European ancestry cases, 37 African American cases, 13 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	10q24.2	10	98922691	HPSE2	HPSE2			ENSG00000172987			rs11189867-?	rs11189867	0	11189867	intron_variant	0		7E-6	5.154901959985743	(AA)	26.8	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002366	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	40 European ancestry cases, 37 African American cases, 13 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	12q14.1	12	62164533	FAM19A2	TAFA2			ENSG00000198673			rs10784285-?	rs10784285	0	10784285	intron_variant	0		9E-6	5.045757490560675	(AA)	4.1	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002366	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	40 European ancestry cases, 37 African American cases, 13 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	19q13.32	19	46297176	HIF3A	HIF3A			ENSG00000124440			rs3826795-?	rs3826795	0	3826795	intron_variant	0		3E-6	5.522878745280337	(Hispanic)	12.8	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002366	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	40 European ancestry cases, 37 African American cases, 13 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	14q24.3	14	77954715	ADCK1	ADCK1 - NA	ENSG00000063761			19701		rs4899685-?	rs4899685	0	4899685	intergenic_variant	1		4E-6	5.3979400086720375	(Hispanic)	14.0	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002366	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	40 European ancestry cases, 37 African American cases, 13 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	20p13	20	945754	RSP04	ANGPT4 - RSPO4	ENSG00000101280	ENSG00000101282		29420	12698	rs502716-?	rs502716	0	502716	regulatory_region_variant	1		4E-6	5.3979400086720375	(Hispanic)	14.0	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002366	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	40 European ancestry cases, 37 African American cases, 13 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	3q13.33	3	121365620	STXBP5L	STXBP5L			ENSG00000145087			rs11707293-?	rs11707293	0	11707293	intron_variant	0		5E-6	5.301029995663981	(Hispanic)	14.2	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002366	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	8 European ancestry cases, 12 African American cases, 3 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	11q12.3	11	62693757	BSCL2	BSCL2, HNRNPUL2-BSCL2			ENSG00000168000, ENSG00000234857			rs575134-?	rs575134	0	575134	intron_variant	0	NR	6E-6	5.221848749616356	(Hispanic)			Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002363	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	8 European ancestry cases, 12 African American cases, 3 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	16p13.13	16	11607793	LITAF	LITAF			ENSG00000189067			rs13333308-?	rs13333308	0	13333308	intron_variant	0	NR	6E-6	5.221848749616356	(AA)	32.3	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002363	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	8 European ancestry cases, 12 African American cases, 3 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	6q12	6	66117392	NEFL	NUFIP1P1 - NA	ENSG00000218890			22483		rs1776368-?	rs1776368	1	1100950	intergenic_variant	1	NR	6E-6	5.221848749616356	(Hispanic)			Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002363	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	8 European ancestry cases, 12 African American cases, 3 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	10q11.21	10	44368720	CXCL12	LINC02881 - CXCL12	ENSG00000277288	ENSG00000107562		74071	1445	rs266095-?	rs266095	0	266095	regulatory_region_variant	1		8E-9	8.096910013008056	(EA)	56.3	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002363	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	8 European ancestry cases, 12 African American cases, 3 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	3p14.1	3	66395177	LRIG1	LRIG1			ENSG00000144749			rs9827908-?	rs9827908	0	9827908	intron_variant	0		6E-8	7.221848749616356	(AA)	48.5	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002363	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	8 European ancestry cases, 12 African American cases, 3 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	10p15.1	10	6061799	IL2RA	IL2RA			ENSG00000134460			rs12722486-?	rs12722486	0	12722486	intron_variant	0		2E-9	8.698970004336019	(EA)	38.2	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002363	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	8 European ancestry cases, 12 African American cases, 3 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	6p25.3	6	221146	intergenic	CICP18 - DUSP22	ENSG00000217929	ENSG00000112679		76063	70484	rs9501753-?	rs9501753	0	9501753	intergenic_variant	1		1E-8	8.0	(EA)		[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002363	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	8 European ancestry cases, 12 African American cases, 3 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	12q15	12	70560684	PTPRB	PTPRB			ENSG00000127329			rs17108344-?	rs17108344	0	17108344	synonymous_variant	0		3E-8	7.522878745280337	(EA)	25.3	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002363	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	8 European ancestry cases, 12 African American cases, 3 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	1q25.3	1	182052148	ZNF648	NA - ZNF648		ENSG00000179930			2422	rs7554182-?	rs7554182	0	7554182	TF_binding_site_variant	1		6E-8	7.221848749616356	(AA)	48.5	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002363	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	8 European ancestry cases, 12 African American cases, 3 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	2p16.3	2	49270867	intergenic	RNU6-439P - NA	ENSG00000206915			36968		rs9636436-?	rs9636436	0	9636436	intron_variant	1		2E-7	6.698970004336019	(AA)	11.1	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002363	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	8 European ancestry cases, 12 African American cases, 3 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	2p25.3	2	1434216	CHST9	TPO			ENSG00000115705			rs1514687-?	rs1514687	0	1514687	intron_variant	0		2E-7	6.698970004336019	(AA)	16.8	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002363	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	8 European ancestry cases, 12 African American cases, 3 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	2p16.3	2	49264671	FSHR	RNU6-439P - NA	ENSG00000206915			30772		rs10495970-?	rs10495970	0	10495970	intron_variant	1		5E-7	6.301029995663981	(AA)	10.3	[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002363	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	8 European ancestry cases, 12 African American cases, 3 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	2q24.2	2	161172602	TANK	TANK			ENSG00000136560			rs7568498-?	rs7568498	0	7568498	intron_variant	0		2E-8	7.698970004336019	(Hispanic)		[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002363	Genome-wide genotyping array
2014-10-28	24554482	Leger PD	2014-02-20	J Neurovirol	www.ncbi.nlm.nih.gov/pubmed/24554482	Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	8 European ancestry cases, 12 African American cases, 3 Hispanic cases, 85 European ancestry controls, 49 African American controls, 30 Hispanic controls	NA	2q32.3	2	194682669	intergenic	Metazoa_SRP - LINC01790	ENSG00000277055	ENSG00000230173		23994	47926	rs801350-?	rs801350	0	801350	intergenic_variant	1		2E-8	7.698970004336019	(Hispanic)		[NR]	Illumina [936149]	N	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0000180, http://www.ebi.ac.uk/efo/EFO_0003100	GCST002363	Genome-wide genotyping array
2012-09-26	22841784	Patin E	2012-07-26	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/22841784	Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.	Hepatitis C induced liver fibrosis	1,161 European ancestry HCV-infected individuals	1,181 European ancestry HCV-infected individuals	3q23	3	141744456	RNF7	RNF7			ENSG00000114125			rs16851720-C	rs16851720	0	16851720	intron_variant	0	0.19	9E-9	8.045757490560675	(QTF)			Illumina [780650] (imputed)	N	hepatitis C virus infection, cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0003047, http://www.ebi.ac.uk/efo/EFO_0001422	GCST001623	Genome-wide genotyping array
2012-09-26	22841784	Patin E	2012-07-26	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/22841784	Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.	Hepatitis C induced liver fibrosis	1,161 European ancestry HCV-infected individuals	1,181 European ancestry HCV-infected individuals				MERTK							rs4374383-A	rs4374383	0	4374383	intron_variant	1	0.42	1E-9	9.0	(Duration F0-1/F3-4, transfused)			Illumina [780650] (imputed)	N	hepatitis C virus infection, cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0003047, http://www.ebi.ac.uk/efo/EFO_0001422	GCST001623	Genome-wide genotyping array
2012-09-26	22841784	Patin E	2012-07-26	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/22841784	Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.	Hepatitis C induced liver fibrosis	1,161 European ancestry HCV-infected individuals	1,181 European ancestry HCV-infected individuals	6p21.31	6	35534425	TULP1	TULP1 - FKBP5	ENSG00000112041	ENSG00000096060		21529	39160	rs9380516-T	rs9380516	0	9380516	TF_binding_site_variant	1	0.17	5E-7	6.301029995663981	(Duration F0-1/F3-4, male)			Illumina [780650] (imputed)	N	hepatitis C virus infection, cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0003047, http://www.ebi.ac.uk/efo/EFO_0001422	GCST001623	Genome-wide genotyping array
2012-09-26	22841784	Patin E	2012-07-26	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/22841784	Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.	Hepatitis C induced liver fibrosis	1,161 European ancestry HCV-infected individuals	1,181 European ancestry HCV-infected individuals	12q23.3	12	104028030	GLT8D2	GLT8D2			ENSG00000120820			rs2629751-G	rs2629751	0	2629751	intron_variant	0	0.31	1E-7	7.0	(Binary F0/F4)			Illumina [780650] (imputed)	N	hepatitis C virus infection, cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0003047, http://www.ebi.ac.uk/efo/EFO_0001422	GCST001623	Genome-wide genotyping array
2012-09-26	22841784	Patin E	2012-07-26	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/22841784	Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.	Hepatitis C induced liver fibrosis	1,161 European ancestry HCV-infected individuals	1,181 European ancestry HCV-infected individuals	9q22.2	9	90419249	LOC340515	LINC01508			ENSG00000231107			rs883924-A	rs883924	0	883924	intron_variant	0	0.26	2E-6	5.698970004336019	(Duration F0-1/F3-4,>20yo)			Illumina [780650] (imputed)	N	hepatitis C virus infection, cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0003047, http://www.ebi.ac.uk/efo/EFO_0001422	GCST001623	Genome-wide genotyping array
2012-09-26	22841784	Patin E	2012-07-26	Gastroenterology	www.ncbi.nlm.nih.gov/pubmed/22841784	Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.	Hepatitis C induced liver fibrosis	1,161 European ancestry HCV-infected individuals	1,181 European ancestry HCV-infected individuals	7p12.3	7	47740371	PKD1L1	PKD1L1			ENSG00000158683			rs7800244-T	rs7800244	0	7800244	3_prime_UTR_variant	0	0.18	3E-6	5.522878745280337	(Binary F0-1/F3-4)			Illumina [780650] (imputed)	N	hepatitis C virus infection, cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0003047, http://www.ebi.ac.uk/efo/EFO_0001422	GCST001623	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	16q12.2	16	54008129		FTO			ENSG00000140718			rs8049988-G	rs8049988	0	8049988	intron_variant	0	NR	3E-6	5.522878745280337		1.2175		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	11p15.4	11	5775532		TRIM5			ENSG00000132256			rs7110476-G	rs7110476	0	7110476	intron_variant	0	NR	3E-6	5.522878745280337		0.8203		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	11p15.1	11	18408444		LDHA - LDHC	ENSG00000134333	ENSG00000166796		19	3874	rs35292478-C	rs35292478	0	35292478	intergenic_variant	1	NR	2E-6	5.698970004336019		1.238		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	22q11.21	22	20877573		SNAP29			ENSG00000099940			rs150481896-A	rs150481896	0	150481896	intron_variant	0	NR	4E-7	6.3979400086720375		2.1705		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	22q13.32	22	48962509		LINC01310 - RPL35P8	ENSG00000205632	ENSG00000226142		64123	251402	rs11705249-T	rs11705249	0	11705249	regulatory_region_variant	1	NR	6E-7	6.221848749616356		1.5183		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	12q23.3	12	107582831		BTBD11			ENSG00000151136			rs35189640-T	rs35189640	0	35189640	intron_variant	0	NR	8E-8	7.096910013008056		1.7894		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	13q22.2	13	75329232		TBC1D4			ENSG00000136111			rs8002811-T	rs8002811	0	8002811	intron_variant	0	NR	5E-6	5.301029995663981		1.311		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	15q21.2	15	49536822		FAM227B			ENSG00000166262			rs10851478-A	rs10851478	0	10851478	intron_variant	0	NR	1E-8	8.0		1.2184		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	15q21.2	15	49706485		DTWD1 - ATP8B4	ENSG00000104047	ENSG00000104043		50253	151753	rs692309-C	rs692309	0	692309	intergenic_variant	1	NR	5E-8	7.301029995663981		0.8152		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	15q26.2	15	96319940		NR2F2-AS1			ENSG00000247809			rs2398180-T	rs2398180	0	2398180	intron_variant	0	NR	5E-6	5.301029995663981		1.1851		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	17p13.2	17	3936580		ATP2A3			ENSG00000074370			rs35334668-G	rs35334668	0	35334668	non_coding_transcript_exon_variant	0	NR	5E-6	5.301029995663981		1.2989		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	2p13.2	2	71858661		DYSF - RPS20P10	ENSG00000135636	ENSG00000233971		171898	125521	rs10206237-G	rs10206237	0	10206237	intergenic_variant	1	NR	8E-7	6.096910013008056		0.7366		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	2q35	2	217406087		DIRC3			ENSG00000231672			rs1479575211-?	rs1479575211	0	1479575211	intron_variant	0	NR	7E-7	6.154901959985743		0.7706		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	4p15.1	4	29367523		LINC02472 - U6	ENSG00000248338	ENSG00000283337		75654	143112	rs73224896-T	rs73224896	0	73224896	intergenic_variant	1	NR	1E-6	6.0		1.5588		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	4q23	4	99318162		ADH1B			ENSG00000196616			rs1229984-G	rs1229984	0	1229984	missense_variant	0	NR	4E-8	7.3979400086720375		0.5916		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	5p15.33	5	1343679		CLPTM1L			ENSG00000049656			rs10462706-T	rs10462706	0	10462706	intron_variant	0	NR	5E-8	7.301029995663981		0.7593		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	6p24.3	6	10415901		TFAP2A-AS1, TFAP2A			ENSG00000229950, ENSG00000137203			rs1051512-T	rs1051512	0	1051512	non_coding_transcript_exon_variant	0	NR	4E-6	5.3979400086720375		1.7163		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	6p21.33	6	31817451		HSPA1A, HSPA1A, HSPA1A, HSPA1A			ENSG00000204389, ENSG00000215328, ENSG00000237724, ENSG00000234475			rs506770-C	rs506770	0	506770	synonymous_variant	0	NR	2E-6	5.698970004336019		1.2434		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	8q23.1	8	105552424		ZFPM2-AS1, ZFPM2			ENSG00000251003, ENSG00000169946			rs28416651-A	rs28416651	0	28416651	intron_variant	0	NR	4E-6	5.3979400086720375		1.174		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	9p22.3	9	14533586		NFIB - CDCA4P1	ENSG00000147862	ENSG00000229029		134603	59991	rs10961555-C	rs10961555	0	10961555	intergenic_variant	1	NR	2E-6	5.698970004336019		0.8174		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	9p21.3	9	22064466		CDKN2B-AS1			ENSG00000240498			rs8181047-G	rs8181047	0	8181047	intron_variant	0	NR	1E-7	7.0		1.2167		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	9q34.12	9	131087186		LAMC3			ENSG00000050555			rs77452476-G	rs77452476	0	77452476	intron_variant	0	NR	3E-7	6.522878745280337		1.2859		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	20q13.33	20	62663902		SLCO4A1-AS1, SLCO4A1			ENSG00000232803, ENSG00000101187			rs111332410-T	rs111332410	0	111332410	intron_variant	0	NR	4E-6	5.3979400086720375		1.4596		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	10q26.13	10	124468877		LHPP			ENSG00000107902			rs201982221-?	rs201982221	0	201982221	intron_variant	0	NR	5E-8	7.301029995663981		1.7449		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	17q22	17	57420875	MSI2	MSI2			ENSG00000153944			rs11868362-?	rs11868362	0	11868362	intron_variant	0		4E-6	5.3979400086720375	(endpoint 2, East Asian)	2.9411764	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	17q22	17	59369227	YPEL2	YPEL2			ENSG00000175155			rs16943470-?	rs16943470	0	16943470	intron_variant	0		5E-6	5.301029995663981	(endpoint 6, dominant)	2.97	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	1q23.2	1	159308078	FCER1A	FCER1A			ENSG00000179639			rs7549785-?	rs7549785	0	7549785	3_prime_UTR_variant	0		5E-7	6.301029995663981	(endpoint 6, East Asian)	8.22	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	2p24.3	2	15245360	ENSG151779	NBAS			ENSG00000151779			rs9287655-?	rs9287655	0	9287655	intron_variant	0		1E-6	6.0	(endpoint 4, additive)	1.5151515	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	2p24.3	2	15245360	ENSG151779	NBAS			ENSG00000151779			rs9287655-?	rs9287655	0	9287655	intron_variant	0		1E-6	6.0	(endpoint 5, additive)	1.5625	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	2p23.3	2	24799729	CENPO	CENPO			ENSG00000138092			rs1550116-?	rs1550116	0	1550116	missense_variant	0		8E-6	5.096910013008056	(endpoint 5, East Asian, additive)	1.7857143	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	2p23.3	2	24815399	Intergenic	CENPO			ENSG00000138092			rs2082881-?	rs2082881	0	2082881	intron_variant	0		7E-6	5.154901959985743	(endpoint 5, East Asian, additive)	1.7857143	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	2p23.3	2	24818751	Intergenic	CENPO			ENSG00000138092			rs1550115-?	rs1550115	0	1550115	intron_variant	0		7E-6	5.154901959985743	(endpoint 5, East Asian, additive)	1.7857143	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	4q12	4	53544057	LNX1	LNX1-AS1, LNX1			ENSG00000250930, ENSG00000072201			rs1040084-?	rs1040084	0	1040084	intron_variant	0		4E-6	5.3979400086720375	(endpoint 3, additive)	2.37	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	4q12	4	53544157	Intergenic	LNX1, LNX1-AS1			ENSG00000072201, ENSG00000250930			rs1913484-?	rs1913484	0	1913484	intron_variant	0		4E-6	5.3979400086720375	(endpoint 3, dominant)	2.36	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	6q26	6	162541796	PARK2	PRKN			ENSG00000185345			rs2803073-?	rs2803073	0	2803073	intron_variant	0		3E-6	5.522878745280337	(endpoint 4, additive)	1.5	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	7p21.1	7	18700047	HDAC9	HDAC9			ENSG00000048052			rs10236906-?	rs10236906	0	10236906	intron_variant	0		8E-6	5.096910013008056	(endpoint 4, dominant)	1.754386	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	7p15.1	7	28690392	CREB5	CREB5			ENSG00000146592			rs9691873-?	rs9691873	0	9691873	intron_variant	0		9E-6	5.045757490560675	(endpoint 5, East Asian)		[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	9p24.3	9	917667	DMRT1	DMRT1			ENSG00000137090			rs2370220-?	rs2370220	0	2370220	intron_variant	0		8E-6	5.096910013008056	(endpoint 5, dominant)	1.75	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	9p24.2	9	4086370	GLIS3	GLIS3			ENSG00000107249			rs10814834-?	rs10814834	0	10814834	intron_variant	0		7E-6	5.154901959985743	(endpoint 6, dominant)	2.173913	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	9q22.33	9	96584288	CDC14B, CDC14C	CDC14B			ENSG00000081377			rs7042473-?	rs7042473	0	7042473	intron_variant	0		5E-6	5.301029995663981	(endpoint 4, dominant)	1.71	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	9q22.33	9	98165350	CORO2A	CORO2A			ENSG00000106789			rs10491723-?	rs10491723	0	10491723	intron_variant	0		5E-6	5.301029995663981	(endpoint 6, additive)	2.11	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	10p12.1	10	27013843	ANKRD26	ANKRD26			ENSG00000107890			rs1411283-?	rs1411283	0	1411283	intron_variant	0		9E-6	5.045757490560675	(endpoint 1, dominant)	2.0408163	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	11q24.1	11	123606644	GRAMD1B	GRAMD1B			ENSG00000023171			rs2279519-?	rs2279519	0	2279519	synonymous_variant	0		8E-6	5.096910013008056	(endpoint 5, dominant)	1.75	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	12p13.31	12	6019818	VWF	VWF			ENSG00000110799			rs216312-?	rs216312	0	216312	intron_variant	0		5E-6	5.301029995663981	(endpoint 5, dominant)	1.5151515	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	12p12.3	12	15996401	DERA	DERA			ENSG00000023697			rs7968170-?	rs7968170	0	7968170	intron_variant	0		5E-6	5.301029995663981	(endpoint 4, East Asian, dominant)	2.0408163	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	12p12.3	12	15996401	DERA	DERA			ENSG00000023697			rs7968170-?	rs7968170	0	7968170	intron_variant	0		5E-6	5.301029995663981	(endpoint 5, East Asian, dominant)	2.173913	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	14q24.2	14	70007490	SMOC1	SMOC1			ENSG00000198732			rs8012912-?	rs8012912	0	8012912	intron_variant	0		7E-6	5.154901959985743	(endpoint 5, East Asian, additive)	1.62	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	14q24.2	14	70012457	Intergenic	SMOC1			ENSG00000198732			rs11158827-?	rs11158827	0	11158827	intron_variant	0		8E-6	5.096910013008056	(endpoint 5, East Asian, additive)	1.62	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	15q12	15	25764093	ATP10A	ATP10A			ENSG00000206190			rs6576456-?	rs6576456	0	6576456	intron_variant	0		8E-6	5.096910013008056	(endpoint 3, dominant)	2.4390244	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	15q23	15	67443685	IQCH	IQCH, IQCH-AS1			ENSG00000103599, ENSG00000259673			rs2899723-?	rs2899723	0	2899723	intron_variant	0		3E-6	5.522878745280337	(endpoint 3, additive)	2.04	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2019-08-28	30972912	Wei L	2019-04-10	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/30972912	Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	up to 1,108 East Asian cases, up to 465 European ancestry cases, up to 63 cases	NA	17q12	17	38920078	LASP1	LASP1			ENSG00000002834			rs646097-?	rs646097	0	646097	3_prime_UTR_variant	0		9E-6	5.045757490560675	(endpoint 2, dominant)	2.173913	[NR]	Illumina [> 750000]	N	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103	GCST008514	Genome-wide genotyping array
2018-09-25	29975729	Kim TH	2018-07-05	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29975729	Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B.	Hepatitis B surface antigen seroclearance in chronic hepatitis B infection	100 Korean ancestry cases, 100 Korean ancestry controls	NA	11q12.1	11	59253514	DTX4, MPEG1	RN7SL42P - WARS1P1	ENSG00000263999	ENSG00000225802		38815	1846	rs7944135-A	rs7944135	0	7944135	regulatory_region_variant	1	0.13	4E-6	5.3979400086720375		4.16	[2.27-7.63]	Illumina [1365088]	N	Hepatitis B virus surface antigen seropositivity	http://www.ebi.ac.uk/efo/EFO_0009345	GCST006364	Genome-wide genotyping array
2018-09-25	29975729	Kim TH	2018-07-05	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29975729	Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B.	Hepatitis B surface antigen seroclearance in chronic hepatitis B infection	100 Korean ancestry cases, 100 Korean ancestry controls	NA	5q14.1	5	79884303	CMYA5, MTX3	CMYA5 - LINC01455	ENSG00000164309	ENSG00000250888		84063	52276	rs171941-A	rs171941	0	171941	intergenic_variant	1	0.19	4E-6	5.3979400086720375		3.69	[2.13-6.42]	Illumina [1365088]	N	Hepatitis B virus surface antigen seropositivity	http://www.ebi.ac.uk/efo/EFO_0009345	GCST006364	Genome-wide genotyping array
2018-09-25	29975729	Kim TH	2018-07-05	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29975729	Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B.	Hepatitis B surface antigen seroclearance in chronic hepatitis B infection	100 Korean ancestry cases, 100 Korean ancestry controls	NA	7p15.2	7	27309860	EVX1, HOXA13	RPL35P4 - HNRNPA1P73	ENSG00000213783	ENSG00000236569		40182	18747	rs6462008-T	rs6462008	0	6462008	intergenic_variant	1	0.42	3E-6	5.522878745280337		2.9411764	[1.85-4.55]	Illumina [1365088]	N	Hepatitis B virus surface antigen seropositivity	http://www.ebi.ac.uk/efo/EFO_0009345	GCST006364	Genome-wide genotyping array
2018-09-25	29975729	Kim TH	2018-07-05	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29975729	Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B.	Hepatitis B surface antigen seroclearance in chronic hepatitis B infection	100 Korean ancestry cases, 100 Korean ancestry controls	NA	2p16.1	2	59481514	intergenic							rs199869387-A	rs199869387	0	199869387	intron_variant	1	0.35	8E-6	5.096910013008056		2.97	[1.84-4.79]	Illumina [1365088]	N	Hepatitis B virus surface antigen seropositivity	http://www.ebi.ac.uk/efo/EFO_0009345	GCST006364	Genome-wide genotyping array
2021-04-12	33485957	Patrick MT	2021-01-21	J Allergy Clin Immunol	www.ncbi.nlm.nih.gov/pubmed/33485957	Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies.	COVID-19 or psoriasis (trans-disease meta-analysis)	1,678 COVID-19 cases, 11,024 psoriasis cases, 690,971 controls	NA	1q21.3	1	152693204		LCE2B - LCE2A	ENSG00000159455	ENSG00000187173		5807	5141	rs12564811-?	rs12564811	0	12564811	intergenic_variant	1	NR	3E-8	7.522878745280337		1.25	NR	NR [NR]	N	psoriasis, COVID-19	http://www.ebi.ac.uk/efo/EFO_0000676, http://purl.obolibrary.org/obo/MONDO_0100096	GCST011477	Genome-wide genotyping array
2021-04-12	33485957	Patrick MT	2021-01-21	J Allergy Clin Immunol	www.ncbi.nlm.nih.gov/pubmed/33485957	Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies.	COVID-19 or atopic dermatitis (trans-disease meta-analysis)	30,937 COVID-19 cases, 21,000 atopic dermatitis cases, 1,566,815 controls	NA	14q23.3	14	66645703	NR	GPHN			ENSG00000171723			rs190850598-?	rs190850598	0	190850598	intron_variant	0	NR	2E-7	6.698970004336019				NR [NR]	N	atopic eczema, COVID-19	http://www.ebi.ac.uk/efo/EFO_0000274, http://purl.obolibrary.org/obo/MONDO_0100096	GCST011476	Genome-wide genotyping array
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	SARS-CoV-2 infection	2,544 African ancestry cases, 31,176 African ancestry controls, 700 Middle Eastern ancestry cases, 13,360 Middle Eastern ancestry controls, 1,495 East Asian ancestry cases, 15,499 East Asian ancestry controls, 38,984 European ancestry cases, 1,644,784 European ancestry controls, 1,688 South Asian ancestry cases, 42,016 South Asian ancestry controls, 4,151 Hispanic or Latin American cases, 23,371 Hispanic or Latin American controls	NA	19q13.33	19	48867352		PLEKHA4			ENSG00000105559			rs4801778-T	rs4801778	0	4801778	intron_variant	0	0.1798	1E-8	8.0		0.9460149	[0.9281405415749607-0.9642334091548289]	Affymetrix, Illumina, Perlegen [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095125	Genome-wide genotyping array, Genome-wide sequencing
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	COVID-19 (hospitalized vs population)	790 African ancestry cases, 20,582 African ancestry controls, 60 Middle Eastern ancestry cases, 13,360 Middle Eastern ancestry controls, 1,414 East Asian ancestry cases, 15,499 East Asian ancestry controls, 9,986 European ancestry cases, 1,877,672 European ancestry controls, 186 South Asian ancestry cases, 43,280 South Asian ancestry controls, 1,678 Hispanic or Latin American cases, 100,316 Hispanic or Latin American controls	NA	3p21.31	3	45823240		SLC6A20 - LZTFL1	ENSG00000163817	ENSG00000163818		26704	76	rs10490770-C	rs10490770	0	10490770	intron_variant	1	0.08141	1E-73	73.0		1.648985	[1.5622524842496601-1.740532881367777]	Affymetrix, Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095124	Genome-wide genotyping array, Genome-wide sequencing
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	COVID-19 (hospitalized vs population)	790 African ancestry cases, 20,582 African ancestry controls, 60 Middle Eastern ancestry cases, 13,360 Middle Eastern ancestry controls, 1,414 East Asian ancestry cases, 15,499 East Asian ancestry controls, 9,986 European ancestry cases, 1,877,672 European ancestry controls, 186 South Asian ancestry cases, 43,280 South Asian ancestry controls, 1,678 Hispanic or Latin American cases, 100,316 Hispanic or Latin American controls	NA	6p21.1	6	41534945		FOXP4-AS1			ENSG00000234753			rs1886814-C	rs1886814	0	1886814	intron_variant	0	0.04242	1E-9	9.0		1.2618514	[1.1708908156456612-1.35987823139442]	Affymetrix, Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095124	Genome-wide genotyping array, Genome-wide sequencing
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	COVID-19 (hospitalized vs population)	790 African ancestry cases, 20,582 African ancestry controls, 60 Middle Eastern ancestry cases, 13,360 Middle Eastern ancestry controls, 1,414 East Asian ancestry cases, 15,499 East Asian ancestry controls, 9,986 European ancestry cases, 1,877,672 European ancestry controls, 186 South Asian ancestry cases, 43,280 South Asian ancestry controls, 1,678 Hispanic or Latin American cases, 100,316 Hispanic or Latin American controls	NA	8q24.13	8	124324323		TMEM65			ENSG00000164983			rs72711165-C	rs72711165	0	72711165	intron_variant	0	0.01337	2E-9	8.698970004336019		1.369547	[1.2355706893674907-1.5180506428830653]	Affymetrix, Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095124	Genome-wide genotyping array, Genome-wide sequencing
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	COVID-19 (hospitalized vs population)	790 African ancestry cases, 20,582 African ancestry controls, 60 Middle Eastern ancestry cases, 13,360 Middle Eastern ancestry controls, 1,414 East Asian ancestry cases, 15,499 East Asian ancestry controls, 9,986 European ancestry cases, 1,877,672 European ancestry controls, 186 South Asian ancestry cases, 43,280 South Asian ancestry controls, 1,678 Hispanic or Latin American cases, 100,316 Hispanic or Latin American controls	NA	9q34.2	9	133274084		ABO, ABO			ENSG00000175164, ENSG00000281879			rs912805253-T	rs912805253	1	529565	intron_variant	0	0.6547	5E-10	9.301029995663981		0.90225327	[0.8734213443494576-0.932036967857528]	Affymetrix, Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095124	Genome-wide genotyping array, Genome-wide sequencing
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	COVID-19 (hospitalized vs population)	790 African ancestry cases, 20,582 African ancestry controls, 60 Middle Eastern ancestry cases, 13,360 Middle Eastern ancestry controls, 1,414 East Asian ancestry cases, 15,499 East Asian ancestry controls, 9,986 European ancestry cases, 1,877,672 European ancestry controls, 186 South Asian ancestry cases, 43,280 South Asian ancestry controls, 1,678 Hispanic or Latin American cases, 100,316 Hispanic or Latin American controls	NA	12q24.13	12	112919388		OAS1			ENSG00000089127			rs10774671-A	rs10774671	0	10774671	splice_acceptor_variant	0	0.6642	6E-10	9.221848749616356		1.1067967	[1.071785554292693-1.1429515551857836]	Affymetrix, Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095124	Genome-wide genotyping array, Genome-wide sequencing
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	COVID-19 (hospitalized vs population)	790 African ancestry cases, 20,582 African ancestry controls, 60 Middle Eastern ancestry cases, 13,360 Middle Eastern ancestry controls, 1,414 East Asian ancestry cases, 15,499 East Asian ancestry controls, 9,986 European ancestry cases, 1,877,672 European ancestry controls, 186 South Asian ancestry cases, 43,280 South Asian ancestry controls, 1,678 Hispanic or Latin American cases, 100,316 Hispanic or Latin American controls	NA	17q21.31	17	46142465		KANSL1, KANSL1, KANSL1			ENSG00000120071, ENSG00000275867, ENSG00000278458			rs1819040-A	rs1819040	0	1819040	intron_variant	0	0.1855	2E-10	9.698970004336019		0.8790179	[0.8448494104431585-0.9145683076087429]	Affymetrix, Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095124	Genome-wide genotyping array, Genome-wide sequencing
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	COVID-19 (hospitalized vs population)	790 African ancestry cases, 20,582 African ancestry controls, 60 Middle Eastern ancestry cases, 13,360 Middle Eastern ancestry controls, 1,414 East Asian ancestry cases, 15,499 East Asian ancestry controls, 9,986 European ancestry cases, 1,877,672 European ancestry controls, 186 South Asian ancestry cases, 43,280 South Asian ancestry controls, 1,678 Hispanic or Latin American cases, 100,316 Hispanic or Latin American controls	NA	17q21.33	17	49863303		TAC4 - RNU6-1313P	ENSG00000176358	ENSG00000199492		15234	102772	rs77534576-T	rs77534576	0	77534576	regulatory_region_variant	1	0.03319	2E-7	6.698970004336019		1.2558091	[1.1520420691888291-1.3689224807814933]	Affymetrix, Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095124	Genome-wide genotyping array, Genome-wide sequencing
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	COVID-19 (hospitalized vs population)	790 African ancestry cases, 20,582 African ancestry controls, 60 Middle Eastern ancestry cases, 13,360 Middle Eastern ancestry controls, 1,414 East Asian ancestry cases, 15,499 East Asian ancestry controls, 9,986 European ancestry cases, 1,877,672 European ancestry controls, 186 South Asian ancestry cases, 43,280 South Asian ancestry controls, 1,678 Hispanic or Latin American cases, 100,316 Hispanic or Latin American controls	NA	19p13.3	19	4719431		DPP9			ENSG00000142002			rs2109069-A	rs2109069	0	2109069	intron_variant	0	0.3118	3E-17	16.522878745280337		1.1544453	[1.1166480216504269-1.1935220479717292]	Affymetrix, Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095124	Genome-wide genotyping array, Genome-wide sequencing
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	COVID-19 (hospitalized vs population)	790 African ancestry cases, 20,582 African ancestry controls, 60 Middle Eastern ancestry cases, 13,360 Middle Eastern ancestry controls, 1,414 East Asian ancestry cases, 15,499 East Asian ancestry controls, 9,986 European ancestry cases, 1,877,672 European ancestry controls, 186 South Asian ancestry cases, 43,280 South Asian ancestry controls, 1,678 Hispanic or Latin American cases, 100,316 Hispanic or Latin American controls	NA	19p13.2	19	10317045		RAVER1			ENSG00000161847			rs74956615-A	rs74956615	0	74956615	3_prime_UTR_variant	0	0.04778	5E-10	9.301029995663981		1.2663516	[1.1755088997465561-1.3642145475810288]	Affymetrix, Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095124	Genome-wide genotyping array, Genome-wide sequencing
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	COVID-19 (hospitalized vs population)	790 African ancestry cases, 20,582 African ancestry controls, 60 Middle Eastern ancestry cases, 13,360 Middle Eastern ancestry controls, 1,414 East Asian ancestry cases, 15,499 East Asian ancestry controls, 9,986 European ancestry cases, 1,877,672 European ancestry controls, 186 South Asian ancestry cases, 43,280 South Asian ancestry controls, 1,678 Hispanic or Latin American cases, 100,316 Hispanic or Latin American controls	NA	21q22.11	21	33242905		IFNAR2			ENSG00000159110			rs13050728-C	rs13050728	0	13050728	intron_variant	0	0.6511	3E-20	19.522878745280337		0.8608199	[0.8338527591429614-0.8886591191741529]	Affymetrix, Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095124	Genome-wide genotyping array, Genome-wide sequencing
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	SARS-CoV-2 infection	2,544 African ancestry cases, 31,176 African ancestry controls, 700 Middle Eastern ancestry cases, 13,360 Middle Eastern ancestry controls, 1,495 East Asian ancestry cases, 15,499 East Asian ancestry controls, 38,984 European ancestry cases, 1,644,784 European ancestry controls, 1,688 South Asian ancestry cases, 42,016 South Asian ancestry controls, 4,151 Hispanic or Latin American cases, 23,371 Hispanic or Latin American controls	NA	3p21.31	3	45796521		SLC6A20			ENSG00000163817			rs2271616-T	rs2271616	0	2271616	5_prime_UTR_variant	0	0.1178	2E-34	33.69897000433602		1.1546069	[1.128340128519996-1.1814852813843186]	Affymetrix, Illumina, Perlegen [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095125	Genome-wide genotyping array, Genome-wide sequencing
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	SARS-CoV-2 infection	2,544 African ancestry cases, 31,176 African ancestry controls, 700 Middle Eastern ancestry cases, 13,360 Middle Eastern ancestry controls, 1,495 East Asian ancestry cases, 15,499 East Asian ancestry controls, 38,984 European ancestry cases, 1,644,784 European ancestry controls, 1,688 South Asian ancestry cases, 42,016 South Asian ancestry controls, 4,151 Hispanic or Latin American cases, 23,371 Hispanic or Latin American controls	NA	3p21.31	3	45823240		SLC6A20 - LZTFL1	ENSG00000163817	ENSG00000163818		26704	76	rs10490770-C	rs10490770	0	10490770	intron_variant	1	0.08514	1E-29	29.0		1.160116	[1.130679206664483-1.1903191685173657]	Affymetrix, Illumina, Perlegen [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095125	Genome-wide genotyping array, Genome-wide sequencing
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	SARS-CoV-2 infection	2,544 African ancestry cases, 31,176 African ancestry controls, 700 Middle Eastern ancestry cases, 13,360 Middle Eastern ancestry controls, 1,495 East Asian ancestry cases, 15,499 East Asian ancestry controls, 38,984 European ancestry cases, 1,644,784 European ancestry controls, 1,688 South Asian ancestry cases, 42,016 South Asian ancestry controls, 4,151 Hispanic or Latin American cases, 23,371 Hispanic or Latin American controls	NA	3q12.3	3	101705614		PDCL3P4			ENSG00000244119			rs11919389-C	rs11919389	0	11919389	intron_variant	0	0.3515	3E-15	14.522878745280337		0.9413578	[0.9273018223094552-0.9556267949509863]	Affymetrix, Illumina, Perlegen [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095125	Genome-wide genotyping array, Genome-wide sequencing
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	SARS-CoV-2 infection	2,544 African ancestry cases, 31,176 African ancestry controls, 700 Middle Eastern ancestry cases, 13,360 Middle Eastern ancestry controls, 1,495 East Asian ancestry cases, 15,499 East Asian ancestry controls, 38,984 European ancestry cases, 1,644,784 European ancestry controls, 1,688 South Asian ancestry cases, 42,016 South Asian ancestry controls, 4,151 Hispanic or Latin American cases, 23,371 Hispanic or Latin American controls	NA	6p21.1	6	41534945		FOXP4-AS1			ENSG00000234753			rs1886814-C	rs1886814	0	1886814	intron_variant	0	0.04664	2E-8	7.698970004336019		1.1057236	[1.0673687203891646-1.1454568121291355]	Affymetrix, Illumina, Perlegen [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095125	Genome-wide genotyping array, Genome-wide sequencing
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	SARS-CoV-2 infection	2,544 African ancestry cases, 31,176 African ancestry controls, 700 Middle Eastern ancestry cases, 13,360 Middle Eastern ancestry controls, 1,495 East Asian ancestry cases, 15,499 East Asian ancestry controls, 38,984 European ancestry cases, 1,644,784 European ancestry controls, 1,688 South Asian ancestry cases, 42,016 South Asian ancestry controls, 4,151 Hispanic or Latin American cases, 23,371 Hispanic or Latin American controls	NA	9q34.2	9	133274084		ABO, ABO			ENSG00000175164, ENSG00000281879			rs912805253-T	rs912805253	1	529565	intron_variant	0	0.6512	1E-39	39.0		0.90480125	[0.8914217954151271-0.9183814681761949]	Affymetrix, Illumina, Perlegen [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095125	Genome-wide genotyping array, Genome-wide sequencing
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	SARS-CoV-2 infection	2,544 African ancestry cases, 31,176 African ancestry controls, 700 Middle Eastern ancestry cases, 13,360 Middle Eastern ancestry controls, 1,495 East Asian ancestry cases, 15,499 East Asian ancestry controls, 38,984 European ancestry cases, 1,644,784 European ancestry controls, 1,688 South Asian ancestry cases, 42,016 South Asian ancestry controls, 4,151 Hispanic or Latin American cases, 23,371 Hispanic or Latin American controls	NA	12q24.13	12	112919388		OAS1			ENSG00000089127			rs10774671-A	rs10774671	0	10774671	splice_acceptor_variant	0	0.6692	2E-11	10.698970004336019		1.0588357	[1.041370910202522-1.0765935887102847]	Affymetrix, Illumina, Perlegen [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095125	Genome-wide genotyping array, Genome-wide sequencing
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	SARS-CoV-2 infection	2,544 African ancestry cases, 31,176 African ancestry controls, 700 Middle Eastern ancestry cases, 13,360 Middle Eastern ancestry controls, 1,495 East Asian ancestry cases, 15,499 East Asian ancestry controls, 38,984 European ancestry cases, 1,644,784 European ancestry controls, 1,688 South Asian ancestry cases, 42,016 South Asian ancestry controls, 4,151 Hispanic or Latin American cases, 23,371 Hispanic or Latin American controls	NA	17q21.31	17	46142465		KANSL1, KANSL1, KANSL1			ENSG00000120071, ENSG00000275867, ENSG00000278458			rs1819040-A	rs1819040	0	1819040	intron_variant	0	0.184	5E-6	5.301029995663981		0.95716834	[0.9393376873334204-0.9753374551691557]	Affymetrix, Illumina, Perlegen [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095125	Genome-wide genotyping array, Genome-wide sequencing
2022-03-14	34237774	COVID-19 Host Genetics Initiative	2021-07-08	Nature	www.ncbi.nlm.nih.gov/pubmed/34237774	Mapping the human genetic architecture of COVID-19.	SARS-CoV-2 infection	2,544 African ancestry cases, 31,176 African ancestry controls, 700 Middle Eastern ancestry cases, 13,360 Middle Eastern ancestry controls, 1,495 East Asian ancestry cases, 15,499 East Asian ancestry controls, 38,984 European ancestry cases, 1,644,784 European ancestry controls, 1,688 South Asian ancestry cases, 42,016 South Asian ancestry controls, 4,151 Hispanic or Latin American cases, 23,371 Hispanic or Latin American controls	NA	19p13.3	19	4719431		DPP9			ENSG00000142002			rs2109069-A	rs2109069	0	2109069	intron_variant	0	0.315	4E-9	8.397940008672037		1.0490416	[1.0324357703246052-1.065914551006182]	Affymetrix, Illumina, Perlegen [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90095125	Genome-wide genotyping array, Genome-wide sequencing
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	21q21.1	21	18275648		TMPRSS15			ENSG00000154646			rs74364162-?	rs74364162	0	74364162	intron_variant	0	NR	5E-7	6.301029995663981		0.7646635	[0.47-1.06] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	21q22.2	21	39013072		LINC01700 - RPL23AP12	ENSG00000232837	ENSG00000228861		35298	114496	rs34194528-?	rs34194528	0	34194528	intron_variant	1	NR	1E-6	6.0		0.3666479	[0.22-0.51] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	21q22.3	21	45608179		LINC01694 - PCBP3	ENSG00000233922	ENSG00000183570		5091	35515	rs117715457-?	rs117715457	0	117715457	non_coding_transcript_exon_variant	1	NR	9E-6	5.045757490560675		0.8502913	[0.48-1.22] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	Xq22.3	X	107471346		FRMPD3			ENSG00000147234			rs57801596-?	rs57801596	0	57801596	intron_variant	0	NR	2E-6	5.698970004336019		0.5201043	[0.31-0.73] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	Xq26.2	X	133129086		USP26 - TFDP3	ENSG00000134588	ENSG00000183434		31977	87576	rs140551089-?	rs140551089	0	140551089	intergenic_variant	1	NR	8E-7	6.096910013008056		0.8250933	[0.5-1.15] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	7q11.21	7	66879664		GTF2IRD1P1 - GTF2IP23	ENSG00000230583	ENSG00000230295		34782	1044	rs142658912-?	rs142658912	0	142658912	intergenic_variant	1	NR	3E-8	7.522878745280337		4.671	[2.711-8.048]	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	10q22.3	10	78069803		GNAI2P2 - LINC00856	ENSG00000231957	ENSG00000230417		265	109382	rs117479047-?	rs117479047	0	117479047	intergenic_variant	1	NR	4E-8	7.3979400086720375		0.104	[0.047-0.232]	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	1q32.1	1	204874531		NFASC			ENSG00000163531			rs112534904-?	rs112534904	0	112534904	intron_variant	0	NR	4E-6	5.3979400086720375		0.7350759	[0.42-1.05] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	1q44	1	247348616		ZNF496 - NLRP3	ENSG00000162714	ENSG00000162711		16749	67540	rs141709616-?	rs141709616	0	141709616	intergenic_variant	1	NR	2E-6	5.698970004336019		0.9348025	[0.55-1.32] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	2p25.3	2	2815772		MYT1L - LINC01250	ENSG00000186487	ENSG00000234423		484108	79276	rs11127334-?	rs11127334	0	11127334	intron_variant	1	NR	4E-6	5.3979400086720375		0.5296516	[0.31-0.75] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	2p25.3	2	3930051		DCDC2C - LINC01304	ENSG00000214866	ENSG00000237401		82043	27601	rs570420259-?	rs570420259	0	570420259	intergenic_variant	1	NR	8E-6	5.096910013008056		0.7368499	[0.41-1.06] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	2p16.2	2	53725325		ASB3			ENSG00000115239			rs376874342-?	rs376874342	0	376874342	intron_variant	0	NR	5E-6	5.301029995663981		0.9412175	[0.54-1.34] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	2p16.2	2	53975992		ACYP2			ENSG00000170634			rs115966727-?	rs115966727	0	115966727	intron_variant	0	NR	7E-6	5.154901959985743		0.9028798	[0.51-1.29] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	2q11.1	2	95038117		MAL			ENSG00000172005			rs144581168-?	rs144581168	0	144581168	intron_variant	0	NR	2E-6	5.698970004336019		1.7091684	[1.01-2.4] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	2q24.3	2	167253843		XIRP2			ENSG00000163092			rs201756261-?	rs201756261	0	201756261	intron_variant	0	NR	6E-6	5.221848749616356		0.6123659	[0.35-0.88] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	2q34	2	210817387		CPS1 - RPS27P10	ENSG00000021826	ENSG00000231017		138280	481554	rs34857342-?	rs34857342	0	34857342	intergenic_variant	1	NR	9E-7	6.045757490560675		0.372072	[0.22-0.52] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	2q36.3	2	226304988		NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		650970	353722	rs77312202-?	rs77312202	0	77312202	regulatory_region_variant	1	NR	6E-7	6.221848749616356		0.8464646	[0.52-1.18] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	3p26.1	3	7849575		GRM7 - LMCD1-AS1	ENSG00000196277	ENSG00000227110		108042	101688	rs391664-?	rs391664	0	391664	intergenic_variant	1	NR	4E-6	5.3979400086720375		0.2731087	[0.16-0.39] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	3p21.31	3	46053730		XCR1			ENSG00000173578			rs183817891-?	rs183817891	0	183817891	intron_variant	0	NR	5E-10	9.301029995663981		0.5780579	[0.4-0.76] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	3q25.2	3	153368202		RN7SL300P - LINC02006	ENSG00000265813	ENSG00000238755		168185	16732	rs553470793-?	rs553470793	0	553470793	intron_variant	1	NR	2E-6	5.698970004336019		0.8941066	[0.53-1.26] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	4q22.1	4	88787699		FAM13A			ENSG00000138640			rs11725153-?	rs11725153	0	11725153	intron_variant	0	NR	7E-6	5.154901959985743		0.3024595	[0.17-0.43] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	4q33	4	170873036		LINC02382 - RNU6ATAC13P	ENSG00000250968	ENSG00000251961		129318	18431	rs1367998-?	rs1367998	0	1367998	regulatory_region_variant	1	NR	7E-6	5.154901959985743		0.4086107	[0.23-0.59] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	4q34.2	4	175991232		GPM6A			ENSG00000150625			rs774822130-?	rs774822130	0	774822130	intron_variant	0	NR	4E-6	5.3979400086720375		0.9440598	[0.54-1.34] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	5p14.1	5	24812897		SNORD29 - LINC02239	ENSG00000223004	ENSG00000248908		1349	22383	rs149500342-?	rs149500342	0	149500342	intron_variant	1	NR	1E-7	7.0		0.9597495	[0.6-1.32] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	5q13.3	5	76332281		SV2C			ENSG00000122012			rs73764328-?	rs73764328	0	73764328	3_prime_UTR_variant	0	NR	5E-7	6.301029995663981		0.6064633	[0.37-0.84] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	16p12.1	16	25522309		CYCSP39 - HS3ST4	ENSG00000260690	ENSG00000182601		67662	169650	rs115475484-?	rs115475484	0	115475484	intergenic_variant	1	NR	3E-6	5.522878745280337		1.8288181	[1.07-2.59] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	16q12.1	16	49501061		ZNF423			ENSG00000102935			rs118179271-?	rs118179271	0	118179271	intron_variant	0	NR	7E-6	5.154901959985743		0.8123349	[0.46-1.16] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	16q12.1	16	51225610		SALL1 - UNGP1	ENSG00000103449	ENSG00000260818		74243	52242	rs28604368-?	rs28604368	0	28604368	intron_variant	1	NR	6E-7	6.221848749616356		0.7479413	[0.45-1.04] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	17p13.1	17	9816674		GSG1L2			ENSG00000214978			rs138253180-?	rs138253180	0	138253180	intron_variant	0	NR	6E-6	5.221848749616356		0.2912772	[0.17-0.42] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	17q25.3	17	80379043		RNF213-AS1, RNF213			ENSG00000263069, ENSG00000173821			rs571739599-?	rs571739599	1	111829552	intron_variant	0	NR	1E-6	6.0		0.6077484	[0.36-0.85] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	18p11.22	18	10676141		PIEZO2			ENSG00000154864			rs9957059-?	rs9957059	0	9957059	intron_variant	0	NR	3E-6	5.522878745280337		1.272229	[0.74-1.81] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	18q22.3	18	74368579		C18orf63 - FAUP1	ENSG00000206043	ENSG00000235297		9390	21305	rs11660152-?	rs11660152	0	11660152	intergenic_variant	1	NR	3E-6	5.522878745280337		0.3977445	[0.23-0.56] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	18q23	18	78308752		RNU6-655P - Y_RNA	ENSG00000199728	ENSG00000199357		271907	235343	rs75808455-?	rs75808455	0	75808455	intergenic_variant	1	NR	6E-6	5.221848749616356		0.6615855	[0.38-0.95] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	19p13.2	19	8522061		MYO1F			ENSG00000142347			rs374214765-?	rs374214765	0	374214765	intron_variant	0	NR	2E-6	5.698970004336019		2.0500288	[1.21-2.89] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	19p13.2	19	10286554		ICAM1			ENSG00000090339			rs75407602-?	rs75407602	0	75407602	3_prime_UTR_variant	0	NR	9E-6	5.045757490560675		0.5674889	[0.32-0.82] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	19p13.12	19	16069520		TPM4			ENSG00000167460			rs200684240-?	rs200684240	0	200684240	intron_variant	0	NR	6E-6	5.221848749616356		0.6636186	[0.38-0.95] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	20p11.21	20	23250553		RNA5SP478 - NXT1-AS1	ENSG00000201527	ENSG00000234832		89582	96388	rs6048644-?	rs6048644	0	6048644	intergenic_variant	1	NR	5E-6	5.301029995663981		0.3516215	[0.2-0.5] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	20q13.33	20	60882904		MIR646HG - LINC01718	ENSG00000228340	ENSG00000229606		229120	196145	rs6093018-?	rs6093018	0	6093018	regulatory_region_variant	1	NR	5E-6	5.301029995663981		0.4810984	[0.28-0.69] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	20q13.33	20	63421491		KCNQ2			ENSG00000075043			rs149329391-?	rs149329391	0	149329391	intron_variant	0	NR	3E-7	6.522878745280337		0.7690801	[0.48-1.06] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	21q21.1	21	18138925		CHODL			ENSG00000154645			rs76351967-?	rs76351967	0	76351967	intron_variant	0	NR	1E-6	6.0		0.9720947	[0.58-1.36] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	12p12.3	12	16830354		LMO3 - SKP1P2	ENSG00000048540	ENSG00000256211		219760	158772	rs182978231-?	rs182978231	0	182978231	intergenic_variant	1	NR	7E-6	5.154901959985743		0.7078409	[0.4-1.01] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	12p12.1	12	22819235		RPS27P22 - SOX5	ENSG00000241451	ENSG00000134532		96766	710269	rs10842075-?	rs10842075	0	10842075	intron_variant	1	NR	4E-6	5.3979400086720375		0.3512774	[0.2-0.5] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	12p11.21	12	30983755		TSPAN11			ENSG00000110900			rs117993590-?	rs117993590	0	117993590	intron_variant	0	NR	2E-6	5.698970004336019		0.4195014	[0.25-0.59] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	12q12	12	45013442		NELL2 - DBX2	ENSG00000184613	ENSG00000185610		91594	1230	rs118121120-?	rs118121120	0	118121120	intergenic_variant	1	NR	3E-6	5.522878745280337		0.5562085	[0.32-0.79] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	12q23.1	12	97551250		RMST			ENSG00000255794			rs17334543-?	rs17334543	0	17334543	intron_variant	0	NR	3E-6	5.522878745280337		0.4372002	[0.26-0.62] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	13q13.3	13	38857698		FREM2			ENSG00000150893			rs115764867-?	rs115764867	0	115764867	intron_variant	0	NR	2E-6	5.698970004336019		0.8628929	[0.51-1.21] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	13q21.1	13	55974809		MIR5007 - HNF4GP1	ENSG00000264387	ENSG00000228611		800261	24391	rs118137757-?	rs118137757	0	118137757	intergenic_variant	1	NR	2E-7	6.698970004336019		0.7032492	[0.44-0.97] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	15q13.1	15	29572822		FAM189A1 - TUBBP8	ENSG00000273564	ENSG00000259300		1843	39748	rs545838826-?	rs545838826	1	113305335	regulatory_region_variant	1	NR	7E-6	5.154901959985743		0.2662914	[0.15-0.38] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	15q25.3	15	87952457		NTRK3			ENSG00000140538			rs117083606-?	rs117083606	0	117083606	intron_variant	0	NR	7E-6	5.154901959985743		0.466016	[0.26-0.67] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	16q12.1	16	51225610		SALL1 - UNGP1	ENSG00000103449	ENSG00000260818		74243	52242	rs28604368-?	rs28604368	0	28604368	intron_variant	1	NR	2E-6	5.698970004336019		0.5233666	[0.31-0.74] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	17q11.2	17	33446845		ASIC2			ENSG00000108684			rs149924615-?	rs149924615	0	149924615	intron_variant	0	NR	8E-7	6.096910013008056		0.7914586	[0.48-1.1] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	18q12.3	18	43885735		SYT4 - RNA5SP455	ENSG00000132872	ENSG00000202060		608200	185848	rs111745540-?	rs111745540	0	111745540	regulatory_region_variant	1	NR	5E-6	5.301029995663981		0.7373145	[0.42-1.05] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	19p13.2	19	10317045		RAVER1			ENSG00000161847			rs74956615-?	rs74956615	0	74956615	3_prime_UTR_variant	0	NR	1E-6	6.0		0.4048036	[0.24-0.57] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	20p11.21	20	23407451		NAPB			ENSG00000125814			rs11480078-?	rs11480078	0	11480078	intron_variant	0	NR	2E-6	5.698970004336019		0.4561216	[0.27-0.64] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	Xp21.2	X	29399618		IL1RAPL1			ENSG00000169306			rs2294534-?	rs2294534	0	2294534	intron_variant	0	NR	5E-6	5.301029995663981		0.1894007	[0.11-0.27] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	Xp11.3	X	47164036		RBM10			ENSG00000182872			rs532201997-?	rs532201997	0	532201997	intron_variant	0	NR	5E-6	5.301029995663981		0.9256902	[0.53-1.32] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	Xq21.1	X	80733004		BRWD3			ENSG00000165288			rs146883672-?	rs146883672	0	146883672	intron_variant	0	NR	5E-7	6.301029995663981		0.5627409	[0.35-0.78] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	Xq21.1	X	81083060		RNU6-995P - HMGN5	ENSG00000212546	ENSG00000198157		146520	30639	rs5913398-?	rs5913398	0	5913398	intergenic_variant	1	NR	3E-8	7.522878745280337		0.5746994	[0.37-0.78] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	Xq26.2	X	132044622		STK26			ENSG00000134602			rs774534540-?	rs774534540	0	774534540	intron_variant	0	NR	4E-7	6.3979400086720375		0.9811652	[0.61-1.36] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	11p13	11	35018963		PDHX			ENSG00000110435			rs118106403-?	rs118106403	0	118106403	intron_variant	0	NR	1E-7	7.0		0.956106	[0.6-1.31] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	11p13	11	35894816		KRT18P14 - LDLRAD3	ENSG00000186082	ENSG00000179241		33318	49165	rs652737-?	rs652737	0	652737	regulatory_region_variant	1	NR	1E-7	7.0		0.6535299	[0.41-0.9] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	11q23.1	11	111377017		POU2AF1			ENSG00000110777			rs45484195-?	rs45484195	0	45484195	intron_variant	0	NR	7E-6	5.154901959985743		0.4595924	[0.26-0.66] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	11q25	11	131735837		NTM			ENSG00000182667			rs57244613-?	rs57244613	0	57244613	intron_variant	0	NR	4E-6	5.3979400086720375		0.8278937	[0.48-1.18] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	12p13.2	12	12059628		BCL2L14			ENSG00000121380			rs61923174-?	rs61923174	0	61923174	intron_variant	0	NR	2E-6	5.698970004336019		0.484794	[0.29-0.68] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	12q14.2	12	62764010		PPM1H			ENSG00000111110			rs73130040-?	rs73130040	0	73130040	intron_variant	0	NR	6E-7	6.221848749616356		0.3883018	[0.24-0.54] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	12q21.1	12	74419912		LINC02882 - ATXN7L3B	ENSG00000251138	ENSG00000253719		17312	117923	rs78450575-?	rs78450575	0	78450575	intergenic_variant	1	NR	8E-6	5.096910013008056		0.5446458	[0.31-0.78] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	12q21.2	12	79296009		SYT1			ENSG00000067715			rs143576372-?	rs143576372	0	143576372	intron_variant	0	NR	8E-6	5.096910013008056		0.9177439	[0.52-1.32] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	12q22	12	92242065		Y_RNA - LINC02391	ENSG00000199357	ENSG00000277851		71612	5632	rs80149000-?	rs80149000	0	80149000	intergenic_variant	1	NR	9E-6	5.045757490560675		0.6504939	[0.36-0.94] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	12q23.1	12	97551250		RMST			ENSG00000255794			rs17334543-?	rs17334543	0	17334543	intron_variant	0	NR	5E-7	6.301029995663981		0.6459637	[0.39-0.9] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	12q24.31	12	120671409		CABP1 - MLEC	ENSG00000157782	ENSG00000110917		4085	15740	rs78025165-?	rs78025165	0	78025165	intergenic_variant	1	NR	6E-7	6.221848749616356		0.9660469	[0.59-1.34] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	12q24.31	12	120930454		RPL12P33 - HNF1A-AS1	ENSG00000244585	ENSG00000241388		13218	11274	rs147363223-?	rs147363223	0	147363223	intergenic_variant	1	NR	2E-6	5.698970004336019		0.9167983	[0.54-1.29] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	12q24.31	12	124517777		NCOR2			ENSG00000196498			rs150954431-?	rs150954431	0	150954431	intron_variant	0	NR	4E-6	5.3979400086720375		1.6217513	[0.94-2.31] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	13q32.3	13	99725705		CLYBL			ENSG00000125246			rs74773246-?	rs74773246	0	74773246	intron_variant	0	NR	9E-7	6.045757490560675		0.9851228	[0.59-1.38] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	14q13.2	14	35162088		PRORP			ENSG00000100890			rs10146133-?	rs10146133	0	10146133	intron_variant	0	NR	2E-6	5.698970004336019		0.8101804	[0.47-1.15] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	15q15.1	15	40232475		BUB1B-PAK6, PAK6			ENSG00000259288, ENSG00000137843			rs11637822-?	rs11637822	0	11637822	non_coding_transcript_exon_variant	0	NR	9E-6	5.045757490560675		0.7833793	[0.44-1.13] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	15q22.2	15	59391951		FAM81A			ENSG00000157470			rs117903030-?	rs117903030	0	117903030	intron_variant	0	NR	1E-7	7.0		0.6059034	[0.38-0.83] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	3p21.31	3	45820440		SLC6A20 - LZTFL1	ENSG00000163817	ENSG00000163818		23904	2876	rs13078854-G	rs13078854	0	13078854	non_coding_transcript_exon_variant	1	NR	2E-18	17.69897000433602		0.592	[0.527-0.665]	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	1p34.2	1	43668164		KDM4A			ENSG00000066135			rs142684389-?	rs142684389	0	142684389	intron_variant	0	NR	3E-6	5.522878745280337		0.602075	[0.35-0.85] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	1p13.3	1	106909908		LINC01661 - PRMT6	ENSG00000237460	ENSG00000198890		44592	146766	rs71092085-?	rs71092085	0	71092085	intergenic_variant	1	NR	5E-6	5.301029995663981		0.2266627	[0.13-0.32] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	2p23.1	2	31422426		XDH - SRD5A2	ENSG00000158125	ENSG00000277893		7684	100054	rs206817-?	rs206817	0	206817	intergenic_variant	1	NR	6E-6	5.221848749616356		0.3798166	[0.22-0.54] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	2q14.2	2	118957663		MARCO			ENSG00000019169			rs147200332-?	rs147200332	0	147200332	intron_variant	0	NR	3E-6	5.522878745280337		0.4567444	[0.27-0.65] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	3p21.31	3	45954233		FYCO1			ENSG00000163820			rs140221038-?	rs140221038	0	140221038	intron_variant	0	NR	1E-13	13.0		0.5297379	[0.39-0.67] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	3p21.31	3	46081695		XCR1			ENSG00000173578			rs111793438-?	rs111793438	1	66818091	intron_variant	0	NR	2E-11	10.698970004336019		0.379308	[0.27-0.49] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	3p21.31	3	46202789		CCR3, CCR1			ENSG00000183625, ENSG00000163823			rs3136668-?	rs3136668	0	3136668	3_prime_UTR_variant	0	NR	8E-6	5.096910013008056		0.285105	[0.16-0.41] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	5q14.1	5	79254055		JMY			ENSG00000152409			rs74989090-?	rs74989090	0	74989090	intron_variant	0	NR	3E-6	5.522878745280337		2.348145	[1.37-3.33] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	5q15	5	97353005		LIX1-AS1			ENSG00000251513			rs7709866-?	rs7709866	0	7709866	intron_variant	0	NR	1E-6	6.0		0.7014854	[0.42-0.98] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	5q21.3	5	106286190		RNA5SP189 - LINC01950	ENSG00000201790	ENSG00000251027		363082	529007	rs142891837-?	rs142891837	0	142891837	intergenic_variant	1	NR	1E-7	7.0		1.0589978	[0.67-1.45] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	5q23.2	5	126801866		LMNB1			ENSG00000113368			rs147567364-?	rs147567364	0	147567364	intron_variant	0	NR	2E-6	5.698970004336019		0.9406806	[0.55-1.33] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	5q33.2	5	153726365		GRIA1			ENSG00000155511			rs560119570-?	rs560119570	0	560119570	intron_variant	0	NR	1E-7	7.0		1.6718858	[1.06-2.29] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	6p24.1	6	11643655		TMEM170B - Metazoa_SRP	ENSG00000205269	ENSG00000277055		60131	412	rs72819604-?	rs72819604	0	72819604	intergenic_variant	1	NR	5E-6	5.301029995663981		0.8061826	[0.46-1.15] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	6p21.1	6	43452718		DLK2			ENSG00000171462			rs111814460-?	rs111814460	0	111814460	intron_variant	0	NR	5E-6	5.301029995663981		0.7084837	[0.41-1.01] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	6q15	6	89489789		ANKRD6			ENSG00000135299			rs149792516-?	rs149792516	0	149792516	intron_variant	0	NR	6E-6	5.221848749616356		0.7740405	[0.44-1.11] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	6q16.1	6	97738091		MMS22L - MIR2113	ENSG00000146263	ENSG00000238367		454874	286440	rs199862836-?	rs199862836	0	199862836	intron_variant	1	NR	4E-6	5.3979400086720375		1.4893959	[0.86-2.12] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	7q11.21	7	66595980		SAPCD2P3 - RPL35P5	ENSG00000232491	ENSG00000225573		38915	10758	rs117379416-?	rs117379416	0	117379416	intergenic_variant	1	NR	7E-7	6.154901959985743		1.4795605	[0.9-2.06] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	7q11.23	7	76687279		POMZP3 - DTX2P1-UPK3BP1-PMS2P11	ENSG00000146707	ENSG00000265479		60000	272556	rs114779080-?	rs114779080	0	114779080	intron_variant	1	NR	7E-7	6.154901959985743		0.8832147	[0.54-1.23] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	7q31.1	7	111446014		IMMP2L			ENSG00000184903			rs189391261-?	rs189391261	0	189391261	intron_variant	0	NR	6E-6	5.221848749616356		0.8164631	[0.46-1.17] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	8p12	8	35988560		UNC5D - MTCYBP19	ENSG00000156687	ENSG00000253504		192010	289203	rs138876514-?	rs138876514	0	138876514	intron_variant	1	NR	9E-6	5.045757490560675		0.4082299	[0.23-0.59] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	8p12	8	36089664		UNC5D - MTCYBP19	ENSG00000156687	ENSG00000253504		293114	188099	rs79724918-?	rs79724918	0	79724918	intron_variant	1	NR	4E-6	5.3979400086720375		0.4232717	[0.24-0.6] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	8q21.13	8	79027501		LINC02605 - RPL3P9	ENSG00000261618	ENSG00000240540		186976	543652	rs79327698-?	rs79327698	0	79327698	intergenic_variant	1	NR	8E-6	5.096910013008056		0.7875551	[0.44-1.13] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	8q24.3	8	141372275		GPR20 - PTP4A3	ENSG00000204882	ENSG00000275575		4989	19720	rs145121262-?	rs145121262	0	145121262	intergenic_variant	1	NR	8E-6	5.096910013008056		0.6713911	[0.38-0.96] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	9p24.2	9	3735706		RFX3-AS1 - GLIS3	ENSG00000232104	ENSG00000107249		43892	88421	rs186900349-?	rs186900349	0	186900349	regulatory_region_variant	1	NR	3E-7	6.522878745280337		0.9195142	[0.57-1.27] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	9q22.32	9	95676494		PTCH1 - LINC00476	ENSG00000185920	ENSG00000175611		159437	82737	rs354277-?	rs354277	0	354277	intron_variant	1	NR	9E-7	6.045757490560675		0.3279305	[0.2-0.46] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	10p12.31	10	19510947		MALRD1			ENSG00000204740			rs118005949-?	rs118005949	0	118005949	intron_variant	0	NR	4E-6	5.3979400086720375		0.8758192	[0.5-1.25] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	10q11.21	10	43346617		RNU6ATAC11P - FXYD4	ENSG00000221468	ENSG00000150201		4707	25019	rs113266413-?	rs113266413	0	113266413	intron_variant	1	NR	8E-6	5.096910013008056		0.7502525	[0.42-1.08] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	10q23.33	10	93995054		PLCE1			ENSG00000138193			rs77497030-?	rs77497030	0	77497030	intron_variant	0	NR	2E-6	5.698970004336019		0.9427744	[0.55-1.33] unit decrease	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	10q25.3	10	116397926		CCDC172 - SNRPGP6	ENSG00000182645	ENSG00000205433		17897	11330	rs78155882-?	rs78155882	0	78155882	intergenic_variant	1	NR	6E-6	5.221848749616356		0.7094254	[0.4-1.02] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	10q26.2	10	126445332		C10orf90			ENSG00000154493			rs145491567-?	rs145491567	0	145491567	intron_variant	0	NR	4E-6	5.3979400086720375		0.6402102	[0.37-0.91] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	11p15.2	11	15594743		LINC02751			ENSG00000254946			rs142867513-?	rs142867513	0	142867513	intron_variant	0	NR	5E-6	5.301029995663981		0.8660631	[0.5-1.24] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid respiratory support vs population)	495 European ancestry cases, 680,440 European ancestry controls, 102 Hispanic or Latin American cases, 94,330 Hispanic or Latin American controls, 39 Black or African American cases, 22,410 Black or African American controls	NA	11p14.3	11	24998558		LUZP2			ENSG00000187398			rs187361301-?	rs187361301	0	187361301	intron_variant	0	NR	4E-7	6.3979400086720375		1.1035289	[0.68-1.53] unit increase	Illumina [9842460] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027248	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	3q21.3	3	126382123		CCDC37-DT	ENSG00000163884			24715		rs143640167-?	rs143640167	0	143640167	intergenic_variant	0	NR	5E-6	5.301029995663981		0.7201101	[0.41-1.03] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	3q26.31	3	174309954		ANAPC15P2 - NAALADL2	ENSG00000232601	ENSG00000177694		6667	128619	rs79553323-?	rs79553323	0	79553323	intergenic_variant	1	NR	6E-6	5.221848749616356		0.5859968	[0.33-0.84] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	3q26.32	3	176320304		EI24P1 - LINC01208	ENSG00000236357	ENSG00000223715		251396	95135	rs140627460-?	rs140627460	0	140627460	intergenic_variant	1	NR	5E-7	6.301029995663981		0.7722549	[0.47-1.07] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	4p14	4	39524995		UGDH			ENSG00000109814			rs114804393-?	rs114804393	0	114804393	intron_variant	0	NR	7E-7	6.154901959985743		0.5691513	[0.35-0.79] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	4q35.2	4	186558766		MTNR1A - FAT1	ENSG00000168412	ENSG00000083857		3199	29028	rs13114144-?	rs13114144	0	13114144	intergenic_variant	1	NR	1E-6	6.0		0.8200182	[0.49-1.15] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	5p14.3	5	20997536		LINC02241 - GUSBP1	ENSG00000251629	ENSG00000183666		59736	344297	rs78053703-?	rs78053703	0	78053703	intron_variant	1	NR	9E-6	5.045757490560675		0.9061561	[0.51-1.3] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	5p14.3	5	21194784		LINC02241 - GUSBP1	ENSG00000251629	ENSG00000183666		256984	147049	rs77795744-?	rs77795744	0	77795744	regulatory_region_variant	1	NR	3E-6	5.522878745280337		0.9694775	[0.56-1.38] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	5q21.3	5	106286190		RNA5SP189 - LINC01950	ENSG00000201790	ENSG00000251027		363082	529007	rs142891837-?	rs142891837	0	142891837	intergenic_variant	1	NR	2E-6	5.698970004336019		0.7320344	[0.43-1.03] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	7p21.1	7	19992560		TMEM196 - RPL21P75	ENSG00000173452	ENSG00000213860		218943	10205	rs73686309-?	rs73686309	0	73686309	intron_variant	1	NR	1E-5	5.0		0.8073195	[0.45-1.16] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	8p23.3	8	1706857		DLGAP2, DLGAP2			ENSG00000198010, ENSG00000282318			rs116950932-?	rs116950932	0	116950932	3_prime_UTR_variant	0	NR	3E-6	5.522878745280337		0.3445323	[0.2-0.49] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	8p23.2	8	3486682		CSMD1			ENSG00000183117			rs11777685-?	rs11777685	0	11777685	intron_variant	0	NR	6E-6	5.221848749616356		0.2177648	[0.12-0.31] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	8p12	8	31912890		NRG1			ENSG00000157168			rs1680170-?	rs1680170	0	1680170	intron_variant	0	NR	2E-6	5.698970004336019		0.2467292	[0.15-0.35] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	8p12	8	35704343		UNC5D			ENSG00000156687			rs78930937-?	rs78930937	0	78930937	intron_variant	0	NR	6E-7	6.221848749616356		0.3574328	[0.22-0.5] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	8p12	8	35988560		UNC5D - MTCYBP19	ENSG00000156687	ENSG00000253504		192010	289203	rs138876514-?	rs138876514	0	138876514	intron_variant	1	NR	6E-6	5.221848749616356		0.2876342	[0.16-0.41] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	8p12	8	36089664		UNC5D - MTCYBP19	ENSG00000156687	ENSG00000253504		293114	188099	rs79724918-?	rs79724918	0	79724918	intron_variant	1	NR	1E-6	6.0		0.3079109	[0.19-0.43] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	8q11.23	8	52281306		ST18			ENSG00000147488			rs117558878-?	rs117558878	0	117558878	intron_variant	0	NR	4E-6	5.3979400086720375		0.5163687	[0.3-0.73] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	8q22.2	8	99953922		COX6C - RGS22	ENSG00000164919	ENSG00000132554		60215	7014	rs187295289-?	rs187295289	0	187295289	intergenic_variant	1	NR	2E-6	5.698970004336019		0.5650243	[0.34-0.79] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	9q31.1	9	102035681		MTND3P4 - ARL2BPP7	ENSG00000230302	ENSG00000230418		241925	19571	rs2795384-?	rs2795384	0	2795384	intergenic_variant	1	NR	1E-5	5.0		0.2493051	[0.14-0.36] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	10p14	10	6711894		LINP1			ENSG00000223784			rs7086011-?	rs7086011	0	7086011	intron_variant	0	NR	2E-6	5.698970004336019		0.1928714	[0.11-0.27] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	10p11.1	10	38296983		PLD5P1			ENSG00000283930			rs377599840-?	rs377599840	0	377599840	intron_variant	0	NR	4E-6	5.3979400086720375		0.4730866	[0.27-0.67] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	10p11.1	10	38773942		CHEK2P5 - KSR1P1	ENSG00000234541	ENSG00000229485		54713	3375368	rs12415367-?	rs12415367	0	12415367	intergenic_variant	1	NR	8E-6	5.096910013008056		0.6102796	[0.34-0.88] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	10q25.3	10	113216539		TCF7L2 - RNU7-165P	ENSG00000148737	ENSG00000238380		48861	136886	rs148627949-?	rs148627949	1	58648552	regulatory_region_variant	1	NR	4E-7	6.3979400086720375		0.2685769	[0.17-0.37] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	10q25.3	10	116329055		CCDC172			ENSG00000182645			rs118035398-?	rs118035398	0	118035398	intron_variant	0	NR	2E-6	5.698970004336019		0.5455479	[0.32-0.77] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	11p15.4	11	9068007		SCUBE2			ENSG00000175356			rs56277831-?	rs56277831	0	56277831	intron_variant	0	NR	6E-6	5.221848749616356		0.2636634	[0.15-0.38] unit increase	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (severe respiratory symptoms vs population)	1,128 European ancestry cases, 679,531 European ancestry controls, 245 Hispanic or Latin American cases, 94,237 Hispanic or Latin American controls, 74 Black or African American cases, 22,383 Black or African American controls	NA	12p13.1	12	13534461		GRIN2B			ENSG00000273079			rs61056024-?	rs61056024	0	61056024	intron_variant	0	NR	5E-6	5.301029995663981		0.3687123	[0.21-0.53] unit decrease	Illumina [9906551] (imputed)	N	respiratory symptom measurement, COVID-19	http://www.ebi.ac.uk/efo/EFO_0007939, http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027249	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	10q24.33	10	103481851		NEURL1-AS1			ENSG00000235470			rs375812923-?	rs375812923	0	375812923	intron_variant	0	NR	3E-6	5.522878745280337		0.634405	[0.37-0.9] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	10q26.2	10	126445332		C10orf90			ENSG00000154493			rs145491567-?	rs145491567	0	145491567	intron_variant	0	NR	5E-6	5.301029995663981		0.5838327	[0.33-0.83] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	10q26.2	10	127911880		PTPRE			ENSG00000132334			rs563873044-?	rs563873044	1	34136371	intron_variant	0	NR	4E-6	5.3979400086720375		0.368137	[0.21-0.52] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	11p15.5	11	1125661		MUC2 - MUC5AC	ENSG00000284971	ENSG00000215182		15150	32292	rs567113841-?	rs567113841	0	567113841	intergenic_variant	1	NR	7E-6	5.154901959985743		0.3188053	[0.18-0.46] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	11p14.3	11	24998558		LUZP2			ENSG00000187398			rs187361301-?	rs187361301	0	187361301	intron_variant	0	NR	6E-6	5.221848749616356		0.9437306	[0.54-1.35] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	11p13	11	35894816		KRT18P14 - LDLRAD3	ENSG00000186082	ENSG00000179241		33318	49165	rs652737-?	rs652737	0	652737	regulatory_region_variant	1	NR	1E-6	6.0		0.54937	[0.33-0.77] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	11q13.4	11	74624577		POLD3			ENSG00000077514			rs72979206-?	rs72979206	0	72979206	intron_variant	0	NR	3E-6	5.522878745280337		0.709909	[0.41-1.01] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	11q25	11	130972901		SNX19 - RN7SL167P	ENSG00000120451	ENSG00000242673		56422	31227	rs148496442-?	rs148496442	0	148496442	intergenic_variant	1	NR	1E-6	6.0		0.7879793	[0.47-1.11] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	12p11.22	12	30018042		TMTC1 - LINC02386	ENSG00000133687	ENSG00000257756		233283	212737	rs141403748-?	rs141403748	0	141403748	intergenic_variant	1	NR	5E-6	5.301029995663981		1.2789932	[0.73-1.83] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	12q14.2	12	62764135		PPM1H			ENSG00000111110			rs73130042-?	rs73130042	0	73130042	intron_variant	0	NR	2E-6	5.698970004336019		0.3325807	[0.2-0.47] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	12q14.2	12	63137228		RSL24D1P5 - AVPR1A	ENSG00000257664	ENSG00000166148		81463	5531	rs147864681-?	rs147864681	0	147864681	intergenic_variant	1	NR	5E-6	5.301029995663981		0.7446883	[0.43-1.06] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	12q15	12	70717827		PTPRR			ENSG00000153233			rs11178377-?	rs11178377	0	11178377	intron_variant	0	NR	2E-6	5.698970004336019		0.2780124	[0.16-0.39] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	12q23.1	12	97527504		RMST			ENSG00000255794			rs17027126-?	rs17027126	0	17027126	intron_variant	0	NR	2E-7	6.698970004336019		0.5984385	[0.37-0.82] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	12q23.1	12	97636026		RMST - PAFAH1B2P2	ENSG00000255794	ENSG00000257501		37611	77386	rs138476573-?	rs138476573	0	138476573	intergenic_variant	1	NR	8E-8	7.096910013008056		0.7780519	[0.5-1.06] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	12q23.1	12	97736422		PAFAH1B2P2			ENSG00000257501			rs75717531-?	rs75717531	0	75717531	intron_variant	0	NR	8E-6	5.096910013008056		0.4569407	[0.26-0.66] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	13q12.12	13	22644858		LINC00540 - FTH1P7	ENSG00000276476	ENSG00000232187		368332	51165	rs138345734-?	rs138345734	0	138345734	intergenic_variant	1	NR	2E-6	5.698970004336019		0.7971496	[0.47-1.13] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	13q13.3	13	36516389		H2ACP1 - SERTM1	ENSG00000223383	ENSG00000180440		25948	157631	rs151142301-?	rs151142301	0	151142301	intergenic_variant	1	NR	1E-6	6.0		0.7263784	[0.43-1.02] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	13q32.3	13	99725705		CLYBL			ENSG00000125246			rs74773246-?	rs74773246	0	74773246	intron_variant	0	NR	3E-6	5.522878745280337		0.8911904	[0.52-1.27] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	15q22.2	15	59391951		FAM81A			ENSG00000157470			rs117903030-?	rs117903030	0	117903030	intron_variant	0	NR	3E-6	5.522878745280337		0.497717	[0.29-0.71] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	16q12.1	16	51225610		SALL1 - UNGP1	ENSG00000103449	ENSG00000260818		74243	52242	rs28604368-?	rs28604368	0	28604368	intron_variant	1	NR	9E-6	5.045757490560675		0.617869	[0.35-0.89] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	17p13.1	17	9816674		GSG1L2			ENSG00000214978			rs138253180-?	rs138253180	0	138253180	intron_variant	0	NR	1E-7	7.0		0.3057261	[0.19-0.42] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	17q25.3	17	77809915		LINC01987 - LINC01973	ENSG00000267790	ENSG00000204283		81356	67415	rs72900470-?	rs72900470	0	72900470	intergenic_variant	1	NR	5E-6	5.301029995663981		0.431311	[0.25-0.62] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	18q21.2	18	54176811		MBD2			ENSG00000134046			rs8083077-?	rs8083077	0	8083077	intron_variant	0	NR	8E-6	5.096910013008056		0.2592356	[0.15-0.37] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	18q22.3	18	74381845		C18orf63 - FAUP1	ENSG00000206043	ENSG00000235297		22656	8039	rs918258-?	rs918258	0	918258	intergenic_variant	1	NR	1E-6	6.0		0.3406333	[0.2-0.48] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	9q34.2	9	133270015		ABO, ABO			ENSG00000175164, ENSG00000281879			rs9411378-C	rs9411378	0	9411378	intron_variant	0	NR	5E-20	19.30102999566398		0.857	[0.829-0.886]	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	12q14.2	12	62764135		PPM1H			ENSG00000111110			rs73130042-?	rs73130042	0	73130042	intron_variant	0	NR	5E-6	5.301029995663981		0.0945804	[0.054-0.135] unit decrease	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	12q15	12	68794686		SLC35E3 - MDM2	ENSG00000175782	ENSG00000135679		722	13491	rs113933710-?	rs113933710	0	113933710	regulatory_region_variant	1	NR	3E-6	5.522878745280337		0.14399403	[0.084-0.204] unit decrease	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	12q24.33	12	132741820		ANKLE2			ENSG00000176915			rs11147040-?	rs11147040	0	11147040	3_prime_UTR_variant	0	NR	8E-6	5.096910013008056		0.12819888	[0.072-0.184] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	16q23.2	16	80044763		LINC01228 - DYNLRB2	ENSG00000261082	ENSG00000168589		217613	495971	rs16952191-?	rs16952191	0	16952191	intron_variant	1	NR	4E-6	5.3979400086720375		0.3232828	[0.19-0.46] unit decrease	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	3p22.2	3	37153902		LRRFIP2			ENSG00000093167			rs114113385-?	rs114113385	0	114113385	intron_variant	0	NR	5E-6	5.301029995663981		0.18256626	[0.1-0.26] unit decrease	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	17p13.1	17	10116315		GAS7			ENSG00000007237			rs55877232-?	rs55877232	0	55877232	intron_variant	0	NR	9E-6	5.045757490560675		0.06959355	[0.039-0.1] unit decrease	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	3p21.31	3	46053612		XCR1			ENSG00000173578			rs35772789-?	rs35772789	0	35772789	intron_variant	0	NR	3E-6	5.522878745280337		0.1030807	[0.06-0.146] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	3p12.3	3	78551748		MRPS17P3 - ROBO1	ENSG00000239226	ENSG00000169855		26263	45491	rs1444472-?	rs1444472	0	1444472	intergenic_variant	1	NR	9E-6	5.045757490560675		0.10784259	[0.061-0.155] unit decrease	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	3q11.2	3	94282562		NSUN3 - ARMC10P1	ENSG00000178694	ENSG00000178660		150730	224204	rs62266986-?	rs62266986	0	62266986	intergenic_variant	1	NR	6E-6	5.221848749616356		0.07076552	[0.04-0.101] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	3q12.3	3	101655382		ZBTB11			ENSG00000066422			rs34624546-?	rs34624546	0	34624546	intron_variant	0	NR	4E-6	5.3979400086720375		0.06775347	[0.039-0.096] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	Xq21.1	X	81216009		SH3BGRL			ENSG00000131171			rs146683006-?	rs146683006	0	146683006	intron_variant	0	NR	6E-6	5.221848749616356		0.09512927	[0.054-0.136] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	3q12.3	3	101894590		NFKBIZ - LINC02085	ENSG00000144802	ENSG00000214407		33568	46269	rs771578-?	rs771578	0	771578	intron_variant	1	NR	4E-6	5.3979400086720375		0.06933079	[0.04-0.099] unit decrease	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	Xq27.3	X	143664353		SLITRK4 - HNRNPH1P2	ENSG00000179542	ENSG00000213924		28252	12800	rs1884248-?	rs1884248	0	1884248	regulatory_region_variant	1	NR	1E-6	6.0		0.13258304	[0.079-0.186] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	4q33	4	170420504		LINC02512 - HSP90AA6P	ENSG00000251061	ENSG00000181359		48193	160966	rs7698024-?	rs7698024	0	7698024	intergenic_variant	1	NR	9E-6	5.045757490560675		0.17802243	[0.1-0.256] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	5p15.31	5	9632463		TAS2R1			ENSG00000169777			rs148943015-?	rs148943015	0	148943015	intron_variant	0	NR	2E-6	5.698970004336019		0.20792061	[0.12-0.29] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	5p13.1	5	38663472		LIFR-AS1			ENSG00000244968			rs12152761-?	rs12152761	0	12152761	intron_variant	0	NR	9E-6	5.045757490560675		0.28717732	[0.16-0.41] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	5q13.3	5	75827825		SLC25A5P9 - BIN2P2	ENSG00000251078	ENSG00000248684		74346	82740	rs6453167-?	rs6453167	0	6453167	intergenic_variant	1	NR	5E-6	5.301029995663981		0.06849295	[0.039-0.098] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	5q23.1	5	119627665		HSD17B4			ENSG00000133835			rs7706019-?	rs7706019	0	7706019	intron_variant	0	NR	1E-6	6.0		0.11705765	[0.071-0.164] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	5q31.1	5	134446462		CDKN2AIPNL - RNU6-456P	ENSG00000237190	ENSG00000207222		34581	53716	rs10056003-?	rs10056003	0	10056003	intron_variant	1	NR	7E-6	5.154901959985743		0.11624841	[0.066-0.167] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	2q33.3	2	206402057		ZDBF2 - ACER2P1	ENSG00000204186	ENSG00000180105		87630	8030	rs10180974-?	rs10180974	0	10180974	intergenic_variant	1	NR	8E-7	6.096910013008056		0.8627113	[0.52-1.2] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	2q36.3	2	226304988		NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		650970	353722	rs77312202-?	rs77312202	0	77312202	regulatory_region_variant	1	NR	3E-6	5.522878745280337		0.7414326	[0.43-1.05] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	7q21.11	7	78715073		MAGI2			ENSG00000187391			rs7793494-?	rs7793494	0	7793494	intron_variant	0	NR	6E-6	5.221848749616356		0.10498892	[0.06-0.15] unit decrease	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	8p23.3	8	2000750		KBTBD11, KBTBD11			ENSG00000176595, ENSG00000273645			rs36027367-?	rs36027367	0	36027367	5_prime_UTR_variant	0	NR	7E-6	5.154901959985743		0.06608382	[0.037-0.095] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	9p22.3	9	16078190		CCDC171 - C9orf92	ENSG00000164989	ENSG00000205549		16527	125745	rs60621229-?	rs60621229	0	60621229	intergenic_variant	1	NR	3E-6	5.522878745280337		0.32588646	[0.19-0.46] unit decrease	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	9p22.3	9	16397290		C9orf92			ENSG00000205549			rs78863817-?	rs78863817	0	78863817	intron_variant	0	NR	3E-6	5.522878745280337		0.10696362	[0.063-0.151] unit decrease	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	19p13.2	19	10381598		TYK2 - CDC37	ENSG00000105397	ENSG00000105401		1026	9535	rs144309607-?	rs144309607	0	144309607	regulatory_region_variant	1	NR	2E-7	6.698970004336019		0.5894346	[0.37-0.81] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	19p13.12	19	16069520		TPM4			ENSG00000167460			rs200684240-?	rs200684240	0	200684240	intron_variant	0	NR	5E-6	5.301029995663981		0.6065821	[0.35-0.87] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	20p12.3	20	7001716		BMP2 - LINC01428	ENSG00000125845	ENSG00000228888		221470	144751	rs6054661-?	rs6054661	0	6054661	intergenic_variant	1	NR	3E-6	5.522878745280337		0.3301961	[0.19-0.47] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	20q13.33	20	63421491		KCNQ2			ENSG00000075043			rs149329391-?	rs149329391	0	149329391	intron_variant	0	NR	6E-7	6.221848749616356		0.6872664	[0.42-0.96] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	21q21.1	21	19589201		RNU1-139P - RPL37P4	ENSG00000212609	ENSG00000230198		243889	4640	rs9808803-?	rs9808803	0	9808803	intergenic_variant	1	NR	9E-6	5.045757490560675		0.5922104	[0.33-0.85] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	22q13.33	22	50246622		HDAC10, MAPK12			ENSG00000100429, ENSG00000188130			rs111248040-?	rs111248040	0	111248040	non_coding_transcript_exon_variant	0	NR	1E-5	5.0		0.7985765	[0.45-1.15] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	Xp11.3	X	47164036		RBM10			ENSG00000182872			rs532201997-?	rs532201997	0	532201997	intron_variant	0	NR	1E-6	6.0		1.0983605	[0.66-1.54] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	Xq21.1	X	81279847		SH3BGRL			ENSG00000131171			rs5912487-?	rs5912487	0	5912487	intron_variant	0	NR	8E-6	5.096910013008056		0.5537284	[0.31-0.8] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	Xq22.3	X	106521685		NAP1L4P2 - SERPINA7P1	ENSG00000224816	ENSG00000227657		54245	41089	rs139316711-?	rs139316711	0	139316711	intergenic_variant	1	NR	2E-6	5.698970004336019		0.5299814	[0.31-0.75] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	Xq22.3	X	106810299		TBC1D8B			ENSG00000133138			rs5916768-?	rs5916768	0	5916768	intron_variant	0	NR	2E-6	5.698970004336019		0.414551	[0.24-0.59] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	Xq22.3	X	107192186		NUP62CL			ENSG00000198088			rs151100624-?	rs151100624	0	151100624	intron_variant	0	NR	1E-6	6.0		0.4327367	[0.26-0.61] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	Xq23	X	109420836		GUCY2F			ENSG00000101890			rs150694572-?	rs150694572	0	150694572	intron_variant	0	NR	1E-6	6.0		0.694812	[0.42-0.97] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	Xq27.3	X	144832792		RRM2P4 - HNRNPCP10	ENSG00000235598	ENSG00000215054		523099	7985	rs73637036-?	rs73637036	0	73637036	intergenic_variant	1	NR	6E-6	5.221848749616356		0.8724512	[0.5-1.25] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	6q25.1	6	150040220		RAET1M - PHBP1	ENSG00000216444	ENSG00000213091		6654	2326	rs73001674-?	rs73001674	0	73001674	intergenic_variant	1	NR	5E-6	5.301029995663981		0.2518505	[0.14-0.36] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	6q25.1	6	151452218		RMND1 - ARMT1	ENSG00000155906	ENSG00000146476		60	40	rs3816778-?	rs3816778	0	3816778	TF_binding_site_variant	1	NR	7E-6	5.154901959985743		0.2309028	[0.13-0.33] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	6q27	6	168619397		SMOC2			ENSG00000112562			rs117229335-?	rs117229335	0	117229335	intron_variant	0	NR	6E-6	5.221848749616356		0.8549121	[0.49-1.22] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	7p21.3	7	12718527		ARL4A - RN7SKP228	ENSG00000122644	ENSG00000222974		27569	158157	rs4719328-?	rs4719328	0	4719328	intergenic_variant	1	NR	4E-6	5.3979400086720375		0.2553625	[0.15-0.36] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	7p15.3	7	22821419		TOMM7			ENSG00000196683			rs4719715-?	rs4719715	0	4719715	intron_variant	0	NR	6E-6	5.221848749616356		0.8562623	[0.49-1.23] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	7q11.21	7	66595980		SAPCD2P3 - RPL35P5	ENSG00000232491	ENSG00000225573		38915	10758	rs117379416-?	rs117379416	0	117379416	intergenic_variant	1	NR	5E-6	5.301029995663981		1.272035	[0.73-1.81] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	7q11.21	7	66879664		GTF2IRD1P1 - GTF2IP23	ENSG00000230583	ENSG00000230295		34782	1044	rs142658912-?	rs142658912	0	142658912	intergenic_variant	1	NR	9E-7	6.045757490560675		1.3005798	[0.78-1.82] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	7q11.23	7	75772666		CCL26			ENSG00000006606			rs4285428-?	rs4285428	0	4285428	intron_variant	0	NR	2E-6	5.698970004336019		1.4241087	[0.83-2.01] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	7q11.23	7	76687279		POMZP3 - DTX2P1-UPK3BP1-PMS2P11	ENSG00000146707	ENSG00000265479		60000	272556	rs114779080-?	rs114779080	0	114779080	intron_variant	1	NR	2E-6	5.698970004336019		0.7757862	[0.46-1.1] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	7q31.33	7	126165205		POT1-AS1 - GRM8	ENSG00000224897	ENSG00000179603		682239	273393	rs73220984-?	rs73220984	0	73220984	intergenic_variant	1	NR	8E-7	6.096910013008056		0.3995203	[0.24-0.56] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	7q34	7	141126888		TMEM178B			ENSG00000261115			rs773619768-?	rs773619768	0	773619768	intron_variant	0	NR	6E-6	5.221848749616356		0.7698139	[0.44-1.1] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	8p23.2	8	3753240		CSMD1			ENSG00000183117			rs144687096-?	rs144687096	0	144687096	intron_variant	0	NR	7E-6	5.154901959985743		0.7948426	[0.45-1.14] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	8p12	8	35704343		UNC5D			ENSG00000156687			rs78930937-?	rs78930937	0	78930937	intron_variant	0	NR	4E-6	5.3979400086720375		0.4322675	[0.25-0.62] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	8p12	8	35988560		UNC5D - MTCYBP19	ENSG00000156687	ENSG00000253504		192010	289203	rs138876514-?	rs138876514	0	138876514	intron_variant	1	NR	3E-6	5.522878745280337		0.3875122	[0.23-0.55] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	8p12	8	36089664		UNC5D - MTCYBP19	ENSG00000156687	ENSG00000253504		293114	188099	rs79724918-?	rs79724918	0	79724918	intron_variant	1	NR	2E-6	5.698970004336019		0.3927137	[0.23-0.55] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	8p12	8	36361406		RNU6-533P - RPL23P10	ENSG00000206871	ENSG00000244708		51716	219774	rs79150654-?	rs79150654	0	79150654	intergenic_variant	1	NR	1E-5	5.0		0.3338458	[0.19-0.48] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	8q11.23	8	52281306		ST18			ENSG00000147488			rs117558878-?	rs117558878	0	117558878	intron_variant	0	NR	5E-7	6.301029995663981		0.6982616	[0.43-0.97] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	8q13.3	8	71486984		EYA1			ENSG00000104313			rs528968210-?	rs528968210	0	528968210	intron_variant	0	NR	2E-6	5.698970004336019		1.513429	[0.9-2.13] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	8q23.2	8	110868730		NDUFB9P3 - LINC01608	ENSG00000253994	ENSG00000253877		58836	31266	rs62520663-?	rs62520663	0	62520663	intergenic_variant	1	NR	3E-6	5.522878745280337		0.8468502	[0.49-1.2] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	9q34.3	9	136051021		NACC2			ENSG00000148411			rs572550786-?	rs572550786	0	572550786	intron_variant	0	NR	8E-6	5.096910013008056		0.9728505	[0.55-1.4] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	10p14	10	11717047		USP6NL-AS1 - ECHDC3	ENSG00000271360	ENSG00000134463		104820	25319	rs73572923-?	rs73572923	0	73572923	intergenic_variant	1	NR	8E-6	5.096910013008056		0.7424202	[0.42-1.07] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	10q22.2	10	74827028		KAT6B			ENSG00000156650			rs574070865-?	rs574070865	1	11327835	intron_variant	0	NR	4E-6	5.3979400086720375		0.8535855	[0.49-1.22] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	10q22.2	10	75047561		DUSP29			ENSG00000188716			rs186851919-?	rs186851919	0	186851919	intron_variant	0	NR	2E-6	5.698970004336019		0.9272557	[0.55-1.31] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	10q22.3	10	78069803		GNAI2P2 - LINC00856	ENSG00000231957	ENSG00000230417		265	109382	rs117479047-?	rs117479047	0	117479047	intergenic_variant	1	NR	9E-7	6.045757490560675		1.8363923	[1.11-2.57] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	10q24.2	10	98895915		HPSE2			ENSG00000172987			rs151000659-?	rs151000659	0	151000659	intron_variant	0	NR	3E-6	5.522878745280337		1.5665317	[0.91-2.22] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	2q37.3	2	241814290		NEU4			ENSG00000204099			rs118164027-?	rs118164027	0	118164027	intron_variant	0	NR	1E-5	5.0		1.6495638	[0.92-2.38] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	3p26.1	3	7849575		GRM7 - LMCD1-AS1	ENSG00000196277	ENSG00000227110		108042	101688	rs391664-?	rs391664	0	391664	intergenic_variant	1	NR	8E-6	5.096910013008056		0.2345648	[0.13-0.34] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	3p25.2	3	12599850		RAF1			ENSG00000132155			rs5746226-?	rs5746226	0	5746226	intron_variant	0	NR	3E-6	5.522878745280337		0.7972535	[0.46-1.13] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	3p24.1	3	28743735		RBMS3			ENSG00000144642			rs4680707-?	rs4680707	0	4680707	intron_variant	0	NR	3E-6	5.522878745280337		0.4522634	[0.26-0.64] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	3p22.2	3	37797934		ITGA9, ITGA9-AS1			ENSG00000144668, ENSG00000235257			rs111854254-?	rs111854254	0	111854254	intron_variant	0	NR	2E-6	5.698970004336019		0.4893659	[0.29-0.69] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	3p22.1	3	39838227		MYRIP			ENSG00000170011			rs146100088-?	rs146100088	0	146100088	intron_variant	0	NR	7E-8	7.154901959985743		1.455542	[0.93-1.98] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	3p21.31	3	46053730		XCR1			ENSG00000173578			rs183817891-?	rs183817891	0	183817891	intron_variant	0	NR	1E-11	11.0		0.5624724	[0.4-0.73] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	3p21.31	3	46285357		CCR3 - UQCRC2P1	ENSG00000183625	ENSG00000236736		18651	25234	rs77116118-?	rs77116118	0	77116118	intron_variant	1	NR	3E-6	5.522878745280337		0.7037993	[0.41-1] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	3p14.1	3	66834271		RPL21P41 - KBTBD8	ENSG00000214560	ENSG00000163376		196859	164036	rs78459863-?	rs78459863	0	78459863	intergenic_variant	1	NR	9E-6	5.045757490560675		0.7152704	[0.4-1.03] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	4p15.2	4	23107225		GBA3 - RFPL4AP3	ENSG00000249948	ENSG00000251220		287650	407715	rs113364911-?	rs113364911	0	113364911	intron_variant	1	NR	3E-6	5.522878745280337		0.8112763	[0.47-1.15] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	4q25	4	109566395		MCUB			ENSG00000005059			rs143556177-?	rs143556177	0	143556177	intron_variant	0	NR	9E-6	5.045757490560675		0.6594786	[0.37-0.95] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	4q26	4	114911219		NDST4			ENSG00000138653			rs112584520-?	rs112584520	1	75385823	intron_variant	0	NR	6E-7	6.221848749616356		0.4386633	[0.27-0.61] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	4q31.3	4	151317100		SH3D19			ENSG00000109686			rs79468174-?	rs79468174	0	79468174	intron_variant	0	NR	5E-6	5.301029995663981		0.855425	[0.49-1.22] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	4q35.1	4	184333045		MYL12BP2 - LINC02363	ENSG00000227765	ENSG00000180712		33405	1247	rs75859548-?	rs75859548	0	75859548	intergenic_variant	1	NR	3E-7	6.522878745280337		0.6404223	[0.4-0.89] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	5p14.1	5	24812897		SNORD29 - LINC02239	ENSG00000223004	ENSG00000248908		1349	22383	rs149500342-?	rs149500342	0	149500342	intron_variant	1	NR	2E-6	5.698970004336019		0.8170401	[0.48-1.16] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	5q13.1	5	68398416		PIK3R1 - VWA8P1	ENSG00000145675	ENSG00000250289		96595	456494	rs57825648-?	rs57825648	0	57825648	intergenic_variant	1	NR	5E-6	5.301029995663981		0.6276162	[0.36-0.9] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	5q13.3	5	76332281		SV2C			ENSG00000122012			rs73764328-?	rs73764328	0	73764328	3_prime_UTR_variant	0	NR	6E-6	5.221848749616356		0.504507	[0.29-0.72] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	5q21.3	5	106286190		RNA5SP189 - LINC01950	ENSG00000201790	ENSG00000251027		363082	529007	rs142891837-?	rs142891837	0	142891837	intergenic_variant	1	NR	9E-6	5.045757490560675		0.8658601	[0.49-1.25] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	5q33.1	5	150675603		MYOZ3			ENSG00000164591			rs147339561-?	rs147339561	0	147339561	intron_variant	0	NR	8E-6	5.096910013008056		1.7496824	[0.99-2.51] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	5q33.2	5	153726365		GRIA1			ENSG00000155511			rs560119570-?	rs560119570	0	560119570	intron_variant	0	NR	5E-6	5.301029995663981		1.3767594	[0.79-1.97] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	5q35.3	5	180412748		GFPT2 - RNU6-525P	ENSG00000131459	ENSG00000200555		59412	31761	rs56055373-?	rs56055373	0	56055373	intergenic_variant	1	NR	8E-6	5.096910013008056		0.5038964	[0.28-0.72] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	6q15	6	89489789		ANKRD6			ENSG00000135299			rs149792516-?	rs149792516	0	149792516	intron_variant	0	NR	2E-6	5.698970004336019		0.7393359	[0.44-1.04] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	6q16.1	6	94058866		EPHA7 - MTCYBP36	ENSG00000135333	ENSG00000216853		639179	387874	rs17505878-?	rs17505878	0	17505878	intergenic_variant	1	NR	8E-6	5.096910013008056		0.7288442	[0.41-1.05] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	6q22.31	6	118174746		SLC35F1			ENSG00000196376			rs144690690-?	rs144690690	0	144690690	intron_variant	0	NR	1E-6	6.0		0.8053994	[0.48-1.13] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	11q12.3	11	62381836		ASRGL1			ENSG00000162174			rs72472161-?	rs72472161	0	72472161	synonymous_variant	0	NR	7E-6	5.154901959985743		0.10070417	[0.057-0.144] unit decrease	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	1q41	1	219803526		SLC30A10			ENSG00000196660			rs148656801-?	rs148656801	0	148656801	intron_variant	0	NR	2E-6	5.698970004336019		0.2880312	[0.17-0.41] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	2p22.3	2	34350828		LINC01320			ENSG00000228262			rs7577875-?	rs7577875	0	7577875	intron_variant	0	NR	7E-7	6.154901959985743		0.06766578	[0.041-0.094] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	2q12.2	2	106283266		SRSF3P4 - RPS21P2	ENSG00000224061	ENSG00000230353		29549	5537	rs13406957-?	rs13406957	0	13406957	TF_binding_site_variant	1	NR	2E-6	5.698970004336019		0.25571647	[0.15-0.36] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	17p13.1	17	9923249		GAS7			ENSG00000007237			rs11413957-?	rs11413957	0	11413957	intron_variant	0	NR	7E-6	5.154901959985743		0.1991879	[0.11-0.29] unit decrease	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	3p21.31	3	45903640		LZTFL1			ENSG00000163818			rs17714228-?	rs17714228	0	17714228	intron_variant	0	NR	2E-7	6.698970004336019		0.11538574	[0.072-0.159] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	18q11.2	18	24512109		HRH4 - EIF4A3P1	ENSG00000134489	ENSG00000266181		32148	10164	rs62090028-?	rs62090028	0	62090028	intergenic_variant	1	NR	4E-6	5.3979400086720375		0.22934857	[0.13-0.33] unit decrease	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	19p13.3	19	710652		PALM			ENSG00000099864			rs763250940-?	rs763250940	0	763250940	intron_variant	0	NR	5E-6	5.301029995663981		0.11053436	[0.063-0.158] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	19p13.3	19	948462		ARID3A			ENSG00000116017			rs147497443-?	rs147497443	0	147497443	intron_variant	0	NR	3E-6	5.522878745280337		0.27590638	[0.16-0.39] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	19q13.33	19	48867245		PLEKHA4			ENSG00000105559			rs758313404-?	rs758313404	1	3830423	intron_variant	0	NR	4E-6	5.3979400086720375		0.08619032	[0.05-0.122] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	21q22.2	21	38568884		ERG			ENSG00000157554			rs74680252-?	rs74680252	0	74680252	intron_variant	0	NR	2E-7	6.698970004336019		0.24994965	[0.16-0.34] unit decrease	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	3q12.3	3	101756089		CEP97			ENSG00000182504			rs2318090-?	rs2318090	0	2318090	intron_variant	0	NR	3E-7	6.522878745280337		0.07546429	[0.047-0.104] unit decrease	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	Xq24	X	120484021		LAMP2 - RNU7-37P	ENSG00000005893	ENSG00000251707		14656	19016	rs6603626-?	rs6603626	0	6603626	intergenic_variant	1	NR	6E-8	7.221848749616356		0.0677461	[0.043-0.092] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	3q26.1	3	164921834		LINC01324 - SI	ENSG00000241767	ENSG00000090402		90354	57064	rs6775748-?	rs6775748	0	6775748	intergenic_variant	1	NR	7E-6	5.154901959985743		0.10853305	[0.062-0.156] unit decrease	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	1p13.3	1	108058560		LINC02785, LINC02785			ENSG00000226822, ENSG00000284338			rs140434246-?	rs140434246	0	140434246	intron_variant	0	NR	7E-6	5.154901959985743		0.7670103	[0.43-1.1] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	1p13.1	1	116435193		LINC01762			ENSG00000233154			rs72693796-?	rs72693796	0	72693796	intron_variant	0	NR	5E-6	5.301029995663981		0.9002026	[0.51-1.29] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	1q31.2	1	191992863		LINC02770			ENSG00000228215			rs143077787-?	rs143077787	0	143077787	intron_variant	0	NR	5E-6	5.301029995663981		0.7795916	[0.45-1.11] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	2p22.3	2	32802119		TTC27			ENSG00000018699			rs11406621-?	rs11406621	0	11406621	intron_variant	0	NR	6E-6	5.221848749616356		0.7638391	[0.44-1.09] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	2p13.3	2	70621603		ADD2			ENSG00000075340			rs192578492-?	rs192578492	0	192578492	intron_variant	0	NR	2E-6	5.698970004336019		0.8185436	[0.48-1.15] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	2q13	2	109025898		EDAR - Metazoa_SRP	ENSG00000135960	ENSG00000277055		36526	98459	rs79588402-?	rs79588402	0	79588402	intergenic_variant	1	NR	9E-6	5.045757490560675		0.8191275	[0.46-1.18] unit increase	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (hospitalized covid vs population)	613 European ancestry cases, 680,416 European ancestry controls, 140 Hispanic or Latin American cases, 94,327 Hispanic or Latin American controls, 49 Black or African American cases, 22,410 Black or African American controls	NA	2q14.3	2	123637314		LINC01826 - ELOAP1	ENSG00000232740	ENSG00000235640		563833	57988	rs143255171-?	rs143255171	0	143255171	intergenic_variant	1	NR	8E-6	5.096910013008056		0.9099719	[0.51-1.31] unit decrease	Illumina [9875426] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027246	Genome-wide genotyping array
2021-09-09	33888907	Shelton JF	2021-04-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33888907	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.	COVID-19 (covid vs negative)	9,913 European ancestry cases, 85,072 European ancestry controls, 2,553 Hispanic or Latin American cases, 13,086 Hispanic or Latin American controls, 506 Black or African American cases, 3,110 Black or African American controls	NA	6q15	6	89383113		RRAGD			ENSG00000025039			rs78937420-?	rs78937420	0	78937420	intron_variant	0	NR	4E-6	5.3979400086720375		0.275741	[0.16-0.39] unit increase	Illumina [9939936] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90027245	Genome-wide genotyping array
2019-08-29	31260374	Pedergnana V	2019-07-01	J Interferon Cytokine Res	www.ncbi.nlm.nih.gov/pubmed/31260374	Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.	Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	325 European, Asian and unknown ancestry responders, 84 European, Asian and unknown ancestry non-responders	NA	6q22.31	6	122670278	NR	PKIB			ENSG00000135549			rs56378326-?	rs56378326	0	56378326	intron_variant	0	NR	7E-7	6.154901959985743		Infinity	NR	Affymetrix [~ 18000000] (imputed)	N	response to antiviral drug	http://www.ebi.ac.uk/efo/EFO_0010123	GCST008520	Genome-wide genotyping array
2019-08-29	31260374	Pedergnana V	2019-07-01	J Interferon Cytokine Res	www.ncbi.nlm.nih.gov/pubmed/31260374	Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.	Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	325 European, Asian and unknown ancestry responders, 84 European, Asian and unknown ancestry non-responders	NA	8q24.22	8	134989069	NR	RPL23AP56 - NA	ENSG00000244413			9790		rs59888390-?	rs59888390	0	59888390	regulatory_region_variant	1	NR	5E-7	6.301029995663981		3.846154	NR	Affymetrix [~ 18000000] (imputed)	N	response to antiviral drug	http://www.ebi.ac.uk/efo/EFO_0010123	GCST008520	Genome-wide genotyping array
2019-08-29	31260374	Pedergnana V	2019-07-01	J Interferon Cytokine Res	www.ncbi.nlm.nih.gov/pubmed/31260374	Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.	Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	325 European, Asian and unknown ancestry responders, 84 European, Asian and unknown ancestry non-responders	NA	21q21.1	21	21017373	NR	NCAM2			ENSG00000154654			rs35384524-?	rs35384524	0	35384524	intron_variant	0	NR	5E-7	6.301029995663981		3.5714285	NR	Affymetrix [~ 18000000] (imputed)	N	response to antiviral drug	http://www.ebi.ac.uk/efo/EFO_0010123	GCST008520	Genome-wide genotyping array
2019-08-29	31260374	Pedergnana V	2019-07-01	J Interferon Cytokine Res	www.ncbi.nlm.nih.gov/pubmed/31260374	Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.	Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	325 European, Asian and unknown ancestry responders, 84 European, Asian and unknown ancestry non-responders	NA	4q25	4	110212212	NR	ELOVL6 - HSBP1P2	ENSG00000170522	ENSG00000166530		13013	39659	rs7670514-?	rs7670514	0	7670514	regulatory_region_variant	1	NR	2E-6	5.698970004336019		2.4	NR	Affymetrix [~ 18000000] (imputed)	N	response to antiviral drug	http://www.ebi.ac.uk/efo/EFO_0010123	GCST008520	Genome-wide genotyping array
2019-08-29	31260374	Pedergnana V	2019-07-01	J Interferon Cytokine Res	www.ncbi.nlm.nih.gov/pubmed/31260374	Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.	Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	325 European, Asian and unknown ancestry responders, 84 European, Asian and unknown ancestry non-responders	NA	4q32.3	4	164845587	NR	SMIM31 - APELA	ENSG00000248771	ENSG00000248329		41792	31591	rs10011468-?	rs10011468	0	10011468	intergenic_variant	1	NR	2E-6	5.698970004336019		2.43	NR	Affymetrix [~ 18000000] (imputed)	N	response to antiviral drug	http://www.ebi.ac.uk/efo/EFO_0010123	GCST008520	Genome-wide genotyping array
2019-08-29	31260374	Pedergnana V	2019-07-01	J Interferon Cytokine Res	www.ncbi.nlm.nih.gov/pubmed/31260374	Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.	Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	325 European, Asian and unknown ancestry responders, 84 European, Asian and unknown ancestry non-responders	NA	15q21.1	15	48938914	NR	SHC4			ENSG00000185634			rs12323963-?	rs12323963	0	12323963	intron_variant	0	NR	2E-6	5.698970004336019		2.75	NR	Affymetrix [~ 18000000] (imputed)	N	response to antiviral drug	http://www.ebi.ac.uk/efo/EFO_0010123	GCST008520	Genome-wide genotyping array
2019-08-29	31260374	Pedergnana V	2019-07-01	J Interferon Cytokine Res	www.ncbi.nlm.nih.gov/pubmed/31260374	Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.	Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	325 European, Asian and unknown ancestry responders, 84 European, Asian and unknown ancestry non-responders	NA	1q21.1	1	143723149	NR	RNVU1-23 - RNVU1-18	ENSG00000252826	ENSG00000206737		2505	6258	rs116399066-?	rs116399066	0	116399066	intergenic_variant	1	NR	1E-6	6.0		6.39	NR	Affymetrix [~ 18000000] (imputed)	N	response to antiviral drug	http://www.ebi.ac.uk/efo/EFO_0010123	GCST008520	Genome-wide genotyping array
2015-08-14	25533491	Rautanen A	2014-12-18	Lancet Respir Med	www.ncbi.nlm.nih.gov/pubmed/25533491	Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study.	Sepsis from pneumonia (survival)	359 European ancestry non-survivor cases, 1,194 European ancestry survivor cases	106 European ancestry non-survivor cases, 432 European ancestry survivor cases	5q21.3	5	109066439	FER	FER			ENSG00000151422			rs4957796-?	rs4957796	0	4957796	intron_variant	0	NR	6E-8	7.221848749616356		1.79	[1.45-2.22]	Affymetrix, Illumina [5888277] (imputed)	N	survival time, pneumonia, septic shock, Sepsis	http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_0003106, http://www.ebi.ac.uk/efo/EFO_0006834, http://purl.obolibrary.org/obo/HP_0100806	GCST002725	Genome-wide genotyping array
2015-08-14	25533491	Rautanen A	2014-12-18	Lancet Respir Med	www.ncbi.nlm.nih.gov/pubmed/25533491	Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study.	Sepsis from pneumonia (survival)	359 European ancestry non-survivor cases, 1,194 European ancestry survivor cases	106 European ancestry non-survivor cases, 432 European ancestry survivor cases	6q16.3	6	103362128	intergenic	NA - WAKMAR2		ENSG00000237499			34461545	rs79423885-?	rs79423885	0	79423885	intergenic_variant	1	NR	2E-6	5.698970004336019		1.89	[NR]	Affymetrix, Illumina [5888277] (imputed)	N	survival time, pneumonia, septic shock, Sepsis	http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_0003106, http://www.ebi.ac.uk/efo/EFO_0006834, http://purl.obolibrary.org/obo/HP_0100806	GCST002725	Genome-wide genotyping array
2017-09-15	28662289	Lin YY	2017-06-29	Cancer	www.ncbi.nlm.nih.gov/pubmed/28662289	Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma.	Familial hepatitis B virus-related hepatocellular carcinoma	139 East Asian ancestry cases, 139 East Asian ancestry controls	NA	4q34.3	4	177496993	AGA	RNA5SP172 - NA	ENSG00000201931			39765		rs117413665-C	rs117413665	0	117413665	intron_variant	1	0.8406	6E-6	5.221848749616356		4.17	[2.17-8.33]	Affymetrix [641398]	N	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	GCST004736	Genome-wide genotyping array
2017-09-15	28662289	Lin YY	2017-06-29	Cancer	www.ncbi.nlm.nih.gov/pubmed/28662289	Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma.	Familial hepatitis B virus-related hepatocellular carcinoma	139 East Asian ancestry cases, 139 East Asian ancestry controls	NA	4p15.33	4	11854239	MIR572	LINC02360 - NA	ENSG00000248300			84771		rs35523062-C	rs35523062	0	35523062	intergenic_variant	1	0.8297	7E-6	5.154901959985743		3.85	[2.08-7.14]	Affymetrix [641398]	N	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	GCST004736	Genome-wide genotyping array
2017-09-15	28662289	Lin YY	2017-06-29	Cancer	www.ncbi.nlm.nih.gov/pubmed/28662289	Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma.	Familial hepatitis B virus-related hepatocellular carcinoma	139 East Asian ancestry cases, 139 East Asian ancestry controls	NA	15q25.3	15	88493060	MRPS11	MRPS11 - DET1	ENSG00000181991	ENSG00000140543		12284	1380	rs4932397-C	rs4932397	0	4932397	intron_variant	1	0.4964	7E-6	5.154901959985743		2.17	[1.56-3.13]	Affymetrix [641398]	N	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	GCST004736	Genome-wide genotyping array
2017-09-15	28662289	Lin YY	2017-06-29	Cancer	www.ncbi.nlm.nih.gov/pubmed/28662289	Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma.	Familial hepatitis B virus-related hepatocellular carcinoma	139 East Asian ancestry cases, 139 East Asian ancestry controls	NA	8p22	8	13261659	DLC1	DLC1			ENSG00000164741			rs77236434-T	rs77236434	0	77236434	intron_variant	0	0.0144	3E-7	6.522878745280337		9.87	[3.46-28.16]	Affymetrix [641398]	N	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	GCST004736	Genome-wide genotyping array
2017-06-13	28130311	Tan W	2017-01-27	Gut	www.ncbi.nlm.nih.gov/pubmed/28130311	Genome-wide association study identies HLA-DR variants conferring risk of HBV-related acute-on-chronic liver failure.	Acute-on-chronic liver failure in hepatitis B	389 Chinese ancestry cases, 391 Chinese ancestry controls	901 Chinese ancestry cases,  1,686 Chinese ancestry controls	6p21.32	6	32433162	HLA-DQB1, HLA-DRA	TSBP1-AS1 - HLA-DRA	ENSG00000225914	ENSG00000204287		25399	6716	rs3129859-C	rs3129859	0	3129859	intergenic_variant	1	0.15	7E-19	18.154901959985743		1.83	[1.60-2.09]	Affymetrix [654960]	N	acute-on-chronic liver failure	http://www.ebi.ac.uk/efo/EFO_0007949	GCST004165	Genome-wide genotyping array
2016-10-05	26870257	Qu LS	2015-11-23	Oncol Lett	www.ncbi.nlm.nih.gov/pubmed/26870257	Nine susceptibility loci for hepatitis B virus-related hepatocellular carcinoma identified by a pilot two-stage genome-wide association study.	Hepatocellular carcinoma in hepatitis B infection	50 Han Chinese ancestry seropositive cases, 50 Han Chinese ancestry seropositive controls	282 Han Chinese ancestry seropositive cases, 278 Han Chinese ancestry seropositive controls	3q25.32	3	157429779	VEPH1	VEPH1			ENSG00000197415			rs2120243-?	rs2120243	0	2120243	intron_variant	0	NR	2E-6	5.698970004336019		1.76	1.39-2.22	Affymetrix [279757]	N	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	GCST003189	Genome-wide genotyping array
2016-10-05	26870257	Qu LS	2015-11-23	Oncol Lett	www.ncbi.nlm.nih.gov/pubmed/26870257	Nine susceptibility loci for hepatitis B virus-related hepatocellular carcinoma identified by a pilot two-stage genome-wide association study.	Hepatocellular carcinoma in hepatitis B infection	50 Han Chinese ancestry seropositive cases, 50 Han Chinese ancestry seropositive controls	282 Han Chinese ancestry seropositive cases, 278 Han Chinese ancestry seropositive controls	11q14.2	11	86933347	FZD4	PRSS23			ENSG00000150687			rs1350171-?	rs1350171	0	1350171	non_coding_transcript_exon_variant	0	NR	6E-6	5.221848749616356		1.66	[1.33-2.07]	Affymetrix [279757]	N	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	GCST003189	Genome-wide genotyping array
2012-04-28	22497812	Clark PJ	2012-02-22	J Viral Hepat	www.ncbi.nlm.nih.gov/pubmed/22497812	Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.	Lipid levels in hepatitis C treatment	1,017 European ancestry cases, 207 African American cases, 95 Hispanic cases	NA	19q13.2	19	39241143	IL28B	IFNL3P1 - IFNL3	ENSG00000268510	ENSG00000197110		3850	2410	rs12980275-?	rs12980275	0	12980275	intergenic_variant	1	NR	5E-17	16.30102999566398				Illumina [565759]	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST001418	Genome-wide genotyping array
2017-03-28	27723809	Matsunami K	2016-10-10	PLoS One	www.ncbi.nlm.nih.gov/pubmed/27723809	Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.	Depression in response to interferon-based therapy in chronic hepatitis C	45 Japanese ancestry cases, 179 Japanese ancestry controls	40 Japanese ancestry cases, 120 Japanese ancestry controls	2q14.2	2	118328332	INSIG2							rs7562732-?	rs7562732	0	7562732	intergenic_variant	1	NR	2E-6	5.698970004336019		5.0	NR	Affymetrix [at least 551176] (imputed)	N	response to interferon, depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007859, http://www.ebi.ac.uk/efo/EFO_0007006	GCST003824	Genome-wide genotyping array
2017-03-28	27723809	Matsunami K	2016-10-10	PLoS One	www.ncbi.nlm.nih.gov/pubmed/27723809	Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.	Depression in response to interferon-based therapy in chronic hepatitis C	45 Japanese ancestry cases, 179 Japanese ancestry controls	40 Japanese ancestry cases, 120 Japanese ancestry controls	5q35.3	5	179112381	ZNF354C, ADAMTS2	ADAMTS2			ENSG00000087116			rs1863918-T	rs1863918	0	1863918	3_prime_UTR_variant	0	NR	8E-8	7.096910013008056		2.55	[1.8-3.61]	Affymetrix [at least 551176] (imputed)	N	response to interferon, depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007859, http://www.ebi.ac.uk/efo/EFO_0007006	GCST003824	Genome-wide genotyping array
2017-03-28	27723809	Matsunami K	2016-10-10	PLoS One	www.ncbi.nlm.nih.gov/pubmed/27723809	Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.	Depression in response to interferon-based therapy in chronic hepatitis C	45 Japanese ancestry cases, 179 Japanese ancestry controls	40 Japanese ancestry cases, 120 Japanese ancestry controls	6q21	6	108752513	intergenic	LINC00222			ENSG00000203801			rs9386749-?	rs9386749	0	9386749	intron_variant	0	NR	9E-6	5.045757490560675		2.173913	NR	Affymetrix [at least 551176] (imputed)	N	response to interferon, depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007859, http://www.ebi.ac.uk/efo/EFO_0007006	GCST003824	Genome-wide genotyping array
2017-03-28	27723809	Matsunami K	2016-10-10	PLoS One	www.ncbi.nlm.nih.gov/pubmed/27723809	Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.	Depression in response to interferon-based therapy in chronic hepatitis C	45 Japanese ancestry cases, 179 Japanese ancestry controls	40 Japanese ancestry cases, 120 Japanese ancestry controls	19p13.3	19	4841139	M6PRBP1	PLIN3			ENSG00000105355			rs2779180-?	rs2779180	0	2779180	intron_variant	0	NR	1E-6	6.0		2.564103	NR	Affymetrix [at least 551176] (imputed)	N	response to interferon, depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007859, http://www.ebi.ac.uk/efo/EFO_0007006	GCST003824	Genome-wide genotyping array
2015-04-01	25030430	Zignego AL	2014-07-17	Genes Immun	www.ncbi.nlm.nih.gov/pubmed/25030430	Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis.	Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection	356 European ancestry cases, 447 European ancestry controls	92 European ancestry cases, 179 European ancestry controls	6p21.32	6	32212119	NOTCH4	NOTCH4, NOTCH4, NOTCH4, NOTCH4, NOTCH4, NOTCH4			ENSG00000235396, ENSG00000223355, ENSG00000204301, ENSG00000232339, ENSG00000234876, ENSG00000206312			rs2071286-?	rs2071286	0	2071286	intron_variant	0	0.29	2E-8	7.698970004336019		2.15	[NR]	Illumina [899641]	N	cryoglobulinemia	http://www.ebi.ac.uk/efo/EFO_0005846	GCST002534	Genome-wide genotyping array
2015-04-01	25030430	Zignego AL	2014-07-17	Genes Immun	www.ncbi.nlm.nih.gov/pubmed/25030430	Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis.	Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection	356 European ancestry cases, 447 European ancestry controls	92 European ancestry cases, 179 European ancestry controls	6p21.32	6	32607958	HLA-DQA1, HLA-DRB1	HLA-DRB1 - HLA-DQA1	ENSG00000206240	ENSG00000196735		18110	20221	rs9461776-G	rs9461776	0	9461776	intron_variant	1	0.29	7E-9	8.154901959985743		2.02	[NR]	Illumina [899641]	N	cryoglobulinemia	http://www.ebi.ac.uk/efo/EFO_0005846	GCST002534	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	6q24.3	6	148226666	intergenic	NA - SASH1		ENSG00000111961			45638	rs9497975-?	rs9497975	0	9497975	regulatory_region_variant	1	NR	7E-8	7.154901959985743	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	6p21.33	6	31125810	CDSN	PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1			ENSG00000231094, ENSG00000233439, ENSG00000206458, ENSG00000233734, ENSG00000204540, ENSG00000235487			rs3815087-?	rs3815087	0	3815087	5_prime_UTR_variant	0	NR	8E-8	7.096910013008056	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	Xq26.2	X	133003128	intergenic	HS6ST2 - USP26	ENSG00000171004	ENSG00000134588		41733	21503	rs17324272-?	rs17324272	0	17324272	intergenic_variant	1	NR	2E-7	6.698970004336019	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	3p23	3	31404088	intergenic	NA - THRAP3P1		ENSG00000227339			48744	rs17027625-?	rs17027625	0	17027625	intergenic_variant	1	NR	4E-6	5.3979400086720375	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	6p22.1	6	30057726	ZNRD1, C6orf12	ZNRD1ASP, ZNRD1ASP, ZNRD1ASP, ZNRD1ASP, ZNRD1ASP, ZNRD1ASP, ZNRD1ASP			ENSG00000204623, ENSG00000235394, ENSG00000196299, ENSG00000225618, ENSG00000235814, ENSG00000229653, ENSG00000232691			rs259919-?	rs259919	0	259919	intron_variant	0	NR	3E-7	6.522878745280337	(setpoint)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	6p21.33	6	32059031	TNXB	TNXB, TNXB, TNXB, TNXB, TNXB, TNXB			ENSG00000168477, ENSG00000236236, ENSG00000206258, ENSG00000229353, ENSG00000233323, ENSG00000231608			rs12198173-?	rs12198173	0	12198173	intron_variant	0	NR	3E-6	5.522878745280337	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	1p32.2	1	57339878	NR	DAB1			ENSG00000173406			rs10159302-?	rs10159302	0	10159302	intron_variant	0	NR	9E-6	5.045757490560675	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	1q21.1	1	147037378	NR	NBPF12 - RNU1-151P	ENSG00000268043	ENSG00000201142		41176	42368	rs12122100-?	rs12122100	0	12122100	intron_variant	1	NR	1E-6	6.0	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	6p21.33	6	31306603	HLA-C	LINC02571 - HLA-B	ENSG00000256166	ENSG00000232126		4961	47269	rs9264942-?	rs9264942	0	9264942	intron_variant	1	NR	6E-12	11.221848749616356	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	4q32.1	4	160585745	intergenic	LINC02477			ENSG00000249425			rs17291045-?	rs17291045	0	17291045	intron_variant	0	NR	5E-8	7.301029995663981	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	5q32	5	150027170	NR	HMGXB3			ENSG00000113716			rs2304069-?	rs2304069	0	2304069	intron_variant	0	NR	7E-6	5.154901959985743	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	21q22.12	21	35161365	NR	RUNX1			ENSG00000159216			rs2834812-?	rs2834812	0	2834812	intron_variant	0	NR	9E-6	5.045757490560675	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	9q21.13	9	73543766	intergenic	DPP3P2 - NA	ENSG00000221844			67693		rs11143609-?	rs11143609	0	11143609	intron_variant	1	NR	7E-6	5.154901959985743	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	11q14.3	11	90853732	intergenic	DISC1FP1			ENSG00000261645			rs12274302-?	rs12274302	0	12274302	non_coding_transcript_exon_variant	0	NR	4E-7	6.3979400086720375	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	2q37.1	2	233593475	intergenic	UGT1A12P - UGT1A11P	ENSG00000228949	ENSG00000227846		7184	10078	rs13394720-?	rs13394720	0	13394720	intergenic_variant	1	NR	5E-7	6.301029995663981	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	16q23.1	16	74847922	intergenic	FA2H - WDR59	ENSG00000103089	ENSG00000103091		73091	23440	rs16948255-?	rs16948255	0	16948255	intergenic_variant	1	NR	1E-6	6.0	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	2p16.1	2	56136242	intergenic	LINC01813 - CCDC85A	ENSG00000229805	ENSG00000055813		45860	47748	rs6751715-?	rs6751715	0	6751715	intron_variant	1	NR	1E-6	6.0	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	10q11.23	10	49353462	intergenic	C10orf71 - DRGX	ENSG00000177354	ENSG00000165606		25970	10604	rs4838508-?	rs4838508	0	4838508	intergenic_variant	1	NR	2E-6	5.698970004336019	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	6q27	6	169558886	NR	WDR27			ENSG00000184465			rs3734905-?	rs3734905	0	3734905	non_coding_transcript_exon_variant	0	NR	2E-6	5.698970004336019	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	2q32.3	2	192469177	intergenic							rs1385351-?	rs1385351	0	1385351	intergenic_variant	1	NR	4E-6	5.3979400086720375	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	6p21.32	6	32408694	NOTCH4, BTNL2	TSBP1-AS1 - HLA-DRA	ENSG00000225914	ENSG00000204287		931	31184	rs3763313-?	rs3763313	0	3763313	intergenic_variant	1	NR	2E-6	5.698970004336019	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	10q26.2	10	128338841	intergenic	LINC01163 - NA	ENSG00000280953			21115		rs11818629-?	rs11818629	0	11818629	intergenic_variant	1	NR	3E-6	5.522878745280337	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	6p21.33	6	31464003	HCP5, HLA-B	HCP5			ENSG00000206337			rs2395029-?	rs2395029	0	2395029	non_coding_transcript_exon_variant	0	NR	1E-11	11.0	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	6p22.1	6	30002812	HLA-A, ZNRD1, RNF39	ZNRD1ASP, ZNRD1ASP, ZNRD1ASP, ZNRD1ASP, ZNRD1ASP, ZNRD1ASP, ZNRD1ASP			ENSG00000204623, ENSG00000235394, ENSG00000196299, ENSG00000225618, ENSG00000235814, ENSG00000229653, ENSG00000232691			rs7758512-?	rs7758512	0	7758512	intron_variant	0	NR	2E-8	7.698970004336019	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	6p21.33	6	31834764	SNORD52	SNHG32, SNHG32, SNHG32, SNHG32			ENSG00000206380, ENSG00000226710, ENSG00000204387, ENSG00000229300			rs9368699-?	rs9368699	0	9368699	5_prime_UTR_variant	0	NR	5E-8	7.301029995663981	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	7p21.1	7	20007952	intergenic	RPL21P75 - NA	ENSG00000213860			4705		rs38152-?	rs38152	0	38152	intron_variant	1	NR	7E-8	7.154901959985743	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	14q23.1	14	57888330	intergenic	SLC35F4			ENSG00000151812			rs8013190-?	rs8013190	0	8013190	intron_variant	0	NR	7E-8	7.154901959985743	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	6p12.1	6	55283305	HCRTR2	HCRTR2 - GFRAL	ENSG00000137252	ENSG00000187871		688	44164	rs9367630-?	rs9367630	0	9367630	intergenic_variant	1	NR	1E-7	7.0	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	11q14.2	11	88588556	intergenic	GRM5			ENSG00000168959			rs16914280-?	rs16914280	0	16914280	intron_variant	0	NR	3E-7	6.522878745280337	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	13q13.3	13	35603682	intergenic	NBEA			ENSG00000172915			rs1777672-?	rs1777672	0	1777672	intron_variant	0	NR	4E-7	6.3979400086720375	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	Xq21.31	X	87935349	intergenic							rs12012519-?	rs12012519	0	12012519	intergenic_variant	1	NR	7E-6	5.154901959985743	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	18q21.31	18	57316323	intergenic	RNU6-737P - ST8SIA3	ENSG00000202240	ENSG00000177511		31615	36234	rs1120787-?	rs1120787	0	1120787	intergenic_variant	1	NR	7E-6	5.154901959985743	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	2q22.3	2	146614456	intergenic	PABPC1P2 - NA	ENSG00000198526			25146		rs10928302-?	rs10928302	0	10928302	intergenic_variant	1	NR	8E-6	5.096910013008056	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	16p13.2	16	10089230	NR	GRIN2A			ENSG00000183454			rs1463132-?	rs1463132	0	1463132	intron_variant	0	NR	8E-6	5.096910013008056	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA				VARS2, DDR1, DPCR1							rs7756521-?	rs7756521	0	7756521	intron_variant	1	NR	1E-6	6.0	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	6p22.1	6	30152113	TRIM10	TRIM10, TRIM10, TRIM10, TRIM10, TRIM10, TRIM10, TRIM10			ENSG00000204613, ENSG00000137394, ENSG00000229381, ENSG00000237703, ENSG00000237192, ENSG00000227472, ENSG00000229346			rs9468692-?	rs9468692	0	9468692	3_prime_UTR_variant	0	NR	1E-6	6.0	(setpoint)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	6p21.33	6	31306603	HLA-C	LINC02571 - HLA-B	ENSG00000256166	ENSG00000232126		4961	47269	rs9264942-C	rs9264942	0	9264942	intron_variant	1	0.412	6E-32	31.221848749616356	(setpoint)	5.3	[NR] % increase	Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	2p25.2	2	5994808	NR	SILC1			ENSG00000232044			rs1405262-?	rs1405262	0	1405262	non_coding_transcript_exon_variant	0	NR	6E-6	5.221848749616356	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	1q42.3	1	234849241	intergenic	RNY4P16 - RN7SL668P	ENSG00000201638	ENSG00000239690		11172	54945	rs2069084-?	rs2069084	0	2069084	intron_variant	1	NR	6E-6	5.221848749616356	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	5q23.2	5	125407574	intergenic	LINC02240			ENSG00000260192			rs2637496-?	rs2637496	0	2637496	intron_variant	0	NR	9E-6	5.045757490560675	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	6p21.33	6	31464003	HCP5, HLA-B	HCP5			ENSG00000206337			rs2395029-G	rs2395029	0	2395029	non_coding_transcript_exon_variant	0	0.048	5E-35	34.30102999566398	(setpoint)	5.8	[NR] % increase	Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2010-01-19	20041166	Fellay J	2009-12-24	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20041166	Common genetic variation and the control of HIV-1 in humans.	HIV-1 control	2,362 European ancestry cases	NA	8q13.3	8	69812519	NR	SLCO5A1			ENSG00000137571			rs16936455-?	rs16936455	0	16936455	intron_variant	0	NR	7E-6	5.154901959985743	(progression)			Illumina [NR]	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000549	Genome-wide genotyping array
2015-05-14	22174851	Lingappa JR	2011-12-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/22174851	Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure.	HIV-1 susceptibility	496 African ancestry cases and 302 African ancestry exposed controls from serodiscordant couples	NA	16p13.3	16	3074919	IL32	IL32			ENSG00000008517			rs4349147-?	rs4349147	0	4349147	intron_variant	0	NR	8E-6	5.096910013008056				Illumina [990115]	N	HIV-1 infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0000180, http://www.orpha.net/ORDO/Orphanet_391311	GCST001353	Genome-wide genotyping array
2015-05-14	22174851	Lingappa JR	2011-12-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/22174851	Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure.	HIV-1 susceptibility	496 African ancestry cases and 302 African ancestry exposed controls from serodiscordant couples	NA	6p24.2	6	11310186	NEDD9	NEDD9			ENSG00000111859			rs4437462-?	rs4437462	0	4437462	intron_variant	0	NR	2E-6	5.698970004336019				Illumina [990115]	N	HIV-1 infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0000180, http://www.orpha.net/ORDO/Orphanet_391311	GCST001353	Genome-wide genotyping array
2015-05-14	22174851	Lingappa JR	2011-12-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/22174851	Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure.	HIV-1 susceptibility	496 African ancestry cases and 302 African ancestry exposed controls from serodiscordant couples	NA	11p15.1	11	19578424	AC023950.6	NAV2			ENSG00000166833			rs10741780-?	rs10741780	0	10741780	intron_variant	0	NR	6E-6	5.221848749616356				Illumina [990115]	N	HIV-1 infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0000180, http://www.orpha.net/ORDO/Orphanet_391311	GCST001353	Genome-wide genotyping array
2015-05-14	22174851	Lingappa JR	2011-12-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/22174851	Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure.	HIV-1 susceptibility	496 African ancestry cases and 302 African ancestry exposed controls from serodiscordant couples	NA	8p11.22	8	39690859	ADAM18	ADAM18, ADAM18			ENSG00000278548, ENSG00000168619			rs1349547-?	rs1349547	0	1349547	intron_variant	0	NR	2E-6	5.698970004336019				Illumina [990115]	N	HIV-1 infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0000180, http://www.orpha.net/ORDO/Orphanet_391311	GCST001353	Genome-wide genotyping array
2015-05-14	22174851	Lingappa JR	2011-12-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/22174851	Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure.	HIV-1 susceptibility	496 African ancestry cases and 302 African ancestry exposed controls from serodiscordant couples	NA	19q13.33	19	47702468	GLTSCR1	BICRA			ENSG00000063169			rs3745760-?	rs3745760	0	3745760	3_prime_UTR_variant	0	NR	8E-7	6.096910013008056				Illumina [990115]	N	HIV-1 infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0000180, http://www.orpha.net/ORDO/Orphanet_391311	GCST001353	Genome-wide genotyping array
2015-05-14	22174851	Lingappa JR	2011-12-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/22174851	Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure.	HIV-1 susceptibility	496 African ancestry cases and 302 African ancestry exposed controls from serodiscordant couples	NA	8q12.3	8	64727703	CYP7B1	CYP7B1			ENSG00000172817			rs10808739-?	rs10808739	0	10808739	intron_variant	0	NR	1E-6	6.0				Illumina [990115]	N	HIV-1 infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0000180, http://www.orpha.net/ORDO/Orphanet_391311	GCST001353	Genome-wide genotyping array
2015-05-14	22174851	Lingappa JR	2011-12-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/22174851	Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure.	HIV-1 susceptibility	496 African ancestry cases and 302 African ancestry exposed controls from serodiscordant couples	NA	11q13.2	11	66895260	PC	PC			ENSG00000173599			rs7122539-?	rs7122539	0	7122539	intron_variant	0	NR	8E-6	5.096910013008056				Illumina [990115]	N	HIV-1 infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0000180, http://www.orpha.net/ORDO/Orphanet_391311	GCST001353	Genome-wide genotyping array
2015-05-14	22174851	Lingappa JR	2011-12-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/22174851	Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure.	HIV-1 susceptibility	496 African ancestry cases and 302 African ancestry exposed controls from serodiscordant couples	NA	4q21.21	4	81088553	PRKG2	PRKG2			ENSG00000138669			rs3796804-?	rs3796804	0	3796804	3_prime_UTR_variant	0	NR	9E-6	5.045757490560675				Illumina [990115]	N	HIV-1 infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0000180, http://www.orpha.net/ORDO/Orphanet_391311	GCST001353	Genome-wide genotyping array
2015-05-14	22174851	Lingappa JR	2011-12-12	PLoS One	www.ncbi.nlm.nih.gov/pubmed/22174851	Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure.	HIV-1 susceptibility	496 African ancestry cases and 302 African ancestry exposed controls from serodiscordant couples	NA	3q13.33	3	120298633	LRRC58	GPR156 - LRRC58	ENSG00000175697	ENSG00000163428		13411	25876	rs796825-?	rs796825	0	796825	intergenic_variant	1	NR	8E-6	5.096910013008056				Illumina [990115]	N	HIV-1 infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0000180, http://www.orpha.net/ORDO/Orphanet_391311	GCST001353	Genome-wide genotyping array
2016-09-30	26553974	McLaren PJ	2015-11-09	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/26553974	Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.	Setpoint viral load in HIV-1 infection	6,315 European ancestry cases	NA	6p21.33	6	31403294	HLA-B	MICA, MICA, MICA			ENSG00000233051, ENSG00000204520, ENSG00000231225			rs59440261-?	rs59440261	0	59440261	intron_variant	0	NR	2E-83	82.69897000433602				Affymetrix, Illumina [~ 8000000] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST003183	Genome-wide genotyping array
2016-09-30	26553974	McLaren PJ	2015-11-09	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/26553974	Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.	Setpoint viral load in HIV-1 infection	6,315 European ancestry cases	NA	3p21.31	3	46410189	CCRL2	CCRL2			ENSG00000121797			rs1015164-?	rs1015164	0	1015164	intron_variant	0	NR	2E-19	18.69897000433602				Affymetrix, Illumina [~ 8000000] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST003183	Genome-wide genotyping array
2016-09-30	26553974	McLaren PJ	2015-11-09	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/26553974	Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.	Setpoint viral load in HIV-1 infection	6,315 European ancestry cases	NA				HLA-B							HLA-B*57:01-?	HLA-B*57:01	0			1	0.05	3E-86	85.52287874528034		0.84	[0.76-0.92] unit decrease	Affymetrix, Illumina [~ 8000000] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST003183	Genome-wide genotyping array
2016-09-30	26553974	McLaren PJ	2015-11-09	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/26553974	Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.	Setpoint viral load in HIV-1 infection	6,315 European ancestry cases	NA				HLA-C							HLA-C*06:02-?	HLA-C*06:02	0			1	0.1	7E-50	49.15490195998574		0.436	[0.38-0.49] unit decrease	Affymetrix, Illumina [~ 8000000] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST003183	Genome-wide genotyping array
2016-09-30	26553974	McLaren PJ	2015-11-09	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/26553974	Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.	Setpoint viral load in HIV-1 infection	6,315 European ancestry cases	NA				HLA-B							HLA-B*27:05-?	HLA-B*27:05	0			1	0.04	4E-20	19.397940008672037		0.417	[0.33-0.51] unit decrease	Affymetrix, Illumina [~ 8000000] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST003183	Genome-wide genotyping array
2016-09-30	26553974	McLaren PJ	2015-11-09	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/26553974	Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.	Setpoint viral load in HIV-1 infection	6,315 European ancestry cases	NA				HLA-C							HLA-C*07:01-?	HLA-C*07:01	0			1	0.14	2E-14	13.698970004336019		0.195	[0.15-0.24] unit increase	Affymetrix, Illumina [~ 8000000] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST003183	Genome-wide genotyping array
2016-09-30	26553974	McLaren PJ	2015-11-09	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/26553974	Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.	Setpoint viral load in HIV-1 infection	6,315 European ancestry cases	NA				HLA-C							HLA-C*07:02-?	HLA-C*07:02	0			1	0.13	4E-13	12.397940008672037		0.194	[0.14-0.25] unit increase	Affymetrix, Illumina [~ 8000000] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST003183	Genome-wide genotyping array
2016-09-30	26553974	McLaren PJ	2015-11-09	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/26553974	Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.	Setpoint viral load in HIV-1 infection	6,315 European ancestry cases	NA				HLA-B							HLA-B*07:02-?	HLA-B*07:02	0			1	0.12	5E-13	12.301029995663981		0.2	[0.15-0.25] unit increase	Affymetrix, Illumina [~ 8000000] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST003183	Genome-wide genotyping array
2016-09-30	26553974	McLaren PJ	2015-11-09	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/26553974	Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.	Setpoint viral load in HIV-1 infection	6,315 European ancestry cases	NA				HLA-B							HLA-B*08:01-?	HLA-B*08:01	0			1	0.09	3E-11	10.522878745280337		0.206	[0.15-0.27] unit increase	Affymetrix, Illumina [~ 8000000] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST003183	Genome-wide genotyping array
2016-09-30	26553974	McLaren PJ	2015-11-09	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/26553974	Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.	Setpoint viral load in HIV-1 infection	6,315 European ancestry cases	NA				HLA-C							HLA-C*08:02-?	HLA-C*08:02	0			1	0.04	9E-11	10.045757490560675		0.307	[0.21-0.4] unit decrease	Affymetrix, Illumina [~ 8000000] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST003183	Genome-wide genotyping array
2016-09-30	26553974	McLaren PJ	2015-11-09	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/26553974	Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.	Setpoint viral load in HIV-1 infection	6,315 European ancestry cases	NA				HLA-C							HLA-C*04:01-?	HLA-C*04:01	0			1	0.11	9E-11	10.045757490560675		0.183	[0.13-0.24] unit increase	Affymetrix, Illumina [~ 8000000] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST003183	Genome-wide genotyping array
2016-09-30	26553974	McLaren PJ	2015-11-09	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/26553974	Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.	Setpoint viral load in HIV-1 infection	6,315 European ancestry cases	NA				HLA-B							HLA-B*13:02-?	HLA-B*13:02	0			1	0.03	4E-10	9.397940008672037		0.346	[0.24-0.45] unit decrease	Affymetrix, Illumina [~ 8000000] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST003183	Genome-wide genotyping array
2016-09-30	26553974	McLaren PJ	2015-11-09	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/26553974	Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.	Setpoint viral load in HIV-1 infection	6,315 European ancestry cases	NA				HLA-B							HLA-B*14:02-?	HLA-B*14:02	0			1	0.03	2E-9	8.698970004336019		0.318	[0.21-0.42] unit decrease	Affymetrix, Illumina [~ 8000000] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST003183	Genome-wide genotyping array
2016-09-30	26553974	McLaren PJ	2015-11-09	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/26553974	Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.	Setpoint viral load in HIV-1 infection	6,315 European ancestry cases	NA				HLA-C							HLA-C*12:02-?	HLA-C*12:02	0			1	0.01	4E-8	7.3979400086720375		0.478	[0.31-0.65] unit decrease	Affymetrix, Illumina [~ 8000000] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST003183	Genome-wide genotyping array
2016-09-30	26553974	McLaren PJ	2015-11-09	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/26553974	Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.	Setpoint viral load in HIV-1 infection	6,315 European ancestry cases	NA				HLA-C							HLA-C*02:02-?	HLA-C*02:02	0			1	0.05	5E-8	7.301029995663981		0.223	[0.14-0.3] unit decrease	Affymetrix, Illumina [~ 8000000] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST003183	Genome-wide genotyping array
2016-09-30	26553974	McLaren PJ	2015-11-09	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/26553974	Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.	Setpoint viral load in HIV-1 infection	6,315 European ancestry cases	NA				HLA-A							HLA-A*25:01-?	HLA-A*25:01	0			1	0.03	7E-8	7.154901959985743		0.301	[0.19-0.41] unit decrease	Affymetrix, Illumina [~ 8000000] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST003183	Genome-wide genotyping array
2016-09-30	26553974	McLaren PJ	2015-11-09	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/26553974	Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.	Setpoint viral load in HIV-1 infection	6,315 European ancestry cases	NA				HLA-B							HLA-B*52:01-?	HLA-B*52:01	0			1	0.01	3E-7	6.522878745280337		0.435	[0.27-0.6] unit decrease	Affymetrix, Illumina [~ 8000000] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST003183	Genome-wide genotyping array
2016-09-30	26553974	McLaren PJ	2015-11-09	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/26553974	Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.	Setpoint viral load in HIV-1 infection	6,315 European ancestry cases	NA				HLA-C							HLA-C*01:02-?	HLA-C*01:02	0			1	0.04	2E-6	5.698970004336019		0.231	[0.13-0.33] unit decrease	Affymetrix, Illumina [~ 8000000] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST003183	Genome-wide genotyping array
2016-01-27	25786224	Johnson EO	2015-03-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25786224	Novel genetic locus implicated for HIV-1 acquisition with putative regulatory links to HIV replication and infectivity: a genome-wide association study.	HIV-1 susceptibility	628 African American high risk-cases, 1,376 African American high-risk controls, 327 European ancestry high-risk cases, 805 European ancestry high-risk controls	1,395 African American high-risk cases, 457 African American high-risk controls, 513 European ancestry high-risk cases, 168 European ancestry high-risk controls	5q31.2	5	137381035	SPOCK1, KDM3B	SPOCK1			ENSG00000152377			rs1229741-A	rs1229741	0	1229741	intron_variant	0	0.10	3E-6	5.522878745280337		1.67	[1.33-2.13] (AA)	Illumina [~ 8000000] (imputed)	N	HIV-1 infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0000180, http://www.orpha.net/ORDO/Orphanet_391311	GCST002818	Genome-wide genotyping array
2016-01-27	25786224	Johnson EO	2015-03-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25786224	Novel genetic locus implicated for HIV-1 acquisition with putative regulatory links to HIV replication and infectivity: a genome-wide association study.	HIV-1 susceptibility	628 African American high risk-cases, 1,376 African American high-risk controls, 327 European ancestry high-risk cases, 805 European ancestry high-risk controls	1,395 African American high-risk cases, 457 African American high-risk controls, 513 European ancestry high-risk cases, 168 European ancestry high-risk controls	19q13.41	19	51210487	SIGLEC17P, CD33	MIR8074 - SIGLEC22P	ENSG00000278617	ENSG00000268849		3478	593	rs3987765-T	rs3987765	0	3987765	intergenic_variant	1	0.19	5E-6	5.301029995663981		1.35	[1.14-1.61] (AA)	Illumina [~ 8000000] (imputed)	N	HIV-1 infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0000180, http://www.orpha.net/ORDO/Orphanet_391311	GCST002818	Genome-wide genotyping array
2016-01-27	25786224	Johnson EO	2015-03-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25786224	Novel genetic locus implicated for HIV-1 acquisition with putative regulatory links to HIV replication and infectivity: a genome-wide association study.	HIV-1 susceptibility	628 African American high risk-cases, 1,376 African American high-risk controls, 327 European ancestry high-risk cases, 805 European ancestry high-risk controls	1,395 African American high-risk cases, 457 African American high-risk controls, 513 European ancestry high-risk cases, 168 European ancestry high-risk controls	9p13.2	9	37654260	FRMPD1	FRMPD1; No mapped genes						rs4878712-A; rs1329568-T	rs4878712; rs1329568	0		intron_variant; regulatory_region_variant			7E-7	6.154901959985743	(AA)	1.64	[1.32-2.00]	Illumina [~ 8000000] (imputed)	N	HIV-1 infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0000180, http://www.orpha.net/ORDO/Orphanet_391311	GCST002818	Genome-wide genotyping array
2016-01-27	25786224	Johnson EO	2015-03-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25786224	Novel genetic locus implicated for HIV-1 acquisition with putative regulatory links to HIV replication and infectivity: a genome-wide association study.	HIV-1 susceptibility	628 African American high risk-cases, 1,376 African American high-risk controls, 327 European ancestry high-risk cases, 805 European ancestry high-risk controls	1,395 African American high-risk cases, 457 African American high-risk controls, 513 European ancestry high-risk cases, 168 European ancestry high-risk controls	9p13.2	9	37654260	FRMPD1	FRMPD1; No mapped genes						rs4878712-A; rs1329568-T	rs4878712; rs1329568	0		intron_variant; regulatory_region_variant			5E-8	7.301029995663981				Illumina [~ 8000000] (imputed)	N	HIV-1 infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0000180, http://www.orpha.net/ORDO/Orphanet_391311	GCST002818	Genome-wide genotyping array
2016-01-27	25786224	Johnson EO	2015-03-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25786224	Novel genetic locus implicated for HIV-1 acquisition with putative regulatory links to HIV replication and infectivity: a genome-wide association study.	HIV-1 susceptibility	628 African American high risk-cases, 1,376 African American high-risk controls, 327 European ancestry high-risk cases, 805 European ancestry high-risk controls	1,395 African American high-risk cases, 457 African American high-risk controls, 513 European ancestry high-risk cases, 168 European ancestry high-risk controls	9p13.2	9	37654260	FRMPD1, PAX5, ZCCHC7, FBXO10	FRMPD1			ENSG00000070601			rs4878712-?	rs4878712	0	4878712	intron_variant	0		4E-7	6.3979400086720375				Illumina [~ 8000000] (imputed)	N	HIV-1 infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0000180, http://www.orpha.net/ORDO/Orphanet_391311	GCST002818	Genome-wide genotyping array
2016-01-27	25786224	Johnson EO	2015-03-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25786224	Novel genetic locus implicated for HIV-1 acquisition with putative regulatory links to HIV replication and infectivity: a genome-wide association study.	HIV-1 susceptibility	628 African American high risk-cases, 1,376 African American high-risk controls, 327 European ancestry high-risk cases, 805 European ancestry high-risk controls	1,395 African American high-risk cases, 457 African American high-risk controls, 513 European ancestry high-risk cases, 168 European ancestry high-risk controls	9p24.1	9	7081674	KDM4C	KDM4C			ENSG00000107077			rs16925298-G	rs16925298	0	16925298	intron_variant	0	0.06	2E-6	5.698970004336019		1.3	[0.97-1.72] (AA)	Illumina [~ 8000000] (imputed)	N	HIV-1 infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0000180, http://www.orpha.net/ORDO/Orphanet_391311	GCST002818	Genome-wide genotyping array
2016-01-27	25786224	Johnson EO	2015-03-18	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25786224	Novel genetic locus implicated for HIV-1 acquisition with putative regulatory links to HIV replication and infectivity: a genome-wide association study.	HIV-1 susceptibility	628 African American high risk-cases, 1,376 African American high-risk controls, 327 European ancestry high-risk cases, 805 European ancestry high-risk controls	1,395 African American high-risk cases, 457 African American high-risk controls, 513 European ancestry high-risk cases, 168 European ancestry high-risk controls	9p13.2	9	37654260	FRMPD1, PAX5, ZCCHC7, FBXO10	FRMPD1			ENSG00000070601			rs4878712-A	rs4878712	0	4878712	intron_variant	0	0.69	5E-7	6.301029995663981	(AA)	1.32	[1.14-1.54]	Illumina [~ 8000000] (imputed)	N	HIV-1 infection, Susceptibility to viral and mycobacterial infections	http://www.ebi.ac.uk/efo/EFO_0000180, http://www.orpha.net/ORDO/Orphanet_391311	GCST002818	Genome-wide genotyping array
2014-02-25	23935489	McLaren PJ	2013-07-25	PLoS Pathog	www.ncbi.nlm.nih.gov/pubmed/23935489	Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls.	HIV-1 susceptibility	6,334 European ancestry cases, 7,247 European ancestry controls	NA	6p21.33	6	31423624	HLA-C, HLA-B	MICA - LINC01149	ENSG00000231225	ENSG00000230174		8309	18043	rs4418214-C	rs4418214	0	4418214	intron_variant	1	NR	4E-11	10.397940008672037		1.52		Affymetrix, Illumina [~ 8000000] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST002101	Genome-wide genotyping array
2021-02-26	32514122	Ishigaki K	2020-06-08	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32514122	Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.	Chronic hepatitis C infection	5,794 Japanese ancestry cases, 206,659 Japanese ancestry controls	NA	19q13.2	19	39252463		IFNL4 - MSRB1P1	ENSG00000272395	ENSG00000213926		3607	2453	rs8113007-T	rs8113007	0	8113007	intergenic_variant	1	0.104228627	7E-28	27.154901959985743		1.4280615	[1.339831592-1.522101518]	Illumina [8919992] (imputed)	N	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220	GCST90013691	Genome-wide genotyping array
2021-07-07	34035401	Dube MP	2021-05-25	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34035401	Genetics of symptom remission in outpatients with COVID-19.	Symptoms in placebo-treated COVID-19 outpatients at risk of severe disease (time to remission)	851 European ancestry individuals	NA	5p13.3	5	32750877	NPR3	NPR3			ENSG00000113389			rs1173773-C	rs1173773	0	1173773	intron_variant	0	0.34	1E-6	6.0		1.32	[1.18-1.48]	Illumina [6392715] (imputed)	N	time to remission of COVID-19 symptoms, COVID-19, response to placebo	http://www.ebi.ac.uk/efo/EFO_0600020, http://purl.obolibrary.org/obo/MONDO_0100096, http://www.ebi.ac.uk/efo/EFO_0008344	GCST012001	Genome-wide genotyping array
2021-07-07	34035401	Dube MP	2021-05-25	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34035401	Genetics of symptom remission in outpatients with COVID-19.	Symptoms in placebo-treated COVID-19 outpatients at risk of severe disease (time to remission)	851 European ancestry individuals	NA	9q33.1	9	115647521	PAPPA, DEC1	NA - U2		ENSG00000274755			86871	rs62575331-G	rs62575331	0	62575331	intron_variant	1	0.12	3E-8	7.522878745280337		1.57	[1.34-1.84]	Illumina [6392715] (imputed)	N	time to remission of COVID-19 symptoms, COVID-19, response to placebo	http://www.ebi.ac.uk/efo/EFO_0600020, http://purl.obolibrary.org/obo/MONDO_0100096, http://www.ebi.ac.uk/efo/EFO_0008344	GCST012001	Genome-wide genotyping array
2021-07-07	34035401	Dube MP	2021-05-25	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34035401	Genetics of symptom remission in outpatients with COVID-19.	Symptoms in COVID-19 outpatients at risk of severe disease (time to remission)	1,723 European ancestry individuals	NA	5p13.3	5	32750877		NPR3			ENSG00000113389			rs1173773-C	rs1173773	0	1173773	intron_variant	0	NR	5E-8	7.301029995663981		1.25	[1.15-1.35]	Illumina [6392715] (imputed)	N	time to remission of COVID-19 symptoms, COVID-19	http://www.ebi.ac.uk/efo/EFO_0600020, http://purl.obolibrary.org/obo/MONDO_0100096	GCST012002	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 positive oropharyngeal cancer	1,078 European ancestry cases, 5,256 European ancestry controls	NA	1p36.12	1	23531510		E2F2 - ID3	ENSG00000007968	ENSG00000117318		277	26416	rs2742976-G	rs2742976	0	2742976	TF_binding_site_variant	1	NR	3E-6	5.522878745280337		0.769		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085699	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	6p21.32	6	32646317		HLA-DQA1, HLA-DQA1, HLA-DQA1, HLA-DQA1, HLA-DQA1			ENSG00000232062, ENSG00000206305, ENSG00000236418, ENSG00000225890, ENSG00000196735			rs115210925-G	rs115210925	0	115210925	non_coding_transcript_exon_variant	0	NR	5E-7	6.301029995663981		1.46		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	7q22.1	7	100912616		RN7SL549P - RPS29P15	ENSG00000239825	ENSG00000235926		6044	15754	rs111276691-T	rs111276691	0	111276691	intergenic_variant	1	NR	5E-6	5.301029995663981		2.29		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	8q21.3	8	89626076		KRT8P4 - RIPK2	ENSG00000248231	ENSG00000104312		211005	131730	rs150615-G	rs150615	0	150615	intron_variant	1	NR	3E-6	5.522878745280337		1.4		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	10q26.3	10	133383872		PAOX			ENSG00000148832			rs11101731-A	rs11101731	0	11101731	intron_variant	0	NR	2E-6	5.698970004336019		1.6		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	12q21.1	12	74107818		LINC02882			ENSG00000251138			rs181745657-C	rs181745657	0	181745657	intron_variant	0	NR	1E-6	6.0		2.94		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	12q23.3	12	107582831		BTBD11			ENSG00000151136			rs35189640-T	rs35189640	0	35189640	intron_variant	0	NR	1E-9	9.0		2.75		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	13q33.3	13	109162764		MYO16			ENSG00000041515			rs55864736-A	rs55864736	0	55864736	intron_variant	0	NR	2E-7	6.698970004336019		1.45		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	14q11.2	14	22780330		SLC7A7			ENSG00000155465			rs12433985-G	rs12433985	0	12433985	non_coding_transcript_exon_variant	0	NR	4E-6	5.3979400086720375		1.38		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	15q21.3	15	54180811		UNC13C			ENSG00000137766			rs12593171-A	rs12593171	0	12593171	intron_variant	0	NR	2E-6	5.698970004336019		1.4		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	16p13.3	16	7451808		RBFOX1			ENSG00000078328			rs146952371-T	rs146952371	0	146952371	intron_variant	0	NR	2E-7	6.698970004336019		2.53		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 positive oropharyngeal cancer	1,078 European ancestry cases, 5,256 European ancestry controls	NA	6p22.1	6	30170385		TRIM15, TRIM15, TRIM15, TRIM15, TRIM15, TRIM15, TRIM15			ENSG00000224145, ENSG00000137384, ENSG00000227147, ENSG00000235960, ENSG00000204610, ENSG00000235259, ENSG00000235905			rs1029239-G	rs1029239	0	1029239	non_coding_transcript_exon_variant	0	NR	3E-6	5.522878745280337		1.2904		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085699	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 positive oropharyngeal cancer	1,078 European ancestry cases, 5,256 European ancestry controls	NA	6p21.33	6	31363011		HLA-B - DHFRP2	ENSG00000232126	ENSG00000230016		5823	3341	rs9266329-A	rs9266329	0	9266329	intergenic_variant	1	NR	1E-12	12.0		0.6064		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085699	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 positive oropharyngeal cancer	1,078 European ancestry cases, 5,256 European ancestry controls	NA	6p21.33	6	31466557		HCP5			ENSG00000206337			rs2523679-T	rs2523679	0	2523679	non_coding_transcript_exon_variant	0	NR	3E-9	8.522878745280337		0.5079		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085699	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 positive oropharyngeal cancer	1,078 European ancestry cases, 5,256 European ancestry controls	NA	6p21.32	6	32651877		HLA-DQA1 - HLA-DQB1	ENSG00000196735	ENSG00000231939		4815	7590	rs28418426-C	rs28418426	0	28418426	intergenic_variant	1	NR	8E-12	11.096910013008056		1.5588		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085699	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 positive oropharyngeal cancer	1,078 European ancestry cases, 5,256 European ancestry controls	NA	6q25.3	6	157609689		ZDHHC14			ENSG00000175048			rs142170828-A	rs142170828	0	142170828	intron_variant	0	NR	1E-6	6.0		1.6965		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085699	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 positive oropharyngeal cancer	1,078 European ancestry cases, 5,256 European ancestry controls	NA	17q21.2	17	42384378		STAT3			ENSG00000168610			rs8070763-C	rs8070763	0	8070763	intron_variant	0	NR	2E-6	5.698970004336019		0.7607		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085699	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	1p36.13	1	17150268		PADI2 - LINC02783	ENSG00000117115	ENSG00000204362		30817	39515	rs12079362-A	rs12079362	0	12079362	intergenic_variant	1	NR	4E-7	6.3979400086720375		3.98		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	1q24.1	1	165702867		ALDH9A1 - TMCO1	ENSG00000143149	ENSG00000143183		4004	21426	rs77570135-G	rs77570135	0	77570135	intron_variant	1	NR	3E-6	5.522878745280337		1.77		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	1q43	1	240794093		RGS7			ENSG00000182901			rs1832905-G	rs1832905	0	1832905	intron_variant	0	NR	2E-6	5.698970004336019		1.38		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	2q23.3	2	152359187		FMNL2			ENSG00000157827			rs72861983-T	rs72861983	0	72861983	intron_variant	0	NR	7E-7	6.154901959985743		2.34		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	2q34	2	210483300		CPS1			ENSG00000021826			rs149882261-T	rs149882261	0	149882261	intron_variant	0	NR	4E-6	5.3979400086720375		3.09		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	3p26.2	3	2863372		CNTN4			ENSG00000144619			rs75622279-A	rs75622279	0	75622279	intron_variant	0	NR	3E-7	6.522878745280337		2.03		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	3q26.1	3	166820205		CBX1P5 - PPIAP74	ENSG00000231516	ENSG00000220343		8638	245626	rs77645982-T	rs77645982	0	77645982	intergenic_variant	1	NR	2E-6	5.698970004336019		2.96		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	4p15.1	4	35419331		LINC02484 - SEC63P2	ENSG00000248685	ENSG00000250416		1083980	68481	rs111651905-T	rs111651905	0	111651905	intergenic_variant	1	NR	1E-6	6.0		2.55		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	5q34	5	163522414		MAT2B - RNU6-168P	ENSG00000038274	ENSG00000251998		3060	273651	rs729353-A	rs729353	0	729353	intergenic_variant	1	NR	2E-7	6.698970004336019		1.4		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	6p24.3	6	10415901		TFAP2A-AS1, TFAP2A			ENSG00000229950, ENSG00000137203			rs1051512-T	rs1051512	0	1051512	non_coding_transcript_exon_variant	0	NR	1E-6	6.0		2.44		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	6p23	6	13509787		GFOD1 - RPS4XP7	ENSG00000145990	ENSG00000218265		22125	11479	rs78671973-A	rs78671973	0	78671973	regulatory_region_variant	1	NR	5E-6	5.301029995663981		2.11		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 positive oropharyngeal cancer	1,078 European ancestry cases, 5,256 European ancestry controls	NA	2p13.2	2	71507144		DYSF			ENSG00000135636			rs11686031-G	rs11686031	0	11686031	intron_variant	0	NR	5E-6	5.301029995663981		1.3192		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085699	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 positive oropharyngeal cancer	1,078 European ancestry cases, 5,256 European ancestry controls	NA	2p11.2	2	86236981		REEP1			ENSG00000068615			rs10206710-A	rs10206710	0	10206710	intron_variant	0	NR	3E-6	5.522878745280337		0.7834		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085699	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 positive oropharyngeal cancer	1,078 European ancestry cases, 5,256 European ancestry controls	NA	2q22.1	2	137285370		THSD7B			ENSG00000144229			rs2573093-C	rs2573093	0	2573093	intron_variant	0	NR	2E-6	5.698970004336019		0.7456		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085699	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 positive oropharyngeal cancer	1,078 European ancestry cases, 5,256 European ancestry controls	NA	3q26.1	3	167024803		CBX1P5 - PPIAP74	ENSG00000231516	ENSG00000220343		213236	41028	rs9836282-C	rs9836282	0	9836282	intergenic_variant	1	NR	1E-7	7.0		0.7541		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085699	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 positive oropharyngeal cancer	1,078 European ancestry cases, 5,256 European ancestry controls	NA	4q35.1	4	182334536		TENM3			ENSG00000218336			rs1516535-C	rs1516535	0	1516535	intron_variant	0	NR	1E-7	7.0		1.427		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085699	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 positive oropharyngeal cancer	1,078 European ancestry cases, 5,256 European ancestry controls	NA	5p15.33	5	3812886		IRX1 - LINC02063	ENSG00000170549	ENSG00000250921		211483	322752	rs10072600-A	rs10072600	0	10072600	intergenic_variant	1	NR	2E-6	5.698970004336019		0.7687		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085699	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 positive oropharyngeal cancer	1,078 European ancestry cases, 5,256 European ancestry controls	NA	6p22.1	6	29959945		HLA-W - MICD	ENSG00000230915	ENSG00000237395		1375	10856	rs2571400-G	rs2571400	0	2571400	intron_variant	1	NR	3E-6	5.522878745280337		1.2905		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085699	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	22q13.31	22	47794978		LINC00898 - MIR3201	ENSG00000205634	ENSG00000266508		163409	479386	rs720441-C	rs720441	0	720441	intron_variant	1	NR	3E-6	5.522878745280337		1.6		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Human papilloma virus 16 negative oropharyngeal cancer	565 European ancestry cases, 5,256 European ancestry controls	NA	1p34.3	1	37471780		LINC01137			ENSG00000233621			rs75778090-T	rs75778090	0	75778090	intron_variant	0	NR	5E-6	5.301029995663981		1.53		Illumina [7574753] (imputed)	N	human papilloma virus infection, oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_1001931	GCST90085700	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	6p22.1	6	29975938		HCG9, HCG9, HCG9, HCG9, HCG9, HCG9, HCG9			ENSG00000206504, ENSG00000204625, ENSG00000236579, ENSG00000237812, ENSG00000227647, ENSG00000234313, ENSG00000234599			rs3823363-A	rs3823363	0	3823363	intron_variant	0	NR	1E-7	7.0		0.8222		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	6p21.33	6	31354782		HLA-B			ENSG00000232126			rs2523608-A	rs2523608	0	2523608	non_coding_transcript_exon_variant	0	NR	4E-6	5.3979400086720375		0.8429		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	6p21.32	6	32454414		HLA-DRA - HLA-DRB9	ENSG00000204287	ENSG00000226035		9368	5407	rs2097442-A	rs2097442	0	2097442	intergenic_variant	1	NR	1E-6	6.0		1.2355		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2021-11-22	34642315	Ferreiro-Iglesias A	2021-10-12	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34642315	Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer.	Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer	2,359 European ancestry cases, 565 European ancestry controls	NA	6p21.32	6	32668343		HLA-DQB1, HLA-DQB1, HLA-DQB1, HLA-DQB1, HLA-DQB1, HLA-DQB1			ENSG00000233209, ENSG00000179344, ENSG00000206302, ENSG00000206237, ENSG00000225824, ENSG00000231939			rs3828805-C	rs3828805	0	3828805	5_prime_UTR_variant	0	NR	3E-9	8.522878745280337		1.2999		Illumina [up to 7574753] (imputed)	N	human papilloma virus infection, oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0001668, http://www.ebi.ac.uk/efo/EFO_0005570	GCST90085701	Genome-wide genotyping array
2022-03-25	34782459	Shevchenko AK	2021-11-01	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/34782459	Genome-wide association study reveals genetic variants associated with HIV-1C infection in a Botswana study population.	HIV-1 susceptibility	256 Sub-Saharan African ancestry cases, 80 Sub-Saharan African ancestry controls	NA	5q14.1	5	78294598		AP3B1			ENSG00000132842			rs572880838-G	rs572880838	0	572880838	5_prime_UTR_variant	0	NR	8E-9	8.096910013008056		6.711		NR [8636400]	N	HIV infection	http://www.ebi.ac.uk/efo/EFO_0000764	GCST90096802	Genome-wide sequencing
2022-03-25	34782459	Shevchenko AK	2021-11-01	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/34782459	Genome-wide association study reveals genetic variants associated with HIV-1C infection in a Botswana study population.	HIV-1 susceptibility	256 Sub-Saharan African ancestry cases, 80 Sub-Saharan African ancestry controls	NA	20p13	20	3032169		PTPRA			ENSG00000132670			rs6076463-T	rs6076463	0	6076463	intron_variant	0	NR	8E-7	6.096910013008056		0.172		NR [8636400]	N	HIV infection	http://www.ebi.ac.uk/efo/EFO_0000764	GCST90096802	Genome-wide sequencing
2017-03-21	27671213	Petros Z	2016-09-26	BMC Genomics	www.ncbi.nlm.nih.gov/pubmed/27671213	Genome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicity.	Liver injury in anti-tuberculosis drug treatment	48 Ethiopian cases with liver injury, 354 Ethiopian cases without liver injury	27 Ethiopian cases with liver injury, 217 Ethiopian cases without liver injury	6p22.3	6	24967012	FAM65B	RIPOR2			ENSG00000111913			rs10946737-A	rs10946737	0	10946737	intron_variant	0	NR	4E-6	5.3979400086720375		3.4	[2.2-5.3]	Illumina [660206]	N	response to rifampicin, drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0007866, http://www.ebi.ac.uk/efo/EFO_0004228	GCST003792	Genome-wide genotyping array
2017-03-21	27671213	Petros Z	2016-09-26	BMC Genomics	www.ncbi.nlm.nih.gov/pubmed/27671213	Genome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicity.	Liver injury in anti-tuberculosis drug treatment	48 Ethiopian cases with liver injury, 354 Ethiopian cases without liver injury	27 Ethiopian cases with liver injury, 217 Ethiopian cases without liver injury	1p33	1	48623525	AGBL4	AGBL4			ENSG00000186094			rs320035-G	rs320035	0	320035	intron_variant	0	NR	5E-6	5.301029995663981		2.3	[1.6-3.3]	Illumina [660206]	N	response to rifampicin, drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0007866, http://www.ebi.ac.uk/efo/EFO_0004228	GCST003792	Genome-wide genotyping array
2019-12-05	30715261	Brouwer WP	2019-02-02	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/30715261	Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study.	Response to (pegylated) interferon in HBeAg-negative hepatitis B	161 Asian, European, African and other ancestry cases, 253 Asian, European, African and other ancestry controls	NA	4q21.1	4	75703167	G3BP2, USO1	G3BP2			ENSG00000138757			rs3821977-A	rs3821977	0	3821977	intron_variant	0	0.8304	2E-6	5.698970004336019		1.126	[0.66-1.59] unit increase	Illumina [8102086] (imputed)	N	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	GCST009172	Genome-wide genotyping array
2019-12-05	30715261	Brouwer WP	2019-02-02	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/30715261	Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study.	Response to (pegylated) interferon in HBeAg-negative hepatitis B	161 Asian, European, African and other ancestry cases, 253 Asian, European, African and other ancestry controls	NA	6p24.3	6	8204180	EEF1E1, BMP6, BLOC1S5, SLC35B3, OFCC1, TFAP2A, GCNT2, TMEM14C, TMEM14B, SYCP2L, MAK, GCM2, ELOVL2	NA - SLC16A10		ENSG00000112394			102883323	rs6928374-A	rs6928374	0	6928374	intron_variant	1	0.5523	3E-6	5.522878745280337		0.8138	[0.47-1.16] unit decrease	Illumina [8102086] (imputed)	N	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	GCST009172	Genome-wide genotyping array
2019-12-05	30715261	Brouwer WP	2019-02-02	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/30715261	Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study.	Response to (pegylated) interferon in HBeAg-negative hepatitis B	161 Asian, European, African and other ancestry cases, 253 Asian, European, African and other ancestry controls	NA	10q26.3	10	131720732	AL450307.1, GLRX3, TCERG1L	NA - LINC01164		ENSG00000189275			51666	rs9419644-G	rs9419644	0	9419644	intergenic_variant	1	0.08867	3E-6	5.522878745280337		1.302	[0.76-1.85] unit increase	Illumina [8102086] (imputed)	N	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	GCST009172	Genome-wide genotyping array
2019-12-05	30715261	Brouwer WP	2019-02-02	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/30715261	Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study.	Response to (pegylated) interferon in HBeAg-negative hepatitis B	161 Asian, European, African and other ancestry cases, 253 Asian, European, African and other ancestry controls	NA	12p12.3	12	17476022	intergenic	TIMM17BP1 - LINC02378	ENSG00000256756	ENSG00000256994		75108	33331	rs11043479-G	rs11043479	0	11043479	intergenic_variant	1	0.3278	2E-6	5.698970004336019		0.8571	[0.51-1.21] unit increase	Illumina [8102086] (imputed)	N	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	GCST009172	Genome-wide genotyping array
2019-12-05	30715261	Brouwer WP	2019-02-02	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/30715261	Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study.	Response to (pegylated) interferon in HBeAG-positive hepatitis B	121 Asian, European, African and other ancestry cases, 388 Asian, European, African and other ancestry controls	NA	5q32	5	145833218	PRELID2, YIPF5, KCTD16, GRXCR2, SH3RF2, PLAC8L1	PRELID2			ENSG00000186314			rs371991-G	rs371991	0	371991	intron_variant	0	0.5519	3E-6	5.522878745280337		0.7406	[0.43-1.05] unit decrease	Illumina [8102086] (imputed)	N	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	GCST009173	Genome-wide genotyping array
2019-12-05	30715261	Brouwer WP	2019-02-02	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/30715261	Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study.	Response to (pegylated) interferon in HBeAG-positive hepatitis B	121 Asian, European, African and other ancestry cases, 388 Asian, European, African and other ancestry controls	NA	6q21	6	105877510	PRDM1, PREP, RN7SKP211	NA - RN7SKP211		ENSG00000200198			26863	rs9399955-T	rs9399955	0	9399955	intron_variant	1	0.08606	4E-6	5.3979400086720375		1.422	[0.82-2.03] unit increase	Illumina [8102086] (imputed)	N	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	GCST009173	Genome-wide genotyping array
2019-12-05	30715261	Brouwer WP	2019-02-02	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/30715261	Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study.	Response to (pegylated) interferon in chronic hepatitis B	282 Asian, European, African and other ancestry cases, 641 Asian, European, African and other ancestry controls	NA	8q24.23	8	138653967	TRAPPC9, COL22A1, FAM135B	COL22A1			ENSG00000169436			rs78900671-C	rs78900671	0	78900671	intron_variant	0	0.03649	6E-7	6.221848749616356		1.434	[0.87-2] unit increase	Illumina [8102086] (imputed)	N	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	GCST009174	Genome-wide genotyping array
2019-12-05	30715261	Brouwer WP	2019-02-02	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/30715261	Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study.	Response to (pegylated) interferon in chronic hepatitis B	282 Asian, European, African and other ancestry cases, 641 Asian, European, African and other ancestry controls	NA	10q23.33	10	94012060	PLCE1, FFAR4, LGI1, SLC35G1, NOC3L, TBC1D12, HELLS, C10orf131	PLCE1			ENSG00000138193			rs61886277-T	rs61886277	0	61886277	intron_variant	0	0.2252	1E-6	6.0		0.6342	[0.38-0.89] unit increase	Illumina [8102086] (imputed)	N	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	GCST009174	Genome-wide genotyping array
2019-12-05	30715261	Brouwer WP	2019-02-02	Clin Infect Dis	www.ncbi.nlm.nih.gov/pubmed/30715261	Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study.	Response to (pegylated) interferon in chronic hepatitis B	282 Asian, European, African and other ancestry cases, 641 Asian, European, African and other ancestry controls	NA	21q21.1	21	16913154	intergenic							rs2824122-A	rs2824122	0	2824122	regulatory_region_variant	1	0.3259	3E-6	5.522878745280337		0.5717	[0.33-0.81] unit decrease	Illumina [8102086] (imputed)	N	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859	GCST009174	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	11p15.4	11	5227002	HBB, HBD, HBBP1, BGLT3, HBG1, HBG2, OR51V1, HBE1, OR51B4, OR52A1, OR52A5, OR51B2, OR51B5, OR51B6, OR51M1, OR52E2, OR52J3, OR51Q1, OR51I1, OR51I2, OR51L1, MMP26, OR52D1, OR51A2, OR51A4, UBQLN3, UBQLNL, OLFM5P, OR51G1, OR51G2, OR52H1, OR51A7, OR51T1, OR52B6, TRIM6, TRIM6-TRIM34, OR51S1, TRIM34, OR51F2, OR52R1, TRIM5, OR51F1, TRIM22, OR56B1, OR52N4, OR51E2, OR52N5, OR52N1, OR51E1, OR51D1, OR52N2, OR52E6, TRIM68, OR52E8, OR52I1, OR52I2, C11orf40, OR52E4, OR52M1, OR56A3, OR52K1, OR56A5, OR52L1, OR56A4, OR52K2, OR56A1, TRIM21, OR52B4, OR56B4, OR52B2, OR52W1, C11orf42, FAM160A2, CNGA4, LOC100506082, CCKBR, RRM1, PRKCDBP, STIM1, SMPD1, APBB1, HPX, TRIM3, ARFIP2, TIMM10B, DNHD1, MIR4687, RRP8, ILK, TAF10, TPP1, RHOG, DCHS1, PGAP2, NUP98, MRPL17, GVINP1, OR2AG2, CHRNA10, OR2AG1, ART1, OR6A2, ART5, TRPC2, OR10A5, OR10A2, OR10A4, LOC101927708, OR2D2, OR2D3, ZNF215, ZNF214, NLRP14, TSSC2, OR7E12P, ZNF195, RBMXL2, MRGPRE, MRGPRG-AS1, MIR302E, MRGPRG, SYT9, OSBPL5, CARS, LOC100506258, NAP1L4, OLFML1, SNORA54, PPFIBP2, PHLDA2, SLC22A18, SLC22A18AS, CDKN1C, KCNQ1DN, KCNQ1-AS1, KCNQ1, CYB5R2, OVCH2, KCNQ1OT1, OR5P2, OR5P3, OR5E1P, LOC283299, OR10A6, OR10A3, NLRP10, EIF3F, CASC23, TRPM5, TUB, TSSC4, CD81, TUB-AS1, CD81-AS1, RIC3, TSPAN32, C11orf21, ASCL2, LMO1	HBB			ENSG00000244734			rs334-?	rs334	0	334	missense_variant	0		1E-55	55.0	(additive)	1.106	[0.97-1.24] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	12p12.1	12	25364251	LMNTD1	NA - RNU4-67P		ENSG00000201439			40037	rs113065354-?	rs113065354	0	113065354	regulatory_region_variant	1		2E-6	5.698970004336019	(additive)	0.234	[0.14-0.33] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	13q21.32	13	65417774	LINC01052							rs9598973-?	rs9598973	0	9598973	intergenic_variant	1		4E-6	5.3979400086720375	(additive)	0.11	[0.063-0.157] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	15q14	15	33951328	AVEN, CHRM5, RYR3, EMC7, PGBD4	AVEN			ENSG00000169857			rs116830894-?	rs116830894	0	116830894	intron_variant	0		5E-6	5.301029995663981	(additive)	0.256	[0.15-0.37] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR				DNAJC17, ZFYVE19, PPP1R14D, C15orf62, GCHFR, SPINT1, RMDN3, RAD51, RHOV, VPS18, LOC105370943, RAD51-AS1, DLL4, CASC5, CHAC1, INO80, RPUSD2, C15orf57, MRPL42P5, CHST14, BAHD1, IVD, KNSTRN, DISP2, PHGR1							chr15:41093534-?	chr15:41093534	0			1		7E-6	5.154901959985743	(additive)	0.215	[0.12-0.31] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	18q12.3	18	41548233	KC6	KC6			ENSG00000267313			rs16974953-?	rs16974953	0	16974953	intron_variant	0		3E-6	5.522878745280337	(additive)	0.248	[0.14-0.35] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	Xp22.11	X	24432031	PDK3, SUPT20HL1, SUPT20HL2	RPS26P58 - PDK3	ENSG00000225071	ENSG00000067992		2111	33239	rs59309986-?	rs59309986	0	59309986	intergenic_variant	1		8E-7	6.096910013008056	(additive)	0.595	[0.36-0.83] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	1q32.1	1	203689343	ATP2B4, SNORA77, LINC00260, LAX1	ATP2B4			ENSG00000058668			rs4951377-?	rs4951377	0	4951377	intron_variant	0		1E-11	11.0	(dominant)	0.401	[0.33-0.47] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	2p25.2	2	5295571	LINC01248							rs116782507-?	rs116782507	0	116782507	intergenic_variant	1		3E-7	6.522878745280337	(dominant)	0.369	[NR] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	2p13.2	2	72374866	EXOC6B, CYP26B1, SPR, EMX1, SFXN5	EXOC6B			ENSG00000144036			rs115075175-?	rs115075175	0	115075175	intron_variant	0		7E-6	5.154901959985743	(dominant)	0.717	[NR] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR				LINC00886, PA2G4P4, LEKR1, TIPARP, TIPARP-AS1, SSR3, LINC00880, LOC105374177, LINC00881							rs5853768-?	rs5853768	0	5853768		1		1E-6	6.0	(dominant)	0.185	[0.026-0.344] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	3q25.33	3	160679075	ARL14, PPM1L, KPNA4, SCARNA7, TRIM59, SMC4, MIR16-2, MIR15B, IFT80, B3GALNT1, C3orf80, IL12A-AS1	ARL14 - SNORA72	ENSG00000179674	ENSG00000201944		627	17854	rs116423146-?	rs116423146	0	116423146	regulatory_region_variant	1		3E-9	8.522878745280337	(dominant)	0.273	[-0.47376-1.01976] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	4q31.1	4	139952603	MAML3	MAML3			ENSG00000196782			rs58491357-?	rs58491357	0	58491357	intron_variant	0		1E-6	6.0	(dominant)	0.264	[NR] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	4q31.21	4	143592208	FREM3, GUSBP5, SMARCA5, SMARCA5-AS1, GAB1, LOC105377458, MIR3139, GYPE, LOC101927636, USP38, GYPB, LOC105377623, GYPA, INPP4B, HHIP-AS1, HHIP, ANAPC10, ABCE1, OTUD4, IL15, SMAD1, SMAD1-AS2, SMAD1-AS1, MMAA, C4orf51, ZNF827, LOC100507639, ZNF330, RNF150, LINC01095, LSM6, SLC10A7, MIR7849, TBC1D9, TNRC18P1, UCP1, ELMOD2, POU4F2, MGAT4D, TTC29, CLGN, SCOC, SCOC-AS1, MAML3	FREM3			ENSG00000183090			rs567544458-?	rs567544458	0	567544458	intron_variant	0		7E-11	10.154901959985743	(dominant)	0.612	[NR] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	5p14.2	5	23566881	PRDM9	PRDM9 - NA	ENSG00000164256			38788		rs2914266-?	rs2914266	0	2914266	intergenic_variant	1		9E-6	5.045757490560675	(dominant)	0.279	[NR] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	5p13.2	5	36723279	SLC1A3, NIPBL-AS1, NIPBL, C5orf42, LOC105374727, NUP155, WDR70	SLC1A3 - NA	ENSG00000079215			34945		rs115594123-?	rs115594123	0	115594123	intron_variant	1		1E-6	6.0	(dominant)	0.351	[NR] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	5q22.3	5	115077821	TRIM36, LOC101927078	NA - TRIM36		ENSG00000152503			46941	rs62380051-?	rs62380051	0	62380051	intergenic_variant	1		7E-6	5.154901959985743	(dominant)	0.151	[0.004-0.298] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	5q31.2	5	139070389	SIL1, CTNNA1, LRRTM2, MATR3, SNHG4, SNORA74A, PAIP2, SLC23A1, LOC105379194, MZB1, PROB1, SPATA24, DNAJC18, ECSCR	SIL1			ENSG00000120725			rs7701116-?	rs7701116	0	7701116	intron_variant	0		4E-7	6.3979400086720375	(dominant)	0.165	[0.043-0.287] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	6p22.3	6	21390601	LINC00581	NA - LINC00581		ENSG00000280989			95295	rs183954794-?	rs183954794	0	183954794	regulatory_region_variant	1		6E-6	5.221848749616356	(dominant)	0.451	[NR] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	6p21.33	6	31048409	HCG22, MUC22, MUC21, C6orf15, PSORS1C1, CDSN, PSORS1C2, CCHCR1, DPCR1, TCF19, POU5F1, SFTA2, VARS2, PSORS1C3, GTF2H4, DDR1, HCG27, MIR4640	MUC22 - HCG22	ENSG00000261272	ENSG00000238234		13007	5041	rs73727186-?	rs73727186	0	73727186	TF_binding_site_variant	1		5E-6	5.301029995663981	(dominant)	0.233	[-0.43732-0.90332] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	6q22.31	6	124585841	NKAIN2	NKAIN2			ENSG00000188580			rs76995465-?	rs76995465	0	76995465	intron_variant	0		2E-6	5.698970004336019	(dominant)	0.275	[NR] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	6q23.3	6	137904008	TNFAIP3, LOC100130476, LOC100507406	TNFAIP3 - LINC02528	ENSG00000118503	ENSG00000226004		20696	39071	rs572459786-?	rs572459786	0	572459786	intergenic_variant	1		2E-6	5.698970004336019	(dominant)	0.451	[NR] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	6q25.1	6	150652487	PLEKHG1	PLEKHG1			ENSG00000120278			rs144224092-?	rs144224092	0	144224092	intron_variant	0		2E-6	5.698970004336019	(dominant)	0.44	[NR] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	7q11.23	7	73716908	STX1A, MIR4284, ABHD11-AS1, WBSCR22, ABHD11, DNAJC30, VPS37D, MLXIPL, TBL2, BCL7B, BAZ1B, FZD9	STX1A			ENSG00000106089			rs549107698-?	rs549107698	0	549107698	intron_variant	0		6E-6	5.221848749616356	(dominant)	0.465	[NR] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	7q31.1	7	109736674	EIF3IP1							rs146842860-?	rs146842860	0	146842860	intergenic_variant	1		9E-6	5.045757490560675	(dominant)	0.331	[NR] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	1q32.1	1	203689343	ATP2B4, SNORA77, LINC00260, LAX1	ATP2B4			ENSG00000058668			rs4951377-?	rs4951377	0	4951377	intron_variant	0		9E-8	7.045757490560675	(additive)	0.14	[0.089-0.191] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	1q44	1	245838142	SMYD3	SMYD3			ENSG00000185420			rs12083051-?	rs12083051	0	12083051	intron_variant	0		4E-7	6.3979400086720375	(additive)	0.14	[0.085-0.195] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	2p25.2	2	5295571	LINC01248							rs116782507-?	rs116782507	0	116782507	intergenic_variant	1		2E-7	6.698970004336019	(additive)	0.375	[0.24-0.51] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	2p13.2	2	72374866	EXOC6B, CYP26B1, SPR, EMX1, SFXN5	EXOC6B			ENSG00000144036			rs115075175-?	rs115075175	0	115075175	intron_variant	0		5E-6	5.301029995663981	(additive)	0.716	[0.41-1.02] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	3p26.2	3	3218754	CRBN	CRBN - NA	ENSG00000113851			39027		rs2874666-?	rs2874666	0	2874666	intergenic_variant	1		9E-7	6.045757490560675	(additive)	0.114	[0.069-0.159] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR				LINC00886, PA2G4P4, LEKR1, TIPARP, TIPARP-AS1, SSR3, LINC00880, LOC105374177, LINC00881							rs5853768-?	rs5853768	0	5853768		1		6E-6	5.221848749616356	(additive)	0.145	[0.082-0.208] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	3q25.33	3	160679075	ARL14, PPM1L, KPNA4, SCARNA7, TRIM59, SMC4, MIR16-2, MIR15B, IFT80, B3GALNT1, C3orf80, IL12A-AS1	ARL14 - SNORA72	ENSG00000179674	ENSG00000201944		627	17854	rs116423146-?	rs116423146	0	116423146	regulatory_region_variant	1		2E-8	7.698970004336019	(additive)	0.244	[0.16-0.33] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	4q31.1	4	139952603	MAML3	MAML3			ENSG00000196782			rs58491357-?	rs58491357	0	58491357	intron_variant	0		9E-7	6.045757490560675	(additive)	0.252	[0.15-0.35] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	4q31.21	4	143592208	FREM3, GUSBP5, SMARCA5, SMARCA5-AS1, GAB1, LOC105377458, MIR3139, GYPE, LOC101927636, USP38, GYPB, LOC105377623, GYPA, INPP4B, HHIP-AS1, HHIP, ANAPC10, ABCE1, OTUD4, IL15, SMAD1, SMAD1-AS2, SMAD1-AS1, MMAA, C4orf51, ZNF827, LOC100507639, ZNF330, RNF150, LINC01095, LSM6, SLC10A7, MIR7849, TBC1D9, TNRC18P1, UCP1, ELMOD2, POU4F2, MGAT4D, TTC29, CLGN, SCOC, SCOC-AS1, MAML3	FREM3			ENSG00000183090			rs567544458-?	rs567544458	0	567544458	intron_variant	0		7E-11	10.154901959985743	(additive)	0.588	[0.41-0.76] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	5p13.2	5	36723279	SLC1A3, NIPBL-AS1, NIPBL, C5orf42, LOC105374727, NUP155, WDR70	SLC1A3 - NA	ENSG00000079215			34945		rs115594123-?	rs115594123	0	115594123	intron_variant	1		5E-6	5.301029995663981	(additive)	0.321	[0.18-0.46] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	5q22.3	5	115077821	TRIM36, LOC101927078	NA - TRIM36		ENSG00000152503			46941	rs62380051-?	rs62380051	0	62380051	intergenic_variant	1		2E-6	5.698970004336019	(additive)	0.134	[0.079-0.189] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	6p21.33	6	31481245	HCG26, MICB, HCP5, MCCD1, ATP6V1G2-DDX39B, DDX39B, SNORD117, SNORD84, DDX39B-AS1, ATP6V1G2, NFKBIL1, MICA, LTA, TNF, LTB, LST1, NCR3, HLA-B, AIF1, PRRC2A, SNORA38, MIR6832, BAG6, APOM, C6orf47, GPANK1, CSNK2B, LY6G5B, LY6G5C, ABHD16A, MIR4646, LY6G6F, LY6G6E, LY6G6D, LY6G6C, C6orf25, DDAH2	MICB-DT			ENSG00000286940			rs2523650-?	rs2523650	0	2523650	non_coding_transcript_exon_variant	0		3E-6	5.522878745280337	(additive)	0.121	[0.07-0.172] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	6q22.31	6	124585841	NKAIN2	NKAIN2			ENSG00000188580			rs76995465-?	rs76995465	0	76995465	intron_variant	0		5E-7	6.301029995663981	(additive)	0.281	[0.17-0.39] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	6q23.3	6	137904008	TNFAIP3, LOC100130476, LOC100507406	TNFAIP3 - LINC02528	ENSG00000118503	ENSG00000226004		20696	39071	rs572459786-?	rs572459786	0	572459786	intergenic_variant	1		2E-6	5.698970004336019	(additive)	0.451	[0.27-0.64] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	6q25.1	6	150652487	PLEKHG1	PLEKHG1			ENSG00000120278			rs144224092-?	rs144224092	0	144224092	intron_variant	0		3E-6	5.522878745280337	(additive)	0.427	[0.25-0.61] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	7q11.23	7	73716908	STX1A, MIR4284, ABHD11-AS1, WBSCR22, ABHD11, DNAJC30, VPS37D, MLXIPL, TBL2, BCL7B, BAZ1B, FZD9	STX1A			ENSG00000106089			rs549107698-?	rs549107698	0	549107698	intron_variant	0		7E-6	5.154901959985743	(additive)	0.45	[0.25-0.65] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	8p21.1	8	28073360	NUGGC, ELP3	NUGGC			ENSG00000189233			rs12335348-?	rs12335348	0	12335348	intron_variant	0		1E-6	6.0	(additive)	0.13	[0.077-0.183] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	8p12	8	31834243	NRG1	NRG1			ENSG00000157168			rs75060108-?	rs75060108	0	75060108	intron_variant	0		6E-6	5.221848749616356	(additive)	0.223	[0.13-0.32] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	8q21.11	8	73585144	STAU2, UBE2W, TCEB1	STAU2			ENSG00000040341			rs199722126-?	rs199722126	0	199722126	intron_variant	0		6E-6	5.221848749616356	(additive)	0.163	[0.092-0.234] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	9q22.31	9	92225835	IARS, LINC00475, MIR3651, SNORA84, NOL8, CENPP, OGN, OMD, ASPN, ECM2, MIR4670, IPPK, LOC100128361, BICD2, LOC101929748, ANKRD19P, ZNF484	IARS1			ENSG00000196305			rs186421274-?	rs186421274	0	186421274	non_coding_transcript_exon_variant	0		6E-6	5.221848749616356	(additive)	0.604	[0.34-0.86] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	9q33.2	9	122159474	NDUFA8, MORN5, MIR4478, LHX6, TTLL11	NDUFA8			ENSG00000119421			rs7045306-?	rs7045306	0	7045306	intron_variant	0		9E-7	6.045757490560675	(additive)	0.266	[0.16-0.37] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	9q33.3	9	126487840	MVB12B, NRON, LOC101929116	MVB12B			ENSG00000196814			rs57032711-?	rs57032711	0	57032711	intron_variant	0		1E-8	8.0	(additive)	0.209	[0.14-0.28] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	9q34.2	9	133257522	ABO, OBP2B, SURF6, MED22, RPL7A, SNORD24, SNORD36B, SNORD36A, SNORD36C, SURF1, SURF2, SURF4, STKLD1, REXO4, ADAMTS13	ABO, ABO			ENSG00000175164, ENSG00000281879			rs8176719-?	rs8176719	0	8176719	frameshift_variant	0		1E-19	19.0	(additive)	0.223	[0.17-0.27] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	10p15.3	10	574544	DIP2C, MIR5699, PRR26, MIR7641-2, ZMYND11	DIP2C			ENSG00000151240			rs74806154-?	rs74806154	0	74806154	intron_variant	0		8E-8	7.096910013008056	(additive)	0.138	[0.087-0.189] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	10q25.3	10	116260869	GFRA1, CCDC172	GFRA1			ENSG00000151892			rs7079449-?	rs7079449	0	7079449	intron_variant	0		3E-6	5.522878745280337	(additive)	0.368	[0.21-0.52] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	3q25.33	3	160679075	ARL14, PPM1L, KPNA4, SCARNA7, TRIM59, SMC4, MIR16-2, MIR15B, IFT80, B3GALNT1, C3orf80, IL12A-AS1	ARL14 - SNORA72	ENSG00000179674	ENSG00000201944		627	17854	rs116423146-?	rs116423146	0	116423146	regulatory_region_variant	1		3E-9	8.522878745280337	(heterogeneous)	0.278	[0.19-0.37] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	3q29	3	196954604	PIGZ, NCBP2-AS2, NCBP2, SENP5, MELTF, MFI2-AS1, PAK2	PIGZ			ENSG00000119227			rs116126306-?	rs116126306	0	116126306	intron_variant	0		8E-6	5.096910013008056	(heterogeneous)	0.403	[0.23-0.58] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	4q31.1	4	139952603	MAML3	MAML3			ENSG00000196782			rs58491357-?	rs58491357	0	58491357	intron_variant	0		3E-6	5.522878745280337	(heterogeneous)	0.257	[0.15-0.36] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	4q31.21	4	143592208	FREM3, GUSBP5, SMARCA5, SMARCA5-AS1, GAB1, LOC105377458, MIR3139, GYPE, LOC101927636, USP38, GYPB, LOC105377623, GYPA, INPP4B, HHIP-AS1, HHIP, ANAPC10, ABCE1, OTUD4, IL15, SMAD1, SMAD1-AS2, SMAD1-AS1, MMAA, C4orf51, ZNF827, LOC100507639, ZNF330, RNF150, LINC01095, LSM6, SLC10A7, MIR7849, TBC1D9, TNRC18P1, UCP1, ELMOD2, POU4F2, MGAT4D, TTC29, CLGN, SCOC, SCOC-AS1, MAML3	FREM3			ENSG00000183090			rs567544458-?	rs567544458	0	567544458	intron_variant	0		4E-10	9.397940008672037	(heterogeneous)	0.596	[0.41-0.78] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	5p14.2	5	23566881	PRDM9	PRDM9 - NA	ENSG00000164256			38788		rs2914266-?	rs2914266	0	2914266	intergenic_variant	1		9E-6	5.045757490560675	(heterogeneous)	0.284	[0.16-0.41] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	5p13.2	5	36723279	SLC1A3, NIPBL-AS1, NIPBL, C5orf42, LOC105374727, NUP155, WDR70	SLC1A3 - NA	ENSG00000079215			34945		rs115594123-?	rs115594123	0	115594123	intron_variant	1		9E-7	6.045757490560675	(heterogeneous)	0.365	[0.22-0.51] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	5q31.2	5	139070389	SIL1, CTNNA1, LRRTM2, MATR3, SNHG4, SNORA74A, PAIP2, SLC23A1, LOC105379194, MZB1, PROB1, SPATA24, DNAJC18, ECSCR	SIL1			ENSG00000120725			rs7701116-?	rs7701116	0	7701116	intron_variant	0		2E-6	5.698970004336019	(heterogeneous)	0.156	[0.091-0.221] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	6p22.3	6	21390601	LINC00581	NA - LINC00581		ENSG00000280989			95295	rs183954794-?	rs183954794	0	183954794	regulatory_region_variant	1		2E-6	5.698970004336019	(heterogeneous)	0.481	[0.28-0.68] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	6p21.33	6	31048409	HCG22, MUC22, MUC21, C6orf15, PSORS1C1, CDSN, PSORS1C2, CCHCR1, DPCR1, TCF19, POU5F1, SFTA2, VARS2, PSORS1C3, GTF2H4, DDR1, HCG27, MIR4640	MUC22 - HCG22	ENSG00000261272	ENSG00000238234		13007	5041	rs73727186-?	rs73727186	0	73727186	TF_binding_site_variant	1		6E-6	5.221848749616356	(heterogeneous)	0.235	[0.13-0.34] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	6q22.31	6	122807710	SMPDL3A, FABP7	SMPDL3A			ENSG00000172594			rs5784724-?	rs5784724	0	5784724	intron_variant	0		3E-7	6.522878745280337	(heterogeneous)	0.208	[0.13-0.29] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	6q23.3	6	137904008	TNFAIP3, LOC100130476, LOC100507406	TNFAIP3 - LINC02528	ENSG00000118503	ENSG00000226004		20696	39071	rs572459786-?	rs572459786	0	572459786	intergenic_variant	1		4E-6	5.3979400086720375	(heterogeneous)	0.441	[0.25-0.63] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	6q25.1	6	150652487	PLEKHG1	PLEKHG1			ENSG00000120278			rs144224092-?	rs144224092	0	144224092	intron_variant	0		3E-6	5.522878745280337	(heterogeneous)	0.44	[0.26-0.62] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	7q11.23	7	73716908	STX1A, MIR4284, ABHD11-AS1, WBSCR22, ABHD11, DNAJC30, VPS37D, MLXIPL, TBL2, BCL7B, BAZ1B, FZD9	STX1A			ENSG00000106089			rs549107698-?	rs549107698	0	549107698	intron_variant	0		8E-6	5.096910013008056	(heterogeneous)	0.464	[0.26-0.67] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	8p12	8	31834243	NRG1	NRG1			ENSG00000157168			rs75060108-?	rs75060108	0	75060108	intron_variant	0		9E-7	6.045757490560675	(heterogeneous)	0.263	[0.16-0.37] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	8q21.11	8	73585144	STAU2, UBE2W, TCEB1	STAU2			ENSG00000040341			rs199722126-?	rs199722126	0	199722126	intron_variant	0		2E-7	6.698970004336019	(heterogeneous)	0.215	[0.13-0.3] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	9q22.31	9	92225835	IARS, LINC00475, MIR3651, SNORA84, NOL8, CENPP, OGN, OMD, ASPN, ECM2, MIR4670, IPPK, LOC100128361, BICD2, LOC101929748, ANKRD19P, ZNF484	IARS1			ENSG00000196305			rs186421274-?	rs186421274	0	186421274	non_coding_transcript_exon_variant	0		9E-6	5.045757490560675	(heterogeneous)	0.603	[0.34-0.87] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	9q33.2	9	122159474	NDUFA8, MORN5, MIR4478, LHX6, TTLL11	NDUFA8			ENSG00000119421			rs7045306-?	rs7045306	0	7045306	intron_variant	0		5E-6	5.301029995663981	(heterogeneous)	0.259	[0.15-0.37] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	9q33.3	9	126487840	MVB12B, NRON, LOC101929116	MVB12B			ENSG00000196814			rs57032711-?	rs57032711	0	57032711	intron_variant	0		2E-7	6.698970004336019	(heterogeneous)	0.219	[0.14-0.3] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	9q34.2	9	133257522	ABO, OBP2B, SURF6, MED22, RPL7A, SNORD24, SNORD36B, SNORD36A, SNORD36C, SURF1, SURF2, SURF4, STKLD1, REXO4, ADAMTS13	ABO, ABO			ENSG00000175164, ENSG00000281879			rs8176719-?	rs8176719	0	8176719	frameshift_variant	0		9E-11	10.045757490560675	(heterogeneous)	0.211	[0.15-0.27] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	11p15.4	11	5227002	HBB, HBD, HBBP1, BGLT3, HBG1, HBG2, OR51V1, HBE1, OR51B4, OR52A1, OR52A5, OR51B2, OR51B5, OR51B6, OR51M1, OR52E2, OR52J3, OR51Q1, OR51I1, OR51I2, OR51L1, MMP26, OR52D1, OR51A2, OR51A4, UBQLN3, UBQLNL, OLFM5P, OR51G1, OR51G2, OR52H1, OR51A7, OR51T1, OR52B6, TRIM6, TRIM6-TRIM34, OR51S1, TRIM34, OR51F2, OR52R1, TRIM5, OR51F1, TRIM22, OR56B1, OR52N4, OR51E2, OR52N5, OR52N1, OR51E1, OR51D1, OR52N2, OR52E6, TRIM68, OR52E8, OR52I1, OR52I2, C11orf40, OR52E4, OR52M1, OR56A3, OR52K1, OR56A5, OR52L1, OR56A4, OR52K2, OR56A1, TRIM21, OR52B4, OR56B4, OR52B2, OR52W1, C11orf42, FAM160A2, CNGA4, LOC100506082, CCKBR, RRM1, PRKCDBP, STIM1, SMPD1, APBB1, HPX, TRIM3, ARFIP2, TIMM10B, DNHD1, MIR4687, RRP8, ILK, TAF10, TPP1, RHOG, DCHS1, PGAP2, NUP98, MRPL17, GVINP1, OR2AG2, CHRNA10, OR2AG1, ART1, OR6A2, ART5, TRPC2, OR10A5, OR10A2, OR10A4, LOC101927708, OR2D2, OR2D3, ZNF215, ZNF214, NLRP14, TSSC2, OR7E12P, ZNF195, RBMXL2, MRGPRE, MRGPRG-AS1, MIR302E, MRGPRG, SYT9, OSBPL5, CARS, LOC100506258, NAP1L4, OLFML1, SNORA54, PPFIBP2, PHLDA2, SLC22A18, SLC22A18AS, CDKN1C, KCNQ1DN, KCNQ1-AS1, KCNQ1, CYB5R2, OVCH2, KCNQ1OT1, OR5P2, OR5P3, OR5E1P, LOC283299, OR10A6, OR10A3, NLRP10, EIF3F, CASC23, TRPM5, TUB, TSSC4, CD81, TUB-AS1, CD81-AS1, RIC3, TSPAN32, C11orf21, ASCL2, LMO1	HBB			ENSG00000244734			rs334-?	rs334	0	334	missense_variant	0		4E-69	68.39794000867204	(heterogeneous)	1.572	[1.4-1.75] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	12q15	12	67624766	DYRK2, LOC101927901	LINC02408 - DYRK2	ENSG00000203585	ENSG00000127334		33995	23572	rs78308377-?	rs78308377	0	78308377	regulatory_region_variant	1		8E-6	5.096910013008056	(heterogeneous)	0.447	[0.25-0.64] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	15q14	15	33951328	AVEN, CHRM5, RYR3, EMC7, PGBD4	AVEN			ENSG00000169857			rs116830894-?	rs116830894	0	116830894	intron_variant	0		3E-6	5.522878745280337	(heterogeneous)	0.274	[0.16-0.39] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR				DNAJC17, ZFYVE19, PPP1R14D, C15orf62, GCHFR, SPINT1, RMDN3, RAD51, RHOV, VPS18, LOC105370943, RAD51-AS1, DLL4, CASC5, CHAC1, INO80, RPUSD2, C15orf57, MRPL42P5, CHST14, BAHD1, IVD, KNSTRN, DISP2, PHGR1							chr15:41093534-?	chr15:41093534	0			1		2E-6	5.698970004336019	(heterogeneous)	0.244	[0.14-0.34] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	18q12.3	18	41548233	KC6	KC6			ENSG00000267313			rs16974953-?	rs16974953	0	16974953	intron_variant	0		6E-6	5.221848749616356	(heterogeneous)	0.257	[0.15-0.37] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	Xp22.11	X	24432031	PDK3, SUPT20HL1, SUPT20HL2	RPS26P58 - PDK3	ENSG00000225071	ENSG00000067992		2111	33239	rs59309986-?	rs59309986	0	59309986	intergenic_variant	1		7E-6	5.154901959985743	(heterogeneous)	0.39	[0.22-0.56] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	8p12	8	31834243	NRG1	NRG1			ENSG00000157168			rs75060108-?	rs75060108	0	75060108	intron_variant	0		1E-6	6.0	(dominant)	0.253	[-0.47612-0.98212] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	8q21.11	8	73585144	STAU2, UBE2W, TCEB1	STAU2			ENSG00000040341			rs199722126-?	rs199722126	0	199722126	intron_variant	0		4E-7	6.3979400086720375	(dominant)	0.205	[-0.089-0.499] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	9q22.31	9	92225835	IARS, LINC00475, MIR3651, SNORA84, NOL8, CENPP, OGN, OMD, ASPN, ECM2, MIR4670, IPPK, LOC100128361, BICD2, LOC101929748, ANKRD19P, ZNF484	IARS1			ENSG00000196305			rs186421274-?	rs186421274	0	186421274	non_coding_transcript_exon_variant	0		6E-6	5.221848749616356	(dominant)	0.613	[NR] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	9q33.2	9	122159474	NDUFA8, MORN5, MIR4478, LHX6, TTLL11	NDUFA8			ENSG00000119421			rs7045306-?	rs7045306	0	7045306	intron_variant	0		1E-6	6.0	(dominant)	0.271	[NR] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	9q33.3	9	126487840	MVB12B, NRON, LOC101929116	MVB12B			ENSG00000196814			rs57032711-?	rs57032711	0	57032711	intron_variant	0		1E-8	8.0	(dominant)	0.234	[-0.05412-0.52212] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	9q34.2	9	133257522	ABO, OBP2B, SURF6, MED22, RPL7A, SNORD24, SNORD36B, SNORD36A, SNORD36C, SURF1, SURF2, SURF4, STKLD1, REXO4, ADAMTS13	ABO, ABO			ENSG00000175164, ENSG00000281879			rs8176719-?	rs8176719	0	8176719	frameshift_variant	0		9E-21	20.045757490560675	(dominant)	0.305	[0.2-0.41] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	10p15.3	10	574544	DIP2C, MIR5699, PRR26, MIR7641-2, ZMYND11	DIP2C			ENSG00000151240			rs74806154-?	rs74806154	0	74806154	intron_variant	0		2E-7	6.698970004336019	(dominant)	0.172	[0.056-0.288] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	11p15.4	11	5227002	HBB, HBD, HBBP1, BGLT3, HBG1, HBG2, OR51V1, HBE1, OR51B4, OR52A1, OR52A5, OR51B2, OR51B5, OR51B6, OR51M1, OR52E2, OR52J3, OR51Q1, OR51I1, OR51I2, OR51L1, MMP26, OR52D1, OR51A2, OR51A4, UBQLN3, UBQLNL, OLFM5P, OR51G1, OR51G2, OR52H1, OR51A7, OR51T1, OR52B6, TRIM6, TRIM6-TRIM34, OR51S1, TRIM34, OR51F2, OR52R1, TRIM5, OR51F1, TRIM22, OR56B1, OR52N4, OR51E2, OR52N5, OR52N1, OR51E1, OR51D1, OR52N2, OR52E6, TRIM68, OR52E8, OR52I1, OR52I2, C11orf40, OR52E4, OR52M1, OR56A3, OR52K1, OR56A5, OR52L1, OR56A4, OR52K2, OR56A1, TRIM21, OR52B4, OR56B4, OR52B2, OR52W1, C11orf42, FAM160A2, CNGA4, LOC100506082, CCKBR, RRM1, PRKCDBP, STIM1, SMPD1, APBB1, HPX, TRIM3, ARFIP2, TIMM10B, DNHD1, MIR4687, RRP8, ILK, TAF10, TPP1, RHOG, DCHS1, PGAP2, NUP98, MRPL17, GVINP1, OR2AG2, CHRNA10, OR2AG1, ART1, OR6A2, ART5, TRPC2, OR10A5, OR10A2, OR10A4, LOC101927708, OR2D2, OR2D3, ZNF215, ZNF214, NLRP14, TSSC2, OR7E12P, ZNF195, RBMXL2, MRGPRE, MRGPRG-AS1, MIR302E, MRGPRG, SYT9, OSBPL5, CARS, LOC100506258, NAP1L4, OLFML1, SNORA54, PPFIBP2, PHLDA2, SLC22A18, SLC22A18AS, CDKN1C, KCNQ1DN, KCNQ1-AS1, KCNQ1, CYB5R2, OVCH2, KCNQ1OT1, OR5P2, OR5P3, OR5E1P, LOC283299, OR10A6, OR10A3, NLRP10, EIF3F, CASC23, TRPM5, TUB, TSSC4, CD81, TUB-AS1, CD81-AS1, RIC3, TSPAN32, C11orf21, ASCL2, LMO1	HBB			ENSG00000244734			rs334-?	rs334	0	334	missense_variant	0		2E-67	66.69897000433602	(dominant)	1.385	[0.84-1.93] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	12p12.1	12	25364251	LMNTD1	NA - RNU4-67P		ENSG00000201439			40037	rs113065354-?	rs113065354	0	113065354	regulatory_region_variant	1		6E-6	5.221848749616356	(dominant)	0.237	[-0.53916-1.01316] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	12q15	12	67624766	DYRK2, LOC101927901	LINC02408 - DYRK2	ENSG00000203585	ENSG00000127334		33995	23572	rs78308377-?	rs78308377	0	78308377	regulatory_region_variant	1		9E-6	5.045757490560675	(dominant)	0.442	[NR] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	13q21.32	13	65417774	LINC01052							rs9598973-?	rs9598973	0	9598973	intergenic_variant	1		5E-7	6.301029995663981	(dominant)	0.226	[0.16-0.29] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	15q14	15	33951328	AVEN, CHRM5, RYR3, EMC7, PGBD4	AVEN			ENSG00000169857			rs116830894-?	rs116830894	0	116830894	intron_variant	0		3E-6	5.522878745280337	(dominant)	0.272	[NR] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR				DNAJC17, ZFYVE19, PPP1R14D, C15orf62, GCHFR, SPINT1, RMDN3, RAD51, RHOV, VPS18, LOC105370943, RAD51-AS1, DLL4, CASC5, CHAC1, INO80, RPUSD2, C15orf57, MRPL42P5, CHST14, BAHD1, IVD, KNSTRN, DISP2, PHGR1							chr15:41093534-?	chr15:41093534	0			1		3E-6	5.522878745280337	(dominant)	0.238	[-0.4872-0.9632] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	18q12.3	18	41548233	KC6	KC6			ENSG00000267313			rs16974953-?	rs16974953	0	16974953	intron_variant	0		3E-6	5.522878745280337	(dominant)	0.263	[NR] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR				SDC4, RBPJL, MATN4, SYS1, SYS1-DBNDD2, TP53TG5, SLPI, DBNDD2, PIGT, MIR6812, SEMG2, SEMG1, PI3							chr20:43956636-?	chr20:43956636	0			1		1E-6	6.0	(dominant)	0.17	[0.092-0.248] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	Xp22.11	X	24432031	PDK3, SUPT20HL1, SUPT20HL2	RPS26P58 - PDK3	ENSG00000225071	ENSG00000067992		2111	33239	rs59309986-?	rs59309986	0	59309986	intergenic_variant	1		8E-6	5.096910013008056	(dominant)	0.384	[0.08-0.688] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	3p26.2	3	3218754	CRBN	CRBN - NA	ENSG00000113851			39027		rs2874666-?	rs2874666	0	2874666	intergenic_variant	1		5E-7	6.301029995663981	(recessive)	0.171	[0.1-0.24] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	6p21.33	6	31481245	HCG26, MICB, HCP5, MCCD1, ATP6V1G2-DDX39B, DDX39B, SNORD117, SNORD84, DDX39B-AS1, ATP6V1G2, NFKBIL1, MICA, LTA, TNF, LTB, LST1, NCR3, HLA-B, AIF1, PRRC2A, SNORA38, MIR6832, BAG6, APOM, C6orf47, GPANK1, CSNK2B, LY6G5B, LY6G5C, ABHD16A, MIR4646, LY6G6F, LY6G6E, LY6G6D, LY6G6C, C6orf25, DDAH2	MICB-DT			ENSG00000286940			rs2523650-?	rs2523650	0	2523650	non_coding_transcript_exon_variant	0		5E-7	6.301029995663981	(recessive)	0.167	[0.1-0.23] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	8p23.2	8	4157057	CSMD1	CSMD1			ENSG00000183117			rs7821609-?	rs7821609	0	7821609	intron_variant	0		5E-6	5.301029995663981	(recessive)	0.191	[0.11-0.27] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	10q25.3	10	116260869	GFRA1, CCDC172	GFRA1			ENSG00000151892			rs7079449-?	rs7079449	0	7079449	intron_variant	0		5E-6	5.301029995663981	(recessive)	0.368	[0.21-0.52] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR				CLEC2A, KLRF2, LOC100506159, LOC400002, CLEC2B, CLEC12A, KLRF1, CLEC1B, CLEC12B, LOC102724020							chr12:10062759-?	chr12:10062759	0			1		1E-6	6.0	(recessive)	0.435	[0.26-0.61] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	16q22.1	16	70794366	VAC14, HYDIN, VAC14-AS1, MTSS1L, IL34, SF3B3, SNORD111, SNORD111B, COG4, FUK, ST3GAL2, DDX19A, LOC100506083, DDX19B, AARS, EXOSC6	VAC14			ENSG00000103043			rs8044133-?	rs8044133	0	8044133	intron_variant	0		6E-7	6.221848749616356	(recessive)	0.19	[0.12-0.26] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	20p12.3	20	6467874	CASC20	CASC20			ENSG00000229876			rs6117276-?	rs6117276	0	6117276	intron_variant	0		4E-7	6.3979400086720375	(recessive)	0.461	[0.28-0.64] unit increase	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	2p25.2	2	5295571	LINC01248							rs116782507-?	rs116782507	0	116782507	intergenic_variant	1		9E-7	6.045757490560675	(heterogeneous)	0.356	[0.21-0.5] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2020-10-30	31844061	Malaria Genomic Epidemiology Network	2019-12-16	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31844061	Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.	Malaria	7,957 African ancestry cases, 7,746 African ancestry controls, 718 Asian ancestry cases, 546 Asian ancestry controls, 402 Oceanian cases, 374 Oceanian controls	NR	2p22.3	2	33976154	LINC01317, LINC01318	LINC01320			ENSG00000228262			rs56291704-?	rs56291704	0	56291704	intron_variant	0		3E-7	6.522878745280337	(heterogeneous)	0.165	[0.1-0.23] unit decrease	Illumina [1492601] (imputed)	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST010725	Genome-wide genotyping array
2009-06-14	19465909	Jallow M	2009-05-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19465909	Genome-wide and fine-resolution association analysis of malaria in West Africa.	Malaria	958 Gambian ancestry cases, 1,382 Gambian ancestry controls	1,087 Gambian ancestry cases, 2,376 Gambian ancestry controls	7p12.1	7	50555014	DDC	DDC			ENSG00000132437			rs1451375-?	rs1451375	0	1451375	intron_variant	0	0.78	6E-6	5.221848749616356		1.33	[1.18-1.52]	Affymetrix [402814]	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST000410	Genome-wide genotyping array
2009-06-14	19465909	Jallow M	2009-05-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19465909	Genome-wide and fine-resolution association analysis of malaria in West Africa.	Malaria	958 Gambian ancestry cases, 1,382 Gambian ancestry controls	1,087 Gambian ancestry cases, 2,376 Gambian ancestry controls	17p13.1	17	10670842	SCO1	MYH3 - SCO1	ENSG00000109063	ENSG00000133028		13533	1632	rs6503319-T	rs6503319	0	6503319	intergenic_variant	1	0.45	7E-7	6.154901959985743		1.21	[1.12-1.31]	Affymetrix [402814]	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST000410	Genome-wide genotyping array
2009-06-14	19465909	Jallow M	2009-05-24	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19465909	Genome-wide and fine-resolution association analysis of malaria in West Africa.	Malaria	958 Gambian ancestry cases, 1,382 Gambian ancestry controls	1,087 Gambian ancestry cases, 2,376 Gambian ancestry controls	11p15.4	11	5204405	HBB	OR51V1 - HBB	ENSG00000176742	ENSG00000244734		3723	21059	rs11036238-?	rs11036238	0	11036238	regulatory_region_variant	1	0.14	4E-11	10.397940008672037		1.59	[1.39-1.82]	Affymetrix [402814]	N	malaria	http://www.ebi.ac.uk/efo/EFO_0001068	GCST000410	Genome-wide genotyping array
2021-10-26	34441435	Corma-Gomez A	2021-08-20	Diagnostics (Basel)	www.ncbi.nlm.nih.gov/pubmed/34441435	A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure.	Liver stiffness changes at sustained virological response following antiviral therapy in HCV infection	242 European ancestry individuals	NA	18p11.22	18	9012998		NA - RPS4XP19		ENSG00000242058			7031	rs12606769-C	rs12606769	0	12606769	intergenic_variant	1	0.207	2E-7	6.698970004336019		13.27	[8.386-18.16] unit decrease	Affymetrix [6939676] (imputed)	N	response to antiviral drug, cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0010123, http://www.ebi.ac.uk/efo/EFO_0001422	GCST90032157	Genome-wide genotyping array
2021-10-26	34441435	Corma-Gomez A	2021-08-20	Diagnostics (Basel)	www.ncbi.nlm.nih.gov/pubmed/34441435	A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure.	Liver stiffness changes at sustained virological response following antiviral therapy in HCV infection	242 European ancestry individuals	NA	6q22.31	6	119450721								rs2649545-A	rs2649545	0	2649545	regulatory_region_variant	1	0.447	3E-6	5.522878745280337		10.98	[6.508-15.45] unit decrease	Affymetrix [6939676] (imputed)	N	response to antiviral drug, cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0010123, http://www.ebi.ac.uk/efo/EFO_0001422	GCST90032157	Genome-wide genotyping array
2021-10-26	34441435	Corma-Gomez A	2021-08-20	Diagnostics (Basel)	www.ncbi.nlm.nih.gov/pubmed/34441435	A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure.	Liver stiffness changes at sustained virological response following antiviral therapy in HCV infection	242 European ancestry individuals	NA	6q16.2	6	99352246		FAXC - COQ3	ENSG00000146267	ENSG00000132423		2184	17155	rs9402699-A	rs9402699	0	9402699	intergenic_variant	1	0.277	5E-6	5.301029995663981		11.49	[6.662-16.31] unit decrease	Affymetrix [6939676] (imputed)	N	response to antiviral drug, cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0010123, http://www.ebi.ac.uk/efo/EFO_0001422	GCST90032157	Genome-wide genotyping array
2021-10-26	34441435	Corma-Gomez A	2021-08-20	Diagnostics (Basel)	www.ncbi.nlm.nih.gov/pubmed/34441435	A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure.	Liver stiffness changes at sustained virological response following antiviral therapy in HCV infection	242 European ancestry individuals	NA	6q16.2	6	99486583		USP45			ENSG00000123552			rs13201542-A	rs13201542	0	13201542	intron_variant	0	0.076	1E-5	5.0		17.47	[9.894-25.04] unit decrease	Affymetrix [6939676] (imputed)	N	response to antiviral drug, cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0010123, http://www.ebi.ac.uk/efo/EFO_0001422	GCST90032157	Genome-wide genotyping array
2021-10-26	34441435	Corma-Gomez A	2021-08-20	Diagnostics (Basel)	www.ncbi.nlm.nih.gov/pubmed/34441435	A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure.	Liver stiffness changes at sustained virological response following antiviral therapy in HCV infection	242 European ancestry individuals	NA	1q32.2	1	208569994		TNFRSF1B - LINC01735	ENSG00000028137	ENSG00000261453		196360766	36570	rs188739258-T	rs188739258	0	188739258	intergenic_variant	1	0.013	4E-6	5.3979400086720375		42.14	[24.75-59.53] unit decrease	Affymetrix [6939676] (imputed)	N	response to antiviral drug, cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0010123, http://www.ebi.ac.uk/efo/EFO_0001422	GCST90032157	Genome-wide genotyping array
2021-10-26	34441435	Corma-Gomez A	2021-08-20	Diagnostics (Basel)	www.ncbi.nlm.nih.gov/pubmed/34441435	A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure.	Liver stiffness changes at sustained virological response following antiviral therapy in HCV infection	242 European ancestry individuals	NA	5p15.33	5	311765		PDCD6-AHRR, PDCD6			ENSG00000288622, ENSG00000249915			rs62330020-T	rs62330020	0	62330020	3_prime_UTR_variant	0	0.047	4E-6	5.3979400086720375		22.65	[13.26-32.03] unit decrease	Affymetrix [6939676] (imputed)	N	response to antiviral drug, cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0010123, http://www.ebi.ac.uk/efo/EFO_0001422	GCST90032157	Genome-wide genotyping array
2021-10-26	34441435	Corma-Gomez A	2021-08-20	Diagnostics (Basel)	www.ncbi.nlm.nih.gov/pubmed/34441435	A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure.	Liver stiffness changes at sustained virological response following antiviral therapy in HCV infection	242 European ancestry individuals	NA	2q24.1	2	158756684		PKP4-AS1 - DAPL1	ENSG00000204380	ENSG00000163331		21682	38633	rs6437198-C	rs6437198	0	6437198	regulatory_region_variant	1	0.277	5E-6	5.301029995663981		11.38	[6.625-16.13] unit decrease	Affymetrix [6939676] (imputed)	N	response to antiviral drug, cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0010123, http://www.ebi.ac.uk/efo/EFO_0001422	GCST90032157	Genome-wide genotyping array
2021-10-26	34441435	Corma-Gomez A	2021-08-20	Diagnostics (Basel)	www.ncbi.nlm.nih.gov/pubmed/34441435	A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure.	Liver stiffness changes at sustained virological response following antiviral therapy in HCV infection	242 European ancestry individuals	NA	4q26	4	114986399		NDST4			ENSG00000138653			rs8180156-C	rs8180156	0	8180156	intron_variant	0	0.11	5E-6	5.301029995663981		16.62	[9.637-23.6] unit increase	Affymetrix [6939676] (imputed)	N	response to antiviral drug, cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0010123, http://www.ebi.ac.uk/efo/EFO_0001422	GCST90032157	Genome-wide genotyping array
2021-10-26	34441435	Corma-Gomez A	2021-08-20	Diagnostics (Basel)	www.ncbi.nlm.nih.gov/pubmed/34441435	A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure.	Liver stiffness changes at sustained virological response following antiviral therapy in HCV infection	242 European ancestry individuals	NA	16q12.2	16	53021189		PHBP21 - CHD9	ENSG00000260326	ENSG00000177200		85554	33802	rs74918996-C	rs74918996	0	74918996	intergenic_variant	1	0.022	7E-6	5.154901959985743		33.49	[19.27-47.71] unit decrease	Affymetrix [6939676] (imputed)	N	response to antiviral drug, cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0010123, http://www.ebi.ac.uk/efo/EFO_0001422	GCST90032157	Genome-wide genotyping array
2021-10-26	34441435	Corma-Gomez A	2021-08-20	Diagnostics (Basel)	www.ncbi.nlm.nih.gov/pubmed/34441435	A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure.	Liver stiffness changes at sustained virological response following antiviral therapy in HCV infection	242 European ancestry individuals	NA	20q13.33	20	63477817		KCNQ2 - EEF1A2	ENSG00000075043	ENSG00000101210		5140	10196	rs310602-A	rs310602	0	310602	regulatory_region_variant	1	0.101	7E-6	5.154901959985743		15.78	[9.059-22.51] unit decrease	Affymetrix [6939676] (imputed)	N	response to antiviral drug, cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0010123, http://www.ebi.ac.uk/efo/EFO_0001422	GCST90032157	Genome-wide genotyping array
2021-10-26	34441435	Corma-Gomez A	2021-08-20	Diagnostics (Basel)	www.ncbi.nlm.nih.gov/pubmed/34441435	A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure.	Liver stiffness changes at sustained virological response following antiviral therapy in HCV infection	242 European ancestry individuals	NA	20p12.3	20	7283109		LINC01428 - LINC01751	ENSG00000228888	ENSG00000261249		28907	18947	rs4815993-A	rs4815993	0	4815993	intergenic_variant	1	0.348	9E-6	5.045757490560675		10.09	[5.749-14.43] unit increase	Affymetrix [6939676] (imputed)	N	response to antiviral drug, cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0010123, http://www.ebi.ac.uk/efo/EFO_0001422	GCST90032157	Genome-wide genotyping array
2021-10-26	34441435	Corma-Gomez A	2021-08-20	Diagnostics (Basel)	www.ncbi.nlm.nih.gov/pubmed/34441435	A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure.	Liver stiffness changes at sustained virological response following antiviral therapy in HCV infection	242 European ancestry individuals	NA	7q11.23	7	73653419		MLXIPL - VPS37D	ENSG00000009950	ENSG00000176428		28876	14412	rs71537604-T	rs71537604	0	71537604	intergenic_variant	1	0.071	7E-6	5.154901959985743		18.85	[10.81-26.9] unit decrease	Affymetrix [6939676] (imputed)	N	response to antiviral drug, cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0010123, http://www.ebi.ac.uk/efo/EFO_0001422	GCST90032157	Genome-wide genotyping array
2021-10-26	34441435	Corma-Gomez A	2021-08-20	Diagnostics (Basel)	www.ncbi.nlm.nih.gov/pubmed/34441435	A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure.	Liver stiffness changes at sustained virological response following antiviral therapy in HCV infection	242 European ancestry individuals	NA	13q21.33	13	72490013		RPL18AP17 - NA	ENSG00000227952			29684		rs61971490-T	rs61971490	0	61971490	intergenic_variant	1	0.045	8E-6	5.096910013008056		24.11	[13.77-34.45] unit decrease	Affymetrix [6939676] (imputed)	N	response to antiviral drug, cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0010123, http://www.ebi.ac.uk/efo/EFO_0001422	GCST90032157	Genome-wide genotyping array
2018-08-03	28921602	Lee MH	2017-09-16	Hepatology	www.ncbi.nlm.nih.gov/pubmed/28921602	Human leukocyte antigen variants and risk of hepatocellular carcinoma modified by hepatitis C virus genotypes: A genome-wide association study.	Hepatocellular carcinoma in hepatitis C infection	502 Chinese ancestry cases, 749 Chinese ancestry controls	669 Chinese ancestry cases, 429 Chinese ancestry controls	6p21.32	6	32699985	HLA-DQB1	HLA-DQB1 - MTCO3P1	ENSG00000231939	ENSG00000237145		31602	6139	rs2856723-?	rs2856723	0	2856723	intergenic_variant	1		3E-43	42.52287874528034		2.68	[2.32-3.09]	Affymetrix [576032]	N	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	GCST006037	Genome-wide genotyping array
2010-01-19	20009918	Shrestha S	2010-01-01	AIDS	www.ncbi.nlm.nih.gov/pubmed/20009918	A genome-wide association study of carotid atherosclerosis in HIV-infected men.	Carotid atherosclerosis in HIV infection	177 European ancestry individuals	NA	5q34	5	165636879	intergenic	RN7SKP60 - NA	ENSG00000252794			27200		rs958994-G	rs958994	0	958994	intron_variant	1	0.27	8E-6	5.096910013008056	(common cIMT)			Illumina [311194]	N	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	GCST000555	Genome-wide genotyping array
2010-01-19	20009918	Shrestha S	2010-01-01	AIDS	www.ncbi.nlm.nih.gov/pubmed/20009918	A genome-wide association study of carotid atherosclerosis in HIV-infected men.	Carotid atherosclerosis in HIV infection	177 European ancestry individuals	NA	7q31.33	7	126684537	GRM8	GRM8			ENSG00000179603			rs17691394-G	rs17691394	0	17691394	intron_variant	0	0.20	9E-7	6.045757490560675	(common cIMT)			Illumina [311194]	N	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	GCST000555	Genome-wide genotyping array
2010-01-19	20009918	Shrestha S	2010-01-01	AIDS	www.ncbi.nlm.nih.gov/pubmed/20009918	A genome-wide association study of carotid atherosclerosis in HIV-infected men.	Carotid atherosclerosis in HIV infection	177 European ancestry individuals	NA	15q14	15	33613209	RYR3	RYR3			ENSG00000198838			rs2229116-G	rs2229116	0	2229116	missense_variant	0	0.18	3E-8	7.522878745280337	(common cIMT)			Illumina [311194]	N	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	GCST000555	Genome-wide genotyping array
2010-01-19	20009918	Shrestha S	2010-01-01	AIDS	www.ncbi.nlm.nih.gov/pubmed/20009918	A genome-wide association study of carotid atherosclerosis in HIV-infected men.	Carotid atherosclerosis in HIV infection	177 European ancestry individuals	NA	7p15.2	7	25568789	intergenic							rs17151904-A	rs17151904	0	17151904	TF_binding_site_variant	1	0.20	1E-6	6.0	(internal cIMT)			Illumina [311194]	N	internal carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0005053	GCST000555	Genome-wide genotyping array
2010-01-19	20009918	Shrestha S	2010-01-01	AIDS	www.ncbi.nlm.nih.gov/pubmed/20009918	A genome-wide association study of carotid atherosclerosis in HIV-infected men.	Carotid atherosclerosis in HIV infection	177 European ancestry individuals	NA	5q12.3	5	67156347	MAST4	MAST4			ENSG00000069020			rs1697137-C	rs1697137	0	1697137	intron_variant	0	0.36	2E-6	5.698970004336019	(internal cIMT)			Illumina [311194]	N	internal carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0005053	GCST000555	Genome-wide genotyping array
2010-01-19	20009918	Shrestha S	2010-01-01	AIDS	www.ncbi.nlm.nih.gov/pubmed/20009918	A genome-wide association study of carotid atherosclerosis in HIV-infected men.	Carotid atherosclerosis in HIV infection	177 European ancestry individuals	NA	10q23.1	10	81393490	intergenic							rs588517-A	rs588517	0	588517	intergenic_variant	1	0.15	8E-6	5.096910013008056	(internal cIMT)			Illumina [311194]	N	internal carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0005053	GCST000555	Genome-wide genotyping array
2010-01-19	20009918	Shrestha S	2010-01-01	AIDS	www.ncbi.nlm.nih.gov/pubmed/20009918	A genome-wide association study of carotid atherosclerosis in HIV-infected men.	Carotid atherosclerosis in HIV infection	177 European ancestry individuals	NA				RFPL1, THOC5, NF2, AP1B1							rs13053817-A	rs13053817	0	13053817	intron_variant	1	0.18	2E-6	5.698970004336019	(common cIMT)			Illumina [311194]	N	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	GCST000555	Genome-wide genotyping array
2013-08-21	21897333	Irvin MR	2011-12-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/21897333	Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.	Fat distribution (HIV)	192 European ancestry male cases	NA	13q12.3	13	30383551	KATNAL1	LINC00426 - LINC01058	ENSG00000238121	ENSG00000225039		6406	35968	rs7335631-C	rs7335631	0	7335631	regulatory_region_variant	1	0.09	3E-6	5.522878745280337	(multivariate)			Illumina [319818]	N	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	GCST001343	Genome-wide genotyping array
2013-08-21	21897333	Irvin MR	2011-12-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/21897333	Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.	Fat distribution (HIV)	192 European ancestry male cases	NA	1p13.3	1	108875057	AKNAD1, STXBP3, GPSM2, CLCC1	AKNAD1			ENSG00000162641			rs7523050-A	rs7523050	0	7523050	intron_variant	0	0.14	5E-6	5.301029995663981	(multivariate)			Illumina [319818]	N	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	GCST001343	Genome-wide genotyping array
2013-08-21	21897333	Irvin MR	2011-12-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/21897333	Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.	Fat distribution (HIV)	192 European ancestry male cases	NA	22q12.1	22	27020862	MIAT	LINC01422 - RNU6-1066P	ENSG00000223704	ENSG00000200443		52099	15025	rs4417-A	rs4417	0	4417	non_coding_transcript_exon_variant	1	0.12	5E-6	5.301029995663981	(multivariate)			Illumina [319818]	N	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	GCST001343	Genome-wide genotyping array
2013-08-21	21897333	Irvin MR	2011-12-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/21897333	Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.	Fat distribution (HIV)	192 European ancestry male cases	NA	22q13.1	22	37675036	PDXP, LGALS1	RN7SL385P - LGALS1	ENSG00000241333	ENSG00000100097		5297	600	rs4820294-A	rs4820294	0	4820294	TF_binding_site_variant	1	0.35	5E-6	5.301029995663981	(multivariate)			Illumina [319818]	N	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	GCST001343	Genome-wide genotyping array
2013-08-21	21897333	Irvin MR	2011-12-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/21897333	Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.	Fat distribution (HIV)	192 European ancestry male cases	NA	1p13.3	1	108875057	AKNAD1, STXBP3, GPSM2, CLCC1	AKNAD1			ENSG00000162641			rs7523050-A	rs7523050	0	7523050	intron_variant	0	0.14	1E-6	6.0	(univariate, leg)			Illumina [319818]	N	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	GCST001343	Genome-wide genotyping array
2013-08-21	21897333	Irvin MR	2011-12-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/21897333	Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.	Fat distribution (HIV)	192 European ancestry male cases	NA	11q23.3	11	118371280	UBE4A	UBE4A			ENSG00000110344			rs502514-G	rs502514	0	502514	intron_variant	0	0.3	2E-6	5.698970004336019	(univariate, leg)			Illumina [319818]	N	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	GCST001343	Genome-wide genotyping array
2013-08-21	21897333	Irvin MR	2011-12-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/21897333	Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.	Fat distribution (HIV)	192 European ancestry male cases	NA	3q29	3	196460737	RNF168	UBXN7-AS1 - RNF168	ENSG00000225822	ENSG00000163961		28207	8046	rs2342371-G	rs2342371	0	2342371	intergenic_variant	1	0.28	4E-6	5.3979400086720375	(univariate, leg)			Illumina [319818]	N	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	GCST001343	Genome-wide genotyping array
2013-08-21	21897333	Irvin MR	2011-12-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/21897333	Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.	Fat distribution (HIV)	192 European ancestry male cases	NA	1p13.3	1	108875057	AKNAD1, STXBP3, GPSM2, CLCC1	AKNAD1			ENSG00000162641			rs7523050-A	rs7523050	0	7523050	intron_variant	0	0.14	4E-6	5.3979400086720375	(univariate, lower trunk)			Illumina [319818]	N	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	GCST001343	Genome-wide genotyping array
2013-08-21	21897333	Irvin MR	2011-12-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/21897333	Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.	Fat distribution (HIV)	192 European ancestry male cases	NA	1q41	1	220428281	MARK1	NA - PRELID3BP1		ENSG00000226226			39673	rs7512221-G	rs7512221	0	7512221	intergenic_variant	1	0.04	7E-6	5.154901959985743	(univariate, lower trunk)			Illumina [319818]	N	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	GCST001343	Genome-wide genotyping array
2013-08-21	21897333	Irvin MR	2011-12-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/21897333	Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.	Fat distribution (HIV)	192 European ancestry male cases	NA	7p22.3	7	1249003	UNCX	UNCX - NA	ENSG00000164853			11677		rs13241427-C	rs13241427	0	13241427	regulatory_region_variant	1	0.22	4E-7	6.3979400086720375	(univariate, upper trunk)			Illumina [319818]	N	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	GCST001343	Genome-wide genotyping array
2013-08-21	21897333	Irvin MR	2011-12-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/21897333	Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.	Fat distribution (HIV)	192 European ancestry male cases	NA	8q21.3	8	91348168	SLC26A7	SLC26A7			ENSG00000147606			rs921231-G	rs921231	0	921231	intron_variant	0	0.17	2E-6	5.698970004336019	(univariate, upper trunk)			Illumina [319818]	N	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	GCST001343	Genome-wide genotyping array
2013-08-21	21897333	Irvin MR	2011-12-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/21897333	Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.	Fat distribution (HIV)	192 European ancestry male cases	NA	9p22.2	9	18215282	ADAMTSL1	ADAMTSL1			ENSG00000178031			rs1944766-C	rs1944766	0	1944766	intron_variant	0	0.44	3E-6	5.522878745280337	(univariate, upper trunk)			Illumina [319818]	N	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	GCST001343	Genome-wide genotyping array
2013-08-21	21897333	Irvin MR	2011-12-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/21897333	Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.	Fat distribution (HIV)	192 European ancestry male cases	NA	15q26.3	15	98063084	ARRDC4	LINC02251			ENSG00000258483			rs1993976-A	rs1993976	0	1993976	intron_variant	0	0.39	8E-7	6.096910013008056	(univariate, arm)			Illumina [319818]	N	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	GCST001343	Genome-wide genotyping array
2013-08-21	21897333	Irvin MR	2011-12-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/21897333	Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.	Fat distribution (HIV)	192 European ancestry male cases	NA	5q35.3	5	180385668	GFPT2	GFPT2 - RNU6-525P	ENSG00000131459	ENSG00000200555		32332	58841	rs10479469-G	rs10479469	0	10479469	intergenic_variant	1	0.33	2E-6	5.698970004336019	(univariate, arm)			Illumina [319818]	N	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	GCST001343	Genome-wide genotyping array
2013-08-21	21897333	Irvin MR	2011-12-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/21897333	Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.	Fat distribution (HIV)	192 European ancestry male cases	NA	5p15.33	5	437987	AHRR	AHRR, PDCD6-AHRR			ENSG00000063438, ENSG00000288622			rs10078-C	rs10078	0	10078	3_prime_UTR_variant	0	0.23	7E-6	5.154901959985743	(univariate, arm)			Illumina [319818]	N	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	GCST001343	Genome-wide genotyping array
2013-08-21	21897333	Irvin MR	2011-12-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/21897333	Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.	Fat distribution (HIV)	192 European ancestry male cases	NA	8q21.3	8	91406400	SLC26A7	SLC26A7 - NA	ENSG00000147606			8245		rs10504906-A	rs10504906	0	10504906	intergenic_variant	1	0.07	8E-6	5.096910013008056	(univariate, arm)			Illumina [319818]	N	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	GCST001343	Genome-wide genotyping array
2013-08-21	21897333	Irvin MR	2011-12-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/21897333	Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.	Fat distribution (HIV)	192 European ancestry male cases	NA	8q21.3	8	91348168	SLC26A7	SLC26A7			ENSG00000147606			rs921231-G	rs921231	0	921231	intron_variant	0	0.17	1E-6	6.0	(multivariate)			Illumina [319818]	N	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341	GCST001343	Genome-wide genotyping array
2016-04-26	26039976	Wei Z	2015-06-17	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26039976	Genome-Wide Association Studies of HIV-1 Host Control in Ethnically Diverse Chinese Populations.	HIV-1 viral setpoint	326 Han Chinese ancestry cases, 58 Dai Chinese ancestry cases, 40 Jingpo Chinese ancestry cases, 83 Uygur Chinese ancestry cases, 11 Hui Chinese ancestry cases, 20 East Asian cases	NA	6p21.33	6	31352761	HLA-C, HLA-B	LINC02571 - HLA-B	ENSG00000256166	ENSG00000232126		51119	1111	rs2442719-A	rs2442719	0	2442719	intron_variant	1	0.4161	8E-7	6.096910013008056	(Han)	0.3298	unit decrease	Illumina [up to 528294]	N	HIV viral set point measurement	http://www.ebi.ac.uk/efo/EFO_0006319	GCST002976	Genome-wide genotyping array
2016-04-26	26039976	Wei Z	2015-06-17	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26039976	Genome-Wide Association Studies of HIV-1 Host Control in Ethnically Diverse Chinese Populations.	HIV-1 viral setpoint	326 Han Chinese ancestry cases, 58 Dai Chinese ancestry cases, 40 Jingpo Chinese ancestry cases, 83 Uygur Chinese ancestry cases, 11 Hui Chinese ancestry cases, 20 East Asian cases	NA	6p21.32	6	32408571	BTNL2, HLA-DRA	TSBP1-AS1 - HLA-DRA	ENSG00000225914	ENSG00000204287		808	31307	rs3763312-A	rs3763312	0	3763312	intergenic_variant	1	0.15	6E-6	5.221848749616356	(Han)	0.4002	unit decrease	Illumina [up to 528294]	N	HIV viral set point measurement	http://www.ebi.ac.uk/efo/EFO_0006319	GCST002976	Genome-wide genotyping array
2016-04-26	26039976	Wei Z	2015-06-17	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26039976	Genome-Wide Association Studies of HIV-1 Host Control in Ethnically Diverse Chinese Populations.	HIV-1 viral setpoint	326 Han Chinese ancestry cases, 58 Dai Chinese ancestry cases, 40 Jingpo Chinese ancestry cases, 83 Uygur Chinese ancestry cases, 11 Hui Chinese ancestry cases, 20 East Asian cases	NA	6q13	6	73028938	KCNQ5	KCNQ5			ENSG00000185760			rs947612-A	rs947612	0	947612	intron_variant	0	0.2661	2E-6	5.698970004336019	(Han)	0.3459	unit increase	Illumina [up to 528294]	N	HIV viral set point measurement	http://www.ebi.ac.uk/efo/EFO_0006319	GCST002976	Genome-wide genotyping array
2016-04-26	26039976	Wei Z	2015-06-17	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26039976	Genome-Wide Association Studies of HIV-1 Host Control in Ethnically Diverse Chinese Populations.	HIV-1 viral setpoint	326 Han Chinese ancestry cases, 58 Dai Chinese ancestry cases, 40 Jingpo Chinese ancestry cases, 83 Uygur Chinese ancestry cases, 11 Hui Chinese ancestry cases, 20 East Asian cases	NA	6p24.1	6	13267979	PHACTR1	TBC1D7, PHACTR1			ENSG00000145979, ENSG00000112137			rs202072-A	rs202072	0	202072	intron_variant	0	0.4497	4E-6	5.3979400086720375	(Yun)	0.4038	unit decrease	Illumina [up to 528294]	N	HIV viral set point measurement	http://www.ebi.ac.uk/efo/EFO_0006319	GCST002976	Genome-wide genotyping array
2016-04-26	26039976	Wei Z	2015-06-17	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26039976	Genome-Wide Association Studies of HIV-1 Host Control in Ethnically Diverse Chinese Populations.	HIV-1 viral setpoint	326 Han Chinese ancestry cases, 58 Dai Chinese ancestry cases, 40 Jingpo Chinese ancestry cases, 83 Uygur Chinese ancestry cases, 11 Hui Chinese ancestry cases, 20 East Asian cases	NA	10q26.12	10	121042993	BRWD2, LOC100129699	NA - RPL19P16		ENSG00000236762			90097	rs2420903-A	rs2420903	0	2420903	intergenic_variant	1	0.3691	6E-6	5.221848749616356	(Yun)	0.4386	unit decrease	Illumina [up to 528294]	N	HIV viral set point measurement	http://www.ebi.ac.uk/efo/EFO_0006319	GCST002976	Genome-wide genotyping array
2016-04-26	26039976	Wei Z	2015-06-17	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26039976	Genome-Wide Association Studies of HIV-1 Host Control in Ethnically Diverse Chinese Populations.	HIV-1 viral setpoint	326 Han Chinese ancestry cases, 58 Dai Chinese ancestry cases, 40 Jingpo Chinese ancestry cases, 83 Uygur Chinese ancestry cases, 11 Hui Chinese ancestry cases, 20 East Asian cases	NA	5q33.2	5	155057701	KIF4B, SGCD	KIF4B - NA	ENSG00000226650			39560		rs460626-G	rs460626	0	460626	intergenic_variant	1	0.07718	8E-6	5.096910013008056	(Yun)	0.7899	unit increase	Illumina [up to 528294]	N	HIV viral set point measurement	http://www.ebi.ac.uk/efo/EFO_0006319	GCST002976	Genome-wide genotyping array
2016-04-26	26039976	Wei Z	2015-06-17	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26039976	Genome-Wide Association Studies of HIV-1 Host Control in Ethnically Diverse Chinese Populations.	HIV-1 viral setpoint	326 Han Chinese ancestry cases, 58 Dai Chinese ancestry cases, 40 Jingpo Chinese ancestry cases, 83 Uygur Chinese ancestry cases, 11 Hui Chinese ancestry cases, 20 East Asian cases	NA	11q12.3	11	62293877	SCGB1D4, SCGB2A2	SCGB2A2 - SCGB1D4	ENSG00000110484	ENSG00000197745		20717	2404	rs11231017-A	rs11231017	0	11231017	intergenic_variant	1	0.3111	7E-7	6.154901959985743	(Xin)	0.7189	unit decrease	Illumina [up to 528294]	N	HIV viral set point measurement	http://www.ebi.ac.uk/efo/EFO_0006319	GCST002976	Genome-wide genotyping array
2016-04-26	26039976	Wei Z	2015-06-17	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26039976	Genome-Wide Association Studies of HIV-1 Host Control in Ethnically Diverse Chinese Populations.	HIV-1 viral setpoint	326 Han Chinese ancestry cases, 58 Dai Chinese ancestry cases, 40 Jingpo Chinese ancestry cases, 83 Uygur Chinese ancestry cases, 11 Hui Chinese ancestry cases, 20 East Asian cases	NA	3q13.31	3	115559835	ZBTB20	NA - GAP43		ENSG00000172020			63675	rs16823858-A	rs16823858	0	16823858	intron_variant	1	0.06667	8E-7	6.096910013008056	(Xin)	1.294	unit decrease	Illumina [up to 528294]	N	HIV viral set point measurement	http://www.ebi.ac.uk/efo/EFO_0006319	GCST002976	Genome-wide genotyping array
2016-04-26	26039976	Wei Z	2015-06-17	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26039976	Genome-Wide Association Studies of HIV-1 Host Control in Ethnically Diverse Chinese Populations.	HIV-1 viral setpoint	326 Han Chinese ancestry cases, 58 Dai Chinese ancestry cases, 40 Jingpo Chinese ancestry cases, 83 Uygur Chinese ancestry cases, 11 Hui Chinese ancestry cases, 20 East Asian cases	NA	8q24.12	8	119994589	DEPDC6	DEPTOR			ENSG00000155792			rs7836436-G	rs7836436	0	7836436	intron_variant	0	0.05	3E-6	5.522878745280337	(Xin)	1.401	unit decrease	Illumina [up to 528294]	N	HIV viral set point measurement	http://www.ebi.ac.uk/efo/EFO_0006319	GCST002976	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	2p25.1	2	8037334	NR	LINC00299, LINC00298			ENSG00000236790, ENSG00000235665			rs17169-T	rs17169	0	17169	intron_variant	0	NR	1E-7	7.0	(phenotype 1)	2.97	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	3q25.1	3	151465283	NR	IGSF10 - MRPL42P6	ENSG00000152580	ENSG00000242810		4222	10521	rs1491976-G	rs1491976	0	1491976	intergenic_variant	1	NR	5E-6	5.301029995663981	(phenotype 1)	2.3255813	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	21q22.11	21	31133966	NR	TIAM1			ENSG00000156299			rs61550741-G	rs61550741	0	61550741	intron_variant	0	NR	1E-6	6.0	(phenotype 2)	2.27	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	6p22.3	6	24077829	NR	HNRNPA1P58 - NRSN1	ENSG00000219582	ENSG00000152954		75396	48357	rs9358749-T	rs9358749	0	9358749	intergenic_variant	1	NR	5E-6	5.301029995663981	(phenotype 1)	3.27	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	8p22	8	18000788	NR	PCM1			ENSG00000078674			rs34975555-C	rs34975555	0	34975555	intron_variant	0	NR	5E-6	5.301029995663981	(phenotype 3)	2.08	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	6q16.2	6	99541358	NR	TSTD3			ENSG00000279170			rs62432346-A	rs62432346	0	62432346	intron_variant	0	NR	5E-6	5.301029995663981	(phenotype 1)	4.6	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	8q22.1	8	93703063	NR	CIBAR1			ENSG00000188343			rs6471393-A	rs6471393	0	6471393	intron_variant	0	NR	7E-6	5.154901959985743	(phenotype 3)	1.57	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	10q23.33	10	93717593	NR	FRA10AC1 - LGI1	ENSG00000148690	ENSG00000108231		15001	40247	rs59824868-A	rs59824868	0	59824868	intergenic_variant	1	NR	5E-6	5.301029995663981	(phenotype 3)	2.12	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	13q33.2	13	105595684	NR	DAOA-AS1 - NA	ENSG00000232307			90003		rs16966918-A	rs16966918	0	16966918	intergenic_variant	1	NR	5E-6	5.301029995663981	(phenotype 1)	4.01	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	12q24.32	12	126763839	NR	LINC00944			ENSG00000256128			rs12306296-G	rs12306296	0	12306296	intron_variant	0	NR	4E-6	5.3979400086720375	(phenotype 3)	1.67	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	5q31.2	5	138446426	NR	REEP2			ENSG00000132563			rs4835796-G	rs4835796	0	4835796	3_prime_UTR_variant	0	NR	6E-7	6.221848749616356	(phenotype 1)	2.89	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	18p11.22	18	8536118	NR	THEMIS3P - AKR1B1P6	ENSG00000229442	ENSG00000225212		22269	9517	rs9961574-G	rs9961574	0	9961574	intergenic_variant	1	NR	3E-6	5.522878745280337	(phenotype 1)	2.33	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	3p14.3	3	58394738	NR	PXK			ENSG00000168297			rs11714574-T	rs11714574	0	11714574	intron_variant	0	NR	9E-6	5.045757490560675	(phenotype 1)	2.38	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	1p12	1	118513635	NR							rs142039564-C	rs142039564	1	113200876	intergenic_variant	1	NR	6E-6	5.221848749616356	(phenotype 2)	1.79	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	7q36.2	7	153359535	NR	LINC01287			ENSG00000234722			rs4726279-T	rs4726279	0	4726279	intron_variant	0	NR	9E-6	5.045757490560675	(phenotype 1)	2.7	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	3q27.3	3	186495995	NR	LINC02052 - CRYGS	ENSG00000224406	ENSG00000213139		2334	42446	rs11918665-G	rs11918665	0	11918665	regulatory_region_variant	1	NR	9E-6	5.045757490560675	(phenotype 2)	2.7	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	17q25.3	17	77261905	NR	SEPTIN9-DT			ENSG00000263718			rs12953285-C	rs12953285	0	12953285	intron_variant	0	NR	3E-6	5.522878745280337	(phenotype 1)	5.88	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	7q31.33	7	125820594	NR							rs7458938-A	rs7458938	0	7458938	intergenic_variant	1	NR	2E-7	6.698970004336019	(phenotype 2)	1.96	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	8p23.1	8	11472832	NR	FAM167A			ENSG00000154319			rs17742757-C	rs17742757	0	17742757	intron_variant	0	NR	8E-6	5.096910013008056	(phenotype 2)	1.64	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	10p13	10	12707063	NR	CAMK1D			ENSG00000183049			rs45479699-A	rs45479699	0	45479699	intron_variant	0	NR	8E-6	5.096910013008056	(phenotype 2)	5.62	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	11q23.3	11	119032329	NR	SLC37A4 - HYOU1	ENSG00000281500	ENSG00000280682		1423	11859	rs10892324-G	rs10892324	0	10892324	intergenic_variant	1	NR	1E-6	6.0	(phenotype 2)	1.64	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	5q21.3	5	109205522	NR	FER - NA	ENSG00000151422			8681		rs6594357-T	rs6594357	0	6594357	intergenic_variant	1	NR	8E-7	6.096910013008056	(phenotype 2)	3.33	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	14q32.2	14	98991100	NR	RPL3P4 - NA	ENSG00000232573			17799		rs116002988-C	rs116002988	0	116002988	intergenic_variant	1	NR	8E-6	5.096910013008056	(phenotype 2)	2.04	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	2p25.1	2	8037334	NR	LINC00299, LINC00298			ENSG00000236790, ENSG00000235665			rs17169-T	rs17169	0	17169	intron_variant	0	NR	1E-7	7.0	(phenotype 3)	2.97	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	3q25.1	3	151465283	NR	IGSF10 - MRPL42P6	ENSG00000152580	ENSG00000242810		4222	10521	rs1491976-G	rs1491976	0	1491976	intergenic_variant	1	NR	5E-6	5.301029995663981	(phenotype 3)	2.33	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	15q26.2	15	96416625	NR	TUBAP12 - PGAM1P12	ENSG00000259614	ENSG00000250825		27569	24941	rs7174156-A	rs7174156	0	7174156	intergenic_variant	1	NR	7E-6	5.154901959985743	(phenotype 2)	1.6	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	17q25.3	17	79915256	NR	LINC01979			ENSG00000262585			rs1663189-T	rs1663189	0	1663189	non_coding_transcript_exon_variant	0	NR	6E-6	5.221848749616356	(phenotype 2)	1.79	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	3q25.32	3	158893105	NR	GPR79 - IQCJ-SCHIP1	ENSG00000232374	ENSG00000283154		51145	69130	rs13064773-A	rs13064773	0	13064773	intergenic_variant	1	NR	8E-7	6.096910013008056	(phenotype 1)	2.26	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	5q11.2	5	57626258	NR	LINCR-0003 - NA	ENSG00000249436			6442		rs2910490-C	rs2910490	0	2910490	intergenic_variant	1	NR	9E-6	5.045757490560675	(phenotype 3)	1.49	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	6q16.1	6	95928822	NR	NA - KRT18P50		ENSG00000219941			62285	rs608114-A	rs608114	0	608114	intron_variant	1	NR	3E-7	6.522878745280337	(phenotype 1)	4.84	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	8p21.2	8	25687163	NR							rs9314308-C	rs9314308	0	9314308	non_coding_transcript_exon_variant	1	NR	9E-6	5.045757490560675	(phenotype 3)	1.55	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	6q25.2	6	154131402	NR	OPRM1			ENSG00000112038			rs538174-C	rs538174	0	538174	3_prime_UTR_variant	0	NR	5E-6	5.301029995663981	(phenotype 1)	2.44	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	11p15.1	11	17094129	NR	PIK3C2A			ENSG00000011405			rs16933829-C	rs16933829	0	16933829	intron_variant	0	NR	1E-6	6.0	(phenotype 1)	4.7619047	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	11p11.2	11	44263881	NR	ALX4			ENSG00000052850			rs117526668-T	rs117526668	0	117526668	3_prime_UTR_variant	0	NR	9E-6	5.045757490560675	(phenotype 1)	3.19	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	10q26.3	10	131491642	NR							rs12414342-A	rs12414342	0	12414342	intergenic_variant	1	NR	3E-6	5.522878745280337	(phenotype 3)	1.79	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	16p13.12	16	13267554	NR	SHISA9 - NA	ENSG00000237515			27138		rs11649112-A	rs11649112	0	11649112	intron_variant	1	NR	1E-6	6.0	(phenotype 1)	2.49	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	17q24.3	17	71733784	NR							rs74976893-T	rs74976893	0	74976893	intron_variant	1	NR	4E-6	5.3979400086720375	(phenotype 1)	4.18	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	3p22.3	3	36169851	NR	RFC3P1			ENSG00000236158			rs7623430-G	rs7623430	0	7623430	non_coding_transcript_exon_variant	0	NR	7E-6	5.154901959985743	(phenotype 1)	3.03	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	18q21.33	18	62171686	NR	PIGN			ENSG00000197563			rs62096106-G	rs62096106	0	62096106	intron_variant	0	NR	9E-6	5.045757490560675	(phenotype 1)	3.57	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	6q25.1	6	150423701	NR	IYD - NA	ENSG00000009765			17732		rs4869908-G	rs4869908	0	4869908	intergenic_variant	1	NR	8E-6	5.096910013008056	(phenotype 1)	2.5	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	2p21	2	46880193	NR	LINC01119 - MCFD2	ENSG00000239332	ENSG00000180398		21186	21677	rs7560018-A	rs7560018	0	7560018	intergenic_variant	1	NR	6E-6	5.221848749616356	(phenotype 2)	1.71	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	3q24	3	144736294	NR	ESYT3 - NA	ENSG00000158220			6254608		rs1512777-T	rs1512777	0	1512777	intergenic_variant	1	NR	4E-6	5.3979400086720375	(phenotype 2)	1.92	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	16q23.2	16	79580219	NR	NA - MAF		ENSG00000178573			5624	rs30388-T	rs30388	0	30388	regulatory_region_variant	1	NR	1E-6	6.0	(phenotype 1)	2.88	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	7p15.2	7	26954548	NR	SKAP2			ENSG00000005020			rs17436410-G	rs17436410	0	17436410	intron_variant	0	NR	4E-6	5.3979400086720375	(phenotype 2)	2.0	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	1p35.2	1	31862344	NR	SPOCD1 - PTP4A2	ENSG00000134668	ENSG00000184007		46293	44077	rs11803434-G	rs11803434	0	11803434	intron_variant	1	NR	2E-6	5.698970004336019	(phenotype 2)	3.57	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	2p22.1	2	40840846	NR	LINC01794 - NA	ENSG00000233128			73394		rs7576600-G	rs7576600	0	7576600	intergenic_variant	1	NR	3E-7	6.522878745280337	(phenotype 2)	5.26	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	4p16.2	4	5151418	NR	STK32B			ENSG00000152953			rs10516173-T	rs10516173	0	10516173	intron_variant	0	NR	5E-6	5.301029995663981	(phenotype 2)	2.85	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	4q13.1	4	63448265	NR	LARP1BP1 - NA	ENSG00000231442			96793		rs1913633-A	rs1913633	0	1913633	intergenic_variant	1	NR	4E-6	5.3979400086720375	(phenotype 2)	3.84	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-22	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals	NA	12q24.11	12	110270941	NR	IFT81 - ATP2A2	ENSG00000122970	ENSG00000174437		52148	9815	rs73206853-A	rs73206853	0	73206853	intergenic_variant	1	NR	4E-6	5.3979400086720375	(phenotype 2)	1.88	[NR]	Illumina [> 8000000] (imputed)	N	response to efavirenz, virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0006906	GCST002771	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	15q14	15	38932685	NR	LINC02694			ENSG00000175779			rs61501627-C	rs61501627	0	61501627	intron_variant	0	NR	4E-6	5.3979400086720375	(phenotype 2)	4.35	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	3q25.32	3	158893105	NR	GPR79 - IQCJ-SCHIP1	ENSG00000232374	ENSG00000283154		51145	69130	rs13064773-A	rs13064773	0	13064773	intergenic_variant	1	NR	8E-7	6.096910013008056	(phenotype 3)	2.26	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	6p22.3	6	24077829	NR	HNRNPA1P58 - NRSN1	ENSG00000219582	ENSG00000152954		75396	48357	rs9358749-T	rs9358749	0	9358749	intergenic_variant	1	NR	5E-6	5.301029995663981	(phenotype 3)	3.27	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	6q16.1	6	95928822	NR	NA - KRT18P50		ENSG00000219941			62285	rs608114-A	rs608114	0	608114	intron_variant	1	NR	3E-7	6.522878745280337	(phenotype 3)	4.84	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	6q16.2	6	99541358	NR	TSTD3			ENSG00000279170			rs62432346-A	rs62432346	0	62432346	intron_variant	0	NR	5E-6	5.301029995663981	(phenotype 3)	4.6	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	6q25.2	6	154131402	NR	OPRM1			ENSG00000112038			rs538174-C	rs538174	0	538174	3_prime_UTR_variant	0	NR	5E-6	5.301029995663981	(phenotype 3)	2.44	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	11p15.1	11	17094129	NR	PIK3C2A			ENSG00000011405			rs16933829-C	rs16933829	0	16933829	intron_variant	0	NR	1E-6	6.0	(phenotype 3)	4.76	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	11p11.2	11	44263881	NR	ALX4			ENSG00000052850			rs117526668-T	rs117526668	0	117526668	3_prime_UTR_variant	0	NR	9E-6	5.045757490560675	(phenotype 3)	3.19	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	13q33.2	13	105595684	NR	DAOA-AS1 - NA	ENSG00000232307			90003		rs16966918-A	rs16966918	0	16966918	intergenic_variant	1	NR	5E-6	5.301029995663981	(phenotype 3)	4.01	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	16p13.12	16	13267554	NR	SHISA9 - NA	ENSG00000237515			27138		rs11649112-A	rs11649112	0	11649112	intron_variant	1	NR	1E-6	6.0	(phenotype 3)	2.49	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	17q24.3	17	71733784	NR							rs74976893-T	rs74976893	0	74976893	intron_variant	1	NR	4E-6	5.3979400086720375	(phenotype 3)	4.18	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	18p11.22	18	8536118	NR	THEMIS3P - AKR1B1P6	ENSG00000229442	ENSG00000225212		22269	9517	rs9961574-G	rs9961574	0	9961574	intergenic_variant	1	NR	3E-6	5.522878745280337	(phenotype 3)	2.33	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-09-21	25461247	Lehmann DS	2015-02-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/25461247	Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Up 346 European ancestry individuals, Up to 265 Black individuals, Up to 175 Hispanic individuals	NA	18q21.33	18	62171686	NR	PIGN			ENSG00000197563			rs62096106-G	rs62096106	0	62096106	intron_variant	0	NR	9E-6	5.045757490560675	(phenotype 3)	3.57	[NR]	Illumina [> 8000000] (imputed)	N	virologic response measurement, response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006906, http://www.ebi.ac.uk/efo/EFO_0006905	GCST002769	Genome-wide genotyping array
2015-10-24	25884002	Moore CB	2015-01-09	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/25884002	Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.	Total bilirubin levels in HIV-1 infection	2,547 individuals	NA	2q37.1	2	233790144	MROH2A, UGT1A9, HJURP	MROH2A			ENSG00000185038			rs2361502-?	rs2361502	0	2361502	intron_variant	0	0.3076	3E-6	5.522878745280337		0.048421808	[NR] unit increase	Illumina [5954294] (imputed)	N	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	GCST002745	Genome-wide genotyping array
2015-10-24	25884002	Moore CB	2015-01-09	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/25884002	Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.	Total bilirubin levels in HIV-1 infection	2,547 individuals	NA	2q37.1	2	233688675	UGT1A10, UGT1A7, UGT1A8, UGT1A, UGT1A9, UGT1A13P, UGT1	UGT1A8, UGT1A9, UGT1A7, UGT1A10			ENSG00000242366, ENSG00000241119, ENSG00000244122, ENSG00000242515			rs10173355-?	rs10173355	0	10173355	intron_variant	0	0.2675	5E-16	15.301029995663981		0.088006854	[NR] unit increase	Illumina [5954294] (imputed)	N	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	GCST002745	Genome-wide genotyping array
2015-10-24	25884002	Moore CB	2015-01-09	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/25884002	Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.	Total bilirubin levels in HIV-1 infection	2,547 individuals	NA	2q37.1	2	233759924	UGT1A7, UGT1A6, UGT1A4, UGT1A, UGT1A9, UGT1A5, UGT1A3, UGT1A10, UGT1A8, UGT, LOC100286922, UGT1A1	UGT1A7, UGT1A4, UGT1A6, UGT1A3, UGT1A5, UGT1A9, UGT1A10, UGT1A8			ENSG00000244122, ENSG00000244474, ENSG00000167165, ENSG00000288702, ENSG00000288705, ENSG00000241119, ENSG00000242515, ENSG00000242366			rs887829-T	rs887829	0	887829	intron_variant	0	0.3656	7E-31	30.154901959985743		0.11449965	[NR] unit increase	Illumina [5954294] (imputed)	N	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	GCST002745	Genome-wide genotyping array
2015-10-24	25884002	Moore CB	2015-01-09	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/25884002	Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.	Total bilirubin levels in HIV-1 infection	2,547 individuals	NA	2q37.1	2	233600317	UGT1A, UGT1A12P, UGT1A11P	UGT1A12P - UGT1A11P	ENSG00000228949	ENSG00000227846		14026	3236	rs2741012-?	rs2741012	0	2741012	intergenic_variant	1	0.2139	2E-9	8.698970004336019		0.07022795	[NR] unit increase	Illumina [5954294] (imputed)	N	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	GCST002745	Genome-wide genotyping array
2015-10-24	25884002	Moore CB	2015-01-09	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/25884002	Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.	Total bilirubin levels in HIV-1 infection	2,547 individuals	NA	2q37.1	2	233702448	UGT1A7, UGT1A9, UGT1A, UGT1A6, UGT1A8, UGT1A10, UGT1A13P, UGT1, UGT1A5	UGT1A6, UGT1A8, UGT1A10, UGT1A7, UGT1A9			ENSG00000167165, ENSG00000242366, ENSG00000242515, ENSG00000244122, ENSG00000241119			rs17863787-?	rs17863787	0	17863787	intron_variant	0	0.2873	1E-22	22.0		0.1023267	[NR] unit increase	Illumina [5954294] (imputed)	N	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	GCST002745	Genome-wide genotyping array
2015-10-24	25884002	Moore CB	2015-01-09	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/25884002	Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.	Total bilirubin levels in HIV-1 infection	2,547 individuals	NA	2q37.1	2	233716976	UGT1A, UGT1A6, UGT1A5, UGT1A10, UGT1A8, UGT1A7, UGT1A13P, UGT1, UGT1A4, UGT1A9	UGT1A6, UGT1A8, UGT1A5, UGT1A7, UGT1A9, UGT1A10			ENSG00000167165, ENSG00000242366, ENSG00000288705, ENSG00000244122, ENSG00000241119, ENSG00000242515			rs1875263-?	rs1875263	0	1875263	intron_variant	0	0.4337	7E-12	11.154901959985743		0.06651771	[NR] unit increase	Illumina [5954294] (imputed)	N	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	GCST002745	Genome-wide genotyping array
2015-10-24	25884002	Moore CB	2015-01-09	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/25884002	Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.	Total bilirubin levels in HIV-1 infection	2,547 individuals	NA	2q37.1	2	233735091	UGT1A9, UGT1A5, UGT1A4, UGT1A6, UGT1A, UGT1A8, UGT1A10, UGT1A7, UGT1A3, RPL17P11, RPL1, DNAJB3	UGT1A4, UGT1A6, UGT1A10, UGT1A7, UGT1A5, UGT1A8, UGT1A9, UGT1A3			ENSG00000244474, ENSG00000167165, ENSG00000242515, ENSG00000244122, ENSG00000288705, ENSG00000242366, ENSG00000241119, ENSG00000288702			rs4477910-?	rs4477910	0	4477910	intron_variant	0	0.4787	5E-16	15.301029995663981		0.07985459	[NR] unit increase	Illumina [5954294] (imputed)	N	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	GCST002745	Genome-wide genotyping array
2015-10-24	25884002	Moore CB	2015-01-09	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/25884002	Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.	Total bilirubin levels in HIV-1 infection	2,547 individuals	NA	2q37.1	2	233746667	UGT1A10, UGT1A, UGT1A7, UGT1A8, UGT1A4, UGT1A5, UGT1A6, UGT1A3, UGT1A9, DNAJB3, UGT1A2P	UGT1A10, UGT1A3, UGT1A4, UGT1A7, UGT1A9, UGT1A6, UGT1A5, UGT1A8			ENSG00000242515, ENSG00000288702, ENSG00000244474, ENSG00000244122, ENSG00000241119, ENSG00000167165, ENSG00000288705, ENSG00000242366			rs4663969-?	rs4663969	0	4663969	intron_variant	0	0.4651	4E-16	15.397940008672037		0.07697108	[NR] unit increase	Illumina [5954294] (imputed)	N	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	GCST002745	Genome-wide genotyping array
2015-10-24	25884002	Moore CB	2015-01-09	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/25884002	Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.	Total bilirubin levels in HIV-1 infection	2,547 individuals	NA	2q37.1	2	233758936	UGT1A10, UGT1A5, UGT1A7, UGT1A4, UGT1A3, UGT1A8, UGT1A, UGT1A9, UGT1A6, LOC100286922, UGT1A1	UGT1A9, UGT1A6, UGT1A4, UGT1A8, UGT1A10, UGT1A5, UGT1A3, UGT1A7			ENSG00000241119, ENSG00000167165, ENSG00000244474, ENSG00000242366, ENSG00000242515, ENSG00000288705, ENSG00000288702, ENSG00000244122			rs3755319-?	rs3755319	0	3755319	intron_variant	0	0.4532	9E-20	19.045757490560675		0.08879298	[NR] unit decrease	Illumina [5954294] (imputed)	N	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	GCST002745	Genome-wide genotyping array
2015-10-24	25884002	Moore CB	2015-01-09	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/25884002	Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.	Total bilirubin levels in HIV-1 infection	2,547 individuals	NA	2q37.1	2	233764663	UGT1A7, UGT1A, UGT1A9, UGT1A5, UGT1A10, UGT1A3, UGT1A1, UGT1A8, UGT1A6, UGT1A4, LOC100286922, MROH2A	UGT1A7, UGT1A9, UGT1A5, UGT1A1, UGT1A6, UGT1A3, UGT1A4, UGT1A10, UGT1A8			ENSG00000244122, ENSG00000241119, ENSG00000288705, ENSG00000241635, ENSG00000167165, ENSG00000288702, ENSG00000244474, ENSG00000242515, ENSG00000242366			rs4148325-?	rs4148325	0	4148325	intron_variant	0	0.3654	1E-30	30.0	rs4148324, rs3771341	0.113883175	[NR] unit increase	Illumina [5954294] (imputed)	N	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	GCST002745	Genome-wide genotyping array
2015-10-24	25884002	Moore CB	2015-01-09	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/25884002	Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.	Total bilirubin levels in HIV-1 infection	2,547 individuals	NA	2q37.1	2	233765830	UGT1A5, UGT1A6, UGT1A, UGT1A10, UGT1A3, UGT1A7, UGT1A9, UGT1A4, UGT1A1, UGT1A8, LOC100286922, MROH2A	UGT1A4, UGT1A10, UGT1A7, UGT1A5, UGT1A9, UGT1A8, UGT1A6, UGT1A1, UGT1A3			ENSG00000244474, ENSG00000242515, ENSG00000244122, ENSG00000288705, ENSG00000241119, ENSG00000242366, ENSG00000167165, ENSG00000241635, ENSG00000288702			rs929596-?	rs929596	0	929596	intron_variant	0	0.3215	3E-24	23.522878745280337		0.10258645	[NR] unit increase	Illumina [5954294] (imputed)	N	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570	GCST002745	Genome-wide genotyping array
2015-10-24	25884002	Moore CB	2015-01-09	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/25884002	Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.	Neutrophil count in HIV-infection	2,547 individuals	NA	1q23.1	1	159042856	PYHIN1, IFI16, AIM2	IFI16			ENSG00000163565			rs2570916-?	rs2570916	0	2570916	intron_variant	0	0.4191	3E-6	5.522878745280337		0.041722316	[NR] unit decrease	Illumina [5954294] (imputed)	N	neutrophil count	http://www.ebi.ac.uk/efo/EFO_0004833	GCST002743	Genome-wide genotyping array
2015-10-24	25884002	Moore CB	2015-01-09	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/25884002	Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.	Neutrophil count in HIV-infection	2,547 individuals	NA	1q23.2	1	159204893	MPTX, DARC, CADM3	ACKR1, CADM3-AS1			ENSG00000213088, ENSG00000225670			rs2814778-C	rs2814778	0	2814778	5_prime_UTR_variant	0	0.31	3E-17	16.522878745280337		0.11156583	[NR] unit decrease	Illumina [5954294] (imputed)	N	neutrophil count	http://www.ebi.ac.uk/efo/EFO_0004833	GCST002743	Genome-wide genotyping array
2015-10-27	25884002	Moore CB	2015-01-09	Open Forum Infect Dis	www.ncbi.nlm.nih.gov/pubmed/25884002	Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.	HDL Cholesterol in HIV-infection	2,547 individuals	NA	16q13	16	56959412	HERPU, HERPUD1, CETP, CET	HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		14548	2511	rs3764261-?	rs3764261	0	3764261	regulatory_region_variant	1	NR	4E-7	6.3979400086720375		0.03580406	[NR] unit increase	Illumina [5954294] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST002744	Genome-wide genotyping array
2020-01-09	28132517	Xie W	2017-01-28	AIDS Res Hum Retroviruses	www.ncbi.nlm.nih.gov/pubmed/28132517	Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa.	HIV progression (CD4 and viral load)	556 Motswana ancestry cases	NA	1p21.3	1	97802581	NR	DPYD			ENSG00000188641			rs6703307-?	rs6703307	0	6703307	intron_variant	0	NR	2E-6	5.698970004336019				Illumina [NR]	N	viral load, disease progression measurement, CD4-positive T-lymphocyte count, HIV infection	http://www.ebi.ac.uk/efo/EFO_0010125, http://www.ebi.ac.uk/efo/EFO_0008336, http://www.ebi.ac.uk/efo/EFO_0010105, http://www.ebi.ac.uk/efo/EFO_0000764	GCST009417	Genome-wide genotyping array
2020-01-09	28132517	Xie W	2017-01-28	AIDS Res Hum Retroviruses	www.ncbi.nlm.nih.gov/pubmed/28132517	Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa.	HIV progression (CD4 and viral load)	556 Motswana ancestry cases	NA	2p22.2	2	38204468	NR	CYP1B1-AS1			ENSG00000232973			rs7606492-?	rs7606492	0	7606492	intron_variant	0	NR	2E-6	5.698970004336019				Illumina [NR]	N	viral load, disease progression measurement, CD4-positive T-lymphocyte count, HIV infection	http://www.ebi.ac.uk/efo/EFO_0010125, http://www.ebi.ac.uk/efo/EFO_0008336, http://www.ebi.ac.uk/efo/EFO_0010105, http://www.ebi.ac.uk/efo/EFO_0000764	GCST009417	Genome-wide genotyping array
2020-01-09	28132517	Xie W	2017-01-28	AIDS Res Hum Retroviruses	www.ncbi.nlm.nih.gov/pubmed/28132517	Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa.	HIV progression (CD4 and viral load)	556 Motswana ancestry cases	NA	2p22.2	2	38204468	NR	CYP1B1-AS1			ENSG00000232973			rs7606492-?	rs7606492	0	7606492	intron_variant	0	NR	2E-6	5.698970004336019				Illumina [NR]	N	viral load, disease progression measurement, CD4-positive T-lymphocyte count, HIV infection	http://www.ebi.ac.uk/efo/EFO_0010125, http://www.ebi.ac.uk/efo/EFO_0008336, http://www.ebi.ac.uk/efo/EFO_0010105, http://www.ebi.ac.uk/efo/EFO_0000764	GCST009417	Genome-wide genotyping array
2020-01-09	28132517	Xie W	2017-01-28	AIDS Res Hum Retroviruses	www.ncbi.nlm.nih.gov/pubmed/28132517	Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa.	HIV progression (CD4 and viral load)	556 Motswana ancestry cases	NA	6p21.33	6	31085964	HCG22	RNU6-1133P - C6orf15	ENSG00000222895	ENSG00000229432		2855	25259	rs2535307-C	rs2535307	0	2535307	intergenic_variant	1	0.48	4E-7	6.3979400086720375				Illumina [NR]	N	viral load, disease progression measurement, CD4-positive T-lymphocyte count, HIV infection	http://www.ebi.ac.uk/efo/EFO_0010125, http://www.ebi.ac.uk/efo/EFO_0008336, http://www.ebi.ac.uk/efo/EFO_0010105, http://www.ebi.ac.uk/efo/EFO_0000764	GCST009417	Genome-wide genotyping array
2020-01-09	28132517	Xie W	2017-01-28	AIDS Res Hum Retroviruses	www.ncbi.nlm.nih.gov/pubmed/28132517	Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa.	HIV progression (CD4 and viral load)	556 Motswana ancestry cases	NA	12p11.21	12	30506287	NR							rs11050931-?	rs11050931	0	11050931	intergenic_variant	1	NR	7E-7	6.154901959985743				Illumina [NR]	N	viral load, disease progression measurement, CD4-positive T-lymphocyte count, HIV infection	http://www.ebi.ac.uk/efo/EFO_0010125, http://www.ebi.ac.uk/efo/EFO_0008336, http://www.ebi.ac.uk/efo/EFO_0010105, http://www.ebi.ac.uk/efo/EFO_0000764	GCST009417	Genome-wide genotyping array
2020-01-09	28132517	Xie W	2017-01-28	AIDS Res Hum Retroviruses	www.ncbi.nlm.nih.gov/pubmed/28132517	Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa.	HIV progression (CD4 and viral load)	556 Motswana ancestry cases	NA				NR							kgp7815029-?	kgp7815029	0			1	NR	1E-6	6.0				Illumina [NR]	N	viral load, disease progression measurement, CD4-positive T-lymphocyte count, HIV infection	http://www.ebi.ac.uk/efo/EFO_0010125, http://www.ebi.ac.uk/efo/EFO_0008336, http://www.ebi.ac.uk/efo/EFO_0010105, http://www.ebi.ac.uk/efo/EFO_0000764	GCST009417	Genome-wide genotyping array
2020-01-09	28132517	Xie W	2017-01-28	AIDS Res Hum Retroviruses	www.ncbi.nlm.nih.gov/pubmed/28132517	Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa.	HIV progression (CD4 and viral load)	556 Motswana ancestry cases	NA				CCNG1							kgp22385164-G	kgp22385164	0			1	0.08	2E-6	5.698970004336019				Illumina [NR]	N	viral load, disease progression measurement, CD4-positive T-lymphocyte count, HIV infection	http://www.ebi.ac.uk/efo/EFO_0010125, http://www.ebi.ac.uk/efo/EFO_0008336, http://www.ebi.ac.uk/efo/EFO_0010105, http://www.ebi.ac.uk/efo/EFO_0000764	GCST009417	Genome-wide genotyping array
2018-06-26	29784950	Sawai H	2018-05-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29784950	Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.	Hepatocellular carcinoma in hepatitis B infection	473 Japanese ancestry chronic hepatitis and hepatocellular carcinoma cases, 516 Japanese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma	153 Japanese ancestry chronic hepatitis and hepatocellular carcinoma cases, 614 Japanese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma, 94 Chinese ancestry chronic hepatitis and hepatocellular carcinoma cases, 187 Chinese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma, 185 Thai ancestry chronic hepatitis and hepatocellular carcinoma cases, 198 Thai ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma	6p22.1	6	30103160	HLA	TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31			ENSG00000226402, ENSG00000224542, ENSG00000223531, ENSG00000137397, ENSG00000224168, ENSG00000204616, ENSG00000233573, ENSG00000225130			rs1110446-?	rs1110446	0	1110446	3_prime_UTR_variant	0	NR	3E-10	9.522878745280337	(Japanese)	1.93	[1.572.37]	Affymetrix [447830]	N	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	GCST005746	Genome-wide genotyping array
2018-06-26	29784950	Sawai H	2018-05-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29784950	Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.	Hepatocellular carcinoma in hepatitis B infection	473 Japanese ancestry chronic hepatitis and hepatocellular carcinoma cases, 516 Japanese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma	153 Japanese ancestry chronic hepatitis and hepatocellular carcinoma cases, 614 Japanese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma, 94 Chinese ancestry chronic hepatitis and hepatocellular carcinoma cases, 187 Chinese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma, 185 Thai ancestry chronic hepatitis and hepatocellular carcinoma cases, 198 Thai ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma	6p21.32	6	33093093	HLA	HLA-DPA2, HLA-DPA2, HLA-DPA2, HLA-DPA2, HLA-DPA2, HLA-DPA2			ENSG00000223990, ENSG00000223894, ENSG00000235528, ENSG00000236898, ENSG00000231461, ENSG00000227286			rs2295119-?	rs2295119	0	2295119	non_coding_transcript_exon_variant	0	NR	6E-7	6.221848749616356	(Japanese)	1.59	[1.32-1.89]	Affymetrix [447830]	N	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	GCST005746	Genome-wide genotyping array
2018-06-26	29784950	Sawai H	2018-05-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29784950	Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.	Hepatocellular carcinoma in hepatitis B infection	473 Japanese ancestry chronic hepatitis and hepatocellular carcinoma cases, 516 Japanese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma	153 Japanese ancestry chronic hepatitis and hepatocellular carcinoma cases, 614 Japanese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma, 94 Chinese ancestry chronic hepatitis and hepatocellular carcinoma cases, 187 Chinese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma, 185 Thai ancestry chronic hepatitis and hepatocellular carcinoma cases, 198 Thai ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma	6p22.1	6	29971803	HLA	MICD, MICD, MICD, MICD, MICD, MICD, MICD			ENSG00000230745, ENSG00000226713, ENSG00000235600, ENSG00000235380, ENSG00000229390, ENSG00000232345, ENSG00000237395			rs2523961-?	rs2523961	0	2523961	non_coding_transcript_exon_variant	0	NR	6E-11	10.221848749616356		1.91	[1.562.37] Japanese	Affymetrix [447830]	N	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	GCST005746	Genome-wide genotyping array
2018-06-26	29784950	Sawai H	2018-05-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29784950	Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.	Hepatocellular carcinoma in hepatitis B infection	473 Japanese ancestry chronic hepatitis and hepatocellular carcinoma cases, 516 Japanese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma	153 Japanese ancestry chronic hepatitis and hepatocellular carcinoma cases, 614 Japanese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma, 94 Chinese ancestry chronic hepatitis and hepatocellular carcinoma cases, 187 Chinese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma, 185 Thai ancestry chronic hepatitis and hepatocellular carcinoma cases, 198 Thai ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma	6p22.1	6	30103160	HLA	TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31			ENSG00000226402, ENSG00000224542, ENSG00000223531, ENSG00000137397, ENSG00000224168, ENSG00000204616, ENSG00000233573, ENSG00000225130			rs1110446-?	rs1110446	0	1110446	3_prime_UTR_variant	0	NR	9E-13	12.045757490560675		1.93	[1.572.37] Japanese	Affymetrix [447830]	N	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	GCST005746	Genome-wide genotyping array
2018-06-26	29784950	Sawai H	2018-05-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29784950	Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.	Hepatocellular carcinoma in hepatitis B infection	473 Japanese ancestry chronic hepatitis and hepatocellular carcinoma cases, 516 Japanese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma	153 Japanese ancestry chronic hepatitis and hepatocellular carcinoma cases, 614 Japanese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma, 94 Chinese ancestry chronic hepatitis and hepatocellular carcinoma cases, 187 Chinese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma, 185 Thai ancestry chronic hepatitis and hepatocellular carcinoma cases, 198 Thai ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma	6p22.1	6	30233096	HLA	TRIM26 - HCG17	ENSG00000137313	ENSG00000241701		19669	943	rs3094137-?	rs3094137	0	3094137	intergenic_variant	1	NR	4E-7	6.3979400086720375	(Japanese)	1.76	[1.412.19]	Affymetrix [447830]	N	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	GCST005746	Genome-wide genotyping array
2018-06-26	29784950	Sawai H	2018-05-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29784950	Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.	Hepatocellular carcinoma in hepatitis B infection	473 Japanese ancestry chronic hepatitis and hepatocellular carcinoma cases, 516 Japanese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma	153 Japanese ancestry chronic hepatitis and hepatocellular carcinoma cases, 614 Japanese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma, 94 Chinese ancestry chronic hepatitis and hepatocellular carcinoma cases, 187 Chinese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma, 185 Thai ancestry chronic hepatitis and hepatocellular carcinoma cases, 198 Thai ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma	6p21.32	6	33093093	HLA	HLA-DPA2, HLA-DPA2, HLA-DPA2, HLA-DPA2, HLA-DPA2, HLA-DPA2			ENSG00000223990, ENSG00000223894, ENSG00000235528, ENSG00000236898, ENSG00000231461, ENSG00000227286			rs2295119-?	rs2295119	0	2295119	non_coding_transcript_exon_variant	0	NR	5E-7	6.301029995663981		1.5873016	[1.32-1.89] Japanese	Affymetrix [447830]	N	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	GCST005746	Genome-wide genotyping array
2018-06-26	29784950	Sawai H	2018-05-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29784950	Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.	Hepatocellular carcinoma in hepatitis B infection	473 Japanese ancestry chronic hepatitis and hepatocellular carcinoma cases, 516 Japanese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma	153 Japanese ancestry chronic hepatitis and hepatocellular carcinoma cases, 614 Japanese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma, 94 Chinese ancestry chronic hepatitis and hepatocellular carcinoma cases, 187 Chinese ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma, 185 Thai ancestry chronic hepatitis and hepatocellular carcinoma cases, 198 Thai ancestry asymptomatic carriers or chronic hepatitis cases without hepatocellular carcinoma	6p22.1	6	29971803	HLA	MICD, MICD, MICD, MICD, MICD, MICD, MICD			ENSG00000230745, ENSG00000226713, ENSG00000235600, ENSG00000235380, ENSG00000229390, ENSG00000232345, ENSG00000237395			rs2523961-?	rs2523961	0	2523961	non_coding_transcript_exon_variant	0	NR	6E-10	9.221848749616356	(Japanese)	1.91	[1.56-2.37]	Affymetrix [447830]	N	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182	GCST005746	Genome-wide genotyping array
2021-07-28	33095540	Sherman BT	2020-10-20	AIDS	www.ncbi.nlm.nih.gov/pubmed/33095540	Genome-wide association study of high-sensitivity C-reactive protein, D-dimer and Interleukin-6 levels in multi-ethnic HIV+ cohorts.	D-dimer levels in HIV infection	4,675 European ancestry individuals, 1,732 African ancestry individuals, 645 Admixed American individuals	NA	1p21.3	1	94586920	F3	F3 - SLC44A3-AS1	ENSG00000117525	ENSG00000224081		45161	26894	rs2022309-T	rs2022309	0	2022309	intron_variant	1	0.233	2E-13	12.698970004336019		0.092	[0.067-0.117] unit increase	Affymetrix [up to 12642786] (imputed)	N	D dimer measurement	http://www.ebi.ac.uk/efo/EFO_0004507	GCST012139	Genome-wide genotyping array
2021-07-28	33095540	Sherman BT	2020-10-20	AIDS	www.ncbi.nlm.nih.gov/pubmed/33095540	Genome-wide association study of high-sensitivity C-reactive protein, D-dimer and Interleukin-6 levels in multi-ethnic HIV+ cohorts.	D-dimer levels in HIV infection	4,675 European ancestry individuals, 1,732 African ancestry individuals, 645 Admixed American individuals	NA	1q24.2	1	169549811	F5	F5			ENSG00000198734			rs6025-T	rs6025	0	6025	missense_variant	0	0.018	4E-11	10.397940008672037		0.257	[0.18-0.33] unit increase	Affymetrix [up to 12642786] (imputed)	N	D dimer measurement	http://www.ebi.ac.uk/efo/EFO_0004507	GCST012139	Genome-wide genotyping array
2021-07-28	33095540	Sherman BT	2020-10-20	AIDS	www.ncbi.nlm.nih.gov/pubmed/33095540	Genome-wide association study of high-sensitivity C-reactive protein, D-dimer and Interleukin-6 levels in multi-ethnic HIV+ cohorts.	D-dimer levels in HIV infection	4,675 European ancestry individuals, 1,732 African ancestry individuals, 645 Admixed American individuals	NA	4q31.3	4	154567669	FGB	FGB			ENSG00000171564			rs6056-T	rs6056	0	6056	synonymous_variant	0	0.163	6E-9	8.221848749616356		0.082	[0.055-0.109] unit decrease	Affymetrix [up to 12642786] (imputed)	N	D dimer measurement	http://www.ebi.ac.uk/efo/EFO_0004507	GCST012139	Genome-wide genotyping array
2021-07-28	33095540	Sherman BT	2020-10-20	AIDS	www.ncbi.nlm.nih.gov/pubmed/33095540	Genome-wide association study of high-sensitivity C-reactive protein, D-dimer and Interleukin-6 levels in multi-ethnic HIV+ cohorts.	D-dimer levels in HIV infection	4,675 European ancestry individuals, 1,732 African ancestry individuals, 645 Admixed American individuals	NA	9q21.13	9	76542076	GCNT1	GCNT1			ENSG00000187210			rs4745559-C	rs4745559	0	4745559	intron_variant	0	0.146	2E-8	7.698970004336019		0.085	[0.055-0.115] unit increase	Affymetrix [up to 12642786] (imputed)	N	D dimer measurement	http://www.ebi.ac.uk/efo/EFO_0004507	GCST012139	Genome-wide genotyping array
2021-07-28	33095540	Sherman BT	2020-10-20	AIDS	www.ncbi.nlm.nih.gov/pubmed/33095540	Genome-wide association study of high-sensitivity C-reactive protein, D-dimer and Interleukin-6 levels in multi-ethnic HIV+ cohorts.	D-dimer levels in HIV infection	4,675 European ancestry individuals, 1,732 African ancestry individuals, 645 Admixed American individuals	NA	19q13.2	19	38369818	CATSPERG	CATSPERG			ENSG00000099338			rs78474816-T	rs78474816	0	78474816	intron_variant	0	NR	4E-12	11.397940008672037	(AA)	1.379	[0.99-1.77] unit increase	Affymetrix [up to 12642786] (imputed)	N	D dimer measurement	http://www.ebi.ac.uk/efo/EFO_0004507	GCST012139	Genome-wide genotyping array
2021-07-28	33095540	Sherman BT	2020-10-20	AIDS	www.ncbi.nlm.nih.gov/pubmed/33095540	Genome-wide association study of high-sensitivity C-reactive protein, D-dimer and Interleukin-6 levels in multi-ethnic HIV+ cohorts.	Interleukin-6 levels in HIV infection	4,675 European ancestry individuals, 1,732 African ancestry individuals, 645 Admixed American individuals	NA	1q21.3	1	154422736	IL6R	IL6R			ENSG00000160712			rs4133213-A	rs4133213	0	4133213	intron_variant	0	0.394	6E-17	16.221848749616356		0.0997	[0.076-0.123] unit increase	Affymetrix [up to 12642786] (imputed)	N	interleukin-6 measurement	http://www.ebi.ac.uk/efo/EFO_0004810	GCST012138	Genome-wide genotyping array
2021-07-28	33095540	Sherman BT	2020-10-20	AIDS	www.ncbi.nlm.nih.gov/pubmed/33095540	Genome-wide association study of high-sensitivity C-reactive protein, D-dimer and Interleukin-6 levels in multi-ethnic HIV+ cohorts.	Interleukin-6 levels in HIV infection	4,675 European ancestry individuals, 1,732 African ancestry individuals, 645 Admixed American individuals	NA	1q32.3	1	213643390	RPS6KC1, PROX1-AS1							rs76497186-C	rs76497186	0	76497186	intergenic_variant	1	NR	1E-8	8.0	(AA)	0.823	[0.54-1.11] unit increase	Affymetrix [up to 12642786] (imputed)	N	interleukin-6 measurement	http://www.ebi.ac.uk/efo/EFO_0004810	GCST012138	Genome-wide genotyping array
2021-07-28	33095540	Sherman BT	2020-10-20	AIDS	www.ncbi.nlm.nih.gov/pubmed/33095540	Genome-wide association study of high-sensitivity C-reactive protein, D-dimer and Interleukin-6 levels in multi-ethnic HIV+ cohorts.	Interleukin-6 levels in HIV infection	4,675 European ancestry individuals, 1,732 African ancestry individuals, 645 Admixed American individuals	NA	8q24.3	8	140416041	TRAPPC9	TRAPPC9			ENSG00000167632			rs28368302-A	rs28368302	0	28368302	intron_variant	0	NR	3E-8	7.522878745280337	(Hispanic/Latino)	0.2322	[0.15-0.31] unit decrease	Affymetrix [up to 12642786] (imputed)	N	interleukin-6 measurement	http://www.ebi.ac.uk/efo/EFO_0004810	GCST012138	Genome-wide genotyping array
2021-07-28	33095540	Sherman BT	2020-10-20	AIDS	www.ncbi.nlm.nih.gov/pubmed/33095540	Genome-wide association study of high-sensitivity C-reactive protein, D-dimer and Interleukin-6 levels in multi-ethnic HIV+ cohorts.	High-sensitivity C-reactive protein levels in HIV infection	4,675 European ancestry individuals, 1,732 African ancestry individuals, 645 Admixed American individuals	NA	1q23.2	1	159707864	CRP	CRPP1 - CRP	ENSG00000223603	ENSG00000132693		2257	4425	rs6667499-A	rs6667499	0	6667499	intergenic_variant	1	0.044	2E-25	24.69897000433602		0.569	[0.46-0.68] unit increase	Affymetrix [up to 12642786] (imputed)	N	C-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	GCST012140	Genome-wide genotyping array
2021-07-28	33095540	Sherman BT	2020-10-20	AIDS	www.ncbi.nlm.nih.gov/pubmed/33095540	Genome-wide association study of high-sensitivity C-reactive protein, D-dimer and Interleukin-6 levels in multi-ethnic HIV+ cohorts.	High-sensitivity C-reactive protein levels in HIV infection	4,675 European ancestry individuals, 1,732 African ancestry individuals, 645 Admixed American individuals	NA	1q23.2	1	159709026	CRP	CRPP1 - CRP	ENSG00000223603	ENSG00000132693		3419	3263	rs2794520-T	rs2794520	0	2794520	intergenic_variant	1	0.309	5E-24	23.30102999566398		0.224	[0.18-0.27] unit decrease	Affymetrix [up to 12642786] (imputed)	N	C-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	GCST012140	Genome-wide genotyping array
2021-07-28	33095540	Sherman BT	2020-10-20	AIDS	www.ncbi.nlm.nih.gov/pubmed/33095540	Genome-wide association study of high-sensitivity C-reactive protein, D-dimer and Interleukin-6 levels in multi-ethnic HIV+ cohorts.	High-sensitivity C-reactive protein levels in HIV infection	4,675 European ancestry individuals, 1,732 African ancestry individuals, 645 Admixed American individuals	NA	12q24.31	12	120986603	HNF1A	HNF1A			ENSG00000135100			rs2393776-G	rs2393776	0	2393776	intron_variant	0	0.386	1E-9	9.0		0.129	[0.088-0.17] unit decrease	Affymetrix [up to 12642786] (imputed)	N	C-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	GCST012140	Genome-wide genotyping array
2021-07-28	33095540	Sherman BT	2020-10-20	AIDS	www.ncbi.nlm.nih.gov/pubmed/33095540	Genome-wide association study of high-sensitivity C-reactive protein, D-dimer and Interleukin-6 levels in multi-ethnic HIV+ cohorts.	High-sensitivity C-reactive protein levels in HIV infection	4,675 European ancestry individuals, 1,732 African ancestry individuals, 645 Admixed American individuals	NA	19q13.32	19	44908684	APOE	APOE			ENSG00000130203			rs429358-C	rs429358	0	429358	missense_variant	0	0.154	2E-22	21.69897000433602		0.282	[0.23-0.34] unit decrease	Affymetrix [up to 12642786] (imputed)	N	C-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458	GCST012140	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	3q13.33	3	120165816	GPR156	GPR156			ENSG00000175697			rs1488763-?	rs1488763	0	1488763	3_prime_UTR_variant	0		9E-6	5.045757490560675	(EA)	0.116307475	[0.065-0.168] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				KCTD8							chr4:44447144-?	chr4:44447144	0			1		3E-6	5.522878745280337	(EA,female)	13.816662	[8.1-19.53] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	6q12	6	67042277	SLC25A51P1, LOC102723883							rs11968427-?	rs11968427	0	11968427	intergenic_variant	1		5E-7	6.301029995663981	(EA)	0.40592232	[0.25-0.56] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				ARL4A, ETV1							chr7:13826915-?	chr7:13826915	0			1		9E-6	5.045757490560675	(EA,female)	0.6648619	[0.38-0.95] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	8q13.2	8	67628737	CPA6	CPA6			ENSG00000165078			rs10092095-?	rs10092095	0	10092095	intron_variant	0		5E-7	6.301029995663981	(EA)	0.12409528	[0.076-0.172] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				CYP2C8, ACSM6							chr10:96896696-?	chr10:96896696	0			1		8E-6	5.096910013008056	(EA,female)	0.69200706	[0.39-0.99] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LINC01163, MGMT							chr10:130225540-?	chr10:130225540	0			1		3E-6	5.522878745280337	(EA,female)	0.35835782	[0.21-0.51] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				AGBL1, LINC00052							chr15:87704194-?	chr15:87704194	0			1		3E-6	5.522878745280337	(EA,female)	0.9848946	[0.58-1.39] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				PKD1L3							chr16:71985222-?	chr16:71985222	0			1		9E-6	5.045757490560675	(EA,female)	0.47122017	[0.27-0.68] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				PIEZO1							chr16:88832113-?	chr16:88832113	0			1		2E-6	5.698970004336019	(EA,female)	0.37436786	[0.22-0.53] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				CCL11, CCL8							chr17:32634098-?	chr17:32634098	0			1		9E-6	5.045757490560675	(EA,female)	0.54967254	[0.31-0.79] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				SLC39A11							chr17:70859391-?	chr17:70859391	0			1		1E-5	5.0	(EA,female)	1.0491092	[0.59-1.51] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	19q13.32	19	44910319	APOE	APOE - APOC1	ENSG00000130203	ENSG00000130208		926	3928	rs75627662-?	rs75627662	0	75627662	non_coding_transcript_exon_variant	1		1E-6	6.0	(EA)	0.14800182	[0.088-0.208] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	1p31.3	1	62583880	DOCK7	DOCK7			ENSG00000116641			rs11207995-?	rs11207995	0	11207995	intron_variant	0		2E-6	5.698970004336019	(African American)	0.11571218	[0.068-0.163] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	2q37.2	2	234948470	LINC01173, SH3BP4	NA - SH3BP4		ENSG00000130147			3547	rs2042831-?	rs2042831	0	2042831	intergenic_variant	1		2E-7	6.698970004336019	(African American)	0.24173836	[0.15-0.33] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LINC02006							chr3:153438198-?	chr3:153438198	0			1		7E-6	5.154901959985743	(African American,female)	0.32297426	[0.18-0.46] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				NLGN1, NAALADL2							chr3:174378851-?	chr3:174378851	0			1		3E-6	5.522878745280337	(African American,female)	0.47345334	[0.28-0.67] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	3q25.2	3	154564071	GPR149, MME	NA - SYPL1P1		ENSG00000243154			87585	rs10513462-?	rs10513462	0	10513462	intergenic_variant	1		7E-6	5.154901959985743	(African American)	0.1202219	[0.068-0.172] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	4q28.1	4	125211924	ANKRD50, FAT4							rs4130333-?	rs4130333	0	4130333	intergenic_variant	1		5E-6	5.301029995663981	(African American)	0.16636615	[0.095-0.238] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	6q12	6	67042277	SLC25A51P1, LOC102723883							rs11968427-?	rs11968427	0	11968427	intergenic_variant	1		5E-7	6.301029995663981	(African American)	0.40592232	[0.25-0.56] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	7p21.1	7	17880630	SNX13	SNX13			ENSG00000071189			rs17138358-?	rs17138358	0	17138358	3_prime_UTR_variant	0		3E-6	5.522878745280337	(African American)	0.11083479	[0.064-0.158] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	8p21.3	8	19973410	LPL, SLC18A1	LPL - RPL30P9	ENSG00000175445	ENSG00000242709		6151	139933	rs10096633-?	rs10096633	0	10096633	intergenic_variant	1		2E-8	7.698970004336019	(African American)	0.13571067	[0.088-0.183] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	8q13.2	8	67628737	CPA6	CPA6			ENSG00000165078			rs10092095-?	rs10092095	0	10092095	intron_variant	0		5E-7	6.301029995663981	(African American)	0.12409528	[0.076-0.172] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	11q23.3	11	116791691	APOA5	APOA5			ENSG00000110243			rs3135506-?	rs3135506	0	3135506	missense_variant	0		2E-9	8.698970004336019	(African American)	0.29291716	[0.2-0.39] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	15q21.3	15	58431476	LIPC	LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs1800588-?	rs1800588	0	1800588	intron_variant	0		3E-6	5.522878745280337	(African American)	0.11128225	[0.065-0.158] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	16p12.1	16	28290166	XPO6, SBK1	SBK1			ENSG00000188322			rs9939450-?	rs9939450	0	9939450	intron_variant	0		6E-7	6.221848749616356	(African American)	0.1207661	[0.073-0.168] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	18q23	18	76499110	C18orf65, LINC00908	ZNF516-DT - LINC00683	ENSG00000275763	ENSG00000266256		1022	29542	rs12456640-?	rs12456640	0	12456640	intergenic_variant	1		3E-6	5.522878745280337	(African American)	0.1329451	[0.077-0.189] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				RESP18, DNPEP							chr2:220233328-?	chr2:220233328	0			1		8E-6	5.096910013008056	(EA,female)	0.34230778	[0.19-0.49] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				BPESC1, PISRT1							chr3:138894951-?	chr3:138894951	0			1		6E-7	6.221848749616356	(EA,female)	0.39750805	[0.24-0.55] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LINC00887, CPN2							chr3:194033312-?	chr3:194033312	0			1		4E-6	5.3979400086720375	(EA,female)	0.8038189	[0.47-1.14] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	4q28.1	4	125211924	ANKRD50, FAT4							rs4130333-?	rs4130333	0	4130333	intergenic_variant	1		5E-6	5.301029995663981	(EA)	0.16636615	[0.095-0.238] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				FAT1, LINC02374							chr4:187969016-?	chr4:187969016	0			1		8E-6	5.096910013008056	(EA,female)	0.37183353	[0.21-0.53] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	8p21.3	8	20079176	LPL, SLC18A1	NA - RPL30P9		ENSG00000242709			34167	rs28597716-?	rs28597716	0	28597716	non_coding_transcript_exon_variant	1		2E-6	5.698970004336019	(EA)	0.14377508	[0.085-0.203] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				COL13A1							chr10:71613604-?	chr10:71613604	0			1		2E-6	5.698970004336019	(EA,female)	0.717494	[0.43-1.01] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	8q24.13	8	125473095	TRIB1, LINC00861	TRIB1 - NA	ENSG00000173334			34692		rs2980860-?	rs2980860	0	2980860	intron_variant	1		6E-12	11.221848749616356	(EA)	0.16575564	[0.12-0.21] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	11q23.3	11	116778201	ZPR1	ZPR1			ENSG00000109917			rs964184-?	rs964184	0	964184	3_prime_UTR_variant	0		7E-15	14.154901959985743	(EA)	0.26723298	[0.2-0.33] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	16p12.1	16	28290166	XPO6, SBK1	SBK1			ENSG00000188322			rs9939450-?	rs9939450	0	9939450	intron_variant	0		6E-7	6.221848749616356	(EA)	0.1207661	[0.073-0.168] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	18q23	18	76499110	C18orf65, LINC00908	ZNF516-DT - LINC00683	ENSG00000275763	ENSG00000266256		1022	29542	rs12456640-?	rs12456640	0	12456640	intergenic_variant	1		3E-6	5.522878745280337	(EA)	0.1329451	[0.077-0.189] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				RNF24, SMOX							chr20:4087727-?	chr20:4087727	0			1		9E-6	5.045757490560675	(EA,female)	0.35697752	[0.2-0.51] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				MIR646HG							chr20:58828664-?	chr20:58828664	0			1		5E-6	5.301029995663981	(EA,female)	0.9272821	[0.54-1.32] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				BSDC1							chr1:32842319-?	chr1:32842319	0			1		9E-6	5.045757490560675	(African American,female)	1.512662	[0.85-2.18] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				DOCK10, NYAP2							chr2:226183918-?	chr2:226183918	0			1		7E-7	6.154901959985743	(African American,female)	0.3059475	[0.19-0.43] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				TM4SF20, MIR5703							chr2:228289059-?	chr2:228289059	0			1		5E-7	6.301029995663981	(African American,female)	0.22941005	[0.14-0.32] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				ULK4							chr3:41477354-?	chr3:41477354	0			1		2E-6	5.698970004336019	(African American,female)	0.21390031	[0.13-0.3] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	3q13.33	3	120165816	GPR156	GPR156			ENSG00000175697			rs1488763-?	rs1488763	0	1488763	3_prime_UTR_variant	0		9E-6	5.045757490560675	(African American)	0.116307475	[0.065-0.168] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				SORCS2, AFAP1-AS1							chr4:7745968-?	chr4:7745968	0			1		8E-7	6.096910013008056	(African American,female)	0.30026034	[0.18-0.42] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				RBM47							chr4:40435838-?	chr4:40435838	0			1		1E-6	6.0	(African American,female)	0.31785893	[0.19-0.45] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				CLGN							chr4:141314370-?	chr4:141314370	0			1		4E-6	5.3979400086720375	(African American,female)	0.5013034	[0.29-0.71] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				TMEM244, L3MBTL3							chr6:130334409-?	chr6:130334409	0			1		2E-6	5.698970004336019	(African American,female)	0.2423917	[0.14-0.34] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				PRKN							chr6:161973869-?	chr6:161973869	0			1		5E-6	5.301029995663981	(African American,female)	0.61362064	[0.35-0.88] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	7q21.11	7	82589141	CACNA2D1, PCLO	NA - MTHFD2P5		ENSG00000213530			707	rs10486973-?	rs10486973	0	10486973	intergenic_variant	1		4E-6	5.3979400086720375	(EA)	0.1312855	[0.076-0.187] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	8q24.22	8	130638567	ASAP1, ADCY8							rs6986527-?	rs6986527	0	6986527	intron_variant	1		8E-6	5.096910013008056	(EA)	0.11216259	[0.063-0.161] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	11q24.3	11	129448080	BARX2	BARX2			ENSG00000043039			rs10894038-?	rs10894038	0	10894038	intron_variant	0		5E-6	5.301029995663981	(EA)	0.13294812	[0.076-0.19] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	12q21.31	12	83113490	TMTC2	TMTC2			ENSG00000179104			rs7302697-?	rs7302697	0	7302697	intron_variant	0		2E-6	5.698970004336019	(EA)	0.12253226	[0.072-0.173] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	15q21.3	15	58381852	AQP9, LIPC	ALDH1A2			ENSG00000128918			rs62001736-?	rs62001736	0	62001736	intron_variant	0		6E-6	5.221848749616356	(EA)	0.12384403	[0.07-0.177] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	15q25.1	15	80885396	CEMIP	CEMIP			ENSG00000103888			rs4778864-?	rs4778864	0	4778864	intron_variant	0		8E-6	5.096910013008056	(EA)	0.15895666	[0.089-0.229] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	16q13	16	56953457	HERPUD1, CETP	HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		8593	8466	rs56156922-?	rs56156922	0	56156922	intergenic_variant	1		3E-19	18.522878745280337	(EA)	0.23222724	[0.18-0.28] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	17q21.32	17	49012936	IGF2BP1	IGF2BP1			ENSG00000159217			rs6504592-?	rs6504592	0	6504592	splice_region_variant	0		6E-6	5.221848749616356	(EA)	0.24448209	[0.14-0.35] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	19q13.2	19	40996617	CYP2B6	CYP2B6			ENSG00000197408			rs8101756-?	rs8101756	0	8101756	intron_variant	0		3E-6	5.522878745280337	(EA)	0.1292686	[0.075-0.184] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	20q13.11	20	43391040	PTPRT, SRSF6	NA - RNU6-743P		ENSG00000201021			14433	rs6103272-?	rs6103272	0	6103272	intergenic_variant	1		8E-6	5.096910013008056	(EA)	0.11249223	[0.063-0.162] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	1q42.11	1	224351238	NVL, CNIH4	NVL - CNIH4	ENSG00000143748	ENSG00000143771		21049	5620	rs11579964-?	rs11579964	0	11579964	intergenic_variant	1		8E-6	5.096910013008056	(African American)	0.262103	[0.15-0.38] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	1q44	1	245104608	EFCAB2	EFCAB2			ENSG00000203666			rs10927395-?	rs10927395	0	10927395	intron_variant	0		5E-6	5.301029995663981	(African American)	0.14135718	[0.081-0.202] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	2p12	2	79262797	REG3A, LOC101927987	CTNNA2			ENSG00000066032			rs17705745-?	rs17705745	0	17705745	intron_variant	0		5E-6	5.301029995663981	(African American)	0.1226016	[0.07-0.175] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	4q34.3	4	178187327	LINC01689, LINC01684	RNU1-45P - NA	ENSG00000253000			70466		rs1563700-?	rs1563700	0	1563700	intergenic_variant	1		8E-6	5.096910013008056	(African American)	0.1396587	[0.079-0.201] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	5p14.3	5	18421401	LINC01689, LINC01684							rs1918340-?	rs1918340	0	1918340	intergenic_variant	1		1E-6	6.0	(African American)	0.60006607	[0.36-0.84] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	5p14.2	5	24482366	C5orf17, CDH10	Metazoa_SRP - CDH10	ENSG00000277055	ENSG00000040731		32751	4734	rs1428365-?	rs1428365	0	1428365	intergenic_variant	1		4E-6	5.3979400086720375	(African American)	0.16326945	[0.094-0.232] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	6p21.1	6	42560164	TRERF1, UBR2	NA - UBR2		ENSG00000024048			3865	rs9394908-?	rs9394908	0	9394908	intergenic_variant	1		9E-7	6.045757490560675	(African American)	0.118978254	[0.072-0.166] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	6p21.1	6	42675358	UBR2	UBR2			ENSG00000024048			rs6905989-?	rs6905989	0	6905989	intron_variant	0		2E-6	5.698970004336019	(African American)	0.1262191	[0.074-0.179] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	7p13	7	43636921	STK17A, COA1	STK17A, COA1			ENSG00000164543, ENSG00000106603			rs17439848-?	rs17439848	0	17439848	intron_variant	0		5E-6	5.301029995663981	(African American)	0.28576183	[0.16-0.41] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	8q13.2	8	68703882	C8orf34	C8orf34			ENSG00000165084			rs12543018-?	rs12543018	0	12543018	intron_variant	0		7E-6	5.154901959985743	(African American)	0.11472299	[0.065-0.165] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	8q24.21	8	129686186	CCDC26, GSDMC	CCDC26 - MTRF1LP2	ENSG00000229140	ENSG00000224110		2416	42558	rs11785932-?	rs11785932	0	11785932	non_coding_transcript_exon_variant	1		6E-6	5.221848749616356	(African American)	0.1731235	[0.098-0.248] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	8q24.23	8	138669240	COL22A1	COL22A1			ENSG00000169436			rs4909828-?	rs4909828	0	4909828	intron_variant	0		4E-6	5.3979400086720375	(African American)	0.11563852	[0.067-0.164] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	9p22.2	9	18027288	SH3GL2, ADAMTSL1	ADAMTSL1			ENSG00000178031			rs7033195-?	rs7033195	0	7033195	intron_variant	0		1E-7	7.0	(African American)	0.13148236	[0.083-0.18] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	10q26.3	10	129758408	MGMT	MGMT			ENSG00000170430			rs7075748-?	rs7075748	0	7075748	intron_variant	0		4E-6	5.3979400086720375	(African American)	0.12672214	[0.073-0.18] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	12p12.3	12	17199356	SKP1P2, LINC02378	RPL7P40 - NA	ENSG00000242991			76896		rs9788058-?	rs9788058	0	9788058	intergenic_variant	1		8E-6	5.096910013008056	(African American)	0.11375368	[0.064-0.164] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	12q13.12	12	49030833	KMT2D	KMT2D			ENSG00000167548			rs11614738-?	rs11614738	0	11614738	intron_variant	0		9E-6	5.045757490560675	(African American)	0.2097678	[0.12-0.3] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	12q15	12	68488260	LINC02384, RAP1B	LINC02384 - RPSAP12	ENSG00000251301	ENSG00000240087		36597	64735	rs7311899-?	rs7311899	0	7311899	intergenic_variant	1		1E-5	5.0	(African American)	0.10948604	[0.061-0.158] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	14q22.3	14	57182836	OTX2-AS1, EXOC5	OTX2-AS1 - EXOC5	ENSG00000248550	ENSG00000070367		30659	17671	rs11848373-?	rs11848373	0	11848373	regulatory_region_variant	1		6E-6	5.221848749616356	(African American)	0.116439104	[0.066-0.167] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	16q13	16	56957451	HERPUD1, CETP	HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		12587	4472	rs183130-?	rs183130	0	183130	intergenic_variant	1		3E-17	16.522878745280337	(African American)	0.23224984	[0.18-0.29] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	16q21	16	58663987	CNOT1, SLC38A7	CNOT1 - SLC38A7	ENSG00000125107	ENSG00000103042		34102	1122	rs6499965-?	rs6499965	0	6499965	intergenic_variant	1		5E-6	5.301029995663981	(African American)	0.14091316	[0.08-0.201] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	19q13.32	19	44908822	APOE	APOE			ENSG00000130203			rs7412-?	rs7412	0	7412	missense_variant	0		3E-6	5.522878745280337	(African American)	0.18373023	[0.11-0.26] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	20q13.2	20	54227811	PFDN4, DOK5	PFDN4			ENSG00000101132			rs12625916-?	rs12625916	0	12625916	intron_variant	0		7E-6	5.154901959985743	(African American)	0.29461488	[0.17-0.42] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	21q21.2	21	24409334	LINC01689, LINC01684	LINC01684			ENSG00000237484			rs2829047-?	rs2829047	0	2829047	intron_variant	0		1E-6	6.0	(African American)	0.118722744	[0.071-0.166] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				ACOT7							chr1:6399288-?	chr1:6399288	0			1		2E-6	5.698970004336019	(EA, female)	0.541375	[0.32-0.76] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				ERRFI1, LINC01714							chr1:8149779-?	chr1:8149779	0			1		6E-6	5.221848749616356	(EA, female)	0.83748174	[0.48-1.19] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				PRDM2, KAZN							chr1:14193271-?	chr1:14193271	0			1		1E-5	5.0	(EA, female)	1.529811	[0.86-2.2] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				STON1-GTF2A1L, FSHR							chr2:49137717-?	chr2:49137717	0			1		8E-6	5.096910013008056	(EA, female)	0.3937552	[0.22-0.56] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				ITPR1							chr3:4659146-?	chr3:4659146	0			1		6E-6	5.221848749616356	(EA, female)	0.36077836	[0.21-0.51] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				PPARG							chr3:12418612-?	chr3:12418612	0			1		1E-5	5.0	(EA, female)	0.35727122	[0.2-0.51] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				MIR1324, FRG2EP							chr3:75682284-?	chr3:75682284	0			1		8E-6	5.096910013008056	(EA, female)	0.334243	[0.19-0.48] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LOC102546299, LINC01947							chr5:165258171-?	chr5:165258171	0			1		3E-6	5.522878745280337	(EA, female)	1.980944	[1.17-2.8] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				INTS4P2, LOC441242							chr7:65130415-?	chr7:65130415	0			1		7E-6	5.154901959985743	(EA, female)	1.2170002	[0.69-1.74] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				EN2							chr7:155256864-?	chr7:155256864	0			1		5E-6	5.301029995663981	(EA, female)	1.4439292	[0.84-2.05] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LOC101927815, CSMD1							chr8:2734438-?	chr8:2734438	0			1		5E-6	5.301029995663981	(EA, female)	0.4497377	[0.26-0.64] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				TMEM261, PTPRD							chr9:8029850-?	chr9:8029850	0			1		8E-6	5.096910013008056	(EA, female)	0.35703498	[0.2-0.51] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				PRKG1							chr10:53418788-?	chr10:53418788	0			1		2E-7	6.698970004336019	(EA, female)	1.6922591	[1.06-2.32] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				SSPN, ITPR2							chr12:26470169-?	chr12:26470169	0			1		6E-6	5.221848749616356	(EA, female)	0.38279083	[0.22-0.55] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				RBM19, LINC02459							chr12:114544267-?	chr12:114544267	0			1		2E-6	5.698970004336019	(EA, female)	0.6775889	[0.41-0.95] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LINC02332							chr14:23026298-?	chr14:23026298	0			1		8E-6	5.096910013008056	(EA, female)	0.39180258	[0.22-0.56] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LINC02315							chr14:41589165-?	chr14:41589165	0			1		4E-6	5.3979400086720375	(EA, female)	1.0680484	[0.62-1.51] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				ADORA2B							chr17:15870401-?	chr17:15870401	0			1		3E-6	5.522878745280337	(EA, female)	0.35422176	[0.21-0.5] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				CELF4							chr18:34858361-?	chr18:34858361	0			1		1E-5	5.0	(EA, female)	0.44917578	[0.25-0.65] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				KLK7							chr19:51483620-?	chr19:51483620	0			1		5E-6	5.301029995663981	(EA, female)	1.2753114	[0.74-1.81] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				KIF16B							chr20:16504137-?	chr20:16504137	0			1		4E-6	5.3979400086720375	(EA, female)	0.34301767	[0.2-0.49] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				MAB21L3, ATP1A1							chr1:116901670-?	chr1:116901670	0			1		6E-6	5.221848749616356	(African American, female)	0.39314917	[0.22-0.56] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				QPCT, CDC42EP3							chr2:37704862-?	chr2:37704862	0			1		3E-6	5.522878745280337	(African American, female)	0.2686339	[0.16-0.38] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				TNS1							chr2:218717053-?	chr2:218717053	0			1		8E-6	5.096910013008056	(African American, female)	0.20613058	[0.12-0.3] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				CNTN4							chr3:2613232-?	chr3:2613232	0			1		8E-6	5.096910013008056	(African American, female)	0.5668162	[0.32-0.81] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				ROBO1							chr3:79055838-?	chr3:79055838	0			1		9E-6	5.045757490560675	(African American, female)	0.45205173	[0.25-0.65] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LINC02010, ZIC4							chr3:146713227-?	chr3:146713227	0			1		8E-6	5.096910013008056	(African American, female)	0.5181701	[0.29-0.74] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LINCR-0002, FGF12							chr3:191349175-?	chr3:191349175	0			1		6E-7	6.221848749616356	(African American, female)	1.5991595	[0.97-2.22] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LCORL, SLIT2							chr4:18526264-?	chr4:18526264	0			1		5E-6	5.301029995663981	(African American, female)	0.2921781	[0.17-0.42] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LOC101929353							chr4:101118666-?	chr4:101118666	0			1		4E-6	5.3979400086720375	(African American, female)	0.62955874	[0.36-0.89] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				SSBP2, ATG10							chr5:81056737-?	chr5:81056737	0			1		5E-6	5.301029995663981	(African American, female)	0.316641	[0.18-0.45] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				MAN2A1							chr5:109024918-?	chr5:109024918	0			1		2E-6	5.698970004336019	(African American, female)	1.4887193	[0.88-2.09] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				GMDS							chr6:2151372-?	chr6:2151372	0			1		7E-6	5.154901959985743	(African American, female)	2.5255146	[1.43-3.62] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LRFN2							chr6:40436322-?	chr6:40436322	0			1		3E-6	5.522878745280337	(African American, female)	0.49119818	[0.29-0.7] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LOC101928516							chr6:75123102-?	chr6:75123102	0			1		4E-6	5.3979400086720375	(African American, female)	0.23713244	[0.14-0.34] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				HTR1B, MEI4							chr6:78202032-?	chr6:78202032	0			1		2E-6	5.698970004336019	(African American, female)	0.43643513	[0.26-0.62] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				RPS6KA2							chr6:167151365-?	chr6:167151365	0			1		9E-6	5.045757490560675	(African American, female)	0.22890568	[0.13-0.33] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				MSR1, FGF20							chr8:16075400-?	chr8:16075400	0			1		1E-6	6.0	(African American, female)	0.84057987	[0.5-1.18] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				PSD3							chr8:18535336-?	chr8:18535336	0			1		4E-6	5.3979400086720375	(African American, female)	0.37587717	[0.22-0.54] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				SNX31							chr8:101586676-?	chr8:101586676	0			1		9E-6	5.045757490560675	(African American, female)	0.3419386	[0.19-0.49] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				RXRA							chr9:137305778-?	chr9:137305778	0			1		5E-6	5.301029995663981	(African American, female)	0.49382532	[0.28-0.7] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LOC105376351, PFKP							chr10:2966644-?	chr10:2966644	0			1		3E-6	5.522878745280337	(African American, female)	0.2171892	[0.13-0.31] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				CNTN5							chr11:99950785-?	chr11:99950785	0			1		2E-6	5.698970004336019	(African American, female)	0.34013155	[0.2-0.48] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LOC100507377, ATXN7L3B							chr12:74875129-?	chr12:74875129	0			1		4E-6	5.3979400086720375	(African American, female)	0.5055653	[0.29-0.72] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				GLT1D1							chr12:129457162-?	chr12:129457162	0			1		1E-5	5.0	(African American, female)	0.50204605	[0.28-0.72] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				MTUS2							chr13:29705959-?	chr13:29705959	0			1		3E-6	5.522878745280337	(African American, female)	0.2415375	[0.14-0.34] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				RBFOX1							chr16:7523475-?	chr16:7523475	0			1		8E-7	6.096910013008056	(African American, female)	0.22334339	[0.14-0.31] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LINC01425, LINC01687							chr21:23293475-?	chr21:23293475	0			1		4E-6	5.3979400086720375	(African American, female)	0.49697617	[0.29-0.71] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				APP, CYYR1-AS1							chr21:27699110-?	chr21:27699110	0			1		8E-6	5.096910013008056	(African American, female)	0.6045548	[0.34-0.87] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	6q22.33	6	127225882	RSPO3, RNF146	RSPO3 - RNF146	ENSG00000146374	ENSG00000118518		26401	40844	rs7759507-?	rs7759507	0	7759507	intergenic_variant	1		6E-6	5.221848749616356	(EA)	0.16121642	[0.091-0.231] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	9q33.1	9	118129492	TLR4, BRINP1	TPT1P9 - NA	ENSG00000234782			46110		rs1115375-?	rs1115375	0	1115375	intergenic_variant	1		5E-6	5.301029995663981	(EA)	0.15491548	[0.088-0.222] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	10q21.1	10	52110815	PRKG1	PRKG1			ENSG00000185532			rs3862583-?	rs3862583	0	3862583	intron_variant	0		6E-6	5.221848749616356	(EA)	0.22263066	[0.13-0.32] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	14q32.31	14	102694864	RCOR1	RCOR1			ENSG00000089902			rs8014003-?	rs8014003	0	8014003	intron_variant	0		9E-6	5.045757490560675	(EA)	0.31549707	[0.18-0.45] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	16p12.2	16	22719662	LOC653786, HS3ST2	NA - HS3ST2		ENSG00000122254			94500	rs12920706-?	rs12920706	0	12920706	intergenic_variant	1		9E-6	5.045757490560675	(EA)	0.119369194	[0.067-0.172] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	19p13.2	19	10415333	CDC37, PDE4A	CDC37			ENSG00000105401			rs6511698-?	rs6511698	0	6511698	intron_variant	0		9E-6	5.045757490560675	(EA)	0.114695325	[0.064-0.165] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	19q13.32	19	44908822	APOE	APOE			ENSG00000130203			rs7412-?	rs7412	0	7412	missense_variant	0		9E-20	19.045757490560675	(EA)	0.45077777	[0.35-0.55] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	1p31.1	1	79057950	ADGRL4, LINC01781	ADGRL4			ENSG00000162618			rs4650387-?	rs4650387	0	4650387	intron_variant	0		4E-6	5.3979400086720375	(African American)	0.151292	[0.087-0.216] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	1p13.3	1	109274968	CELSR2	CELSR2			ENSG00000143126			rs12740374-?	rs12740374	0	12740374	3_prime_UTR_variant	0		1E-7	7.0	(African American)	0.15287153	[0.097-0.209] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	1q42.12	1	225410973	LBR	LBR			ENSG00000143815			rs6660819-?	rs6660819	0	6660819	intron_variant	0		2E-6	5.698970004336019	(African American)	0.29744157	[0.17-0.42] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	2p24.1	2	21002613	APOB	APOB			ENSG00000084674			rs1801702-?	rs1801702	0	1801702	missense_variant	0		5E-7	6.301029995663981	(African American)	0.20006934	[0.12-0.28] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	2p24.1	2	21158305	TDRD15, LINC01822	TDRD15 - NA	ENSG00000218819			13937		rs12997242-?	rs12997242	0	12997242	intergenic_variant	1		3E-6	5.522878745280337	(African American)	0.14060627	[0.082-0.199] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	5q33.1	5	151068815	TNIP1	TNIP1			ENSG00000145901			rs1862364-?	rs1862364	0	1862364	intron_variant	0		7E-6	5.154901959985743	(African American)	0.15747027	[0.089-0.226] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	6p21.1	6	45737342	RUNX2, CLIC5	RUNX2 - NA	ENSG00000124813			72993		rs10948250-?	rs10948250	0	10948250	intergenic_variant	1		5E-6	5.301029995663981	(African American)	0.11508503	[0.066-0.164] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	6q22.33	6	127225882	RSPO3, RNF146	RSPO3 - RNF146	ENSG00000146374	ENSG00000118518		26401	40844	rs7759507-?	rs7759507	0	7759507	intergenic_variant	1		6E-6	5.221848749616356	(African American)	0.16121642	[0.091-0.231] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	8p23.1	8	9330085	LOC157273	RNU6-1151P - RNU6-526P	ENSG00000284864	ENSG00000201815		42507	41005	rs7004769-?	rs7004769	0	7004769	intron_variant	1		6E-6	5.221848749616356	(African American)	0.13150437	[0.075-0.188] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	9q33.1	9	118129492	TLR4, BRINP1	TPT1P9 - NA	ENSG00000234782			46110		rs1115375-?	rs1115375	0	1115375	intergenic_variant	1		5E-6	5.301029995663981	(African American)	0.15491548	[0.088-0.222] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	10q21.1	10	52110815	PRKG1	PRKG1			ENSG00000185532			rs3862583-?	rs3862583	0	3862583	intron_variant	0		6E-6	5.221848749616356	(African American)	0.22263066	[0.13-0.32] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	14q32.31	14	102694864	RCOR1	RCOR1			ENSG00000089902			rs8014003-?	rs8014003	0	8014003	intron_variant	0		9E-6	5.045757490560675	(African American)	0.31549707	[0.18-0.45] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	16p12.2	16	22719662	LOC653786, HS3ST2	NA - HS3ST2		ENSG00000122254			94500	rs12920706-?	rs12920706	0	12920706	intergenic_variant	1		9E-6	5.045757490560675	(African American)	0.119369194	[0.067-0.172] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	16q22.2	16	72015313	DHODH	DHODH			ENSG00000102967			rs7184117-?	rs7184117	0	7184117	intron_variant	0		6E-6	5.221848749616356	(African American)	0.12157466	[0.069-0.174] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	19p13.2	19	10415333	CDC37, PDE4A	CDC37			ENSG00000105401			rs6511698-?	rs6511698	0	6511698	intron_variant	0		9E-6	5.045757490560675	(African American)	0.114695325	[0.064-0.165] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	19p13.2	19	11079088	SMARCA4, LDLR	SMARCA4			ENSG00000127616			rs73015011-?	rs73015011	0	73015011	missense_variant	0		2E-7	6.698970004336019	(African American)	0.16858114	[0.11-0.23] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	19q13.32	19	44908822	APOE	APOE			ENSG00000130203			rs7412-?	rs7412	0	7412	missense_variant	0		4E-42	41.39794000867204	(African American)	0.5423542	[0.47-0.62] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LINC01346, LINC01777							chr1:4408320-?	chr1:4408320	0			1		8E-6	5.096910013008056	(EA, female)	0.6388005	[0.36-0.91] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LINC00693							chr3:28645126-?	chr3:28645126	0			1		5E-6	5.301029995663981	(African American, female)	0.61024463	[0.35-0.87] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				ZNF717, ROBO2							chr3:76533109-?	chr3:76533109	0			1		1E-5	5.0	(African American, female)	0.19939284	[0.11-0.29] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				ATP8A1							chr4:42554984-?	chr4:42554984	0			1		1E-5	5.0	(African American, female)	0.27031332	[0.15-0.39] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				EPHA5-AS1, MIR1269A							chr4:66578699-?	chr4:66578699	0			1		8E-6	5.096910013008056	(African American, female)	0.45261192	[0.26-0.65] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				NDST4, MIR1973							chr4:117035893-?	chr4:117035893	0			1		6E-7	6.221848749616356	(African American, female)	0.45966834	[0.28-0.64] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				SORBS2							chr4:186523749-?	chr4:186523749	0			1		5E-6	5.301029995663981	(African American, female)	0.45268822	[0.26-0.65] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				ADCY2							chr5:7491239-?	chr5:7491239	0			1		3E-6	5.522878745280337	(African American, female)	0.26850262	[0.16-0.38] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LINC01554							chr5:95194445-?	chr5:95194445	0			1		9E-6	5.045757490560675	(African American, female)	0.41493776	[0.23-0.6] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				ARHGAP26							chr5:142468009-?	chr5:142468009	0			1		7E-6	5.154901959985743	(African American, female)	0.59713584	[0.34-0.86] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				EYS							chr6:65244865-?	chr6:65244865	0			1		6E-6	5.221848749616356	(African American, female)	0.44232446	[0.25-0.63] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				TNRC18							chr7:5356270-?	chr7:5356270	0			1		3E-7	6.522878745280337	(African American, female)	0.9114656	[0.56-1.26] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				FABP12							chr8:82440311-?	chr8:82440311	0			1		3E-6	5.522878745280337	(African American, female)	0.4259458	[0.25-0.6] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				TMEM250, LHX3							chr9:139049385-?	chr9:139049385	0			1		2E-6	5.698970004336019	(African American, female)	0.22133984	[0.13-0.31] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LOC100506082, OR52B4							chr11:4264563-?	chr11:4264563	0			1		8E-6	5.096910013008056	(African American, female)	0.3284507	[0.18-0.47] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				CWC15							chr11:94700612-?	chr11:94700612	0			1		1E-6	6.0	(African American, female)	0.38382387	[0.23-0.54] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LINC00423, KL							chr13:33559127-?	chr13:33559127	0			1		7E-7	6.154901959985743	(African American, female)	0.46760252	[0.28-0.65] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				FARP1							chr13:98984155-?	chr13:98984155	0			1		8E-6	5.096910013008056	(African American, female)	0.4859951	[0.27-0.7] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				C15orf59-AS1, TBC1D21							chr15:74127131-?	chr15:74127131	0			1		1E-7	7.0	(African American, female)	0.39744818	[0.25-0.54] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				NPIPB4							chr16:21845724-?	chr16:21845724	0			1		9E-6	5.045757490560675	(African American, female)	1.6845852	[0.94-2.43] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				RBFOX3							chr17:77239458-?	chr17:77239458	0			1		4E-6	5.3979400086720375	(African American, female)	0.66454226	[0.38-0.94] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				KIF16B							chr20:16263600-?	chr20:16263600	0			1		2E-6	5.698970004336019	(African American, female)	0.22633435	[0.13-0.32] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	1p31.3	1	68260207	WLS, RPE65	RPS7P4 - COX6B1P7	ENSG00000229133	ENSG00000225242		17152	22181	rs17130635-?	rs17130635	0	17130635	regulatory_region_variant	1		6E-6	5.221848749616356	(EA)	0.18786351	[0.11-0.27] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	2q24.3	2	167779405	XIRP2, LOC105616981	CTAGE14P - B3GALT1-AS1	ENSG00000214211	ENSG00000235335		63340	35352	rs10497329-?	rs10497329	0	10497329	intergenic_variant	1		3E-6	5.522878745280337	(EA)	0.2644751	[0.15-0.38] unit decrease	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	3p26.1	3	7122536	GRM7	GRM7			ENSG00000196277			rs9872427-?	rs9872427	0	9872427	intron_variant	0		4E-6	5.3979400086720375	(EA)	0.14203545	[0.082-0.202] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	HDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	5q23.1	5	119329463	TNFAIP8	TNFAIP8			ENSG00000145779			rs4392658-?	rs4392658	0	4392658	intron_variant	0		1E-5	5.0	(EA)	0.20990263	[0.12-0.3] unit increase	Illumina [13620258] (imputed)	N	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612	GCST011743	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				GREB1							chr2:11720299-?	chr2:11720299	0			1		9E-6	5.045757490560675	(EA, female)	0.64601326	[0.37-0.93] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				CTNNA2, LINC01815							chr2:80957886-?	chr2:80957886	0			1		8E-6	5.096910013008056	(EA, female)	0.36067423	[0.21-0.52] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				ARGFX							chr3:121286179-?	chr3:121286179	0			1		9E-6	5.045757490560675	(EA, female)	0.45528618	[0.26-0.65] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LINC02267, STPG2-AS1							chr4:97820409-?	chr4:97820409	0			1		2E-6	5.698970004336019	(EA, female)	0.93625736	[0.56-1.32] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				ATG10							chr5:81415573-?	chr5:81415573	0			1		9E-6	5.045757490560675	(EA, female)	0.42471778	[0.24-0.61] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LINC01845, LINC01847							chr5:159004759-?	chr5:159004759	0			1		3E-6	5.522878745280337	(EA, female)	0.7818339	[0.46-1.11] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LINC00972, GRM3							chr7:85166637-?	chr7:85166637	0			1		8E-6	5.096910013008056	(EA, female)	0.6432131	[0.37-0.92] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LHFPL3							chr7:104112838-?	chr7:104112838	0			1		7E-6	5.154901959985743	(EA, female)	0.9546817	[0.54-1.36] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				DLC1							chr8:12981008-?	chr8:12981008	0			1		3E-6	5.522878745280337	(EA, female)	0.41167036	[0.24-0.58] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				MRPL15, SOX17							chr8:55266580-?	chr8:55266580	0			1		7E-6	5.154901959985743	(EA, female)	2.2397923	[1.28-3.2] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LOC105369423, RAB38							chr11:87599916-?	chr11:87599916	0			1		4E-6	5.3979400086720375	(EA, female)	0.455416	[0.27-0.65] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				PKNOX2							chr11:125101432-?	chr11:125101432	0			1		9E-6	5.045757490560675	(EA, female)	1.1660321	[0.66-1.67] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				TMEM132B, LINC00939							chr12:126203333-?	chr12:126203333	0			1		4E-6	5.3979400086720375	(EA, female)	0.5744462	[0.34-0.81] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LOC283665, AQP9							chr15:58392940-?	chr15:58392940	0			1		4E-7	6.3979400086720375	(EA, female)	0.4258377	[0.26-0.59] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				ANKRD24							chr19:4225748-?	chr19:4225748	0			1		2E-6	5.698970004336019	(EA, female)	0.4658622	[0.28-0.65] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LOC284379, DPRX							chr19:54117338-?	chr19:54117338	0			1		4E-6	5.3979400086720375	(EA, female)	0.47891095	[0.28-0.68] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				SYNDIG1, CST7							chr20:24898485-?	chr20:24898485	0			1		5E-7	6.301029995663981	(EA, female)	0.41596153	[0.26-0.57] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				HUNK							chr21:33333549-?	chr21:33333549	0			1		1E-5	5.0	(EA, female)	1.7888114	[1.01-2.57] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				TIPRL, SFT2D2							chr1:168178297-?	chr1:168178297	0			1		8E-6	5.096910013008056	(African American, female)	0.2746507	[0.15-0.39] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				SHCBP1L, LAMC1							chr1:182965654-?	chr1:182965654	0			1		4E-6	5.3979400086720375	(African American, female)	1.2519463	[0.72-1.78] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				ESRRG, GPATCH2							chr1:217353640-?	chr1:217353640	0			1		4E-6	5.3979400086720375	(African American, female)	0.3244241	[0.19-0.46] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				NCKAP5							chr2:134093889-?	chr2:134093889	0			1		4E-6	5.3979400086720375	(African American, female)	0.6381066	[0.37-0.91] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				TEX41, PABPC1P2							chr2:145860335-?	chr2:145860335	0			1		3E-7	6.522878745280337	(African American, female)	0.29129198	[0.18-0.4] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LOC101927960, MAP2							chr2:209878650-?	chr2:209878650	0			1		1E-5	5.0	(African American, female)	0.1992595	[0.11-0.29] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				DOCK10, NYAP2							chr2:226003093-?	chr2:226003093	0			1		4E-6	5.3979400086720375	(African American, female)	1.3713361	[0.8-1.95] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LOC389602, LOC285889							chr7:155945756-?	chr7:155945756	0			1		6E-6	5.221848749616356	(African American,female)	0.4890557	[0.28-0.7] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				PTPRD							chr9:8438993-?	chr9:8438993	0			1		6E-6	5.221848749616356	(African American,female)	1.0806648	[0.62-1.55] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				CCDC171, C9orf92							chr9:16105056-?	chr9:16105056	0			1		4E-6	5.3979400086720375	(African American,female)	0.4420056	[0.26-0.63] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				PLPPR1							chr9:103972264-?	chr9:103972264	0			1		6E-6	5.221848749616356	(African American,female)	0.4377953	[0.25-0.63] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				DEC1, LOC101928775							chr9:118347899-?	chr9:118347899	0			1		5E-7	6.301029995663981	(African American,female)	0.26438257	[0.16-0.37] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				TLR4, BRINP1							chr9:120888077-?	chr9:120888077	0			1		4E-6	5.3979400086720375	(African American,female)	0.21090114	[0.12-0.3] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				CFAP77							chr9:135367661-?	chr9:135367661	0			1		2E-6	5.698970004336019	(African American,female)	0.29443336	[0.17-0.42] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				CAMK1D							chr10:12577901-?	chr10:12577901	0			1		7E-6	5.154901959985743	(African American,female)	0.21410231	[0.12-0.31] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				FAM13C							chr10:61113993-?	chr10:61113993	0			1		5E-6	5.301029995663981	(African American,female)	0.2117634	[0.12-0.3] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				NELL1							chr11:20841394-?	chr11:20841394	0			1		9E-6	5.045757490560675	(African American,female)	0.19714083	[0.11-0.28] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				LINC02098, ETS1							chr11:128260138-?	chr11:128260138	0			1		7E-6	5.154901959985743	(African American,female)	0.37198475	[0.21-0.53] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				TSPAN11, DDX11-AS1							chr12:31157515-?	chr12:31157515	0			1		2E-6	5.698970004336019	(African American,female)	0.33520645	[0.2-0.47] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				PIWIL1							chr12:130839645-?	chr12:130839645	0			1		7E-7	6.154901959985743	(African American,female)	0.22847618	[0.14-0.32] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				SLC24A4							chr14:92934509-?	chr14:92934509	0			1		9E-6	5.045757490560675	(African American,female)	0.22815454	[0.13-0.33] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				PAPOLA							chr14:96973712-?	chr14:96973712	0			1		6E-6	5.221848749616356	(African American,female)	0.21230687	[0.12-0.3] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				C14orf177, BCL11B							chr14:99605517-?	chr14:99605517	0			1		7E-6	5.154901959985743	(African American,female)	0.60679746	[0.34-0.87] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				MIR4313, UBE2Q2							chr15:76056561-?	chr15:76056561	0			1		1E-6	6.0	(African American,female)	0.21762848	[0.13-0.31] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				MTHFSD							chr16:86562874-?	chr16:86562874	0			1		7E-6	5.154901959985743	(African American,female)	0.6753842	[0.38-0.97] unit increase	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				CCR7, SMARCE1							chr17:38775805-?	chr17:38775805	0			1		4E-6	5.3979400086720375	(African American,female)	0.21101123	[0.12-0.3] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	Triglyceride levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA				EMID1							chr22:29627944-?	chr22:29627944	0			1		6E-6	5.221848749616356	(African American,female)	0.46523005	[0.26-0.67] unit decrease	Illumina [13620258] (imputed)	N	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530	GCST011742	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	1p31.1	1	79057950	ADGRL4, LINC01781	ADGRL4			ENSG00000162618			rs4650387-?	rs4650387	0	4650387	intron_variant	0		4E-6	5.3979400086720375	(EA)	0.151292	[0.087-0.216] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	1p13.3	1	109274968	CELSR2	CELSR2			ENSG00000143126			rs12740374-?	rs12740374	0	12740374	3_prime_UTR_variant	0		1E-6	6.0	(EA)	0.14413212	[0.086-0.202] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	1q42.12	1	225410973	LBR	LBR			ENSG00000143815			rs6660819-?	rs6660819	0	6660819	intron_variant	0		2E-6	5.698970004336019	(EA)	0.29744157	[0.17-0.42] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	5q33.1	5	151068815	TNIP1	TNIP1			ENSG00000145901			rs1862364-?	rs1862364	0	1862364	intron_variant	0		7E-6	5.154901959985743	(EA)	0.15747027	[0.089-0.226] unit decrease	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2021-05-27	33109212	Chang H	2020-10-28	BMC Med	www.ncbi.nlm.nih.gov/pubmed/33109212	Genetic architecture of cardiometabolic risks in people living with HIV.	LDL cholesterol levels in HIV infection	3,095 European ancestry individuals, 3,189 African American individuals	NA	6p21.1	6	45737342	RUNX2, CLIC5	RUNX2 - NA	ENSG00000124813			72993		rs10948250-?	rs10948250	0	10948250	intergenic_variant	1		5E-6	5.301029995663981	(EA)	0.11508503	[0.066-0.164] unit increase	Illumina [13620258] (imputed)	N	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611	GCST011741	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	20q13.13	20	48624820	NR	PREX1			ENSG00000124126			rs2664570-?	rs2664570	0	2664570	3_prime_UTR_variant	0		9E-6	5.045757490560675	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	3p25.1	3	14815331	NR	FGD5			ENSG00000154783			rs731580-?	rs731580	0	731580	intron_variant	0		2E-6	5.698970004336019	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	6q14.2	6	84030677	NR	LINC02857 - MRAP2	ENSG00000230852	ENSG00000135324		4577	3095	rs2480181-?	rs2480181	0	2480181	intergenic_variant	1		5E-6	5.301029995663981	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12q22	12	93020495	NR	LINC02413 - Y_RNA	ENSG00000257345	ENSG00000199357		675	1111	rs11106805-?	rs11106805	0	11106805	intron_variant	1		7E-6	5.154901959985743	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5q14.3	5	88598828	NR	LINC00461			ENSG00000245526			rs2112424-?	rs2112424	0	2112424	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5q14.3	5	88618709	NR	LINC00461			ENSG00000245526			rs324898-?	rs324898	0	324898	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5q14.3	5	88565282	NR	LINC00461			ENSG00000245526			rs324884-?	rs324884	0	324884	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5q14.3	5	88583650	NR	LINC00461			ENSG00000245526			rs2438466-?	rs2438466	0	2438466	intron_variant	0		4E-6	5.3979400086720375	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	20q13.13	20	48614297	NR	NA - PREX1		ENSG00000124126			9955	rs73135714-?	rs73135714	0	73135714	intergenic_variant	1		6E-6	5.221848749616356	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12q12	12	45143962	NR	RNA5SP361 - PLEKHA8P1	ENSG00000199556	ENSG00000134297		26074	29102	rs12230258-?	rs12230258	0	12230258	intergenic_variant	1		9E-6	5.045757490560675	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	3q13.32	3	119132020	NR	IGSF11			ENSG00000144847			rs141827060-?	rs141827060	0	141827060	intron_variant	0		1E-6	6.0	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	3q13.32	3	119125638	NR	IGSF11			ENSG00000144847			rs11926663-?	rs11926663	0	11926663	intron_variant	0		1E-6	6.0	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	3q13.32	3	119121264	NR	IGSF11			ENSG00000144847			rs11914494-?	rs11914494	0	11914494	intron_variant	0		1E-6	6.0	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56505171	NR	OR5M7P - OR5M6P	ENSG00000254490	ENSG00000254603		3900	7064	rs652106-?	rs652106	0	652106	intergenic_variant	1		6E-6	5.221848749616356	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56505351	NR	OR5M7P - OR5M6P	ENSG00000254490	ENSG00000254603		4080	6884	rs610410-?	rs610410	0	610410	intergenic_variant	1		6E-6	5.221848749616356	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA				NR							chr7:140468067-?	chr7:140468067	0			1		6E-6	5.221848749616356	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56473714	NR	OR5M3 - OR5M2P	ENSG00000174937	ENSG00000254752		362	2573	rs582939-?	rs582939	0	582939	intergenic_variant	1		7E-6	5.154901959985743	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56477759	NR	OR5M2P			ENSG00000254752			rs603926-?	rs603926	0	603926	non_coding_transcript_exon_variant	0		7E-6	5.154901959985743	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA				NR							chr11:56250191-?	chr11:56250191	0			1		7E-6	5.154901959985743	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56483758	NR	OR5M2P			ENSG00000254752			rs594854-?	rs594854	0	594854	intron_variant	0		7E-6	5.154901959985743	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56493213	NR	OR5M8 - OR5M7P	ENSG00000181371	ENSG00000254490		1843	7087	rs669501-?	rs669501	0	669501	intergenic_variant	1		7E-6	5.154901959985743	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	3p14.3	3	55916101	NR	ERC2			ENSG00000187672			rs11705830-?	rs11705830	0	11705830	intron_variant	0		3E-6	5.522878745280337	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	3q13.32	3	119140849	NR	IGSF11			ENSG00000144847			rs11923949-?	rs11923949	0	11923949	intron_variant	0		3E-6	5.522878745280337	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12q22	12	93020495	NR	LINC02413 - Y_RNA	ENSG00000257345	ENSG00000199357		675	1111	rs11106805-?	rs11106805	0	11106805	intron_variant	1		5E-6	5.301029995663981	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	4q22.2	4	93155023	NR	GRID2			ENSG00000152208			rs2870682-?	rs2870682	0	2870682	intron_variant	0		6E-6	5.221848749616356	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56626174	NR	OR5AM1P - OR5M12P	ENSG00000255172	ENSG00000197866		5364	2758	rs1355242-?	rs1355242	0	1355242	intergenic_variant	1		4E-6	5.3979400086720375				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56639492	NR	OR5AP1P - OR5AP2	ENSG00000254795	ENSG00000172464		5389	1997	rs906956-?	rs906956	0	906956	intergenic_variant	1		4E-6	5.3979400086720375				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56286353	NR	OR5T1 - OR8H1	ENSG00000181698	ENSG00000181693		9534	2109	rs17150276-?	rs17150276	0	17150276	intergenic_variant	1		5E-6	5.301029995663981				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56566682	NR	OR5M11 - OR5M10	ENSG00000255223	ENSG00000254834		23425	10092	rs1945279-?	rs1945279	0	1945279	intergenic_variant	1		5E-6	5.301029995663981				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	1p36.23	1	9093570	NR	SLC2A5 - GPR157	ENSG00000142583	ENSG00000180758		5092	6735	rs12061999-?	rs12061999	0	12061999	regulatory_region_variant	1		3E-6	5.522878745280337	(Hispanic)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	1p36.32	1	4130625	NR	NA - EEF1DP6		ENSG00000229280			44903	rs4282783-?	rs4282783	0	4282783	regulatory_region_variant	1		7E-6	5.154901959985743	(Hispanic)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	17q22	17	58522103	SEPT4	SEPTIN4-AS1, SEPTIN4			ENSG00000264672, ENSG00000108387			rs113162402-?	rs113162402	0	113162402	splice_acceptor_variant	0		1E-7	7.0				Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	16p13.2	16	9728154	C16orf72, GRIN2A	NA - GRIN2A		ENSG00000183454			25250	rs1833170-?	rs1833170	0	1833170	intergenic_variant	1		8E-6	5.096910013008056				Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	17q22	17	57885718	CUEDC1	CUEDC1			ENSG00000180891			rs2586052-?	rs2586052	0	2586052	5_prime_UTR_variant	0		2E-7	6.698970004336019				Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	6p21.2	6	39322933	KCNK16	KCNK16			ENSG00000095981			rs3807044-?	rs3807044	0	3807044	5_prime_UTR_variant	0		6E-7	6.221848749616356				Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	9q31.3	9	108830800	KLF4, IKBKAP	RPL36AP35 - ACTL7B	ENSG00000231810	ENSG00000148156		8796	23788	rs17199679-?	rs17199679	0	17199679	intergenic_variant	1		9E-6	5.045757490560675				Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	3p21.31	3	48345739	NR	SPINK8 - FBXW12	ENSG00000229453	ENSG00000164049		17398	26480	rs75158213-?	rs75158213	0	75158213	intergenic_variant	1		3E-7	6.522878745280337	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	3p21.31	3	48340996	NR	SPINK8 - FBXW12	ENSG00000229453	ENSG00000164049		12655	31223	rs7640677-?	rs7640677	0	7640677	intergenic_variant	1		3E-7	6.522878745280337	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	3p21.31	3	48342403	NR	SPINK8 - FBXW12	ENSG00000229453	ENSG00000164049		14062	29816	rs139231591-?	rs139231591	0	139231591	regulatory_region_variant	1		3E-7	6.522878745280337	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	3p21.31	3	48194468	NR	CDC25A - MIR4443	ENSG00000164045	ENSG00000265483		6051	2096	rs75281979-?	rs75281979	0	75281979	TF_binding_site_variant	1		2E-6	5.698970004336019	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	3p21.31	3	48195305	NR	CDC25A - MIR4443	ENSG00000164045	ENSG00000265483		6888	1259	rs138708216-?	rs138708216	0	138708216	regulatory_region_variant	1		2E-6	5.698970004336019	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	3p21.31	3	48216832	NR	MIR4443 - CAMP	ENSG00000265483	ENSG00000164047		20216	6515	rs114356151-?	rs114356151	0	114356151	regulatory_region_variant	1		2E-6	5.698970004336019	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	3p21.31	3	48224479	NR	CAMP			ENSG00000164047			rs7645101-?	rs7645101	0	7645101	intron_variant	0		2E-6	5.698970004336019	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	3p21.31	3	48232141	NR	CAMP - ZNF589	ENSG00000164047	ENSG00000164048		6650	8959	rs7645493-?	rs7645493	0	7645493	intergenic_variant	1		3E-6	5.522878745280337	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	3p21.31	3	48232141	NR	CAMP - ZNF589	ENSG00000164047	ENSG00000164048		6650	8959	rs7645493-?	rs7645493	0	7645493	intergenic_variant	1		3E-6	5.522878745280337	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	3p21.31	3	48235481	NR	CAMP - ZNF589	ENSG00000164047	ENSG00000164048		9990	5619	rs7618694-?	rs7618694	0	7618694	intergenic_variant	1		3E-6	5.522878745280337	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	3p21.31	3	48236415	NR	CAMP - ZNF589	ENSG00000164047	ENSG00000164048		10924	4685	rs79901854-?	rs79901854	0	79901854	intergenic_variant	1		3E-6	5.522878745280337	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	3p21.31	3	48236590	NR	CAMP - ZNF589	ENSG00000164047	ENSG00000164048		11099	4510	rs74358307-?	rs74358307	0	74358307	intergenic_variant	1		3E-6	5.522878745280337	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	3p21.31	3	48238448	NR	CAMP - ZNF589	ENSG00000164047	ENSG00000164048		12957	2652	rs6789249-?	rs6789249	0	6789249	intergenic_variant	1		3E-6	5.522878745280337	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA				NR							chr3:48283878-?	chr3:48283878	0			1		3E-6	5.522878745280337	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA				NR							chr3:48285797-?	chr3:48285797	0			1		3E-6	5.522878745280337	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	3p21.31	3	48244677	NR	ZNF589			ENSG00000164048			rs76227692-?	rs76227692	0	76227692	intron_variant	0		3E-6	5.522878745280337	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	1p36.32	1	4130625	NR	NA - EEF1DP6		ENSG00000229280			44903	rs4282783-?	rs4282783	0	4282783	regulatory_region_variant	1		7E-6	5.154901959985743	(Hispanic)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	1q31.1	1	187555131	NR	LINC01036			ENSG00000230426			rs10912094-?	rs10912094	0	10912094	intron_variant	0		9E-6	5.045757490560675	(Hispanic)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA				NR							chr1:205412525-?	chr1:205412525	0			1		9E-6	5.045757490560675	(Hispanic)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	1q31.1	1	187555131	NR	LINC01036			ENSG00000230426			rs10912094-?	rs10912094	0	10912094	intron_variant	0		9E-6	5.045757490560675	(Hispanic)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	4p16.3	4	1291100	NR	MAEA			ENSG00000090316			rs2141654-?	rs2141654	0	2141654	intron_variant	0		7E-6	5.154901959985743	(Hispanic)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	4p16.3	4	1292174	NR	MAEA			ENSG00000090316			rs11727297-?	rs11727297	0	11727297	intron_variant	0		7E-6	5.154901959985743	(Hispanic)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	4p16.3	4	1319132	NR	MAEA			ENSG00000090316			rs28660352-?	rs28660352	0	28660352	intron_variant	0		7E-6	5.154901959985743	(Hispanic)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	4p16.3	4	1338387	NR	MAEA			ENSG00000090316			rs13147602-?	rs13147602	0	13147602	non_coding_transcript_exon_variant	0		9E-6	5.045757490560675	(Hispanic)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	7q36.1	7	151805216	NR	PRKAG2			ENSG00000106617			rs9648724-?	rs9648724	0	9648724	intron_variant	0		1E-6	6.0	(Hispanic)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	7q36.1	7	151805216	NR	PRKAG2			ENSG00000106617			rs9648724-?	rs9648724	0	9648724	intron_variant	0		1E-6	6.0	(Hispanic)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	9q22.31	9	93144825	NR	NINJ1 - WNK2	ENSG00000131669	ENSG00000165238		10574	40091	rs2398827-?	rs2398827	0	2398827	intergenic_variant	1		2E-6	5.698970004336019	(Hispanic)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	9q22.31	9	93144825	NR	NINJ1 - WNK2	ENSG00000131669	ENSG00000165238		10574	40091	rs2398827-?	rs2398827	0	2398827	intergenic_variant	1		3E-6	5.522878745280337	(Hispanic)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	14q21.2	14	45770163	NR	LINC02303 - NA	ENSG00000258616			54211		rs12879808-?	rs12879808	0	12879808	intergenic_variant	1		4E-6	5.3979400086720375	(Hispanic)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	14q21.2	14	45753643	NR	LINC02303 - NA	ENSG00000258616			37691		rs143370239-?	rs143370239	0	143370239	intergenic_variant	1		6E-6	5.221848749616356	(Hispanic)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	16p12.3	16	17289920	NR	XYLT1			ENSG00000103489			rs76170904-?	rs76170904	0	76170904	intron_variant	0		7E-6	5.154901959985743	(Hispanic)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	18q12.2	18	36003353	NR	RPRD1A			ENSG00000141425			rs17562912-?	rs17562912	0	17562912	intron_variant	0		6E-6	5.221848749616356	(Hispanic)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	6p22.2	6	25784253	SLC17A1	SLC17A1			ENSG00000124568			rs12662869-?	rs12662869	0	12662869	intron_variant	0		7E-9	8.154901959985743				Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	6p22.2	6	25872956	SLC17A3	SLC17A3			ENSG00000124564			rs1408270-?	rs1408270	0	1408270	intron_variant	0		6E-7	6.221848749616356				Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	18q23	18	76070681	SMIM21, ZNF516							rs359770-?	rs359770	0	359770	intergenic_variant	1		4E-6	5.3979400086720375				Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	3p21.31	3	48245424	NR	ZNF589			ENSG00000164048			rs75899098-?	rs75899098	0	75899098	intron_variant	0		3E-6	5.522878745280337	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	3p21.31	3	48250588	NR	ZNF589			ENSG00000164048			rs138424282-?	rs138424282	0	138424282	intron_variant	0		3E-6	5.522878745280337	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA				NR							chr3:48297176-?	chr3:48297176	0			1		3E-6	5.522878745280337	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	6q25.3	6	155880114	NR	NA - MIR1202		ENSG00000221456			66683	rs6909587-?	rs6909587	0	6909587	intergenic_variant	1		3E-7	6.522878745280337	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-01-24	29206233	Shendre A	2017-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29206233	Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS).	Common carotid intima-media thickness in HIV infection	682 Black non-Hispanic HIV-positive women	NA	11q21	11	95175494	SESN3	SESN3			ENSG00000149212			rs11021065-T	rs11021065	0	11021065	splice_region_variant	0	NR	5E-6	5.301029995663981		0.01649	[NR] unit increase	Illumina [1124301]	N	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	GCST005184	Genome-wide genotyping array
2018-01-24	29206233	Shendre A	2017-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29206233	Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS).	Common carotid intima-media thickness in HIV infection	682 Black non-Hispanic HIV-positive women	NA	20p12.1	20	14931037	MACROD2	MACROD2			ENSG00000172264			rs11087114-A	rs11087114	0	11087114	intron_variant	0	NR	1E-6	6.0		0.02726	[NR] unit increase	Illumina [1124301]	N	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	GCST005184	Genome-wide genotyping array
2018-01-24	29206233	Shendre A	2017-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29206233	Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS).	Common carotid intima-media thickness in HIV infection	682 Black non-Hispanic HIV-positive women	NA	5p15.2	5	9950293	LOC285692, FAM173B	LINC02112 - NA	ENSG00000249781			46441		rs12152807-C	rs12152807	0	12152807	intergenic_variant	1	NR	4E-6	5.3979400086720375		0.03086	[NR] unit increase	Illumina [1124301]	N	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	GCST005184	Genome-wide genotyping array
2018-01-24	29206233	Shendre A	2017-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29206233	Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS).	Common carotid intima-media thickness in HIV infection	682 Black non-Hispanic HIV-positive women	NA	4q21.21	4	78711421	LINC01094, BMP2K	LINC01094 - BMP2K	ENSG00000251442	ENSG00000138756		28236	64921	rs1469290-G	rs1469290	0	1469290	intergenic_variant	1	NR	2E-6	5.698970004336019		0.0187	[NR] unit increase	Illumina [1124301]	N	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	GCST005184	Genome-wide genotyping array
2018-01-24	29206233	Shendre A	2017-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29206233	Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS).	Common carotid intima-media thickness in HIV infection	682 Black non-Hispanic HIV-positive women	NA	8q24.11	8	117750197	EXT1, MED30	NA - EXT1		ENSG00000182197			44293	rs2280828-C	rs2280828	0	2280828	intergenic_variant	1	NR	3E-7	6.522878745280337		0.02708	[NR] unit decrease	Illumina [1124301]	N	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	GCST005184	Genome-wide genotyping array
2018-01-24	29206233	Shendre A	2017-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29206233	Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS).	Common carotid intima-media thickness in HIV infection	682 Black non-Hispanic HIV-positive women	NA	5p15.2	5	11047569	CTNND2	CTNND2			ENSG00000169862			rs2907092-G	rs2907092	0	2907092	intron_variant	0	NR	2E-7	6.698970004336019		0.02498	[NR] unit increase	Illumina [1124301]	N	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	GCST005184	Genome-wide genotyping array
2018-01-24	29206233	Shendre A	2017-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29206233	Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS).	Common carotid intima-media thickness in HIV infection	682 Black non-Hispanic HIV-positive women	NA	5q23.1	5	118646351	LOC102467225, DTWD2	LINC02215 - NA	ENSG00000249128			18259		rs2914908-G	rs2914908	0	2914908	intergenic_variant	1	NR	7E-6	5.154901959985743		0.01357	[NR] unit decrease	Illumina [1124301]	N	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	GCST005184	Genome-wide genotyping array
2018-01-24	29206233	Shendre A	2017-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29206233	Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS).	Common carotid intima-media thickness in HIV infection	682 Black non-Hispanic HIV-positive women	NA	2q31.1	2	169782560	SSB, PHOSPHO2, KLHL23	KLHL23 - CYB5AP2	ENSG00000213160	ENSG00000214369		5571	7533	rs4668163-T	rs4668163	0	4668163	regulatory_region_variant	1	NR	5E-6	5.301029995663981		0.01439	[NR] unit increase	Illumina [1124301]	N	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	GCST005184	Genome-wide genotyping array
2018-01-24	29206233	Shendre A	2017-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29206233	Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS).	Common carotid intima-media thickness in HIV infection	682 Black non-Hispanic HIV-positive women	NA	12q22	12	94793846	TMCC3, MIR492	NA - KRT19P2		ENSG00000216306			40301	rs4761669-G	rs4761669	0	4761669	intergenic_variant	1	NR	1E-6	6.0		0.0273	[NR] unit decrease	Illumina [1124301]	N	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	GCST005184	Genome-wide genotyping array
2018-01-24	29206233	Shendre A	2017-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29206233	Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS).	Common carotid intima-media thickness in HIV infection	682 Black non-Hispanic HIV-positive women	NA	5q12.3	5	67247451	CD180, LOC101928858	CD180 - NA	ENSG00000134061			50652		rs73112098-G	rs73112098	0	73112098	regulatory_region_variant	1	NR	1E-6	6.0		0.0222	[NR] unit increase	Illumina [1124301]	N	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	GCST005184	Genome-wide genotyping array
2018-01-24	29206233	Shendre A	2017-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29206233	Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS).	Common carotid intima-media thickness in HIV infection	682 Black non-Hispanic HIV-positive women	NA	4q21.21	4	78706323	LINC01094, BMP2K	LINC01094 - BMP2K	ENSG00000251442	ENSG00000138756		23138	70019	rs7699519-T	rs7699519	0	7699519	regulatory_region_variant	1	NR	4E-6	5.3979400086720375		0.01657	[NR] unit increase	Illumina [1124301]	N	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	GCST005184	Genome-wide genotyping array
2018-01-24	29206233	Shendre A	2017-12-04	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29206233	Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS).	Common carotid intima-media thickness in HIV infection	682 Black non-Hispanic HIV-positive women	NA	14q21.1	14	38898874	LINC00639	LINC00639			ENSG00000259070			rs80093141-T	rs80093141	0	80093141	intron_variant	0	NR	8E-6	5.096910013008056		0.02664	[NR] unit increase	Illumina [1124301]	N	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860	GCST005184	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	8p12	8	33141855	NR							rs10098430-?	rs10098430	0	10098430	intergenic_variant	1		3E-6	5.522878745280337	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	8p12	8	33145354	NR							rs55983391-?	rs55983391	0	55983391	intergenic_variant	1		3E-6	5.522878745280337	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA				NR							chr8:33032156-?	chr8:33032156	0			1		3E-6	5.522878745280337	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	9q21.31	9	80667356	NR							rs72749479-?	rs72749479	0	72749479	intergenic_variant	1		7E-7	6.154901959985743	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	9q21.31	9	80670259	NR							rs72749483-?	rs72749483	0	72749483	intergenic_variant	1		7E-7	6.154901959985743	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	10p11.21	10	37531016	NR	TACC1P1			ENSG00000224920			rs11011237-?	rs11011237	0	11011237	intron_variant	0		2E-7	6.698970004336019	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	10p11.21	10	37530781	NR	TACC1P1			ENSG00000224920			rs10827791-?	rs10827791	0	10827791	intron_variant	0		2E-6	5.698970004336019	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	18q12.1	18	29443322	NR							rs73412830-?	rs73412830	0	73412830	intergenic_variant	1		5E-6	5.301029995663981	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	Xq23	X	115373069	NR	LUZP4 - TUBAP6	ENSG00000102021	ENSG00000274374		65506	50995	rs10521695-?	rs10521695	0	10521695	regulatory_region_variant	1		8E-6	5.096910013008056	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12q21.31	12	80916873	NR	LIN7A			ENSG00000111052			rs11114652-?	rs11114652	0	11114652	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	10q26.2	10	126609535	NR	C10orf90			ENSG00000154493			rs4962347-?	rs4962347	0	4962347	intron_variant	0		4E-6	5.3979400086720375	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12p13.31	12	9235414	NR	A2MP1			ENSG00000256069			rs17804080-?	rs17804080	0	17804080	intron_variant	0		5E-6	5.301029995663981	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12p13.31	12	9232362	NR	A2MP1			ENSG00000256069			rs16918212-?	rs16918212	0	16918212	splice_region_variant	0		7E-6	5.154901959985743	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	2p25.3	2	3461039	NR	TRAPPC12, TRAPPC12			ENSG00000274891, ENSG00000171853			rs7585799-?	rs7585799	0	7585799	intron_variant	0		7E-6	5.154901959985743	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	10p11.21	10	37530781	NR	TACC1P1			ENSG00000224920			rs10827791-?	rs10827791	0	10827791	intron_variant	0		2E-6	5.698970004336019	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	10p11.21	10	37530427	NR	TACC1P1			ENSG00000224920			rs7082049-?	rs7082049	0	7082049	non_coding_transcript_exon_variant	0		3E-6	5.522878745280337	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	10q24.32	10	103095521	NR	NT5C2			ENSG00000076685			rs11191554-?	rs11191554	0	11191554	intron_variant	0		3E-6	5.522878745280337	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	10q24.32	10	103097461	NR	NT5C2			ENSG00000076685			rs10786737-?	rs10786737	0	10786737	3_prime_UTR_variant	0		4E-6	5.3979400086720375	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	10q24.32	10	103097461	NR	NT5C2			ENSG00000076685			rs10786737-?	rs10786737	0	10786737	3_prime_UTR_variant	0		4E-6	5.3979400086720375	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA				NR							chr10:104857205-?	chr10:104857205	0			1		5E-6	5.301029995663981	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	10p11.21	10	37548585	NR	TACC1P1 - MTND1P18	ENSG00000224920	ENSG00000225276		3884	52211	rs10827797-?	rs10827797	0	10827797	intergenic_variant	1		7E-6	5.154901959985743	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12q22	12	93020495	NR	LINC02413 - Y_RNA	ENSG00000257345	ENSG00000199357		675	1111	rs11106805-?	rs11106805	0	11106805	intron_variant	1		3E-6	5.522878745280337	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12q22	12	93020495	NR	LINC02413 - Y_RNA	ENSG00000257345	ENSG00000199357		675	1111	rs11106805-?	rs11106805	0	11106805	intron_variant	1		3E-6	5.522878745280337	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	13q14.13	13	45895072	NR	SIAH3 - ZC3H13	ENSG00000215475	ENSG00000123200		43319	59393	rs17067414-?	rs17067414	0	17067414	intergenic_variant	1		4E-6	5.3979400086720375	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	13q14.13	13	45896242	NR	SIAH3 - ZC3H13	ENSG00000215475	ENSG00000123200		44489	58223	rs7996510-?	rs7996510	0	7996510	intergenic_variant	1		6E-6	5.221848749616356	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	18q12.1	18	29441032	NR							rs10468897-?	rs10468897	0	10468897	intergenic_variant	1		5E-6	5.301029995663981	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	1q43	1	239901238	NR	CHRM3			ENSG00000133019			rs10399860-?	rs10399860	0	10399860	intron_variant	0		9E-6	5.045757490560675	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11p15.4	11	11376738	NR	GALNT18			ENSG00000110328			rs2129530-?	rs2129530	0	2129530	intron_variant	0		9E-6	5.045757490560675	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA				NR							chr12:9365073-?	chr12:9365073	0			1		2E-6	5.698970004336019	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12q21.31	12	80917670	NR	LIN7A			ENSG00000111052			rs17007660-?	rs17007660	0	17007660	intron_variant	0		2E-6	5.698970004336019	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12q21.31	12	80915504	NR	LIN7A			ENSG00000111052			rs7974884-?	rs7974884	0	7974884	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12q21.31	12	80917603	NR	LIN7A			ENSG00000111052			rs34500073-?	rs34500073	0	34500073	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12q21.31	12	80918934	NR	LIN7A			ENSG00000111052			rs6539535-?	rs6539535	0	6539535	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12q21.31	12	80919031	NR	LIN7A			ENSG00000111052			rs7959128-?	rs7959128	0	7959128	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12q21.31	12	80916873	NR	LIN7A			ENSG00000111052			rs11114652-?	rs11114652	0	11114652	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12p13.31	12	9235414	NR	A2MP1			ENSG00000256069			rs17804080-?	rs17804080	0	17804080	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	10q26.2	10	126609535	NR	C10orf90			ENSG00000154493			rs4962347-?	rs4962347	0	4962347	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11p15.4	11	11376812	NR	GALNT18			ENSG00000110328			rs2129532-?	rs2129532	0	2129532	intron_variant	0		4E-6	5.3979400086720375	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	10q26.2	10	126614850	NR	C10orf90			ENSG00000154493			rs978471-?	rs978471	0	978471	intron_variant	0		4E-6	5.3979400086720375	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	10q26.2	10	126615939	NR	C10orf90			ENSG00000154493			rs1436793-?	rs1436793	0	1436793	intron_variant	0		4E-6	5.3979400086720375	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	10q26.2	10	126616457	NR	C10orf90			ENSG00000154493			rs2842161-?	rs2842161	0	2842161	intron_variant	0		4E-6	5.3979400086720375	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12p13.31	12	9225633	NR	PZP - A2MP1	ENSG00000126838	ENSG00000256069		17238	2900	rs57961998-?	rs57961998	0	57961998	intergenic_variant	1		6E-6	5.221848749616356	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12p13.31	12	9227522	NR	PZP - A2MP1	ENSG00000126838	ENSG00000256069		19127	1011	rs73057767-?	rs73057767	0	73057767	intergenic_variant	1		6E-6	5.221848749616356	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12p13.31	12	9227541	NR	PZP - A2MP1	ENSG00000126838	ENSG00000256069		19146	992	rs73057770-?	rs73057770	0	73057770	intergenic_variant	1		6E-6	5.221848749616356	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12p13.31	12	9228478	NR	PZP - A2MP1	ENSG00000126838	ENSG00000256069		20083	55	rs67775007-?	rs67775007	0	67775007	intergenic_variant	1		6E-6	5.221848749616356	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA				NR							chr12:9383002-?	chr12:9383002	0			1		6E-6	5.221848749616356	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5q14.3	5	88560042	NR	LINC00461			ENSG00000245526			rs7710776-?	rs7710776	0	7710776	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5q14.3	5	88560241	NR	LINC00461			ENSG00000245526			rs10071077-?	rs10071077	0	10071077	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	18q23	18	77568791	NR	DCC - NA	ENSG00000187323			24032888		rs2897639-?	rs2897639	0	2897639	intergenic_variant	1		2E-7	6.698970004336019	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	18q12.1	18	29446329	NR							rs73412846-?	rs73412846	0	73412846	intergenic_variant	1		5E-6	5.301029995663981	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	2p22.1	2	41139011	NR	NA - HNRNPA1P57		ENSG00000237442			4769	rs7562658-?	rs7562658	0	7562658	intergenic_variant	1		3E-6	5.522878745280337	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	6q14.1	6	77374254	NR	NA - HTR1B		ENSG00000135312			86670	rs1342634-?	rs1342634	0	1342634	regulatory_region_variant	1		4E-6	5.3979400086720375	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	18q21.31	18	56601279	NR	TXNL1			ENSG00000091164			rs625001-?	rs625001	0	625001	3_prime_UTR_variant	0		4E-6	5.3979400086720375	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	9q34.3	9	135117933	NR	OLFM1			ENSG00000130558			rs11103683-?	rs11103683	0	11103683	intron_variant	0		4E-6	5.3979400086720375	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	6q14.1	6	77351264	NR	TSBP1-AS1 - NA	ENSG00000225914			44943501		rs6902991-?	rs6902991	0	6902991	intergenic_variant	1		4E-6	5.3979400086720375	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	6q14.1	6	77352894	NR							rs9361224-?	rs9361224	0	9361224	intergenic_variant	1		5E-6	5.301029995663981	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	16q24.1	16	86220110	NR	LINC01082 - LINC01081	ENSG00000269186	ENSG00000268754		20390	1310	rs904200-?	rs904200	0	904200	intergenic_variant	1		7E-6	5.154901959985743	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	7q21.11	7	83876076	NR	NA - SEMA3A		ENSG00000075213			79701	rs11981075-?	rs11981075	0	11981075	intergenic_variant	1		7E-6	5.154901959985743	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	9q34.3	9	135121473	NR	OLFM1 - NA	ENSG00000130558			293		rs7039098-?	rs7039098	0	7039098	intergenic_variant	1		2E-7	6.698970004336019	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	9q34.3	9	135121519	NR	OLFM1 - NA	ENSG00000130558			339		rs7035473-?	rs7035473	0	7035473	intergenic_variant	1		2E-7	6.698970004336019	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	9q34.3	9	135121569	NR	OLFM1 - NA	ENSG00000130558			389		rs7047901-?	rs7047901	0	7047901	intergenic_variant	1		2E-7	6.698970004336019	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	9q34.3	9	135122706	NR	OLFM1 - NA	ENSG00000130558			1526		rs10119043-?	rs10119043	0	10119043	intergenic_variant	1		2E-7	6.698970004336019	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	4p15.1	4	29333941	NR	LINC02472 - NA	ENSG00000248338			42072		rs6448638-?	rs6448638	0	6448638	intergenic_variant	1		7E-7	6.154901959985743	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	18q12.3	18	43280443	NR	SYT4 - NA	ENSG00000132872			2908		rs79666748-?	rs79666748	0	79666748	intergenic_variant	1		7E-7	6.154901959985743	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	18q12.3	18	43300829	NR	SYT4 - NA	ENSG00000132872			23294		rs116965780-?	rs116965780	0	116965780	intergenic_variant	1		7E-7	6.154901959985743	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	18q12.3	18	43322011	NR	SYT4 - NA	ENSG00000132872			44476		rs4435343-?	rs4435343	0	4435343	intergenic_variant	1		7E-7	6.154901959985743	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	6q14.1	6	77349634	NR							rs2226150-?	rs2226150	0	2226150	intergenic_variant	1		7E-7	6.154901959985743	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	4p15.1	4	29332870	NR	LINC02472 - NA	ENSG00000248338			41001		rs1836778-?	rs1836778	0	1836778	intergenic_variant	1		9E-7	6.045757490560675	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	4p15.1	4	29322410	NR	LINC02472 - NA	ENSG00000248338			30541		rs1966678-?	rs1966678	0	1966678	intergenic_variant	1		1E-6	6.0	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	4p15.1	4	29331415	NR	LINC02472 - NA	ENSG00000248338			39546		rs55920741-?	rs55920741	0	55920741	intergenic_variant	1		1E-6	6.0	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	6q14.1	6	77375469	NR	NA - HTR1B		ENSG00000135312			85455	rs9341664-?	rs9341664	0	9341664	intergenic_variant	1		1E-6	6.0	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5p14.2	5	24058406	NR	C5orf17			ENSG00000248874			rs73055009-?	rs73055009	0	73055009	intron_variant	0		1E-6	6.0	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5p14.2	5	24059742	NR	C5orf17			ENSG00000248874			rs10054178-?	rs10054178	0	10054178	intron_variant	0		1E-6	6.0	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5p14.2	5	24060490	NR	C5orf17			ENSG00000248874			rs113051092-?	rs113051092	0	113051092	intron_variant	0		1E-6	6.0	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5p14.2	5	24062454	NR	C5orf17			ENSG00000248874			rs73055087-?	rs73055087	0	73055087	intron_variant	0		1E-6	6.0	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5p14.2	5	24063287	NR	C5orf17			ENSG00000248874			rs79056512-?	rs79056512	0	79056512	intron_variant	0		1E-6	6.0	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5p14.2	5	24064827	NR	C5orf17			ENSG00000248874			rs10041590-?	rs10041590	0	10041590	intron_variant	0		1E-6	6.0	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5p14.2	5	24069684	NR	C5orf17			ENSG00000248874			rs10056373-?	rs10056373	0	10056373	intron_variant	0		1E-6	6.0	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56639492	NR	OR5AP1P - OR5AP2	ENSG00000254795	ENSG00000172464		5389	1997	rs906956-?	rs906956	0	906956	intergenic_variant	1		4E-6	5.3979400086720375				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5q31.3	5	143153779	NR	ARHGAP26			ENSG00000145819			rs121882-?	rs121882	0	121882	intron_variant	0		6E-6	5.221848749616356				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56269311	NR	OR5T3 - OR5T1	ENSG00000172489	ENSG00000181698		16089	4843	rs11227719-?	rs11227719	0	11227719	intergenic_variant	1		6E-6	5.221848749616356				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA				NR							GA021270-?	GA021270	0			1		6E-6	5.221848749616356				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56604281	NR	OR5M13P - OR5M1	ENSG00000166693	ENSG00000255012		5919	4955	rs1397050-?	rs1397050	0	1397050	intergenic_variant	1		7E-6	5.154901959985743				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56289943	NR	OR8H1, OR8H1			ENSG00000262611, ENSG00000181693			rs17150286-?	rs17150286	0	17150286	3_prime_UTR_variant	0		9E-6	5.045757490560675				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	10p11.22	10	33198261	NR	NRP1			ENSG00000099250			rs10827209-?	rs10827209	0	10827209	intron_variant	0		7E-7	6.154901959985743				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56597931	NR	OR5M13P			ENSG00000166693			rs11228672-?	rs11228672	0	11228672	non_coding_transcript_exon_variant	0		1E-6	6.0				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56495636	NR	OR5M8 - OR5M7P	ENSG00000181371	ENSG00000254490		4266	4664	rs638436-?	rs638436	0	638436	intergenic_variant	1		1E-6	6.0				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56495642	NR	OR5M8 - OR5M7P	ENSG00000181371	ENSG00000254490		4272	4658	rs638452-?	rs638452	0	638452	intergenic_variant	1		1E-6	6.0				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56423917	NR	OR8U3 - OR5M4P	ENSG00000279961	ENSG00000230416		5685	24751	rs11228326-?	rs11228326	0	11228326	intergenic_variant	1		2E-6	5.698970004336019				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56505171	NR	OR5M7P - OR5M6P	ENSG00000254490	ENSG00000254603		3900	7064	rs652106-?	rs652106	0	652106	intergenic_variant	1		2E-6	5.698970004336019				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	3p24.1	3	26547929	NR	NA - LRRC3B		ENSG00000179796			74877	rs13076411-?	rs13076411	0	13076411	intergenic_variant	1		3E-6	5.522878745280337				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	3p24.1	3	26526585	NR	NA - LRRC3B		ENSG00000179796			96221	rs10510578-?	rs10510578	0	10510578	intergenic_variant	1		3E-6	5.522878745280337				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56622809	NR	OR5AM1P - OR5M12P	ENSG00000255172	ENSG00000197866		1999	6123	rs10896497-?	rs10896497	0	10896497	intergenic_variant	1		3E-6	5.522878745280337				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	3p24.1	3	26535293	NR	NA - LRRC3B		ENSG00000179796			87513	rs13072945-?	rs13072945	0	13072945	intergenic_variant	1		3E-6	5.522878745280337				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	3p24.1	3	26537687	NR	NA - LRRC3B		ENSG00000179796			85119	rs62249990-?	rs62249990	0	62249990	intergenic_variant	1		3E-6	5.522878745280337				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA				NR							chr3:26596160-?	chr3:26596160	0			1		3E-6	5.522878745280337				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	3p24.1	3	26524192	NR	NA - LRRC3B		ENSG00000179796			98614	rs35524753-?	rs35524753	0	35524753	intergenic_variant	1		4E-6	5.3979400086720375				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA				NR							chr3:26593850-?	chr3:26593850	0			1		4E-6	5.3979400086720375				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56543614	NR	OR5M11 - OR5M10	ENSG00000255223	ENSG00000254834		357	33160	rs1080800-?	rs1080800	0	1080800	intergenic_variant	1		4E-6	5.3979400086720375				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56548598	NR	OR5M11 - OR5M10	ENSG00000255223	ENSG00000254834		5341	28176	rs12787983-?	rs12787983	0	12787983	intergenic_variant	1		4E-6	5.3979400086720375				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	6q12	6	65378418	NR	EYS			ENSG00000188107			rs9453288-?	rs9453288	0	9453288	intron_variant	0		7E-6	5.154901959985743	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	13q14.13	13	45777530	NR	SIAH3			ENSG00000215475			rs77197299-?	rs77197299	0	77197299	3_prime_UTR_variant	0		7E-6	5.154901959985743	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	3q26.33	3	182309318	NR							rs4859214-?	rs4859214	0	4859214	regulatory_region_variant	1		8E-6	5.096910013008056	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12q12	12	45143962	NR	RNA5SP361 - PLEKHA8P1	ENSG00000199556	ENSG00000134297		26074	29102	rs12230258-?	rs12230258	0	12230258	intergenic_variant	1		8E-6	5.096910013008056	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	3p25.1	3	14815331	NR	FGD5			ENSG00000154783			rs731580-?	rs731580	0	731580	intron_variant	0		1E-6	6.0	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	7q34	7	140795773	NR	BRAF			ENSG00000157764			rs1733826-?	rs1733826	0	1733826	intron_variant	0		4E-6	5.3979400086720375	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5q14.3	5	88598828	NR	LINC00461			ENSG00000245526			rs2112424-?	rs2112424	0	2112424	intron_variant	0		4E-6	5.3979400086720375	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5q14.3	5	88583650	NR	LINC00461			ENSG00000245526			rs2438466-?	rs2438466	0	2438466	intron_variant	0		4E-6	5.3979400086720375	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	20q13.13	20	48611439	NR	NA - PREX1		ENSG00000124126			12813	rs16993962-?	rs16993962	0	16993962	intergenic_variant	1		8E-6	5.096910013008056	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56493486	NR	OR5M8 - OR5M7P	ENSG00000181371	ENSG00000254490		2116	6814	rs2511145-?	rs2511145	0	2511145	intergenic_variant	1		7E-6	5.154901959985743	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56495636	NR	OR5M8 - OR5M7P	ENSG00000181371	ENSG00000254490		4266	4664	rs638436-?	rs638436	0	638436	intergenic_variant	1		7E-6	5.154901959985743	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56495642	NR	OR5M8 - OR5M7P	ENSG00000181371	ENSG00000254490		4272	4658	rs638452-?	rs638452	0	638452	intergenic_variant	1		7E-6	5.154901959985743	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q12.1	11	56482648	NR	OR5M2P			ENSG00000254752			rs676794-?	rs676794	0	676794	intron_variant	0		7E-6	5.154901959985743	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	4p15.1	4	29333941	NR	LINC02472 - NA	ENSG00000248338			42072		rs6448638-?	rs6448638	0	6448638	intergenic_variant	1		7E-7	6.154901959985743	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	18q12.3	18	43322011	NR	SYT4 - NA	ENSG00000132872			44476		rs4435343-?	rs4435343	0	4435343	intergenic_variant	1		8E-7	6.096910013008056	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	4p15.1	4	29322410	NR	LINC02472 - NA	ENSG00000248338			30541		rs1966678-?	rs1966678	0	1966678	intergenic_variant	1		1E-6	6.0	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	6q14.1	6	77349634	NR							rs2226150-?	rs2226150	0	2226150	intergenic_variant	1		1E-6	6.0	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5p14.2	5	24072508	NR	C5orf17			ENSG00000248874			rs16893073-?	rs16893073	0	16893073	intron_variant	0		1E-6	6.0	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	9q34.3	9	135116709	NR	OLFM1			ENSG00000130558			rs13292946-?	rs13292946	0	13292946	intron_variant	0		2E-6	5.698970004336019	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	4p15.1	4	29323274	NR	LINC02472 - NA	ENSG00000248338			31405		rs16867887-?	rs16867887	0	16867887	intergenic_variant	1		3E-6	5.522878745280337	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	9q34.3	9	135120224	NR	OLFM1			ENSG00000130558			rs11103684-?	rs11103684	0	11103684	3_prime_UTR_variant	0		3E-6	5.522878745280337	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	9q34.3	9	135120566	NR	OLFM1			ENSG00000130558			rs11834-?	rs11834	0	11834	3_prime_UTR_variant	0		3E-6	5.522878745280337	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	9q21.13	9	74276496	NR							rs2604271-?	rs2604271	0	2604271	intergenic_variant	1		3E-6	5.522878745280337	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	6q14.1	6	77389978	NR	NA - HTR1B		ENSG00000135312			70946	rs1592216-?	rs1592216	0	1592216	intergenic_variant	1		3E-6	5.522878745280337	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	6q14.1	6	77364760	NR	NA - HTR1B		ENSG00000135312			96164	rs1935737-?	rs1935737	0	1935737	intergenic_variant	1		3E-6	5.522878745280337	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006072	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12p13.31	12	9230942	NR	A2MP1			ENSG00000256069			rs73251320-?	rs73251320	0	73251320	intron_variant	0		6E-6	5.221848749616356	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12p13.31	12	9231340	NR	A2MP1			ENSG00000256069			rs67033239-?	rs67033239	0	67033239	intron_variant	0		6E-6	5.221848749616356	(EA)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	8p23.3	8	1203198	NR	DLGAP2, DLGAP2			ENSG00000198010, ENSG00000282318			rs17062789-?	rs17062789	0	17062789	intron_variant	0		3E-7	6.522878745280337	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q24.1	11	123047451	NR	RPL34P23 - RPS26P43	ENSG00000243669	ENSG00000244641		11227	2336	rs4936767-?	rs4936767	0	4936767	intergenic_variant	1		6E-7	6.221848749616356	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q24.1	11	123055777	NR	RPL31P47 - HSPA8	ENSG00000233541	ENSG00000109971		4376	1712	rs1461494-?	rs1461494	0	1461494	intergenic_variant	1		3E-7	6.522878745280337	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q24.1	11	123058167	NR	HSPA8			ENSG00000109971			rs4936770-?	rs4936770	0	4936770	intron_variant	0		9E-7	6.045757490560675	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q24.1	11	123058167	NR	HSPA8			ENSG00000109971			rs4936770-?	rs4936770	0	4936770	intron_variant	0		3E-7	6.522878745280337	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	6q14.1	6	77389978	NR	NA - HTR1B		ENSG00000135312			70946	rs1592216-?	rs1592216	0	1592216	intergenic_variant	1		3E-6	5.522878745280337	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q24.1	11	123095918	NR	CLMP			ENSG00000166250			rs7121616-?	rs7121616	0	7121616	intron_variant	0		5E-7	6.301029995663981	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	1q43	1	237396237	NR	RYR2			ENSG00000198626			rs6677658-?	rs6677658	0	6677658	intron_variant	0		3E-6	5.522878745280337	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA				NR							chr11:122962586-?	chr11:122962586	0			1		6E-7	6.221848749616356	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	18q12.2	18	36700168	NR	FHOD3			ENSG00000134775			rs505601-?	rs505601	0	505601	intron_variant	0		5E-6	5.301029995663981	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	8p21.2	8	26046363	NR	EBF2 - RNA5SP258	ENSG00000221818	ENSG00000199620		950	90517	rs55980452-?	rs55980452	0	55980452	regulatory_region_variant	1		1E-6	6.0	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	6q14.1	6	77374254	NR	NA - HTR1B		ENSG00000135312			86670	rs1342634-?	rs1342634	0	1342634	regulatory_region_variant	1		5E-6	5.301029995663981	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	8p21.2	8	26048781	NR	EBF2 - RNA5SP258	ENSG00000221818	ENSG00000199620		3368	88099	rs72609945-?	rs72609945	0	72609945	intergenic_variant	1		1E-6	6.0	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	2p22.1	2	41139011	NR	NA - HNRNPA1P57		ENSG00000237442			4769	rs7562658-?	rs7562658	0	7562658	intergenic_variant	1		6E-6	5.221848749616356	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	6q14.1	6	77351264	NR	TSBP1-AS1 - NA	ENSG00000225914			44943501		rs6902991-?	rs6902991	0	6902991	intergenic_variant	1		6E-6	5.221848749616356	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	10q23.33	10	92722160	NR	Y_RNA - NA	ENSG00000199357			11552		rs7923837-?	rs7923837	0	7923837	intergenic_variant	1		7E-6	5.154901959985743	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	6q26	6	163586391	NR	QKI - NA	ENSG00000112531			7799		rs4709724-?	rs4709724	0	4709724	regulatory_region_variant	1		7E-6	5.154901959985743	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q24.1	11	123079805	NR	CLMP			ENSG00000166250			rs7941144-?	rs7941144	0	7941144	intron_variant	0		8E-6	5.096910013008056	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	15q11.2	15	24925023	NR	SNRPN			ENSG00000128739			rs12592731-?	rs12592731	0	12592731	intron_variant	0		8E-6	5.096910013008056	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	6q22.1	6	117432671	NR	RAP1BP3 - DCBLD1	ENSG00000219703	ENSG00000164465		229	21146	rs36111427-?	rs36111427	0	36111427	intron_variant	1		9E-6	5.045757490560675	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5p15.1	5	18238325	NR	SNORD81 - NA	ENSG00000202023			2129		rs6863176-?	rs6863176	0	6863176	intergenic_variant	1		4E-6	5.3979400086720375	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	8p23.3	8	1203431	NR	DLGAP2, DLGAP2			ENSG00000198010, ENSG00000282318			rs17062791-?	rs17062791	0	17062791	intron_variant	0		2E-7	6.698970004336019	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	8p12	8	33138620	NR	RANP9 - NA	ENSG00000253393			98827		rs75989043-?	rs75989043	0	75989043	intergenic_variant	1		3E-6	5.522878745280337	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q24.1	11	123094779	NR	CLMP			ENSG00000166250			rs7109445-?	rs7109445	0	7109445	intron_variant	0		3E-7	6.522878745280337	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	4p15.31	4	20721189	NR	PACRGL			ENSG00000163138			rs7696218-?	rs7696218	0	7696218	intron_variant	0		3E-7	6.522878745280337	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	8p23.3	8	1203431	NR	DLGAP2, DLGAP2			ENSG00000198010, ENSG00000282318			rs17062791-?	rs17062791	0	17062791	intron_variant	0		2E-7	6.698970004336019	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	8p23.3	8	1203645	NR	DLGAP2, DLGAP2			ENSG00000198010, ENSG00000282318			rs73670671-?	rs73670671	0	73670671	intron_variant	0		3E-7	6.522878745280337	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q24.1	11	123094779	NR	CLMP			ENSG00000166250			rs7109445-?	rs7109445	0	7109445	intron_variant	0		7E-7	6.154901959985743	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q24.1	11	123057914	NR	HSPA8			ENSG00000109971			rs4802-?	rs4802	0	4802	synonymous_variant	0		3E-7	6.522878745280337	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	6q14.1	6	77349634	NR							rs2226150-?	rs2226150	0	2226150	intergenic_variant	1		2E-6	5.698970004336019	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q24.1	11	123090950	NR	CLMP			ENSG00000166250			rs11218976-?	rs11218976	0	11218976	intron_variant	0		5E-7	6.301029995663981	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	1p36.13	1	18240357	NR	IGSF21			ENSG00000117154			rs2883821-?	rs2883821	0	2883821	intron_variant	0		3E-6	5.522878745280337	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	8p21.2	8	26048063	NR	EBF2 - RNA5SP258	ENSG00000221818	ENSG00000199620		2650	88817	rs57580384-?	rs57580384	0	57580384	regulatory_region_variant	1		5E-7	6.301029995663981	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	4p15.31	4	20730711	NR	KCNIP4, PACRGL			ENSG00000185774, ENSG00000163138			rs7688805-?	rs7688805	0	7688805	3_prime_UTR_variant	0		4E-6	5.3979400086720375	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q24.1	11	123093392	NR	CLMP			ENSG00000166250			rs10892961-?	rs10892961	0	10892961	intron_variant	0		6E-7	6.221848749616356	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	6q14.1	6	77364760	NR	NA - HTR1B		ENSG00000135312			96164	rs1935737-?	rs1935737	0	1935737	intergenic_variant	1		5E-6	5.301029995663981	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	Xq23	X	112671016	NR	LHFPL1			ENSG00000182508			rs7064462-?	rs7064462	0	7064462	synonymous_variant	0		5E-6	5.301029995663981	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	6q14.1	6	77349634	NR							rs2226150-?	rs2226150	0	2226150	intergenic_variant	1		1E-6	6.0	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	8p21.2	8	26050704	NR	EBF2 - RNA5SP258	ENSG00000221818	ENSG00000199620		5291	86176	rs59926619-?	rs59926619	0	59926619	intergenic_variant	1		1E-6	6.0	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	6q14.1	6	77375469	NR	NA - HTR1B		ENSG00000135312			85455	rs9341664-?	rs9341664	0	9341664	intergenic_variant	1		1E-6	6.0	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	12q24.32	12	127505259	TMEM132B, TMEM132C	IRAG2 - NA	ENSG00000118308			102396925		rs2682618-?	rs2682618	0	2682618	intron_variant	1		5E-6	5.301029995663981				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	9q21.12	9	70524146	KLF9, TRPM3	NA - TRPM3		ENSG00000083067			4914	rs34574970-?	rs34574970	0	34574970	intergenic_variant	1		9E-6	5.045757490560675				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	1p31.1	1	82786827	LPHN2, TTLL7	NA - RNPEP		ENSG00000176393			119195545	rs390296-?	rs390296	0	390296	intron_variant	1		2E-6	5.698970004336019				Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	4p15.1	4	30214051	NR							rs2571468-?	rs2571468	0	2571468	intergenic_variant	1		6E-6	5.221848749616356	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5p15.1	5	18238325	NR	SNORD81 - NA	ENSG00000202023			2129		rs6863176-?	rs6863176	0	6863176	intergenic_variant	1		3E-6	5.522878745280337	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	8p23.3	8	1206131	NR	DLGAP2, DLGAP2			ENSG00000198010, ENSG00000282318			rs34003842-?	rs34003842	0	34003842	intron_variant	0		2E-7	6.698970004336019	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	5p13.1	5	40948388	NR	C7			ENSG00000112936			rs2459464-?	rs2459464	0	2459464	intron_variant	0		5E-6	5.301029995663981	(African)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	243 European American ancestry tenofovir-treated cases, 149 African American tenofovir-treated cases, 100 Hispanic American tenofovir-treated cases, 9 unknown ancestry tenofovir-treated cases, 243 European American ancestry abacavir-treated cases, 189 African American abacavir-treated cases, 102 Hispanic American abacavir-treated cases, 14 unknown ancestry abacavir-treated cases.	NA	11q24.1	11	123047451	NR	RPL34P23 - RPS26P43	ENSG00000243669	ENSG00000244641		11227	2336	rs4936767-?	rs4936767	0	4936767	intergenic_variant	1		2E-7	6.698970004336019	(Hispanic)			Illumina [~ 5140000] (imputed)	N	response to tenofovir, creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0009279, http://www.ebi.ac.uk/efo/EFO_0007934	GCST006069	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	6p22.2	6	25765162	NR	SLC17A4			ENSG00000146039			rs1317816-?	rs1317816	0	1317816	intron_variant	0		5E-6	5.301029995663981	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	6p22.2	6	25841975	NR	SLC17A3			ENSG00000124564			rs4712976-?	rs4712976	0	4712976	intron_variant	0		8E-6	5.096910013008056	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	14q32.12	14	92577033	NR	RIN3			ENSG00000100599			rs7154653-?	rs7154653	0	7154653	intron_variant	0		2E-7	6.698970004336019	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	14q32.12	14	92580988	NR	RIN3			ENSG00000100599			rs6575267-?	rs6575267	0	6575267	intron_variant	0		2E-7	6.698970004336019	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	14q32.12	14	92580988	NR	RIN3			ENSG00000100599			rs6575267-?	rs6575267	0	6575267	intron_variant	0		4E-7	6.3979400086720375	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	14q32.12	14	92580298	NR	RIN3			ENSG00000100599			rs12587266-?	rs12587266	0	12587266	intron_variant	0		4E-7	6.3979400086720375	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	14q32.12	14	92578323	NR	RIN3			ENSG00000100599			rs7160376-?	rs7160376	0	7160376	intron_variant	0		2E-6	5.698970004336019	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	14q32.12	14	92578323	NR	RIN3			ENSG00000100599			rs7160376-?	rs7160376	0	7160376	intron_variant	0		4E-6	5.3979400086720375	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	14q32.12	14	92578339	NR	RIN3			ENSG00000100599			rs7159925-?	rs7159925	0	7159925	intron_variant	0		4E-6	5.3979400086720375	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	1p31.1	1	82787449	LPHN2, TTLL7							rs438697-?	rs438697	0	438697	intron_variant	1		8E-6	5.096910013008056				Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233759924	NR	UGT1A7, UGT1A4, UGT1A6, UGT1A3, UGT1A5, UGT1A9, UGT1A10, UGT1A8			ENSG00000244122, ENSG00000244474, ENSG00000167165, ENSG00000288702, ENSG00000288705, ENSG00000241119, ENSG00000242515, ENSG00000242366			rs887829-?	rs887829	0	887829	intron_variant	0	NR	7E-12	11.154901959985743				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233764663	NR	UGT1A7, UGT1A9, UGT1A5, UGT1A1, UGT1A6, UGT1A3, UGT1A4, UGT1A10, UGT1A8			ENSG00000244122, ENSG00000241119, ENSG00000288705, ENSG00000241635, ENSG00000167165, ENSG00000288702, ENSG00000244474, ENSG00000242515, ENSG00000242366			rs4148325-?	rs4148325	0	4148325	intron_variant	0	NR	1E-11	11.0				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233763993	NR	UGT1A3, UGT1A4, UGT1A6, UGT1A10, UGT1A8, UGT1A5, UGT1A9, UGT1A7, UGT1A1			ENSG00000288702, ENSG00000244474, ENSG00000167165, ENSG00000242515, ENSG00000242366, ENSG00000288705, ENSG00000241119, ENSG00000244122, ENSG00000241635			rs6742078-?	rs6742078	0	6742078	intron_variant	0	NR	4E-11	10.397940008672037				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233764076	NR	UGT1A10, UGT1A8, UGT1A3, UGT1A9, UGT1A6, UGT1A4, UGT1A7, UGT1A1, UGT1A5			ENSG00000242515, ENSG00000242366, ENSG00000288702, ENSG00000241119, ENSG00000167165, ENSG00000244474, ENSG00000244122, ENSG00000241635, ENSG00000288705			rs4148324-?	rs4148324	0	4148324	intron_variant	0	NR	9E-11	10.045757490560675				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233765830	NR	UGT1A4, UGT1A10, UGT1A7, UGT1A5, UGT1A9, UGT1A8, UGT1A6, UGT1A1, UGT1A3			ENSG00000244474, ENSG00000242515, ENSG00000244122, ENSG00000288705, ENSG00000241119, ENSG00000242366, ENSG00000167165, ENSG00000241635, ENSG00000288702			rs929596-?	rs929596	0	929596	intron_variant	0	NR	1E-10	10.0				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233764593	NR	UGT1A7, UGT1A3, UGT1A6, UGT1A4, UGT1A10, UGT1A8, UGT1A5, UGT1A9, UGT1A1			ENSG00000244122, ENSG00000288702, ENSG00000167165, ENSG00000244474, ENSG00000242515, ENSG00000242366, ENSG00000288705, ENSG00000241119, ENSG00000241635			rs3771341-?	rs3771341	0	3771341	intron_variant	0	NR	1E-10	10.0				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233741916	NR	UGT1A4, UGT1A5, UGT1A6, UGT1A10, UGT1A3, UGT1A8, UGT1A9, UGT1A7			ENSG00000244474, ENSG00000288705, ENSG00000167165, ENSG00000242515, ENSG00000288702, ENSG00000242366, ENSG00000241119, ENSG00000244122			rs34352510-?	rs34352510	0	34352510	non_coding_transcript_exon_variant	0	NR	3E-10	9.522878745280337				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233749337	NR	UGT1A7, UGT1A6, UGT1A4, UGT1A3, UGT1A5, UGT1A9, UGT1A10, UGT1A8			ENSG00000244122, ENSG00000167165, ENSG00000244474, ENSG00000288702, ENSG00000288705, ENSG00000241119, ENSG00000242515, ENSG00000242366			rs10179091-?	rs10179091	0	10179091	intron_variant	0	NR	1E-9	9.0				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233757136	NR	UGT1A6, UGT1A3, UGT1A10, UGT1A4, UGT1A7, UGT1A9, UGT1A8, UGT1A5			ENSG00000167165, ENSG00000288702, ENSG00000242515, ENSG00000244474, ENSG00000244122, ENSG00000241119, ENSG00000242366, ENSG00000288705			rs10929302-?	rs10929302	0	10929302	intron_variant	0	NR	2E-9	8.698970004336019				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233755708	NR	UGT1A8, UGT1A3, UGT1A4, UGT1A6, UGT1A5, UGT1A10, UGT1A7, UGT1A9			ENSG00000242366, ENSG00000288702, ENSG00000244474, ENSG00000167165, ENSG00000288705, ENSG00000242515, ENSG00000244122, ENSG00000241119			rs6747843-?	rs6747843	0	6747843	non_coding_transcript_exon_variant	0	NR	2E-9	8.698970004336019				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233756119	NR	UGT1A4, UGT1A7, UGT1A3, UGT1A8, UGT1A5, UGT1A6, UGT1A9, UGT1A10			ENSG00000244474, ENSG00000244122, ENSG00000288702, ENSG00000242366, ENSG00000288705, ENSG00000167165, ENSG00000241119, ENSG00000242515			rs6714634-?	rs6714634	0	6714634	non_coding_transcript_exon_variant	0	NR	2E-9	8.698970004336019				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233750415	NR	UGT1A4, UGT1A9, UGT1A10, UGT1A6, UGT1A8, UGT1A5, UGT1A3, UGT1A7			ENSG00000244474, ENSG00000241119, ENSG00000242515, ENSG00000167165, ENSG00000242366, ENSG00000288705, ENSG00000288702, ENSG00000244122			rs2885296-?	rs2885296	0	2885296	intron_variant	0	NR	2E-9	8.698970004336019				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233745803	NR	UGT1A3, UGT1A6, UGT1A8, UGT1A9, UGT1A4, UGT1A7, UGT1A5, UGT1A10			ENSG00000288702, ENSG00000167165, ENSG00000242366, ENSG00000241119, ENSG00000244474, ENSG00000244122, ENSG00000288705, ENSG00000242515			rs11695484-?	rs11695484	0	11695484	intron_variant	0	NR	3E-9	8.522878745280337				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233755414	NR	UGT1A3, UGT1A8, UGT1A7, UGT1A5, UGT1A4, UGT1A10, UGT1A6, UGT1A9			ENSG00000288702, ENSG00000242366, ENSG00000244122, ENSG00000288705, ENSG00000244474, ENSG00000242515, ENSG00000167165, ENSG00000241119			rs11673726-?	rs11673726	0	11673726	non_coding_transcript_exon_variant	0	NR	4E-9	8.397940008672037				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233744071	NR	UGT1A8, UGT1A4, UGT1A10, UGT1A7, UGT1A3, UGT1A6, UGT1A9, UGT1A5			ENSG00000242366, ENSG00000244474, ENSG00000242515, ENSG00000244122, ENSG00000288702, ENSG00000167165, ENSG00000241119, ENSG00000288705			rs17864701-?	rs17864701	0	17864701	intron_variant	0	NR	5E-9	8.301029995663981				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	7q22.1	7	103480601	NR	RELN			ENSG00000189056			rs3808044-?	rs3808044	0	3808044	non_coding_transcript_exon_variant	0		2E-6	5.698970004336019	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	10q22.1	10	69552267	NR	TMEM256P1 - NEUROG3	ENSG00000233197	ENSG00000122859		28617	19431	rs10823406-?	rs10823406	0	10823406	regulatory_region_variant	1		9E-6	5.045757490560675	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	15q25.1	15	78324744	NR	WDR61 - CRABP1	ENSG00000140395	ENSG00000166426		25041	15609	rs8040826-?	rs8040826	0	8040826	regulatory_region_variant	1		4E-6	5.3979400086720375	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	15q21.2	15	51861156	NR	TMOD3			ENSG00000138594			rs2570249-?	rs2570249	0	2570249	non_coding_transcript_exon_variant	0		5E-6	5.301029995663981	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	15q21.2	15	51909434	NR	TMOD3			ENSG00000138594			rs2570218-?	rs2570218	0	2570218	3_prime_UTR_variant	0		5E-6	5.301029995663981	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	15q21.2	15	51938495	NR	TMOD3, LEO1			ENSG00000138594, ENSG00000166477			rs2554341-?	rs2554341	0	2554341	intron_variant	0		6E-6	5.221848749616356	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	15q21.2	15	51942335	NR	LEO1, TMOD3			ENSG00000166477, ENSG00000138594			rs2554321-?	rs2554321	0	2554321	intron_variant	0		6E-6	5.221848749616356	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	18q21.2	18	55083238	NR	NA - LINC01929		ENSG00000267013			22666	rs4309482-?	rs4309482	0	4309482	intergenic_variant	1		9E-6	5.045757490560675	(African)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2p25.1	2	8728387	NR	KIDINS220			ENSG00000134313			rs74885319-?	rs74885319	0	74885319	intron_variant	0		2E-6	5.698970004336019	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2p25.1	2	8736912	NR	KIDINS220			ENSG00000134313			rs61742863-?	rs61742863	0	61742863	synonymous_variant	0		2E-6	5.698970004336019	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2p25.1	2	8739425	NR	KIDINS220			ENSG00000134313			rs72786317-?	rs72786317	0	72786317	intron_variant	0		2E-6	5.698970004336019	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	4q24	4	100647799	NR	EMCN			ENSG00000164035			rs10025419-?	rs10025419	0	10025419	intron_variant	0		1E-6	6.0	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	4q24	4	100649444	NR	EMCN			ENSG00000164035			rs2866233-?	rs2866233	0	2866233	intron_variant	0		1E-6	6.0	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	4q24	4	100619148	NR	EMCN			ENSG00000164035			rs2866220-?	rs2866220	0	2866220	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	4q24	4	100620445	NR	EMCN			ENSG00000164035			rs12505444-?	rs12505444	0	12505444	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	4q24	4	100621270	NR	EMCN			ENSG00000164035			rs4493542-?	rs4493542	0	4493542	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	4q24	4	100632743	NR	EMCN			ENSG00000164035			rs4417977-?	rs4417977	0	4417977	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	4q24	4	100633888	NR	EMCN			ENSG00000164035			rs4635820-?	rs4635820	0	4635820	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	4q24	4	100634019	NR	EMCN			ENSG00000164035			rs6532889-?	rs6532889	0	6532889	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	4q24	4	100634613	NR	EMCN			ENSG00000164035			rs4334765-?	rs4334765	0	4334765	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	4q24	4	100641700	NR	EMCN			ENSG00000164035			rs2903216-?	rs2903216	0	2903216	intron_variant	0		3E-6	5.522878745280337	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA				NR							chr4:101569837-?	chr4:101569837	0			1		3E-6	5.522878745280337	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	4q22.3	4	95471966	NR	UNC5C			ENSG00000182168			rs10013079-?	rs10013079	0	10013079	intron_variant	0		4E-6	5.3979400086720375	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	4q24	4	100630158	NR	EMCN			ENSG00000164035			rs4401457-?	rs4401457	0	4401457	intron_variant	0		5E-6	5.301029995663981	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Tenofovir clearance in HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	4q22.3	4	95471966	NR	UNC5C			ENSG00000182168			rs10013079-?	rs10013079	0	10013079	intron_variant	0		5E-6	5.301029995663981	(EA)			Illumina [~ 5190000] (imputed)	N	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279	GCST006073	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233740656	NR	UGT1A5, UGT1A8, UGT1A3, UGT1A6, UGT1A4, UGT1A9, UGT1A10, UGT1A7			ENSG00000288705, ENSG00000242366, ENSG00000288702, ENSG00000167165, ENSG00000244474, ENSG00000241119, ENSG00000242515, ENSG00000244122			rs17862875-?	rs17862875	0	17862875	intron_variant	0	NR	6E-9	8.221848749616356				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233747994	NR	UGT1A7, UGT1A10, UGT1A6, UGT1A8, UGT1A4, UGT1A3, UGT1A2P, UGT1A5, UGT1A9			ENSG00000244122, ENSG00000242515, ENSG00000167165, ENSG00000242366, ENSG00000244474, ENSG00000288702, ENSG00000228445, ENSG00000288705, ENSG00000241119			rs11888459-?	rs11888459	0	11888459	non_coding_transcript_exon_variant	0	NR	6E-9	8.221848749616356				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233749231	NR	UGT1A4, UGT1A10, UGT1A7, UGT1A6, UGT1A5, UGT1A9, UGT1A3, UGT1A8			ENSG00000244474, ENSG00000242515, ENSG00000244122, ENSG00000167165, ENSG00000288705, ENSG00000241119, ENSG00000288702, ENSG00000242366			rs10178992-?	rs10178992	0	10178992	intron_variant	0	NR	6E-9	8.221848749616356				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233749470	NR	UGT1A10, UGT1A7, UGT1A6, UGT1A5, UGT1A4, UGT1A3, UGT1A9, UGT1A8			ENSG00000242515, ENSG00000244122, ENSG00000167165, ENSG00000288705, ENSG00000244474, ENSG00000288702, ENSG00000241119, ENSG00000242366			rs7604115-?	rs7604115	0	7604115	intron_variant	0	NR	6E-9	8.221848749616356				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2018-08-13	26148204	Wanga V	2015-09-01	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/26148204	Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.	Bilirubin levels in tenofovir-treated HIV infection	243 European ancestry cases, 149 African American cases, 100 Hispanic American cases, 9 unknown ancestry cases	NA	2q37.1	2	233755003	NR	UGT1A7, UGT1A5, UGT1A4, UGT1A10, UGT1A6, UGT1A9, UGT1A8, UGT1A3			ENSG00000244122, ENSG00000288705, ENSG00000244474, ENSG00000242515, ENSG00000167165, ENSG00000241119, ENSG00000242366, ENSG00000288702			rs10929301-?	rs10929301	0	10929301	splice_region_variant	0	NR	7E-9	8.154901959985743				Illumina [~ 5190000] (imputed)	N	bilirubin measurement, response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0004570, http://www.ebi.ac.uk/efo/EFO_0009279	GCST006074	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	6p21.33	6	31368014	HLA-B, MIR6891	DHFRP2 - RNU6-283P	ENSG00000230016	ENSG00000201658		1116	2120	rs57989216-A	rs57989216	0	57989216	intron_variant	1	0.053	7E-13	12.154901959985743		0.4	[0.28-0.52] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	4p15.1	4	28961215	intergenic	NA - LINC02364		ENSG00000250190			35283	rs11933652-C	rs11933652	0	11933652	intergenic_variant	1	0.117	3E-16	15.522878745280337		0.3	[0.23-0.37] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	1p36.13	1	18240357	IGSF21	IGSF21			ENSG00000117154			rs2883821-C	rs2883821	0	2883821	intron_variant	0	0.802	1E-15	15.0		0.23	[0.18-0.29] unit increase	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	1p36.13	1	19308470	AKR7A2, PQLC2	AKR7A2			ENSG00000053371			rs859208-G	rs859208	0	859208	missense_variant	0	0.069	2E-17	16.69897000433602		0.42	[0.33-0.52] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	1p35.1	1	32362000	BSDC1, TSSK3, FAM229A	TSSK3, FAM229A			ENSG00000162526, ENSG00000225828			rs57541735-C	rs57541735	0	57541735	missense_variant	0	0.058	4E-16	15.397940008672037		0.44	[0.33-0.54] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	1p34.3	1	34749623	intergenic	SMIM12			ENSG00000163866			rs626096-T	rs626096	0	626096	intron_variant	0	0.056	2E-16	15.698970004336019		0.41	[0.32-0.51] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	1p34.2	1	42960707	SLC2A1, SLC2A1-AS1	SLC2A1-AS1			ENSG00000227533			rs3806400-T	rs3806400	0	3806400	intron_variant	0	0.114	1E-17	17.0		0.31	[0.24-0.38] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	1q23.3	1	164652278	PBX1	PBX1			ENSG00000185630			rs2800778-T	rs2800778	0	2800778	intron_variant	0	0.944	2E-21	20.69897000433602		0.53	[0.42-0.63] unit increase	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	1q24.2	1	167426238	CD247, POU2F1	POU2F1			ENSG00000143190			rs552304070-A	rs552304070	1	58096512	3_prime_UTR_variant	0	0.932	6E-17	16.221848749616356		0.42	[0.33-0.52] unit increase	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	1q43	1	242242264	PLD5	PLD5			ENSG00000180287			rs429360-T	rs429360	0	429360	intron_variant	0	0.945	7E-21	20.154901959985743		0.48	[0.38-0.58] unit increase	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	1q44	1	244750932	intergenic	DESI2 - COX20	ENSG00000121644	ENSG00000203667		41899	84684	rs113974007-C	rs113974007	0	113974007	intergenic_variant	1	0.078	1E-15	15.0		0.35	[0.27-0.44] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	2p25.3	2	3630187	COLEC11	COLEC11			ENSG00000118004			rs7602243-G	rs7602243	0	7602243	intron_variant	0	0.053	8E-17	16.096910013008056		0.47	[0.36-0.58] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	2p23.3	2	24946443	DNAJC27	DNAJC27			ENSG00000115137			rs74654316-A	rs74654316	0	74654316	3_prime_UTR_variant	0	0.088	1E-15	15.0		0.33	[0.25-0.41] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	2p23.2	2	28788221	PPP1CB	PPP1CB, SPDYA			ENSG00000213639, ENSG00000163806			rs10182825-A	rs10182825	0	10182825	intron_variant	0	0.079	4E-19	18.397940008672037		0.39	[0.3-0.47] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	2p23.1	2	29804123	ALK	ALK			ENSG00000171094			rs6731759-G	rs6731759	0	6731759	intron_variant	0	0.443	7E-18	17.154901959985743		0.2	[0.16-0.25] unit increase	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	2p16.1	2	58218738	FANCL	FANCL			ENSG00000115392			rs6742445-T	rs6742445	0	6742445	intron_variant	0	0.07	4E-16	15.397940008672037		0.4	[0.31-0.5] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	2q22.1	2	136609937	intergenic	SMC4P1 - NA	ENSG00000229568			64395		rs13391004-A	rs13391004	0	13391004	intergenic_variant	1	0.079	1E-15	15.0		0.35	[0.26-0.43] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	3p24.1	3	30504455	intergenic	NA - LINC01985		ENSG00000227260			14378	rs72847487-T	rs72847487	0	72847487	regulatory_region_variant	1	0.095	7E-17	16.154901959985743		0.33	[0.26-0.41] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	3p21.31	3	45527650	LARS2	LARS2			ENSG00000011376			rs2578673-T	rs2578673	0	2578673	intron_variant	0	0.927	4E-16	15.397940008672037		0.4	[0.3-0.49] unit increase	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	3p21.31	3	46410189	CCRL2	CCRL2			ENSG00000121797			rs1015164-A	rs1015164	0	1015164	intron_variant	0	0.792	1E-15	15.0		0.23	[0.18-0.29] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	3p14.2	3	62542448	CADPS	CADPS			ENSG00000163618			rs1349596-T	rs1349596	0	1349596	intron_variant	0	0.075	6E-18	17.221848749616356		0.38	[0.3-0.47] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	3p14.1	3	65852193	MAGI1	MAGI1			ENSG00000151276			rs77700841-C	rs77700841	0	77700841	intron_variant	0	0.086	4E-16	15.397940008672037		0.34	[0.26-0.42] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	3q24	3	143686482	SLC9A9	SLC9A9			ENSG00000181804			rs1868175-A	rs1868175	0	1868175	intron_variant	0	0.748	7E-17	16.154901959985743		0.22	[0.17-0.27] unit increase	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	3q29	3	196941488	NCBP2, NCBP2-AS2, PIGZ	NCBP2, NCBP2-AS1			ENSG00000114503, ENSG00000225578			rs548853-C	rs548853	0	548853	splice_region_variant	0	0.53	2E-17	16.69897000433602		0.2	[0.15-0.24] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	4p16.1	4	9686390	intergenic	ENPP7P11 - FAM86MP	ENSG00000250942	ENSG00000186234		8456	6105	rs7691759-T	rs7691759	0	7691759	intron_variant	1	0.72	3E-16	15.522878745280337		0.21	[0.16-0.26] unit increase	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	4p15.2	4	22173148	intergenic	RNU6-420P - NA	ENSG00000239001			54059		rs7697101-T	rs7697101	0	7697101	intron_variant	1	0.588	8E-16	15.096910013008056		0.19	[0.15-0.24] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	4p14	4	40240871	RHOH	RHOH			ENSG00000168421			rs148332376-T	rs148332376	0	148332376	intron_variant	0	0.07	7E-16	15.154901959985743		0.4	[0.3-0.5] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	4q12	4	56781880	intergenic	RPL17P20 - RN7SL492P	ENSG00000241250	ENSG00000240545		71266	12468	rs9992616-C	rs9992616	0	9992616	intergenic_variant	1	0.705	3E-16	15.522878745280337		0.21	[0.16-0.26] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	4q13.3	4	70997893	DCK	MOB1B, DCK			ENSG00000173542, ENSG00000156136			rs9993633-A	rs9993633	0	9993633	intron_variant	0	0.109	8E-16	15.096910013008056		0.3	[0.23-0.38] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	4q23	4	99522696	C4orf17	C4orf17			ENSG00000138813			rs17029090-G	rs17029090	0	17029090	synonymous_variant	0	0.081	2E-16	15.698970004336019		0.35	[0.27-0.44] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	4q35.2	4	187219164	intergenic	LINC02374 - NA	ENSG00000249747			9818		rs35290534-C	rs35290534	0	35290534	regulatory_region_variant	1	0.41	6E-16	15.221848749616356		0.19	[0.15-0.24] unit increase	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	5p15.2	5	10133592	intergenic	NA - ATPSCKMT		ENSG00000150756			91915	rs2662411-G	rs2662411	0	2662411	intergenic_variant	1	0.518	1E-15	15.0		0.19	[0.14-0.23] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	5q23.1	5	117580137	LINC00992	LINC00992 - NA	ENSG00000248663			33839		rs7719972-A	rs7719972	0	7719972	intergenic_variant	1	0.075	3E-18	17.522878745280337		0.39	[0.3-0.47] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	5q31.2	5	139413007	DNAJC18	DNAJC18			ENSG00000170464			rs9285942-A	rs9285942	0	9285942	3_prime_UTR_variant	0	0.057	2E-16	15.698970004336019		0.42	[0.32-0.52] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	5q31.3	5	142644691	FGF1	SPRY4-AS1, FGF1			ENSG00000231185, ENSG00000113578			rs2070715-C	rs2070715	0	2070715	intron_variant	0	0.46	5E-16	15.301029995663981		0.19	[0.15-0.24] unit increase	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	5q35.1	5	170487960	KCNIP1	KCNIP1			ENSG00000182132			rs10039039-T	rs10039039	0	10039039	intron_variant	0	0.083	1E-16	16.0		0.35	[0.27-0.43] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	5q35.3	5	179974542	RNF130	RNF130			ENSG00000113269			rs17079875-A	rs17079875	0	17079875	intron_variant	0	0.07	9E-16	15.045757490560675		0.37	[0.28-0.46] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	6p25.3	6	1545111	intergenic	RN7SL352P - FOXCUT	ENSG00000243439	ENSG00000280916		37513	56543	rs6596833-C	rs6596833	0	6596833	intergenic_variant	1	0.086	4E-16	15.397940008672037		0.34	[0.26-0.42] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	6p22.1	6	28925757	TRIM27	TRIM27 - LINC01556	ENSG00000237462	ENSG00000231041		1769	18120	rs3131103-G	rs3131103	0	3131103	intergenic_variant	1	0.07	9E-16	15.045757490560675		0.37	[0.28-0.46] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	6p21.31	6	33957119	intergenic	MIR7159 - MIR1275	ENSG00000276824	ENSG00000221697		57919	42853	rs9688730-C	rs9688730	0	9688730	intergenic_variant	1	0.062	9E-18	17.045757490560675		0.42	[0.32-0.51] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA				FUT9							chr6:96634970-A	chr6:96634970	0			1	0.929	2E-17	16.69897000433602		0.42	[0.32-0.51] unit increase	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	6q24.2	6	144158325	STX11	STX11			ENSG00000135604			rs7755842-T	rs7755842	0	7755842	intron_variant	0	0.082	2E-17	16.69897000433602		0.36	[0.28-0.44] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	6q25.1	6	148588135	intergenic	SNRPEP6 - RPSAP40	ENSG00000217824	ENSG00000231368		20481	59572	rs60463810-T	rs60463810	0	60463810	intergenic_variant	1	0.108	6E-16	15.221848749616356		0.3	[0.23-0.38] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	6q27	6	166681163	RPS6KA2	RPS6KA2			ENSG00000071242			rs718084-T	rs718084	0	718084	intron_variant	0	0.398	8E-17	16.096910013008056		0.2	[0.15-0.25] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	7p15.3	7	21927090	CDCA7L	CDCA7L			ENSG00000164649			rs12532102-A	rs12532102	0	12532102	intron_variant	0	0.832	4E-18	17.397940008672037		0.27	[0.21-0.33] unit increase	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	7p15.1	7	28506192	CREB5	CREB5			ENSG00000146592			rs217514-C	rs217514	0	217514	intron_variant	0	0.257	5E-16	15.301029995663981		0.22	[0.17-0.27] unit increase	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	7p14.1	7	40294343	SUGCT	SUGCT			ENSG00000175600			rs17171670-G	rs17171670	0	17171670	intron_variant	0	0.072	3E-17	16.522878745280337		0.38	[0.29-0.47] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	7q22.1	7	99771178	CYP3A4	CYP3A4			ENSG00000160868			rs28908768-TC	rs28908768	0	28908768	intron_variant	0	0.053	3E-18	17.522878745280337		0.45	[0.35-0.55] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	7q36.1	7	151202976	ABCF2	IQCA1L			ENSG00000278685			rs61733346-G	rs61733346	0	61733346	missense_variant	0	0.093	4E-17	16.397940008672037		0.33	[0.26-0.41] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA				intergenic							chr7:155175005-T	chr7:155175005	0			1	0.059	4E-16	15.397940008672037		0.4	[0.3-0.49] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	8p23.1	8	6894170	intergenic	GS1-24F4.2 - RPL23AP96	ENSG00000245857	ENSG00000250752		8894	4708	rs28711761-G	rs28711761	0	28711761	intergenic_variant	1	0.07	8E-19	18.096910013008056		0.4	[0.32-0.49] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	8q11.23	8	54303623	intergenic	NA - RNU105C		ENSG00000199212			27064	rs56775982-T	rs56775982	0	56775982	regulatory_region_variant	1	0.091	2E-17	16.69897000433602		0.34	[0.27-0.42] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	8q21.13	8	80793161	ZNF704	ZNF704			ENSG00000164684			rs7006546-C	rs7006546	0	7006546	intron_variant	0	0.239	4E-17	16.397940008672037		0.23	[0.18-0.28] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	9q21.13	9	74737882	TRPM6	TRPM6			ENSG00000119121			rs944857-G	rs944857	0	944857	intron_variant	0	0.268	4E-16	15.397940008672037		0.21	[0.16-0.27] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	9q21.33	9	85800845	intergenic	AGTPBP1 - PHBP7	ENSG00000135049	ENSG00000213711		58816	98058	rs73649983-T	rs73649983	0	73649983	intron_variant	1	0.06	1E-15	15.0		0.43	[0.32-0.53] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	9q34.2	9	133934793	VAV2	VAV2			ENSG00000160293			rs2789845-C	rs2789845	0	2789845	intron_variant	0	0.805	9E-16	15.045757490560675		0.24	[0.18-0.29] unit increase	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	10p12.1	10	25728984	LINC00836	LINC00836			ENSG00000280809			rs2505447-A	rs2505447	0	2505447	intron_variant	0	0.769	1E-15	15.0		0.22	[0.17-0.28] unit increase	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	10q22.3	10	76449748	C10orf11	LRMDA			ENSG00000148655			rs72642263-G	rs72642263	0	72642263	intron_variant	0	0.095	2E-16	15.698970004336019		0.33	[0.25-0.4] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	10q23.1	10	85322237	intergenic	CUX2P1 - LINC02647	ENSG00000272436	ENSG00000223993		75064771	56090	rs6585943-A	rs6585943	0	6585943	intergenic_variant	1	0.394	8E-16	15.096910013008056		0.19	[0.15-0.24] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	11p15.5	11	1897978	intergenic	LINC01150			ENSG00000229671			rs61433759-G	rs61433759	0	61433759	intron_variant	0	0.067	2E-16	15.698970004336019		0.39	[0.29-0.48] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	11p13	11	34267878	ABTB2	ABTB2			ENSG00000166016			rs73495598-T	rs73495598	0	73495598	intron_variant	0	0.083	5E-21	20.30102999566398		0.4	[0.32-0.48] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	11p11.2	11	46918742	LRP4	LRP4 - C11orf49	ENSG00000134569	ENSG00000149179		100	17947	rs78245588-T	rs78245588	0	78245588	regulatory_region_variant	1	0.063	1E-17	17.0		0.44	[0.34-0.55] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	11q14.3	11	91221441	intergenic	LINC02748			ENSG00000255187			rs2514923-C	rs2514923	0	2514923	intron_variant	0	0.602	6E-16	15.221848749616356		0.19	[0.15-0.24] unit increase	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	11q24.3	11	129980320	PRDM10	PRDM10			ENSG00000170325			rs7130078-A	rs7130078	0	7130078	intron_variant	0	0.057	2E-18	17.69897000433602		0.44	[0.34-0.54] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	11q24.3	11	130190674	ST14	ST14			ENSG00000149418			rs7126904-A	rs7126904	0	7126904	missense_variant	0	0.072	3E-19	18.522878745280337		0.44	[0.35-0.54] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	11q25	11	131630365	NTM	NTM, NTM-AS1			ENSG00000182667, ENSG00000224795			rs78430868-A	rs78430868	0	78430868	intron_variant	0	0.068	1E-16	16.0		0.39	[0.3-0.48] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	12p13.31	12	8336986	intergenic	LINC00937			ENSG00000226091			rs2953235-G	rs2953235	0	2953235	intron_variant	0	0.586	6E-16	15.221848749616356		0.19	[0.15-0.24] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA				KERA							chr12:91449984-T	chr12:91449984	0			1	0.232	8E-17	16.096910013008056		0.23	[0.18-0.28] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	12q24.11	12	111266635	CUX2	CUX2			ENSG00000111249			rs2157999-A	rs2157999	0	2157999	intron_variant	0	0.078	4E-16	15.397940008672037		0.35	[0.27-0.44] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	13q14.11	13	41459562	RGCC	RGCC			ENSG00000102760			rs10467472-C	rs10467472	0	10467472	intron_variant	0	0.243	6E-16	15.221848749616356		0.22	[0.17-0.27] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	13q32.1	13	97248751	MBNL2	MBNL2			ENSG00000139793			rs75122859-T	rs75122859	0	75122859	intron_variant	0	0.065	3E-18	17.522878745280337		0.45	[0.35-0.55] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	14q32.33	14	106125683	intergenic	IGHV1-12 - IGHV3-13	ENSG00000282366	ENSG00000211942		2974	3857	rs28508297-C	rs28508297	0	28508297	intergenic_variant	1	0.086	5E-17	16.30102999566398		0.35	[0.27-0.43] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	14q32.33	14	106587377	intergenic	IGHV3-52 - IGHV3-53	ENSG00000282188	ENSG00000211967		551	5299	rs2516928-T	rs2516928	0	2516928	regulatory_region_variant	1	0.069	1E-15	15.0		0.4	[0.3-0.49] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	15q11.2	15	23569519	MKRN3	MKRN3			ENSG00000179455			rs6576462-C	rs6576462	0	6576462	non_coding_transcript_exon_variant	0	0.937	1E-15	15.0		0.39	[0.29-0.48] unit increase	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	16p13.3	16	3739076	CREBBP	CREBBP			ENSG00000005339			rs3025678-T	rs3025678	0	3025678	intron_variant	0	0.059	3E-18	17.522878745280337		0.43	[0.33-0.52] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	16p11.1	16	35734888	intergenic	RNA5SP407 - RNA5SP408	ENSG00000222207	ENSG00000251924		140	484	rs17841547-G	rs17841547	0	17841547	intergenic_variant	1	0.063	8E-16	15.096910013008056		0.38	[0.29-0.48] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	16q23.1	16	74411734	CLEC18B	CLEC18B			ENSG00000140839			rs150933152-T	rs150933152	0	150933152	missense_variant	0	0.072	8E-18	17.096910013008056		0.42	[0.33-0.52] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	17p13.3	17	2872448	RAP1GAP2	RAP1GAP2			ENSG00000132359			rs4287603-A	rs4287603	0	4287603	intron_variant	0	0.372	6E-17	16.221848749616356		0.2	[0.15-0.25] unit increase	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	17p12	17	13627527	intergenic	HS3ST3A1 - NA	ENSG00000153976			25598		rs28404523-A	rs28404523	0	28404523	intergenic_variant	1	0.222	2E-16	15.698970004336019		0.23	[0.18-0.29] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	17q21.2	17	41746019	intergenic	HAP1 - JUP	ENSG00000173805	ENSG00000173801		11375	8585	rs7219088-T	rs7219088	0	7219088	intergenic_variant	1	0.584	1E-15	15.0		0.19	[0.14-0.24] unit increase	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	18p11.31	18	5940342	intergenic	TMEM200C - L3MBTL4	ENSG00000206432	ENSG00000154655		44387	14364	rs8094014-G	rs8094014	0	8094014	intron_variant	1	0.139	3E-19	18.522878745280337		0.3	[0.24-0.37] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	18q21.1	18	48131482	ZBTB7C	ZBTB7C			ENSG00000184828			rs79272944-T	rs79272944	0	79272944	intron_variant	0	0.06	5E-16	15.301029995663981		0.4	[0.3-0.49] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	18q21.32	18	59519354	CCBE1	CCBE1			ENSG00000183287			rs949214-C	rs949214	0	949214	intron_variant	0	0.303	6E-16	15.221848749616356		0.21	[0.16-0.26] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	19p13.2	19	8085509	FBN3	FBN3			ENSG00000142449			rs17160151-T	rs17160151	0	17160151	missense_variant	0	0.064	2E-19	18.69897000433602		0.42	[0.33-0.52] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	19p12	19	20118360	ZNF90	ZNF90			ENSG00000213988			rs61998208-T	rs61998208	0	61998208	missense_variant	0	0.055	9E-16	15.045757490560675		0.45	[0.34-0.55] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	19q13.11	19	32543335	intergenic	DPY19L3 - PDCD5	ENSG00000178904	ENSG00000105185		57440	37855	rs7250377-T	rs7250377	0	7250377	regulatory_region_variant	1	0.101	8E-16	15.096910013008056		0.31	[0.24-0.38] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	19q13.42	19	54162804	LENG1, TMC4	TMC4, TMC4, TMC4, TMC4, TMC4			ENSG00000277789, ENSG00000274384, ENSG00000167608, ENSG00000278363, ENSG00000273722			rs9636146-A	rs9636146	0	9636146	intron_variant	0	0.063	2E-16	15.698970004336019		0.4	[0.3-0.49] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	20p13	20	5079306	intergenic	TMEM230			ENSG00000089063			rs11905359-A	rs11905359	0	11905359	intron_variant	0	0.068	2E-16	15.698970004336019		0.38	[0.29-0.48] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	21q11.2	21	13297803	intergenic	NA - FGF7P2		ENSG00000185390			51462	rs2801270-G	rs2801270	0	2801270	intergenic_variant	1	0.084	3E-17	16.522878745280337		0.35	[0.27-0.44] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	21q21.3	21	26678731	intergenic							rs9975780-T	rs9975780	0	9975780	intergenic_variant	1	0.105	2E-17	16.69897000433602		0.33	[0.25-0.4] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	21q22.3	21	43056923	CBS	CBS			ENSG00000160200			rs1005585-C	rs1005585	0	1005585	intron_variant	0	0.115	1E-15	15.0		0.29	[0.22-0.36] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	21q22.3	21	46430193	PCNT	PCNT			ENSG00000160299			rs8131693-A	rs8131693	0	8131693	missense_variant	0	0.052	1E-16	16.0		0.43	[0.33-0.54] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2019-09-24	31219150	Ekenberg C	2019-06-13	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/31219150	Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-nave participants from the START trial.	Pre-treatment viral load in HIV-1 infection	1,398 European ancestry individuals, 572 Black individuals, 418 Hispanic individuals, 13 Asian ancestry individuals, 39 individuals	NA	22q11.1	22	16587858	CCT8L2	KCNMB3P1 - CCT8L2	ENSG00000239435	ENSG00000198445		5151	2893	rs5993499-T	rs5993499	0	5993499	intergenic_variant	1	0.068	4E-16	15.397940008672037		0.38	[0.29-0.47] unit decrease	Affymetrix [339439]	N	viral load	http://www.ebi.ac.uk/efo/EFO_0010125	GCST008758	Genome-wide genotyping array
2017-08-03	28447399	Jia P	2017-04-26	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/28447399	Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.	Neurocognitive impairment in HIV-1 infection (continuous)	490 African American individuals, 443 European ancestry individuals, 99 Hispanic individuals, 17 individuals	NA	14q11.2	14	22168978	TRA-alpha	TRAV30			ENSG00000259092			rs11157436-T	rs11157436	0	11157436	synonymous_variant	0	NR	2E-7	6.698970004336019		0.155	unit increase	Affymetrix [NR]	N	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	GCST004406	Genome-wide genotyping array
2017-08-03	28447399	Jia P	2017-04-26	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/28447399	Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.	Neurocognitive impairment in HIV-1 infection (continuous)	490 African American individuals, 443 European ancestry individuals, 99 Hispanic individuals, 17 individuals	NA	19p13.2	19	8066356	CCL25, FBN3	FBN3			ENSG00000142449			rs12460243-A	rs12460243	0	12460243	intron_variant	0		4E-7	6.3979400086720375		0.166	unit increase	Affymetrix [NR]	N	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	GCST004406	Genome-wide genotyping array
2017-08-03	28447399	Jia P	2017-04-26	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/28447399	Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.	Neurocognitive impairment in HIV-1 infection (continuous)	490 African American individuals, 443 European ancestry individuals, 99 Hispanic individuals, 17 individuals	NA	3p26.3	3	1383484	CNTN6	CNTN6			ENSG00000134115			rs17038463-G	rs17038463	0	17038463	intron_variant	0		1E-6	6.0		0.173	unit increase	Affymetrix [NR]	N	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	GCST004406	Genome-wide genotyping array
2017-08-03	28447399	Jia P	2017-04-26	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/28447399	Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.	Neurocognitive impairment in HIV-1 infection (continuous)	490 African American individuals, 443 European ancestry individuals, 99 Hispanic individuals, 17 individuals	NA	18q12.3	18	44344072	intergenic	LINC01478			ENSG00000267337			rs978490-A	rs978490	0	978490	intron_variant	0		2E-6	5.698970004336019		0.168	unit increase	Affymetrix [NR]	N	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	GCST004406	Genome-wide genotyping array
2017-08-03	28447399	Jia P	2017-04-26	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/28447399	Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.	Neurocognitive impairment in HIV-1 infection (continuous)	490 African American individuals, 443 European ancestry individuals, 99 Hispanic individuals, 17 individuals	NA	1p36.12	1	21617011	RAP1GAP	RAP1GAP			ENSG00000076864			rs829418-A	rs829418	0	829418	intron_variant	0		3E-6	5.522878745280337		0.159	unit increase	Affymetrix [NR]	N	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	GCST004406	Genome-wide genotyping array
2017-08-03	28447399	Jia P	2017-04-26	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/28447399	Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.	Neurocognitive impairment in HIV-1 infection (continuous)	490 African American individuals, 443 European ancestry individuals, 99 Hispanic individuals, 17 individuals	NA	8p23.1	8	8752370	intergenic	CLDN23 - MFHAS1	ENSG00000285098	ENSG00000285022		48274	30984	rs17154702-A	rs17154702	0	17154702	intron_variant	1		3E-6	5.522878745280337		0.118	unit decrease	Affymetrix [NR]	N	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	GCST004406	Genome-wide genotyping array
2017-08-03	28447399	Jia P	2017-04-26	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/28447399	Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.	Neurocognitive impairment in HIV-1 infection (dichotomous)	140 African American cases, 167 European ancestry cases, 53 Hispanic cases, 6 cases, 350 African American controls, 276 European ancestry controls, 46 Hispanic controls, 11 controls	NA	2q13	2	109433263	SH3RF3	SH3RF3			ENSG00000172985			rs6542826-G	rs6542826	0	6542826	intron_variant	0		7E-7	6.154901959985743		1.703	[NR]	Affymetrix [NR]	N	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	GCST004407	Genome-wide genotyping array
2017-08-03	28447399	Jia P	2017-04-26	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/28447399	Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.	Neurocognitive impairment in HIV-1 infection (dichotomous)	140 African American cases, 167 European ancestry cases, 53 Hispanic cases, 6 cases, 350 African American controls, 276 European ancestry controls, 46 Hispanic controls, 11 controls	NA	2p13.3	2	70875156	intergenic	CD207 - LINC01143	ENSG00000116031	ENSG00000237751		39340	12715	rs6723162-T	rs6723162	0	6723162	intergenic_variant	1		1E-6	6.0		1.6528925	[NR]	Affymetrix [NR]	N	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	GCST004407	Genome-wide genotyping array
2017-08-03	28447399	Jia P	2017-04-26	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/28447399	Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.	Neurocognitive impairment in HIV-1 infection (dichotomous)	140 African American cases, 167 European ancestry cases, 53 Hispanic cases, 6 cases, 350 African American controls, 276 European ancestry controls, 46 Hispanic controls, 11 controls	NA	3q22.2	3	134499715	ANAPC13, CEP63	CEP63			ENSG00000182923			rs9814567-C	rs9814567	0	9814567	intron_variant	0		2E-6	5.698970004336019		1.6891892	[NR]	Affymetrix [NR]	N	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	GCST004407	Genome-wide genotyping array
2017-08-03	28447399	Jia P	2017-04-26	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/28447399	Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.	Neurocognitive impairment in HIV-1 infection (dichotomous)	140 African American cases, 167 European ancestry cases, 53 Hispanic cases, 6 cases, 350 African American controls, 276 European ancestry controls, 46 Hispanic controls, 11 controls	NA	13q33.3	13	107165321	FAM155A	FAM155A						rs4772857-G	rs4772857	0	4772857	3_prime_UTR_variant	0		2E-6	5.698970004336019		1.604	[NR]	Affymetrix [NR]	N	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	GCST004407	Genome-wide genotyping array
2017-08-03	28447399	Jia P	2017-04-26	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/28447399	Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.	Neurocognitive impairment in HIV-1 infection (dichotomous)	140 African American cases, 167 European ancestry cases, 53 Hispanic cases, 6 cases, 350 African American controls, 276 European ancestry controls, 46 Hispanic controls, 11 controls	NA	12q21.2	12	78269687	intergenic	NAV3 - LINC02424	ENSG00000067798	ENSG00000258220		56677	56993	rs795943-G	rs795943	0	795943	intergenic_variant	1		3E-6	5.522878745280337		1.697793	[NR]	Affymetrix [NR]	N	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	GCST004407	Genome-wide genotyping array
2017-08-03	28447399	Jia P	2017-04-26	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/28447399	Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.	Neurocognitive impairment in HIV-1 infection (dichotomous)	140 African American cases, 167 European ancestry cases, 53 Hispanic cases, 6 cases, 350 African American controls, 276 European ancestry controls, 46 Hispanic controls, 11 controls	NA	8q24.12	8	120089283	intergenic	COL14A1			ENSG00000187955			rs876084-T	rs876084	0	876084	intron_variant	0		5E-6	5.301029995663981		1.5748031	[NR]	Affymetrix [NR]	N	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	GCST004407	Genome-wide genotyping array
2017-08-03	28447399	Jia P	2017-04-26	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/28447399	Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.	Neurocognitive impairment in HIV-1 infection (dichotomous)	140 African American cases, 167 European ancestry cases, 53 Hispanic cases, 6 cases, 350 African American controls, 276 European ancestry controls, 46 Hispanic controls, 11 controls	NA	3q22.2	3	134630088	KY	KY			ENSG00000174611			rs11915964-T	rs11915964	0	11915964	intron_variant	0		6E-6	5.221848749616356		1.6103059	[NR]	Affymetrix [NR]	N	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	GCST004407	Genome-wide genotyping array
2017-08-03	28447399	Jia P	2017-04-26	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/28447399	Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.	Neurocognitive impairment in HIV-1 infection (dichotomous)	140 African American cases, 167 European ancestry cases, 53 Hispanic cases, 6 cases, 350 African American controls, 276 European ancestry controls, 46 Hispanic controls, 11 controls	NA	8q11.22	8	51367179	PXDNL	PXDNL			ENSG00000147485			rs2915495-A	rs2915495	0	2915495	intron_variant	0		8E-6	5.096910013008056		1.698	[NR]	Affymetrix [NR]	N	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	GCST004407	Genome-wide genotyping array
2017-08-03	28447399	Jia P	2017-04-26	Am J Med Genet B Neuropsychiatr Genet	www.ncbi.nlm.nih.gov/pubmed/28447399	Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.	Neurocognitive impairment in HIV-1 infection (dichotomous)	140 African American cases, 167 European ancestry cases, 53 Hispanic cases, 6 cases, 350 African American controls, 276 European ancestry controls, 46 Hispanic controls, 11 controls	NA	8p23.2	8	3820465	CSMD1	CSMD1			ENSG00000183117			rs7840128-A	rs7840128	0	7840128	intron_variant	0		8E-6	5.096910013008056		2.17	[NR]	Affymetrix [NR]	N	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998	GCST004407	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				TAFA2							chr12:62070198-?	chr12:62070198	0			1	NR	7E-7	6.154901959985743				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				DLGAP1							chr18:3724602-?	chr18:3724602	0			1	NR	1E-7	7.0				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				PKN2-AS1							chr1:88527468-?	chr1:88527468	0			1	NR	4E-6	5.3979400086720375				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				DDX1							chr2:15584186-?	chr2:15584186	0			1	NR	1E-6	6.0				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				LOC105374313							chr3:150088196-?	chr3:150088196	0			1	NR	7E-6	5.154901959985743				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				AL158198.1							chr6:20314488-?	chr6:20314488	0			1	NR	4E-6	5.3979400086720375				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				AL139231.1							chr6:23379132-?	chr6:23379132	0			1	NR	5E-6	5.301029995663981				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				AL132996.1							chr6:90301105-?	chr6:90301105	0			1	NR	6E-6	5.221848749616356				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				PTPRN2							chr7:158227455-?	chr7:158227455	0			1	NR	5E-6	5.301029995663981				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				HAS2-AS1							chr8:121836590-?	chr8:121836590	0			1	NR	5E-6	5.301029995663981				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				AC016074.2							chr8:125940223-?	chr8:125940223	0			1	NR	8E-6	5.096910013008056				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				TRIM5							chr11:5670244-?	chr11:5670244	0			1	NR	4E-6	5.3979400086720375				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				LINC02313							chr14:31953540-?	chr14:31953540	0			1	NR	2E-6	5.698970004336019				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				WDR59							chr16:74902133-?	chr16:74902133	0			1	NR	4E-6	5.3979400086720375				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				RN7SKP190							chr16:82304801-?	chr16:82304801	0			1	NR	4E-6	5.3979400086720375				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				MYHAS							chr17:10473241-?	chr17:10473241	0			1	NR	7E-6	5.154901959985743				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				ZNF521							chr18:25044743-?	chr18:25044743	0			1	NR	9E-6	5.045757490560675				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				DPP9							chr19:4717660-?	chr19:4717660	0			1	NR	5E-6	5.301029995663981				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				TINCR							chr19:5518481-?	chr19:5518481	0			1	NR	7E-6	5.154901959985743				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				B3GNT3							chr19:17812745-?	chr19:17812745	0			1	NR	4E-6	5.3979400086720375				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				AL589669.1							chrX:147243907-?	chrX:147243907	0			1	NR	9E-6	5.045757490560675				Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA				SLC6A20, LZTFL1, CCR9, FYCO1, CXCR6, XCR1							rs11385942-GA	rs11385942	0	11385942		1	0.09	1E-10	10.0		1.77	[1.48-2.11]	Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis II)	1,610 European ancestry cases, 2,180 European ancestry controls	NA				SLC6A20, LZTFL1, CCR9, FYCO1, CXCR6, XCR1							rs11385942-GA	rs11385942	0	11385942		1	0.09	9E-12	11.045757490560675		2.11	[1.70-2.61]	Illumina [8582560] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000256	Genome-wide genotyping array
2021-01-11	33307546	Pairo-Castineira E	2020-12-11	Nature	www.ncbi.nlm.nih.gov/pubmed/33307546	Genetic mechanisms of critical illness in Covid-19.	COVID-19 (critical illness vs population)	2,804 European ancestry cases, 2,415 European, South Asian and Hispanic or Latin American ancestry cases, 687,911 European ancestry controls, 477,741 European, South Asian and Hispanic or Latin American ancestry controls	NA	3p21.31	3	45821460		SLC6A20 - LZTFL1	ENSG00000163817	ENSG00000163818		24924	1856	rs71325088-C	rs71325088	0	71325088	non_coding_transcript_exon_variant	1	NR	3E-54	53.52287874528034		1.9	[1.73-2.0]	Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST010936	Genome-wide genotyping array
2021-01-11	33307546	Pairo-Castineira E	2020-12-11	Nature	www.ncbi.nlm.nih.gov/pubmed/33307546	Genetic mechanisms of critical illness in Covid-19.	COVID-19 (critical illness vs population)	2,804 European ancestry cases, 2,415 European, South Asian and Hispanic or Latin American ancestry cases, 687,911 European ancestry controls, 477,741 European, South Asian and Hispanic or Latin American ancestry controls	NA	6p21.33	6	31153649		CCHCR1			ENSG00000206457			rs143334143-A	rs143334143	0	143334143	intron_variant	0	NR	2E-10	9.698970004336019		1.3	[1.27-1.48]	Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST010936	Genome-wide genotyping array
2021-01-11	33307546	Pairo-Castineira E	2020-12-11	Nature	www.ncbi.nlm.nih.gov/pubmed/33307546	Genetic mechanisms of critical illness in Covid-19.	COVID-19 (critical illness vs population)	2,804 European ancestry cases, 2,415 European, South Asian and Hispanic or Latin American ancestry cases, 687,911 European ancestry controls, 477,741 European, South Asian and Hispanic or Latin American ancestry controls	NA	12q24.13	12	112925745		OAS1			ENSG00000089127			rs6489867-T	rs6489867	0	6489867	intron_variant	0	NR	1E-9	9.0		1.2	[1.14-1.25]	Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST010936	Genome-wide genotyping array
2021-01-11	33307546	Pairo-Castineira E	2020-12-11	Nature	www.ncbi.nlm.nih.gov/pubmed/33307546	Genetic mechanisms of critical illness in Covid-19.	COVID-19 (critical illness vs population)	2,804 European ancestry cases, 2,415 European, South Asian and Hispanic or Latin American ancestry cases, 687,911 European ancestry controls, 477,741 European, South Asian and Hispanic or Latin American ancestry controls	NA	19p13.3	19	4719431		DPP9			ENSG00000142002			rs2109069-A	rs2109069	0	2109069	intron_variant	0	NR	7E-13	12.154901959985743		1.2	[1.19-1.31]	Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST010936	Genome-wide genotyping array
2021-01-11	33307546	Pairo-Castineira E	2020-12-11	Nature	www.ncbi.nlm.nih.gov/pubmed/33307546	Genetic mechanisms of critical illness in Covid-19.	COVID-19 (critical illness vs population)	2,804 European ancestry cases, 2,415 European, South Asian and Hispanic or Latin American ancestry cases, 687,911 European ancestry controls, 477,741 European, South Asian and Hispanic or Latin American ancestry controls	NA	19p13.2	19	10355447		TYK2			ENSG00000105397			rs11085727-T	rs11085727	0	11085727	intron_variant	0	NR	1E-13	13.0		1.2	[1.18-1.31]	Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST010936	Genome-wide genotyping array
2021-01-11	33307546	Pairo-Castineira E	2020-12-11	Nature	www.ncbi.nlm.nih.gov/pubmed/33307546	Genetic mechanisms of critical illness in Covid-19.	COVID-19 (critical illness vs population)	2,804 European ancestry cases, 2,415 European, South Asian and Hispanic or Latin American ancestry cases, 687,911 European ancestry controls, 477,741 European, South Asian and Hispanic or Latin American ancestry controls	NA	21q22.11	21	33242905		IFNAR2			ENSG00000159110			rs13050728-T	rs13050728	0	13050728	intron_variant	0	NR	5E-12	11.301029995663981		1.2	[1.16-1.28]	Illumina [NR] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST010936	Genome-wide genotyping array
2021-01-11	33307546	Pairo-Castineira E	2020-12-11	Nature	www.ncbi.nlm.nih.gov/pubmed/33307546	Genetic mechanisms of critical illness in Covid-19.	COVID-19 (critical illness vs population)	1,676 European ancestry cases, 8,380 European ancestry controls	2,415 European, South Asian and Hispanic or Latin American ancestry cases, 477,741 European, South Asian and Hispanic or Latin American ancestry controls, 1,128 European ancestry cases, 679,531 European ancestry controls	3p21.31	3	45859597	LZTFL1	LZTFL1			ENSG00000163818			rs73064425-T	rs73064425	0	73064425	intron_variant	0	NR	2E-28	27.69897000433602		1.7	NR	Illumina [4700000] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90013414	Genome-wide genotyping array
2021-01-11	33307546	Pairo-Castineira E	2020-12-11	Nature	www.ncbi.nlm.nih.gov/pubmed/33307546	Genetic mechanisms of critical illness in Covid-19.	COVID-19 (critical illness vs population)	1,676 European ancestry cases, 8,380 European ancestry controls	2,415 European, South Asian and Hispanic or Latin American ancestry cases, 477,741 European, South Asian and Hispanic or Latin American ancestry controls, 1,128 European ancestry cases, 679,531 European ancestry controls	19p13.2	19	10317045	TYK2	RAVER1			ENSG00000161847			rs74956615-A	rs74956615	0	74956615	3_prime_UTR_variant	0	NR	2E-6	5.698970004336019		1.4	NR	Illumina [4700000] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90013414	Genome-wide genotyping array
2017-06-01	28062682	Carr DF	2017-01-05	J Antimicrob Chemother	www.ncbi.nlm.nih.gov/pubmed/28062682	Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population.	Nevirapine-induced hypersensitivity in HIV	151 Sub-saharan African ancestry cases, 182 Sub-saharan African ancestry controls	62 Sub-Saharan African ancestry cases, 60 Sub-Saharan African ancestry controls	6p21.33	6	31350802	HLA-B	LINC02571 - HLA-B	ENSG00000256166	ENSG00000232126		49160	3070	rs34213790-A	rs34213790	0	34213790	intron_variant	1	0.37	7E-7	6.154901959985743		2.06	[1.55-2.74]	Illumina [14218511] (imputed)	N	response to reverse transcriptase inhibitor, hypersensitivity reaction disease	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_1002003	GCST004118	Genome-wide genotyping array
2017-06-29	28388302	Petros Z	2017-04-01	OMICS	www.ncbi.nlm.nih.gov/pubmed/28388302	Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs.	Liver injury in anti-retroviral drug treated HIV	14 Ethiopian cases with HIV, 293 Ethiopian controls with HIV.	7 Ethiopian cases with HIV, 66 Ethiopian controls with HIV.	17q23.3	17	64044166	ERN1	ERN1			ENSG00000178607			rs199650082-T	rs199650082	0	199650082	missense_variant	0	0.03	2E-6	5.698970004336019		18.2	[7.1-46.9]	Illumina [662282]	N	response to efavirenz, drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0006904, http://www.ebi.ac.uk/efo/EFO_0004228	GCST004261	Genome-wide genotyping array
2021-08-16	32675224	Thorball CW	2020-07-16	Haematologica	www.ncbi.nlm.nih.gov/pubmed/32675224	Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma.	Non-hodgkin's lymphoma in HIV infection	278 European ancestry cases, 1,924 European ancestry controls	NA	10q11.21	10	44178109								rs7919208-?	rs7919208	0	7919208	intergenic_variant	1	NR	5E-11	10.301029995663981		1.23		Illumina [6200000] (imputed)	N	non-Hodgkins lymphoma	http://www.ebi.ac.uk/efo/EFO_0005952	GCST90025870	Genome-wide genotyping array
2022-01-07	33974707	Gabrielaite M	2021-05-11	J Infect Dis	www.ncbi.nlm.nih.gov/pubmed/33974707	Human immunotypes impose selection on viral genotypes through viral epitope specificity.	Viral variant GAG242N carrier status in HIV infection	21 Asian ancestry individuals, 432 African ancestry individuals, 382 Hispanic or Latin American individuals, 1,250 European ancestry individuals, 37 individuals	NA	6p21.33	6	31265339		HCG27 - HLA-C	ENSG00000220890	ENSG00000228299		61371	3410	rs1248395773-?	rs1248395773	0	1248395773	downstream_gene_variant	1	NR	1E-79	79.0				Affymetrix [388501]	N	viral subtype carrier status	http://www.ebi.ac.uk/efo/EFO_0010234	GCST90092542	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis I)	1,610 European ancestry cases, 2,205 European ancestry controls	NA	9q34.2	9	133263862	ABO	ABO, ABO			ENSG00000175164, ENSG00000281879			rs657152-A	rs657152	0	657152	intron_variant	0	0.35	5E-8	7.301029995663981		1.32	[1.20-1.47]	Illumina [8582968] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000255	Genome-wide genotyping array
2020-06-26	32558485	Ellinghaus D	2020-06-17	N Engl J Med	www.ncbi.nlm.nih.gov/pubmed/32558485	Genomewide Association Study of Severe Covid-19 with Respiratory Failure.	Severe COVID-19 infection with respiratory failure (analysis II)	1,610 European ancestry cases, 2,180 European ancestry controls	NA	9q34.2	9	133263862	ABO	ABO, ABO			ENSG00000175164, ENSG00000281879			rs657152-A	rs657152	0	657152	intron_variant	0	0.35	5E-7	6.301029995663981		1.39	[1.22-1.59]	Illumina [8582560] (imputed)	N	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096	GCST90000256	Genome-wide genotyping array
2017-06-01	28062682	Carr DF	2017-01-05	J Antimicrob Chemother	www.ncbi.nlm.nih.gov/pubmed/28062682	Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population.	Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)	21 Sub-saharan African ancestry cases, 182 Sub-saharan African ancestry controls	16 Sub-Saharan African ancestry cases, 27 African ancestry cases, 60 Sub-Saharan African ancestry controls, 8 African ancestry controls	20p13	20	3977969	RNF24	RNF24			ENSG00000101236			rs6139258-C	rs6139258	0	6139258	intron_variant	0	0.02	6E-7	6.221848749616356		13.62	[4.90-37.84]	Illumina [14218511] (imputed)	N	response to reverse transcriptase inhibitor, drug-induced liver injury	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0004228	GCST004114	Genome-wide genotyping array
2017-06-01	28062682	Carr DF	2017-01-05	J Antimicrob Chemother	www.ncbi.nlm.nih.gov/pubmed/28062682	Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population.	Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	51 Sub-saharan African ancestry cases, 182 Sub-saharan African ancestry controls	11 Sub-Saharan African ancestry cases, 27 African ancestry cases, 60 Sub-Saharan African ancestry controls, 8 African ancestry controls	6p21.33	6	31273255	HLA-C	HLA-C - USP8P1	ENSG00000228299	ENSG00000236374		1125	2317	rs5010528-G	rs5010528	0	5010528	intron_variant	1	0.14	8E-8	7.096910013008056		4.84	[2.71-8.61]	Illumina [14218511] (imputed)	N	response to reverse transcriptase inhibitor, Stevens-Johnson syndrome, toxic epidermal necrolysis	http://purl.obolibrary.org/obo/GO_0061479, http://www.ebi.ac.uk/efo/EFO_0004276, http://www.ebi.ac.uk/efo/EFO_0004775	GCST004115	Genome-wide genotyping array
2011-01-13	21051598	Pereyra F	2010-11-04	Science	www.ncbi.nlm.nih.gov/pubmed/21051598	The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.	HIV-1 control	516 European cases, 1,196 European controls, 341 African American cases, 892 African American controls, 117 Hispanic cases, 560 Hispanic controls	NA	6p21.33	6	31423624	MICA	MICA - LINC01149	ENSG00000231225	ENSG00000230174		8309	18043	rs4418214-C	rs4418214	0	4418214	intron_variant	1	0.075	1E-34	34.0	(EA)	4.4	[NR]	Illumina [1384048] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000863	Genome-wide genotyping array
2011-01-13	21051598	Pereyra F	2010-11-04	Science	www.ncbi.nlm.nih.gov/pubmed/21051598	The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.	HIV-1 control	516 European cases, 1,196 European controls, 341 African American cases, 892 African American controls, 117 Hispanic cases, 560 Hispanic controls	NA	6p21.33	6	31359287	HLA-B	HLA-B - DHFRP2	ENSG00000232126	ENSG00000230016		2099	7065	rs2523590-C	rs2523590	0	2523590	intergenic_variant	1	0.164	2E-13	12.698970004336019	(AA)	2.4	[NR]	Illumina [1384048] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000863	Genome-wide genotyping array
2011-01-13	21051598	Pereyra F	2010-11-04	Science	www.ncbi.nlm.nih.gov/pubmed/21051598	The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.	HIV-1 control	516 European cases, 1,196 European controls, 341 African American cases, 892 African American controls, 117 Hispanic cases, 560 Hispanic controls	NA	6p21.33	6	31354782	HLA-B	HLA-B			ENSG00000232126			rs2523608-G	rs2523608	0	2523608	non_coding_transcript_exon_variant	0	0.326	9E-20	19.045757490560675	(AA)	2.6	[NR]	Illumina [1384048] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000863	Genome-wide genotyping array
2011-01-13	21051598	Pereyra F	2010-11-04	Science	www.ncbi.nlm.nih.gov/pubmed/21051598	The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.	HIV-1 control	516 European cases, 1,196 European controls, 341 African American cases, 892 African American controls, 117 Hispanic cases, 560 Hispanic controls	NA	6p21.33	6	31463914	intergenic	HCP5			ENSG00000206337			rs2255221-T	rs2255221	0	2255221	non_coding_transcript_exon_variant	0	0.137	4E-14	13.397940008672037	(AA)	2.7	[NR]	Illumina [1384048] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000863	Genome-wide genotyping array
2011-01-13	21051598	Pereyra F	2010-11-04	Science	www.ncbi.nlm.nih.gov/pubmed/21051598	The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.	HIV-1 control	516 European cases, 1,196 European controls, 341 African American cases, 892 African American controls, 117 Hispanic cases, 560 Hispanic controls	NA	6p21.33	6	31464003	HLA-B	HCP5			ENSG00000206337			rs2395029-G	rs2395029	0	2395029	non_coding_transcript_exon_variant	0	0.032	1E-25	25.0	(EA)	5.3	[NR]	Illumina [1384048] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000863	Genome-wide genotyping array
2011-01-13	21051598	Pereyra F	2010-11-04	Science	www.ncbi.nlm.nih.gov/pubmed/21051598	The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.	HIV-1 control	516 European cases, 1,196 European controls, 341 African American cases, 892 African American controls, 117 Hispanic cases, 560 Hispanic controls	NA	6p21.33	6	31306603	HLA-C	LINC02571 - HLA-B	ENSG00000256166	ENSG00000232126		4961	47269	rs9264942-C	rs9264942	0	9264942	intron_variant	1	0.34	3E-35	34.52287874528034	(EA)	2.9	[NR]	Illumina [1384048] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000863	Genome-wide genotyping array
2011-01-13	21051598	Pereyra F	2010-11-04	Science	www.ncbi.nlm.nih.gov/pubmed/21051598	The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.	HIV-1 control	516 European cases, 1,196 European controls, 341 African American cases, 892 African American controls, 117 Hispanic cases, 560 Hispanic controls	NA	6p21.33	6	31175805	PSORS1C3	POU5F1, POU5F1, POU5F1, POU5F1, POU5F1, POU5F1, POU5F1, PSORS1C3, PSORS1C3, PSORS1C3, PSORS1C3, PSORS1C3, PSORS1C3, PSORS1C3			ENSG00000204531, ENSG00000233911, ENSG00000229094, ENSG00000230336, ENSG00000206454, ENSG00000237582, ENSG00000235068, ENSG00000223364, ENSG00000224056, ENSG00000226422, ENSG00000230983, ENSG00000224744, ENSG00000231450, ENSG00000204528			rs3131018-C	rs3131018	0	3131018	intron_variant	0	0.625	4E-16	15.397940008672037	(EA)	2.1	[NR]	Illumina [1384048] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000863	Genome-wide genotyping array
2011-01-13	21051598	Pereyra F	2010-11-04	Science	www.ncbi.nlm.nih.gov/pubmed/21051598	The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.	HIV-1 control	516 European cases, 1,196 European controls, 341 African American cases, 892 African American controls, 117 Hispanic cases, 560 Hispanic controls	NA	6p21.33	6	31057031	intergenic	HCG22, HCG22, HCG22, HCG22, HCG22, HCG22, HCG22			ENSG00000228789, ENSG00000237894, ENSG00000227974, ENSG00000229501, ENSG00000237093, ENSG00000225629, ENSG00000238234			rs9262632-G	rs9262632	0	9262632	intron_variant	0	0.10	1E-8	8.0	(AA)	3.1	[NR]	Illumina [1384048] (imputed)	N	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180	GCST000863	Genome-wide genotyping array
